Citrus Sinensis ID: 038466
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 572 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.729 | 0.399 | 0.386 | 5e-83 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.729 | 0.372 | 0.378 | 5e-76 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.708 | 0.367 | 0.342 | 6e-62 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.706 | 0.366 | 0.335 | 5e-59 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.736 | 0.712 | 0.300 | 9e-54 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.727 | 0.366 | 0.315 | 4e-53 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.711 | 0.356 | 0.336 | 5e-53 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.748 | 0.427 | 0.324 | 6e-53 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.709 | 0.372 | 0.315 | 1e-52 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.701 | 0.321 | 0.305 | 7e-52 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 308 bits (790), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 193/499 (38%), Positives = 275/499 (55%), Gaps = 82/499 (16%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
NL L + + IPP ++ L +L ++LS N L TIP + L L L++ N L
Sbjct: 551 NLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQL 610
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP----VRL 242
G I S SL NL LDLS N LSG+IPP M LT +D+S+NN++G IP R
Sbjct: 611 DGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRN 670
Query: 243 SP------NKGLCG--GNFLDLPSCDTT------KPATLFVEIFLPLA---IVLSVI--V 283
+P NK LCG L C T K L + I +P+ I+LSV +
Sbjct: 671 APPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGI 730
Query: 284 FACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG------------------------YG 319
F C +++ K+ + + + + SI+++DG +G
Sbjct: 731 FICF---RKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHG 787
Query: 320 SVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
VYKA+LPN + A+KKL+ + ++ + F NE + L+++ HRN+VKL+GFC HR
Sbjct: 788 KVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHR 846
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAST-- 434
+ FL+YEYM+RGSL L N+++A +LDW KR+N+VK +AHAL+Y+HHD SP+I
Sbjct: 847 RNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDI 906
Query: 435 ------------------------CPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
PDSSN + +AGTYGY+APELAY M +TEKCDVYSF
Sbjct: 907 SSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSF 966
Query: 471 GVVTLEVLMGKHPRDLLSSLSSS-SDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA 529
GV+TLEV+ G+HP DL+S+LSSS D + L + D RLP P ++ ++L ++
Sbjct: 967 GVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTP-EIKEEVLEILKVALL 1025
Query: 530 CLQSNPKSRPTMQYVSQEF 548
CL S+P++RPTM +S F
Sbjct: 1026 CLHSDPQARPTMLSISTAF 1044
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 5e-76, Method: Compositional matrix adjust.
Identities = 196/518 (37%), Positives = 269/518 (51%), Gaps = 101/518 (19%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP------------------- 167
NL +L + L+G +P +S L+ L+ LDLSSN + IP
Sbjct: 607 NLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKF 666
Query: 168 ----PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKN 223
P + L L +L++ N L G IPS L SL +L LDLS N LSG IP GM
Sbjct: 667 DGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIA 726
Query: 224 LTWLDLSNNNIKGSIPVR----------LSPNKGLCGG---NFLDLPSCDTTKP---ATL 267
LT +D+SNN ++G +P L N GLC L P + KP L
Sbjct: 727 LTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLK-PCRELKKPKKNGNL 785
Query: 268 FVEIFLPLAIVLSVIVFAC-----LLLAKRKYKK-----PKLEE---------------- 301
V I +P+ VL VI+ C + KRK + P+ E
Sbjct: 786 VVWILVPILGVL-VILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDI 844
Query: 302 -RATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQV 357
+TN D + GY VY+A L + + A+K+LH + EE++ + F NE +
Sbjct: 845 IESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKA 903
Query: 358 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMA 417
L+++ HRN+VKL+GFC HR+ FLIYEYM++GSL L N+E+A L W KR+N+VK +A
Sbjct: 904 LTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVA 963
Query: 418 HALAYLHHD-CSPSIASTCP-------------------------DSSNRTLLAGTYGYI 451
HAL+Y+HHD +P + DSSN + +AGTYGY+
Sbjct: 964 HALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYV 1023
Query: 452 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511
APE AYTM +TEKCDVYSFGV+ LE+++GKHP DL+SSLSSS + L + D+R+ P
Sbjct: 1024 APEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEP 1083
Query: 512 VDRKVIRDILLAST-ISFACLQSNPKSRPTMQYVSQEF 548
R R+ LL ++ CLQ+NP+SRPTM +S F
Sbjct: 1084 --RGQNREKLLKMVEMALLCLQANPESRPTMLSISTTF 1119
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 167/488 (34%), Positives = 233/488 (47%), Gaps = 83/488 (17%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL-IELNVGSNSLIGPIPSALGS 196
LTG IP L++L L L N L+ IP E+G L +L I LN+ N+L G IP +LG+
Sbjct: 583 LTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGN 642
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP----------VRLSPNK 246
L L L L+ NKLSG+IP I + +L ++SNNN+ G++P + N
Sbjct: 643 LQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH 702
Query: 247 GLCGGNFLD----LPSCDT---------TKPATLFVEIFLPLAIVLSVIVFACLLLAKRK 293
GLC +P D+ + L + + ++ L + C + +R+
Sbjct: 703 GLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRRE 762
Query: 294 YKKPKLEER-----------------------ATNNIDVFSIWNYDGYGSVYKAQLPNGK 330
LE++ AT N + G+VYKA++ G+
Sbjct: 763 PAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGE 822
Query: 331 VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390
V A+KKL+ S E + SFR E L ++ HRNIVKLYGFC H+ L+YEYM +GS
Sbjct: 823 VIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGS 881
Query: 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTL------- 443
L L E LDW R I A L YLHHDC P I S+N L
Sbjct: 882 LGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAH 941
Query: 444 --------------------LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
+AG+YGYIAPE AYTM +TEKCD+YSFGVV LE++ GK P
Sbjct: 942 VGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
Query: 484 -------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPK 536
DL++ + S I I++ D RL D++ + ++ L I+ C ++P
Sbjct: 1002 VQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPA 1060
Query: 537 SRPTMQYV 544
SRPTM+ V
Sbjct: 1061 SRPTMREV 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 172/513 (33%), Positives = 242/513 (47%), Gaps = 109/513 (21%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
+G++P E+ +L +L+LL LS+N L+GTIP +GNL L EL +G N G IP LGSL
Sbjct: 565 FSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSL 624
Query: 198 TNLS-NLDLSSNKLSGKIPPEI------------------------AGMKNLTWLDLSNN 232
T L L+LS NKL+G+IPPE+ A + +L + S N
Sbjct: 625 TGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN 684
Query: 233 NIKGSIPV-------RLSPNKGLCGGNFLD-------LPSCDTTKPATL----FVEIFLP 274
++ G IP+ N+GLCG PS T KP + + I
Sbjct: 685 SLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAA 744
Query: 275 LAIVLSVIVFACLLLAKRK---------------------YKKPK----LEE--RATNNI 307
+ +S+++ A ++ R+ Y PK ++ AT+N
Sbjct: 745 VIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNF 804
Query: 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRN 365
D + G+VYKA LP G A+KKL ++ SFR E L + HRN
Sbjct: 805 DESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRN 864
Query: 366 IVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425
IVKL+GFC H+ L+YEYM +GSL LH + + LDW+KR I A LAYLHH
Sbjct: 865 IVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHH 922
Query: 426 DCSPSI---------------------------ASTCPDSSNRTLLAGTYGYIAPELAYT 458
DC P I P S + + +AG+YGYIAPE AYT
Sbjct: 923 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYT 982
Query: 459 MVMTEKCDVYSFGVVTLEVLMGKHP-------RDLLSSLSSSSDPKIMLIDVLDQRLPPP 511
M +TEK D+YS+GVV LE+L GK P D+++ + S + VLD RL
Sbjct: 983 MKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE 1042
Query: 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYV 544
D +++ +L I+ C +P +RP+M+ V
Sbjct: 1043 -DERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 166/552 (30%), Positives = 240/552 (43%), Gaps = 131/552 (23%)
Query: 86 DHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPE 145
D C W G+TC++ ++ L + + + G +PP+
Sbjct: 60 DPCNWNGVTCDAKTK--------------------------RVITLNLTYHKIMGPLPPD 93
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
I L L+LL L +N L G IP +GN L E+++ SN GPIP+ +G L L LD+
Sbjct: 94 IGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGDLPGLQKLDM 153
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV----------RLSPNKGLCGGNFLD 255
SSN LSG IP + +K L+ ++SNN + G IP N LCG +
Sbjct: 154 SSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDV 213
Query: 256 LPSCDTTKPAT--------------LFVEIFLPLAIVLSVIV---FACLL---LAKRKYK 295
+ D+ P++ L + + +L V + + C L L K + K
Sbjct: 214 VCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALMCFWGCFLYKKLGKVEIK 273
Query: 296 KPKLEERATNNIDVFS---------------------IWNYDGYGSVYKAQLPNGKVFAL 334
+ +I +F I G+G+VYK + +GKVFAL
Sbjct: 274 SLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFAL 333
Query: 335 KK-LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFC 393
K+ L +E F + F E ++L + HR +V L G+C L+Y+Y+ GSL
Sbjct: 334 KRILKLNE----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDE 389
Query: 394 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN------------- 440
LH E +LDW RVNI+ A L+YLHHDCSP I SSN
Sbjct: 390 ALH--ERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 447
Query: 441 --------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486
T++AGT+GY+APE + TEK DVYSFGV+ LEVL GK P D
Sbjct: 448 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 507
Query: 487 ------------LSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSN 534
L L S P+ D++D P + + + +I+ C+ +
Sbjct: 508 SFIEKGLNVVGWLKFLISEKRPR----DIVD----PNCEGMQMESLDALLSIATQCVSPS 559
Query: 535 PKSRPTMQYVSQ 546
P+ RPTM V Q
Sbjct: 560 PEERPTMHRVVQ 571
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 157/498 (31%), Positives = 235/498 (47%), Gaps = 82/498 (16%)
Query: 128 LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL-IELNVGSNSL 186
L +L + + G IP + + LQLLDLSSN ++GTIP E+ ++++L I LN+ NSL
Sbjct: 565 LNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSL 624
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP------- 239
G IP + +L LS LD+S N LSG + ++G++NL L++S+N G +P
Sbjct: 625 DGFIPERISALNRLSVLDISHNMLSGDLSA-LSGLENLVSLNISHNRFSGYLPDSKVFRQ 683
Query: 240 ---VRLSPNKGLCGGNFLDLPSCDTTKPAT----------LFVEIFLPLAIVLSVIVFAC 286
+ N GLC F ++++ T + + + + + VL+V+
Sbjct: 684 LIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLA 743
Query: 287 LLLAKRKYKKPKLEERATN----NIDVFSIWNY----------DG-------YGSVYKAQ 325
++ AK+ + E N F N+ +G G VYKA+
Sbjct: 744 VIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAE 803
Query: 326 LPNGKVFALKKLH-------TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378
+PN +V A+KKL +T+ SF E + L + H+NIV+ G C ++
Sbjct: 804 MPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNT 863
Query: 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAS----- 433
L+Y+YM GSL LH L W R I+ A LAYLHHDC P I
Sbjct: 864 RLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKA 923
Query: 434 ----TCPD-------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
PD + + +AG+YGYIAPE Y+M +TEK DVYS+
Sbjct: 924 NNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSY 983
Query: 471 GVVTLEVLMGKHPRD-LLSSLSSSSD--PKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
GVV LEVL GK P D + D KI I V+DQ L + +V +++ ++
Sbjct: 984 GVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEV-EEMMQTLGVA 1042
Query: 528 FACLQSNPKSRPTMQYVS 545
C+ P+ RPTM+ V+
Sbjct: 1043 LLCINPIPEDRPTMKDVA 1060
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 5e-53, Method: Compositional matrix adjust.
Identities = 171/508 (33%), Positives = 235/508 (46%), Gaps = 101/508 (19%)
Query: 128 LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL-IELNVGSNSL 186
L KL + +GSIP + S LQLLDL SN L+G IP E+G+++NL I LN+ SN L
Sbjct: 564 LNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRL 623
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP-----VR 241
G IPS + SL LS LDLS N L G + P +A ++NL L++S N+ G +P +
Sbjct: 624 TGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQ 682
Query: 242 LSP-----NKGLC-------------GGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIV 283
LSP NK LC G D T+ L + + + L +VL ++
Sbjct: 683 LSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILG 742
Query: 284 FACLLLAKRKYKKPKLEERATN-----------NIDVFSIW------NYDGYGS---VYK 323
++ A+R + E N V I N G G VY+
Sbjct: 743 AVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYR 802
Query: 324 AQLPNGKVFALKKL--------HTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
A + NG+V A+KKL H +T+ + SF E + L + H+NIV+ G C +
Sbjct: 803 ADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR--DSFSAEVKTLGTIRHKNIVRFLGCCWN 860
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTC 435
R L+Y+YM GSL LH + LDW R I+ A LAYLHHDC P I
Sbjct: 861 RNTRLLMYDYMPNGSLGSLLHERRGS-SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRD 919
Query: 436 PDSSN----------------------------RTLLAGTYGYIAPELAYTMVMTEKCDV 467
++N +AG+YGYIAPE Y+M +TEK DV
Sbjct: 920 IKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDV 979
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID----------VLDQRLPPPVDRKVI 517
YS+GVV LEVL GK P D + I L+D VLD L + +
Sbjct: 980 YSYGVVVLEVLTGKQPID------PTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEAD 1033
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVS 545
+ + T + C+ S+P RPTM+ V+
Sbjct: 1034 EMMQVLGT-ALLCVNSSPDERPTMKDVA 1060
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 6e-53, Method: Compositional matrix adjust.
Identities = 162/499 (32%), Positives = 230/499 (46%), Gaps = 71/499 (14%)
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP 189
KL + +GSIPPEI L +L LD S N +G I PEI K L +++ N L G
Sbjct: 484 KLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGD 543
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP---------- 239
IP+ L + L+ L+LS N L G IP IA M++LT +D S NN+ G +P
Sbjct: 544 IPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNY 603
Query: 240 VRLSPNKGLCG---GNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKYKK 296
N LCG G KP + ++ L L ++ +VFA + + K + +
Sbjct: 604 TSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLR 663
Query: 297 PKLEERA----------------TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTS 340
E +A +++ +I G G VYK +P G + A+K+L T
Sbjct: 664 NASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATM 723
Query: 341 ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNED 400
+ + F E Q L ++ HR+IV+L GFC + + L+YEYM GSL LH +
Sbjct: 724 -SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 782
Query: 401 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTL----------------- 443
L W R I A L YLHHDCSP I S+N L
Sbjct: 783 G-HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 841
Query: 444 -----------LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------RD 485
+AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ GK P D
Sbjct: 842 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVD 901
Query: 486 LLSSLSSSSDP-KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYV 544
++ + S +D K ++ V+D RL + ++ ++ C++ RPTM+ V
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRL----SSVPVHEVTHVFYVALLCVEEQAVERPTMREV 957
Query: 545 SQEFLITRKTPLVKHAAIQ 563
Q K PL K A +
Sbjct: 958 VQILTEIPKIPLSKQQAAE 976
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 156/495 (31%), Positives = 235/495 (47%), Gaps = 89/495 (17%)
Query: 128 LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL-IELNVGSNSL 186
L KL + L+G IP EIS LQLL+L N +G IP E+G + +L I LN+ N
Sbjct: 551 LTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRF 610
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP------- 239
+G IPS L NL LD+S N+L+G + + ++NL L++S N+ G +P
Sbjct: 611 VGEIPSRFSDLKNLGVLDVSHNQLTGNLN-VLTDLQNLVSLNISYNDFSGDLPNTPFFRR 669
Query: 240 ---VRLSPNKGLCGGNFLDL-PSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKYK 295
L+ N+GL N + P T + + + I + + + +++ A L + +
Sbjct: 670 LPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAA 729
Query: 296 KPKLEERATNNIDV-------FSI---------WNYDGYGS---VYKAQLPNGKVFALKK 336
+L ++ +V FSI N G GS VY+ +P+G+ A+KK
Sbjct: 730 GKQLLGEEIDSWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKK 789
Query: 337 LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLH 396
+ + E +F +E + L + HRNIV+L G+C +R L Y+Y+ GSL LH
Sbjct: 790 MWSKEES-----GAFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLH 844
Query: 397 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI------------------------- 431
+DW R ++V +AHALAYLHHDC P+I
Sbjct: 845 GAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGL 904
Query: 432 ---ASTCPDS-------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 481
S P++ +NR +AG+YGY+APE A +TEK DVYS+GVV LEVL GK
Sbjct: 905 ARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGK 964
Query: 482 HPRD------------LLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA 529
HP D + L+ DP +L LD R ++ ++L ++F
Sbjct: 965 HPLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGR-----TDSIMHEMLQTLAVAFL 1019
Query: 530 CLQSNPKSRPTMQYV 544
C+ + RP M+ V
Sbjct: 1020 CVSNKANERPLMKDV 1034
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 158/517 (30%), Positives = 234/517 (45%), Gaps = 116/517 (22%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE-LNVGSNSLIGPIPSALGS 196
+GS+P + LSKL L LS N LTG IP EIG L++L L++ N+ G IPS +G+
Sbjct: 731 FSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGT 790
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS--------PNKGL 248
L+ L LDLS N+L+G++P + MK+L +L++S NN+ G + + S N GL
Sbjct: 791 LSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGL 850
Query: 249 CGGNFLDLPSCD-----------TTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKY--- 294
CG L C+ + + + I AI L ++V A + +
Sbjct: 851 CGS---PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKK 907
Query: 295 ------------------KKPKLEE-------------RATNNIDVFSIWNYDGYGSVYK 323
KP AT+N+ + G G VYK
Sbjct: 908 VGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYK 967
Query: 324 AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL 381
A+L NG+ A+KK+ + +L KSF E + L ++ HR++VKL G+C + L
Sbjct: 968 AELENGETVAVKKILWKD--DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLL 1025
Query: 382 IYEYMKRGSLFCNLHNNEDAVE-----LDWAKRVNIVKAMAHALAYLHHDCSPSIASTCP 436
IYEYMK GS++ LH ++ +E LDW R+ I +A + YLHHDC P I
Sbjct: 1026 IYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDI 1085
Query: 437 DSSN------------------------------RTLLAGTYGYIAPELAYTMVMTEKCD 466
SSN T A +YGYIAPE AY++ TEK D
Sbjct: 1086 KSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSD 1145
Query: 467 VYSFGVVTLEVLMGKHPRD------------LLSSLSSSSDPKIMLIDVLDQRLPP--PV 512
VYS G+V +E++ GK P D + + L + + LI D +L P P
Sbjct: 1146 VYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLI---DPKLKPLLPF 1202
Query: 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
+ +L I+ C +++P+ RP+ + L
Sbjct: 1203 EEDAACQVL---EIALQCTKTSPQERPSSRQACDSLL 1236
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 572 | ||||||
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.748 | 0.542 | 0.456 | 1e-116 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.748 | 0.507 | 0.456 | 1e-116 | |
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.762 | 0.502 | 0.454 | 1e-115 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.762 | 0.498 | 0.454 | 1e-115 | |
| 225466223 | 736 | PREDICTED: probable leucine-rich repeat | 0.758 | 0.589 | 0.467 | 1e-114 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.708 | 0.493 | 0.442 | 1e-113 | |
| 359484063 | 1003 | PREDICTED: probable LRR receptor-like se | 0.737 | 0.420 | 0.433 | 1e-110 | |
| 225452698 | 727 | PREDICTED: probable LRR receptor-like se | 0.720 | 0.566 | 0.457 | 1e-110 | |
| 296085298 | 610 | unnamed protein product [Vitis vinifera] | 0.729 | 0.683 | 0.472 | 1e-110 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.751 | 0.567 | 0.415 | 1e-108 |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-116, Method: Compositional matrix adjust.
Identities = 234/513 (45%), Positives = 300/513 (58%), Gaps = 85/513 (16%)
Query: 120 LNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
L+F L L + + GSIPP I L L L L N LTG IP +G L +L E
Sbjct: 257 LSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEF 316
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
N+ N + G IPS +G+L NL+ LDLS+N + GKIP ++ +K LT+L+LS+N + GSIP
Sbjct: 317 NISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIP 376
Query: 240 VRL---------------------------------SPNKGLCGGNFLDLPSCDTTKPAT 266
L NKGLCG + LP C T
Sbjct: 377 TLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCG-DIKGLPHCKEEYKTT 435
Query: 267 LFVEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG--------- 317
+ I L + L +V LLL+ RK +K + +E T N D+FS+WNYDG
Sbjct: 436 RIIVISLSTTLFLFFVVLGFLLLS-RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIK 494
Query: 318 ---------------YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 362
YGSVYKAQLP G V ALKKLH E +E ++KSF+NE Q+LS++
Sbjct: 495 ATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIR 554
Query: 363 HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 422
HRNIVKL G+CLH++CMFLIY YM RGSL+C L N +A+ELDW KRVN+VK++ HA+ Y
Sbjct: 555 HRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCY 614
Query: 423 LHHDCSPSIAST--------------------------CPDSSNRTLLAGTYGYIAPELA 456
+HHDC+P I PDSSN+TLLAGTYGYIAPELA
Sbjct: 615 MHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELA 674
Query: 457 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516
YTMV+TEKCDVYSFGVV LE +MGKHP +L + LSSSS IML ++LD RLP P D++V
Sbjct: 675 YTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQV 734
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
RD++L ++ C+ SNP+SRPTMQ++ + L
Sbjct: 735 ARDVVLVVWLALKCIHSNPRSRPTMQHILSKLL 767
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-116, Method: Compositional matrix adjust.
Identities = 234/513 (45%), Positives = 300/513 (58%), Gaps = 85/513 (16%)
Query: 120 LNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
L+F L L + + GSIPP I L L L L N LTG IP +G L +L E
Sbjct: 311 LSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEF 370
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
N+ N + G IPS +G+L NL+ LDLS+N + GKIP ++ +K LT+L+LS+N + GSIP
Sbjct: 371 NISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIP 430
Query: 240 VRL---------------------------------SPNKGLCGGNFLDLPSCDTTKPAT 266
L NKGLCG + LP C T
Sbjct: 431 TLLIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCG-DIKGLPHCKEEYKTT 489
Query: 267 LFVEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG--------- 317
+ I L + L +V LLL+ RK +K + +E T N D+FS+WNYDG
Sbjct: 490 RIIVISLSTTLFLFFVVLGFLLLS-RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIK 548
Query: 318 ---------------YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 362
YGSVYKAQLP G V ALKKLH E +E ++KSF+NE Q+LS++
Sbjct: 549 ATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIR 608
Query: 363 HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 422
HRNIVKL G+CLH++CMFLIY YM RGSL+C L N +A+ELDW KRVN+VK++ HA+ Y
Sbjct: 609 HRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCY 668
Query: 423 LHHDCSPSIAST--------------------------CPDSSNRTLLAGTYGYIAPELA 456
+HHDC+P I PDSSN+TLLAGTYGYIAPELA
Sbjct: 669 MHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELA 728
Query: 457 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516
YTMV+TEKCDVYSFGVV LE +MGKHP +L + LSSSS IML ++LD RLP P D++V
Sbjct: 729 YTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQV 788
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
RD++L ++ C+ SNP+SRPTMQ++ + L
Sbjct: 789 ARDVVLVVWLALKCIHSNPRSRPTMQHILSKLL 821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1083), Expect = e-115, Method: Compositional matrix adjust.
Identities = 231/508 (45%), Positives = 308/508 (60%), Gaps = 72/508 (14%)
Query: 116 RLSQLNFSCFP------NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE 169
R +Q+N S P NL+ L + LTG IP + L L + ++ N + G IP +
Sbjct: 353 RYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIP-SLGYLIHLNVFNIRRNRIRGHIPSK 411
Query: 170 IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDL 229
IGNL NL L++ N + G IPS L +L +L +L+LS NKLSG IPP + + +D
Sbjct: 412 IGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDF 471
Query: 230 SNNNIKGSIPVRL---------SPNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLS 280
S+N+ +G IP L NKGLCG LP C L + L + LS
Sbjct: 472 SHNDFEGHIPHELQFVYPPRVFGHNKGLCGERE-GLPHCKRGHKTILIIS--LSTILFLS 528
Query: 281 VIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG----------------------- 317
+ LLL+ RK ++ + + +T N D+FS+WNYDG
Sbjct: 529 FVALGILLLS-RKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTG 587
Query: 318 -YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YGSVYKAQLP G V ALKKLH E +E ++KSF+NE QVLS++ HRNI+KL+G+CLH+
Sbjct: 588 GYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHK 647
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAST-- 434
+CMFLIY+YM+RGSL+C L N +A+ELDW KRVN++K++ HAL Y+HHD +P I
Sbjct: 648 RCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDV 707
Query: 435 ------------------------CPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
PDSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSF
Sbjct: 708 SSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSF 767
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFAC 530
GVV LE +MG+HPR+L + LSSSS IML D+LD RLP P DR+V RD++L ++ C
Sbjct: 768 GVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKC 827
Query: 531 LQSNPKSRPTMQYVSQEFLITRKTPLVK 558
+ SNP+SRPTMQ++S + LI ++P ++
Sbjct: 828 IHSNPRSRPTMQHISSKLLI--QSPFLE 853
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1082), Expect = e-115, Method: Compositional matrix adjust.
Identities = 231/508 (45%), Positives = 308/508 (60%), Gaps = 72/508 (14%)
Query: 116 RLSQLNFSCFP------NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE 169
R +Q+N S P NL+ L + LTG IP + L L + ++ N + G IP +
Sbjct: 359 RYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIP-SLGYLIHLNVFNIRRNRIRGHIPSK 417
Query: 170 IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDL 229
IGNL NL L++ N + G IPS L +L +L +L+LS NKLSG IPP + + +D
Sbjct: 418 IGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDF 477
Query: 230 SNNNIKGSIPVRL---------SPNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLS 280
S+N+ +G IP L NKGLCG LP C L + L + LS
Sbjct: 478 SHNDFEGHIPHELQFVYPPRVFGHNKGLCGERE-GLPHCKRGHKTILIIS--LSTILFLS 534
Query: 281 VIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG----------------------- 317
+ LLL+ RK ++ + + +T N D+FS+WNYDG
Sbjct: 535 FVALGILLLS-RKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTG 593
Query: 318 -YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YGSVYKAQLP G V ALKKLH E +E ++KSF+NE QVLS++ HRNI+KL+G+CLH+
Sbjct: 594 GYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHK 653
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAST-- 434
+CMFLIY+YM+RGSL+C L N +A+ELDW KRVN++K++ HAL Y+HHD +P I
Sbjct: 654 RCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDV 713
Query: 435 ------------------------CPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
PDSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSF
Sbjct: 714 SSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSF 773
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFAC 530
GVV LE +MG+HPR+L + LSSSS IML D+LD RLP P DR+V RD++L ++ C
Sbjct: 774 GVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKC 833
Query: 531 LQSNPKSRPTMQYVSQEFLITRKTPLVK 558
+ SNP+SRPTMQ++S + LI ++P ++
Sbjct: 834 IHSNPRSRPTMQHISSKLLI--QSPFLE 859
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1078), Expect = e-114, Method: Compositional matrix adjust.
Identities = 232/496 (46%), Positives = 310/496 (62%), Gaps = 62/496 (12%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
NL L + +TGSIP EI +L KL L L +N L G IP E+GN +L L++ N L
Sbjct: 230 NLTSLHLASNQITGSIPSEIGSLKKLVDLALDNNKLVGVIPKELGNCHSLRYLSMKFNRL 289
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL---- 242
G IPS +G L L LDLS N +SG IP + +L +LDLS N ++G +P L
Sbjct: 290 NGSIPSEIGGLVALRKLDLSVNNISGTIPLQFQNFNSLEYLDLSYNYLEGYVPFELHLPS 349
Query: 243 -----SPNKGLCGGNFLDLPSCDTTKPATLFVEIFLPL--AIVLSVIVFACLLLAKRKYK 295
NKGLCG +P C T+ + + + L A+++S I+F LL+ +RK +
Sbjct: 350 LFRAFEHNKGLCGDTKFGIPPCRKRNRITIIIIVVICLCSALLISSIIFGVLLIWRRKTR 409
Query: 296 KPKLEE-RATNNIDVFSIWNYDG------------------------YGSVYKAQLPNGK 330
K + EE T N D+FSIW+YDG YGSVY+A+L NGK
Sbjct: 410 KLQPEEATTTQNGDIFSIWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGK 469
Query: 331 VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390
ALKKLHT E++ ++KSF NE +VLS++ HRNIVKLYGFCLH++CMFL+YEYM+RGS
Sbjct: 470 EVALKKLHTLESQNPTYMKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGS 529
Query: 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-----SIASTC---------- 435
L C L + +A+E DW KRVN+VK++A+AL+Y+H+DC P I+S
Sbjct: 530 LHCVLSDEIEALEFDWIKRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAV 589
Query: 436 -----------PDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484
PDSSN+TLLAGTYGY+APELAYTMV+TEKCDVYSFGV+TLE++MGKHPR
Sbjct: 590 VSDFGTARLLDPDSSNQTLLAGTYGYVAPELAYTMVVTEKCDVYSFGVLTLEIMMGKHPR 649
Query: 485 DLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYV 544
+L++ LS+SS IML+D+LD RL P +D +VI +++L ++ C+ NP SRPTMQ+V
Sbjct: 650 ELVTILSTSSSQNIMLVDILDPRLAPHIDPEVIDNVVLIIRLALKCINLNPTSRPTMQHV 709
Query: 545 SQEFLITRKTPLVKHA 560
+EF P+ HA
Sbjct: 710 CKEFETCTPFPIPFHA 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1066), Expect = e-113, Method: Compositional matrix adjust.
Identities = 227/513 (44%), Positives = 291/513 (56%), Gaps = 108/513 (21%)
Query: 120 LNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
L+F NL L + + + GSIPP I L L L L N LTG IP +G L +L E
Sbjct: 311 LSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLHEF 370
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
N+ N + G IPS++G+L NL+ LDLS N + GKIP ++ +K L +L+LS+N + GSIP
Sbjct: 371 NISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIP 430
Query: 240 VRL---------------------------------SPNKGLCGGNFLDLPSCDTTKPAT 266
L NKGLCG + LP C T
Sbjct: 431 TLLIYDHIRPSLDLSYNDLEGHIPFELQSKFSQGSFDNNKGLCG-DIKGLPHCKEEYKTT 489
Query: 267 LFVEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG--------- 317
+ +K + +E T N D+FS+WNYDG
Sbjct: 490 RIIT------------------------RKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIK 525
Query: 318 ---------------YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 362
YGSVYKAQLP G V ALKKLH ET+E ++KSF+NE Q+LS++
Sbjct: 526 ATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIR 585
Query: 363 HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 422
HRNIVKL G+CLH++CMFLIY YM RGSL+C L N +A+ELDW KRVN+VK++ HA+ Y
Sbjct: 586 HRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCY 645
Query: 423 LHHDCSPSIAST--------------------------CPDSSNRTLLAGTYGYIAPELA 456
+HHDC+P I PDSSN+TLL+GTYGYIAPELA
Sbjct: 646 MHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELA 705
Query: 457 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516
YTMV+TEKCDVYSFGVV LE +MGKHP +L + LSSSS IML D+LD RLP P D++V
Sbjct: 706 YTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQV 765
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
RD++L ++ C+ SNP+SRPTMQ++S + L
Sbjct: 766 ARDVVLVVWLALKCIHSNPRSRPTMQHISSKLL 798
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-110, Method: Compositional matrix adjust.
Identities = 230/530 (43%), Positives = 300/530 (56%), Gaps = 108/530 (20%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
NL L + F ++ GSIP EI L L L+LSSN L+ IP +GNL NL+ L++ NSL
Sbjct: 453 NLEYLDLSFNSINGSIPSEIGNLKNLAALNLSSNYLSSVIPSSLGNLTNLVTLSLTLNSL 512
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN-------------- 232
+G IPS++G+L NL+ ++ N++ G IP EI +KN+ LDLS+N
Sbjct: 513 VGAIPSSVGNLINLTEFNICGNQIRGCIPFEIGNLKNMASLDLSDNLINVKIPSQLQNLE 572
Query: 233 --------------------------------NIKGSIPVRL---------SPNKGLCGG 251
+++G IP+ L S NKGLCG
Sbjct: 573 SLENLNLSHNKLSGHIPTLPKYGWLSIDLSYNDLEGHIPIELQLEHSPEVFSYNKGLCG- 631
Query: 252 NFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAK--RKYKKPKLEERATNNIDV 309
P C L I + + L VF LLL++ R+ + ++ N D+
Sbjct: 632 EIKGWPHCKRGHKTMLITTIAISTILFLLFAVFGFLLLSRKMRQNQTKTPLKKNEKNGDI 691
Query: 310 FSIWNYDG------------------------YGSVYKAQLPNGKVFALKKLHTSETEEL 345
FSIWNYDG YG+VYKAQLP G V ALKKLH E +E
Sbjct: 692 FSIWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGTVYKAQLPTGNVVALKKLHGWERDEA 751
Query: 346 AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELD 405
+ KSF+NE QVLS++ HRNI+KL+G+CLH++CMFLIY+YM+RGSLF L N +A+ELD
Sbjct: 752 TYFKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLFGVLSNEVEALELD 811
Query: 406 WAKRVNIVKAMAHALAYLHHDCS-PSIASTCP-------------------------DSS 439
W KRVN+VK++ HAL Y+HHD + P I DSS
Sbjct: 812 WIKRVNVVKSIVHALCYMHHDYTLPIIHRDISSSNILLDSKLDAFLSDFGTARLLHHDSS 871
Query: 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499
N+T+LAGTYGYIAPELAYTMV+TEKCDVYSFGVV LE +MGKHPR+L + LSSSS IM
Sbjct: 872 NQTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPRELFTLLSSSSAQSIM 931
Query: 500 LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
L D+LD RLP P D++V RD++L ++ C+ SNP+SRPTMQ +S L
Sbjct: 932 LTDILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQLISSRLL 981
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-110, Method: Compositional matrix adjust.
Identities = 228/498 (45%), Positives = 295/498 (59%), Gaps = 86/498 (17%)
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS 196
L GSIP ++ AL+KL DLS N L+G IP G+L NLI L + +N + GPIP +G+
Sbjct: 206 VLNGSIPHQLGALAKLTYFDLSWNELSGDIPSSFGHLSNLISLCLNNNQINGPIPEDIGN 265
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNL------------------------TWLDLSNN 232
L +L +LDLSSN +SGKIP +I +K L T +DLS N
Sbjct: 266 LEDLVDLDLSSNSISGKIPSQIQNLKRLENLNLSRNKLSGAIPPSLTYDYKWTSIDLSYN 325
Query: 233 NIKGSIPVRL---SP------NKGLCGGNFLDLPSCDTTKPATLFVEIFL--PLAIVLSV 281
+++G IP L SP NK LCG P C + TL + I L L I +
Sbjct: 326 DLEGHIPFELQFESPPGVFEHNKHLCG-EIRHWPHCKKGQKITLILVISLLATLCIAFAF 384
Query: 282 IVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDG------------------------ 317
+ F L RK + T D+FS+W+YDG
Sbjct: 385 LKFLLLPRKMRKMRHMSASAAETRRGDLFSVWDYDGTIAYQDIIQSTENFDIKYCVGVGG 444
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
YGSVY+AQLP GKV ALKKLH E EE ++KSF NEAQ+LS++ HRNIVKL+GFCLHR+
Sbjct: 445 YGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENEAQILSKIRHRNIVKLHGFCLHRR 504
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAST--- 434
MFL+Y++M+RGSLFC L + +A+ELDW KR+N+VK++AHAL+Y+HHDCSP I
Sbjct: 505 SMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVKSIAHALSYMHHDCSPPIIHRDIS 564
Query: 435 -----------------------CPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
PDSS +TLL GTYGYIAPELAYTM +T+KCDVYSFG
Sbjct: 565 SNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPELAYTMTVTKKCDVYSFG 624
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACL 531
VV LE +MGKHPR++++SLSSSS I+L DVLD RL P + +V +DI+ ++ C+
Sbjct: 625 VVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRLALPENPQVAKDIVFVVLLALKCI 684
Query: 532 QSNPKSRPTMQYVSQEFL 549
SNP+SRPTMQ +S + L
Sbjct: 685 HSNPQSRPTMQQISYKLL 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085298|emb|CBI29030.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 225/476 (47%), Positives = 293/476 (61%), Gaps = 59/476 (12%)
Query: 127 NLVKLTIQF-FALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
NL+ L + F + L+G IPP + L L+ LDLS N + G+IP +IGNLKNL L + SNS
Sbjct: 119 NLIHLDLSFNYGLSGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLTHLYLVSNS 178
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWL-DLSNNNIKGSIPVRLSP 244
L G IPS L +L+NL L L+ N+++G IP EI +KNL L DLS+N I G IP ++
Sbjct: 179 LSGVIPSPLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLLDLSDNLIHGKIPSQVQN 238
Query: 245 NKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKYK-KPKLEERA 303
K L N L + P L + P S+ + L ++ + K + +
Sbjct: 239 LKRLVYLN-LSHNKLSGSIPTLLIYDHIRP-----SLDLSYNDLEGHIPFELQSKFSQGS 292
Query: 304 TNNIDVFSIWNYDG------------------------YGSVYKAQLPNGKVFALKKLHT 339
+N +WNYDG YGSVYKAQLP G V ALKKLH
Sbjct: 293 FDNNKGLCVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHG 352
Query: 340 SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNE 399
ET+E ++KSF+NE Q+LS++ HRNIVKL G+CLH++CMFLIY YM RGSL+C L N
Sbjct: 353 WETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEV 412
Query: 400 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIAST------------------------- 434
+A+ELDW KRVN+VK++ HA+ Y+HHDC+P I
Sbjct: 413 EALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRL 472
Query: 435 -CPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 493
PDSSN+TLL+GTYGYIAPELAYTMV+TEKCDVYSFGVV LE +MGKHP +L + LSSS
Sbjct: 473 LHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSS 532
Query: 494 SDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
S IML D+LD RLP P D++V RD++L ++ C+ SNP+SRPTMQ++S + L
Sbjct: 533 STQNIMLTDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQHISSKLL 588
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1026), Expect = e-108, Method: Compositional matrix adjust.
Identities = 233/561 (41%), Positives = 304/561 (54%), Gaps = 131/561 (23%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
++G IPP+I + L+ L LS NGL G IPPEIG +KNL +LN+G N+L G IPS+ G+L
Sbjct: 200 ISGLIPPQIGKMKNLKSLLLSHNGLHGPIPPEIGGMKNLNKLNLGYNNLTGVIPSSFGNL 259
Query: 198 TN------------------------LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNN 233
TN LS LDLS N++SG IP EI +K L+ LD+SNN
Sbjct: 260 TNMNSLSFRGNQISGFIPLEIWYLLNLSYLDLSENQISGFIPEEIVNLKKLSHLDMSNNL 319
Query: 234 IKGSIPVRLS-------------------------------------------------- 243
I G IP +L
Sbjct: 320 ISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLIDLSNNRLEGQTRAPVEA 379
Query: 244 --PNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEE 301
NKGLCG P C TL + + L ++LS+ + L +R K LE
Sbjct: 380 FGHNKGLCG-EIKGRPRCKKRHQITLIIVVSLSTTLLLSIAILGFLFHKRRIRKNQLLET 438
Query: 302 RATNNIDVFSIWNYDG------------------------YGSVYKAQLPNGKVFALKKL 337
N D+FSIW+YDG YGSVY+AQLP+GKV ALKKL
Sbjct: 439 TKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKL 498
Query: 338 HTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHN 397
H E + ++KSF NE Q+L+++ HRNIVKL+GFCLH++CMFL+Y+YM++GSL+C L +
Sbjct: 499 HGWERGDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRD 558
Query: 398 NEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIASTCP-------------------- 436
+AVELDW KRVN+VK++A+AL+Y+HHDC P I
Sbjct: 559 EVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTA 618
Query: 437 -----DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 491
DSSNRTLL GTYGYIAPELAYTMV+TEKCD+YSFG+V LE +MG HP + ++SLS
Sbjct: 619 RLLDNDSSNRTLLVGTYGYIAPELAYTMVVTEKCDIYSFGMVALETMMGMHPGEFVTSLS 678
Query: 492 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551
SSS L DVLD RL P +V +I L +++ CL SNP+ RP+MQ VS + + T
Sbjct: 679 SSSTQNTTLKDVLDSRLSSPKSTQVANNIALIVSLALKCLHSNPQFRPSMQEVSSKLVST 738
Query: 552 RKTPLVKHAAIQDISISELRN 572
R P I IS+ +L++
Sbjct: 739 RSFP----QPISTISLLQLKD 755
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 572 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.248 | 0.135 | 0.452 | 4.1e-71 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.265 | 0.135 | 0.431 | 5.5e-69 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.239 | 0.124 | 0.434 | 1.1e-49 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.222 | 0.115 | 0.450 | 1.6e-49 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.211 | 0.107 | 0.429 | 1e-48 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.223 | 0.117 | 0.367 | 1.4e-47 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.237 | 0.140 | 0.374 | 3.7e-47 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.346 | 0.181 | 0.327 | 1.2e-46 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.25 | 0.147 | 0.360 | 6.8e-45 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.223 | 0.132 | 0.367 | 6.3e-44 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 4.1e-71, Sum P(3) = 4.1e-71
Identities = 67/148 (45%), Positives = 99/148 (66%)
Query: 302 RATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQVL 358
+AT D + G+G VYKA+LPN + A+KKL+ + ++ + F NE + L
Sbjct: 770 KATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRAL 828
Query: 359 SQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 418
+++ HRN+VKL+GFC HR+ FL+YEYM+RGSL L N+++A +LDW KR+N+VK +AH
Sbjct: 829 TEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAH 888
Query: 419 ALAYLHHDCSPSIASTCPDSSNRTLLAG 446
AL+Y+HHD SP+I D S+ +L G
Sbjct: 889 ALSYMHHDRSPAIVHR--DISSGNILLG 914
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 316 (116.3 bits), Expect = 5.5e-69, Sum P(3) = 5.5e-69
Identities = 69/160 (43%), Positives = 100/160 (62%)
Query: 293 KYKKPKLEERATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA--FIKS 350
K+K + E +TN D + GY VY+A L + + A+K+LH + EE++ +K
Sbjct: 838 KFKYQDIIE-STNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQ 895
Query: 351 -FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKR 409
F NE + L+++ HRN+VKL+GFC HR+ FLIYEYM++GSL L N+E+A L W KR
Sbjct: 896 EFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKR 955
Query: 410 VNIVKAMAHALAYLHHD-CSPSIASTCPDSSNRTLLAGTY 448
+N+VK +AHAL+Y+HHD +P + SS LL Y
Sbjct: 956 INVVKGVAHALSYMHHDRITPIVHRDI--SSGNILLDNDY 993
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 274 (101.5 bits), Expect = 1.1e-49, Sum P(3) = 1.1e-49
Identities = 60/138 (43%), Positives = 74/138 (53%)
Query: 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 362
AT N + G+VYKA++ G+V A+KKL+ S E + SFR E L ++
Sbjct: 795 ATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIR 853
Query: 363 HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 422
HRNIVKLYGFC H+ L+YEYM +GSL L E LDW R I A L Y
Sbjct: 854 HRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCY 913
Query: 423 LHHDCSPSIASTCPDSSN 440
LHHDC P I S+N
Sbjct: 914 LHHDCRPQIVHRDIKSNN 931
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 260 (96.6 bits), Expect = 1.6e-49, Sum P(3) = 1.6e-49
Identities = 59/131 (45%), Positives = 73/131 (55%)
Query: 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQ 360
AT+N D + G+VYKA LP G A+KKL ++ SFR E L
Sbjct: 800 ATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGN 859
Query: 361 VLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 420
+ HRNIVKL+GFC H+ L+YEYM +GSL LH + + LDW+KR I A L
Sbjct: 860 IRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGL 917
Query: 421 AYLHHDCSPSI 431
AYLHHDC P I
Sbjct: 918 AYLHHDCKPRI 928
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 238 (88.8 bits), Expect = 1.0e-48, Sum P(3) = 1.0e-48
Identities = 55/128 (42%), Positives = 69/128 (53%)
Query: 319 GSVYKAQLPNGKVFALKKLHTSE----TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
G+VYKA +P+GK A+KKL ++ SFR E L ++ HRNIV+LY FC
Sbjct: 831 GTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCY 890
Query: 375 HR--KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIA 432
H+ L+YEYM RGSL LH + +DW R I A LAYLHHDC P I
Sbjct: 891 HQGSNSNLLLYEYMSRGSLGELLHGGKSH-SMDWPTRFAIALGAAEGLAYLHHDCKPRII 949
Query: 433 STCPDSSN 440
S+N
Sbjct: 950 HRDIKSNN 957
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 232 (86.7 bits), Expect = 1.4e-47, Sum P(3) = 1.4e-47
Identities = 50/136 (36%), Positives = 75/136 (55%)
Query: 319 GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378
G VY+ +P+G+ A+KK+ + E ++F +E L + HRNI++L G+C +R
Sbjct: 770 GVVYRVTIPSGETLAVKKMWSKEEN-----RAFNSEINTLGSIRHRNIIRLLGWCSNRNL 824
Query: 379 MFLIYEYMKRGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPD 437
L Y+Y+ GSL LH + + DW R ++V +AHALAYLHHDC P I
Sbjct: 825 KLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVK 884
Query: 438 SSNRTLLAGTY-GYIA 452
+ N LL + Y+A
Sbjct: 885 AMN-VLLGSRFESYLA 899
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 241 (89.9 bits), Expect = 3.7e-47, Sum P(3) = 3.7e-47
Identities = 52/139 (37%), Positives = 73/139 (52%)
Query: 302 RATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 361
R T N++ I Y +VYK L + + A+K+L+ L + F E + + +
Sbjct: 643 RVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNL---REFETELETIGSI 699
Query: 362 LHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 421
HRNIV L+G+ L L Y+YM+ GSL+ LH + V+LDW R+ I A LA
Sbjct: 700 RHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLA 759
Query: 422 YLHHDCSPSIASTCPDSSN 440
YLHHDC+P I SSN
Sbjct: 760 YLHHDCTPRIIHRDIKSSN 778
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 245 (91.3 bits), Expect = 1.2e-46, Sum P(3) = 1.2e-46
Identities = 74/226 (32%), Positives = 111/226 (49%)
Query: 228 DLSNNNIKGSIPVR-LSPNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFAC 286
DL N +P+ L+ N+GL N + TT+ +++ L L +V +V+V
Sbjct: 660 DLPNTPFFRRLPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMA 719
Query: 287 L--LLAKRKYKKPKLEERATN-------NIDVFSI---------WNYDGYGS---VYKAQ 325
+ L+ R K L E + +D FSI N G GS VY+
Sbjct: 720 VYTLVRARAAGKQLLGEEIDSWEVTLYQKLD-FSIDDIVKNLTSANVIGTGSSGVVYRIT 778
Query: 326 LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385
+P+G+ A+KK+ + E +F +E + L + HRNIV+L G+C +R L Y+Y
Sbjct: 779 IPSGESLAVKKMWSKEESG-----AFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDY 833
Query: 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 431
+ GSL LH +DW R ++V +AHALAYLHHDC P+I
Sbjct: 834 LPNGSLSSRLHGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTI 879
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 234 (87.4 bits), Expect = 6.8e-45, Sum P(3) = 6.8e-45
Identities = 53/147 (36%), Positives = 73/147 (49%)
Query: 302 RATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 361
R T N+D I Y +VYK + A+K+++ + F E + + +
Sbjct: 646 RVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNF---REFETELETIGSI 702
Query: 362 LHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 421
HRNIV L+G+ L L Y+YM+ GSL+ LH V+LDW R+ I A LA
Sbjct: 703 RHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLA 762
Query: 422 YLHHDCSPSIASTCPDSSNRTLLAGTY 448
YLHHDC+P I SSN LL G +
Sbjct: 763 YLHHDCTPRIIHRDIKSSN-ILLDGNF 788
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 221 (82.9 bits), Expect = 6.3e-44, Sum P(3) = 6.3e-44
Identities = 50/136 (36%), Positives = 73/136 (53%)
Query: 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA------FIKSFRNEAQVLSQVLHR 364
+I + G G+VY+ +L +G+V A+KKL + ++ A K + E + L + H+
Sbjct: 660 NIVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASEDKMHLNKELKTEVETLGSIRHK 719
Query: 365 NIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
NIVKL+ + C L+YEYM G+L+ LH V L+W R I +A LAYLH
Sbjct: 720 NIVKLFSYFSSLDCSLLVYEYMPNGNLWDALHKG--FVHLEWRTRHQIAVGVAQGLAYLH 777
Query: 425 HDCSPSIASTCPDSSN 440
HD SP I S+N
Sbjct: 778 HDLSPPIIHRDIKSTN 793
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00012014001 | SubName- Full=Chromosome undetermined scaffold_2769, whole genome shotgun sequence; (595 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 572 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.001 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.003 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.004 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.004 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 9e-43
Identities = 130/495 (26%), Positives = 217/495 (43%), Gaps = 99/495 (20%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
L L + +G++P ++ +LS+L L LS N L+G IP E+ + K L+ L++ N L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP------- 239
G IP++ + LS LDLS N+LSG+IP + +++L +++S+N++ GS+P
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
Query: 240 ---VRLSPNKGLCGGNFLD-LPSC---DTTKPATLFVEIFLPLAIVLSVIVFACLLLAKR 292
++ N LCGG+ LP C T ++ L +VL+++ F + + R
Sbjct: 596 INASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655
Query: 293 KYKKPKLEE-------------RATNNIDVFSIWN--------YDGY-GSVYKAQLPNGK 330
+ K E + + +I + I + G G+ YK +
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG 715
Query: 331 V-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389
+ F +K+++ + + I ++ H NIVKL G C K +LI+EY++
Sbjct: 716 MQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768
Query: 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI------------------ 431
+L L N L W +R I +A AL +LH CSP++
Sbjct: 769 NLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 432 -------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484
C D+ A Y+APE T +TEK D+Y FG++ +E+L GK P
Sbjct: 823 HLRLSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 485 DLLSSLSSS---------SDPKI-MLIDVLDQRLPPPVDRKVI---RDILLASTISFACL 531
D + S SD + M ID P + V +I+ ++ C
Sbjct: 879 DAEFGVHGSIVEWARYCYSDCHLDMWID-------PSIRGDVSVNQNEIVEVMNLALHCT 931
Query: 532 QSNPKSRPTMQYVSQ 546
++P +RP V +
Sbjct: 932 ATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 44/251 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G VY A+ GK+ A+K + + ++ + E ++L ++ H NIV+LY
Sbjct: 11 SFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPNIVRLYDVFED 68
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
++L+ EY + G LF +L + D A+ ++ + AL YLH H D P
Sbjct: 69 EDKLYLVMEYCEGGDLF-DLLKKRGRLSEDEARF--YLRQILSALEYLHSKGIVHRDLKP 125
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+A T GT Y+APE+ + D++S GV+
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVI 185
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI----RDILLASTISFA 529
E+L GK P + + + P P I +D++
Sbjct: 186 LYELLTGKPP------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR------K 233
Query: 530 CLQSNPKSRPT 540
L +P+ R T
Sbjct: 234 LLVKDPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 65/260 (25%), Positives = 102/260 (39%), Gaps = 44/260 (16%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G+VYKA+ GK+ A+K L + + R E ++L ++ H NIV+L
Sbjct: 11 SFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLIDAFED 69
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----------- 424
+ ++L+ EY + G LF L L + I + L YLH
Sbjct: 70 KDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126
Query: 425 ------HDCSPSIA-------STCPDSSNRTLLAGTYGYIAPE--LAYTMVMTEKCDVYS 469
+ IA SS T GT Y+APE L K DV+S
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY-GPKVDVWS 184
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST-ISF 528
GV+ E+L GK P S + + + ++ + L PP++ + +
Sbjct: 185 LGVILYELLTGKPP--------FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 529 A--CLQSNPKSRPTMQYVSQ 546
CL +P RPT + + Q
Sbjct: 237 IKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G+VY A+ GK A+K + ++ ++ E ++L ++ H NIVKLYG
Sbjct: 5 GFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFED 62
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----------- 424
++L+ EY + GSL L NE +L + + I+ + L YLH
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 425 -----HDCSPSIA--------STCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSF 470
+ + D S + GT Y+APE L +EK D++S
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 471 GVVTLE 476
GV+ E
Sbjct: 181 GVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 72/209 (34%), Positives = 97/209 (46%), Gaps = 47/209 (22%)
Query: 78 WNSSFWTTDHCKWEGITCNSAGSIFELYLSG----------------------------- 108
WNSS D C W+GITCN++ + + LSG
Sbjct: 51 WNSS---ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG 107
Query: 109 ------YYAGFNWR---LSQLNFS------CFPNLVKLTIQFFALTGSIPPEISALSKLQ 153
+ + R LS NF+ PNL L + L+G IP +I + S L+
Sbjct: 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLK 167
Query: 154 LLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK 213
+LDL N L G IP + NL +L L + SN L+G IP LG + +L + L N LSG+
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 214 IPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242
IP EI G+ +L LDL NN+ G IP L
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 62/270 (22%)
Query: 318 YGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G VYK L KV A+K L +EE + F EA ++ ++ H NIV+L G
Sbjct: 12 FGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEE--REEFLEEASIMKKLSHPNIVRLLG 68
Query: 372 FCLHRKCMFLIYEYMKRGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------ 423
C + ++++ EYM G L F L + + + L + + +A + YL
Sbjct: 69 VCTQGEPLYIVTEYMPGGDLLDF--LRKHGEKLTLKD--LLQMALQIAKGMEYLESKNFV 124
Query: 424 HHD----------------CSPSIASTCPDSSNRTLLAGTYG---YIAPELAYTMVMTEK 464
H D ++ + G ++APE T K
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK 184
Query: 465 CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDR-KVIR 518
DV+SFGV+ E+ +L P + +VL+ RLP P + +
Sbjct: 185 SDVWSFGVLLWEIF----------TLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY 234
Query: 519 DILLASTISFACLQSNPKSRPTMQYVSQEF 548
+++L C +P+ RPT + ++
Sbjct: 235 ELML------QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 2e-23
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 69/273 (25%)
Query: 318 YGSVYKAQLPNGKVF-----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G VYK +L A+K L +E+ I+ F EA+++ ++ H N+VKL G
Sbjct: 12 FGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVVKLLGV 69
Query: 373 CLHRKCMFLIYEYMKRGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----- 425
C + ++++ EYM+ G L + L N +L + ++ +A + YL
Sbjct: 70 CTEEEPLYIVMEYMEGGDLLSY--LRKNRP--KLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 426 -DCSPSIAS-TCPDSSNRTL------LA---GTYGYI------------APELAYTMVMT 462
D +A+ C N + L+ Y APE T
Sbjct: 126 RD----LAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 463 EKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PPVDRK 515
K DV+SFGV+ E+ +G+ P P + +VL+ RLP PP
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPY-----------PGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ D++L C +P+ RPT + +
Sbjct: 231 ELYDLML------QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 54/106 (50%), Positives = 67/106 (63%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
L+G IP EI L+ L LDL N LTG IP +GNLKNL L + N L GPIP ++ SL
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
L +LDLS N LSG+IP + ++NL L L +NN G IPV L+
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 67/271 (24%), Positives = 106/271 (39%), Gaps = 64/271 (23%)
Query: 318 YGSVYKAQL----PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G VYK L +V A+K L +E+ I+ F EA+++ ++ H NIVKL G
Sbjct: 12 FGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIVKLLGV 69
Query: 373 CLHRKCMFLIYEYMKRGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 430
C + + ++ EYM G L + L N EL + ++ +A + YL
Sbjct: 70 CTEEEPLMIVMEYMPGGDLLDY--LRKNRPK-ELSLSDLLSFALQIARGMEYLES--KNF 124
Query: 431 I-----ASTCPDSSNRTL------LA---GTYGYI------------APELAYTMVMTEK 464
I A C N + L+ Y APE T K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 465 CDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVI 517
DV+SFGV+ E+ +G+ P P + +VL+ RLP P + +
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPY-----------PGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548
++L C +P+ RPT + +
Sbjct: 234 YKLML------QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 64/138 (46%), Positives = 76/138 (55%), Gaps = 10/138 (7%)
Query: 123 SCFPNLVKLTIQFF---ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
S NL L F L+G IPP I +L KL LDLS N L+G IP + L+NL L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
++ SN+ G IP AL SL L L L SNK SG+IP + NLT LDLS NN+ G IP
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
Query: 240 VRLSPNKGLC-GGNFLDL 256
+GLC GN L
Sbjct: 374 ------EGLCSSGNLFKL 385
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 65/259 (25%), Positives = 100/259 (38%), Gaps = 61/259 (23%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G VYKA GK A+K + E+ I NE Q+L + H NIVK YG L
Sbjct: 12 GFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHPNIVKYYGSYLK 68
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYL------ 423
+ ++++ E+ GSL +D ++ + + + K + L YL
Sbjct: 69 KDELWIVMEFCSGGSL-------KDLLK-STNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 424 HHDCSP----------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
H D +++ D+ R + GT ++APE+ K D+
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR------KVIRDIL 521
+S G+ +E+ GK P S+ M PP R +D L
Sbjct: 181 WSLGITAIELAEGKPPY---------SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 522 LASTISFACLQSNPKSRPT 540
CLQ NP+ RPT
Sbjct: 232 K------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 52/109 (47%), Positives = 69/109 (63%)
Query: 131 LTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI 190
LT+ L G IP E+ + L+ + L N L+G IP EIG L +L L++ N+L GPI
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 191 PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
PS+LG+L NL L L NKLSG IPP I ++ L LDLS+N++ G IP
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 48/115 (41%), Positives = 70/115 (60%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
F +L L + L G IP ++ L+ L+ L L+SN L G IP E+G +K+L + +G N
Sbjct: 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+L G IP +G LT+L++LDL N L+G IP + +KNL +L L N + G IP
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 61/265 (23%), Positives = 97/265 (36%), Gaps = 67/265 (25%)
Query: 317 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+GSVY A G++ A+K + S E +++ E ++LS + H NIV+ YG
Sbjct: 12 SFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRYYGSERD 70
Query: 376 R-KCMFLIY-EYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH----- 424
K I+ EY+ GSL L E + ++ + + LAYLH
Sbjct: 71 EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKY--TRQILEGLAYLHSNGIV 123
Query: 425 H---------------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE 463
H C+ + + + GT ++APE+
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMAPEVIRGEEYGR 182
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP-----KIM---LIDVLDQRLPPPVDRK 515
D++S G +E+ GK P S +P KI + + L
Sbjct: 183 AADIWSLGCTVIEMATGKPP------WSELGNPMAALYKIGSSGEPPEIPEHLSE----- 231
Query: 516 VIRDILLASTISFACLQSNPKSRPT 540
+D L CL+ +PK RPT
Sbjct: 232 EAKDFLR------KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.2 bits (235), Expect = 4e-21
Identities = 67/275 (24%), Positives = 106/275 (38%), Gaps = 38/275 (13%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLH 375
+G VY A+ K+ ALK L + ++ F E Q+L+ + H NIVKLY F
Sbjct: 12 SFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------- 427
++L+ EY+ GSL L L ++ + I+ + AL YLH
Sbjct: 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKP 129
Query: 428 ----------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMV---MT 462
P ST + + GT GY+APE+ + +
Sbjct: 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189
Query: 463 EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-PKIMLIDVLDQRLPPPVDRKVIRDIL 521
D++S G+ E+L G P + + S++S KI+L P
Sbjct: 190 SSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISK 249
Query: 522 LASTISFACLQSNPKSRPTM-QYVSQEFLITRKTP 555
AS + L +PK+R + +S + L K
Sbjct: 250 AASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284
|
Length = 384 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 64/277 (23%), Positives = 105/277 (37%), Gaps = 69/277 (24%)
Query: 318 YGSVYKAQL---PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G VYK +L A+K L +EE K F EA+V+ ++ H N+V+L G C
Sbjct: 8 FGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVC 65
Query: 374 LHRKCMFLIYEYMKRGSL------FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL---- 423
+ ++L+ EYM+ G L + + + L ++ +A + YL
Sbjct: 66 TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125
Query: 424 --HHDCSPSIASTCPDSSN-----------RTLLAGTYGYI-----------APELAYTM 459
H D + A C + R + Y APE
Sbjct: 126 FVHRDLA---ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 460 VMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512
+ T K DV+SFGV+ E+ +G P ++L L RLP P
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK------------GYRLPKPE 230
Query: 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ +++L +C Q +P+ RPT + +
Sbjct: 231 YCPDELYELML------SCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 50/121 (41%), Positives = 63/121 (52%), Gaps = 3/121 (2%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
LTG IP + L LQ L L N L+G IPP I +L+ LI L++ NSL G IP + L
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLP 257
NL L L SN +GKIP + + L L L +N G IP L + L LDL
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL---TVLDLS 364
Query: 258 S 258
+
Sbjct: 365 T 365
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 66/256 (25%), Positives = 96/256 (37%), Gaps = 53/256 (20%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G VYK + P GK++ALKK+H EE F K E + L +VK YG
Sbjct: 14 SGVVYKVRHKPTGKIYALKKIHVDGDEE--FRKQLLRELKTLRSCESPYVVKCYGAFYKE 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSP 429
+ ++ EYM GSL L E A I + + L YLH D P
Sbjct: 72 GEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTKRHIIHRDIKP 128
Query: 430 S----------------IASTCPDSSNRTLLA-GTYGYIAPEL----AYTMVMTEKCDVY 468
S I+ ++ ++ GT Y++PE +Y+ D++
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY----AADIW 184
Query: 469 SFGVVTLEVLMGKHPRDLLSSLSSSSDPKI--MLIDVLDQRLPPPVDRKVIRDILLASTI 526
S G+ LE +GK P P ++ + D P +
Sbjct: 185 SLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSLPA-----EEFSPEFR 233
Query: 527 SF--ACLQSNPKSRPT 540
F ACLQ +PK RP+
Sbjct: 234 DFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 42/253 (16%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G V K P GK+ A+K + E + K E +L + IV YG +
Sbjct: 14 SGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKCNSPYIVGFYGAFYNN 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSP 429
+ + EYM GSL L + + ++ + A+ L YLH D P
Sbjct: 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHKIIHRDVKP 129
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
S ++ +S +T GT Y+APE + K D++S G+
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDILLASTISF--A 529
+E+ G+ P +DP + ++L + PPP ++ F
Sbjct: 189 LIELATGRFP------YPPENDPPDGIFELLQYIVNEPPP---RLPSGKFSPDFQDFVNL 239
Query: 530 CLQSNPKSRPTMQ 542
CL +P+ RP+ +
Sbjct: 240 CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
L G IP +IS L LQ ++LS N + G IPP +G++ +L L++ NS G IP +LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLP 257
T+L L+L+ N LSG++P + G + + + N GLCG L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRL-----------LHRAS-FNFTDNAGLCG--IPGLR 535
Query: 258 SCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRK 293
+C + I +++ +V + KR+
Sbjct: 536 ACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 57/156 (36%), Positives = 79/156 (50%), Gaps = 16/156 (10%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
L+ L + +L+G IP + L L++L L SN TG IP + +L L L + SN
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP------- 239
G IP LG NL+ LDLS+N L+G+IP + NL L L +N+++G IP
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 240 ----VRLSPNKGLCGGNFLDLPSCDTTKPATLFVEI 271
VRL N G +LPS T P F++I
Sbjct: 405 SLRRVRLQDN-SFSG----ELPSEFTKLPLVYFLDI 435
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 50/132 (37%), Positives = 67/132 (50%), Gaps = 2/132 (1%)
Query: 112 GFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIG 171
F+ L F+ P + L I L G I + LQ+L L+ N G +P G
Sbjct: 415 SFSGELPS-EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
+ K L L++ N G +P LGSL+ L L LS NKLSG+IP E++ K L LDLS+
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 232 NNIKGSIPVRLS 243
N + G IP S
Sbjct: 533 NQLSGQIPASFS 544
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 45/119 (37%), Positives = 68/119 (57%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVG 182
+ P L L + +G IP + + L +LDLS+N LTG IP + + NL +L +
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241
SNSL G IP +LG+ +L + L N SG++P E + + +LD+SNNN++G I R
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 1/122 (0%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
+L ++ +Q + +G +P E + L + LD+S+N L G I ++ +L L++ N
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246
G +P + GS L NLDLS N+ SG +P ++ + L L LS N + G IP LS K
Sbjct: 465 FGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523
Query: 247 GL 248
L
Sbjct: 524 KL 525
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 72/262 (27%), Positives = 107/262 (40%), Gaps = 59/262 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G VY A L G++ A+K++ + + IK +E +VL + H N+VK YG +HR
Sbjct: 13 FGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLH-----H-D 426
+ +++ EY G+L E+ +E ++++ LAYLH H D
Sbjct: 72 EKVYIFMEYCSGGTL-------EELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 427 CSPS--------------IASTCPDSSNRTL-------LAGTYGYIAPELAYTMVMTEK- 464
P+ +N T LAGT Y+APE+
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 465 --CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522
D++S G V LE+ GK P L + IM + PP I D L
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMF--HVGAGHKPP-----IPDSLQ 232
Query: 523 AST--ISF--ACLQSNPKSRPT 540
S F CL+S+PK RPT
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 63/253 (24%), Positives = 98/253 (38%), Gaps = 53/253 (20%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
+G V + + GK++A+K L + + ++ E +LS++ H IVKL Y F
Sbjct: 5 SFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT 64
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCS 428
K ++L+ EY G LF + + E + A+ + AL YLH D
Sbjct: 65 EEK-LYLVLEYAPGGELF-SHLSKEGRFSEERARF--YAAEIVLALEYLHSLGIIYRDLK 120
Query: 429 PS---------IAST--------CPDSSNRTLLAGTYGYIAPEL----AYTMVMTEKCDV 467
P I T + S GT Y+APE+ Y D
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA----VDW 176
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDILLAST 525
+S GV+ E+L GK P + D K + +L L P + + RD++
Sbjct: 177 WSLGVLLYEMLTGKPPFY-------AEDRKEIYEKILKDPLRFPEFLSPEA-RDLIS--- 225
Query: 526 ISFACLQSNPKSR 538
LQ +P R
Sbjct: 226 ---GLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 3e-14
Identities = 64/273 (23%), Positives = 109/273 (39%), Gaps = 65/273 (23%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G VY + +GK++ LK++ S E + NE ++L ++ H NI+K Y
Sbjct: 12 SFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEE 70
Query: 376 RKCMFLIYEYMKRGSLF--------CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--- 424
+ + ++ EY G L E+ + LDW V + AL YLH
Sbjct: 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCL----ALKYLHSRK 123
Query: 425 --H-DCSPS----------------IA----STCPDSSNRTLLAGTYGYIAPEL----AY 457
H D P I+ ST +T++ GT Y++PEL Y
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVV-GTPYYLSPELCQNKPY 180
Query: 458 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517
K D++S G V E+ KHP + + + L + + PP+ +
Sbjct: 181 ----NYKSDIWSLGCVLYELCTLKHPFE--------GENLLELALKILKGQYPPIPSQYS 228
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550
++ + + LQ +P+ RP++ + Q I
Sbjct: 229 SEL---RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 53/254 (20%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V+K + + +V+A+K K++ E EE +EA+VL+++ I++ Y
Sbjct: 13 FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLAKLDSSYIIRYYE 66
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNN------EDAVELDWAKRVNIVKAMA--HALAYL 423
L + + ++ EY + G L L ED V W + I+ +A H+ L
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLGLAHLHSKKIL 123
Query: 424 HHDCSP----------------SIASTCPDSSN--RTLLAGTYGYIAPELAYTMVMTEKC 465
H D +A D++N T++ GT Y++PEL EK
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKS 182
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525
DV++ GVV E GKHP D ++ + LI + + + PPV + + + +
Sbjct: 183 DVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVSQMYSQQL---AQ 231
Query: 526 ISFACLQSNPKSRP 539
+ CL + + RP
Sbjct: 232 LIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 51/255 (20%)
Query: 319 GSVYKA-QLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G VYKA GK A+KK+ + +EL NE ++ H NIV Y L
Sbjct: 33 GEVYKATDRATGKEVAIKKMRLRKQNKELII-----NEILIMKDCKHPNIVDYYDSYLVG 87
Query: 377 KCMFLIYEYMKRGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------- 424
++++ EYM GSL + NE + + + + L YLH
Sbjct: 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQI-------AYVCREVLQGLEYLHSQNVIHR 140
Query: 425 ----------HDCSPSI------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVY 468
D S + A + S R + GT ++APE+ K D++
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 469 SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF 528
S G++ +E+ G+ P +P + + ++ + PP+ ++
Sbjct: 201 SLGIMCIEMAEGEPPY--------LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252
Query: 529 ACLQSNPKSRPTMQY 543
CL +P+ RP+ +
Sbjct: 253 -CLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 69/274 (25%), Positives = 106/274 (38%), Gaps = 76/274 (27%)
Query: 317 GYGS---VYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
G G+ VY A LPN + A+K++ + + + R E Q +SQ H N+VK Y
Sbjct: 10 GVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 373 CLHRKCMFLIYEYMKRGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLH-----H- 425
+ ++L+ Y+ GSL + + LD A ++K + L YLH H
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQIHR 126
Query: 426 -----------DCSPSIA----------STCPDSSNRTLLAGTYGYIAPELAYTMVMTE- 463
D S IA R GT ++APE VM +
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-----VMEQV 181
Query: 464 -----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD----- 513
K D++SFG+ +E+ G P S K++++ + Q PP ++
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP---YSKYPPM---KVLMLTL--QNDPPSLETGADY 233
Query: 514 -------RKVIRDILLASTISFACLQSNPKSRPT 540
RK+I CLQ +P RPT
Sbjct: 234 KKYSKSFRKMISL----------CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 37/246 (15%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
+G V Q K+FA+K ++ + E +++ NE ++L ++ H +V L Y F
Sbjct: 12 AFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ- 70
Query: 375 HRKCMFLIYEYMKRGSLFCNL----HNNEDAVELDWAKRVNIVKAMA--HALAYLHHDCS 428
+ M+L+ + + G L +L +E+ V+ W IV A+ H+ +H D
Sbjct: 71 DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WI--CEIVLALEYLHSKGIIHRDIK 127
Query: 429 P----------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
P +IA+ + T +GT GY+APE+ + D +S GV
Sbjct: 128 PDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGV 187
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQ 532
E L GK P S +I L P D + L+
Sbjct: 188 TAYECLRGKRPYRGHSRTIRD---QIRAKQETADVLYPATWSTEAIDAIN------KLLE 238
Query: 533 SNPKSR 538
+P+ R
Sbjct: 239 RDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 68/283 (24%), Positives = 105/283 (37%), Gaps = 67/283 (23%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+G VYKA +V A+K + E E E+ I+ E Q LSQ I K YG L
Sbjct: 13 SFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ---QEIQFLSQCRSPYITKYYGSFL 69
Query: 375 HRKCMFLIYEYMKRGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD--- 426
+++I EY GS L A I++ + L YLH +
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVLLGLEYLHEEGKI 120
Query: 427 -----------------------CSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE 463
S + ST S R GT ++APE+ E
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST---MSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP-KIMLIDVLDQRLPPPVDRKVIRDILL 522
K D++S G+ +E+ G+ P S P +++ ++ + PP ++
Sbjct: 178 KADIWSLGITAIELAKGEPPL-------SDLHPMRVLF--LIPKNNPPSLEGNKFSK-PF 227
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDI 565
+S CL +PK RP+ ++E L K +K A
Sbjct: 228 KDFVS-LCLNKDPKERPS----AKELL---KHKFIKKAKKTSY 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 41/249 (16%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G VYK L G A+K++ + +E +KS E +L + H NIVK G
Sbjct: 12 AFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIET 70
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
+++I EY + GSL + E A V + LAYLH H D
Sbjct: 71 SDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 430 S----------------IASTCPDSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
+ +A+ D S + + GT ++APE+ + D++S G
Sbjct: 128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLASTISFACL 531
+E+L G P L+ ++ + V D P P ++D L+ C
Sbjct: 188 TVIELLTGNPPYYDLNPMA------ALFRIVQDDHPPLPEGISPELKDFLM------QCF 235
Query: 532 QSNPKSRPT 540
Q +P RPT
Sbjct: 236 QKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 70/275 (25%)
Query: 318 YGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V+ + + + + A+K L + + + K F EA++L+ H NIVK YG
Sbjct: 18 FGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENIVKFYG 75
Query: 372 FCLHRKCMFLIYEYMKRGSL--FCNLH---------NNEDAVELDWAKRVNIVKAMAHAL 420
C +++EYM+ G L F H + EL ++ + I +A +
Sbjct: 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135
Query: 421 AYL------HHDCSPSIASTCPDSSNRTLLAGTYG----------------------YIA 452
YL H D + C + + G +G ++
Sbjct: 136 VYLASQHFVHRDLA---TRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192
Query: 453 PE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-- 508
PE + Y TE DV+SFGVV E+ GK P LS+ +I+ + Q
Sbjct: 193 PESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECITQGRLL 243
Query: 509 -PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
P + DI+L C + +P+ R ++
Sbjct: 244 QRPRTCPSEVYDIML------GCWKRDPQQRINIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 62/243 (25%)
Query: 333 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF 392
A+K + E FI+ EA+V+ ++ H N+V+LYG C ++ +F++ EYM G L
Sbjct: 32 AIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87
Query: 393 CNLHNNEDAVELDWAKRV--NIVKAMAH--ALAYLHHDCSPSIASTCPDSSNRTLLAGTY 448
L + + +W + ++ +AM + + ++H D + A C + + +
Sbjct: 88 NYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA---ARNCLVGEDNVVKVSDF 144
Query: 449 G---------------------YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDL 486
G + PE+ + K DV+SFGV+ EV GK P +
Sbjct: 145 GLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
Query: 487 LSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRDILLAS----TISFACLQSNPKS 537
S+ +V++ RL P LA TI ++C P+
Sbjct: 205 FSNS-----------EVVESVSAGYRLYRPK---------LAPTEVYTIMYSCWHEKPED 244
Query: 538 RPT 540
RP
Sbjct: 245 RPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 70/259 (27%), Positives = 111/259 (42%), Gaps = 53/259 (20%)
Query: 318 YGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V + +LP K A+K L +++ F EA ++ Q H NI++L G
Sbjct: 17 FGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIRLEGVV 74
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC 427
+ + +I EYM+ GSL L N+ + + V +++ +A + YL H D
Sbjct: 75 TKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132
Query: 428 SP-----SIASTCPDSS---NRTL--LAGTY----GYI-----APE-LAYTMVMTEKCDV 467
+ + C S +R L TY G I APE +AY T DV
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDV 191
Query: 468 YSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-RKVIRDILLA 523
+SFG+V EV+ G+ P +S+ +I ++ RLPPP+D + ++L
Sbjct: 192 WSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLPPPMDCPSALYQLML- 242
Query: 524 STISFACLQSNPKSRPTMQ 542
C Q + RPT
Sbjct: 243 -----DCWQKDRNERPTFS 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 50/110 (45%), Positives = 68/110 (61%), Gaps = 4/110 (3%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
PNL L + F L+ +P +S LS L LDLS N ++ +PPEI L L EL++ +NS
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+I + S+L +L NLS L+LS+NKL +P I + NL LDLSNN I
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 59/287 (20%)
Query: 319 GSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
GSV K + +P G V A K +H + K E Q++ + IV YG L+
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYGAFLNEN 76
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAK-RVNIV----KAMAHALAYL-------HH 425
+ + E+M GSL D + V I+ A+ L YL H
Sbjct: 77 NICMCMEFMDCGSL--------DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 426 DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
D PS ++ +S T + GT Y++PE T K DV+S
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-GTSTYMSPERIQGGKYTVKSDVWS 187
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-------RLPPPVDRKVIRDILL 522
G+ +E+ +GK P + D + ++D+L Q RLP + +RD +
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD 247
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISISE 569
ACL +P RPT Q + P ++ ++ +
Sbjct: 248 ------ACLLKDPTERPTPQ------QLCAMPPFIQALRASNVDLQA 282
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 62/267 (23%)
Query: 318 YGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VY+ A+K L E+ ++ F EA V+ ++ H N+V+L G C
Sbjct: 19 YGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
++I E+M G+L L + E++ + + ++ A+ YL H D +
Sbjct: 75 PPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA-- 131
Query: 431 IASTCPDSSNRTLLAGTYG---------------------YIAPE-LAYTMVMTEKCDVY 468
A C N + +G + APE LAY K DV+
Sbjct: 132 -ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVW 189
Query: 469 SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV---LDQ--RL--PPPVDRKVIRDIL 521
+FGV+ E+ ++ S P I L V L++ R+ P KV +
Sbjct: 190 AFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239
Query: 522 LASTISFACLQSNPKSRPTMQYVSQEF 548
AC Q NP RP+ + Q F
Sbjct: 240 -------ACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 47/254 (18%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V++ N A+K L + F+ EAQ++ ++ H +++LY C +
Sbjct: 19 FGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAVCTLEE 74
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP-- 429
++++ E MK GSL L L + +++ +A +AYL H D +
Sbjct: 75 PIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN 133
Query: 430 ------SIASTCPDSSNRTLLAGTY----------GYIAPELAYTMVMTEKCDVYSFGVV 473
+I R + Y + APE A + K DV+SFG++
Sbjct: 134 VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGIL 193
Query: 474 TLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-RKVIRDILLASTISFA 529
E V G+ P +++ ++ +DQ R+P P K + DI+L
Sbjct: 194 LTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCPPGCPKELYDIML------D 239
Query: 530 CLQSNPKSRPTMQY 543
C + +P RPT +
Sbjct: 240 CWKEDPDDRPTFET 253
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 37/200 (18%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG V+ A+ + G ++A+K + ++ + E +LSQ +VKLY
Sbjct: 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG 64
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP 429
+K ++L+ EY+ G L L N +++ D A+ + + AL YL H D P
Sbjct: 65 KKNLYLVMEYLPGGDLASLLE-NVGSLDEDVAR--IYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 430 --------------------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE 463
I + ++ ++ GT YIAPE+ ++
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVILGQGHSK 180
Query: 464 KCDVYSFGVVTLEVLMGKHP 483
D +S G + E L+G P
Sbjct: 181 TVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 62/270 (22%), Positives = 99/270 (36%), Gaps = 79/270 (29%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ + G++ A+K + ++ I + E +L + H NIV +G L R
Sbjct: 16 YGDVYKARDIATGELVAIKVIKLEPGDDFEII---QQEISMLKECRHPNIVAYFGSYLRR 72
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH-------ALAYLHHD--- 426
++++ EY GSL + +A+ LAYLH
Sbjct: 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSEL---------QIAYVCRETLKGLAYLHETGKI 123
Query: 427 -----------------------CSPSIASTCPDSSNRTLLAGTYGYIAPELA------- 456
S + +T + R GT ++APE+A
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTAT---IAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 457 YTMVMTEKCDVYSFGVVTLEVLMGK------HPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510
Y KCD+++ G+ +E+ + HP L +S S+ P PP
Sbjct: 181 Y----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP------------PP 224
Query: 511 PVDRKVIRDILLASTISFACLQSNPKSRPT 540
+ K + I CL +PK RPT
Sbjct: 225 KLKDKEKWSPVFHDFIK-KCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 55/263 (20%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G VYK L A+K ++ +L + F EA++L Q H NIVKL G C+ ++
Sbjct: 8 FGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
++++ E + GSL L ++ + + K + + A + YL H D +
Sbjct: 66 PIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKNCIHRDLA--- 120
Query: 432 ASTCPDSSNRTLLAGTYG----------------------YIAPELAYTMVMTEKCDVYS 469
A C N L +G + APE T + DV+S
Sbjct: 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWS 180
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRDILLAS 524
+G++ E SL + P + ++ R+P P ++ + +
Sbjct: 181 YGILLWETF----------SLGDTPYPGMSNQQTRERIESGYRMPAP---QLCPEEI--Y 225
Query: 525 TISFACLQSNPKSRPTMQYVSQE 547
+ C +P++RP+ + E
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 60/262 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V KV A+K L ++ ++F EA V++ + H N+V+L G L
Sbjct: 19 FGDVMLGDYRGQKV-AVKCLK----DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD----- 426
++++ EYM +GSL L + AV + A+++ + + YL H D
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132
Query: 427 --CSPSIASTCPD-----SSNRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEV 477
S + + D +++ +G + APE + K DV+SFG++ E+
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 478 L-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL------PPPVDRKVIRDILLAST 525
G+ P P+I L DV+ R+ PP V KV++D
Sbjct: 193 YSFGRVPY-----------PRIPLKDVVPHVEKGYRMEAPEGCPPEV-YKVMKD------ 234
Query: 526 ISFACLQSNPKSRPTMQYVSQE 547
C + +P RPT + + ++
Sbjct: 235 ----CWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 63/271 (23%), Positives = 104/271 (38%), Gaps = 56/271 (20%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+VYK P G+++ALK ++ + + + E ++L V H N+VK + H
Sbjct: 88 GTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPD 437
+ ++ E+M GSL H ++ D A+++ A H +H D PS + +
Sbjct: 146 EIQVLLEFMDGGSLE-GTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPS--NLLIN 202
Query: 438 SSNRTLLA-------------------GTYGYIAPELAYTMVMTEKC-----DVYSFGVV 473
S+ +A GT Y++PE T + D++S GV
Sbjct: 203 SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 474 TLEVLMGKHP---------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524
LE +G+ P L+ ++ S P+ P + R
Sbjct: 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE-----------APATASREFRHF---- 307
Query: 525 TISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
IS CLQ P R + + Q I R P
Sbjct: 308 -ISC-CLQREPAKRWSAMQLLQHPFILRAQP 336
|
Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 51/130 (39%), Positives = 68/130 (52%), Gaps = 14/130 (10%)
Query: 141 SIPPEISAL-SKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
IPP I L S L+ LDLS N + ++P + NL NL L++ N L +P L +L+N
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSN 187
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI----------KGSIPVRLSPNKGLC 249
L+NLDLS NK+S +PPEI + L LDLSNN+I K + LS NK
Sbjct: 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246
Query: 250 GGNFLDLPSC 259
+ S
Sbjct: 247 LPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 58/285 (20%)
Query: 317 GYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V+ A+ N K L + + LA K F+ EA++L+ + H +IVK YG C
Sbjct: 17 AFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC 76
Query: 374 LHRKCMFLIYEYMKRGSL--FCNLHNNEDAV-----------ELDWAKRVNIVKAMAHAL 420
+ +++EYMK G L F H + + EL ++ ++I +A +
Sbjct: 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 136
Query: 421 AYL--HHDCSPSIAS-TCPDSSNRTLLAGTYG----------------------YIAPEL 455
YL H +A+ C +N + G +G ++ PE
Sbjct: 137 VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES 196
Query: 456 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPV 512
T + DV+SFGV+ E+ GK P LS ++ + R+ P V
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEVIECITQGRVLERPRV 249
Query: 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE-FLITRKTPL 556
K + DI+L C Q P+ R ++ + + + + TP+
Sbjct: 250 CPKEVYDIML------GCWQREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 62/267 (23%), Positives = 98/267 (36%), Gaps = 62/267 (23%)
Query: 318 YGSVYK---AQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G VY+ + G+ A+K ++ E + F NEA V+ + ++V+L G
Sbjct: 19 FGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVMKEFNCHHVVRLLG 76
Query: 372 FCLHRKCMFLIYEYMKRGSL------------FCNLHNNEDAVE-LDWAKRVNIVKAMA- 417
+ ++ E M +G L + + A I MA
Sbjct: 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA--AEIADGMAY 134
Query: 418 -HALAYLHHDCSPSIASTCPDSSNRTLLAGTYG----------------------YIAPE 454
A ++H D + A C + + T+ G +G ++APE
Sbjct: 135 LAAKKFVHRDLA---ARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 455 LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513
V T K DV+SFGVV E+ + + P LS+ ++ LD P
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK--FVIDGGHLDLPENCP-- 247
Query: 514 RKVIRDILLASTISFACLQSNPKSRPT 540
D LL + C Q NPK RPT
Sbjct: 248 -----DKLL--ELMRMCWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 45/102 (44%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 143 PPEISALSKLQLLDLSSNGLTGTIPPEIGNLK-NLIELNVGSNSLIGPIPSALGSLTNLS 201
E+ L+ L LDL +N +T IPP IG LK NL EL++ N I +PS L +L NL
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLK 166
Query: 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
NLDLS N LS +P ++ + NL LDLS N I +P +
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE 206
|
Length = 394 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 70/291 (24%)
Query: 318 YGSVYKA-QLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLH---RNIVKLYGF 372
YG+VY+ +P G+V ALK ++ + ++++ I+ E +LSQ+ NI K YG
Sbjct: 14 YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQPPNITKYYGS 70
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------ 426
L +++I EY + GS+ + A + I++ + AL Y+H
Sbjct: 71 YLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126
Query: 427 ----------------CSPSI-ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE------ 463
C + A +SS R+ GT ++APE V+TE
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VITEGKYYDT 181
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLI-DVLDQRLPPPVDRKVIRDI 520
K D++S G+ E+ G P S D +MLI RL K++R+
Sbjct: 182 KADIWSLGITIYEMATGNPPY-------SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234
Query: 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK-HAAIQDISISEL 570
+ ACL PK R + ++E L K+ +K H+ + EL
Sbjct: 235 VA------ACLDEEPKERLS----AEELL---KSKWIKAHSKTPVSILKEL 272
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (144), Expect = 1e-09
Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 5/108 (4%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ G++ ALKK+ EE + R E +L ++ H NIVKL
Sbjct: 12 YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLLDVIHTE 70
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
+ ++L++EY L L + + K I+ + LAY H
Sbjct: 71 RKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH 115
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/256 (20%), Positives = 107/256 (41%), Gaps = 46/256 (17%)
Query: 318 YGSVYKAQ-LPNGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ S Y+A+ + G + A+K++ + +E+ +++ R E ++++++ H +I+++ G
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 430
L E+M GS+ L ++AV +++ +++ + H +H D
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG- 131
Query: 431 IASTCPDSSNRTL------------------------LAGTYGYIAPELAYTMVMTEKCD 466
A+ DS+ + L L GT ++APE+ CD
Sbjct: 132 -ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCD 190
Query: 467 VYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD---RKVIRDILLA 523
V+S G V +E+ K P + S+ ++ + P + +RD+ L
Sbjct: 191 VWSVGCVIIEMATAKPPWN----AEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL- 245
Query: 524 STISFACLQSNPKSRP 539
CL+ P+ RP
Sbjct: 246 -----RCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 67/279 (24%)
Query: 318 YGSVYKAQ-LPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G+VYK +P G+ A+K L + + K +EA V++ V H ++V+L G
Sbjct: 20 FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHVVRLLGI 77
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL----- 423
CL + LI + M G L + N++D + L+W V I K M +YL
Sbjct: 78 CLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYLEEKRL 130
Query: 424 -HHDC--------SPS--------IASTCPDSSNRTLLAG---TYGYIAPELAYTMVMTE 463
H D +P +A G ++A E + T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 464 KCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD-----QRLP-PPVDRKV 516
K DV+S+GV E++ G P + I +++ D +RLP PP+
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYE-----------GIPAVEIPDLLEKGERLPQPPICTID 239
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
+ +L+ C + +SRPT + + EF + P
Sbjct: 240 VYMVLV------KCWMIDAESRPTFKELINEFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 60/266 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A+K L AF++ EAQ++ ++ H +V+LY C +
Sbjct: 19 FGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAVCSEEE 74
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
++++ EYM +GSL L + E +L + V++ +A +AYL H D +
Sbjct: 75 PIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA--- 130
Query: 432 ASTCPDSSNRTLLAGTYG---------------------YIAPELAYTMVMTEKCDVYSF 470
A N +G + APE A T K DV+SF
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190
Query: 471 GVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLA 523
G++ E++ G+ P P + +VL+Q R+P P + + + D++L
Sbjct: 191 GILLTEIVTYGRVPY-----------PGMTNREVLEQVERGYRMPRPPNCPEELYDLML- 238
Query: 524 STISFACLQSNPKSRPTMQYVSQEFL 549
C +P+ RPT +Y+ Q FL
Sbjct: 239 -----QCWDKDPEERPTFEYL-QSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 45/217 (20%), Positives = 78/217 (35%), Gaps = 71/217 (32%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G+V K + +GK+ K++ +E E+ + +E +L ++ H NIV+ Y
Sbjct: 13 FGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILRELKHPNIVRYYDRI 68
Query: 374 LHR--KCMFLIYEYMKRGSLFCNLHN--------NEDAVELDWAKRVNIVKAMAHALAY- 422
+ R + ++++ EY + G L + E+ + W I+ + AL
Sbjct: 69 IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RILTQLLLALYEC 121
Query: 423 ----------LHHDCSP--------------------------SIASTCPDSSNRTLLAG 446
LH D P S A T G
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY---------VG 172
Query: 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
T Y++PE M EK D++S G + E+ P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 48/222 (21%)
Query: 351 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNL----HNNEDAVELDW 406
F EA+V+ ++ H +V+LYG C ++ ++++ EYM G L L + + L+
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 407 AKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLLAGTYG---YI------------ 451
K V A + ++H D + A C + +G Y+
Sbjct: 106 CKDVCEGMAYLESKQFIHRDLA---ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162
Query: 452 ------APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVL 504
PE+ + K DV++FGV+ EV +GK P + ++ + +
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF------NNSETVEKVSQ 216
Query: 505 DQRLPPPVDRKVIRDILLAS----TISFACLQSNPKSRPTMQ 542
RL P LAS I ++C + RPT Q
Sbjct: 217 GLRLYRP---------HLASEKVYAIMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 349 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL--FCNLHNNEDAV---- 402
K F EA++L+ + H +IVK YG C+ + +++EYMK G L F H DAV
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAE 110
Query: 403 -----ELDWAKRVNIVKAMAHALAYL--HHDCSPSIAS-TCPDSSNRTLLAGTYG----- 449
EL ++ ++I + +A + YL H +A+ C N + G +G
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170
Query: 450 -----------------YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489
++ PE T + DV+S GVV E+ GK P LS+
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 53/235 (22%), Positives = 100/235 (42%), Gaps = 46/235 (19%)
Query: 333 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF 392
A+K ++ E FI+ EA+V+ ++ H +V+LYG C +K ++++ E+M+ G L
Sbjct: 32 AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87
Query: 393 CNLHNNEDAVELDWAKRV--NIVKAMAHAL--AYLHHDCSPSIASTCPDSSNRTLLAGTY 448
L + + D + ++ + M + +++H D + A C SS + +
Sbjct: 88 NYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA---ARNCLVSSTGVVKVSDF 144
Query: 449 G---------YI------------APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDL 486
G Y PE+ + K DV+SFGV+ EV GK P
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP--- 201
Query: 487 LSSLSSSSDPKIMLIDVLDQRL-PPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
S+ +++ + RL P + + +++ ++C P+ RPT
Sbjct: 202 ---FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM------YSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 53/262 (20%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A+K L AF++ EAQV+ ++ H +V+LY + +
Sbjct: 19 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYA-VVSEE 73
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA------YLHHDCSPS- 430
++++ EYM +GSL + E L + V++ +A +A Y+H D +
Sbjct: 74 PIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 132
Query: 431 ---------------IASTCPDSSNRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVV 473
+A D+ + + APE A T K DV+SFG++
Sbjct: 133 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PPVDRKVIRDILLASTIS 527
E L++ P ++ +VLDQ R+P PP + + D++
Sbjct: 193 LTE----------LTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC----- 237
Query: 528 FACLQSNPKSRPTMQYVSQEFL 549
C + P+ RPT +Y+ Q FL
Sbjct: 238 -QCWRKEPEERPTFEYL-QAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 49/231 (21%)
Query: 349 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNED-AVEL--- 404
+SF EAQ++ ++ H +V+LY + + ++++ EYM +GSL L + E A++L
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 405 -DWAKRVNIVKAMAHALAYLHHDCSPS----------------IASTCPDSSNRTLLAGT 447
D A +V A + Y+H D + +A D+
Sbjct: 105 VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 448 Y--GYIAPELAYTMVMTEKCDVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVL 504
+ + APE A T K DV+SFG++ E V G+ P P + +VL
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY-----------PGMNNREVL 213
Query: 505 DQ-----RLPPPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549
+Q R+P P D + + +++L C + +P+ RPT +Y+ Q FL
Sbjct: 214 EQVERGYRMPCPQDCPISLHELML------QCWKKDPEERPTFEYL-QSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 62/256 (24%), Positives = 97/256 (37%), Gaps = 49/256 (19%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V + + GKV A+K L + + ++ + F EA ++ + H N+++LYG
Sbjct: 8 FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIRLYGVV 65
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDA-----VELDWAKRVNIVKAMA--HALAYLHHD 426
L M ++ E GSL L + D+A V I M + ++H D
Sbjct: 66 LTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYA--VQIANGMRYLESKRFIHRD 122
Query: 427 --------CSPSIASTCPDSSNRTLLAGTYGYI------------APELAYTMVMTEKCD 466
S R L Y+ APE T + D
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 467 VYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM-LIDVLDQRLPPPVD-RKVIRDILLAS 524
V+ FGV E M + + + LS S +I+ ID +RL P + I +++L
Sbjct: 183 VWMFGVTLWE--MFTYGEEPWAGLSGS---QILKKIDKEGERLERPEACPQDIYNVML-- 235
Query: 525 TISFACLQSNPKSRPT 540
C NP RPT
Sbjct: 236 ----QCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 56/254 (22%)
Query: 329 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYEYM 386
G+V A+KKL S E L + F E ++L + H NIVK G C R+ + L+ EY+
Sbjct: 33 GEVVAVKKLQHSTAEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89
Query: 387 KRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAH--ALAYLHHDCSPSIASTCPDSSN 440
GSL L + + ++ L +A + I K M + + Y+H D + + +S N
Sbjct: 90 PYGSLRDYLQKHRERLDHRKLLLYASQ--ICKGMEYLGSKRYVHRDLATR--NILVESEN 145
Query: 441 RTLLAGTYG-----------------------YIAPELAYTMVMTEKCDVYSFGVVTLEV 477
R + G +G + APE + DV+SFGVV E+
Sbjct: 146 RVKI-GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
Query: 478 L----MGKHPRDLLSSLSSSSDPKIM----LIDVL--DQRLPPPVDRKV-IRDILLASTI 526
P + + M LI++L + RLP P I I+
Sbjct: 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMK---- 260
Query: 527 SFACLQSNPKSRPT 540
C ++P RP+
Sbjct: 261 --ECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 59/259 (22%), Positives = 98/259 (37%), Gaps = 46/259 (17%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+K L + A+K +EL F +EA++L Q H NIVKL G C R+
Sbjct: 8 FGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGVCTQRQ 65
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
++++ E + G L +D EL + V A +AYL H D +
Sbjct: 66 PIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKNCIHRDLA--- 120
Query: 432 ASTCPDSSNRTLLAGTYG---------------------YIAPELAYTMVMTEKCDVYSF 470
A C N L +G + APE + + DV+S+
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180
Query: 471 GVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA 529
G++ E +G P +++ + + Q+ P V + + R
Sbjct: 181 GILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR----------- 229
Query: 530 CLQSNPKSRPTMQYVSQEF 548
C P++RP + +E
Sbjct: 230 CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/261 (23%), Positives = 96/261 (36%), Gaps = 63/261 (24%)
Query: 329 GKVFA--LKKLHTSETEELAFIKS------------FRNEAQVLSQVLHRNIVKLYGFCL 374
G+VF K + E L +K+ FR E + ++ H+N+V+L G C
Sbjct: 19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVE------LDWAKRVNIVKAMAHALAYL----- 423
+ ++I EY G L L + E L ++V + +A + +L
Sbjct: 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF 138
Query: 424 -HHDCSPSIASTCPDSSNR-------TLLAGTYG--------------YIAPELAYTMVM 461
H D + A C SS R +L Y ++APE
Sbjct: 139 VHRDLA---ARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195
Query: 462 TEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRD 519
+ K DV+SFGV+ EV G+ P L S + + + LP P +
Sbjct: 196 STKSDVWSFGVLMWEVFTQGELPFYGL-----SDEEVLNRLQAGKLELPVPEGCPSRLYK 250
Query: 520 ILLASTISFACLQSNPKSRPT 540
++ C NPK RP+
Sbjct: 251 LMT------RCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 59/234 (25%), Positives = 86/234 (36%), Gaps = 61/234 (26%)
Query: 319 GSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--H 375
GSV K +L N +FALK + T +L K E ++ IVK YG L
Sbjct: 15 GSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYGAFLDES 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN---------IVKAMAHALAYL--- 423
+ + EY + GSL D++ KR I +++ L+YL
Sbjct: 73 SSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 424 ---HHDCSPS--------IASTCPD--------SSNRTLLAGTYGYIAPE----LAYTMV 460
H D PS C D +S GT Y+APE Y++
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLC-DFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSI- 182
Query: 461 MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 512
DV+S G+ LEV + P +P + I++L +P P
Sbjct: 183 ---TSDVWSLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNMPNPE 227
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 72/309 (23%), Positives = 112/309 (36%), Gaps = 97/309 (31%)
Query: 311 SIWNYDG------YGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLH 363
IW G +G VYKAQ +F A K + EEL + F E +LS+ H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKH 61
Query: 364 RNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN------IVKAMA 417
NIV LY + ++++ E+ G+L D++ L+ + + + + M
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGAL--------DSIMLELERGLTEPQIRYVCRQML 113
Query: 418 HALAYLHHD--------------------------CSPSIASTCPDSSNRTLLAGTYGYI 451
AL +LH S ST R GT ++
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---LQKRDTFIGTPYWM 170
Query: 452 APELAYTMVMTE---------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 502
APE+ V E K D++S G+ +E+ + P L+ P +L+
Sbjct: 171 APEV----VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLK 219
Query: 503 VLDQRLPPPVDR-----KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557
+L PP +D+ D L +CL +P RPT L+
Sbjct: 220 ILKSE-PPTLDQPSKWSSSFNDFLK------SCLVKDPDDRPTA------------AELL 260
Query: 558 KHAAIQDIS 566
KH + D S
Sbjct: 261 KHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 54/258 (20%)
Query: 318 YGSVYKAQL-PNGK---VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V + +L GK A+K L + TE+ + F +EA ++ Q H NI+ L G
Sbjct: 17 FGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD- 426
+ + +I E+M+ G+L L N+ + + V +++ +A + YL H D
Sbjct: 75 TKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132
Query: 427 ------------CSPSIASTC----PDSSNRTLLAGTYGYI-----APELAYTMVMTEKC 465
C S D+S+ T + G I APE T
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS 192
Query: 466 DVYSFGVVTLEVL-MGKHPR-DLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDIL 521
DV+S+G+V EV+ G+ P D+ S+ D +I+ ++Q RLPPP+D L
Sbjct: 193 DVWSYGIVMWEVMSYGERPYWDM-----SNQD----VINAIEQDYRLPPPMDCPTALHQL 243
Query: 522 LASTISFACLQSNPKSRP 539
+ C Q + +RP
Sbjct: 244 M-----LDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 30/184 (16%)
Query: 329 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCLHRKCMFLIYEYMK 387
G ++A+K + S + F E +LS I +L Y F + ++L+ EY
Sbjct: 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-QDKDNLYLVMEYQP 84
Query: 388 RGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHALAYLHHDCSPS------------- 430
G L L+ ED + D A+ +V A+ H + Y+H D P
Sbjct: 85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144
Query: 431 -IASTCPDSSNRTLLA----GTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLM 479
S ++N+ + + GT YIAPE+ TM K CD +S GV+ E++
Sbjct: 145 DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
Query: 480 GKHP 483
G+ P
Sbjct: 205 GRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 68/269 (25%), Positives = 100/269 (37%), Gaps = 62/269 (23%)
Query: 318 YGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+GSV K + +GK A+K L + A K F EA V++Q+ H IV+L G C
Sbjct: 8 FGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYL------H 424
M L+ E G L L + D A +V A +AYL H
Sbjct: 66 KGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKHFVH 118
Query: 425 HDCSP------------------SIASTCPDSSNRTLLAGTY--GYIAPELAYTMVMTEK 464
D + S A R AG + + APE + K
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 465 CDVYSFGVVTLEVL-MGKHP-RDLLSSLSSSSDPKIMLIDVLDQ--RLP-PPVDRKVIRD 519
DV+S+GV E G P ++ +++ +L+ RLP P + I
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVI--AMLESGERLPRPEECPQEIYS 229
Query: 520 ILLASTISFACLQSNPKSRPTMQYVSQEF 548
I+L +C + P+ RPT + F
Sbjct: 230 IML------SCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 32/193 (16%)
Query: 317 GYGSVYKAQL-PNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
G+G V ++ + FALK K H ET + I +E ++L + H IVKLY
Sbjct: 5 GFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVKLYRT 61
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------D 426
+K ++++ EY G L+ L D D + + A YLH+ D
Sbjct: 62 FKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 427 CSPS---IAST----CPD--------SSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSF 470
P + S D S +T GT Y+APE+ D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178
Query: 471 GVVTLEVLMGKHP 483
G++ E+L G+ P
Sbjct: 179 GILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 33/194 (17%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ + A+K + E FI+ EAQV+ ++ H +V+LYG C R
Sbjct: 17 FGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGVCTERS 72
Query: 378 CMFLIYEYMKRGSL--FCNLHNNEDAVELDWAKRVNIVKAMAH--ALAYLHHDCSPSIAS 433
+ L++E+M+ G L + + + E +++ + MA+ + +H D + A
Sbjct: 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA---AR 129
Query: 434 TCPDSSNRTLLAGTYG---------------------YIAPELAYTMVMTEKCDVYSFGV 472
C N+ + +G + +PE+ + K DV+SFGV
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189
Query: 473 VTLEVLM-GKHPRD 485
+ EV GK P +
Sbjct: 190 LMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 60/274 (21%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG V K + G++ A+KK SE +E + R E +VL Q+ H NIV L +
Sbjct: 14 YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRK 72
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYLHHDCSPS-- 430
++L++EY++R +L L + + D + +++A+A H+ +H D P
Sbjct: 73 GRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131
Query: 431 -IAS---------------TCPDSSNRTLLAGTYGYIAPELAYTMVMTEK-CDVYSFGVV 473
++ +S T T Y APEL K DV++ G +
Sbjct: 132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 474 TLEVLMGK-------------HPRDLLSSLSSS------SDPK--------IMLIDVLDQ 506
E+L G+ + L L S S+P+ + L++
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER 251
Query: 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
R P V + L ACL+ +PK R T
Sbjct: 252 RYPGKVSSPALD--FLK-----ACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 48/188 (25%), Positives = 75/188 (39%), Gaps = 26/188 (13%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNE-AQVLSQVLHRNIVKLYGFCLH 375
+GSVY A+ G FA+K L S+ + + + E A ++ Q + KLY
Sbjct: 9 FGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS 68
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKR-----VNIVKAMAHALAYLHHDCSPS 430
+ ++L+ EY+ G +L + DWAK+ V V+ + H +H D P
Sbjct: 69 KDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDL-HQRGIIHRDIKP- 125
Query: 431 IASTCPDSSNRTLLA---------------GTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475
+ D + L GT Y+APE + + D +S G V
Sbjct: 126 -ENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 476 EVLMGKHP 483
E L G P
Sbjct: 185 EFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-08
Identities = 24/60 (40%), Positives = 32/60 (53%)
Query: 175 NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
NL L++ +N L A L NL LDLS N L+ P +G+ +L LDLS NN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 318 YGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V++ ++P K A+K L TE+ + F +EA ++ Q H NI++L G
Sbjct: 18 FGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIRLEGVV 75
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC 427
K +I EYM+ G+L L +++ E + V +++ +A + YL H D
Sbjct: 76 TKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDL 133
Query: 428 SPS---IAST--CPDSS---NRTLL---AGTYG---------YIAPELAYTMVMTEKCDV 467
+ + S C S +R L GTY + APE T DV
Sbjct: 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDV 193
Query: 468 YSFGVVTLEVL-MGKHPR-DLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513
+SFG+V EV+ G+ P D+ S+ ++M RLP P+D
Sbjct: 194 WSFGIVMWEVMSFGERPYWDM-------SNHEVMKAINDGFRLPAPMD 234
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 60/253 (23%)
Query: 333 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF 392
A+K L T++ K F EA ++S H NIVKL G CL + ++I E M+ G L
Sbjct: 30 AVKTLRKGATDQEK--KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 393 CNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL------HHD--CSPSIASTCPDSSN 440
L + L + ++I +A YL H D + S ++
Sbjct: 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDAD 147
Query: 441 RTLLAGTYG----------------------YIAPELAYTMVMTEKCDVYSFGVVTLEVL 478
R + G +G ++APE T + DV+SFGV+ E+L
Sbjct: 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
Query: 479 -MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL-PPPVDRKVIRDILLASTISFACL 531
+G+ P L++ +VL RL P I ++ C
Sbjct: 208 TLGQQPYPALNN-----------QEVLQHVTAGGRLQKPENCPDKIYQLMT------NCW 250
Query: 532 QSNPKSRPTMQYV 544
+P RPT +
Sbjct: 251 AQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 47/262 (17%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+K KV A+K + E E+ I+ + E VLSQ + K YG L
Sbjct: 17 FGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKD 74
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHD------- 426
+++I EY+ GS D +E LD + I++ + L YLH +
Sbjct: 75 TKLWIIMEYLGGGSAL-------DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 427 ---------------CSPSIASTCPDSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
+A D+ R GT ++APE+ K D++S
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFAC 530
G+ +E+ G+ P L + K++ + + + PP ++ + + AC
Sbjct: 188 GITAIELAKGEPPHSELHPM------KVLFL--IPKNNPPTLEGNYSKPL---KEFVEAC 236
Query: 531 LQSNPKSRPTMQYVSQEFLITR 552
L P RPT + + + I R
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVR 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238
L + + L G IP+ + L +L +++LS N + G IPP + + +L LDLS N+ GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 239 PVRL----SPNKGLCGGNFL 254
P L S GN L
Sbjct: 483 PESLGQLTSLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 45/187 (24%), Positives = 69/187 (36%), Gaps = 26/187 (13%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+KA+ G+ ALKK+ E E + L H +VKL H
Sbjct: 13 HGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHG 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYLHHDCSPS-- 430
L+ EYM L L + E + K ++K +A HA +H D P+
Sbjct: 72 SGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130
Query: 431 -IAST---------------CPDSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVV 473
I++ + + T Y APEL Y D+++ G +
Sbjct: 131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190
Query: 474 TLEVLMG 480
E+L G
Sbjct: 191 FAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 52/209 (24%)
Query: 316 DGYGSVYKAQL--PNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 366
+G VYK +L PN + + LK+ + ++ FR EA+++S + H NI
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-----EFRQEAELMSDLQHPNI 70
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSL--FCNLHNNEDAVE-----------LDWAKRVNIV 413
V L G C + +++EY+ G L F ++ V LD + ++I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 414 KAMAHALAYL--HHDCSPSIAS-TCPDSSNRTLLAGTYG--------------------- 449
+A + YL HH +A+ C T+ +G
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 450 -YIAPELAYTMVMTEKCDVYSFGVVTLEV 477
++ PE T + D++SFGVV E+
Sbjct: 191 RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 61/272 (22%), Positives = 100/272 (36%), Gaps = 61/272 (22%)
Query: 318 YGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G V + G+ A+K L+ S E F E ++L + H NIVK G
Sbjct: 17 FGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGV 74
Query: 373 C--LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKR-----VNIVKAMA--HALAYL 423
C + + LI EY+ GSL L + D + L KR I K M + Y+
Sbjct: 75 CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSSQICKGMDYLGSQRYI 131
Query: 424 HHDCSPSIASTCPDSSNRTLLAGTYG-----------------------YIAPELAYTMV 460
H D + A S + +G + APE T
Sbjct: 132 HRDLA---ARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 461 MTEKCDVYSFGVVTLEVLM----GKHPRDLLSSLSSSSDPKIMLIDVLD-----QRLPPP 511
+ DV+SFGV E+ + P + + ++++ +L+ +RLP P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 512 VD-RKVIRDILLASTISFACLQSNPKSRPTMQ 542
+ D++ C ++ P+ RP+
Sbjct: 249 PSCPDEVYDLMK------LCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 28/206 (13%)
Query: 306 NIDVFSIWNYDGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 364
+ ++ + +G V +L N KVFA+K L+ E + A FR E VL ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 365 NIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK----RVNIVKAMAHAL 420
I L+ ++L+ +Y G L L ED + D A+ + I H L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 421 AYLHHDCSP-----------------SIASTCPDSSNRTLLA-GTYGYIAPELAYTMV-- 460
Y+H D P S D + ++ +A GT YI+PE+ M
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 461 ---MTEKCDVYSFGVVTLEVLMGKHP 483
+CD +S GV E+L G+ P
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 33/191 (17%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ G++ A+KK+ E + R E ++L ++ H NI+KL H+
Sbjct: 12 YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHK 70
Query: 377 KCMFLIYEYMKRGSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAY------LHHDCS 428
++L++E+M +L+ + L + + + + LA+ LH D
Sbjct: 71 GDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 429 PS---IASTC--------------PDSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSF 470
P I + T T Y APEL + D++S
Sbjct: 126 PENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185
Query: 471 GVVTLEVLMGK 481
G + E+L +
Sbjct: 186 GCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 65/265 (24%), Positives = 103/265 (38%), Gaps = 49/265 (18%)
Query: 318 YGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G VYK K V A+K + E E+ I+ + E VLSQ I + YG L
Sbjct: 17 FGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYGSYLKG 74
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---------- 426
+++I EY+ GS L L+ I++ + L YLH +
Sbjct: 75 TKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 427 ------------CSPSIASTCPDSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+A D+ R GT ++APE+ K D++S G+
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGIT 190
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV----DRKVIRDILLASTISFA 529
+E+ G+ P +SD M + L + PP K ++ + A
Sbjct: 191 AIELAKGEPP---------NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE------A 235
Query: 530 CLQSNPKSRPTMQYVSQEFLITRKT 554
CL +P+ RPT + + + ITR T
Sbjct: 236 CLNKDPRFRPTAKELLKHKFITRYT 260
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 13/114 (11%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAF-IKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG VYKA+ G++ ALKK+ E E+ F I + R E ++L ++ H NIV+L
Sbjct: 12 YGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTS 69
Query: 376 RKC--MFLIYEYMKR--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425
+ +++++EYM L L + E K +K + L YLH
Sbjct: 70 KGKGSIYMVFEYMDHDLTGL---LDSPEVKFTESQIKC--YMKQLLEGLQYLHS 118
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 22/187 (11%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
GYG V+ A+ + G++ ALK++ S +L ++ E +L+ +VKL Y F
Sbjct: 13 GYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-Q 71
Query: 375 HRKCMFLIYEYMKRG---SLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 430
+ ++L EY+ G +L NL +ED A+ V A+ H L Y+H D P
Sbjct: 72 DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HELGYIHRDLKPE 130
Query: 431 ---IAST----CPD---SSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 476
I ++ D S A G+ Y+APE+ D +S G + E
Sbjct: 131 NFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190
Query: 477 VLMGKHP 483
L G P
Sbjct: 191 FLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 54/230 (23%)
Query: 328 NGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385
+GK+ A+KK L + EL F NE ++ H N+V++Y L ++++ E+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98
Query: 386 MKRGSL---FCNLHNNEDAVELDWAKRVNIVKAMA--HALAYLHHDC-SPSI-------- 431
++ G+L + NE+ + A + ++KA++ HA +H D S SI
Sbjct: 99 LEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155
Query: 432 --------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
A + R L GT ++APEL + + D++S G++ +E++ G+ P
Sbjct: 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 484 RDLLSSLSSSSDPKIMLIDVLDQRLPPP--------------VDRKVIRD 519
++P + + ++ LPP +DR ++RD
Sbjct: 216 --------YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 2e-07
Identities = 26/61 (42%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 151 KLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209
L+ LDLS+N LT IP L NL L++ N+L P A L +L +LDLS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 210 L 210
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 56/195 (28%), Positives = 83/195 (42%), Gaps = 30/195 (15%)
Query: 318 YGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCLH 375
+G V ++ N G+V+A+K L+ E + A FR E VL R I L Y F
Sbjct: 14 FGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-QD 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHALAYLHHDCSP-- 429
++L+ +Y G L L ED + D A+ +V A+ H L Y+H D P
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132
Query: 430 ---------------SIASTCPDSSNRTLLA-GTYGYIAPELAYTM-----VMTEKCDVY 468
S D + ++ +A GT YI+PE+ M +CD +
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 469 SFGVVTLEVLMGKHP 483
S GV E+L G+ P
Sbjct: 193 SLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 53/248 (21%), Positives = 89/248 (35%), Gaps = 49/248 (19%)
Query: 332 FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391
A+K L ++ + F E ++LS++ NI +L G C + +I EYM+ G L
Sbjct: 49 VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 392 --FCNLHNNEDAVELDWAKR----------VNIVKAMAH--ALAYLHHD---------CS 428
F H E + +K I M + +L ++H D +
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166
Query: 429 PSIASTCPDSSNRTLLAGTYGYI-----------APELAYTMVMTEKCDVYSFGVVTLEV 477
+I +R L + Y + A E T K DV++FGV E+
Sbjct: 167 YTIKI-ADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 478 LM--GKHPRDLLSSLSSSSDPKIMLIDVLDQRL---PPPVDRKVIRDILLASTISFACLQ 532
L + P + L+ + D Q PP + + +L C +
Sbjct: 226 LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELML-------ECWR 278
Query: 533 SNPKSRPT 540
+ + RPT
Sbjct: 279 RDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 56/259 (21%), Positives = 97/259 (37%), Gaps = 49/259 (18%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
YGSVYK + L + + +ALK++ S+ E + NE ++L+ V H NI+
Sbjct: 13 YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASVNHPNIISYKEAF 68
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNN--------EDAVELDWAKRVNIVKAMA--HALAYL 423
L + ++ EY G L + E + W + +++ + H L
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQLLRGLQALHEQKIL 125
Query: 424 HHDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
H D + I+ + +T + GT Y+APE+ + K D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPYSYKSDI 184
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
+S G + E+ P + S D + + +PP + L + I
Sbjct: 185 WSLGCLLYEMATFAPPFE----ARSMQDLRYKVQRGKYPPIPPIYSQD------LQNFIR 234
Query: 528 FACLQSNPKSRPTMQYVSQ 546
LQ PK RP +
Sbjct: 235 S-MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 51/264 (19%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+K +V A+K + E E+ I+ + E VLSQ + K YG L
Sbjct: 17 FGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKG 74
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---------- 426
+++I EY+ GS L A D + ++K + L YLH +
Sbjct: 75 TKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 427 ------------CSPSIASTCPDSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+A D+ R GT ++APE+ K D++S G+
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 190
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF----- 528
+E+ G+ P +SD M + L + PP + + F
Sbjct: 191 AIELAKGEPP---------NSDMHPMRVLFLIPKNNPPT-------LTGEFSKPFKEFID 234
Query: 529 ACLQSNPKSRPTMQYVSQEFLITR 552
ACL +P RPT + + + I +
Sbjct: 235 ACLNKDPSFRPTAKELLKHKFIVK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 47/197 (23%), Positives = 74/197 (37%), Gaps = 41/197 (20%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YGSVYKA G+V A+K + E ++ E +L Q IVK YG
Sbjct: 15 SYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 376 RKCMFLIYEYMKRGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------ 424
++++ EY GS+ N E+ + I+ L YLH
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGLEYLHSNKKIH 122
Query: 425 -----------HDCSPSIA----STCPDSSN--RTLLAGTYGYIAPELAYTMVMTEKCDV 467
+ +A S + R + GT ++APE+ + K D+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182
Query: 468 YSFGVVTLEVLMGKHPR 484
+S G+ +E+ GK P
Sbjct: 183 WSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 334 LKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFC 393
L K H + +E SF A ++SQ+ H+++V YG C+ ++ EY+K GSL
Sbjct: 35 LDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 394 NLHNNEDAVELDWAKRVNIVKAMAHALAYL 423
L N++ + + W ++ + K +A AL +L
Sbjct: 89 YLKKNKNLINISW--KLEVAKQLAWALHFL 116
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 36/193 (18%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V + +GK +ALK L ++ +L ++ NE ++L + H +V LYG
Sbjct: 14 FGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD 73
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAMAHALAYLHH------DCS 428
++L+ EY+ G LF + A+ +V AL YLH D
Sbjct: 74 SNLYLVMEYVPGGELF-SHLRKSGRFPEPVARFYAAQVVL----ALEYLHSLDIVYRDLK 128
Query: 429 P---------SIAST----CPDSSNRT-LLAGTYGYIAPELAYTMVMTEKC----DVYSF 470
P I T RT L GT Y+APE +++++ D ++
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPE----IILSKGYGKAVDWWAL 184
Query: 471 GVVTLEVLMGKHP 483
G++ E+L G P
Sbjct: 185 GILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ + + +ALK + E L + NE +VL +V H I++L+ +
Sbjct: 14 FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ 73
Query: 377 KCMFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMA--HALAYLHHDCSPS- 430
+ ++++ EY+ G LF L N+ ++ L +A IV A+ H+ ++ D P
Sbjct: 74 RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--IVCALEYLHSKEIVYRDLKPEN 131
Query: 431 --------IAST----CPDSSNRT-LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 477
I T +RT L GT Y+APE+ + + D ++ G++ E+
Sbjct: 132 ILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
Query: 478 LMGKHP 483
L+G P
Sbjct: 192 LVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 55/220 (25%)
Query: 318 YGSVYKAQ----LPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V+ A+ LP + A+K L E E A + F+ EA++L+ + H++IV+ YG
Sbjct: 18 FGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLTVLQHQHIVRFYG 74
Query: 372 FCLHRKCMFLIYEYMKRGSL--FCNLHNNEDAVELDWAKRV-----------NIVKAMAH 418
C + + +++EYM+ G L F H DA L + V I +A
Sbjct: 75 VCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKILAGGEDVAPGQLTLGQMLAIASQIAS 133
Query: 419 ALAYL------HHDCSPSIASTCPDSSNRTLLAGTYG----------------------Y 450
+ YL H D + C + G +G +
Sbjct: 134 GMVYLASLHFVHRDLA---TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 451 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489
+ PE T + D++SFGVV E+ GK P LS+
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 56/241 (23%)
Query: 333 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL- 391
A+K L TE+ + F +EA ++ Q H NI+ L G K + ++ EYM+ GSL
Sbjct: 36 AIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 392 -FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDSSNRTLL 444
F H+ + V + V +++ +A + YL H D + A +SN
Sbjct: 94 AFLRKHDGQFTV----IQLVGMLRGIASGMKYLSDMGYVHRDLA---ARNILVNSNLVCK 146
Query: 445 AGTYGYIA-----PELAYTMV------------------MTEKCDVYSFGVVTLEVL-MG 480
+G PE AYT T DV+S+G+V EV+ G
Sbjct: 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 206
Query: 481 KHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSR 538
+ P +S+ +I +++ RLP P+D L+ C Q + R
Sbjct: 207 ERPYWEMSNQD--------VIKAIEEGYRLPAPMDCPAALHQLM-----LDCWQKDRNER 253
Query: 539 P 539
P
Sbjct: 254 P 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 27/164 (16%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
NL L + +PPEI LS L+ LDLS+N + + + NLKNL L + +N
Sbjct: 186 SNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 186 LIGPI---------------------PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL 224
L S+LGSLTNL LDLS N LS P IA + L
Sbjct: 244 LEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLS-NALPLIALLLLL 302
Query: 225 TWLDLSNNNIKGSIPVRLS---PNKGLCGGNFLDLPSCDTTKPA 265
L L+ ++ ++L+ N + P + +
Sbjct: 303 LELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILES 346
|
Length = 394 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 56/260 (21%)
Query: 328 NGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385
+G+ A+K L + EL F NE ++ H+N+V++Y L + ++++ E+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99
Query: 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------SPSI------- 431
++ G+L + L+ + + +++ AL YLH S SI
Sbjct: 100 LQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 432 ---------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 482
A D R L GT ++APE+ + D++S G++ +E++ G+
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 483 PRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK------VIRDILLASTISFACLQSNPK 536
P SD + + L PPP + V+RD L L P+
Sbjct: 216 P--------YFSDSPVQAMKRLRDS-PPPKLKNAHKISPVLRDFLE------RMLTREPQ 260
Query: 537 SRPTMQYVSQE-FLITRKTP 555
R T Q + FL+ P
Sbjct: 261 ERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 51/268 (19%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN---EAQVLSQVLHRNIVKLYGFCL 374
YG+VY G++ A+K++ + LA K + E +L + H NIV+ G CL
Sbjct: 13 YGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------- 426
+ + E++ GS+ L+ E + K K + +AYLH++
Sbjct: 73 DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNCVVHRDIK 129
Query: 427 ------------------CSPSIASTCPDSSNRTLLAGTYG---YIAPELAYTMVMTEKC 465
C+ +A ++ +L +G ++APE+ K
Sbjct: 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKS 189
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIRDILLAS 524
D++S G E+ GK P +S D + + R P + D A+
Sbjct: 190 DIWSIGCTVFEMATGKPPL-------ASMDRLAAMFYIGAHRGLMPRLP-----DSFSAA 237
Query: 525 TISF--ACLQSNPKSRPT-MQYVSQEFL 549
I F +CL + RP+ +Q + +FL
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 43/253 (16%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ N A+K L +++F EA ++ + H +V+LY +
Sbjct: 19 FGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA------YLHHD----- 426
+++I EYM +GSL L ++E ++ K ++ +A +A Y+H D
Sbjct: 75 PIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN 133
Query: 427 --CSPSIASTCPDSS-NRTLLAGTY----------GYIAPELAYTMVMTEKCDVYSFGVV 473
S S+ D R + Y + APE T K DV+SFG++
Sbjct: 134 VLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 193
Query: 474 TLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV-IRDILLASTISFACL 531
E++ GK P S+ +M R+P + + DI+ C
Sbjct: 194 LYEIVTYGKIP------YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK------TCW 241
Query: 532 QSNPKSRPTMQYV 544
+ + RPT Y+
Sbjct: 242 KEKAEERPTFDYL 254
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 66/278 (23%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375
+ +V A+ K +A+K L + + +K + E +VL+++ H I+KLY
Sbjct: 14 FSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD 73
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H----- 425
+ ++ + EY G L + LD + AL YLH H
Sbjct: 74 EENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLHSKGIIHRDLKP 130
Query: 426 ----------------------DCSPSIASTCPDS-----------SNRTLLAGTYGYIA 452
D + S S D+ GT Y++
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190
Query: 453 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML-IDVLDQRLPP- 510
PEL + D+++ G + ++L GK P S++ I L+ PP
Sbjct: 191 PELLNEKPAGKSSDLWALGCIIYQMLTGKPP------FRGSNEYLTFQKILKLEYSFPPN 244
Query: 511 -PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547
P D K + + L L +P+ R + E
Sbjct: 245 FPPDAKDLIEKL---------LVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 28/192 (14%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
G+G V Q+ GK++A KKL ++ + NE ++L +V R IV L Y F
Sbjct: 5 GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-- 62
Query: 375 HRKC-MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DC 427
K + L+ M G L +++N + A+ + + L +LH D
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQRRIVYRDL 121
Query: 428 SPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
P +A AGT GY+APE+ V D ++ G
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181
Query: 472 VVTLEVLMGKHP 483
E++ G+ P
Sbjct: 182 CTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 60/258 (23%), Positives = 94/258 (36%), Gaps = 51/258 (19%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YGSVYK P G A+K++ E +E F E +L + + IV YG
Sbjct: 14 YGSVYKVLHRPTGVTMAMKEIRL-ELDESKF-NQIIMELDILHKAVSPYIVDFYGAFFIE 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL-------HHDCSP 429
+++ EYM GSL + I A+ L +L H D P
Sbjct: 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKP 131
Query: 430 S--IAST------CPDSSNRTLLA-------GTYGYIAPELAYTMVMTE------KCDVY 468
+ + + C + L+A G Y+APE + + + DV+
Sbjct: 132 TNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 469 SFGVVTLEVLMGKHP------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522
S G+ LE+ +G++P ++ + LS+ ++D LP
Sbjct: 192 SLGLSILEMALGRYPYPPETYANIFAQLSA-------IVDGDPPTLPSGYSDD------- 237
Query: 523 ASTISFACLQSNPKSRPT 540
A CL P RPT
Sbjct: 238 AQDFVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 55/263 (20%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A+K L AF++ EAQ++ ++ H +V LY + +
Sbjct: 19 FGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA-VVSEE 73
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA------YLHHDCSPS- 430
++++ E+M +GSL + D L + V++ +A +A Y+H D +
Sbjct: 74 PIYIVTEFMGKGSLL-DFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAAN 132
Query: 431 ---------------IASTCPDSSNRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVV 473
+A D+ + + APE A T K DV+SFG++
Sbjct: 133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192
Query: 474 TLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLASTI 526
E V G+ P P ++ +VL+Q R+P P + + +++
Sbjct: 193 LTELVTKGRVPY-----------PGMVNREVLEQVERGYRMPCPQGCPESLHELMK---- 237
Query: 527 SFACLQSNPKSRPTMQYVSQEFL 549
C + +P RPT +Y+ Q FL
Sbjct: 238 --LCWKKDPDERPTFEYI-QSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 61/258 (23%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V++ N A+K L + + + + F+ E Q L ++ H++++ L+ C +
Sbjct: 19 FGEVWEGLWKNRVRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKHLISLFAVCSVGE 75
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPD 437
+++I E M++GSL L + E V L A +++ +A +AYL S D
Sbjct: 76 PVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE-----EQNSIHRD 129
Query: 438 SSNRTLLAGT----------------------------YGYIAPELAYTMVMTEKCDVYS 469
+ R +L G Y + APE A + K DV+S
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189
Query: 470 FGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PPVDRKVIRDILL 522
FG++ E+ G+ P P + +V DQ R+P P + I I+L
Sbjct: 190 FGILLYEMFTYGQVPY-----------PGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238
Query: 523 ASTISFACLQSNPKSRPT 540
C + P+ RP+
Sbjct: 239 ------ECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 5/73 (6%)
Query: 318 YGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
YG VYKA+ N GK +A+KK + + +S E +L ++ H N+V L L
Sbjct: 13 YGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL 72
Query: 375 HR--KCMFLIYEY 385
K ++L+++Y
Sbjct: 73 EHADKSVYLLFDY 85
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 32/243 (13%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+VYKA L ++ A+K + T EL K +E ++L + I+ YG
Sbjct: 15 GTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFYGAFFVEN 72
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH--ALAYLHHDCSPSI---- 431
+ + E+M GSL E + V +VK + + +L LH D PS
Sbjct: 73 RISICTEFMDGGSLDVYRKIPEHVLG---RIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129
Query: 432 -----------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 480
ST +S GT Y+APE DV+S G+ +E+ +G
Sbjct: 130 TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
Query: 481 KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST-ISF--ACLQSNPKS 537
+ P + S P +L ++D+ P V+ + + F C++ PK
Sbjct: 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPP------VLPVGQFSEKFVHFITQCMRKQPKE 243
Query: 538 RPT 540
RP
Sbjct: 244 RPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 60/266 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQVLHRNIVKL 369
YG VY A + G++ A+K++ T + +K+ R+E + L + H NIV+
Sbjct: 14 YGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQY 73
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHH 425
GF + + + EY+ GS+ L E V + + LAYLH
Sbjct: 74 LGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGLAYLH- 125
Query: 426 DCSPSI--------------ASTCP--------------DSSNRTLLAGTYGYIAPEL-- 455
S I C D+ + G+ ++APE+
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 456 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515
+Y+ + K D++S G V LE+ G+ P ++++ + + ++R PP+
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-------MFKLGNKRSAPPIPPD 236
Query: 516 VIRDIL-LASTISFACLQSNPKSRPT 540
V ++ +A AC NP +RPT
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 57/259 (22%), Positives = 106/259 (40%), Gaps = 54/259 (20%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G+V + + KV A+K + T + +F E V++++ H+N+V+L G LH
Sbjct: 19 FGAVLQGEYTGQKV-AVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP-- 429
++++ E M +G+L L A+ + + + +A + YL H D +
Sbjct: 73 -LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130
Query: 430 --------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475
+A + + L + APE + K DV+S+GV+
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VKWTAPEALKHKKFSSKSDVWSYGVLLW 188
Query: 476 EVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRDILLASTISFA 529
EV G+ P PK+ L +V + R+ PP +L+ S
Sbjct: 189 EVFSYGRAPY-----------PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS----- 232
Query: 530 CLQSNPKSRPTMQYVSQEF 548
C ++ PK RP+ + ++
Sbjct: 233 CWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 56/268 (20%), Positives = 112/268 (41%), Gaps = 50/268 (18%)
Query: 318 YGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG V K + G++ A+KK SE +++ + R E ++L Q+ H N+V L +
Sbjct: 14 YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRK 72
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYLHHDCSPS-- 430
K ++L++E++ ++ +L + ++ ++ I++ + H+ +H D P
Sbjct: 73 KRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131
Query: 431 ------IASTCPDSSNRTLLAG---------TYGYIAPELAYTMVMTEK----CDVYSFG 471
+ C RTL A T Y APEL +V K D+++ G
Sbjct: 132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDTKYGRAVDIWAVG 188
Query: 472 VVTLEVLMGK-------------HPRDLLSSLSS------SSDPKIMLIDVLDQRLPPPV 512
+ E+L G+ H L +L +P + + + + P+
Sbjct: 189 CLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPL 248
Query: 513 DRKVIRDILLASTISFACLQSNPKSRPT 540
+++ + L ++ CL+ +P RP+
Sbjct: 249 EKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 32/90 (35%), Positives = 55/90 (61%), Gaps = 7/90 (7%)
Query: 334 LKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFC 393
LK L + + LAF ++ A ++SQ+ H+++VKLYG C+ + + ++ EY+K G L
Sbjct: 35 LKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDV 89
Query: 394 NLHNNEDAVELDWAKRVNIVKAMAHALAYL 423
LH ++ V L W ++++ K +A AL YL
Sbjct: 90 FLHREKNNVSLHW--KLDVAKQLASALHYL 117
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 39/202 (19%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHT------SETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+GSVY +G++ A+K++ S+ + + + + E +L ++ H NIV+
Sbjct: 13 FGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYL 72
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----- 425
G L + + EY+ GS+ L NN A E + N V+ + L YLH+
Sbjct: 73 GSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVR--NFVRQILKGLNYLHNRGIIH 129
Query: 426 ----------DCSPSI--------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVM 461
D I + + + R L G+ ++APE+
Sbjct: 130 RDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189
Query: 462 TEKCDVYSFGVVTLEVLMGKHP 483
T K D++S G + +E+L GKHP
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 58/267 (21%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ +L + A+K + +L F EA++L Q H NIV+L G C +
Sbjct: 8 FGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIGVCTQK 65
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
+ ++++ E ++ G L + L + + +V+ A + YL H D +
Sbjct: 66 QPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA-- 121
Query: 431 IASTCPDSSNRTLLAGTYG----------------------YIAPE-LAYTMVMTEKCDV 467
A C + L +G + APE L Y +E DV
Sbjct: 122 -ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES-DV 179
Query: 468 YSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPP--VDRKVIRDILL 522
+SFG++ E +G P LS+ + + ++Q RLP P V R +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCPELCPDAVYRLME- 230
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549
C + +P RP+ V QE
Sbjct: 231 ------RCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 40/183 (21%)
Query: 329 GKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386
G+ A+KK L + EL F NE ++ H NIV++Y L ++++ E++
Sbjct: 44 GRQVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98
Query: 387 KRGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC-SPSI----- 431
+ G+L + NE+ + + A+ AL++L H D S SI
Sbjct: 99 EGGALTDIVTHTRMNEEQI-------ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151
Query: 432 -----------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 480
A + R L GT ++APE+ + + D++S G++ +E++ G
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
Query: 481 KHP 483
+ P
Sbjct: 212 EPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 24/152 (15%)
Query: 350 SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF------CNLHNNEDAVE 403
+ +NE QVL + H NI++ Y L K + ++ EY G+L CN +ED +
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI- 103
Query: 404 LDWAKRVNIVKAMAHALAYLHHDCSPS-----------------IASTCPDSSNRTLLAG 446
L + ++ + H LH D I+ S + G
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG 163
Query: 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 478
T YI+PEL +K D+++ G V E+
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 9e-06
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 25/122 (20%)
Query: 316 DG-YGSVYKAQ-LPNGKVFALKKL-----HTSETEELAFIKSFR--NEAQVLSQVLHRNI 366
DG +GSVY A+ G++ A+KK+ E L +KS R NE H NI
Sbjct: 9 DGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE--------HPNI 60
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHALAYL 423
VKL ++ ++EYM+ NL+ + + +I+ + LA++
Sbjct: 61 VKLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 424 HH 425
H
Sbjct: 116 HK 117
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 62/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 317 GYGSVYKAQL----PNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 367
G GS KA L +GK + +K K+ E EE R E VLS + H NIV
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES------RKEVAVLSNMKHPNIV 62
Query: 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALA 421
+ ++++ +Y + G L+ ++ ED + LDW ++ + H
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQICLALKHVHDRK 121
Query: 422 YLHHDCSPSIASTCPDSS------------NRTL-LA----GTYGYIAPELAYTMVMTEK 464
LH D D + N T+ LA GT Y++PE+ K
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 465 CDVYSFGVVTLEVLMGKHP------RDLLSSLSSSSDPKI---------MLIDVLDQRLP 509
D+++ G V E+ KH ++L+ + S P + L+ L +R
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR-- 239
Query: 510 PPVDRKVIRDIL 521
P DR + IL
Sbjct: 240 NPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 58/255 (22%), Positives = 109/255 (42%), Gaps = 48/255 (18%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A+K L AF+ EA ++ Q+ H +V+LY + ++
Sbjct: 19 FGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA-VVTQE 73
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD----- 426
+++I EYM+ GSL L + ++L K +++ +A +A++ H D
Sbjct: 74 PIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAAN 132
Query: 427 --CSPSIASTCPDSS-NRTLLAGTY----------GYIAPELAYTMVMTEKCDVYSFGVV 473
S ++ D R + Y + APE T K DV+SFG++
Sbjct: 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 192
Query: 474 TLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-RKVIRDILLASTISFA 529
E V G+ P ++P++ I L++ R+P P + + + +++
Sbjct: 193 LTEIVTYGRIP------YPGMTNPEV--IQNLERGYRMPRPDNCPEELYELMR------L 238
Query: 530 CLQSNPKSRPTMQYV 544
C + P+ RPT +Y+
Sbjct: 239 CWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 45/194 (23%)
Query: 329 GKVFALKKLHTSETEELAFIKSFR-------------NEAQVLSQVLHRNIVKL-YGFCL 374
GKVF ++K+ + +L +K + E +L++V H IVKL Y F
Sbjct: 10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69
Query: 375 HRKCMFLIYEYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMA----HALAYLHHD 426
K ++LI ++++ G LF L E+ V+ A+ A+A H+L ++ D
Sbjct: 70 EGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALALDHLHSLGIIYRD 123
Query: 427 CSPS----------------IASTCPDSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYS 469
P ++ D + GT Y+APE+ T+ D +S
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWS 183
Query: 470 FGVVTLEVLMGKHP 483
FGV+ E+L G P
Sbjct: 184 FGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 13/116 (11%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G VYKA Q+ G+V ALKK+ ++ I + R E ++L ++ H N+V L + R
Sbjct: 21 FGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVER 79
Query: 377 --------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
++++ YM L N V+L ++ + + + YLH
Sbjct: 80 PDKSKRKRGSVYMVTPYMD--HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH 132
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 63/265 (23%), Positives = 102/265 (38%), Gaps = 66/265 (24%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ L G++ A+K + ++ + I+ E ++ + H NIV +G L R
Sbjct: 22 YGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHCNIVAYFGSYLSR 78
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---------- 426
+ +++ EY GSL H EL A + + LAYLH
Sbjct: 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLHSKGKMHRDIKGA 135
Query: 427 ----------------CSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK------ 464
+ I +T + R GT ++APE+A EK
Sbjct: 136 NILLTDNGDVKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVA----AVEKNGGYNQ 188
Query: 465 -CDVYSFGVVTLEV------LMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517
CD+++ G+ +E+ + HP L +S S+ PP + K
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ------------PPKLKDKTK 236
Query: 518 RDILLASTISFACLQSNPKSRPTMQ 542
+ + + L NPK RPT +
Sbjct: 237 WSSTFHNFVKIS-LTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 334 LKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF 392
LK L S + LAF ++ A ++ QV H++IV LYG C+ ++ E+++ G L
Sbjct: 37 LKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 393 CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 423
+H D + W + + K +A AL+YL
Sbjct: 93 LFMHRKSDVLTTPW--KFKVAKQLASALSYL 121
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 18/123 (14%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ + ALKK+ + +E + R E +L ++ H NIV+L
Sbjct: 15 YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSE 73
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVK----------AMAHALAYLHHD 426
K ++L++EY L +L + D+ D+AK ++K A H+ LH D
Sbjct: 74 KRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 427 CSP 429
P
Sbjct: 128 LKP 130
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 38/185 (20%)
Query: 330 KVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386
+V+A+K L E + AF F E +++ IV+L+ K ++++ EYM
Sbjct: 69 QVYAMKLLSKFEMIKRSDSAF---FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125
Query: 387 KRGSLFCNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPSIASTCPDSSNRT 442
G L NL +N D E WA+ +V A+ H++ ++H D P + D S
Sbjct: 126 PGGDL-VNLMSNYDIPE-KWARFYTAEVVLALDAIHSMGFIHRDVKPD--NMLLDKSGHL 181
Query: 443 LLA--------------------GTYGYIAPEL----AYTMVMTEKCDVYSFGVVTLEVL 478
LA GT YI+PE+ +CD +S GV E+L
Sbjct: 182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 479 MGKHP 483
+G P
Sbjct: 242 VGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 32/197 (16%)
Query: 317 GYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
G G+ + QL + KV+A+K L E + + F E +++ +V+L+
Sbjct: 52 GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHALAYLHHDCS 428
K ++++ EYM G L NL +N D E WAK +V A+ H++ +H D
Sbjct: 112 FQDDKYLYMVMEYMPGGDL-VNLMSNYDVPE-KWAKFYTAEVVLALDAIHSMGLIHRDVK 169
Query: 429 P-------------SIASTCPDSSNRTLL-----AGTYGYIAPELAYTM----VMTEKCD 466
P + TC ++ GT YI+PE+ + +CD
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 467 VYSFGVVTLEVLMGKHP 483
+S GV E+L+G P
Sbjct: 230 WWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 329 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYM 386
G++ A+K L ++ ++ E +L + H NIVK G C + K + LI EY+
Sbjct: 33 GEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 387 KRGSLFCNL--HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLL 444
GSL L H A L +A+++ A H+ Y+H D + A ++R +
Sbjct: 91 PLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLA---ARNVLLDNDRLVK 147
Query: 445 AGTYG-----------------------YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-- 479
G +G + A E + DV+SFGV E+L
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207
Query: 480 --GKHPRDLLSSL---SSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQ 532
+ P + + LI++L+ RLP P + IL+ + C +
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKN-----CWE 262
Query: 533 SNPKSRPTMQYVSQEF 548
+ K RPT + +
Sbjct: 263 TEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 55/234 (23%), Positives = 84/234 (35%), Gaps = 54/234 (23%)
Query: 317 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V+ + G+V+A+K L S+ + I R E +L+ IVKLY
Sbjct: 13 AFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHALAYLHHDCSP-- 429
+ ++L+ EYM G L NL +D + A+ +V A+ H L ++H D P
Sbjct: 73 EEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDN 131
Query: 430 --------------------------------SIASTCPDSSN------------RTLLA 445
S D+
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTV 191
Query: 446 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499
GT YIAPE+ +CD +S GV+ E+L G P S + KI+
Sbjct: 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP--FYSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 3e-05
Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
TNL LDLS+N+++ +PP ++ + NL LDLS N I
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 40/153 (26%), Positives = 56/153 (36%), Gaps = 47/153 (30%)
Query: 363 HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 422
+ N +KLY K LI +Y+K G LF L L A+ I++ + AL
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124
Query: 423 LH-----HD-----------------------CSPSIASTCPDSSNRTLLAGTYGYIAPE 454
LH H+ C +C D GT Y +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPE 176
Query: 455 ----LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
Y + D ++ GV+T E+L GKHP
Sbjct: 177 KIKGHNYDVSF----DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 37/192 (19%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+VY A + G+ A+K+++ + + I NE V+ + H NIV L
Sbjct: 33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELII---NEILVMRENKHPNIVNYLDSYLVGD 89
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDC------- 427
++++ EY+ GSL D V +D + + + AL +LH +
Sbjct: 90 ELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 428 SPSI----------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
S +I A P+ S R+ + GT ++APE+ K D++S G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 472 VVTLEVLMGKHP 483
++ +E++ G+ P
Sbjct: 203 IMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 54/234 (23%), Positives = 88/234 (37%), Gaps = 68/234 (29%)
Query: 328 NGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384
G ++A+KKL S E E++A +++ R+ +L++ + +VKLY ++LI E
Sbjct: 25 TGHIYAMKKLRKSEMLEKEQVAHVRAERD---ILAEADNPWVVKLYYSFQDENYLYLIME 81
Query: 385 YMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHD-------------- 426
Y+ G + L E+ A+ + + ++ H L Y+H D
Sbjct: 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI-HKLGYIHRDIKPDNLLLDAKGHI 140
Query: 427 -------C----------------------SPSIASTCPDSS--------NRTLLA---- 445
C S S NR LA
Sbjct: 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200
Query: 446 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499
GT YIAPE+ ++CD +S GV+ E+L+G P S + KI+
Sbjct: 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP--FCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 57/258 (22%), Positives = 109/258 (42%), Gaps = 48/258 (18%)
Query: 328 NGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385
GK A+KK L + EL F NE ++ H N+V +Y L ++++ E+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100
Query: 386 MKRGSL---FCNLHNNEDAVELDWAKRVNIVKAMA--HALAYLHHDC-SPSI-------- 431
++ G+L + NE+ + +++++A++ H +H D S SI
Sbjct: 101 LEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI 157
Query: 432 --------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
A + R L GT ++APE+ + + D++S G++ +E++ G+ P
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 484 RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQY 543
++P + + + LPP V +D S++ L P+ +
Sbjct: 218 --------YFNEPPLQAMRRIRDNLPPRV-----KDSHKVSSVLRGFLDLMLVREPSQRA 264
Query: 544 VSQEFLITRKTPLVKHAA 561
+QE L + P +K A
Sbjct: 265 TAQELL---QHPFLKLAG 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 56/242 (23%), Positives = 90/242 (37%), Gaps = 56/242 (23%)
Query: 338 HTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLH 396
H+SE E L +E +++S + H NIV L G C + +I EY G L L
Sbjct: 78 HSSEREALM------SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131
Query: 397 NNEDAVELDWAKRVNIVKAMAHALAYL------HHD--------CSPSIASTCP------ 436
++ L ++ +A +A+L H D I C
Sbjct: 132 RKRESF-LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 437 --DSSNRTLLAGTY---GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 491
+ SN + ++APE + V T + DV+S+G++ E+ SL
Sbjct: 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF----------SLG 240
Query: 492 SSSDPKIM-------LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYV 544
S+ P + LI + P I DI+ C ++P RPT + +
Sbjct: 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK------TCWDADPLKRPTFKQI 294
Query: 545 SQ 546
Q
Sbjct: 295 VQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 51/272 (18%)
Query: 317 GYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G+VYK +P G+ + K+ T A ++ F +EA +++ + H ++V+L G
Sbjct: 19 AFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVRLLGV 77
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAH--ALAYLHHD 426
CL + L+ + M G L +H ++D + L+W V I K M + +H D
Sbjct: 78 CL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMMYLEERRLVHRD 134
Query: 427 CSP-SIASTCPDSSNRT------LLAGT------------YGYIAPELAYTMVMTEKCDV 467
+ ++ P+ T LL G ++A E + T + DV
Sbjct: 135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 194
Query: 468 YSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLP-PPVDRKVIRDILLA 523
+S+GV E++ G P D + P + D+L+ +RLP PP+ D+ +
Sbjct: 195 WSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQPPI---CTIDVYM- 242
Query: 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
+ C + SRP + ++ EF + P
Sbjct: 243 --VMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 10/78 (12%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFC 373
YG+VYKA+ L G+ ALKK+ +EE + + R E +L Q+ H NIV+L C
Sbjct: 12 YGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVC 70
Query: 374 ----LHRKC-MFLIYEYM 386
R+ + L++E++
Sbjct: 71 HGPRTDRELKLTLVFEHV 88
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 305 NNIDVFSIWNYDGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 363
++ ++ + +G V ++ + +++A+K L+ E + A FR E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 364 RNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHA 419
+ I L+ ++L+ +Y G L L ED + D A+ +V A+ H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 420 LAYLHHDCSP-----------------SIASTCPDSSNRTLLA-GTYGYIAPELAYTM-- 459
L Y+H D P S D + ++ +A GT YI+PE+ M
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 460 ---VMTEKCDVYSFGVVTLEVLMGKHP 483
+CD +S GV E+L G+ P
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 50/228 (21%), Positives = 83/228 (36%), Gaps = 52/228 (22%)
Query: 349 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK 408
+ F EA L Q H NIV+L G M ++ EYM G+L L +E +L +
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQ 108
Query: 409 RVNIVKAMAHALAYL------------HH-------DCSPSIASTCPDSSNRTLLAGTYG 449
+ ++ +A + YL H C S + + + G
Sbjct: 109 LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 450 -----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPK 497
+ APE + DV+SFG+V EV+ G+ P +D++ ++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--- 225
Query: 498 IMLIDVLDQRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYV 544
RLP P + ++ ++L C Q RP +
Sbjct: 226 ---------RLPAPRNCPNLLHQLML------DCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 60/265 (22%), Positives = 99/265 (37%), Gaps = 58/265 (21%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ + G++ A+K + E+ A ++ E ++ H NIV +G L R
Sbjct: 22 YGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKHSNIVAYFGSYLRR 78
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---------- 426
+++ E+ GSL H E A + + L YLH
Sbjct: 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYLHSKGKMHRDIKGA 135
Query: 427 ----------------CSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMV---MTEKCDV 467
S I +T + R GT ++APE+A + CD+
Sbjct: 136 NILLTDNGHVKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192
Query: 468 YSFGVVTLEV------LMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521
++ G+ +E+ + HP L ++ S+ PP + K+
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ------------PPKLKDKMKWSNS 240
Query: 522 LASTISFACLQSNPKSRPTMQYVSQ 546
+ A L NPK RPT + + Q
Sbjct: 241 FHHFVKMA-LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 8/80 (10%)
Query: 318 YGSVYKAQLPN---GKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V++A+ P + F A+K L E F+ EA ++++ H NIVKL G
Sbjct: 18 FGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNIVKLLG 75
Query: 372 FCLHRKCMFLIYEYMKRGSL 391
C K M L++EYM G L
Sbjct: 76 VCAVGKPMCLLFEYMAYGDL 95
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 46/199 (23%), Positives = 74/199 (37%), Gaps = 35/199 (17%)
Query: 320 SVYKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF----C 373
S+YK N +V KK H I NE + L ++ NI+K+YGF
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHK---VLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDC 427
+ LI EY RG L L +D L + ++++ L L+ +
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148
Query: 428 SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMV-----------------MTEKCDVYSF 470
S++ ++ ++ I + V T K D+YS
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 471 GVVTLEVLMGKHPRDLLSS 489
GVV E+ GK P + L++
Sbjct: 209 GVVLWEIFTGKIPFENLTT 227
|
Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 37/192 (19%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+V+ A + G+ A+K+++ + + I NE V+ ++ + NIV L
Sbjct: 33 GTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLDSFLVGD 89
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHD-------- 426
+F++ EY+ GSL D V +D A+ + + AL +LH +
Sbjct: 90 ELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 427 -------CSPSI--------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
S+ A P+ S R+ + GT ++APE+ K D++S G
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 472 VVTLEVLMGKHP 483
++ +E++ G+ P
Sbjct: 203 IMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 346 AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLIYEYMKRGSLFCNLHNNEDAVEL 404
A ++F EA V++Q+ H N+V+L G + K ++++ EYM +GSL L + +V L
Sbjct: 41 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-L 99
Query: 405 DWAKRVNIVKAMAHALAYL------HHDCSP--------SIAS------TCPDSSNRTLL 444
+ + A+ YL H D + ++A T SS +
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
Query: 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 477
+ APE + K DV+SFG++ E+
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 330 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389
KV+A+K L E + + F E +++ +V+L+ + ++++ EYM G
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128
Query: 390 SLFCNLHNNEDAVELDWAK--RVNIVKAM--AHALAYLHHDCSP-------------SIA 432
L NL +N D E WA+ +V A+ H++ ++H D P +
Sbjct: 129 DL-VNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186
Query: 433 STCPDSSNRTLL-----AGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 483
TC + ++ GT YI+PE+ + +CD +S GV E+L+G P
Sbjct: 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 74/305 (24%)
Query: 301 ERATNNIDVFSIWNYDG------YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN 353
E ++D +W G +G VYKA+ G + A K + T EEL + +
Sbjct: 2 EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMV 58
Query: 354 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN-- 411
E ++L+ H IVKL G ++++ E+ G++ DA+ L+ + +
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEP 110
Query: 412 ----IVKAMAHALAYLHH-----------------DCSPSIASTCPDSSN------RTLL 444
I + M AL YLH D +A + N R
Sbjct: 111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170
Query: 445 AGTYGYIAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499
GT ++APE+ M + K D++S G+ +E+ + P L +P +
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRV 223
Query: 500 LIDVLDQRLPPPVDRKV-----IRDILLASTISFACLQSNPKSRPT-MQYVSQEFL--IT 551
L+ + PP + + RD L + L +P++RP+ Q + F+ +T
Sbjct: 224 LLKIAKSE-PPTLSQPSKWSMEFRDFLKTA------LDKHPETRPSAAQLLEHPFVSSVT 276
Query: 552 RKTPL 556
PL
Sbjct: 277 SNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 26/116 (22%)
Query: 432 ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD------ 485
A+T D RT GT Y+APE+ ++K D++S GV+ E+L K P D
Sbjct: 194 AATVSDDVGRTF-CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
Query: 486 -LLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
+ +L+ DP LPP + ++ I A L S+PK RP+
Sbjct: 253 VMHKTLAGRYDP-----------LPPSISPEM-------QEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 26/137 (18%)
Query: 306 NIDVFSIWNYDG---YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 361
+D F I G YG VYKA+ G++ ALKK+ +E I + R E ++L Q+
Sbjct: 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL 63
Query: 362 LHRNIVKLY----------GFCLHRKCMFLIYEYMKR---GSLFCNL-HNNEDAVELDWA 407
HRNIV L F + +L++EYM G L L H +ED ++
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK---- 119
Query: 408 KRVNIVKAMAHALAYLH 424
+ +K + L Y H
Sbjct: 120 ---SFMKQLLEGLNYCH 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 63/267 (23%), Positives = 94/267 (35%), Gaps = 66/267 (24%)
Query: 329 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYM 386
G+ A+K L I + E ++L + H NIVK G C + LI E++
Sbjct: 33 GEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 387 KRGSLFCNLHNNEDAVELDWAKR--VNIVKAMAH--ALAYLHHDCSPSIASTCPDSSNRT 442
GSL L N++ + L + V I K M + + Y+H D + A S
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA---ARNVLVESEHQ 147
Query: 443 LLAGTYG-----------------------YIAPELAYTMVMTEKCDVYSFGVVTLEVLM 479
+ G +G + APE DV+SFGV E
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE--- 204
Query: 480 GKHPRDLLSSLSSSSDPKIM----------------LIDVLDQ--RLPPPVDRKVIRDIL 521
LL+ S S P + L+ VL++ RLP P + L
Sbjct: 205 ------LLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQL 258
Query: 522 LASTISFACLQSNPKSRPTMQYVSQEF 548
+ C + P R T Q + + F
Sbjct: 259 MRK-----CWEFQPSKRTTFQNLIEGF 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 65/274 (23%), Positives = 97/274 (35%), Gaps = 76/274 (27%)
Query: 318 YGSVYKAQ---LPNGKV---FALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKL 369
+G VY+ V A+K L SE +E F+ EA ++S+ H+NIV+L
Sbjct: 19 FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL----MEALIMSKFNHQNIVRL 74
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL-- 423
G R F++ E M G L L N E L + + +A YL
Sbjct: 75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134
Query: 424 ----HHDCSPSIAS-----TCPDSSNRTLLAGTYG----------------------YIA 452
H D IA+ TC R +G ++
Sbjct: 135 NHFIHRD----IAARNCLLTCKGPG-RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 453 PELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511
PE + T K DV+SFGV+ E+ +G P ++ ++M RL PP
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP------YPGRTNQEVMEFVTGGGRLDPP 243
Query: 512 VD-----RKVIRDILLASTISFACLQSNPKSRPT 540
+++ D C Q P+ RP
Sbjct: 244 KGCPGPVYRIMTD----------CWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 50/226 (22%)
Query: 351 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG-------SLFCNLHNNEDAVE 403
F NEA V+ + ++V+L G + +I E M RG SL + NN
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 404 LDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDSSNRTLLAGTYG-------- 449
K + + +A +AYL H D + A C + + T+ G +G
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 450 --------------YIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDLLSSLSSSS 494
+++PE V T DV+SFGVV E+ + + P +S+
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----- 227
Query: 495 DPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
+ +L V++ L D D+L + C Q NPK RP+
Sbjct: 228 --EQVLRFVMEGGLLDKPDN--CPDMLF--ELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 50/265 (18%)
Query: 318 YGSVYKAQLPNG--KVFALKKLH-------TSETEELAFIKSFRNEAQVLSQVL-HRNIV 367
+G VYK + N + ALK+++ + E I +E ++ + L H NIV
Sbjct: 13 FGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72
Query: 368 KLYGFCLHRKCMFLIYEYMKRGSL---FCNLHNNEDAVELDWAKRV-NIVKAMAHALAYL 423
+ Y L ++++ + ++ L F +L + +R+ NI M AL YL
Sbjct: 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVLALRYL 129
Query: 424 H-------HDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMV 460
H D +P+ +A S T + GT Y PE+
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189
Query: 461 MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520
EK DV++FG + ++ + P S+ S KI ++ + + LP + + + D+
Sbjct: 190 YGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKI--VEAVYEPLPEGMYSEDVTDV 245
Query: 521 LLASTISFACLQSNPKSRPTMQYVS 545
+ +CL + ++RP + VS
Sbjct: 246 IT------SCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 27/82 (32%), Positives = 37/82 (45%), Gaps = 12/82 (14%)
Query: 318 YGSVYKAQ------LPNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 369
+G V KA A+K L + S +E + F +L QV H +++KL
Sbjct: 13 FGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF----NLLKQVNHPHVIKL 68
Query: 370 YGFCLHRKCMFLIYEYMKRGSL 391
YG C + LI EY K GSL
Sbjct: 69 YGACSQDGPLLLIVEYAKYGSL 90
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 50/206 (24%), Positives = 74/206 (35%), Gaps = 52/206 (25%)
Query: 317 GYGSVYKAQLPNGKV---------FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 367
G GS K L K L K+ E E + + E +L+++ H NIV
Sbjct: 9 GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE------ASKKEVILLAKMKHPNIV 62
Query: 368 KLYGFCLHRKCMFLIYEY-----------MKRGSLFCNLHNNEDAVELDWAKRVNIVKAM 416
+ +F++ EY +RG LF +ED + L W ++++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF-----SEDQI-LSWFVQISLGLKH 116
Query: 417 AHALAYLHHDCSPS-----------------IASTCPDSSN--RTLLAGTYGYIAPELAY 457
H LH D IA DS T GT Y++PE+
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQ 175
Query: 458 TMVMTEKCDVYSFGVVTLEVLMGKHP 483
K D++S G V E+ KHP
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 37/192 (19%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+VY A + G+ A+K+++ + + I NE V+ + + NIV L
Sbjct: 33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVNYLDSYLVGD 89
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHH--------- 425
++++ EY+ GSL D V +D + + + AL +LH
Sbjct: 90 ELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 426 --------DCSPSI------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
D S + A P+ S R+ + GT ++APE+ K D++S G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 472 VVTLEVLMGKHP 483
++ +E++ G+ P
Sbjct: 203 IMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 59/222 (26%)
Query: 334 LKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391
+K+L S T E+L F++ E Q ++ H N+++ G C+ L+ E+ G L
Sbjct: 27 VKELRASATPDEQLLFLQ----EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL 82
Query: 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALA----------YLHHDCSPSIASTCPDSSNR 441
L +N V K V ++ MA +A ++H D + C +++
Sbjct: 83 KNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWLHQADFIHSDLA---LRNCQLTADL 137
Query: 442 TLLAGTYG----------------------YIAPELA-------YTMVMTEKCDVYSFGV 472
++ G YG ++APEL T+K +++S GV
Sbjct: 138 SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197
Query: 473 VTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPP 511
E+ P SD +++ V +Q +LP P
Sbjct: 198 TMWELFTAADQP------YPDLSDEQVLKQVVREQDIKLPKP 233
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 82/297 (27%)
Query: 319 GSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIVKLYGFC 373
G V K P+G + A K +H L + RN+ +VLH IV YG
Sbjct: 15 GVVTKVLHRPSGLIMARKLIH------LEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHALAYL---- 423
+ + E+M GSL D V L A R+ I A+ L YL
Sbjct: 69 YSDGEISICMEHMDGGSL--------DQV-LKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 424 ---HHDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
H D PS ++ DS + + GT Y++PE T +
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERLQGTHYTVQ 178
Query: 465 CDVYSFGVVTLEVLMGKHP----------------------RDLLSSLSS--SSDPKIML 500
D++S G+ +E+ +G++P ++ +S P+ M
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238
Query: 501 I-DVLDQRL--PPPVDRKVIRDILLASTISF--ACLQSNPKSRPTMQYVSQEFLITR 552
I ++LD + PPP K+ F CL+ NPK R ++ +++ I R
Sbjct: 239 IFELLDYIVNEPPP---KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 65/275 (23%), Positives = 96/275 (34%), Gaps = 76/275 (27%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIVKLYGFC 373
YG VYKA G++ A+K + E EE + + E +L S H NI YG
Sbjct: 19 YGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN--HPNIATFYGAF 72
Query: 374 L------HRKCMFLIYEYMKRGS---LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
+ + ++L+ E GS L L ++ +W I++ LAYLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH 130
Query: 425 -----H---------------------DCSPSIASTCPDSSNRTLLAGTYGYIAPEL--- 455
H S + ST R GT ++APE+
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST---LGRRNTFIGTPYWMAPEVIAC 187
Query: 456 --AYTMVMTEKCDVYSFGVVTLEVLMGK------HPRDLLSSLSSSSDPKIMLIDVLDQR 507
+ DV+S G+ +E+ GK HP L + + P +
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK-------- 239
Query: 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
P K D IS CL N + RP M+
Sbjct: 240 -SPENWSKKFNDF-----IS-ECLIKNYEQRPFME 267
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 37/192 (19%)
Query: 319 GSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
G+VY A + G+ A+++++ + + I NE V+ + + NIV L
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLDSYLVGD 90
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHH--------- 425
++++ EY+ GSL D V +D + + + AL +LH
Sbjct: 91 ELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 426 --------DCSPSI------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
D S + A P+ S R+ + GT ++APE+ K D++S G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 472 VVTLEVLMGKHP 483
++ +E++ G+ P
Sbjct: 204 IMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 31/98 (31%), Positives = 44/98 (44%), Gaps = 23/98 (23%)
Query: 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL- 508
++APE + V T + DV+SFGV+ E+ SL +S P + + + QRL
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQINEEFCQRLK 291
Query: 509 ------PPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
P I I+L AC Q +PK RPT
Sbjct: 292 DGTRMRAPENATPEIYRIML------ACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 54/198 (27%), Positives = 81/198 (40%), Gaps = 45/198 (22%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-- 374
YG VY+A+ +G++ ALKK+ + I S R E +L + H NIV+L +
Sbjct: 20 YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGK 78
Query: 375 HRKCMFLIYEYMKR--GSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 430
H +FL+ EY ++ SL N+ +E V+ ++ + L YLH +
Sbjct: 79 HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYLHENF--- 128
Query: 431 IASTCPDSSNRTL------------LAGTYG--------------YIAPELAYTM-VMTE 463
I SN L LA TYG Y APEL T
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 464 KCDVYSFGVVTLEVLMGK 481
D+++ G + E+L K
Sbjct: 189 AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 59/263 (22%), Positives = 113/263 (42%), Gaps = 38/263 (14%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ + N +V A+KK+ S + + E + L ++ H N ++ G L
Sbjct: 28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87
Query: 377 KCMFLIYEY-MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDC------S 428
+L+ EY + S +H + E++ A + LAYLH H+ +
Sbjct: 88 HTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAA---VTHGALQGLAYLHSHNMIHRDVKA 143
Query: 429 PSIASTCP------DSSNRTLLA------GTYGYIAPELAYTMVMTE---KCDVYSFGVV 473
+I + P D + +++A GT ++APE+ M + K DV+S G+
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQS 533
+E+ K P ++++S+ + + Q P + + +CLQ
Sbjct: 204 CIELAERKPPLFNMNAMSA--------LYHIAQNESPALQSGHWSEYF--RNFVDSCLQK 253
Query: 534 NPKSRPTMQYVSQEFLITRKTPL 556
P+ RPT + + + + R+ P
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 39/249 (15%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELA--FIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+GSVY+ L +G FA+K++ ++ + +K E +LS++ H NIV+ G
Sbjct: 13 FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER 72
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--HDCSPSI- 431
+++ E + GSL L + + + L YLH + I
Sbjct: 73 EEDNLYIFLELVPGGSL-AKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129
Query: 432 -ASTCPDSSNRTLLA------------------GTYGYIAPE-LAYTMVMTEKCDVYSFG 471
A+ D++ LA G+ ++APE +A D++S G
Sbjct: 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACL 531
LE+ GK P S + + + + PP+ + + A CL
Sbjct: 190 CTVLEMATGKPP-------WSQLEGVAAVFKIGRSKELPPIPDHLSDE---AKDFILKCL 239
Query: 532 QSNPKSRPT 540
Q +P RPT
Sbjct: 240 QRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 47/188 (25%)
Query: 333 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KC----MFLIYEYMK 387
A+K L T EE FR E + +++ H NIV L L + +F ++EY+
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFAVFEYVP 62
Query: 388 RGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALA--YLHHDCSPS--IASTCPDS 438
+L L + + L + ++ A+A A +H D P + S
Sbjct: 63 GRTLREVLAADGALPAGETGRL----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 439 SNRTLL-------------------------AGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+ +L GT Y APE +T D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 474 TLEVLMGK 481
LE L G+
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 49/223 (21%), Positives = 102/223 (45%), Gaps = 40/223 (17%)
Query: 348 IKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWA 407
+++F EA V+ + H +VKL+ + ++ +++I E+M +GSL + +++ +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLL-DFLKSDEGSKQPLP 102
Query: 408 KRVNIVKAMAHALA------YLHHDCSP-----SIASTCPDSS---NRTLLAGTY----- 448
K ++ +A +A Y+H D S + C + R + Y
Sbjct: 103 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
Query: 449 -----GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLID 502
+ APE T K DV+SFG++ +E++ G+ P +S+ P+++
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRAL 216
Query: 503 VLDQRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYV 544
R+P P + + + +I++ C ++ P+ RPT +Y+
Sbjct: 217 ERGYRMPRPENCPEELYNIMM------RCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 22/70 (31%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ G++ ALKK+ +E + R E +L ++ H NIV+L
Sbjct: 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSE 70
Query: 377 KCMFLIYEYM 386
++L++E++
Sbjct: 71 NKLYLVFEFL 80
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 19/38 (50%), Positives = 25/38 (65%), Gaps = 2/38 (5%)
Query: 199 NLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIK 235
NL +LDLS+N+L+ IP G+ NL LDLS NN+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLT 37
|
Length = 60 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 66/269 (24%), Positives = 104/269 (38%), Gaps = 72/269 (26%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFC 373
YG V K + +P G + A+K++ + ++E K + + + + V YG
Sbjct: 13 AYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDLDISMRSVDCPYTVTFYG-A 68
Query: 374 LHRK-----CMFLIYEYMK-------RGSLFCNLHNNEDAVELDWAK-RVNIVKAMAH-- 418
L R+ CM E M + L ED + K V+IVKA+ +
Sbjct: 69 LFREGDVWICM----EVMDTSLDKFYKKVYDKGLTIPEDIL----GKIAVSIVKALEYLH 120
Query: 419 -ALAYLHHDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPEL------ 455
L+ +H D PS I+ DS +T+ AG Y+APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 456 --AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513
Y + K DV+S G+ +E+ G+ P D S P L V+++ P P
Sbjct: 181 QKGYDV----KSDVWSLGITMIELATGRFPYD------SWKTPFQQLKQVVEE--PSP-- 226
Query: 514 RKVIRDILLASTISFA--CLQSNPKSRPT 540
++ + F CL+ N K RP
Sbjct: 227 -QLPAEKFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 50/268 (18%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ + +V A+KK+ S + + E + L ++ H N ++ G L
Sbjct: 38 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97
Query: 377 KCMFLIYEY-MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDC------- 427
+L+ EY + S +H L + I LAYLH H+
Sbjct: 98 HTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153
Query: 428 -----------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE---KCDV 467
S SIAS P +S GT ++APE+ M + K DV
Sbjct: 154 GNILLTEPGQVKLADFGSASIAS--PANS----FVGTPYWMAPEVILAMDEGQYDGKVDV 207
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
+S G+ +E+ K P ++++S+ + + Q P + D
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQSNEWSDYF--RNFV 257
Query: 528 FACLQSNPKSRPTMQYVSQEFLITRKTP 555
+CLQ P+ RPT + + + + R+ P
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 30/194 (15%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+G VY + G+ A+K++ E + + E Q+L + H IV+ YG
Sbjct: 15 FGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR 74
Query: 375 HRKCMFLIYEYMKRGSL-------------------------FCNLHNNEDAVELDWAKR 409
+ + + EYM GS+ LH+N V D K
Sbjct: 75 DDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM-IVHRD-IKG 132
Query: 410 VNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
NI++ A + S + + C + + GT +++PE+ K DV+S
Sbjct: 133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWS 192
Query: 470 FGVVTLEVLMGKHP 483
G +E+L K P
Sbjct: 193 VGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 24/190 (12%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G V Q+ GK++A KKL ++ NE Q+L +V R +V L
Sbjct: 12 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
+ + L+ M G L ++++ +A + + V + L LH D P
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+A P+ GT GY+APE+ T D ++ G +
Sbjct: 131 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 190
Query: 474 TLEVLMGKHP 483
E++ G+ P
Sbjct: 191 LYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ G+V ALKK+ +TE + E +L ++ H NIVKL
Sbjct: 13 YGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71
Query: 377 KCMFLIYEYM 386
++L++E++
Sbjct: 72 NKLYLVFEFL 81
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 42/265 (15%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A +V A+KK+ S + + E + L Q+ H N ++ G L
Sbjct: 34 FGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93
Query: 377 KCMFLIYEY-MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------S 428
+L+ EY + S +H L + I LAYLH +
Sbjct: 94 HTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149
Query: 429 PSIASTCPD------------SSNRTLLAGTYGYIAPELAYTMVMTE---KCDVYSFGVV 473
+I T P SS GT ++APE+ M + K DV+S G+
Sbjct: 150 GNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 209
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA--CL 531
+E+ K P ++++S+ + + Q P + D S F CL
Sbjct: 210 CIELAERKPPLFNMNAMSA--------LYHIAQNDSPTLQSNEWTD----SFRGFVDYCL 257
Query: 532 QSNPKSRPTMQYVSQEFLITRKTPL 556
Q P+ RP + + + R P
Sbjct: 258 QKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 56/245 (22%), Positives = 98/245 (40%), Gaps = 45/245 (18%)
Query: 328 NGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM-FLIY 383
+GK + +KKL + S E K+ EAQ+LSQ+ H NIV + +++
Sbjct: 24 DGKQYVIKKLNLRNASRRER----KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79
Query: 384 EYMKRGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPS------- 430
+ + G L+ L E+ V ++W ++ + H LH D
Sbjct: 80 GFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138
Query: 431 ---------IASTCPDSSNR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 480
IA + + + L GT Y++PEL K DV++ G E+
Sbjct: 139 NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198
Query: 481 KHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDRKVIRDILLASTISFACLQSNPKSRP 539
KH + + D ++ +++ +LPP P D L I+ L P+ RP
Sbjct: 199 KHAFN-------AKDMNSLVYRIIEGKLPPMPKD----YSPELGELIA-TMLSKRPEKRP 246
Query: 540 TMQYV 544
+++ +
Sbjct: 247 SVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
G+G V Q+ N GK++A KKL ++ + K E ++L +V IV L Y F
Sbjct: 5 GFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-E 63
Query: 375 HRKCMFLIYEYMKRGSLFCNLHN-NEDAVELD----WAKRVNIVKAMAHALAYLHHDCSP 429
+ + L+ M G L +++N E +E++ ++ ++ H++ ++ D P
Sbjct: 64 SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKP 123
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+A D T AGT GY+APE+ + D ++ G
Sbjct: 124 ENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183
Query: 474 TLEVLMGKHP 483
E++ G+ P
Sbjct: 184 IYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 50/209 (23%)
Query: 316 DGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
D +G VYK L P + A+ + E + F++EA + S++ H NIV L G
Sbjct: 16 DRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLG 75
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNL-----HNNEDAVE--------LDWAKRVNIVKAMAH 418
+ + +I+ Y L L H++ + + L+ A V+IV +A
Sbjct: 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA 135
Query: 419 ALAYL--HHDCSPSIAST---CPDSSN---------RTLLAGTY-----------GYIAP 453
+ +L HH +A+ D N R + A Y +++P
Sbjct: 136 GMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195
Query: 454 ELAYTMVMTEKC----DVYSFGVVTLEVL 478
E +M K D++S+GVV EV
Sbjct: 196 E----AIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 58/241 (24%), Positives = 89/241 (36%), Gaps = 56/241 (23%)
Query: 348 IKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------CMFLIYEYMKRGSLFCNL---HNN 398
++ F +EA + + H N+++L G CL +I +MK G L L
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 399 EDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDSSNRTLLAGTYG--- 449
+ L V + +A + YL H D + A C + N + +G
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA---ARNCMLNENMNVCVADFGLSK 160
Query: 450 -------------------YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489
+IA E V T K DV+SFGV E+ G+ P
Sbjct: 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPG 217
Query: 490 LSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547
+ +S + D L Q RL P D D L + + +C NPK RP+ + + E
Sbjct: 218 VENSE-----IYDYLRQGNRLKQPPD---CLDGLYS--LMSSCWLLNPKDRPSFETLRCE 267
Query: 548 F 548
Sbjct: 268 L 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 58/225 (25%)
Query: 316 DG-YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
DG +G VYKAQ V A K+ +++EE ++ + E +L+ H NIVKL
Sbjct: 15 DGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHH--- 425
+ ++++ E+ G++ DAV L+ + + + K AL YLH
Sbjct: 73 YENNLWILIEFCAGGAV--------DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 426 --------------DCSPSIASTCPDSSN-RTL-----LAGTYGYIAPELAYTMVMTE-- 463
D +A + N RT+ GT ++APE+ VM E
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV----VMCETS 180
Query: 464 -------KCDVYSFGVVTLEVLMGKHPRDLLSSLS-----SSSDP 496
K DV+S G+ +E+ + P L+ + + S+P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 22/69 (31%), Positives = 40/69 (57%), Gaps = 2/69 (2%)
Query: 318 YGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG+V+KA+ ++ ALK++ + +E + R E +L ++ H+NIV+LY
Sbjct: 13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSD 71
Query: 377 KCMFLIYEY 385
K + L++EY
Sbjct: 72 KKLTLVFEY 80
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 19/185 (10%)
Query: 318 YGSVYKAQLPNGKV--FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V A N A+K+ S+ + + +E ++L+ + H V LYG
Sbjct: 43 FGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIA 432
++L+ E++ G F L N+ + V +A ++ ++ +L ++ D P
Sbjct: 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162
Query: 433 STCPDS-------------SNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 478
D RT L GT YIAPE+ + + D ++ G+ E+L
Sbjct: 163 LLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 479 MGKHP 483
+G P
Sbjct: 223 VGCPP 227
|
Length = 340 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 35/135 (25%), Positives = 53/135 (39%), Gaps = 29/135 (21%)
Query: 148 ALSKLQLLDLSSNGLT--------GTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS--- 196
A L++LDL++NGLT T+ +LK+L LN+G N+L +AL S
Sbjct: 191 ANCNLEVLDLNNNGLTDEGASALAETLA----SLKSLEVLNLGDNNLTDAGAAALASALL 246
Query: 197 --LTNLSNLDLSSNKL----SGKIPPEIAGMKNLTWLDLSNNNIKG-----SIPVRLSPN 245
+L L LS N + + + +A ++L LDL N L P
Sbjct: 247 SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPG 306
Query: 246 KGLCGGNFLDLPSCD 260
L +
Sbjct: 307 ---NELESLWVKDDS 318
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 50/199 (25%)
Query: 319 GSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIVKLYGFC 373
G V K Q P+G + A K +H L + RN+ QVLH IV YG
Sbjct: 19 GVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHALAYL---- 423
+ + E+M GSL D V L AKR+ + A+ LAYL
Sbjct: 73 YSDGEISICMEHMDGGSL--------DQV-LKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 424 ---HHDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
H D PS ++ DS + + GT Y++PE + +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 465 CDVYSFGVVTLEVLMGKHP 483
D++S G+ +E+ +G++P
Sbjct: 183 SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 27/193 (13%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
G+G V Q+ GK++A KKL+ ++ + E ++L++V R IV L Y F
Sbjct: 5 GFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-Q 63
Query: 375 HRKCMFLIYEYMKRGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHH------DC 427
+ + L+ M G L +++N +E+ + + L +LH D
Sbjct: 64 TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123
Query: 428 SPS----------------IASTCPDSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSF 470
P +A D ++T AGT G++APEL D ++
Sbjct: 124 KPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFAL 183
Query: 471 GVVTLEVLMGKHP 483
GV E++ + P
Sbjct: 184 GVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 48/224 (21%), Positives = 83/224 (37%), Gaps = 58/224 (25%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V Q + G V+A+K L ++ E + R E +L + +VK++
Sbjct: 13 AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-- 429
+ ++LI E++ G + L E+ + A+ V + ++ H L ++H D P
Sbjct: 73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQLGFIHRDIKPDN 131
Query: 430 ------------------------------SIASTCPD----------------SSNRTL 443
++ + P NR
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 444 LA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
LA GT YIAPE+ + CD +S GV+ E+L+G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 350 SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKR 409
+F A ++SQV H ++ ++G C+ ++ E+++ G L L + V + W +
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119
Query: 410 VNIVKAMAHALAYLH----------------------HDCSPSIASTCPDSS----NRTL 443
+ + + +A AL+YL SP I + P S +R
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 444 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 501
+IAPE + ++ D +SFG LE+ G+ P L + +
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP------LKERTPSEKERF 233
Query: 502 DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
RLP P ++ LA+ IS CL P RP+ + + ++
Sbjct: 234 YEKKHRLPEPSCKE------LATLIS-QCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 61/274 (22%), Positives = 105/274 (38%), Gaps = 62/274 (22%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ + +V A+KK+ S + + E + L Q+ H N ++ G L
Sbjct: 28 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE 87
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVE-----LDWAKRVNIVKAMAHALAYLHHDC---- 427
+L+ EY C L + D +E L + I LAYLH
Sbjct: 88 HTAWLVMEY-------C-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 428 ---------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTM---VMTE 463
S S+ P +S GT ++APE+ M
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLV--SPANS----FVGTPYWMAPEVILAMDEGQYDG 193
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523
K DV+S G+ +E+ K P ++++S+ + + Q P + D
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTLSSNDWSD---- 241
Query: 524 STISF--ACLQSNPKSRPTMQYVSQEFLITRKTP 555
+F +CLQ P+ RP+ + + + + R+ P
Sbjct: 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 18/40 (45%), Positives = 25/40 (62%)
Query: 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
L GT YIAPE+ T+ CD +S GV+ E+L+G+ P
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 572 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.92 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.92 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.92 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.92 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.91 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.91 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.9 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.89 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.87 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.87 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.84 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.83 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.8 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.79 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.77 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.76 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.75 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.73 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.73 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.62 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.59 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.57 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.57 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.54 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.51 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.5 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.29 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.19 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.18 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.16 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.15 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.1 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.09 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.07 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.99 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.99 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.95 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.94 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.92 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.9 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.71 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.71 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.71 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 98.64 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.61 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.61 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.56 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.55 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.53 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.51 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.49 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.47 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.42 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.39 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.35 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.34 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.22 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.2 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.19 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.15 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.12 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.01 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 97.99 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.96 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.93 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.8 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.77 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.75 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.74 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.69 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.68 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.6 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.52 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 97.48 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 97.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.37 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.19 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.0 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.84 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.77 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 96.63 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 96.59 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 96.51 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 96.37 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 96.37 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 96.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.31 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=502.03 Aligned_cols=415 Identities=29% Similarity=0.481 Sum_probs=299.5
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|++++|.+.|.+|..+.++++|+.|+|++|++++.+|..++++++|++|+|++|.++|.+|..++++++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 35678888888888888888888899999999999999999999999999999999999999999999999999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCCcccc----------CCCCCCCCCCC-ccCCCCCCCCCCc-cceeeee
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR----------LSPNKGLCGGN-FLDLPSCDTTKPA-TLFVEIF 272 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~----------~s~n~~l~~~~-~~~l~~c~~~~~~-~~~~~i~ 272 (572)
|++|+++|.+|..+..+.+|+.|++++|+++|.+|.. +.+|.++|+.. ....+.|...... ...+.++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 9999999999999999999999999999999988854 13455677643 2234566532221 1112222
Q ss_pred hhhhhhhhhhhhHhhhhhhhhccC--cchhhh----------------------ccCCccccccccccCeeEEEEEEc-C
Q 038466 273 LPLAIVLSVIVFACLLLAKRKYKK--PKLEER----------------------ATNNIDVFSIWNYDGYGSVYKAQL-P 327 (572)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----------------------~~~~~~~~~~~~~~~fG~Vyk~~~-~ 327 (572)
+.++++++++++++.++.+|++++ .+..+. ....+....++|.|+||.||+|+. .
T Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~ 713 (968)
T PLN00113 634 CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIK 713 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECC
Confidence 111111111121122222222211 111000 001123345789999999999986 5
Q ss_pred CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHH
Q 038466 328 NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWA 407 (572)
Q Consensus 328 ~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~ 407 (572)
+|..||||++...... ...|++.+++++|||||+++|+|.+++..++|||||++|+|.++++ .++|.
T Consensus 714 ~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~ 780 (968)
T PLN00113 714 NGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWE 780 (968)
T ss_pred CCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHH
Confidence 7999999998754321 1246889999999999999999999999999999999999999996 27899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC---------------------ccccccccCccccccccCCCcCcccc
Q 038466 408 KRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN---------------------RTLLAGTYGYIAPELAYTMVMTEKCD 466 (572)
Q Consensus 408 ~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~---------------------~~~~~gt~~y~APE~~~~~~~s~ksD 466 (572)
++.+|+.++|+|++|||+.+.++++|.+.+..+ .....||++|||||++.+..++.|+|
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD 860 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSD 860 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccccCcccccCCCCCcccc
Confidence 999999999999999998877777776433221 11224678999999999999999999
Q ss_pred hHHHHHHHHHHHcCCCCCCccccccCCC-------CcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCC
Q 038466 467 VYSFGVVTLEVLMGKHPRDLLSSLSSSS-------DPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRP 539 (572)
Q Consensus 467 VySfGvvl~ElltG~~P~~~~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RP 539 (572)
||||||++|||+||+.|++......... ........++++.+..... ...+++..+.+++.+||+.||++||
T Consensus 861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-VNQNEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC-ccHHHHHHHHHHHHhhCcCCchhCc
Confidence 9999999999999999985321110000 0001122334454433211 1223445567889999999999999
Q ss_pred CHHHHHHHHhhccC
Q 038466 540 TMQYVSQEFLITRK 553 (572)
Q Consensus 540 sm~~V~~~l~~~~~ 553 (572)
||+||++++.....
T Consensus 940 t~~evl~~L~~~~~ 953 (968)
T PLN00113 940 CANDVLKTLESASR 953 (968)
T ss_pred CHHHHHHHHHHhhc
Confidence 99999999976544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=378.18 Aligned_cols=243 Identities=38% Similarity=0.632 Sum_probs=198.7
Q ss_pred hccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-eEE
Q 038466 302 RATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMF 380 (572)
Q Consensus 302 ~~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~ 380 (572)
.++++|.....+|.||||.||+|.+++|+.||||++....... .++|.+|++++++++|||+|+|+|||.+.+ +.+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 4567888778999999999999999999999999988765432 256999999999999999999999999998 599
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCCc-------------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNR------------------- 441 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~~------------------- 441 (572)
||||||+||+|.++|+..... .++|.+|++||.++|+||+|||..+.|+++|.+.++++.
T Consensus 149 LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999999999999999986554 789999999999999999999999999998875432211
Q ss_pred -----c--cc-ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhhhcc
Q 038466 442 -----T--LL-AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDVLD 505 (572)
Q Consensus 442 -----~--~~-~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~~~~ 505 (572)
. .. .||+||+||||...+..+.|+|||||||+|+||+||++|.+....... ....+....+++|
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 0 11 799999999999999999999999999999999999998764320000 0011114567888
Q ss_pred cCCCC-CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 506 QRLPP-PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 506 ~~l~~-~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+++.. ..+.. +++..+..+|..|++.+|++||+|.||++++..
T Consensus 308 ~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 308 PRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred CCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 88763 22211 455667889999999999999999999999843
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.33 Aligned_cols=231 Identities=30% Similarity=0.487 Sum_probs=177.8
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-eEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 385 (572)
......+|.|+||+||+|.+.....||||++......... .++|.+|+.+|.+++|||||+++|+|.++. ...+||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445568999999999999986666999999876544433 679999999999999999999999999988 79999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC--------------------------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS-------------------------- 439 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~-------------------------- 439 (572)
|++|+|.++++.. ....++|..++++|.+||+||.|||.... ++|.+.++.
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999874 33469999999999999999999997543 555433221
Q ss_pred -CccccccccCcccccccc--CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 440 -NRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~--~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
..+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ......++....+++.+...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCccC
Confidence 122257999999999999 66999999999999999999999999965432 11112222222222221111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. .+..++..||+.||+.||+|.+|+..+...
T Consensus 272 ~~---~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 272 PP---HLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CH---HHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11 123455679999999999999999988644
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.85 Aligned_cols=225 Identities=25% Similarity=0.412 Sum_probs=170.5
Q ss_pred cccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.....+|+|.||+||+|+.. +.+.||||.++.....+ ..++|++|+++++.++|||||+++|.|.+++..++
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~--~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ--ARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH--HHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 44567899999999999753 35689999998765442 35899999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCC-----------cccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCCCCCccc-
Q 038466 382 IYEYMKRGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDSSNRTL- 443 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~-----------~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~~~~~~~- 443 (572)
|+|||..|||.++|+.+.. +.+|+-.+.+.||.|||.||.|| |+|..-.+... +.+..+
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceEEE
Confidence 9999999999999975321 22388899999999999999998 77765432211 111111
Q ss_pred -----------------cc----cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhh
Q 038466 444 -----------------LA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 501 (572)
Q Consensus 444 -----------------~~----gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 501 (572)
.. =.+.||+||.+..++||++||||||||||||++| |+.|+..... ...+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~EVIe 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QEVIE 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HHHHH
Confidence 11 1367999999999999999999999999999996 9999864421 11222
Q ss_pred hhcccC-CCCCCC-hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 502 DVLDQR-LPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 502 ~~~~~~-l~~~~~-~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+-+.. ++.|.. +. .+-.++..||+.+|++||+|+||...|..
T Consensus 717 ~i~~g~lL~~Pe~CP~------~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 717 CIRAGQLLSCPENCPT------EVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred HHHcCCcccCCCCCCH------HHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 222222 332221 22 22356668999999999999999988854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.42 Aligned_cols=223 Identities=25% Similarity=0.459 Sum_probs=171.2
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.....+|.|-||.||.|.+.....||+|.++...... ++|.+|+++|.+++|+|||+++|+|..++.++||||||+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3456789999999999999888899999998764433 578899999999999999999999999899999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCCC---------------CCcccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDS---------------SNRTLLAG 446 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~~---------------~~~~~~~g 446 (572)
+|+|.++|+.. ....+...+.+.++.|||+||+|| |||....++....+. ...+...|
T Consensus 285 ~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 285 KGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999999973 334578889999999999999998 677665544332111 00011111
Q ss_pred ---ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCCC-ChHHHHH
Q 038466 447 ---TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPV-DRKVIRD 519 (572)
Q Consensus 447 ---t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~-~~~~~~~ 519 (572)
...|.|||.+..++++.|||||||||+||||+| |+.|+..+.. ....+.++ .+++.|. .+..+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRlp~P~~CP~~v-- 433 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRLPRPEGCPDEV-- 433 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcCCCCCCCCHHH--
Confidence 356999999999999999999999999999997 9999864421 11222232 3555443 22222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
-+++..||+.+|++||||+.....+.
T Consensus 434 ----Y~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 434 ----YELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred ----HHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 34666899999999999997766654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=286.37 Aligned_cols=238 Identities=24% Similarity=0.349 Sum_probs=179.3
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-eEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~ 383 (572)
+.+....+|.|..|+|||++++ +++.+|+|.+..... .+..++..+|++++.+.+||+||++||.|.++. .+.++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~--~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID--PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4556678999999999999974 799999999954432 334578999999999999999999999999988 599999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh-------cCCCCCceeeCCC---------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-------HDCSPSIASTCPD---------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH-------~~~~~~i~~~~~~---------------~~~~ 441 (572)
|||.+|||++.+...+ .++....-+|+.+|.+||.||| ||++|.++..+.+ .+-.
T Consensus 158 EYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred hhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 9999999999887542 3667777789999999999997 4666665433211 1122
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH-HHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK-VIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~ 520 (572)
...+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+-... ......-..+..+++...|. .+.. ...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~ppP~-lP~~~fS~-- 309 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEPPPR-LPEGEFSP-- 309 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCCCCC-CCcccCCH--
Confidence 45789999999999999999999999999999999999999985320 00111111223333322221 1111 111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+..+.-.|+++||.+||+.+|+++|.|..+..
T Consensus 310 -ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 -EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 223455589999999999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.59 Aligned_cols=230 Identities=23% Similarity=0.328 Sum_probs=180.1
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.....+|.|||+.||+++. .+|++||+|++.+.........+...+||++.++++|||||+++++|++.+++|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 355667899999999999996 8899999999988665555566788999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee-----------------CCCCCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST-----------------CPDSSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~-----------------~~~~~~~ 441 (572)
+|++|+|..+++.+ ..++..+...+..||+.|+.|||+ |.+-++... ..+....
T Consensus 99 LC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred ecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999999888733 357888888899999999999984 443332211 1122344
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
.+.+|||.|+|||++....++..+||||+||+||-|++|++||+... ...........+..+|.....
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~Y~~P~~ls~------- 243 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNEYSMPSHLSA------- 243 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcCcccccccCH-------
Confidence 56899999999999999999999999999999999999999996321 111112222333444443221
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+.+++...+++||++|||.++|+.+-+.
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 12344557899999999999999998777
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.10 Aligned_cols=178 Identities=24% Similarity=0.395 Sum_probs=150.3
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.++.....+|.|+||+||+|++. ++..||||.+...... ....+....|+++|++++|||||++++++..++.+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45666777999999999999964 5899999999876432 223467789999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCCCCC-----------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDSSN----------------- 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~~~~----------------- 440 (572)
|||.+|+|.++++.++ .++.......+.|+|.|+++| |+|.+|.++.......+
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999765 467777778899999999998 57888876654322111
Q ss_pred -----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 -----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 -----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
...++|++-|||||++...+|+.|+|+||.|+++||+++|+.||+.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 1236799999999999999999999999999999999999999973
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=286.79 Aligned_cols=221 Identities=25% Similarity=0.420 Sum_probs=164.2
Q ss_pred cccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 310 FSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
..-+|.|+.|.||.|++. ++.||||+++.-. ..+|+-|++|+||||+.+.|+|.....++||||||+.|
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 345799999999999997 4678999886332 14688899999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC----------------CCCCccccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP----------------DSSNRTLLAGT 447 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~----------------~~~~~~~~~gt 447 (572)
-|...|+... .+.-...+....+||.||.||| +|.+.+.+.... +-+....++||
T Consensus 198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 9999998643 3455556678889999999996 566655443210 11223347899
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~ 527 (572)
..|||||++.....++|.||||||||||||+||+.||.+.+.. ..+.-+-...+.-|.+....+.. ..+.
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwGVGsNsL~LpvPstcP~Gf---klL~ 344 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWGVGSNSLHLPVPSTCPDGF---KLLL 344 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------eeEEeccCCcccccCcccCchHH---HHHH
Confidence 9999999999999999999999999999999999998644321 11111111111111111111222 2345
Q ss_pred HHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 528 FACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 528 ~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
..||+..|..||+|.+|+.|+-+..+.
T Consensus 345 Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 589999999999999999999777654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=274.13 Aligned_cols=226 Identities=21% Similarity=0.270 Sum_probs=166.7
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeEEEEEecc
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLIYEYM 386 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 386 (572)
..++.|++|.||+|.. +|+.||||+++..........+.|.+|+++|++++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4678999999999998 688999999986654444446789999999999999999999999977 34689999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCCC--------------CCccccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPDS--------------SNRTLLA 445 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~~--------------~~~~~~~ 445 (572)
++|+|.++++... .++|..+.+++.++++|+.|||.. .+|..+..+.+. .......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 181 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccccccc
Confidence 9999999997643 578999999999999999999852 333332221110 0012245
Q ss_pred cccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 446 GTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 446 gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
||..|+|||++.+ ..++.++|||||||++|||+||+.||+... .......+......++.+..... .+
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~---~l 251 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLIINKNNSLKLPLDCPL---EI 251 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcCCCCCCCCcCcH---HH
Confidence 7899999999876 679999999999999999999999986331 11111111111111111101111 23
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..++.+||+.||++|||+++|++.+..
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 456678999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.19 Aligned_cols=227 Identities=27% Similarity=0.416 Sum_probs=177.5
Q ss_pred ccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 309 VFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+..++|.|.||.||+|+++ ....||||.++....+. +..+|..|+.||++++||||++|.|+......+++|.|
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek--qrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHH--HHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3468899999999999875 24689999999776544 35799999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeC-----------------CCCCC-
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTC-----------------PDSSN- 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~-----------------~~~~~- 440 (572)
||+||+|+.+|+.+.+ .++|.+.+.+.++||.||.|| |+|....++..+ .+...
T Consensus 711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999998654 488999999999999999987 888766544221 01111
Q ss_pred cccccc--ccCccccccccCCCcCcccchHHHHHHHHHHH-cCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 441 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~g--t~~y~APE~~~~~~~s~ksDVySfGvvl~Ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.+...| ...|.|||.+...++|..||||||||||||.+ .|++||.++.. ++....-..+.++|+|-+...
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------QdVIkaIe~gyRLPpPmDCP~- 861 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVIKAIEQGYRLPPPMDCPA- 861 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------HHHHHHHHhccCCCCCCCCcH-
Confidence 111112 36799999999999999999999999999977 69999865431 222212223457777654321
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+-++++.||++|-.+||+|.||+..|-.
T Consensus 862 ----aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 862 ----ALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ----HHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 12367789999999999999999998843
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=303.14 Aligned_cols=228 Identities=24% Similarity=0.411 Sum_probs=169.1
Q ss_pred ccccccccCeeEEEEEEcCC--Cc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 309 VFSIWNYDGYGSVYKAQLPN--GK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~--g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
....+|.|.||.||+|...+ |. .||||.+......+ ...+|.+|+.+|++++|||||+++|.|.+....+++
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~--~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ--EVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 34578999999999998643 43 49999998765433 357899999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCC----cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------
Q 038466 383 YEYMKRGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~----~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------- 437 (572)
+|||++|+|..+|++.+. ...+.-.+.+.++.|||+|+.||| +|+...+......
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 999999999999997532 345788888999999999999994 5543322211100
Q ss_pred CCCcccccc----ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 438 SSNRTLLAG----TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 438 ~~~~~~~~g----t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
........| ...|||||++..+.++.|+|||||||++||++| |..||...+. .+.+..-.-..++++|.
T Consensus 854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHHHHhCCccCCCC
Confidence 000000111 257999999999999999999999999999997 8899853321 11111122344666553
Q ss_pred C-hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 513 ~-~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. +.. +-+++..||+.+|++||+|..++.++..
T Consensus 928 ~CP~~------ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 928 YCPEK------LYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred CCChH------HHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 2 222 2356778999999999999999986643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=272.67 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=175.3
Q ss_pred CccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHH----HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
.+-+.+.+|.|+||.|-+|. -.+|+.||||.+++..... ........+|+++|++++|||||++++++..++..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 34556789999999999997 4679999999998654322 112234579999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
||||||+||+|.+.+-.++. +....-..++.|+..|+.||| ||++|..+....+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999876542 333334568899999999996 6788876543211
Q ss_pred --CCCccccccccCccccccccCCCc---CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC--C
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVM---TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--P 510 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~---s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~--~ 510 (572)
.+-+.+++||+.|.|||++.+..+ ..|.|+||+||+||-+++|.+||.... .+.-...++...+.. +
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~------~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY------TDPSLKEQILKGRYAFGP 403 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc------CCccHHHHHhcCcccccC
Confidence 223456789999999999976543 347899999999999999999985221 111122333333332 2
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
+......+ .+..++.+++..||++|||..|+++|.|....+
T Consensus 404 ~~w~~Ise---ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 LQWDRISE---EALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhhH---HHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 22222222 345677789999999999999999999987543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=284.06 Aligned_cols=235 Identities=27% Similarity=0.419 Sum_probs=171.7
Q ss_pred CCccccccccccCeeEEEEEEcCC--C--cE-EEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN--G--KV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~--g--~~-vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
+++.....+|+|.||.||+|++.. + .. ||||..+.+.......+++|.+|+++|++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556889999999999998643 3 23 899999864433345578999999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----CC---------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----SN--------- 440 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----~~--------- 440 (572)
++|||+|+||+|.++|++..+ .++..+++.++.+.|.||+|||. |+...+.....+. ++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999999997654 58899999999999999999984 3222211111000 00
Q ss_pred cc----ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCCCC
Q 038466 441 RT----LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVD 513 (572)
Q Consensus 441 ~~----~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~ 513 (572)
.. ...-...|+|||.+....|++++|||||||++||+.+ |..||..+.. ......++. .+.+.+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~~~~r~~~~~- 386 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVKNGYRMPIPS- 386 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHhcCccCCCCC-
Confidence 00 0112367999999999999999999999999999998 8889864421 111222212 2222222
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
....++ ..+...||..+|++||+|.+|.+.+.....
T Consensus 387 -~~p~~~---~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 387 -KTPKEL---AKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred -CCHHHH---HHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 111222 234458999999999999999998866543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=265.49 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=179.1
Q ss_pred ccCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++..++|.|.-++||+|+ .+.++.||||+++....... ++..++|++.|+.++||||++++..|..+.++|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 34567888899999999999998 57889999999987654432 5788999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS---------------- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~---------------- 439 (572)
||.||.+||+.+.++..-. ..++......|.+++.+||.||| ||.+++.+..+.++.
T Consensus 102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999999986422 23777788889999999999997 466666553322110
Q ss_pred C----c-cccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 440 N----R-TLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 440 ~----~-~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
. . ..++||++|||||+++. ..|+.|+|||||||+..||.+|..||..+. +-.++...+....|.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-------PmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-------PMKVLLLTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-------hHHHHHHHhcCCCCCcc
Confidence 1 1 45689999999999654 469999999999999999999999985432 11122222222222110
Q ss_pred ----ChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 ----DRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ----~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.+. ..--..+..+.-.|+++||++|||+++++++-|....
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1110 0001123344558999999999999999998765533
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=281.65 Aligned_cols=230 Identities=22% Similarity=0.355 Sum_probs=167.4
Q ss_pred ccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 309 VFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
+...+|.|.||+||+|++.+ .||||.++....... ..+.|++|+..+++-||.||+-+.|||..++. .+|..+|+|
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 34578999999999999874 489999987665443 67899999999999999999999999998887 999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------------Cccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------------NRTL 443 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------------~~~~ 443 (572)
-+|+.+||-.+ ..++..+.+.||.|||+||.|||. |.+..++....+.. ....
T Consensus 472 sSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q 549 (678)
T KOG0193|consen 472 SSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ 549 (678)
T ss_pred chhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence 99999999654 468888999999999999999983 44433322211100 0111
Q ss_pred cccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 444 LAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 444 ~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
-.|...|||||+++. ..|+..+||||||||+|||+||..||. .. ..+..+..+-...+.+.........-
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~------~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQ------NRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CC------ChhheEEEecccccCccchhhhccCH
Confidence 235677999999874 468999999999999999999999985 21 11111122211111111100011111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+.++...||..++++||.+.+|+..+...
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 1234566789999999999999999976544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=265.95 Aligned_cols=221 Identities=24% Similarity=0.411 Sum_probs=171.1
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++|++.+++|.|+||+||.++. ++++.+|+|++++....+....+...+|..+|.+++||+||+++-.|++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356788889999999999999985 5699999999998776665556788899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-----------------CCC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-----------------PDS 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-----------------~~~ 438 (572)
|+||+.||.|+.+|.+.+. +......-++.+|+.||.||| ||.+|.++..+ .++
T Consensus 103 Vld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999986543 455544557789999999998 57777655321 122
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC-CCC-ChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPV-DRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~-~~~~ 516 (572)
.....++||+.|||||++.+..|+..+|+||+||++|||+||.+||.... ...+...+...+++ ++. -...
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~~~~p~~ls~~ 252 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKLPLPPGYLSEE 252 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcCCCCCccCCHH
Confidence 33445799999999999999999999999999999999999999986321 12223333333322 211 1222
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 038466 517 IRDILLASTISFACLQSNPKSRP 539 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RP 539 (572)
. .++...-++.||++|-
T Consensus 253 a------rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 253 A------RDLLKKLLKRDPRQRL 269 (357)
T ss_pred H------HHHHHHHhccCHHHhc
Confidence 2 2334467899999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=257.23 Aligned_cols=232 Identities=22% Similarity=0.287 Sum_probs=169.8
Q ss_pred cCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEE-EEEeCCe-EE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG-FCLHRKC-MF 380 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~ 380 (572)
..++.+...+|.|.||.|||++ +.+|..+|.|.++-... +....++..+|+.+|++++|||||++++ .+.++.+ ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3456778899999999999997 68999999999985443 3345678999999999999999999999 4555555 89
Q ss_pred EEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh----------cCCCCCceeeCCC------------
Q 038466 381 LIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH----------HDCSPSIASTCPD------------ 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH----------~~~~~~i~~~~~~------------ 437 (572)
||||||..|+|...++..+ ....++.....++..|++.||..+| +|++|.++..+..
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987633 2334666677788888888887665 5777765543211
Q ss_pred -----CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc-CCCCC
Q 038466 438 -----SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPP 511 (572)
Q Consensus 438 -----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~ 511 (572)
.......+|||.||+||.+....|+.||||||+||++|||..-++||.... -..+...+.+ ..++
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qgd~~~- 247 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQGDYPP- 247 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcCCCCC-
Confidence 111234679999999999999999999999999999999999999985321 1111222222 2222
Q ss_pred CC-hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 512 VD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 512 ~~-~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+ ..-..+ +..++-.|+..||+.||+.-..+++.
T Consensus 248 ~p~~~YS~~---l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 248 LPDEHYSTD---LRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CcHHHhhhH---HHHHHHHHccCCcccCCCcchHHHHH
Confidence 22 222222 23455679999999999855555544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.00 Aligned_cols=233 Identities=22% Similarity=0.322 Sum_probs=167.1
Q ss_pred CCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+.+++.+.+|.|+||.||+|.. .+++.||||++......+ ..+.+.+|++++.++ +|||||+++|+|...+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH--HHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4566778899999999999963 235789999997543222 246788999999999 8999999999987644
Q ss_pred -eEEEEEecccCCChhhhhhcCCC--------------------------------------------------------
Q 038466 378 -CMFLIYEYMKRGSLFCNLHNNED-------------------------------------------------------- 400 (572)
Q Consensus 378 -~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------------- 400 (572)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 58999999999999999875321
Q ss_pred ---cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------CCccccccccCccc
Q 038466 401 ---AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------SNRTLLAGTYGYIA 452 (572)
Q Consensus 401 ---~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------~~~~~~~gt~~y~A 452 (572)
...+++.....++.|+++|++||| +|++|..+..+.+. .......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 124778888999999999999997 45666654332110 00011234678999
Q ss_pred cccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccC-CCCCCChHHHHHHHHHHHHHHHc
Q 038466 453 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-LPPPVDRKVIRDILLASTISFAC 530 (572)
Q Consensus 453 PE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~i~~~C 530 (572)
||++.+..++.++|||||||++|||+| |+.||..... .........+.. ...+. .... .+..++..|
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~--~~~~---~l~~li~~c 313 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTRMRAPE--NATP---EIYRIMLAC 313 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCCCCCCC--CCCH---HHHHHHHHH
Confidence 999999999999999999999999997 9999853211 011111111111 11111 1111 234567799
Q ss_pred cccCCCCCCCHHHHHHHHhh
Q 038466 531 LQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 531 l~~dP~~RPsm~~V~~~l~~ 550 (572)
|+.||++|||+.+|++.+..
T Consensus 314 l~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 314 WQGDPKERPTFSALVEILGD 333 (338)
T ss_pred ccCChhhCcCHHHHHHHHHH
Confidence 99999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=258.61 Aligned_cols=234 Identities=22% Similarity=0.346 Sum_probs=186.2
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+-|++...+|+|+||+||||..+ .|+++|||++..... +++..+|+.+|++++.|++|++||.|.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 34677888999999999999864 699999999976542 467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~ 440 (572)
|||..||+.+.++.+.+ .+...+...+..+..+||+||| +|++.+.+....++ ..
T Consensus 108 EYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999999986543 5777777788889999999996 67777665443221 12
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
+..+.||+-|||||++..-.|+.++|+||+||+..||..|++||.++..+ ..-..-|.-|||.-+......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEeccCCCCCCCCChHhhh
Confidence 34578999999999999999999999999999999999999998644321 112223444444433333333
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
-.+.++...|+-++|++|-|+-++++|.+.....
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 4456777899999999999999999999876654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=273.86 Aligned_cols=236 Identities=20% Similarity=0.314 Sum_probs=178.8
Q ss_pred CccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++.+..+|.|+-|.||.|. ..+++.||||++....+... +-..+|+.+|+..+|+|||+++..|..++++|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 45667789999999999997 56789999999987765543 346789999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee-----------------CCCCCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST-----------------CPDSSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~-----------------~~~~~~~ 441 (572)
||++|+|.+.+... .++..+...|+.++++||+|||. |++..++.. ......+
T Consensus 351 ym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999999888653 37888999999999999999983 444333321 1122345
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC-hHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~ 520 (572)
...+|||.|||||+.....|++|.||||+||+++||+-|++||-....+. .-..+..--.+.+..+.. ....+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----AlyLIa~ng~P~lk~~~klS~~~k-- 500 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLIATNGTPKLKNPEKLSPELK-- 500 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----HHHHHhhcCCCCcCCccccCHHHH--
Confidence 67889999999999999999999999999999999999999984221110 011111112222222110 11222
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCccc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK 558 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~ 558 (572)
++..+|++.||++||+++|+++|.+.....|...
T Consensus 501 ----dFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ss 534 (550)
T KOG0578|consen 501 ----DFLDRCLVVDVEQRASAKELLEHPFLKMAKPESS 534 (550)
T ss_pred ----HHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHH
Confidence 3445899999999999999999998865554443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=269.63 Aligned_cols=232 Identities=27% Similarity=0.413 Sum_probs=172.9
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.....+|.|.||.||||.. .+++.||+|++......+ .+++.++|+.++++++|+||.++||.+..+..+|++|||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34446889999999999985 579999999998765443 256788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-----------------CCCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP-----------------DSSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~-----------------~~~~~~ 442 (572)
|.+|++.+.+....- ++.....-|.+++.+|+.||| +|+++..+.... ....+.
T Consensus 93 ~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999999998875321 233344457788999999997 455554332211 112235
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
.++||+.|||||++....|+.|+||||+||+.+||.+|.+|+.... + ......+....||..+... . ..
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h-------P-mrvlflIpk~~PP~L~~~~-S--~~ 238 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH-------P-MRVLFLIPKSAPPRLDGDF-S--PP 238 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC-------c-ceEEEeccCCCCCcccccc-C--HH
Confidence 6789999999999998899999999999999999999999974332 1 1112223333333222211 1 11
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
+.+++..|+++||+.||++.++++|-++.+..
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 23445579999999999999999998876643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=257.80 Aligned_cols=230 Identities=23% Similarity=0.322 Sum_probs=167.8
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++++..++|.|+||.||+|.+. .+..||+|.++...... ..+.|.+|+..+++++||||++++|++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34667788999999999999753 36789999998654322 2467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.+++.... ..++|.+...++.+++.|++|||. |++|..+....+..
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999987543 257899999999999999999974 45554432211100
Q ss_pred ---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 440 ---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 440 ---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
......++..|+|||++.+..++.++|||||||++||+++ |+.||..... ......+.+. ...+.+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~~~~ 232 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDG-FRLPAPRN 232 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCC-CCCCCCCC
Confidence 0001224578999999999999999999999999999775 9999853311 1111111111 11111111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... .+.+++..||+.+|++||++++|.+.+.
T Consensus 233 ~~~---~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 233 CPN---LLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CCH---HHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 111 2345667899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.07 Aligned_cols=235 Identities=21% Similarity=0.242 Sum_probs=171.2
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
|+....+|.|+||.||+|.. .+|+.||+|.+.............+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 44567899999999999985 57999999998755433323345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~ 443 (572)
+++|+|.+++.... ...+++.....++.+++.|++|||+ |++|..+..+.. ......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999988876432 2357888999999999999999984 455543322110 111123
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~ 521 (572)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .............. .+...+ .
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~s----~--- 230 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER---VKREEVDRRVKEDQEEYSEKFS----E--- 230 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHHhhcccccCCccCC----H---
Confidence 46899999999999999999999999999999999999998632210 00000001111111 111111 1
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHHHHhhcc
Q 038466 522 LASTISFACLQSNPKSRPT-----MQYVSQEFLITR 552 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~~ 552 (572)
.+..+...||+.||++||+ +++++++.+...
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 1235666899999999997 899998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=261.52 Aligned_cols=223 Identities=34% Similarity=0.500 Sum_probs=156.3
Q ss_pred cccccccCeeEEEEEEcC-----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 310 FSIWNYDGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
...+|.|.||.||+|.+. .+..|+||.++.....+ ..+.|.+|++.+++++||||++++|+|...+..++|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE--EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--cceeeeeccccccccccccccccccccccccccccccc
Confidence 457899999999999865 36789999996543322 25789999999999999999999999998888999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC----------------C---
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS----------------S--- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~----------------~--- 439 (572)
|+++|+|.++|+... ...++|..+..|+.++|+||.|||.. ..+..+..+... .
T Consensus 82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999998752 23589999999999999999999953 222111111000 0
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccC-CCCCC-ChHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-LPPPV-DRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~-~~~~ 516 (572)
......+...|+|||++....++.++||||||+++|||+| |+.|+.... .......+.+.. .+.+. .+..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 233 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQRLPIPDNCPKD 233 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEETTSBTTSBHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccceeccchhHH
Confidence 0011235678999999998889999999999999999999 778875321 111111221211 11111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
+..++..||+.||++||||+++++.|
T Consensus 234 ------~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 234 ------IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23456689999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=252.70 Aligned_cols=225 Identities=21% Similarity=0.363 Sum_probs=167.2
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++++.+.+|.|+||.||+|+..++..+|+|.+...... .++|.+|++++++++||||++++++|.+++..++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45667789999999999999888888999998754332 25688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~ 441 (572)
+++|+|.++++.... .++|..+..++.+++.|++|||. |.+|..+....+.. ..
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999875432 47899999999999999999974 44454433211100 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~ 519 (572)
....++..|+|||+.....++.++||||||+++|||+| |+.|+..... ......+... ....+.. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~~~~~~--~~-- 227 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRLYRPKL--AS-- 227 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCCCCCCC--CC--
Confidence 11124567999999988889999999999999999999 8999853211 1111111111 1111110 00
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
..+..++.+||+.+|++||+|+++++.+
T Consensus 228 -~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 228 -MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1235677799999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=264.21 Aligned_cols=237 Identities=23% Similarity=0.371 Sum_probs=176.5
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++|+..+++|.|+||.||.|+- .+|.++|+|+++++.......++..+.|-.+|...++|+||++|..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 346788889999999999999985 5699999999999988888888999999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHH----HHHHHHHHHHHHHhcCCCCCceeeC----------------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRV----NIVKAMAHALAYLHHDCSPSIASTC---------------------- 435 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~----~i~~~ia~gl~yLH~~~~~~i~~~~---------------------- 435 (572)
||||.|||++...|.+.+ ...-+|++.+ -.|++..|-+.|+|||++|.+...+
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999999999998643 2334565432 2345556788899999998643110
Q ss_pred ------------------CCCC-----Cc-------------------cccccccCccccccccCCCcCcccchHHHHHH
Q 038466 436 ------------------PDSS-----NR-------------------TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473 (572)
Q Consensus 436 ------------------~~~~-----~~-------------------~~~~gt~~y~APE~~~~~~~s~ksDVySfGvv 473 (572)
.+.. .. ...+|||.|||||++.+..|+..+|+||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 00 01469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 038466 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPT---MQYVSQEF 548 (572)
Q Consensus 474 l~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs---m~~V~~~l 548 (572)
+|||+.|-+||... .+......++.- .+..|...... ..+.+++.+|+. ||++|-- .+||-+|+
T Consensus 378 myEmLvGyPPF~s~-------tp~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSE-------TPQETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HHHHHhCCCCCCCC-------CHHHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 99999999999532 222222223222 23222211111 223455556777 9999975 78888777
Q ss_pred hhc
Q 038466 549 LIT 551 (572)
Q Consensus 549 ~~~ 551 (572)
+..
T Consensus 447 fF~ 449 (550)
T KOG0605|consen 447 FFK 449 (550)
T ss_pred ccc
Confidence 654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=268.04 Aligned_cols=234 Identities=22% Similarity=0.282 Sum_probs=167.5
Q ss_pred CCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+++++.+.+|.|+||.||+|+. .++..||||+++...... ..+.+.+|+++++.+ +|||||+++|+|.+++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3466778899999999999963 246789999997543222 236788999999999 8999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC---------------------------------------------------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED--------------------------------------------------------- 400 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~--------------------------------------------------------- 400 (572)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864321
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------CC---
Q 038466 401 ---------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------SN--- 440 (572)
Q Consensus 401 ---------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~~--- 440 (572)
...++|.....++.++++|+.|||. |++|..+...... ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 1247888899999999999999983 5555543221100 00
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....++..|+|||++.+..++.++|||||||++|||+| |..||..... .......+........+.....
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~- 344 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPECAPS- 344 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCCCCCH-
Confidence 001223567999999999999999999999999999998 8888753211 0011111221111110000011
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+..++..||+.||++||+|.+|++.+..
T Consensus 345 --~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 345 --EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 23456678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=260.09 Aligned_cols=176 Identities=25% Similarity=0.294 Sum_probs=144.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||.||+++.. +|..+|+|.+...... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 46777888999999999999864 6899999998754322 23467999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC---------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD---------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~---------------~~~~ 441 (572)
||+++|+|.+++.... .+++.....++.++++|+.|||. |.+|..+....+ ....
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 9999999999987543 47788888999999999999984 334443322110 0111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 23458999999999998899999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=259.97 Aligned_cols=229 Identities=22% Similarity=0.307 Sum_probs=172.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+|... +|+.||+|++......+....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4566778999999999999864 689999999975543333345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCcccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNRTLL 444 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~~~~ 444 (572)
|+++|+|.+++.... .+++.....++.+++.|++|||+ |++|..+..+.+. ......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999987543 47788888899999999999984 4454433221110 111234
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDILL 522 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~~~ 522 (572)
.||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... +...+ . .
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~-~------~ 224 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILAGKLEFPRHLD-L------Y 224 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCcCCCccCC-H------H
Confidence 58999999999998889999999999999999999999985321 1111112222222 22111 1 1
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 523 ASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+.++..+|++.||++||+ ++++++|.|..
T Consensus 225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred HHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 235666899999999995 99999987764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=258.43 Aligned_cols=235 Identities=24% Similarity=0.372 Sum_probs=171.2
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--eEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 383 (572)
......+|.|.||+||.+... +|+..|||.+....... .+.+.+|+++|++++|||||+++|...... .+++.|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 334567899999999999865 49999999998663322 467889999999999999999999855544 689999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------------- 437 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------------- 437 (572)
||+++|||.+++.+.+. .++......+..+|.+|++|||+ |++|.++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999987654 57888888999999999999983 566655433220
Q ss_pred -CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
........||+.|||||++..+ ....++||||+||+++||+||++||... .........+......|..+..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~ip~~ 247 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEIPDS 247 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCCCcc
Confidence 0112236799999999999864 3345999999999999999999998532 0011111112111111112111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
...+ +.++...|++.||++|||+++++.|++.....+
T Consensus 248 ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 248 LSDE---AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHH---HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 1111 234455899999999999999999998876554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=261.54 Aligned_cols=230 Identities=21% Similarity=0.277 Sum_probs=173.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++...+|.|+||.||+|+.. +|+.||+|.+...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677788999999999999864 68999999997654333344567899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCccc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNRTL 443 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~~~ 443 (572)
||+++|+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.+. .....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 9999999999987543 36677777889999999999974 4555443321110 11123
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC--CChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP--VDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~ 521 (572)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.... +......+....+..+ .+ .
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~p~~~~-~------ 240 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKILAGRLKFPNWFD-G------ 240 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCCcCCCCCCC-H------
Confidence 468999999999999999999999999999999999999985321 1111112222222211 11 1
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 522 LASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
.+..+...||+.||++||+ +++++.|.+..
T Consensus 241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 1235666899999999996 79999887654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.29 Aligned_cols=223 Identities=21% Similarity=0.277 Sum_probs=167.9
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.+|.|+||.||+++. .+|+.||||+++............+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 579999999999985 5689999999976543333345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCccccccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAGT 447 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~gt 447 (572)
|.+++.... .+++.+...++.|++.|++|||. |++|..+..+.+ ........||
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999887543 47888888899999999999974 555544322111 0111234689
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~ 525 (572)
+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+. +...+...... +..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~~~~-------~~~ 224 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRTLSPE-------AKS 224 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 99999999999999999999999999999999999985321 111111111 11222222111 234
Q ss_pred HHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 526 ISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 526 i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+...||+.||++|| +..+++++.+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~ 255 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 55689999999999 899999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=258.80 Aligned_cols=223 Identities=22% Similarity=0.302 Sum_probs=166.5
Q ss_pred ccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 588999999999864 5889999998754333333456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccccc
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAGTY 448 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~gt~ 448 (572)
.+++.... .+++.....++.+++.|+.|||. |++|..+..+.+ ........||+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99997543 47888888999999999999974 555544322110 11122346899
Q ss_pred CccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHHHH
Q 038466 449 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLASTI 526 (572)
Q Consensus 449 ~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~i 526 (572)
.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.... .+...+ .. +..+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~-~~------~~~l 223 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPLRFPDGFD-RD------AKDL 223 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCCCCCcCC-HH------HHHH
Confidence 9999999999999999999999999999999999985321 111111222221 122121 11 2345
Q ss_pred HHHccccCCCCCC---CHHHHHHHHhhcc
Q 038466 527 SFACLQSNPKSRP---TMQYVSQEFLITR 552 (572)
Q Consensus 527 ~~~Cl~~dP~~RP---sm~~V~~~l~~~~ 552 (572)
...||+.||++|| ++.+++.|.+...
T Consensus 224 i~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 224 LIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 5689999999997 4788888876543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=257.26 Aligned_cols=231 Identities=19% Similarity=0.289 Sum_probs=163.7
Q ss_pred CccccccccccCeeEEEEEEcC-----------------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCccc
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-----------------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~ 368 (572)
.+.+...+|.|+||.||+|... ++..||+|.+....... ..++|.+|++++.+++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH--HHHHHHHHHHHHhhcCCCCeeE
Confidence 4556678999999999999743 23479999987653322 3467999999999999999999
Q ss_pred EEEEEEeCCeEEEEEecccCCChhhhhhcCC----------------CcccCCHHHHHHHHHHHHHHHHHHhc------C
Q 038466 369 LYGFCLHRKCMFLIYEYMKRGSLFCNLHNNE----------------DAVELDWAKRVNIVKAMAHALAYLHH------D 426 (572)
Q Consensus 369 l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~----------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~ 426 (572)
++|++.+.+..++||||+++|+|.+++.... ....++|.....++.+++.|+.|||. |
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999999886431 11247888899999999999999974 5
Q ss_pred CCCCceeeCCCC---------C------C----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc--CCCCCC
Q 038466 427 CSPSIASTCPDS---------S------N----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRD 485 (572)
Q Consensus 427 ~~~~i~~~~~~~---------~------~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt--G~~P~~ 485 (572)
++|..+..+... . . .....++..|+|||++....++.++||||||+++|||++ |..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 555544322110 0 0 011234678999999988899999999999999999987 556664
Q ss_pred ccccccCCCCcchhhhhhcc-------cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 486 LLSSLSSSSDPKIMLIDVLD-------QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~-------~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...... .......... ...+++. +. .+.+++..||+.||++|||+++|.+.+.
T Consensus 244 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELTDEQ----VIENAGEFFRDQGRQVYLFRPPPC-PQ------GLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCHHH----HHHHHHHHhhhccccccccCCCCC-CH------HHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 321100 0000000000 0011111 11 2345667999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=262.20 Aligned_cols=231 Identities=24% Similarity=0.321 Sum_probs=175.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+.+.+|.|.||.||||+.+ +.++||+|.+.+....+. ..+..++|++++++++|||||.++++|....++|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4667788999999999999864 689999999987665443 35789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-----------------CCCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP-----------------DSSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~-----------------~~~~~ 441 (572)
|+.+ +|+.+|...+ .++..+...|+.++..||.||| +|.+|..+.... .....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9987 9999998644 4777788899999999999997 466665543211 11112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
+.+.|||-|||||...+..|+..+|.||+||++||+.+|++||....- -........|+..+++........
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d~v~~p~~~S~~f~n-- 229 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKDPVKPPSTASSSFVN-- 229 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcCCCCCcccccHHHHH--
Confidence 345799999999999999999999999999999999999999852210 011111122333333321222222
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+...-+.+||..|-|-.+++.|.+....
T Consensus 230 ----fl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 230 ----FLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 2225679999999999999998765543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=261.54 Aligned_cols=237 Identities=19% Similarity=0.224 Sum_probs=173.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+|+.. +|+.||||++...........+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4667788999999999999865 589999999976543333345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCcccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNRTLL 444 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~~~~ 444 (572)
|+++|+|.+++.... .+++.....++.+++.|+.|||. |++|..+..+.+. ......
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999997543 47788888899999999999973 5555443322110 011234
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChH-HHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRK-VIRDIL 521 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~-~~~~~~ 521 (572)
.||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+. ...+..+.... ......
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-------NETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-------HHHHHHHHhccccccCCCCCccccccCH
Confidence 689999999999988999999999999999999999999853211 00000000 01111110000 000001
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+..+...|++.+|++||++++++++.+...
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 1234556899999999999999999876553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=261.49 Aligned_cols=232 Identities=20% Similarity=0.296 Sum_probs=174.0
Q ss_pred cCCccccccccccCeeEEEEEEcCC--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++...+|.|+||.||+|...+ +..||+|++...........+.+.+|+++++.++|||||++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3456777899999999999997543 46899999875443333345678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~ 441 (572)
||||+++|+|.+++.... .+++.....++.+++.|+.||| +|.+|..+..+.+. ...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999999997543 4778888899999999999997 45555443321110 111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~ 519 (572)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... +......+.... .+...+..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~~~~---- 254 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-------PLLIYQKILEGIIYFPKFLDNN---- 254 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCCCCHH----
Confidence 23468999999999998889999999999999999999999985321 111112222222 22222111
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 520 ILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
+..+..+|++.||++|+ +++++.++.+...
T Consensus 255 ---~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 255 ---CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred ---HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 23455689999999995 8999999877653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=250.84 Aligned_cols=232 Identities=23% Similarity=0.379 Sum_probs=169.7
Q ss_pred CCccccccccccCeeEEEEEEcCC------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
+++++...+|.|+||.||+|.... ...||+|.+...... ...++|.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 356777889999999999997532 367999999755432 234679999999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-
Q 038466 379 MFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~- 438 (572)
.+++|||+++|+|.+++..... ...+++.....++.+++.|+.|||. |++|..+....+.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 9999999999999999875321 1347888889999999999999984 5555544321110
Q ss_pred --------------C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchh
Q 038466 439 --------------S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM 499 (572)
Q Consensus 439 --------------~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~ 499 (572)
. ......+++.|+|||++....++.++|||||||++|||+| |..||.... ...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------~~~- 234 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------NQE- 234 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-------HHH-
Confidence 0 0112235678999999988899999999999999999998 999985321 111
Q ss_pred hhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 500 LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 500 ~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.+.....++....... .+..+...||+.||++||++++|++++.
T Consensus 235 ~~~~i~~~~~~~~~~~~~~---~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 235 VIEMIRSRQLLPCPEDCPA---RVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHHcCCcCCCcccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 1112211111111111111 2345667899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=257.51 Aligned_cols=223 Identities=21% Similarity=0.271 Sum_probs=167.3
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
++|.|+||.||+++. .+|+.||+|++.............+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 579999999999985 5689999999976543333345678889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCccccccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAGT 447 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~gt 447 (572)
|..++.... .+++.....++.+++.|++|||. |++|..+..+.+ ........||
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 998887543 47888888999999999999984 455544322111 0111234689
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 525 (572)
+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+... ..+...+.. +..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~~~~-------~~~ 224 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRTLSPE-------AKS 224 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCCCCCCCHH-------HHH
Confidence 99999999999999999999999999999999999985321 11111111111 222222211 234
Q ss_pred HHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 526 ISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 526 i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+...||+.||++|| ++.+++++.+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 55589999999998 899999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=248.06 Aligned_cols=229 Identities=23% Similarity=0.359 Sum_probs=168.8
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++++...+|.|+||.||+|...+++.||+|.+...... .+.|.+|+.++++++|+||+++++++.+++..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 456777889999999999999888889999998754332 3678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~--~ 440 (572)
|+++|+|.++++... ...+++.++..++.+++.|++|||+ |.+|..+....+. . .
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 82 YMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred cCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999997542 2357888999999999999999984 3444433221110 0 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....++..|+|||+.....++.++|||||||++|||+| |+.||.... .... ...+....+.+.......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~- 231 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-------NSDV-MSALQRGYRMPRMENCPD- 231 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-------HHHH-HHHHHcCCCCCCCCCCCH-
Confidence 011234567999999988889999999999999999998 999984221 1111 111111111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+++.+|++.+|++||+++++.+.+.
T Consensus 232 --~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 232 --ELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred --HHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 2345677999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=263.15 Aligned_cols=229 Identities=24% Similarity=0.320 Sum_probs=169.6
Q ss_pred ccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 309 VFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
+.+.+|+|-||.|..++...+..||||.++...... ..++|.+|+++|++++|||||+++|+|..++.+.+|+|||++
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 346789999999999999889999999999765443 257999999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCC--------CCCcccc----------
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPD--------SSNRTLL---------- 444 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~--------~~~~~~~---------- 444 (572)
|+|.+++..+.... ..-..-++|+.|||.||+|| |+|..+.....+.. ...+...
T Consensus 620 GDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 620 GDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred CcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 99999998764432 33345677999999999998 88877665433211 1111111
Q ss_pred -ccccCccccccccCCCcCcccchHHHHHHHHHHH--cCCCCCCccccccCCCCcchhhhhhccc-----CCC-CCCChH
Q 038466 445 -AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL--MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PPVDRK 515 (572)
Q Consensus 445 -~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ell--tG~~P~~~~~~~~~~~~~~~~~~~~~~~-----~l~-~~~~~~ 515 (572)
+-...|||||.+.-++++++||||+|||++||++ +.+.||..+..-... .....+++. .++ |+..+.
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcceeccCCCcCcH
Confidence 1246799999999999999999999999999987 478898644311000 000111111 111 112222
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+ +.++++.||..|.++||+++++...|..
T Consensus 775 ---~---lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 775 ---G---LYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred ---H---HHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1 2356679999999999999999887754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=247.58 Aligned_cols=237 Identities=19% Similarity=0.214 Sum_probs=170.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+.+.+|.|+||.||+|+. .+++.||||.+......+....++|.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 466777899999999999985 4689999998865433333345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 385 YMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
|+++|+|.+++.... ....++......++.++++|+.|||+ |++|..+....+. ..
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 999999998886422 22346777888999999999999984 3444333221110 00
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|++.|+|||+..+..++.++||||||+++|||+||+.|+.... . ......+.+.....++...... .
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~--~ 234 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----M-NLFSLCQKIEQCDYPPLPTEHY--S 234 (267)
T ss_pred HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----c-cHHHHHHHHhcCCCCCCChhhc--C
Confidence 112357889999999988889999999999999999999999974211 0 0011112222211111111111 1
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+.+++.+||+.+|++||++++|++.+..
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 123456668999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=263.99 Aligned_cols=234 Identities=23% Similarity=0.323 Sum_probs=167.6
Q ss_pred CCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+++++.+.+|.|+||.||+|+. .++..||||+++.....+ ..+.+.+|+++++.+ +|||||+++|+|...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4567788999999999999873 234689999997654332 246788999999999 8999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC---------------------------------------------------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED--------------------------------------------------------- 400 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~--------------------------------------------------------- 400 (572)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998864211
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------CC---ccccc
Q 038466 401 ----------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------SN---RTLLA 445 (572)
Q Consensus 401 ----------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~~---~~~~~ 445 (572)
...++|.+..+++.++++|+.||| +|.+|..+..+.+. .. .....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 124788888999999999999997 45555543321110 00 00112
Q ss_pred cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHH
Q 038466 446 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 446 gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 524 (572)
++..|||||++....++.++|||||||++|||++ |+.||..... .............+........ .+.
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~---~l~ 345 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPDFAPP---EIY 345 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCCCCCH---HHH
Confidence 4567999999998899999999999999999997 9999853211 0011111111111111000001 123
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 525 TISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.++..||+.||++|||+.+|++.+..
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 56668999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.08 Aligned_cols=177 Identities=24% Similarity=0.294 Sum_probs=143.2
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++.+.+|.|+||.||+|... +|+.+|+|.+...... ...+.+.+|++++++++|||||+++++|.+++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 356777889999999999999865 6889999988754322 2246788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCCC---------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPDS---------------SN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~~---------------~~ 440 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.|||. |++|..+..+.+. ..
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999997533 36777788899999999999984 2334333221110 00
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 122358899999999998889999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=236.47 Aligned_cols=237 Identities=27% Similarity=0.396 Sum_probs=183.6
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++|++...+|.|-||.||.|+.+ ++-.||+|++.++........+++.+|+++-+.++||||.++||+|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567888889999999999999864 688999999987776555556789999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee---------------CCCCCC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST---------------CPDSSN 440 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~---------------~~~~~~ 440 (572)
++||.++|++...|+.... ..++...-..++.|+|.|+.|+| +|++|..... ......
T Consensus 100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 9999999999999985332 23444445568899999999986 6666653321 111345
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
+.+++||..|.+||...+..++.+.|+|++||+.||++.|.+||+... ..........+|-..|......
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI~k~~~~~p~~is~~----- 248 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRIRKVDLKFPSTISGG----- 248 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHHHHccccCCcccChh-----
Confidence 677899999999999999999999999999999999999999996432 1111111122333333322222
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+.++...|+..+|.+|.+..||+.++|+..
T Consensus 249 --a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 249 --AADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --HHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 234556899999999999999999998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=262.97 Aligned_cols=236 Identities=19% Similarity=0.285 Sum_probs=168.2
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 375 (572)
..+.+.+...+|.|+||.||+|... .+..||||++....... ..+.|.+|+++++++. |||||+++|+|.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS--EKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3455667788999999999999742 23579999997543322 2467999999999996 9999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC-------------------------------------------------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED------------------------------------------------------- 400 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~------------------------------------------------------- 400 (572)
.+..++|||||++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865310
Q ss_pred --------------------------------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC
Q 038466 401 --------------------------------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP 436 (572)
Q Consensus 401 --------------------------------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~ 436 (572)
...++|..+..++.++++|+.|||. |++|..+....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 1247788889999999999999974 45554332211
Q ss_pred CC----------------C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCc
Q 038466 437 DS----------------S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 ~~----------------~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~ 496 (572)
.. . ......+++.|+|||++.+..++.++|||||||++|||++ |..|+..... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~------~ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV------D 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch------h
Confidence 00 0 0111235678999999998899999999999999999997 9999753210 0
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. .....+......+.+..... .+..++.+||+.||++||++.+|.+.+..
T Consensus 347 ~-~~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 347 S-TFYNKIKSGYRMAKPDHATQ---EVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred H-HHHHHHhcCCCCCCCccCCH---HHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0 01111111111111111111 23456779999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=249.02 Aligned_cols=217 Identities=22% Similarity=0.343 Sum_probs=158.5
Q ss_pred cccccCeeEEEEEEcCC-------------------------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCc
Q 038466 312 IWNYDGYGSVYKAQLPN-------------------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 366 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~ni 366 (572)
.+|.|+||.||+|.+.. ...||+|.+..... ...++|.+|++++++++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 57999999999997421 23589999875432 234678899999999999999
Q ss_pred ccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--
Q 038466 367 VKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-- 438 (572)
Q Consensus 367 v~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-- 438 (572)
++++|+|.+++..++||||+++|+|..++..... .+++..++.++.|+++|++|||+ |++|..+......
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999998875332 47888899999999999999984 4555544321100
Q ss_pred ---------C---------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHH-cCCCCCCccccccCCCCcch
Q 038466 439 ---------S---------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKI 498 (572)
Q Consensus 439 ---------~---------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~Ell-tG~~P~~~~~~~~~~~~~~~ 498 (572)
. ......++..|+|||++.+ ..++.++|||||||++|||+ +|+.|+..... ..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP------SE- 229 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh------HH-
Confidence 0 0011246788999998865 56899999999999999995 79999753211 00
Q ss_pred hhhhhccc--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 499 MLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 499 ~~~~~~~~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
....... ..+.+... .+..++..||+.+|++||||.+|+++|
T Consensus 230 -~~~~~~~~~~~~~~~~~-------~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KERFYEKKHRLPEPSCK-------ELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHHhccCCCCCCCh-------HHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111111 22222211 234566789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=251.65 Aligned_cols=232 Identities=22% Similarity=0.273 Sum_probs=167.1
Q ss_pred ccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||+||++.. .+|+.||+|++...........+.+..|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 57899999999985 46899999999765443333446788999999999999999999999999999999999999999
Q ss_pred hhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCccccccc
Q 038466 392 FCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAGT 447 (572)
Q Consensus 392 ~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~gt 447 (572)
..++.... ....+++.....++.|++.|+.|||+ |++|..+..+.. ........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 88875432 23458899999999999999999984 444443322110 0011224688
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~ 527 (572)
+.|+|||++.+..++.++|||||||++|||+||+.||...... .................+ ..... .+..+.
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~---~~~~li 232 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILNDSVTYP--DKFSP---ASKSFC 232 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHhhcccCCCCc--ccCCH---HHHHHH
Confidence 9999999999999999999999999999999999998532110 000011111111111111 00111 123456
Q ss_pred HHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 528 FACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 528 ~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
..|++.||++|| ++++++++.+...
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 689999999999 7889998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=253.04 Aligned_cols=237 Identities=22% Similarity=0.234 Sum_probs=171.3
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++..+.+|.|+||.||++.. .+++.||+|++.............+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 45667899999999999985 46899999999765433333345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~ 443 (572)
+++|+|.+++.... ...+++.....++.++++|+.|||. |++|..+..... ......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999998886532 2358888999999999999999984 344433221110 011122
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........+..... ........ .+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~---~~ 232 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKEDQE-EYSEKFSE---AA 232 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhccc-ccCcccCH---HH
Confidence 4688999999999888899999999999999999999999863211 0000011111111111 11111111 12
Q ss_pred HHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 524 STISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
..++..||+.||++|| +++++.++.+...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 3566789999999999 8899988876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=245.11 Aligned_cols=229 Identities=23% Similarity=0.386 Sum_probs=169.1
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+.+.+.+|.|+||.||+|...+++.||+|.++..... .++|.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456677889999999999999877889999999765432 2568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------Cccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---------------NRTL 443 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---------------~~~~ 443 (572)
|+++|+|.+++.... ...++|.....++.+++.|+.|||. |++|..+....... ....
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999997643 3357899999999999999999984 44444332211110 0000
Q ss_pred ccc---ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 444 LAG---TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 444 ~~g---t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
..| +..|+|||+..+..++.++||||||+++|||+| |+.|+.... ... ....+......+......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~~~~-- 230 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-------NAE-VLQQVDQGYRMPCPPGCP-- 230 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-------HHH-HHHHHHcCCCCCCCCcCC--
Confidence 112 347999999998999999999999999999999 999985321 111 111111111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..++.+|++.+|++||+++++.+.+.
T Consensus 231 -~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 231 -KELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred -HHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 12345677999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=256.44 Aligned_cols=223 Identities=21% Similarity=0.278 Sum_probs=167.6
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.+|.|+||.||+++. .+|+.||+|++...........+.+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 578999999999985 5689999999976543333345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCccccccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAGT 447 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~gt 447 (572)
|..++.... .+++.+...++.+++.|++|||. |++|..+..+.. ........||
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 998887533 47888889999999999999984 555544322110 0111234689
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~ 525 (572)
+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+. +..++...... +..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~~~~-------~~~ 224 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEDIKFPRTLSAD-------AKS 224 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhccCCccCCCCCCHH-------HHH
Confidence 99999999998899999999999999999999999985321 111111111 11222222211 234
Q ss_pred HHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 526 ISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 526 i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+...|++.||++|| ++.+++++.+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 55689999999997 899999886653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=256.48 Aligned_cols=230 Identities=19% Similarity=0.319 Sum_probs=169.0
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
++|.|+||.||+|+.. +++.||||.++.....+....+.+..|..++.++ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5799999999999864 6899999999865433334456788999999998 7999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.. ........|
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9998886542 47888999999999999999974 455543322110 111223568
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--CCCcchhhhhhcccC--CCCCCChHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--SSDPKIMLIDVLDQR--LPPPVDRKVIRDILL 522 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~ 522 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||+....... ..........+.... ++...+. .
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~ 231 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV-------K 231 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH-------H
Confidence 9999999999999999999999999999999999999964321110 000111111122222 2222211 1
Q ss_pred HHHHHHHccccCCCCCCC------HHHHHHHHhhc
Q 038466 523 ASTISFACLQSNPKSRPT------MQYVSQEFLIT 551 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPs------m~~V~~~l~~~ 551 (572)
+..+...|++.||++||+ ++++++|.+..
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 234566899999999987 78999886654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=259.97 Aligned_cols=232 Identities=21% Similarity=0.349 Sum_probs=168.5
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++..+.+|.|+||+||+|+. .+++.||||++......+....+.+.+|++++.+++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 466778899999999999985 4689999999976544344445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------C----------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------S---------- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------~---------- 439 (572)
|+++|+|.+++.... .+++.....++.+++.|++||| +|++|.++..+.+. .
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999997543 4788888899999999999997 45555433221100 0
Q ss_pred ---------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 ---------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ---------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 00124699999999999999999999999999999999999999853
Q ss_pred cccccCCCCcchhhhhhcc----cCCCCCCC-hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 487 LSSLSSSSDPKIMLIDVLD----QRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~----~~l~~~~~-~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. +......+.. ...++... .....+++ ..+.|...++..||+++||++|.+..
T Consensus 239 ~~-------~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li----~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 239 ET-------PQETYKKVMNWKETLIFPPEVPISEKAKDLI----LRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred CC-------HHHHHHHHHcCcCcccCCCcCCCCHHHHHHH----HHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 21 1111111111 11222111 11122221 11235555566789999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=245.07 Aligned_cols=236 Identities=19% Similarity=0.230 Sum_probs=171.1
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+.+.+|.|+||.||+|+. .+|+.+|||.+......+....++|.+|++++++++||||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 455667899999999999985 5789999998876544344445789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 385 YMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
|+++|+|.+++.... ....++|.....++.++++|++|||. +.+|..+..+... ..
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 999999999886422 23357899999999999999999984 4444433221110 00
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|+..|+|||+..+..++.++||||||+++|||++|..|+..... ........+.....+ +.......
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~-- 234 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYP-PLPSDHYS-- 234 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCC-CCCccccc--
Confidence 1123578899999999888899999999999999999999999742210 000000111111111 11111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..++.+||+.||++||||.+|++.+.
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 12335666899999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=246.01 Aligned_cols=225 Identities=21% Similarity=0.364 Sum_probs=166.1
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++.+...+|.|+||+||+|...++..+|+|.+...... .++|.+|++++.+++||||++++|+|.+.+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35566789999999999998877778999998754432 25688999999999999999999999998899999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~ 441 (572)
+++|+|.+++..... .++|.++..++.++++|++|||. |.+|..+..+.+.. ..
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999875432 57899999999999999999983 45554432211100 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~ 519 (572)
....++..|+|||+.....++.++|||||||++|||+| |+.|+..... ......+... ....+. ...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~~-- 227 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRLYRPH--LAS-- 227 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCCCCCC--CCC--
Confidence 11224567999999988889999999999999999998 9999753211 1111111111 111111 001
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
..+.+++..||+.+|++||++.++++.+
T Consensus 228 -~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 228 -EKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred -HHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 1234566789999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=260.50 Aligned_cols=225 Identities=25% Similarity=0.393 Sum_probs=165.5
Q ss_pred ccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+-..+|.|-||.||.|.|+. .-.||||.++....+ +++|.+|+.+|+.++|||+|+++|+|......|||.||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3344578889999999999875 678999999865543 57899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeC--------C-------CCCCcccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTC--------P-------DSSNRTLL 444 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~--------~-------~~~~~~~~ 444 (572)
|.+|+|.++|++... ..+.-...+.+|.||+.||+|| |+|......... . .....+.-
T Consensus 345 M~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred ccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999999997543 2455556678999999999988 666543221110 0 00111122
Q ss_pred cc---ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCCC-ChHHH
Q 038466 445 AG---TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPV-DRKVI 517 (572)
Q Consensus 445 ~g---t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~-~~~~~ 517 (572)
+| .+.|.|||-+....++.|+|||+|||+|||+.| |..||..++. . ...+.+. .++..|. ++.
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------S-qVY~LLEkgyRM~~PeGCPp-- 493 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------S-QVYGLLEKGYRMDGPEGCPP-- 493 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------H-HHHHHHhccccccCCCCCCH--
Confidence 23 356999999999999999999999999999996 8889853321 0 1122222 2333222 122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+-.++..||+-+|++||++.|+.+.+..
T Consensus 494 ----kVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 494 ----KVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ----HHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 22345568999999999999999887754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=254.03 Aligned_cols=175 Identities=18% Similarity=0.252 Sum_probs=137.7
Q ss_pred ccccccc--CeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 310 FSIWNYD--GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 310 ~~~~~~~--~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
..++|.| +||+||+++. .+|+.||+|++....... ...+.+.+|+++++.++|||||+++++|..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 4567877 7899999985 579999999997553222 23456778999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------------
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------------- 439 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------------- 439 (572)
++|+|.+++..... ..+++.....++.|++.|++|||. |.+|..+....+..
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 99999999865322 247888999999999999999974 55555443211100
Q ss_pred ---CccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 ---NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ---~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
......++..|+|||++.. ..++.++|||||||++|||+||+.||+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0011235677999999876 4589999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=246.82 Aligned_cols=233 Identities=23% Similarity=0.333 Sum_probs=166.3
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..++++...+|.|+||.||+|+. .+|+.||+|++....... .+.+.+|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 34577788899999999999985 578999999987553322 24677899999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~ 439 (572)
|||+++|+|.++++... .+++.....++.++++|+.|||+ |.+|..+..... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999999887532 47888889999999999999984 344433222110 00
Q ss_pred CccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 440 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
......|++.|+|||.+. ...++.++|||||||++|||++|+.|+........ ..........++.....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMSKSNFQPPKLKDK 234 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------heeeecCCCCCCCCccc
Confidence 112245788999999874 34578899999999999999999999753221100 00111111111100000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
......+.++...||+.+|++||++++++++++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000112345667899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=261.55 Aligned_cols=230 Identities=20% Similarity=0.326 Sum_probs=168.4
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+...+.+|.|+||+||+|+. .+++.||||++...........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 55677899999999999985 56899999999765443444457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------------------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------------- 439 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------------- 439 (572)
+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+..+....
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 83 IPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999987543 3677777788899999999997 455555432211000
Q ss_pred --------------------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHH
Q 038466 440 --------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475 (572)
Q Consensus 440 --------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ 475 (572)
......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 001246999999999999888999999999999999
Q ss_pred HHHcCCCCCCccccccCCCCcchhhhhhcc----cCCCCC--CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 476 EVLMGKHPRDLLSSLSSSSDPKIMLIDVLD----QRLPPP--VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 476 ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~~~--~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
||+||+.||.... +......+.. ...+.. .+.. ..+++. .+.|+..+|..||+++++++|.+
T Consensus 240 elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~-~~dli~----~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 240 EMLVGQPPFLAPT-------PTETQLKVINWENTLHIPPQVKLSPE-AVDLIT----KLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred HHHhCCCCCcCCC-------HHHHHHHHHccccccCCCCCCCCCHH-HHHHHH----HHccCcccccCCCCHHHHhcCcc
Confidence 9999999985321 1111111111 111211 1111 111111 12477888888999999999977
Q ss_pred hc
Q 038466 550 IT 551 (572)
Q Consensus 550 ~~ 551 (572)
..
T Consensus 308 f~ 309 (381)
T cd05626 308 FS 309 (381)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=262.87 Aligned_cols=236 Identities=24% Similarity=0.449 Sum_probs=174.4
Q ss_pred ccccccccccCeeEEEEEEcC--CCc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP--NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~--~g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+...+.+|.|.||+|++|.|. +|+ .||||.+....... .+.+|.+|+.+|-+++|||+|+|||...+ ....||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344568899999999999875 354 58999998765442 46799999999999999999999999887 678899
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCcee--------eCC--------CCCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIAS--------TCP--------DSSN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~--------~~~--------~~~~ 440 (572)
+|.++.|||.+.|++ .....+--.....++.|||.||.|| |+|....++. .+. ....
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999999997 3333455667778999999999998 7775433221 110 1111
Q ss_pred ccccc----cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCCCC
Q 038466 441 RTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVD 513 (572)
Q Consensus 441 ~~~~~----gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~ 513 (572)
.-.+. -.+.|.|||.+....++.+||||+|||++|||+| |+.||-.. ....+.+.+| ++++.|.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHHhccccccCCCCCC
Confidence 11111 2467999999999999999999999999999996 78887321 1222333333 34544432
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~ 559 (572)
..+++ -++++.||..+|++||||..+..++...+..+.+..
T Consensus 340 --csedI---Y~imk~cWah~paDRptFsair~~~~l~eaqp~~a~ 380 (1039)
T KOG0199|consen 340 --CSEDI---YQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVAR 380 (1039)
T ss_pred --ChHHH---HHHHHHhccCCccccccHHHHHHhHHHHhcCCceee
Confidence 22333 356779999999999999999988887777655544
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=245.13 Aligned_cols=232 Identities=20% Similarity=0.297 Sum_probs=167.3
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+++++....+|.|+||.||+|.. .++..||+|.+....... .+.+.+|++++++++|+||++++|++..++..++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH---HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44555567899999999999985 467899999987654332 36788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------ 438 (572)
+||+++++|.++++........++.....++.++++|++|||+ +.+|..+..+.+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999999864322223777888899999999999984 4444433321100
Q ss_pred CCccccccccCccccccccCCC--cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh--hcccCCCCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID--VLDQRLPPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~--~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~ 514 (572)
.......|++.|+|||++.... ++.++|||||||++|||++|+.|+....... ....... ...+.++...+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~- 238 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMFKIHPEIPESLS- 238 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhhccCCCCCcccC-
Confidence 0011234788999999986543 7899999999999999999999985321100 0000000 01111222111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+ +..++.+||+.+|++|||+.+++.+.|
T Consensus 239 ---~~---~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 239 ---AE---AKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ---HH---HHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 11 235566899999999999999998865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=245.10 Aligned_cols=228 Identities=23% Similarity=0.341 Sum_probs=166.8
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+...+|.|+||.||+|... +++.||+|.+...... .++|.+|++++++++||||++++++|..++..++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3556678899999999999864 5889999998754322 3578899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------C-----
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------N----- 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------~----- 440 (572)
|+++|+|.+++.... ...++|..+..++.++++|++|||. |.+|..+....... .
T Consensus 83 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 83 FMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred eCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999987543 2357899999999999999999984 45555433211100 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....++..|+|||+..+..++.++|||||||++|||+| |..|+.... .. .....+.....++.+.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~- 232 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS-QVYELLEKGYRMERPEGCPP- 232 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HH-HHHHHHHCCCCCCCCCCCCH-
Confidence 001123567999999988899999999999999999998 899975321 00 01111111111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++.+||+.||++||++.++.+.+.
T Consensus 233 --~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 233 --KVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred --HHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 2345667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=247.16 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=167.9
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+++.+.+.+|.|+||.||+|... .+..||+|.+....... ....|.+|+.++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345677788999999999999864 36789999887543322 2357899999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC----cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------C
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------N 440 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~----~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------~ 440 (572)
..++||||+++|+|.++++.... ...++|.+++.++.++++|++|||. |.+|..+....... +
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999876432 2358999999999999999999984 44444333221100 0
Q ss_pred c---------------cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 441 R---------------TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 441 ~---------------~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
. .....+..|+|||++.+..++.++|||||||++|||++ |+.||+... .+. ..+.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~------~~~--~~~~~ 234 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------NQE--VMEFV 234 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHH--HHHHH
Confidence 0 00112357999999998899999999999999999997 999985321 111 11111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
........+..... .+..++.+|++.+|++||++.+|++++.
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRLDPPKGCPG---PVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcCCCCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111110011111 2345667899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=242.38 Aligned_cols=238 Identities=20% Similarity=0.232 Sum_probs=173.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||.||+|... +|+.||+|.++.....+....+++.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35667788999999999999875 79999999987543333333568899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~ 439 (572)
||+++|+|.+++.... ....+++.+...++.+++.|+.|||. |.+|..+..+.. ..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999999886532 23357888999999999999999974 444443322110 00
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
......|++.|+|||+..+..++.++|||||||++|||++|+.|+..... ......+.+.....++.......
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~- 234 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPLPADHYS- 234 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCCChhhcC-
Confidence 11224578899999999888899999999999999999999999742210 00001111111111111110111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+..++..||+.+|++|||+.+|++.+..
T Consensus 235 -~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 235 -EELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred -HHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 123456678999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=243.32 Aligned_cols=229 Identities=25% Similarity=0.377 Sum_probs=168.4
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++.+...+|.|+||+||+|... +...||||.++...... ..++|.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 34666778999999999999864 24689999987554322 2467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.+++..... .++|.....++.+++.|++|||. |++|..+..+.+..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999976432 58899999999999999999984 44554433221100
Q ss_pred C----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCC
Q 038466 440 N----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVD 513 (572)
Q Consensus 440 ~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~ 513 (572)
. .....+++.|+|||+.....++.++||||||+++|||++ |..|+..... ......+.+. ..+.+..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 232 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRLPPPMD 232 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCCCCCC
Confidence 0 001123567999999998899999999999999999998 9999853211 1111111111 1111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... .+.+++..||+.+|++||++++|++++.
T Consensus 233 --~~~---~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 233 --CPS---ALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred --CCH---HHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 2346777999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=261.44 Aligned_cols=232 Identities=21% Similarity=0.300 Sum_probs=169.2
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||.||+|+. .+|+.||||++...........+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 466778899999999999986 4689999999976543333445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------- 439 (572)
|+++|+|.+++.... .+++.....++.|++.|++|||. |++|..+..+.+..
T Consensus 82 ~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999987543 47888888899999999999973 55554332211000
Q ss_pred ------------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCC
Q 038466 440 ------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483 (572)
Q Consensus 440 ------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P 483 (572)
......||+.|+|||++....++.++|||||||++|||++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00013589999999999999999999999999999999999999
Q ss_pred CCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhhc
Q 038466 484 RDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT---MQYVSQEFLIT 551 (572)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs---m~~V~~~l~~~ 551 (572)
|..... ......+.. +.+..+.......+ +.++...|+. +|++|++ +++++++.+..
T Consensus 239 f~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~---~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 239 FCSDNP-------QETYRKIINWKETLQFPDEVPLSPE---AKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred CCCCCH-------HHHHHHHHcCCCccCCCCCCCCCHH---HHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 853211 111111111 11111111000111 1233345675 8999998 99999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=242.19 Aligned_cols=223 Identities=22% Similarity=0.365 Sum_probs=162.4
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.+|.|+||.||+|+. .+|+.+|+|.+......+ ....|.+|++++++++||||++++++|...+..++||||+++|+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 578999999999986 478999999886543222 24678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----C-----------c----cccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----N-----------R----TLLA 445 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----~-----------~----~~~~ 445 (572)
|.++++... ..++|.....++.+++.|+.|||. |.+|..+....+.. + . ....
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999997533 347899999999999999999984 44554433221110 0 0 0011
Q ss_pred cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHH
Q 038466 446 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 446 gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 524 (572)
++..|+|||++.+..++.++|||||||++|||++ |..|++.... . .....+....+.+.+..... .+.
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~---~~~ 226 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------Q-QTREAIEQGVRLPCPELCPD---AVY 226 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------H-HHHHHHHcCCCCCCcccCCH---HHH
Confidence 2346999999988889999999999999999997 8888753321 0 01111111111111111111 234
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHh
Q 038466 525 TISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.++.+|++.+|++|||+.+|.+.+.
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 5667999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=240.57 Aligned_cols=220 Identities=23% Similarity=0.342 Sum_probs=163.8
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
++|.|+||.||+|...++..+|+|.++.....+ ....|.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 578999999999998889999999987654332 235788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cccccccc
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NRTLLAGT 447 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~~~~~gt 447 (572)
.+++.... ..++|..+..++.++++++.|+|. |.+|..+....+.. ......++
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 99887543 247899999999999999999983 44554332211100 00112335
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~~~~ 523 (572)
+.|+|||+..+..++.++||||||+++||+++ |..||..... ......+. ....+...+ ..+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-------~~~ 223 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-------QQAREQVEKGYRMSCPQKCP-------DDV 223 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCC-------HHH
Confidence 67999999998899999999999999999998 9999853211 00001111 111111111 123
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..++.+|++.+|++||++.++.+++.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 45777999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=242.27 Aligned_cols=230 Identities=22% Similarity=0.317 Sum_probs=169.5
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.....+|.|+||.||+|.. .+|+.||+|.+....... ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 34556789999999999986 468999999987543222 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++++|.++++... ...+++.....++.+++.|+.|||. +.+|..+....+. ....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999998642 2358888889999999999999984 3444433221100 0011
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|++.|+|||+..+..++.++|||||||+++||+||+.|+.... .............++ ...... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~~~~---~~ 228 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKIIRGVFPP-VSQMYS---QQ 228 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCC-CccccC---HH
Confidence 2357889999999998889999999999999999999999985321 111111222222211 111111 12
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..++.+||+.+|++||++.+++++.+
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 345667999999999999999988753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=252.10 Aligned_cols=240 Identities=20% Similarity=0.218 Sum_probs=166.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||.||+|+.. +++.||||++......+ ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4566778999999999999875 68899999987543222 234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC------------------CCC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------------SSN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------------~~~ 440 (572)
|+++|.+....... ..+++.....++.+++.|+.|||. |++|..+....+ ...
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99998776544321 247888888999999999999984 445443322110 001
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchhhhhhccc-----
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDVLDQ----- 506 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~~~~~~~~----- 506 (572)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 122458999999999988889999999999999999999999986332100 000000000000000
Q ss_pred CCCCCCC-hHHHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 RLPPPVD-RKVIR-----DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 ~l~~~~~-~~~~~-----~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.... ..... ....+.++...|++.||++|||++++++|.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0000000 00000 0112456777999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=246.38 Aligned_cols=231 Identities=21% Similarity=0.338 Sum_probs=166.8
Q ss_pred CccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
++++.+.+|.|+||+||+|.. .++..+|+|.+...... ...+.|.+|++++++++||||+++++++..++..+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 456677899999999999973 34688999999754332 22467889999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCC--------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-
Q 038466 381 LIYEYMKRGSLFCNLHNNED--------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~--------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~- 439 (572)
+||||+++|+|.+++..... ...+++.+.+.++.++++|+.|||+ |.+|..+..+.+..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 99999999999999863211 1247888889999999999999984 44554433221100
Q ss_pred ------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhh
Q 038466 440 ------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 440 ------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~ 500 (572)
......++..|+|||+..+..++.++|||||||++|||+| |..|+.... . ...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-------~-~~~ 235 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------N-QEV 235 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------H-HHH
Confidence 0111234567999999988889999999999999999998 998874221 1 111
Q ss_pred hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 501 IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 501 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.++.....+.+..... .+..+...||+.||++||++.+|.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHcCCcCCCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 222222111111111111 1234566899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=249.09 Aligned_cols=225 Identities=20% Similarity=0.238 Sum_probs=159.6
Q ss_pred ccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||.||+++.. +|+.+|+|++...........+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 578999999999864 6999999999754332222234556799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccccccccC
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTLLAGTYG 449 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~~~gt~~ 449 (572)
.++++... ...+++.....++.+++.|++|||. |++|..+..... ........||..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 98886533 2347899999999999999999984 455544322111 011122458899
Q ss_pred ccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHH
Q 038466 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA 529 (572)
Q Consensus 450 y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~ 529 (572)
|+|||++.+..++.++||||+||++|||++|+.||...... ...............+.+.. .... .+.++...
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~li~~ 232 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTLEDEVKFEHQ-NFTE---ESKDICRL 232 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch---hhHHHHHHHhhccccccccc-cCCH---HHHHHHHH
Confidence 99999998888999999999999999999999998532110 00011111111111111100 0001 12456668
Q ss_pred ccccCCCCCCCHHHHH
Q 038466 530 CLQSNPKSRPTMQYVS 545 (572)
Q Consensus 530 Cl~~dP~~RPsm~~V~ 545 (572)
||+.||++||+++|++
T Consensus 233 ~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 233 FLAKKPEDRLGSREKN 248 (277)
T ss_pred HhccCHhhCCCCccch
Confidence 9999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=256.43 Aligned_cols=233 Identities=24% Similarity=0.337 Sum_probs=163.0
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++....+|.|+||.||+|+. .+|+.||||++...... ...+.|.+|++++++++|+||+++++++.+++..++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345567899999999999985 46899999998654322 234678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~ 441 (572)
|+++|+|.... ...+.....++.+++.||+|||. |+++..+....+. ...
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 99999986432 23455667899999999999984 4444433221110 011
Q ss_pred cccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 442 TLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..... ...... ....+......
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~~~~-~~~~~~-~~~~~~~~~~~ 300 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GDWAS-LMCAIC-MSQPPEAPATA 300 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHH-HHHHHh-ccCCCCCCCcc
Confidence 23468999999998743 2345689999999999999999999862110 00000 000110 00111110011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.. .+.++...||+.||++||+++||+++.|..+..+
T Consensus 301 ~~---~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 301 SR---EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CH---HHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 11 1235566899999999999999999998877643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=245.67 Aligned_cols=236 Identities=23% Similarity=0.289 Sum_probs=167.2
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||.||+|.. .+++.||+|.+......+ ..++|.+|++++++++||||++++++|..++..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 456677899999999999985 578999999986543222 23678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC---------------CCCCccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP---------------DSSNRTL 443 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~---------------~~~~~~~ 443 (572)
|+++|+|..+. .+++.....++.+++.|+.|||. |.+|..+.... .......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 99999996542 35677778899999999999984 33433222111 0111223
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
..||..|+|||++.+..++.++||||||+++|||+||+.||....................++..+......... .+
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 229 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE---KF 229 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH---HH
Confidence 468899999999998899999999999999999999999986432111110111111111111111100000001 23
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+++.+|++.+|++||++++++++.+....
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 456668999999999999999999876533
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=259.90 Aligned_cols=238 Identities=24% Similarity=0.313 Sum_probs=178.6
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
|.....+|-|+||.||.|+. .+.++||||++..+.....+..++..+|++.|++++|||+|.+-|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 34456789999999999985 57899999999987776666678999999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC---------CC----CCcccccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP---------DS----SNRTLLAG 446 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~---------~~----~~~~~~~g 446 (572)
|- ||-.+.+.-+++ ++.......|+.|..+||+||| +|++.+++.... .+ .....++|
T Consensus 108 Cl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvG 184 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVG 184 (948)
T ss_pred Hh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccC
Confidence 97 466666643332 4666677789999999999997 566665543211 01 12245789
Q ss_pred ccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 447 TYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 447 t~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
||.|||||++. .+.|+.|+||||+||+..|+.-.++|...+..+. ....+.+.-+|........ ..+
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNesPtLqs~eWS--~~F 254 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTLQSNEWS--DYF 254 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCCCCCCCchhH--HHH
Confidence 99999999874 5789999999999999999999999975443221 1122222222222111111 123
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
..+.-.|+++-|.+|||.++++.|.+..+..|..
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t 288 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT 288 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence 3455589999999999999999999988886553
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=245.97 Aligned_cols=231 Identities=24% Similarity=0.364 Sum_probs=168.7
Q ss_pred CccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+.+...+|.|+||.||+|... +++.||||.++.....+ ..+.|.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH--HHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4566778999999999999753 35789999997654432 246899999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCC-----------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----
Q 038466 380 FLIYEYMKRGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~-----------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---- 438 (572)
++||||+++|+|.++++.... ...+++.+...++.+++.|+.|||. |++|..+....+.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 999999999999999975421 2347888899999999999999984 4555443221100
Q ss_pred ---------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhh
Q 038466 439 ---------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLID 502 (572)
Q Consensus 439 ---------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~ 502 (572)
.......+++.|+|||++....++.++|||||||++|||++ |+.||.... .......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-------~~~~~~~ 236 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------NEEVIEC 236 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHH
Confidence 00112234678999999999999999999999999999998 999975321 1111111
Q ss_pred hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 503 VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 503 ~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+.....+.+. ..... .+..+...||+.||++||+++||++.+.
T Consensus 237 ~~~~~~~~~~-~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQRP-RTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCCC-CCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111111 11111 2345667899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=245.58 Aligned_cols=233 Identities=22% Similarity=0.283 Sum_probs=166.8
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+++++...+|.|+||+||+|... ++..||||++....... ...+|.+|+.++++++||||+++++++.++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345677788999999999998642 35789999986543221 2357889999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC-------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-----
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----- 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~-------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----- 439 (572)
..++||||+++|+|.++++.... ...++|...+.++.+++.|++|||. |.+|..+....+..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 99999999999999999875321 1246788889999999999999984 44454432221100
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
......+++.|+|||++.+..++.++|||||||++|||+| |+.|+.... .......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~~~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRFVM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHH
Confidence 0011234678999999988889999999999999999999 788874321 111111111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....+... ..... .+..++.+||+.||++|||+.++++++.
T Consensus 236 ~~~~~~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGLLDKP-DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCcCCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111 11111 2345677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=242.65 Aligned_cols=217 Identities=21% Similarity=0.308 Sum_probs=158.0
Q ss_pred cccccCeeEEEEEEcCC-------------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 312 IWNYDGYGSVYKAQLPN-------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
.+|.|+||.||+|...+ ...||+|.+..... ...+.|.+|+.++++++||||++++|++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 47899999999997532 23589998875432 234678899999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------- 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------- 439 (572)
.++||||+++|+|..+++... ..+++..+..++.|+++|++||| +|.+|..+.......
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998887533 24788889999999999999997 455665443321110
Q ss_pred -------CccccccccCcccccccc-CCCcCcccchHHHHHHHHHHH-cCCCCCCccccccCCCCcchhhhhhcccC--C
Q 038466 440 -------NRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQR--L 508 (572)
Q Consensus 440 -------~~~~~~gt~~y~APE~~~-~~~~s~ksDVySfGvvl~Ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l 508 (572)
......|+..|+|||++. ...++.++|||||||++|||+ +|+.|+..... .. ........ .
T Consensus 157 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~--~~~~~~~~~~~ 228 (262)
T cd05077 157 GIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL------AE--KERFYEGQCML 228 (262)
T ss_pred CCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch------hH--HHHHHhcCccC
Confidence 011234678899999886 466899999999999999998 58888642210 00 00111111 1
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
..+.. . .+..++..||+.||++||++.+|++++
T Consensus 229 ~~~~~----~---~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSC----K---ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCh----H---HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111 1 234566799999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=249.20 Aligned_cols=240 Identities=24% Similarity=0.305 Sum_probs=171.4
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||+||++.. ++|+.||+|++...... ...+.|.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456677899999999999985 46899999988654322 234688999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC---------------CCCcc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD---------------SSNRT 442 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~---------------~~~~~ 442 (572)
|+++|+|.+++...+ .+++.....++.++++|+.|||+. .+|..+..... .....
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 999999998887532 478888899999999999999852 22322211110 00112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcch----hhhhhcccCCCCCCChHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI----MLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~ 518 (572)
...|+..|+|||++.+..++.++|||||||++|||+||+.||+............. ..........+. ......
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 238 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR-LPSSDF- 238 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-CCchhc-
Confidence 24688999999999888999999999999999999999999864321100000000 011111111111 111100
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.+++.+|++.||++|||+.||+++.+..+.
T Consensus 239 -~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 239 -PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1123456678999999999999999998755443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=251.43 Aligned_cols=233 Identities=21% Similarity=0.311 Sum_probs=166.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+++....+|.|+||.||+|++. +|+ .||+|.++..... ...++|.+|+.+++.++||||++++|+|..+ ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 35677788999999999999853 444 3899998754322 2346788999999999999999999999765 57
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
++|+||+++|+|.++++... ..+++...+.++.++++||+|||. |.+|..+....+.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 79999999999999998643 247888889999999999999984 4555543321110
Q ss_pred -CC---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 439 -SN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 439 -~~---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
.. .....++..|+|||++....++.++|||||||++|||+| |+.|++.... . ....++......+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~ 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------S-EISSILEKGERLPQP 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------H-HHHHHHhCCCCCCCC
Confidence 00 001123567999999999999999999999999999998 9999853211 0 111111111111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... ..+..++..||+.+|++||++.+++.++.....
T Consensus 234 ~~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 234 PICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1110 123456778999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=244.26 Aligned_cols=230 Identities=23% Similarity=0.365 Sum_probs=170.8
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++.+...+|.|+||.||+|...++..+|+|.+....... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4566778899999999999998889999999998655422 3568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-----------------Cc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-----------------NR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-----------------~~ 441 (572)
|+++|+|.++++... ...+++.++..++.++++|+.|||. |++|..+....+.. ..
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999998643 2358999999999999999999984 44444332211100 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....++..|+|||+.....++.++||||||++++||++ |+.|+.... .... ...+......+.......
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~-- 231 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEV-YDQITAGYRMPCPAKCPQ-- 231 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHH-HHHHHhCCcCCCCCCCCH--
Confidence 11234567999999988889999999999999999998 899985321 1111 111111111111111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++.+||+.||++|||++++.+.|.
T Consensus 232 -~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 232 -EIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred -HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2345667999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=254.67 Aligned_cols=230 Identities=20% Similarity=0.330 Sum_probs=166.8
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+. .+++.||+|.++.....+....+.+..|+.++.++ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 579999999999986 46889999999865433333456778899988877 7999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++.....++.+++.|++|||. |++|..+....+ ........|
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9988886532 47888888999999999999974 455544322111 111223568
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCC--CcchhhhhhcccC--CCCCCChHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS--DPKIMLIDVLDQR--LPPPVDRKVIRDILL 522 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~--~~~~~~~~~~~~~--l~~~~~~~~~~~~~~ 522 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||+......... ........+.... ++..... .
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~-------~ 231 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV-------K 231 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH-------H
Confidence 999999999999999999999999999999999999986432111100 0011111112222 2222211 1
Q ss_pred HHHHHHHccccCCCCCCC------HHHHHHHHhhc
Q 038466 523 ASTISFACLQSNPKSRPT------MQYVSQEFLIT 551 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPs------m~~V~~~l~~~ 551 (572)
+..+..+|++.||++||+ +.++++|.+..
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~ 266 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 235566899999999998 68888886553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=247.74 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=177.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+...+.+|.|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++|||++++++++..++..++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 4566778899999999999985 568999999987654332 356889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++|+|.+++.+. .+++.+...++.+++.|++|||. |++|..+....+. ..
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999999988642 36888899999999999999974 4444332221100 01
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|++.|+|||+..+..++.++|||||||++|||+||+.||...... ............+.+.......
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-- 244 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSA-- 244 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCCCCCCCccccCH--
Confidence 12246888999999998888999999999999999999999998532110 0000011111111111111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCccccccccc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQD 564 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~~~~~~ 564 (572)
.+..+..+||+.+|++||++++|+++.+.....+....+.+..
T Consensus 245 -~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~ 287 (296)
T cd06654 245 -IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287 (296)
T ss_pred -HHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCccccHHHHH
Confidence 1235667899999999999999999987776666555444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=234.91 Aligned_cols=180 Identities=26% Similarity=0.396 Sum_probs=157.1
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++++...++|.|+||.|..++.+ +|..+|+|+++.....+..+.+...+|..+|+.+.||++|++++.|.+.+.+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4466788889999999999999865 589999999998887777778889999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------CCCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------SSNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------~~~~ 441 (572)
||||++||.|+.++++.+ .++.....-+|.+|+.|++||| ||.+|.++..+.. ....
T Consensus 122 vmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 999999999999998754 3566666779999999999999 4778876644321 1234
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
-+++|||.|+|||++.+..|+..+|.|||||++|||+.|.+||.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 46789999999999999999999999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.53 Aligned_cols=225 Identities=21% Similarity=0.329 Sum_probs=165.3
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+.. +++.||||++...........+.+..|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5789999999999864 6899999998754332223346677888888876 6999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9998887543 47888888999999999999973 455543322111 111223468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTI 526 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i 526 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.......+. .... .+..+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~--~~~~---~~~~l 226 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDEVVYPT--WLSQ---DAVDI 226 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCCCCCCC--CCCH---HHHHH
Confidence 999999999998899999999999999999999999985321 11111122222111111 0011 12345
Q ss_pred HHHccccCCCCCCCH------HHHHHHHhhc
Q 038466 527 SFACLQSNPKSRPTM------QYVSQEFLIT 551 (572)
Q Consensus 527 ~~~Cl~~dP~~RPsm------~~V~~~l~~~ 551 (572)
...|++.||++||+. +++++|.+..
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 568999999999997 8888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=242.80 Aligned_cols=226 Identities=23% Similarity=0.367 Sum_probs=165.6
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++.+.+.+|.|+||.||+|...++..+|+|.+....... .+|.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 355677899999999999998777889999987544322 4678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------C-----c
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------N-----R 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------~-----~ 441 (572)
+++|+|.++++.... .++|.....++.++++|++|||. |.+|..+..+.+.. + .
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999975433 57899999999999999999974 44444332211100 0 0
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....++..|+|||+..+..++.++|||||||++|||+| |+.|++...... .............+...+ .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~-~----- 228 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVESVSAGYRLYRPKLAP-T----- 228 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HHHHHHcCCcCCCCCCCC-H-----
Confidence 01112357999999998899999999999999999999 888885321100 000001111111111111 1
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+.+++.+||+.+|++||||++|++.+
T Consensus 229 -~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 229 -EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 234677799999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=252.14 Aligned_cols=224 Identities=25% Similarity=0.343 Sum_probs=165.5
Q ss_pred ccccccCeeEEEEEEc----CCCcEEEEEecCCcch-HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQL----PNGKVFALKKLHTSET-EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+|.|+||.||+++. .+++.||||.++.... ......+.+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4689999999999974 3588999999875432 1222345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~ 442 (572)
+++|+|.+++.... .+.+.....++.+++.|++|||+ |++|..+..+.+ .....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999987543 35666777889999999999974 455543322111 11112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDI 520 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~ 520 (572)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... ++..+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~------ 225 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKGKLNLPPYLTP------ 225 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH------
Confidence 3468999999999998889999999999999999999999985321 1111122222222 222211
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 521 LLASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
.+.++..+|++.||++|| +++++.++.+..
T Consensus 226 -~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~ 260 (323)
T cd05584 226 -EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260 (323)
T ss_pred -HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence 123556689999999999 899998887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=250.49 Aligned_cols=235 Identities=26% Similarity=0.389 Sum_probs=169.9
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHH--hcCCCCcccEEEEEEeCC----eEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS--QVLHRNIVKLYGFCLHRK----CMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~ 380 (572)
...+.++|.|+||.||||++.+ +.||||++...+ .++|++|-++.+ .++|+||++++++-.... +++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4567789999999999999875 899999997543 367888888866 568999999999877655 899
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCCCCccc-----------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDSSNRTL----------- 443 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~~~~~~----------- 443 (572)
||+||.++|||.++|..+ .++|....+|+..+++||+|||.+ .+|+|+|++.++.|..+
T Consensus 285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999864 489999999999999999999976 46788888776654321
Q ss_pred -----------------cccccCccccccccCCC-c-----CcccchHHHHHHHHHHHcCCCCCC--------ccccccC
Q 038466 444 -----------------LAGTYGYIAPELAYTMV-M-----TEKCDVYSFGVVTLEVLMGKHPRD--------LLSSLSS 492 (572)
Q Consensus 444 -----------------~~gt~~y~APE~~~~~~-~-----s~ksDVySfGvvl~ElltG~~P~~--------~~~~~~~ 492 (572)
-+||..|||||++.+.. + -.+.||||.|.|||||+++-.-.+ ....-.-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 35899999999986532 1 236999999999999998533221 1000000
Q ss_pred CCCc--chhhhhhcccCCCCCCChHH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 493 SSDP--KIMLIDVLDQRLPPPVDRKV--IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 493 ~~~~--~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...+ +.+...++..+.+|...... ...+..+.+....||..||+.|-|.+=|.+++....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 1111 11222333333333222111 123444456677899999999999998888775543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.22 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=165.3
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----eEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 380 (572)
+++...+|.|+||.||+|+. .+|+.||||++....... ....++.+|++++++++||||+++++++...+ ..|
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 44567899999999999985 468999999987432211 12356889999999999999999999886432 489
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||+. ++|.+++.... .+++.....++.|+++|+.|||+ |++|..+..+.+.
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 68988886532 47888999999999999999974 4555433221110
Q ss_pred -C---CccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhh----
Q 038466 439 -S---NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML---- 500 (572)
Q Consensus 439 -~---~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~---- 500 (572)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 0 0112358899999999865 6789999999999999999999999853211000 00000000
Q ss_pred -------hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 501 -------IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 501 -------~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
...+.+..+.+...........+..+...||+.||++|||+++++++.+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0001111111100000000012345677999999999999999999987754433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=252.45 Aligned_cols=223 Identities=21% Similarity=0.315 Sum_probs=166.2
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
++|.|+||.||+|+.. +|+.||||++...........+.+..|.+++..+ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5799999999999864 5889999999765433333346678899999866 7999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|...+.... .+++.....++.+++.|+.|||+ |++|..+..+.+ ........|
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9998887543 47888888999999999999984 555544322111 111223458
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||+... .......+..... +...+. .+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~~~-------~~~ 224 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILHDDVLYPVWLSK-------EAV 224 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 999999999998899999999999999999999999986321 1111112222221 111111 123
Q ss_pred HHHHHccccCCCCCC-------CHHHHHHHHhhc
Q 038466 525 TISFACLQSNPKSRP-------TMQYVSQEFLIT 551 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RP-------sm~~V~~~l~~~ 551 (572)
.+...|++.||++|| ++++++++.+..
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~ 258 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence 455689999999999 899999887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=251.70 Aligned_cols=225 Identities=20% Similarity=0.343 Sum_probs=163.6
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHH---HhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++.+.+|.|+||.||+|.. .+|+.||||+++..........+.+..|++++ ++++||||+++++++.+++..|+||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 4567889999999999985 46899999999754322222345566666554 5778999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|..+++.. .+++.....++.+++.|+.|||. |++|..+..+.+ ...
T Consensus 82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 999999998887642 48899999999999999999984 455443322110 011
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+... ..+...+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~~~~~--- 227 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIVNDEVRYPRFLSRE--- 227 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCHH---
Confidence 223568999999999999999999999999999999999999985321 11111112111 122222111
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhh
Q 038466 519 DILLASTISFACLQSNPKSRP-----TMQYVSQEFLI 550 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~ 550 (572)
+..+..+|++.||++|| ++.+++++.+.
T Consensus 228 ----~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 228 ----AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred ----HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 23456689999999999 57888877654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=258.93 Aligned_cols=232 Identities=24% Similarity=0.312 Sum_probs=171.5
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+...+|.|+||+||+|+.. +|+.||||+++..........+.+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4566788999999999999864 699999999976543333345678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C----
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S---- 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~---- 438 (572)
|+++|+|.+++... ..+++.....++.+++.||+|||. |++|..+....+ .
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999764 247788888899999999999974 555543321110 0
Q ss_pred --------------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC
Q 038466 439 --------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS 492 (572)
Q Consensus 439 --------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~ 492 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---- 234 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT---- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC----
Confidence 01123468999999999999999999999999999999999999985322
Q ss_pred CCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhhc
Q 038466 493 SSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT-MQYVSQEFLIT 551 (572)
Q Consensus 493 ~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs-m~~V~~~l~~~ 551 (572)
.......+.. .....+....... .+..+...|++ ||++||+ +++++++.+..
T Consensus 235 ---~~~~~~~i~~~~~~~~~p~~~~~~~---~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 235 ---LQETYNKIINWKESLRFPPDPPVSP---EAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred ---HHHHHHHHhccCCcccCCCCCCCCH---HHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 1111111111 1111111110011 12344557887 9999999 99999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=245.09 Aligned_cols=217 Identities=22% Similarity=0.389 Sum_probs=159.2
Q ss_pred cccccCeeEEEEEEcCC--------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 312 IWNYDGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~--------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+|.|+||.||+|.... ...+|+|.+..... ...+.|.+|+.++++++|||+|++++++..++..++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 57899999999997532 23488888764432 23467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------------ 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------------ 439 (572)
||+++|+|.++++.... .++|..+..++.|++.|++||| +|++|..+....+..
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999986433 5788889999999999999997 355555433221110
Q ss_pred ---CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCC-CCCCccccccCCCCcchhhhhhcc--cCCCCCC
Q 038466 440 ---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPV 512 (572)
Q Consensus 440 ---~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~-~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~ 512 (572)
......+++.|+|||++.+ ..++.++|||||||++|||++|. .|+..... . ....... ..++.+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~~~~~ 228 (258)
T cd05078 157 TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-------Q-KKLQFYEDRHQLPAPK 228 (258)
T ss_pred ccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-------H-HHHHHHHccccCCCCC
Confidence 1112457889999999876 45799999999999999999995 55532211 0 0111111 1222222
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
. . .+..++..||+.||++|||++++++++
T Consensus 229 ~----~---~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 229 W----T---ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred c----H---HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1 1 234566789999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=251.54 Aligned_cols=223 Identities=20% Similarity=0.308 Sum_probs=166.3
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||+||+|+.. +++.||||+++..........+.+..|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999865 5889999999865433333346778899999888 6999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++.....++.+++.|+.|||. |++|..+....+ ........|
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9998887543 48899999999999999999984 444443322110 011123458
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||+... .......+.... .+...+. .+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~-------~~~ 224 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILEDEVRYPRWLSK-------EAK 224 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCcCCH-------HHH
Confidence 999999999999999999999999999999999999985321 111111111111 1211111 123
Q ss_pred HHHHHccccCCCCCCCH-----HHHHHHHhhc
Q 038466 525 TISFACLQSNPKSRPTM-----QYVSQEFLIT 551 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm-----~~V~~~l~~~ 551 (572)
.+..+||+.||++||++ .+++++.+..
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~ 256 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 56668999999999999 9998886654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=243.96 Aligned_cols=233 Identities=19% Similarity=0.283 Sum_probs=165.3
Q ss_pred CccccccccccCeeEEEEEEc-CCCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++..+.+|.|+||+||+|.+ .+|+ .+|+|.+...... ...+++..|+..+++++||||++++|++. +...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 456677899999999999985 3454 4788887643321 22467888999999999999999999885 45578
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+++||+++|+|.++++... ..++|.....++.|++.|++|||+ |++|..+..+.+.
T Consensus 85 ~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999997543 258899999999999999999984 4455443221110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......|+..|+|||+.....++.++|||||||++|||+| |+.|+.... +. ...+.+......+...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~ 234 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-------PH-EVPDLLEKGERLAQPQ 234 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HH-HHHHHHHCCCcCCCCC
Confidence 00112346678999999998899999999999999999998 999985321 11 1112222111111100
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.... ....++..||+.||++|||+.++++.+.....+
T Consensus 235 ~~~~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 235 ICTI---DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0001 123456689999999999999999988664433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=251.83 Aligned_cols=229 Identities=21% Similarity=0.322 Sum_probs=167.3
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+. .+++.||+|++......+....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 579999999999986 46889999999865444444456788999999988 6999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++..+..++.+++.|++|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9998886432 48888999999999999999974 555543322110 111223568
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||+.................+.... .+...+. .+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~~~ 231 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV-------KAS 231 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 9999999999999999999999999999999999999964321111111111111112221 2221211 123
Q ss_pred HHHHHccccCCCCCCC------HHHHHHHHhh
Q 038466 525 TISFACLQSNPKSRPT------MQYVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPs------m~~V~~~l~~ 550 (572)
.+..+|++.||++||+ ++++.+|.+.
T Consensus 232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f 263 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263 (327)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence 4556899999999998 5688877654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=245.76 Aligned_cols=233 Identities=24% Similarity=0.350 Sum_probs=169.9
Q ss_pred CccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
++.+...+|.|+||.||+|+. .++..+|+|.+....... .+.|.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 355667899999999999974 235679999987654332 36788999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--
Q 038466 380 FLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-- 438 (572)
++||||+++|+|.+++..... ...++|..++.++.++++|++|||. |.+|..+..+.+.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 999999999999999975321 2348899999999999999999974 4555543221110
Q ss_pred -----------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhh
Q 038466 439 -----------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 439 -----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~ 500 (572)
.......|+..|+|||++....++.++|||||||++|||+| |+.|+..... ....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TEVI 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence 00112335678999999998999999999999999999999 9999753211 1111
Q ss_pred hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..+.....+... ... ...+.++..+||+.+|++||++++|++.+....
T Consensus 236 ~~~~~~~~~~~~-~~~---~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 ECITQGRVLERP-RVC---PKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHhCCCCCCCC-ccC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111111110 000 012346677999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=243.04 Aligned_cols=231 Identities=26% Similarity=0.409 Sum_probs=170.7
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|... +++.||+|.+...... .....+.+|++++++++|+|++++++++.++...++|+||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 455678899999999999864 6899999998754322 2235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC-----------------CCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD-----------------SSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~-----------------~~~~~ 442 (572)
+++|+|.++++.. .+++.....++.+++.|+.|||.. .+|..+..... .....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 9999999998753 578899999999999999999853 33322211110 01122
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH-HHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK-VIRDIL 521 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~ 521 (572)
...|++.|+|||++.+..++.++|||||||++|||+||+.|++... +..... .+....++..... ...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-------~~~~~~-~~~~~~~~~~~~~~~~~--- 225 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-------PMRVLF-LIPKNNPPSLEGNKFSK--- 225 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-------hHHHHH-HhhhcCCCCCcccccCH---
Confidence 3457888999999998889999999999999999999999985322 111111 1111111111111 001
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+..+...||..+|++|||+++++++.+..+..
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 123456689999999999999999998876643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=254.33 Aligned_cols=223 Identities=21% Similarity=0.265 Sum_probs=166.8
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.+|.|+||.||+++. .+|+.||+|.+.............+..|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 578999999999985 5789999999975433233334677889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
|..++.... .+++.....++.+++.|+.|||. |++|..+..+.+ ........|
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 998886533 47888889999999999999984 345544332111 011123468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.. ...+...+.. +.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~~~~-------~~ 224 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRTLSPE-------AK 224 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHhcCCCCCCCCCCHH-------HH
Confidence 999999999998899999999999999999999999985321 1111111111 1222222211 23
Q ss_pred HHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 525 TISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
.+...|++.||++|+ ++.+++++.+..
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 455689999999996 899999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=251.90 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=167.2
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR- 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~- 376 (572)
+.+++.+.+|.|+||.||+|+.. +++.||+|+++.....+ ..+.+.+|++++.++ +|+||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--EYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH--HHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45677789999999999999632 35789999997543322 235678899999999 899999999988754
Q ss_pred CeEEEEEecccCCChhhhhhcCCC--------------------------------------------------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNED-------------------------------------------------------- 400 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------------- 400 (572)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568899999999999998864211
Q ss_pred --cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------------CccccccccCcccc
Q 038466 401 --AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------------NRTLLAGTYGYIAP 453 (572)
Q Consensus 401 --~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------------~~~~~~gt~~y~AP 453 (572)
...++|..+..++.+++.|++||| +|++|..+..+.+.. ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 125789999999999999999997 356665543321110 01122346789999
Q ss_pred ccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccc
Q 038466 454 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQ 532 (572)
Q Consensus 454 E~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~ 532 (572)
|++.+..++.++|||||||++|||+| |+.||..... .......+........+..... .+.+++.+||+
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~~cl~ 314 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFCRRLKEGTRMRAPEYATP---EIYSIMLDCWH 314 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHHHHHhccCCCCCCccCCH---HHHHHHHHHcc
Confidence 99999999999999999999999997 9999853210 0011111111111111111111 23467779999
Q ss_pred cCCCCCCCHHHHHHHHhh
Q 038466 533 SNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 533 ~dP~~RPsm~~V~~~l~~ 550 (572)
.+|++||++.+|++++..
T Consensus 315 ~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 315 NNPEDRPTFSELVEILGD 332 (337)
T ss_pred CChhhCcCHHHHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=244.55 Aligned_cols=233 Identities=24% Similarity=0.359 Sum_probs=168.7
Q ss_pred CccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
++.+...+|.|+||.||++.. .++..+|+|.+...... ..+.|.+|++++++++||||++++++|...+..
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 456667899999999999974 23567999998765432 246789999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCC----------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----
Q 038466 380 FLIYEYMKRGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~----------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---- 439 (572)
++||||+++|+|.+++.... ....+++.....++.+++.|++|||. |.+|..+....+..
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999987532 12348999999999999999999984 45554432211100
Q ss_pred ---------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh
Q 038466 440 ---------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV 503 (572)
Q Consensus 440 ---------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 503 (572)
......+++.|+|||++.+..++.++|||||||+++||+| |+.|+.... .......+
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-------~~~~~~~i 235 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIECI 235 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence 0011224678999999998899999999999999999998 899875321 11111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
....... ....... .+..+..+||+.||.+|||+++|.+.+....
T Consensus 236 ~~~~~~~-~~~~~~~---~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVLQ-RPRTCPK---EVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcCC-CCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1111111 2346777999999999999999988875443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=261.26 Aligned_cols=230 Identities=22% Similarity=0.343 Sum_probs=168.4
Q ss_pred cccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
++|.|.||+||-|+..+ ...+|||.+......+ .+-+.+|+.+.++++|+|||+++|.|.+++..-+.||-+||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 78999999999999654 5568999998665433 4677889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC------------------CCCcccccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------------SSNRTLLAG 446 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------------~~~~~~~~g 446 (572)
|.+.|+..=++..-.....--+..||.+||.|||. |++...+..+.. .....++.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999865332222444455578999999999984 444333221100 001234679
Q ss_pred ccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 524 (572)
|..|||||++..+ .|+..+|||||||++.||.||++||-.+.+-... +..+---+.-|+.+.+... .+.
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGmyKvHP~iPeelsa---eak 809 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGMYKVHPPIPEELSA---EAK 809 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcceecCCCCcHHHHH---HHH
Confidence 9999999999765 4889999999999999999999998654332211 2222111222333333322 234
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 525 TISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+.++|..+||.+||++++++++.+....
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccCcccccC
Confidence 56779999999999999999998876533
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=250.13 Aligned_cols=222 Identities=22% Similarity=0.328 Sum_probs=161.5
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+.. +++.||||+++..........+.+..|..++.. .+||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5799999999999864 588999999976532212223556678888876 49999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|.+++.... .+++.+...++.++++|+.|||. |++|..+..... ........|
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 82 DLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999887532 47888888999999999999984 444443322110 011123458
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhh--hhcccCCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI--DVLDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... ...... ....+..+...+. .+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~-------~~~ 224 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSIRMDNPCYPRWLTR-------EAK 224 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccCCH-------HHH
Confidence 999999999998899999999999999999999999985321 111111 1111222221111 123
Q ss_pred HHHHHccccCCCCCCCHH-HHHHHHhh
Q 038466 525 TISFACLQSNPKSRPTMQ-YVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~-~V~~~l~~ 550 (572)
.+..+|++.||++||++. ++.++.+.
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQHPFF 251 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHcCccc
Confidence 455689999999999996 77776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=246.86 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=169.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+++. .+|..+|+|.++..... ...+++.+|++++.+++||||++++++|.+++..++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 466777899999999999985 46889999998754322 234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC---------------CCCcc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD---------------SSNRT 442 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~---------------~~~~~ 442 (572)
|+++|+|.++++... .+++.....++.++++|+.|||.. .+|..+....+ .....
T Consensus 80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 999999999997542 467888889999999999999952 22322221110 00112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc------CC----CCcc---------------
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------SS----SDPK--------------- 497 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~------~~----~~~~--------------- 497 (572)
...|+..|+|||+..+..++.++|||||||++|||+||+.|+....... .. ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 2457889999999988889999999999999999999999975321000 00 0000
Q ss_pred hhhhhhcc---cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 498 IMLIDVLD---QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 498 ~~~~~~~~---~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
....+..+ ...++..+.... ...+..++.+||+.+|++||++++|+++.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAF--SDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCccc--CHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000 000000000000 012346777999999999999999999988765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.55 Aligned_cols=232 Identities=21% Similarity=0.272 Sum_probs=166.5
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+...+|.|+||.||+++. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 456678899999999999985 5789999999875543333445788999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------CC---------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------SN--------- 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------~~--------- 440 (572)
|+++|+|.+++.... .++......++.+++.|++||| +|++|..+...... ..
T Consensus 82 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999987543 3667777788999999999997 45565433221000 00
Q ss_pred ----------------------------------------------ccccccccCccccccccCCCcCcccchHHHHHHH
Q 038466 441 ----------------------------------------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 474 (572)
Q Consensus 441 ----------------------------------------------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl 474 (572)
.....||++|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0013599999999999988999999999999999
Q ss_pred HHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHHHHccccCCCC---CCCHHHHHHHHh
Q 038466 475 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQSNPKS---RPTMQYVSQEFL 549 (572)
Q Consensus 475 ~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~---RPsm~~V~~~l~ 549 (572)
|||+||+.||..... ......+.. ..+.-+....... .+..+...|+. +|.+ ||++.+++++.+
T Consensus 239 ~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~---~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 239 FECLIGWPPFCSENS-------HETYRKIINWRETLYFPDDIHLSV---EAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred hhhhcCCCCCCCCCH-------HHHHHHHHccCCccCCCCCCCCCH---HHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 999999999853211 111111111 1111111100001 12234446776 6665 469999999987
Q ss_pred hc
Q 038466 550 IT 551 (572)
Q Consensus 550 ~~ 551 (572)
..
T Consensus 308 ~~ 309 (377)
T cd05629 308 FR 309 (377)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=255.77 Aligned_cols=236 Identities=20% Similarity=0.303 Sum_probs=168.5
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 375 (572)
..+++.+...+|.|+||.||+|++. .+..||||+++...... ..+.+.+|++++.++. |||||+++|+|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3345666778999999999999853 35689999998653322 2357889999999997 9999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC-------------------------------------------------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED------------------------------------------------------- 400 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~------------------------------------------------------- 400 (572)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999975321
Q ss_pred ----------------------------------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee
Q 038466 401 ----------------------------------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST 434 (572)
Q Consensus 401 ----------------------------------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~ 434 (572)
...++|.....++.++++|+.|||. |.+|..+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 1236788888999999999999984 444443321
Q ss_pred CCCC----------------C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCC
Q 038466 435 CPDS----------------S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS 494 (572)
Q Consensus 435 ~~~~----------------~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~ 494 (572)
.... . ......+++.|+|||++....++.++|||||||++|||++ |+.|+.....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~----- 347 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM----- 347 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-----
Confidence 1100 0 0111245678999999988889999999999999999998 8889753211
Q ss_pred CcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 495 DPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 495 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.......+....+++.+..... .+..++..||+.+|++||++++|++.|..
T Consensus 348 --~~~~~~~~~~~~~~~~p~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 --NEQFYNAIKRGYRMAKPAHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred --hHHHHHHHHcCCCCCCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111122222211111111111 23456668999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=244.15 Aligned_cols=230 Identities=25% Similarity=0.382 Sum_probs=168.4
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.....+|.|+||.||+|.. .+++.||+|.+....... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34456789999999999985 468899999987543322 246789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++... .+.+.....++.++++|+.|||. +.+|..+....+. ....
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 9999999888642 47888888999999999999985 3344332221100 0011
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|+..|+|||+..+..++.++|||||||+++||+||+.|+..... ... ...+....++...... ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~~~-~~~~~~~~~~~~~~~~---~~~ 228 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-------MRV-LFLIPKNSPPTLEGQY---SKP 228 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-------hhH-HhhhhcCCCCCCCccc---CHH
Confidence 23578899999999988899999999999999999999999753211 000 1111111111111111 112
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.++...||+.+|++||+|.+|+++.+..+.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 229 FKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 3456678999999999999999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=241.35 Aligned_cols=230 Identities=23% Similarity=0.334 Sum_probs=166.4
Q ss_pred CCccccccccccCeeEEEEEEcC-CC---cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g---~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
++++....+|.|+||.||+|... ++ ..+|+|.+....... ..++|.+|++++++++|||++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 34566678999999999999864 23 379999987653322 2467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----C----------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----N---------- 440 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----~---------- 440 (572)
+||||+++|+|.++++... ..++|.++..++.+++.|++|||. |++|..+....+.. +
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999987543 358899999999999999999974 44554432211100 0
Q ss_pred -c-----cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 441 -R-----TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 441 -~-----~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
. .....++.|+|||+.....++.++|||||||++|||+| |+.|+.... .......+ ......+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-------~~~~~~~i-~~~~~~~~~ 232 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-------NHEVMKAI-NDGFRLPAP 232 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHH-hcCCCCCCC
Confidence 0 00112346999999988889999999999999999997 999985321 11111111 111111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..... .+.+++..||+.+|++||+|++|++.+.
T Consensus 233 ~~~~~---~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 233 MDCPS---AVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111 2346777899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=245.58 Aligned_cols=233 Identities=21% Similarity=0.237 Sum_probs=168.0
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
...+.+|.|+||+||+|.. .+++.+|+|.+...........+.+.+|++++++++|+|++++++++..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 3456789999999999985 568999999987654333333456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCcccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTLL 444 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~~ 444 (572)
++|+|.+++.... ...+++.....++.|++.|+.|||. |.+|..+..+.. .......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 83 NGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred cCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999998887533 2358999999999999999999984 344433221100 0011224
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILL 522 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~ 522 (572)
.|+..|+|||++.+..++.++|+|||||++|||+||+.||....... ........+... ..+.... . .
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~---~ 231 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETEEVYSAKFS----E---E 231 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccccccCccCC----H---H
Confidence 58899999999988889999999999999999999999985321100 000000111111 1111111 1 1
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 523 ASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+..++..|++.||++||+ +++++.+.+..
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 235666899999999999 77888776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=253.88 Aligned_cols=240 Identities=18% Similarity=0.195 Sum_probs=169.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+.+.+|.|+||.||++.. .+++.||+|+... +.+.+|++++++++|||||++++++..+...++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4577888999999999999985 5689999997532 34678999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------S 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~ 439 (572)
||+. |+|.+++.... .+++.....++.+++.||+||| +|++|..+...... .
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9995 78888886532 4788899999999999999997 45666544321100 0
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhh-------------------
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML------------------- 500 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~------------------- 500 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.|+...............+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 1123468999999999999899999999999999999999998863211100000000000
Q ss_pred ---hhh----ccc--CCCC--CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 501 ---IDV----LDQ--RLPP--PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 501 ---~~~----~~~--~l~~--~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
... ... ..+. +...........+..+..+|++.||++|||++|++++.+........
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 000 000 0000 00000001111344567799999999999999999998876644333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=251.87 Aligned_cols=235 Identities=19% Similarity=0.266 Sum_probs=174.2
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchH-H-HHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETE-E-LAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~-~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 379 (572)
.+.+.+...+|.|+||+||.|.. .+|+.||||.+...... . ....+...+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34567778899999999999975 56899999977654211 1 122355668999999999 99999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------- 437 (572)
|+||||+.+|+|.+++.+.+ .+.......+..|++.|++|+| +|.+|..+..+..
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999998733 3555677789999999999997 4566554332211
Q ss_pred --CCCccccccccCccccccccCCC-cC-cccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMV-MT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
.......+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+... .......+......-|..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcCCccCCCC
Confidence 12234568999999999999876 75 78999999999999999999997521 111112222222222211
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. ...+..+..+|+..||.+|+|+.+|+.+.|...
T Consensus 246 ~~----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LL----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cC----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 10 112234556899999999999999999988876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-28 Score=238.47 Aligned_cols=222 Identities=23% Similarity=0.362 Sum_probs=163.5
Q ss_pred cccccCeeEEEEEEcCC--Cc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQLPN--GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~--g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.+|.|+||.||+|.+.+ ++ .||||.+...... ...++|.+|++++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 47899999999998643 33 6999999876543 345789999999999999999999999988 88999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------------CCc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------------SNR 441 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------------~~~ 441 (572)
+|+|.+++..... ..++|.....++.+++.|++|||. +.+|..+..+.+. ...
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999986542 458999999999999999999984 4444433221110 001
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIR 518 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~ 518 (572)
....++.+|+|||+.....++.++|||||||++|||+| |+.|++.... ........ ....+.+. ..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--~~-- 226 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGERLERPE--AC-- 226 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCcCCCCc--cC--
Confidence 12346788999999998899999999999999999998 9999853211 00011111 11111111 00
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...+..++..|++.+|++||++.+|++.+.
T Consensus 227 -~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 -PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 012345667899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=261.94 Aligned_cols=229 Identities=21% Similarity=0.214 Sum_probs=167.0
Q ss_pred ccccccccccCeeEEEEEEc-CC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+...+|.|+||.||+|.. .+ ++.||+|.+....... ...+.+|+++++.++|||||+++++|..++..|+|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~---~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ---AAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 55667899999999999974 34 6788888876543322 3567889999999999999999999999999999999
Q ss_pred cccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------C--
Q 038466 385 YMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------S-- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~-- 439 (572)
|+++|+|.++++.. .....+++.....++.+++.||.||| +|++|.++..+... .
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999999988643 22335788888889999999999997 45666544322110 0
Q ss_pred -CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......||++|+|||++.+..++.++|||||||++|||+||+.||.... .............++ .......
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~-~~~~~s~ 297 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLYGKYDP-FPCPVSS 297 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCC-CCccCCH
Confidence 0123458999999999999999999999999999999999999985321 111111222221111 1001111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++..||+.||++||++++++.+.+
T Consensus 298 ---~~~~li~~~L~~dP~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 298 ---GMKALLDPLLSKNPALRPTTQQLLHTEF 325 (478)
T ss_pred ---HHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence 1235566899999999999999987543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=238.91 Aligned_cols=228 Identities=24% Similarity=0.375 Sum_probs=168.8
Q ss_pred CCccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++++....+|.|+||.||+|...+ +..+|+|.+..... .++|.+|++++++++||||++++|++.+++..++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 456777889999999999998764 88999999875432 467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++++|.+++.... ..++|.....++.+++.|+.|||. +.+|..+....+. ..
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999987533 357899999999999999999984 3444333221110 01
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC-hHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~ 519 (572)
.....|+..|+|||++.+..++.++|||||||++|||+||+.|++...... .... ......+... .....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~- 226 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFM-IPNKPPPTLSDPEKWS- 226 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhh-hccCCCCCCCchhhcC-
Confidence 122447889999999988899999999999999999999999986332110 0000 0111111000 00000
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..+...||+.||++|||+++|+++.|
T Consensus 227 -~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 227 -PEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred -HHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 12345666899999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=244.21 Aligned_cols=234 Identities=24% Similarity=0.319 Sum_probs=166.6
Q ss_pred CCccccccccccCeeEEEEEEcCC-Cc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+++.+...+|.|+||.||+|...+ +. .+|+|.++..... ...+.|.+|++++.++ +||||+++++++.+.+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 356677889999999999998643 43 4788888743222 2246789999999999 7999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--
Q 038466 381 LIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-- 439 (572)
+||||+++|+|.++++.... ...+++.....++.+++.|++|||. |.+|..+....+..
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999999975321 1247888999999999999999974 55555443321110
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
.......+..|+|||+..+..++.++|||||||++|||+| |+.||.... ... ..+.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-------~~~-~~~~~ 231 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAE-LYEKL 231 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHH-HHHHH
Confidence 0001112456999999988889999999999999999997 999985321 111 11111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+.+..... .+..++..||+.+|.+||++++|++++...
T Consensus 232 ~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 232 PQGYRMEKPRNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred hcCCCCCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111111 134566799999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=257.32 Aligned_cols=177 Identities=21% Similarity=0.311 Sum_probs=143.1
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+...+.+|.|+||.||+|+. .+++.||+|++...........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 56677899999999999985 56899999999865443344457889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------------------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------------- 439 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------------- 439 (572)
|++|+|.+++.+.. .++......++.+++.|++||| +|++|..+....+..
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 83 IPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999987543 3566666778899999999997 455554332210000
Q ss_pred --------------------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHH
Q 038466 440 --------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475 (572)
Q Consensus 440 --------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ 475 (572)
......||+.|+|||++.+..++.++||||+||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 001246899999999999999999999999999999
Q ss_pred HHHcCCCCCCc
Q 038466 476 EVLMGKHPRDL 486 (572)
Q Consensus 476 ElltG~~P~~~ 486 (572)
||+||+.||..
T Consensus 240 elltG~~Pf~~ 250 (382)
T cd05625 240 EMLVGQPPFLA 250 (382)
T ss_pred HHHhCCCCCCC
Confidence 99999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=249.70 Aligned_cols=227 Identities=19% Similarity=0.287 Sum_probs=166.6
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC-CcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E 384 (572)
+++.+.+|.|+||.||+|+.. +++.||||++...........+.+..|++++..++|+ +|+++++++.+.+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456678999999999999864 5789999999764332233356788899999999775 58889999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++|+|.+++.... .+++.....++.+++.|++|||. |++|..+....+ ....
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 82 YVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999999998887543 47888888999999999999984 455543322111 0111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~ 519 (572)
....||+.|+|||++.+..++.++||||+||++|||+||+.||+... .......+.... .+...+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~----- 226 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKSLSK----- 226 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH-----
Confidence 23468999999999999999999999999999999999999985321 111111222222 2222221
Q ss_pred HHHHHHHHHHccccCCCCCCCH-----HHHHHHHhh
Q 038466 520 ILLASTISFACLQSNPKSRPTM-----QYVSQEFLI 550 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm-----~~V~~~l~~ 550 (572)
.+..+..+|++.||++||+. +++.++.+.
T Consensus 227 --~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 227 --EAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred --HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 12355668999999999976 677776554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=241.44 Aligned_cols=225 Identities=22% Similarity=0.277 Sum_probs=155.7
Q ss_pred cccccCeeEEEEEEcCC---CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~---g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||.||+|...+ +..+|+|+++...... ....|.+|+.++++++||||++++|++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 47899999999997543 4679999987654322 235788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC--cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------CCc
Q 038466 389 GSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------SNR 441 (572)
Q Consensus 389 GsL~~~l~~~~~--~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------~~~ 441 (572)
|+|.++++.... ....++.....++.++++|++||| +|.+|..+...... ...
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999999975332 234567777889999999999997 35555443221100 001
Q ss_pred cccccccCccccccccCC-------CcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh--cccCCCCC
Q 038466 442 TLLAGTYGYIAPELAYTM-------VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV--LDQRLPPP 511 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~-------~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~--~~~~l~~~ 511 (572)
....|+..|+|||++... .++.++||||||+++|||++ |+.||..... .......+ .....+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD------EQVLTYTVREQQLKLPKP 233 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHhhcccCCCCCC
Confidence 123467789999987532 35789999999999999996 9999853211 01000000 01111111
Q ss_pred CCh-HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 512 VDR-KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 512 ~~~-~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
... .... .+..+...|| .+|++|||+++|++.|
T Consensus 234 ~~~~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 234 RLKLPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred ccCCCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 100 0001 1233555798 5899999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=248.37 Aligned_cols=222 Identities=22% Similarity=0.335 Sum_probs=159.4
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+.. +++.||||.++.....+....+.+..|.+++.. .+||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999864 588999999976443222234456667777765 48999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .++......++.+++.|++|||. |++|..+....+ ........|
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9998887543 46777788899999999999984 444443322110 011223468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.. +..+...+. . +.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~-~------~~ 224 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSILNDRPHFPRWISK-E------AK 224 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH-H------HH
Confidence 999999999998899999999999999999999999985321 1111111111 112211111 1 23
Q ss_pred HHHHHccccCCCCCCCHH-HHHHHHhh
Q 038466 525 TISFACLQSNPKSRPTMQ-YVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~-~V~~~l~~ 550 (572)
.+...||+.||++||++. ++.++.+.
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCccc
Confidence 455689999999999874 67665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=238.69 Aligned_cols=222 Identities=18% Similarity=0.272 Sum_probs=158.9
Q ss_pred ccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 313 WNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
+|.|+||.||+|.+. ++..||+|.+...... ...+.|.+|++++++++||||++++|+|. .+..++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 689999999999753 4567999999765432 23467999999999999999999999885 45689999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------C-----------Cccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------S-----------NRTL 443 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------~-----------~~~~ 443 (572)
+|.+++.... ..+++..+..++.++++|+.|||. |.+|..+....+. . ....
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999987533 257889999999999999999984 4555443221110 0 0011
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
..+++.|+|||+.....++.++|||||||++||+++ |+.||..... .. ....+....+.+.+..... .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~---~ 226 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PE-VMSFIEQGKRLDCPAECPP---E 226 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HH-HHHHHHCCCCCCCCCCCCH---H
Confidence 122468999999988889999999999999999996 9999853321 10 1111111111111111111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+.++...||+.+|++||++.+|.+.+..
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2346668999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=244.88 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=171.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.++..+.+|.|+||.||+|... +|+.||+|++...........+++.+|++++++++||||++++|+|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34666788999999999999864 68999999987543333334567899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------CCcccc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------SNRTLL 444 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------~~~~~~ 444 (572)
||++ |++.+.+..... .+++..+..++.+++.|+.|||. +.+|..+..+.+. ......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~ 171 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence 9997 577666654322 47899999999999999999984 3444433222111 011224
Q ss_pred ccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 445 AGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 445 ~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
.|++.|+|||++. ...++.++||||||+++|||+||+.|+..... ............ +....... ..
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~--~~ 241 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDS-PTLSSNDW--SD 241 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhcCCC-CCCCchhh--CH
Confidence 5788999999874 45688999999999999999999999753211 001111111111 11111111 11
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
.+..+...||+.+|++||+|.+|+.+.+..+..+.
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 23456669999999999999999999888776544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=241.86 Aligned_cols=231 Identities=21% Similarity=0.326 Sum_probs=163.6
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR----- 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----- 376 (572)
.+.++....+|.|+||.||+|... +++.||+|.+...... ...+..|+.++.++ +||||++++++|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 345666778999999999999864 6899999998755432 24677899999998 799999999998753
Q ss_pred -CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC------------
Q 038466 377 -KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD------------ 437 (572)
Q Consensus 377 -~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~------------ 437 (572)
+..++||||+++|+|.+++.... ...+.|.....++.+++.|++|||.. .+|..+.....
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 46899999999999999987532 23578888899999999999999853 33332211100
Q ss_pred -----CCCccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 438 -----SSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 438 -----~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
........|++.|+|||++. ...++.++|||||||++|||++|+.|++....... ...........
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~ 235 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLIPRNPAPR 235 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHHHhcCCCCC
Confidence 01122356889999999975 34588899999999999999999999853321000 00000000111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
........ .+.++..+||+.+|++|||+.+|+.+.|
T Consensus 236 ~~~~~~~~------~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 236 LKSKKWSK------KFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CCCCCcCH------HHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 11111011 2345667999999999999999998765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=240.47 Aligned_cols=237 Identities=21% Similarity=0.277 Sum_probs=181.5
Q ss_pred cCCccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
...++..+.+|.|.-|+||.+++.+ +..+|+|++.+..........+.+.|.+||+.++||.+..||+.+..++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456677889999999999999765 689999999987766666677888999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee----------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST---------------------- 434 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~---------------------- 434 (572)
||||+||+|...++++.. ..++.....-+|.+|.-||+||| ||.+|.++..
T Consensus 156 meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999988876543 34666666668899999999999 5666653310
Q ss_pred ----------------------C-----C-C-C----------------------CCccccccccCccccccccCCCcCc
Q 038466 435 ----------------------C-----P-D-S----------------------SNRTLLAGTYGYIAPELAYTMVMTE 463 (572)
Q Consensus 435 ----------------------~-----~-~-~----------------------~~~~~~~gt~~y~APE~~~~~~~s~ 463 (572)
+ . . . .....++||-.|+|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 0 0011256899999999999999999
Q ss_pred ccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC---
Q 038466 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT--- 540 (572)
Q Consensus 464 ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs--- 540 (572)
+.|+|+|||++|||+.|+.||... ..+.....++.+.+.-|.... -...+.+++..-+.+||++|-.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~-------~~~~Tl~NIv~~~l~Fp~~~~---vs~~akDLIr~LLvKdP~kRlg~~r 384 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGS-------NNKETLRNIVGQPLKFPEEPE---VSSAAKDLIRKLLVKDPSKRLGSKR 384 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCC-------CchhhHHHHhcCCCcCCCCCc---chhHHHHHHHHHhccChhhhhcccc
Confidence 999999999999999999998532 223344555555544333221 1122345556788999999998
Q ss_pred -HHHHHHHHhhc
Q 038466 541 -MQYVSQEFLIT 551 (572)
Q Consensus 541 -m~~V~~~l~~~ 551 (572)
+.||-+|.+..
T Consensus 385 GA~eIK~HpFF~ 396 (459)
T KOG0610|consen 385 GAAEIKRHPFFE 396 (459)
T ss_pred chHHhhcCcccc
Confidence 88988876554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.96 Aligned_cols=223 Identities=19% Similarity=0.325 Sum_probs=167.3
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 380 (572)
..++|.+.+++|.|.||+|+.+..+ +++.+|||.+++...-....++....|.+++.-.. ||.++++++.++..+.+|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3456778889999999999999975 58999999999877655555678888888887775 999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC-------------C----C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC-------------P----D 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~-------------~----~ 437 (572)
.||||+.||++..+.+. ..++.++..-+|..|+-||.|||. |.+-.++..+ . .
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999996555542 247777777899999999999994 3333332211 1 1
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.....+++|||.|||||++.+..|+...|+|||||+||||+.|++||... +++.....++.....-|. ...
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-------dEee~FdsI~~d~~~yP~--~ls 592 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-------DEEEVFDSIVNDEVRYPR--FLS 592 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHhcCCCCCCC--ccc
Confidence 23446789999999999999999999999999999999999999998522 122222222222222221 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 038466 518 RDILLASTISFACLQSNPKSRPTM 541 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm 541 (572)
.+ +..|..+.+.++|++|--+
T Consensus 593 ~e---a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KE---AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HH---HHHHHHHHhccCcccccCC
Confidence 22 2345557889999999876
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-28 Score=242.17 Aligned_cols=230 Identities=24% Similarity=0.305 Sum_probs=168.4
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++.+.+|.|+||.||+|... ++..+|+|.+...... ..+.|.+|+++++.++|||+++++++|..++..++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 345677899999999999865 5888999998755432 246788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|..++.... ..++|..+..++.++++|+.|||. |.+|..+...... ....
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99999988876532 258899999999999999999984 4455443221100 0112
Q ss_pred ccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCCh
Q 038466 443 LLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDR 514 (572)
Q Consensus 443 ~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~ 514 (572)
...||+.|+|||++. ...++.++|||||||++|||++|+.|+..... ........ .+....+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~-- 232 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLAQPS-- 232 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCCCCCCCcc--
Confidence 245788999999874 34578899999999999999999999853221 11111111 11111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... .+.++...||+.||++||++.+++++.+....
T Consensus 233 ~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 233 RWSS---EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ccCH---HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0001 23456679999999999999999999876644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=238.53 Aligned_cols=228 Identities=22% Similarity=0.398 Sum_probs=166.2
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+++.+.+|.|+||.||+|...++..+|+|.+....... ++|.+|++++++++|+|++++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3466778899999999999998888889999997654322 46889999999999999999999875 456899999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~--~ 440 (572)
|+++|+|.++++... ...+++.++..++.+++.|++|||. |.+|..+....+. . .
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 81 YMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999997543 2347899999999999999999984 4444433221110 0 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....++..|+|||+.....++.++||||||+++|||++ |+.||.... .. ...+.+....+.+.+....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~~~-- 229 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-------NR-EVLEQVERGYRMPCPQDCP-- 229 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-------HH-HHHHHHHcCCCCCCCCcCC--
Confidence 001124567999999988889999999999999999999 888885321 11 1111122211111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..+..+|++.+|++|||+.++...+.
T Consensus 230 -~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 230 -ISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred -HHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 12346777999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-27 Score=239.15 Aligned_cols=230 Identities=23% Similarity=0.371 Sum_probs=170.4
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++..+.+|.|+||.||+|... +++.||+|.+....... ..+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 445567899999999999864 58999999987543222 246889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++... .+++.+...++.+++.|++|||+ +..|..+..+... ....
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 9999999988642 36778888899999999999984 3444433221110 0111
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...++..|+|||++.+..++.++|||||||++|||+||+.|+..... .. ....+....++...... ...
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~---~~~ 228 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-------MR-VLFLIPKNNPPTLTGEF---SKP 228 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-------Hh-HhhhhhcCCCCCCchhh---hHH
Confidence 23578889999999888899999999999999999999999853321 00 01111111112111111 122
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..+...||+.+|++||++++++++.+..+.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 3467779999999999999999999876555
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=241.29 Aligned_cols=230 Identities=22% Similarity=0.346 Sum_probs=165.9
Q ss_pred CccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
++.....+|.|+||.||++.. .++..+|+|.+...... ..+.|.+|++++++++|+||+++++++.+.+..
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 455677899999999999963 24678999998765432 246799999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCC------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--
Q 038466 380 FLIYEYMKRGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-- 439 (572)
++||||+++|+|.++++.... ...++|.++..++.+++.|++|||. |.+|..+....+..
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 999999999999999875431 1247899999999999999999983 44554332211100
Q ss_pred --C---------------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhh
Q 038466 440 --N---------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 501 (572)
Q Consensus 440 --~---------------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 501 (572)
+ .....+++.|+|||+..+..++.++|||||||++|||+| |+.||..... .....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~ 235 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------TEAIE 235 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------HHHHH
Confidence 0 011224578999999998899999999999999999998 8999753211 11111
Q ss_pred hhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 502 DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 502 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..... .+...+..... .+..+...||+.||++||++++|.+.+.
T Consensus 236 ~~~~~-~~~~~~~~~~~---~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQG-RELERPRTCPP---EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcC-ccCCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111 11110000001 1235667899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=238.67 Aligned_cols=228 Identities=23% Similarity=0.345 Sum_probs=166.6
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcch---HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.....+|.|+||.||+|...+|+.+|||.+..... ......+.+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 44567899999999999988899999999874321 122334678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD--------------------- 437 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~--------------------- 437 (572)
|+++|+|.+++.... .+++.....++.++++|++|||. +.+|..+.....
T Consensus 83 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 83 FVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999997543 36788888899999999999985 334433222110
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh--hcccCCCCCCC
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID--VLDQRLPPPVD 513 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~ 513 (572)
........|+..|+|||+..+..++.++|||||||+++||+||+.||........ ...... ...+.++...+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----HHHhhhccCCCCCCCCCCC
Confidence 0001123578899999999988899999999999999999999999853321100 000000 01111222111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
. .+..+..+||+.+|++||++.+++++.+
T Consensus 236 ----~---~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 236 ----A---AAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred ----H---HHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 1 1234556899999999999999988754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=248.45 Aligned_cols=228 Identities=18% Similarity=0.271 Sum_probs=166.2
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++...+|.|+||.||+|+.. +++.||||.+...........+.+..|.+++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456778999999999999864 5889999999764432223345677788888877 58999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++|+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.+ ....
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 82 YVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 999999998887543 47888899999999999999974 555544322111 1112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+... .......+.......+.. ...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--~s~--- 226 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS--MSK--- 226 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCc--CCH---
Confidence 23568999999999999999999999999999999999999986321 111112222222211111 111
Q ss_pred HHHHHHHHccccCCCCCCCH-----HHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTM-----QYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm-----~~V~~~l~ 549 (572)
.+..++.+|++.||++|++. .++.++.+
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 227 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred HHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence 12456678999999999984 77776644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=242.27 Aligned_cols=233 Identities=24% Similarity=0.367 Sum_probs=167.6
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+++++.+.+|.|+||.||+|... ++..||+|.+...... ...++|.+|++++++++||||++++++|.+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 345677788999999999999753 4688999998754432 22467899999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCC-------------------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCce
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE-------------------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIA 432 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~-------------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~ 432 (572)
..++||||+++|+|.+++.... ....+++..++.++.+++.|++|||. |++|..+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997431 11247888899999999999999984 4444433
Q ss_pred eeCCCCC-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccC
Q 038466 433 STCPDSS-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS 492 (572)
Q Consensus 433 ~~~~~~~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~ 492 (572)
....+.. ......+++.|+|||+..+..++.++|||||||++|||++ |..|+....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---- 237 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---- 237 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 2211100 0011123567999999988899999999999999999997 888874221
Q ss_pred CCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 493 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 493 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.......+.+....+ .+.... ..+..++.+||+.+|++|||+.|+++.|.
T Consensus 238 ---~~~~~~~~~~~~~~~-~~~~~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 ---HEEVIYYVRDGNVLS-CPDNCP---LELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ---HHHHHHHHhcCCCCC-CCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111111222111 000111 12345677999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=237.17 Aligned_cols=224 Identities=22% Similarity=0.378 Sum_probs=166.0
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++++...+|.|+||.||+|...++..+|+|.+....... .+|.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 456677899999999999988778899999987554332 4688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~ 441 (572)
+++|+|.++++.... .+.|.....++.+++.|++|||. |++|..+....... ..
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999875432 47888888999999999999984 45554433221100 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCC-CCCCChHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRL-PPPVDRKVIR 518 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l-~~~~~~~~~~ 518 (572)
....++.+|+|||+..+..++.++||||||+++|||++ |+.|++.... ......... ... .+....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~---- 227 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGFRLYKPRLAS---- 227 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCCCCCCCCCCC----
Confidence 11224568999999988899999999999999999998 9999853210 111111100 011 111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
..+.+++.+||+.+|++|||+++|++++
T Consensus 228 --~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 228 --QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1234677799999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=239.31 Aligned_cols=238 Identities=23% Similarity=0.340 Sum_probs=164.6
Q ss_pred CCccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~ 377 (572)
+.+.+.+.+|.|+||.||+|.. .++..||+|++...... ..+.|.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3456678899999999999974 35889999998765432 24678999999999999999999998764 34
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------ 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------ 439 (572)
..++||||+++|+|.+++.... ..++|..+..++.+++.|++|||. |.+|..+....+..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 6899999999999999997543 247899999999999999999984 44444332211100
Q ss_pred ---Cc-----cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc-c----cCCCCcc---hhhhhh
Q 038466 440 ---NR-----TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-L----SSSSDPK---IMLIDV 503 (572)
Q Consensus 440 ---~~-----~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~-~----~~~~~~~---~~~~~~ 503 (572)
.. ....++..|+|||+..+..++.++|||||||++|||++|..|+..... . ....... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 00 001123459999999888899999999999999999998776532211 0 0000000 001111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+......+....... .+..++.+||+.+|++|||+++|++.+..
T Consensus 239 ~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGRLPAPPGCPA---EIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCcCCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111111111111111 23456779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.49 Aligned_cols=230 Identities=21% Similarity=0.308 Sum_probs=166.0
Q ss_pred ccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++.+.+|.|+||.||+|... ++..||||+++..... ...+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 455678899999999999753 3578999999855432 23467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---
Q 038466 381 LIYEYMKRGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--- 438 (572)
+++||+++++|.+++.... ....+++.....++.++++|+.||| +|++|..+....+.
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 9999999999999885321 1124788888999999999999997 45555544322110
Q ss_pred ------------CC----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhh
Q 038466 439 ------------SN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 501 (572)
Q Consensus 439 ------------~~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 501 (572)
.. .....+++.|+|||++....++.++||||||+++|||+| |..|+.... ......
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~ 237 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQDVIE 237 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Confidence 00 011234678999999988889999999999999999998 888874321 111111
Q ss_pred hhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 502 DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 502 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+....+ ....... .+..++..||+.+|++||++++|++.+.
T Consensus 238 ~i~~~~~~~-~~~~~~~---~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 238 MIRNRQVLP-CPDDCPA---WVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHcCCcCC-CCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 122222111 1111111 1345667899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=241.00 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=164.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++.....+|.|+||.||+|+. .+++.||+|.++...... ...+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3566677899999999999985 568999999987654322 246788999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++...+ .+++.+...++.+++.|+.|||+ |.+|..+..... ...
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999887543 47888889999999999999985 344433221110 011
Q ss_pred ccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.....|++.|+|||++. ...++.++||||+||++|||++|+.|+..... .............++......
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMTKSNFQPPKLKDKM 235 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-------hhhHHhhhccCCCCCcccccC
Confidence 12346889999999874 45688999999999999999999999742211 000000001111111000000
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.-...+..+...|++.+|++||++++|+++.
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 0001234566789999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=242.48 Aligned_cols=232 Identities=24% Similarity=0.352 Sum_probs=170.8
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||.||+|... ++..+|+|.+...... ..+.|.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 44667788999999999999864 6899999998755432 2467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++..... .+++.....++.+++.|+.|||. |.+|..+....+ ...
T Consensus 82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998875432 47888899999999999999984 444443322110 001
Q ss_pred ccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCCCCC
Q 038466 441 RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPV 512 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~ 512 (572)
.....||+.|+|||++. ...++.++||||||+++|||++|+.|+..... ......+... .+..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 232 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSEPPTLDQPS 232 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCCCCCcCCcc
Confidence 12245889999999874 34467899999999999999999999853321 1111111111 111110
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... .+.++...||+.+|++||++++|+++.|....
T Consensus 233 --~~~~---~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 233 --KWSS---SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --cCCH---HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0001 12345668999999999999999999887655
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=255.37 Aligned_cols=235 Identities=21% Similarity=0.267 Sum_probs=168.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++...+|.|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 346777889999999999999864 6899999999754333333345688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++++. .++......++.+++.|++|||. |++|..+..+...
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999988753 24555666788999999999973 5555433221100
Q ss_pred CCccccccccCccccccccCC----CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 512 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~----~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~ 512 (572)
.......||+.|+|||++... .++.++|||||||++|||+||+.||.... .......+.+. .+..+.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCcCCCCC
Confidence 011234689999999988643 47899999999999999999999985321 11111222221 111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhhcc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKS--RPTMQYVSQEFLITR 552 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~--RPsm~~V~~~l~~~~ 552 (572)
...... .+..+...|++.+|++ ||++++++++.+...
T Consensus 271 ~~~~s~---~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 271 DIEISK---QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred cCCCCH---HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 100011 2234556899999987 999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=238.01 Aligned_cols=228 Identities=22% Similarity=0.386 Sum_probs=166.8
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+++...+|.|+||.||+|..++++.||+|.+...... .++|.+|++++++++|+||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 456677889999999999999888999999999865433 256889999999999999999999874 456899999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------C---C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------S---N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------~---~ 440 (572)
|+++|+|.+++.... ...+++.++..++.+++.|++|||. |++|..+....+. . .
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 81 YMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999987543 2358899999999999999999984 3444332221100 0 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....++..|+|||+.....++.++||||||+++|||++ |+.||.... .+. ..+.+......+.......
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~--~~~~~~~~~~~~~~~~~~~- 230 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPE--VIQNLERGYRMPRPDNCPE- 230 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHH--HHHHHHcCCCCCCCCCCCH-
Confidence 011234568999999988889999999999999999999 999985321 111 1111111111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++.+|++.+|++||+++++...+.
T Consensus 231 --~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 231 --ELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred --HHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 2345667899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=237.12 Aligned_cols=231 Identities=21% Similarity=0.293 Sum_probs=167.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcch--HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+++..+.+|.|+||.||+|.. .+++.+|+|.+..... ......+.+.+|++++++++||||++++|++.+++..++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 466677899999999999985 4689999999874432 1222346789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++.... .+++.....++.++++|+.|||. |.+|..+......
T Consensus 83 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999887543 36777888899999999999984 4444432221100
Q ss_pred --CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
.......|+..|+|||++.+..++.++||||+|+++|||++|+.|+..... .............+..+...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPQLPSHV 232 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCCCCCCCccC
Confidence 000123477889999999998899999999999999999999999853211 01111111111111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.. .+..+...||..+|++|||+++++++.+
T Consensus 233 ~~---~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 233 SP---DARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred CH---HHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 11 1234556899999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=258.16 Aligned_cols=232 Identities=19% Similarity=0.278 Sum_probs=165.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||.||+|+. .+++.||||.+...........+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 456678899999999999985 4689999999975543333345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------------- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------------- 439 (572)
|+++|+|.+++.... .++......++.+++.|++||| +|++|..+....+..
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999997543 3566666778899999999997 455554332211000
Q ss_pred -----------------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHH
Q 038466 440 -----------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 478 (572)
Q Consensus 440 -----------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ell 478 (572)
......||++|||||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 001246999999999999999999999999999999999
Q ss_pred cCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHHhhc
Q 038466 479 MGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQSNPKSRP---TMQYVSQEFLIT 551 (572)
Q Consensus 479 tG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RP---sm~~V~~~l~~~ 551 (572)
||+.||..... ......+.. .....+.......+ +..+..+|+ .+|++|+ ++.+++++.+..
T Consensus 239 ~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~---~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 239 VGQPPFLADTP-------AETQLKVINWETTLHIPSQAKLSRE---ASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred hCCCCCCCCCH-------HHHHHHHhccCccccCCCCCCCCHH---HHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 99999863221 100111111 11111110000011 112223444 4999999 899999987754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=239.85 Aligned_cols=225 Identities=24% Similarity=0.356 Sum_probs=161.7
Q ss_pred cccccCeeEEEEEEcCC-------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 312 IWNYDGYGSVYKAQLPN-------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+|.|+||.||+|+..+ ++.+|||.+...... .....|.+|++++++++||||++++|+|...+..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 47899999999998542 367999988654322 224678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC----CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------CC-----
Q 038466 385 YMKRGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------SN----- 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~----~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------~~----- 440 (572)
|+++|+|.++++... ....++|.+++.++.++++|++|||. |.+|..+...... .+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 999999999997532 22347899999999999999999984 3444433322111 00
Q ss_pred ----------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCC
Q 038466 441 ----------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509 (572)
Q Consensus 441 ----------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~ 509 (572)
.....++..|+|||++.+..++.++|||||||++|||+| |+.|+..... ......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~~~ 231 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTAGGR 231 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhcCCc
Confidence 001123578999999999999999999999999999998 9999753211 011111111111
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
......... .+.+++.+||+.+|++||++.+|.+.+.
T Consensus 232 ~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 LQKPENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCcccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111 2345677999999999999999998774
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=237.04 Aligned_cols=222 Identities=20% Similarity=0.288 Sum_probs=159.7
Q ss_pred cccccCeeEEEEEEc---CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~---~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||.||+|.+ .++..+|+|+++..... ....++|.+|+.++++++||||++++|++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 478999999999964 35789999998754332 234578999999999999999999999985 4567899999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CC------cc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SN------RT 442 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~------~~ 442 (572)
|+|.+++.... .+++.....++.++++|++|||. |++|..+....+. .. ..
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999987532 47888899999999999999984 4455443221100 00 01
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
...++..|+|||+.....++.++|||||||++|||+| |+.||..... . ...+.+.....++.+.....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~-~~~~~i~~~~~~~~~~~~~~--- 225 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------N-EVTQMIESGERMECPQRCPP--- 225 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHCCCCCCCCCCCCH---
Confidence 1123468999999988889999999999999999998 9999863211 0 11112222111111111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.++...||+.||++||+|.+|.+.|.
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 1235667899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=245.03 Aligned_cols=234 Identities=21% Similarity=0.257 Sum_probs=170.2
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
|+..+.+|.|+||.||++.. .+++.||||.+...........+.+.+|+.++++++|+|++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 34567789999999999985 46899999998754433333345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~ 443 (572)
+++|+|.+++.... ...+++..+..++.+++.|+.|||. |++|..+..+.. ......
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999886532 2347888899999999999999984 444433222110 011122
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKVIRDI 520 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~ 520 (572)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... . ......... ....+...+.
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~------ 230 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---I-KREEVERLVKEVQEEYSEKFSP------ 230 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc---c-hHHHHHhhhhhhhhhcCccCCH------
Confidence 46889999999999889999999999999999999999998632110 0 000011111 1111111111
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHHHHhhcc
Q 038466 521 LLASTISFACLQSNPKSRPT-----MQYVSQEFLITR 552 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~~ 552 (572)
...++...||+.||++||| +++++++.+..+
T Consensus 231 -~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 231 -DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred -HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 1235566899999999999 899999887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=248.84 Aligned_cols=222 Identities=23% Similarity=0.319 Sum_probs=160.4
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||+||+|+. .+|+.||||++...........+++..|.. +++.++||||+++++++.+++..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 578999999999986 469999999997543322222344555554 568899999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++.....++.++++|+.|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999887533 46777888899999999999984 455543322111 011123468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+... .+++..+ . .+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~-~------~~~ 224 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNKPLRLKPNIS-V------SAR 224 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCC-H------HHH
Confidence 999999999999899999999999999999999999985321 11111122222 1222221 1 123
Q ss_pred HHHHHccccCCCCCCCH----HHHHHHHhh
Q 038466 525 TISFACLQSNPKSRPTM----QYVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm----~~V~~~l~~ 550 (572)
.+...|++.||++||++ .+++++.+.
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 45568999999999987 577766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.47 Aligned_cols=233 Identities=18% Similarity=0.267 Sum_probs=167.8
Q ss_pred CCccccccccccCeeEEEEEEcCC-----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 378 (572)
+.+.+..++|.|+||.||+|...+ +..||+|++...... ...+.+.+|++++++++||||++++|++.. +..
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 345666789999999999998654 788999998754322 224678899999999999999999999876 467
Q ss_pred EEEEEecccCCChhhhhhcCCCc-----ccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDA-----VELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~-----~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------- 438 (572)
.++++||+++|+|.+++...... ..+++..+..++.+++.|++|||. |++|..+....+.
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998754322 458899999999999999999984 3444333221100
Q ss_pred ------CC----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccC
Q 038466 439 ------SN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 439 ------~~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
.. .....++..|+|||+.....++.++||||||+++||+++ |+.|++.... . .....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~ 235 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------F-EMAAYLKDG 235 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------H-HHHHHHHcC
Confidence 00 011235667999999988889999999999999999999 9999853211 0 111111111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...+....... .+.+++..||+.||++|||+.+|++.+..
T Consensus 236 ~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 236 YRLAQPINCPD---ELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred CCCCCCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11111100011 23456779999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=251.05 Aligned_cols=222 Identities=23% Similarity=0.327 Sum_probs=162.9
Q ss_pred ccccccCeeEEEEEEc----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 311 SIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
+.+|.|+||.||+++. .+|+.+|+|++....... .....+..|++++++++||||+++++++.+++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4679999999999864 368999999997543322 22356778999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C-CCccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S-SNRTL 443 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~-~~~~~ 443 (572)
++|+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.+ . .....
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 9999999986532 47888899999999999999984 444443322110 0 11123
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~ 521 (572)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.... ++...+. .
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~~~~~~~p~~~~~-~----- 224 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMILKAKLGMPQFLSP-E----- 224 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH-H-----
Confidence 468999999999998889999999999999999999999985321 111111122222 2222211 1
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHHHHhh
Q 038466 522 LASTISFACLQSNPKSRPT-----MQYVSQEFLI 550 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~ 550 (572)
+..+...||+.||++||+ +.+++.+.+.
T Consensus 225 -~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 225 -AQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred -HHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 234556899999999999 5667766443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=244.99 Aligned_cols=232 Identities=20% Similarity=0.276 Sum_probs=164.8
Q ss_pred CCccccccccccCeeEEEEEEcCC---------------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN---------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 369 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~---------------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l 369 (572)
+.+++.+.+|.|+||.||+++..+ ...||+|.++..... ...+.|.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCcCeE
Confidence 346677889999999999987532 235899999764332 224679999999999999999999
Q ss_pred EEEEEeCCeEEEEEecccCCChhhhhhcCC---------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee
Q 038466 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNNE---------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST 434 (572)
Q Consensus 370 ~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~ 434 (572)
++++..++..++||||+++|+|.+++.... ....++|..++.++.++++|++|||. |++|..+..
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999986532 11247888999999999999999974 555554432
Q ss_pred CCCC---------------CC----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc--CCCCCCccccccCC
Q 038466 435 CPDS---------------SN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSLSSS 493 (572)
Q Consensus 435 ~~~~---------------~~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt--G~~P~~~~~~~~~~ 493 (572)
..+. .. .....++..|+|||+.....++.++|||||||+++||+| |..|++.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~- 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV- 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH-
Confidence 2110 00 011123568999999988889999999999999999998 5667653211000
Q ss_pred CCcchhhhhhcc---c----CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 494 SDPKIMLIDVLD---Q----RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 494 ~~~~~~~~~~~~---~----~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
........+ . ..++..+ . .+.+++.+||+.||++||+|.+|++.|.
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~~~~~~-~------~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQGRQIYLSQTPLCP-S------PVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhccccccCCCCCCCC-H------HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000000000 0 0111111 1 2456777999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=243.37 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=167.2
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++...+|.|+||.||+|+.. +|+.||||++........ ...+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 45677888999999999999865 689999999875432221 235678999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||++ |+|.+++.... ..++......++.+++.|++|||+ |++|..+..... ...
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9996 67877776533 246777888899999999999974 555544322110 001
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccCC---------C-----Ccchhhhhhcc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS---------S-----DPKIMLIDVLD 505 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~---------~-----~~~~~~~~~~~ 505 (572)
.....||+.|+|||++.+ ..++.++||||+||++|||+||+.||......... . .+........+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 122457889999998765 45889999999999999999999998643211000 0 00000000000
Q ss_pred c-CCC--CCCC-hHHHHH---HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 506 Q-RLP--PPVD-RKVIRD---ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 506 ~-~l~--~~~~-~~~~~~---~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+ ... .+.. ...... ...+.++...|++.||++|||++|+++|.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0 000 0000 000000 0123456678999999999999999999877544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=244.47 Aligned_cols=233 Identities=23% Similarity=0.328 Sum_probs=166.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+++++.+.+|.|+||.||+|... +|. .+|+|.++..... ...++|.+|++++.++ +||||+++++++.+++..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 45667788999999999999864 454 4688877643322 2246788999999999 8999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--
Q 038466 381 LIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-- 439 (572)
+||||+++|+|.++++.... ...+++.+...++.++++|++|||+ |++|..+..+.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 99999999999999975421 1247888999999999999999984 45555443321110
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
......++..|+|||+.....++.++|||||||++|||+| |..||..... .. ..+.+
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~-~~~~~ 236 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEKL 236 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HH-HHHHH
Confidence 0011123567999999988889999999999999999998 9999853211 00 11111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
......+....... .+..++.+||+.+|++||+++++++++..
T Consensus 237 ~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 PQGYRLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred hcCCcCCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111111000011 23467779999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=269.57 Aligned_cols=234 Identities=24% Similarity=0.349 Sum_probs=168.6
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||.||+|+.. +|+.||||++...........++|.+|++++++++|||||++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4667788999999999999864 689999999975433333345689999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC--------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------
Q 038466 385 YMKRGSLFCNLHNNE--------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------ 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~--------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------ 438 (572)
|+++|+|.+++.... .....++...+.++.++++|++||| +|.+|.++..+...
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 999999999886421 1224567788899999999999997 46666544321100
Q ss_pred -----------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCC
Q 038466 439 -----------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 495 (572)
Q Consensus 439 -----------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~ 495 (572)
.......||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~------ 236 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG------ 236 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch------
Confidence 000124689999999999999999999999999999999999999853211
Q ss_pred cchhhhh-hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHh
Q 038466 496 PKIMLID-VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT-MQYVSQEFL 549 (572)
Q Consensus 496 ~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs-m~~V~~~l~ 549 (572)
....... ..++....+. ..... .+..++.+|++.||++||+ ++++.+.+.
T Consensus 237 ~ki~~~~~i~~P~~~~p~-~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 237 RKISYRDVILSPIEVAPY-REIPP---FLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hhhhhhhhccChhhcccc-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0000001 1111000000 00001 1245667899999999975 666666553
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=236.69 Aligned_cols=227 Identities=22% Similarity=0.350 Sum_probs=164.3
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
.+.+.+.+|.|+||.||+|+..++..||+|++...... .++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 45667789999999999998877778999999854432 2468899999999999999999998754 557999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C--Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S--NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~--~~ 441 (572)
+++|+|.++++... ...++|..+..++.++++|++|||+ |.+|..+....+. . ..
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 82 MSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999997542 2357899999999999999999984 4455433221110 0 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....++..|+|||+..+..++.++||||||+++|||+| |+.||.... ..... +.+....+.+......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------~~~~~-~~~~~~~~~~~~~~~~--- 229 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVL-DQVERGYRMPCPPECP--- 229 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------hHHHH-HHHhcCCCCCCccccC---
Confidence 11234567999999988889999999999999999999 888875321 11111 1111111111111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.+++.+|++.||++||+++++.+.+.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 12346777999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=238.66 Aligned_cols=226 Identities=25% Similarity=0.415 Sum_probs=164.2
Q ss_pred ccccccccccCeeEEEEEEcC-CC---cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g---~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+++.+.+|.|+||.||+|... ++ ..||||.+...... ...++|..|++++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 456678999999999999864 23 46999998754322 2346899999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----------------N 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----------------~ 440 (572)
|||+++|+|.+++.... ..+++.++..++.++++|++|||. |++|..+..+.... .
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999987543 257899999999999999999984 44554332211100 0
Q ss_pred ---cc-ccc--cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCC
Q 038466 441 ---RT-LLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPP 511 (572)
Q Consensus 441 ---~~-~~~--gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~ 511 (572)
.. ... ++..|+|||++....++.++|||||||++|||++ |..||..... . ...+.+. ...+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------~-~~~~~i~~~~~~~~~ 233 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------Q-DVINAIEQDYRLPPP 233 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-------H-HHHHHHHcCCcCCCc
Confidence 00 011 1346999999998999999999999999999886 9999853211 0 0111111 112221
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+ ... .+..++..||+.+|++||+|++|++.+.
T Consensus 234 ~~--~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 234 MD--CPT---ALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred cc--CCH---HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 111 1245667899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=240.72 Aligned_cols=231 Identities=23% Similarity=0.350 Sum_probs=166.5
Q ss_pred ccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+...+|.|+||.||+|... ....+|+|.+....... ..+++.+|++++++++||||++++++|..++..+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS--ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH--HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 345678899999999999742 24679999887554322 2467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCC---------------------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCcee
Q 038466 381 LIYEYMKRGSLFCNLHNNE---------------------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAS 433 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~---------------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~ 433 (572)
+||||+++|+|.+++.... ....+++.....++.+++.|+.|||+ |.+|..+.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999886421 11347888999999999999999974 45554433
Q ss_pred eCCCCC-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCC
Q 038466 434 TCPDSS-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSS 493 (572)
Q Consensus 434 ~~~~~~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~ 493 (572)
...+.. ......++..|+|||+..+..++.++||||||++++||+| |+.|+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----- 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA----- 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 211100 0111234678999999988889999999999999999998 999975321
Q ss_pred CCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 494 SDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 494 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+ ....+........+.+..... .+..++..||+.+|++||+++++++.+..
T Consensus 235 --~-~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 235 --P-ERLFNLLKTGYRMERPENCSE---EMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred --H-HHHHHHHhCCCCCCCCCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1 111122222111111111111 23456678999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=237.97 Aligned_cols=225 Identities=23% Similarity=0.339 Sum_probs=160.5
Q ss_pred cccccCeeEEEEEEcCC-Cc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQLPN-GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
++|.|+||.||+|+..+ |. .+|+|.++..... ...+.|.+|+++++++ +||||++++++|...+..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 57899999999998653 43 4688888743322 2235788999999999 89999999999999999999999999
Q ss_pred CCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------
Q 038466 388 RGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------- 439 (572)
Q Consensus 388 ~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------- 439 (572)
+|+|.++++... ....+.+.++..++.++++|++|||. |.+|..+.......
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999987532 11247889999999999999999984 45554433221100
Q ss_pred -------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 440 -------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 440 -------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
.......++.|+|||+.....++.++|||||||++|||+| |+.||..... .. ....+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~--~~~~~~~~~~~~ 231 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE--LYEKLPQGYRLE 231 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HH--HHHHHhCCCCCC
Confidence 0011123457999999988889999999999999999997 9999853210 00 111111111111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....... .+..++..||+.+|.+|||+.++++.+.
T Consensus 232 ~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 232 KPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCcCCH---HHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 1001111 2346777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.14 Aligned_cols=239 Identities=23% Similarity=0.325 Sum_probs=170.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||.||++... +|+.||+|.+...... ...+++.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4567788999999999999865 6899999998754222 223678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC---------------CCCcc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD---------------SSNRT 442 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~---------------~~~~~ 442 (572)
|+++++|..+++.......+++.....++.+++.|+.|||+. ++|..+..... .....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 999999998887643333588999999999999999999853 22222211110 01112
Q ss_pred ccccccCccccccccCC------CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 443 LLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~------~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
...|+++|+|||++.+. .++.++|||||||++|||+||+.||..... ...........+.. ++......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~~~~~~ 234 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGD-PPTLPSGY 234 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcC-CCCCCccc
Confidence 23578899999998544 358899999999999999999999853210 00000111111111 11111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. .+..++.+||+.+|++||++++++.+.+.....
T Consensus 235 ~~---~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SD---DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CH---HHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 11 123566689999999999999999998765554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=237.08 Aligned_cols=233 Identities=25% Similarity=0.378 Sum_probs=169.7
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+|.. .++..+|+|++....... ..+.+.+|+++++.++|+|++++++.+..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 456677899999999999985 468899999987544332 34678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C---
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S--- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~--- 439 (572)
|+++++|.++++.......+++.....++.++++|++|||. +.+|..+..+... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999764333457888888999999999999984 3333332211100 0
Q ss_pred --CccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCCCCCC
Q 038466 440 --NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPVD 513 (572)
Q Consensus 440 --~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~ 513 (572)
......|+..|+|||++... .++.++|||||||+++||++|+.|++...... ...+.... ..+....
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPSLETGAD 232 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCCCCCcCCccc
Confidence 11224588899999998776 78999999999999999999999986432110 01111111 1111100
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.... ...+..+...||+.||++||++++++++.+
T Consensus 233 ~~~~--~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 233 YKKY--SKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cccc--cHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 0000 012245666899999999999999998764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=242.30 Aligned_cols=232 Identities=21% Similarity=0.285 Sum_probs=168.2
Q ss_pred CCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+++.+...+|.|+||.||+|.. .++..||||.++...... ..+.|.+|+++++++ +||||++++++|...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS--EREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH--HHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 4566677899999999999963 235689999987553322 246789999999999 7999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------- 438 (572)
..++||||+++|+|.++++.... ..+++.+...++.++++|+.|||. |.+|..+......
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999999975432 248999999999999999999984 3445433221100
Q ss_pred ---C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 439 ---S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 439 ---~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
. ......++..|+|||++....++.++|||||||++|||+| |+.|+..... ............+.+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 264 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIKEGYRMA 264 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHHcCCcCC
Confidence 0 0011234677999999998889999999999999999998 9999753211 111111222211111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....... .+.+++.+|++.+|++|||+.+|++.+.
T Consensus 265 ~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 265 QPEHAPA---EIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 1111111 2345677899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=246.29 Aligned_cols=223 Identities=20% Similarity=0.307 Sum_probs=162.1
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+.. +|+.||+|.++..........+.+..|.+++.. .+||||+++++++.+++..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5789999999999864 689999999976432222223556778888875 48999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++.+...++.+++.|++||| +|++|..+..+.+ ........|
T Consensus 82 ~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 82 DLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9998887532 4778888889999999999997 3555544322111 011123568
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhh--cccCCCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV--LDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+ ..+..+..... . +.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~-~------~~ 224 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRVDTPHYPRWITK-E------SK 224 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCH-H------HH
Confidence 999999999999999999999999999999999999985321 11111111 11222221111 1 23
Q ss_pred HHHHHccccCCCCCCCH-HHHHHHHhhc
Q 038466 525 TISFACLQSNPKSRPTM-QYVSQEFLIT 551 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm-~~V~~~l~~~ 551 (572)
.+...|++.||++||++ +++.+|.+..
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~h~~f~ 252 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRGHPFFK 252 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCCCcC
Confidence 45568999999999997 5777666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=243.29 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=167.2
Q ss_pred CCccccccccccCeeEEEEEEcC--------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~--------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
+.+.+.+.+|.|+||.||+|+.. ++..+|+|.++...... ..+++..|+++++++ +||||++++++|..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH--HHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45667788999999999999742 23579999998643222 235788899999999 79999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP 436 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~ 436 (572)
.+..++||||+++|+|.+++..... ...++|.+++.++.+++.|++|||. |.+|..+..+.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 9999999999999999999976421 1248899999999999999999984 44444332221
Q ss_pred CC---------C----------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCc
Q 038466 437 DS---------S----------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 ~~---------~----------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~ 496 (572)
+. . ......+++.|+|||++.+..++.++|||||||++|||++ |+.|+.... .
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-------~ 248 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------V 248 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------H
Confidence 10 0 0001123467999999988889999999999999999998 888874221 1
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. ...+.+......+.+..... .+.+++..||+.+|++||+|.+|++++...
T Consensus 249 ~-~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 E-ELFKLLKEGHRMDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred H-HHHHHHHcCCCCCCCCcCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1 11111111111111111111 223566789999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=252.57 Aligned_cols=233 Identities=24% Similarity=0.295 Sum_probs=168.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+++. .+|+.||+|+++..........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 466778899999999999985 4689999999986544333345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------C--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------S--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~--~ 440 (572)
|+++|+|.+++..... .+++.....++.+++.|++||| +|++|..+..+... . .
T Consensus 82 ~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999976422 4788888889999999999997 45566544321110 0 0
Q ss_pred ccccccccCcccccccc------CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCC
Q 038466 441 RTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 512 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~------~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~ 512 (572)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+... ....+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFLKFPE 232 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCccCCCC
Confidence 11235899999999986 45678999999999999999999999853211 0111111111 111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+ +..+...|++ +|++||++++++++.+..
T Consensus 233 ~~~~~~~---~~~li~~ll~-~p~~R~t~~~l~~h~~~~ 267 (330)
T cd05601 233 DPKVSSD---FLDLIQSLLC-GQKERLGYEGLCCHPFFS 267 (330)
T ss_pred CCCCCHH---HHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence 0011111 2234446887 999999999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=241.87 Aligned_cols=233 Identities=21% Similarity=0.328 Sum_probs=167.7
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+.++....+|.|+||.||+|... +...+|+|.+......+ ...++.+|++++.++ +|+||++++++|..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45666778999999999999753 24689999987543322 235788999999999 8999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~ 438 (572)
..+++|||+++|+|.++++... ....++|..++.++.+++.|++|||. |.+|..+....+.
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 9999999999999999987531 23458899999999999999999984 4445433221110
Q ss_pred C-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcch
Q 038466 439 S-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKI 498 (572)
Q Consensus 439 ~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~ 498 (572)
. ......++..|+|||+..+..++.++|||||||++|||++ |..|+.... ..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~- 241 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------VE- 241 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-------HH-
Confidence 0 0011124567999999988899999999999999999997 888874221 00
Q ss_pred hhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 499 MLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...+.+......+.+..... .+..++.+||+.||++|||++++++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 242 ELFKLLKEGYRMEKPQNCTQ---ELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHHHHcCCcCCCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11111111111111111111 23467779999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=247.14 Aligned_cols=224 Identities=20% Similarity=0.280 Sum_probs=159.2
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
++|.|+||.||+|+. .+|+.||+|++...........+.+..|.. +++.++|||||++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999986 468999999997554332223345555654 688999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+.......++.++++|+.|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9988886532 35666777899999999999974 455544322111 011123468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTI 526 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i 526 (572)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.......+.... . .+..+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~--~---~~~~l 226 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHKPLQLPGGKT--V---AACDL 226 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCCCC--H---HHHHH
Confidence 999999999998899999999999999999999999985321 11111222222222111111 1 12345
Q ss_pred HHHccccCCCCCCCH----HHHHHHHhh
Q 038466 527 SFACLQSNPKSRPTM----QYVSQEFLI 550 (572)
Q Consensus 527 ~~~Cl~~dP~~RPsm----~~V~~~l~~ 550 (572)
...|++.||++||+. .++.++.+.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 668999999999874 466665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=237.39 Aligned_cols=229 Identities=22% Similarity=0.311 Sum_probs=165.1
Q ss_pred CccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
++++...+|.|+||.||+|+.. .+..+|+|.++...... ..+.|.+|++++++++||||+++++++.+++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4556678999999999999753 23479999987544322 24688999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---------------- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---------------- 439 (572)
||||+++|+|.+++.... ..+++.+...++.+++.|++|||+ |++|..+....+..
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999997543 257899999999999999999984 45554432211100
Q ss_pred --Cc--cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 440 --NR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 440 --~~--~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.. ....++..|+|||+.....++.++||||||+++||+++ |+.||..... ......+.+. ...+...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~~~ 232 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-------QDVIKAIEEG-YRLPAPM 232 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-------HHHHHHHhCC-CcCCCCC
Confidence 00 00112457999999998889999999999999999886 9999853211 0001111111 1111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.... .+..++.+|++.+|++||+|.++++.+.
T Consensus 233 ~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 233 DCPA---ALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCCH---HHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 1111 1245667899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=233.91 Aligned_cols=230 Identities=19% Similarity=0.272 Sum_probs=169.6
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++..+.+|.|+||.||.++. .+++.+++|++....... ...+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 45677899999999999974 568999999987544222 2246788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~ 442 (572)
+++|+|.+++.... ...+++.....++.++++|+.|||+ |.+|..+....+ .....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999987643 2357888999999999999999984 344433221110 00112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|++.|+|||+..+..++.++||||||++++||++|+.|++... .......+.....++. ...... .
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~-~~~~~~---~ 228 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQGNYTPV-VSVYSS---E 228 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCC-ccccCH---H
Confidence 3458899999999988889999999999999999999999985321 1111112222222211 111111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..+...||+.+|++||++++++++++
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 235666899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.22 Aligned_cols=231 Identities=19% Similarity=0.267 Sum_probs=167.1
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 383 (572)
+++...+|.|+||.||++.. .+|+.+|+|.+....... ...+++.+|++++++++||||+++++++.. +...+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 45567789999999999985 568999999987543322 224678899999999999999999998764 45689999
Q ss_pred ecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeeCCCC----------------------
Q 038466 384 EYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIASTCPDS---------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--~~~i~~~~~~~---------------------- 438 (572)
||+++|+|.+++... .....+++.....++.+++.|+.|||..+ ...++|.+.+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998753 22346889999999999999999999432 33333321110
Q ss_pred --CC--ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 --SN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 --~~--~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.. .....|++.|+|||++....++.++||||||++++||++|+.|++... ... ..+.+.....+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~ 232 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-------QLQ-LASKIKEGKFRRIPY 232 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-------HHH-HHHHHhcCCCCCCcc
Confidence 00 122457899999999988889999999999999999999999986321 111 111111111111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... ..+..++..|++.+|++||++++|+++.+
T Consensus 233 ~~~---~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 233 RYS---SELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred ccC---HHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 111 12345667899999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=242.39 Aligned_cols=238 Identities=23% Similarity=0.297 Sum_probs=170.8
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|+. .+|..+|+|++...........+++.+|++++++++|||+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55567789999999999985 46899999998754333333456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------CCcccccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------SNRTLLAG 446 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------~~~~~~~g 446 (572)
++ |++.+.+.... ..++|.++..++.+++.|+.|||. +.+|..+....+. .......|
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 97 57777775432 248899999999999999999984 3444433221110 11123457
Q ss_pred ccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 447 TYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 447 t~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
++.|+|||++. ...++.++|||||||++|||++|+.|+.... .......+.....+......... .+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~---~l 253 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTLQSNEWSD---YF 253 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCCCCCCccccH---HH
Confidence 88999999974 4568999999999999999999999974321 11111112221111111111111 23
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
..++.+||+.+|++||++.+|+++++.....+..
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 4566689999999999999999998776555444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=238.37 Aligned_cols=231 Identities=24% Similarity=0.295 Sum_probs=167.8
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
+++.+...+|.|+||.||+|... ++..||+|.+....... ....|.+|++++++++||||++++|++..++.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34666788999999999999754 24789999987554322 23578899999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCC-------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~-------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------- 438 (572)
.++||||+++|+|.+++..... ...++|...+.++.+++.|+.|||. |++|..+......
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 9999999999999999875321 1247888999999999999999984 4444433221100
Q ss_pred ------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc
Q 038466 439 ------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD 505 (572)
Q Consensus 439 ------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 505 (572)
.......++..|+|||+.....++.++|||||||++||++| |+.|+.... .........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~~~~~~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------NEEVLKFVID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-------HHHHHHHHhc
Confidence 00112335778999999988889999999999999999998 899875321 1111111111
Q ss_pred cC-CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 506 QR-LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 506 ~~-l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.. ...+.. .. ..+..++..||+.+|++|||+.++++.+.
T Consensus 237 ~~~~~~~~~--~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPEN--CP---DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCC--CC---HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 111111 11 12346777999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=245.56 Aligned_cols=226 Identities=17% Similarity=0.282 Sum_probs=165.1
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 384 (572)
++..+.+|.|+||.||+|+. .+|+.||+|++...........+.+..|.+++..+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45677899999999999985 468999999997543323333467788999998886 5678889999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++|+|.+++.... .+++.+...++.+++.|+.|||. |++|..+..+.+ ....
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999887543 47888999999999999999984 455543322111 0011
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~ 519 (572)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... +...+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~p~~~~~----- 226 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKSLSK----- 226 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccCCH-----
Confidence 23458999999999998889999999999999999999999985321 1111122222222 221111
Q ss_pred HHHHHHHHHHccccCCCCCCCH-----HHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTM-----QYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm-----~~V~~~l~ 549 (572)
.+..+..+|++.+|++|++. +++.++.+
T Consensus 227 --~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 227 --EAVSICKGLMTKHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred --HHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence 12345668999999999984 56666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=241.84 Aligned_cols=239 Identities=21% Similarity=0.294 Sum_probs=174.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+...+|.|+||.||+|.. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 4566778899999999999985 579999999997554332 256889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++.+. .+++.++..++.+++.|+.|||. |.+|..+....+ ...
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999999988642 36888899999999999999984 444433322110 001
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|++.|+|||+..+..++.++|||||||++|||+||+.||....... ..........+.........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-- 242 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPELQNPERLS-- 242 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------heeeeccCCCCCCCCccccC--
Confidence 123457889999999998889999999999999999999999985321100 00001101111100011111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~ 559 (572)
..+..+..+||+.+|++||++++|+++.+.....+..+.
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 281 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL 281 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence 112345668999999999999999999887765544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=235.36 Aligned_cols=227 Identities=21% Similarity=0.340 Sum_probs=163.9
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
.+.+...+|.|+||.||+|...++..+|+|.+...... .+.|.+|++++++++|||++++++++. .+..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 35556678999999999999877778999998754322 256889999999999999999999875 4568899999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~ 441 (572)
+++|+|.++++... ...++|..+..++.++++|++|||. |.+|..+....... ..
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 82 MGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999997543 2347899999999999999999984 44444332211100 00
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....++..|+|||+..+..++.++|||||||++|||+| |+.|+.... ....... +......+......
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~~~~--- 229 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NREVLEQ-VERGYRMPCPQGCP--- 229 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH-HHcCCCCCCCcccC---
Confidence 01234567999999988899999999999999999999 899985321 1111111 11111111111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..++.+||+.||++||++++|.+.+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 12345666899999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=243.81 Aligned_cols=235 Identities=22% Similarity=0.274 Sum_probs=173.8
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++....+|.|+||.||+|... +++.+|+|.+...........+.+..|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4566678999999999999865 589999999986654433345789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------------- 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------------- 438 (572)
|+.+|+|.+++.... ...+++.....++.++++|+.|||. |.+|..+......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999987532 2357888888999999999999973 4555433221100
Q ss_pred --------------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC
Q 038466 439 --------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS 492 (572)
Q Consensus 439 --------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~ 492 (572)
.......||..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~---- 236 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN---- 236 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc----
Confidence 00012357889999999998889999999999999999999999985321
Q ss_pred CCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC----HHHHHHHHhhc
Q 038466 493 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT----MQYVSQEFLIT 551 (572)
Q Consensus 493 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs----m~~V~~~l~~~ 551 (572)
.......+.......+...... ..+.++...||+.||++||+ +++++++.+..
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 237 ---RDETFSNILKKEVTFPGSPPVS---SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred ---hHHHHHHHhcCCccCCCccccC---HHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 1111222222222221111111 12345667899999999999 88888876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=237.52 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=167.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
+.++..+.+|.|+||+||+|+. .+|+ .||+|.+....... ..+.+.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH--HHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 4566778899999999999984 4454 48999987543322 246788999999999999999999999754 57
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------- 439 (572)
+++|||+++|+|.++++... ..+++...+.++.++++|++|||. |++|..+.......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 89999999999999997543 247888999999999999999973 55555432211100
Q ss_pred --C---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 440 --N---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 440 --~---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
. .....+++.|+|||+..+..++.++|||||||++|||+| |+.|++.... ......+......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 233 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGERLPQP 233 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcCCCC
Confidence 0 001123567999999988899999999999999999998 8999753211 1111111111111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.... ..+..++..||+.||++||++.++++.+......|
T Consensus 234 ~~~~---~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 PICT---IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111 12345667899999999999999999886655544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=268.54 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=170.6
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCM 379 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 379 (572)
....+.+...+|.|+||.||+|... ++..||+|.+....... ...+.|..|+.++++++|||||++++++.+ .+..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456778889999999999999864 57899999987543322 224678999999999999999999998865 4568
Q ss_pred EEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhcCCC----CCceeeCCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCS----PSIASTCPDSSN-------------- 440 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~~~----~~i~~~~~~~~~-------------- 440 (572)
|+||||+++|+|.++|.... ....+++.....|+.||+.||.|||.... ..++|.+.+..+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987532 22358888999999999999999996321 123333211100
Q ss_pred ----------------------------ccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccc
Q 038466 441 ----------------------------RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL 490 (572)
Q Consensus 441 ----------------------------~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~ 490 (572)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 012358999999999854 4588999999999999999999999853211
Q ss_pred cCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 491 SSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 491 ~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
... ....+. +.++.+.... .+..++..||+.+|++||++.|++++.++...
T Consensus 249 -----~~q-li~~lk~~p~lpi~~~S~------eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 -----FSQ-LISELKRGPDLPIKGKSK------ELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred -----HHH-HHHHHhcCCCCCcCCCCH------HHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 111 111111 1222111111 12356668999999999999999987766533
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=247.40 Aligned_cols=234 Identities=20% Similarity=0.284 Sum_probs=165.3
Q ss_pred CCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR- 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~- 376 (572)
+.+++.+.+|.|+||.||+|.. .+++.||||+++.....+ ..+.+.+|++++.++ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH--HHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3567778899999999999963 357899999997543322 245788999999999 689999999988654
Q ss_pred CeEEEEEecccCCChhhhhhcCCC--------------------------------------------------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNED-------------------------------------------------------- 400 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------------- 400 (572)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 468899999999999998864311
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------------Cccccccc
Q 038466 401 --------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------------NRTLLAGT 447 (572)
Q Consensus 401 --------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------------~~~~~~gt 447 (572)
...++|.+...++.++++|++||| +|++|..+....... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 123678888999999999999997 455665443321100 00112245
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTI 526 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i 526 (572)
+.|+|||++.+..++.++||||||+++|||++ |..|+..... ... ....+......+.+..... .+..+
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~--~~~~~~~~~~~~~~~~~~~---~~~~~ 314 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----DEE--FCRRLKEGTRMRAPDYTTP---EMYQT 314 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-----cHH--HHHHHhccCCCCCCCCCCH---HHHHH
Confidence 67999999988899999999999999999996 9999753211 001 1111111111110000001 23466
Q ss_pred HHHccccCCCCCCCHHHHHHHHhh
Q 038466 527 SFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 527 ~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+..||+.||++|||+.+|++++..
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 778999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=241.02 Aligned_cols=231 Identities=21% Similarity=0.304 Sum_probs=171.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+++...+|.|+||.||+|.. .+|+.||+|.+....... .+.+.+|++++++++|||++++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 3466778899999999999984 578999999987544322 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++... .++|.++..++.+++.|++|||. |.+|..+..+.+ ...
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999999988642 47899999999999999999984 444443322110 001
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~~~ 517 (572)
.....|+..|+|||.+.+..++.++|||||||++|||+||+.||..... .......... .+..+. ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~--~~~ 242 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPELQNPE--KLS 242 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCcccCCcc--cCC
Confidence 1224578899999999988899999999999999999999999853211 0001111111 111111 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
. .+..++.+||+.||++||++.+|+++.+.....
T Consensus 243 ~---~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 243 P---IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred H---HHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 1 123456689999999999999999998876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=241.74 Aligned_cols=234 Identities=19% Similarity=0.286 Sum_probs=167.4
Q ss_pred CCccccccccccCeeEEEEEEcCC-----------------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcc
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-----------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 367 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv 367 (572)
+.+++.+.+|.|+||.||+|...+ +..||+|.+...... ...++|.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCEe
Confidence 456778899999999999987542 356899998765433 2346899999999999999999
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhhhhcCCC--------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCcee
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNED--------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAS 433 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~ 433 (572)
+++++|..++..++||||+++|+|.+++..... ...+++.....++.+++.|++|||. |++|..+.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 999999999999999999999999999876431 1257899999999999999999974 45555433
Q ss_pred eCCCC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc--CCCCCCccccccC
Q 038466 434 TCPDS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSLSS 492 (572)
Q Consensus 434 ~~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt--G~~P~~~~~~~~~ 492 (572)
..... .......+++.|+|||+.....++.++|||||||++|||++ |..|++....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--- 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence 21110 00112235678999999988889999999999999999998 6677643211
Q ss_pred CCCcch--hhhhhc---ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 493 SSDPKI--MLIDVL---DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 493 ~~~~~~--~~~~~~---~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... ...... +.....+...... ..+.+++..||+.||++|||+.+|++.|.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ---QQVIENAGHFFRDDGRQIYLPRPPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHHhccccccccccCCCccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 000 000000 0000000000000 12356777999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=237.60 Aligned_cols=234 Identities=22% Similarity=0.289 Sum_probs=163.4
Q ss_pred cccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 380 (572)
.....+|.|+||+||.+.. .++..||+|.+...... ...+.|.+|++++++++||||++++++|... ...+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4556789999999987642 46889999998765322 1236788999999999999999999998764 4689
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.+++... .++|.++..++.++++|+.|||. |.+|..+....+..
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999998753 48999999999999999999984 45554433211100
Q ss_pred -C----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccc-c------CCCCcchhhhhhcccC
Q 038466 440 -N----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-S------SSSDPKIMLIDVLDQR 507 (572)
Q Consensus 440 -~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~-~------~~~~~~~~~~~~~~~~ 507 (572)
. .....++..|+|||+.....++.++||||||++++||+||+.|+...... . ..........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 0 01112455699999998888999999999999999999999997532110 0 0000000111111111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...+.+.... ..+..++..||+.+|++|||+++|++.+..
T Consensus 241 ~~~~~~~~~~---~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 241 MRLPCPKNCP---QEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred CCCCCCCCCC---HHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111111111 123456779999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=233.53 Aligned_cols=232 Identities=25% Similarity=0.353 Sum_probs=168.3
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++...+|.|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||++++|++.+++..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 45667778999999999999864 5789999998765433 2467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++++|.+++.... ..++......++.+++.|+.|||. |.+|..+..+.+. ..
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999887542 247888888999999999999984 4444433221110 01
Q ss_pred ccccccccCccccccccCC---CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~---~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.....|+..|+|||..... .++.++||||||+++|||+||+.|+..... .............++......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-------MRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCccccchh
Confidence 1224578889999998776 889999999999999999999999853221 011111111111111100000
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.....+..++.+||+.+|++|||+++|+.+-
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 1112234677799999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=255.55 Aligned_cols=235 Identities=21% Similarity=0.295 Sum_probs=174.6
Q ss_pred CccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++...+|-|+||+||||..++ +-..|.|++.....++ +++|.-||+||+.++||+||++++.|+..+.+|+..|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE---LEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE---LEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH---HhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 35566778889999999998765 5567788887665443 5789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~ 441 (572)
||.||.++..+-.-+ ..|...+..-++.+++.+|.||| +|.+.+.+....++ ..+
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999988876533 35788888889999999999997 45555544321111 113
Q ss_pred cccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 442 TLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
..+.|||+|||||+.+. ..|+.++|||||||+|.||.-+.+|..... +-..+..+.....|.-..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSePPTLlqPS- 259 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTLLQPS- 259 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcCCCcccCcc-
Confidence 45789999999998753 569999999999999999999999965332 11112222222211111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.....+.++...|+.+||..||+..++++|.|....+
T Consensus 260 -~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 260 -HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 2222345666789999999999999999999877554
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=235.81 Aligned_cols=230 Identities=22% Similarity=0.302 Sum_probs=163.7
Q ss_pred cccccccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe-----
Q 038466 308 DVFSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC----- 378 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 378 (572)
.+.+.+|.|+||.||+|.... +..||+|+++...... .....|.+|++.+++++||||++++|++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 355678999999999998532 4789999987543322 234678999999999999999999999876554
Q ss_pred -EEEEEecccCCChhhhhhcCC---CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------
Q 038466 379 -MFLIYEYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 379 -~~lV~Ey~~~GsL~~~l~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------- 438 (572)
.++||||+++|+|..++.... ....+++.....++.+++.|+.|||+ |.+|..+....+.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999998886532 22358888899999999999999984 4455443221110
Q ss_pred -----C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCC
Q 038466 439 -----S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508 (572)
Q Consensus 439 -----~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l 508 (572)
. ......++..|+|||++....++.++||||||+++|||++ |..|+..... ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLRHGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 0 0011224568999999988899999999999999999999 8888753211 111111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
. ....... ..+.+++.+||+.||++|||+.+|++++.
T Consensus 234 ~-~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 234 L-KQPEDCL---DELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred C-CCCcCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 1111111 12345667899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=233.83 Aligned_cols=229 Identities=22% Similarity=0.387 Sum_probs=167.0
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+.+.+.+|.|+||.||+|...++..+|+|.+...... .+.|.+|++++++++|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH----HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3456777889999999999999877888999998754322 3578899999999999999999999887 7789999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CC--
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SS-- 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~-- 439 (572)
||+++|+|.+++.... ...++|..+..++.+++.|++|||. |.+|..+..... ..
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999997643 3357899999999999999999984 444443322110 00
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......++..|+|||++....++.++|||||||++||++| |+.|+..... .. ....+......+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~--~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PE--VIRALERGYRMPRPENCPE 230 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH------HH--HHHHHhCCCCCCCcccCCH
Confidence 0011234567999999988889999999999999999999 8999853211 11 1111111111111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..+..+|++.+|++||++.++.+.|.
T Consensus 231 ---~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 231 ---ELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred ---HHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 2345667899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=240.29 Aligned_cols=240 Identities=20% Similarity=0.264 Sum_probs=160.2
Q ss_pred CccccccccccCeeEEEEEEc-C-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEEe-----
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-P-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH----- 375 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 375 (572)
.+++...+|.|+||.||+|+. . +|+.||+|+++.....+. ....+.+|+++++++ +||||++++++|..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 356677899999999999985 3 478899999875432211 123455677776665 69999999999863
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------ 437 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------ 437 (572)
....++||||++ |+|.+++..... ..+++..+..++.+++.|+.||| +|.+|..+....+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 346899999997 689888875432 34788899999999999999997 4555544332111
Q ss_pred ----CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------C-CCcchh-----
Q 038466 438 ----SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------S-SDPKIM----- 499 (572)
Q Consensus 438 ----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~-~~~~~~----- 499 (572)
........||+.|+|||++....++.++|||||||++|||++|++||........ . ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 0111234589999999999888899999999999999999999999863221000 0 000000
Q ss_pred -hhhhcccCCCCCCChHHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 500 -LIDVLDQRLPPPVDRKVIR-DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 500 -~~~~~~~~l~~~~~~~~~~-~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
......+..+.+. ..... ....+.++..+|++.||++|||+.+++++.+
T Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 239 LPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred ccchhccCCCCCCH-HHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0000000000000 00000 0012345677999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=238.85 Aligned_cols=235 Identities=22% Similarity=0.268 Sum_probs=167.6
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+.+++.+.+|.|+||.||+|... .+..||+|.+....... ....|.+|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345677889999999999999643 25589999987554322 2346889999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC-------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-----
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----- 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~-------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----- 439 (572)
..++||||+++|+|.++++.... ....++.....++.+++.|+.|||+ |++|..+....+..
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999999975321 2345677788899999999999974 45555443221100
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
......++..|+|||+..+..++.++|||||||++|||++ |+.|+.... .......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~ 235 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVM 235 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence 0011124567999999998899999999999999999998 788874321 111111122
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+...... ..... ..+..++..|++.||++|||+.++++.+...
T Consensus 236 ~~~~~~~-~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 DGGYLDQ-PDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred cCCCCCC-CCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2211110 00100 1234667799999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=242.22 Aligned_cols=239 Identities=17% Similarity=0.169 Sum_probs=163.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+.+.+|.|+||.||+|+.. +++.||+|+++...... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4666778999999999999854 68999999987543221 12457789999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~ 441 (572)
|++ |+|.+++.... ..+++.....++.+++.|++|||+ |.+|..+..+.+. ...
T Consensus 84 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 998 48988886543 246788888899999999999974 4555443221110 011
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc--------CCCCcchh---------hhhh
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKIM---------LIDV 503 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~--------~~~~~~~~---------~~~~ 503 (572)
....||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... ....+... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 22457889999998865 568999999999999999999999985321000 00000000 0000
Q ss_pred cccCCCC-CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 504 LDQRLPP-PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 504 ~~~~l~~-~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.... +.............++...|++.||++|||++|+++|.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 0000000 000000000012345667899999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=235.22 Aligned_cols=231 Identities=20% Similarity=0.294 Sum_probs=163.4
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcc--hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 380 (572)
++...+.+|.|+||.||+|.. .+|..||+|++.... .......+.+.+|++++++++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 456677899999999999986 468999999886432 1222335678999999999999999999998875 35788
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
++|||+++++|.+++.... .+++.....++.+++.|+.|||. +.+|..+..+...
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999987533 37888888999999999999984 2333322211100
Q ss_pred ----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......|+.+|+|||++.+..++.++|||||||++|||+||+.||..... .............+..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~ 232 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTNPQLPS 232 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCCCCCch
Confidence 001123478899999999888899999999999999999999999853211 111111111111111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.....+ ...+.||..+|++||+|+||+++.+.
T Consensus 233 ~~~~~~----~~li~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 233 HISEHA----RDFLGCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred hcCHHH----HHHHHHhcCChhhCcCHHHHhcCccc
Confidence 111111 11236888999999999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.52 Aligned_cols=234 Identities=24% Similarity=0.339 Sum_probs=180.7
Q ss_pred hhccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCe
Q 038466 301 ERATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 301 ~~~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 378 (572)
....++|.+.+++|.|+|.+||+|+. .+++.+|||++.+........++-...|-++|.+| .||.||+||-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34566788889999999999999984 56999999999876655444456677899999999 89999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------- 437 (572)
+|.|+||++||+|.++|++.+ .++.....-++.+|..|++||| ||.+|.++..+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999999764 3555545568899999999996 6788765532110
Q ss_pred ---------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhh--
Q 038466 438 ---------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML-- 500 (572)
Q Consensus 438 ---------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~-- 500 (572)
.+....++||..|.+||++.....+..+|+|+|||++|+|+.|++||..... -...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yliFqk 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YLIFQK 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HHHHHH
Confidence 1112458899999999999999999999999999999999999999853321 1111
Q ss_pred hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 501 IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 501 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...++-..++..++ .. .++..+-+..||.+|+|.++|.+|.+..
T Consensus 299 I~~l~y~fp~~fp~-~a------~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 299 IQALDYEFPEGFPE-DA------RDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred HHHhcccCCCCCCH-HH------HHHHHHHHccCccccccHHHHhhCcccc
Confidence 12234455554432 22 2344466789999999999999887654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=233.68 Aligned_cols=217 Identities=26% Similarity=0.395 Sum_probs=158.2
Q ss_pred cccccCeeEEEEEEcCC-C----------cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 312 IWNYDGYGSVYKAQLPN-G----------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~-g----------~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
.+|.|+||.||+|...+ + ..+++|.+...... .+.|.+|++++++++||||++++|+|.. +..+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 57899999999998754 3 25788877654322 3678899999999999999999999988 7789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.+++..... .+++..++.++.+++.|+.|||. |++|..+....+..
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999986432 57888899999999999999973 55555544322210
Q ss_pred C-----ccccccccCccccccccCC--CcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 440 N-----RTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 440 ~-----~~~~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
. .....++..|+|||++... .++.++|||||||++|||++ |..|+..... ........ .....+.+
T Consensus 155 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHHh-cCCCCCCC
Confidence 0 0122467789999998776 78999999999999999999 5677643210 00000001 11112222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.. ..+.+++..||..+|++|||+.+|++.+
T Consensus 229 ~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 229 DC-------AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred Cc-------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 2234566799999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=238.19 Aligned_cols=231 Identities=25% Similarity=0.387 Sum_probs=163.2
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcch-------HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET-------EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~-------~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
..+.+|.|+||.||+|.. .+|+.+|+|.++.... ......+.+.+|++++++++|||++++++++..++..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 345789999999999975 4689999998864221 11223467889999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------- 437 (572)
+||||+++|+|.+++++.. .+++..+..++.+++.|+.|||+ |++|..+.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 9999999999999997642 47888888899999999999985 333332221100
Q ss_pred --CCCccccccccCccccccccCCC--cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
........|+..|+|||+..... ++.++||||||++++|+++|+.|+...... ....+..........+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKRSAPPIP 234 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccccCCcCC
Confidence 00012235788999999987654 889999999999999999999998532110 0111111111111000
Q ss_pred hHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... ..-...+..+...||+.+|++||++++|+++.+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 000 000012334566899999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=240.47 Aligned_cols=233 Identities=21% Similarity=0.321 Sum_probs=166.1
Q ss_pred CCccccccccccCeeEEEEEEc--------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~--------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
.++.+...+|.|+||.||+|+. .++..||+|.+...... ...+++.+|+++++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3456667899999999999963 13458999998754322 2246788999999999 89999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP 436 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~ 436 (572)
.+..++||||+++|+|.+++..... ...++|.++..++.++++|+.|||. |++|..+....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 9999999999999999999976421 1347888999999999999999984 45555432211
Q ss_pred CCC-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCc
Q 038466 437 DSS-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 ~~~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~ 496 (572)
... ......+++.|+|||+..+..++.++||||||+++|||+| |..|+.... .
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~ 245 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------V 245 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-------H
Confidence 000 0011234567999999988889999999999999999998 788874221 0
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. ...+.+.............. .+..++.+||+.+|++||||.+|++.+..
T Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 246 E-ELFKLLKEGHRMDKPANCTN---ELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred H-HHHHHHHcCCcCCCCCCCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1 11111111111111011111 23356678999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=234.03 Aligned_cols=230 Identities=19% Similarity=0.285 Sum_probs=167.4
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++..+.+|.|+||.||+++. .+|+.||+|++....... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 45567899999999999985 468999999987543222 2236788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++..... ..+++.+...++.+++.|+.|||. +..|..+...... ....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999998875322 347888889999999999999984 3333322211100 0011
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|++.|+|||+..+...+.++|||||||+++||+||+.|+.... .......+.....++ ....... .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~---~ 228 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKIIRGSYPP-VSSHYSY---D 228 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHHhcCCCCC-CcccCCH---H
Confidence 2347889999999988889999999999999999999999985321 111111222222111 1111111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..++..||+.+|++||+|.+|+++.+
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 345666899999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=237.93 Aligned_cols=236 Identities=23% Similarity=0.322 Sum_probs=174.8
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+.++....++.|+||.||+|... ++..+|+|++..... ..+.+.+|++++++++|+|++++++++..++..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 3455677788999999999999876 688999999976543 23678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------- 438 (572)
|+||+++++|.+++.... ..+++..+..++.+++.|+.|||. +.+|..+....+.
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999999998643 358999999999999999999985 3344333221110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......|+..|+|||++.+..++.++|||||||++|||+||+.|+..... ............+.........
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFLITTKGIPPLKNPEKWS 243 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCcchhhCC
Confidence 011223467889999999888899999999999999999999999753211 1111111111111110010000
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+..+...||+.+|.+||++.+|+.+.+..+.
T Consensus 244 --~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 244 --PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred --HHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 123456678999999999999999998877663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=238.33 Aligned_cols=243 Identities=24% Similarity=0.264 Sum_probs=169.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 382 (572)
.++....+|.|+||.||++... +++.+|+|.+...... ....++.+|++++++++||||++++++|.+. +..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3556678899999999999864 6899999998754332 2346788999999999999999999998653 468999
Q ss_pred EecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC---------------CCC
Q 038466 383 YEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD---------------SSN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~---------------~~~ 440 (572)
|||+++|+|.+++.... ....++......++.++++|+.|||.. ..|..+..+.. ...
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999999988876421 233477788889999999999999842 33322221110 001
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc---cCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~ 517 (572)
.....++..|+|||...+..++.++||||+||++|||+||+.|++..... . ...........+ +.++...... .
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-P-LGPIELLSYIVNMPNPELKDEPGNG-I 236 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-C-CChHHHHHHHhcCCchhhccCCCCC-C
Confidence 11235688899999999889999999999999999999999998643210 0 000011111111 1111110000 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.-...+.++...||+.+|++|||+.||+++.+..+.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 001123567789999999999999999999876433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=233.45 Aligned_cols=230 Identities=23% Similarity=0.381 Sum_probs=169.0
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+++.+.+.+|.|+||.||+|...++..+|||.+...... .+++.+|++++++++|+||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3456677889999999999999888889999999865432 256889999999999999999999999888999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCCC-----------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSSN----------------- 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~~----------------- 440 (572)
||+++|+|.+++.... ...+++..+..++.+++.|+.|||. |++|..+....+..-
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999997643 2358899999999999999999984 444443332211100
Q ss_pred -ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 441 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 441 -~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.....++..|+|||...+..++.++||||||++++|++| |+.||.... ....... +......+.+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~ 231 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQ-VERGYRMPRPPNCPE 231 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH-HHcCCCCCCCCCCCH
Confidence 001123457999999998889999999999999999998 999974221 1111111 111111111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+++.+|++.+|++||+++++.+.+.
T Consensus 232 ---~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 232 ---ELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ---HHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 2345677899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=233.00 Aligned_cols=228 Identities=21% Similarity=0.341 Sum_probs=167.9
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++++...+|.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 34566778999999999999865 78899999976543 24678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------Ccccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------NRTLL 444 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------~~~~~ 444 (572)
|+++|+|.+++..... ..++|.....++.+++.|+.|||. |.+|..+..+.+.. .....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 81 YMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 9999999999876432 258999999999999999999984 44554433221110 00112
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
.++..|+|||+.....++.++||||||++++||++ |+.|+.... .. .....+........+..... .+
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~---~~ 228 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LK-DVVPHVEKGYRMEAPEGCPP---EV 228 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-------HH-HHHHHHhcCCCCCCccCCCH---HH
Confidence 24567999999988889999999999999999997 999975321 01 01111111111111101111 23
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+++.+||..+|++||++++++.++.
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHh
Confidence 45667899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=235.63 Aligned_cols=230 Identities=17% Similarity=0.280 Sum_probs=167.2
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+...+.+|.|+||.||+|... +|..+|+|.+....... ...+.+.+|++++++++|+||+++++.+.+++..++|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 345667899999999999864 58899999987543211 1235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~~ 441 (572)
+++++|.+++..... ..++|..+..++.++++|+.|||+ |.+|..+....+.. ..
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999875432 357899999999999999999985 33333222111100 01
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|++.|+|||+.....++.++|||||||+++||++|+.|+.... ......+......++.. .....
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~--- 228 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGYFAPIS-PNFSR--- 228 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcccCCCCC-CCCCH---
Confidence 12357889999999988889999999999999999999999985321 11111122222221110 00001
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.++..+||+.+|++|||+.+|+++.+
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 1234556899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=237.98 Aligned_cols=231 Identities=22% Similarity=0.300 Sum_probs=164.0
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEE-----e
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL-----H 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~ 375 (572)
..+++++...+|.|+||.||++.. .+++.+|+|.+...... ..++.+|+.+++++ +||||++++++|. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 455677888999999999999986 46889999988654322 24677899999999 6999999999884 3
Q ss_pred CCeEEEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------- 438 (572)
++..++||||+++|+|.++++... ....+++.....++.++++|+.|||. |.+|..+......
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 456899999999999998876422 22357888888899999999999984 4444433221110
Q ss_pred -------CCccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc-
Q 038466 439 -------SNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD- 505 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~- 505 (572)
.......|++.|+|||++.. ..++.++||||+||++|||+||+.|+....... .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------~~~~~~~~ 244 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------ALFKIPRN 244 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------HHhhcccc
Confidence 01123458899999998753 447889999999999999999999985332110 0011100
Q ss_pred --cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 506 --QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 506 --~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+....+. .... .+..++.+||+.||++|||+++|+++++
T Consensus 245 ~~~~~~~~~--~~~~---~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 245 PPPTLHQPE--LWSN---EFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred CCCcccCCC--CcCH---HHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 1111110 0001 1345667899999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=232.02 Aligned_cols=230 Identities=19% Similarity=0.287 Sum_probs=167.7
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||++.. .+++.+|+|.+....... ...+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 45567889999999999985 468899999987543322 2346889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++.... ...+++.....++.++++|++|||. |.+|..+..+.+. ....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999997643 2347888889999999999999984 3333322211100 0111
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|+..|+|||+..+..++.++||||||+++|||++|+.|++... ..............+ ....... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~---~ 228 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSGTFAP-ISDRYSP---D 228 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhcCCCC-CCCCcCH---H
Confidence 2457889999999988889999999999999999999999985321 111111111111111 1001111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..+...||+.+|++|||+++++++.+
T Consensus 229 l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 229 LRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 235566899999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=252.26 Aligned_cols=178 Identities=22% Similarity=0.344 Sum_probs=145.0
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++....+|.|+||.||+++.. +++.||||+++..........+.+.+|++++.+++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4667788999999999999864 689999999975443333445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------------- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------------- 439 (572)
|+++|+|.+++.+.. .++......++.+++.|++||| +|++|..+..+.+..
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999987543 4677788889999999999997 455554432211000
Q ss_pred ---------------------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 ---------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ---------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 00124699999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.32 Aligned_cols=232 Identities=21% Similarity=0.304 Sum_probs=167.4
Q ss_pred ccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 380 (572)
+++.+.+|.|+||.||+++. .+|+.||+|++...... .....+.+..|++++.+++ ||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45667899999999999874 36899999998754322 2223457889999999994 999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------- 437 (572)
+||||+++|+|.+++.... .+++.....++.+++.|++|||. |++|..+..+.+
T Consensus 82 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999987543 47788888899999999999973 555544322111
Q ss_pred -CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCC
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVD 513 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~ 513 (572)
........||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .........+. ++..+...+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILKCDPPFPSFIG 235 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC---CCHHHHHHHHhcCCCCCCCCCC
Confidence 0011234689999999998765 4789999999999999999999998532110 00111111111 222222221
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
.. +..+..+|++.||++|| ++++++++.+..
T Consensus 236 -~~------~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 236 -PE------AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred -HH------HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 11 23455689999999999 788999887654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=232.43 Aligned_cols=223 Identities=28% Similarity=0.421 Sum_probs=166.8
Q ss_pred cccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.+|.|+||.||+|.... +..||+|.++...... ..+.+.+|++.+++++|+|++++++++.++...++||||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 57899999999998653 7899999998665433 34688999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCC------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------
Q 038466 388 RGSLFCNLHNNED------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------- 438 (572)
Q Consensus 388 ~GsL~~~l~~~~~------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------- 438 (572)
+|+|.+++..... ...+++.++..++.+++.|++|||. |++|..+..+...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999986421 2468999999999999999999985 4555443322110
Q ss_pred --CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCCh
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDR 514 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~ 514 (572)
.......+++.|+|||......++.++||||+|++++||++ |+.|++... .........+. ....+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-- 230 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLRKGYRLPKPE-- 230 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCc--
Confidence 00122346788999999988899999999999999999999 699986431 11111111111 111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
... ..+..++..||+.+|++|||+.++++++
T Consensus 231 ~~~---~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 231 YCP---DELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred cCC---hHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111 1234566789999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=245.40 Aligned_cols=233 Identities=22% Similarity=0.322 Sum_probs=164.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||.||+++. .+++.||+|++...........+.|.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 466778899999999999985 4689999999975443333445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C--CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S--SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~--~~ 440 (572)
|+++|+|.+++.... ..++......++.|++.|++|||. |.+|..+....+ . ..
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999997532 246777788899999999999984 455543322110 0 01
Q ss_pred ccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--c--CCCCC
Q 038466 441 RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--Q--RLPPP 511 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~--~l~~~ 511 (572)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+.. . .+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~ 232 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQFPPD 232 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCcccCCCc
Confidence 122458999999999863 4578899999999999999999999853211 000011111 1 11111
Q ss_pred C--ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 V--DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~--~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. ......+++. .+.|...++..||++++++++.+..
T Consensus 233 ~~~~~~~~~~li~----~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 233 VTDVSEEAKDLIR----RLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred cCCCCHHHHHHHH----HHccCcccccCCCCHHHHhcCCCCC
Confidence 0 0111222211 1235566666799999999998764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=237.19 Aligned_cols=233 Identities=21% Similarity=0.313 Sum_probs=169.3
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||.||+|+.. +++.+|+|.+...... ..++|.+|++++++++||||+++++++..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 44667788999999999999864 5899999998765432 2467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++|+|..++.+.. ..+++.....++.+++.|+.|||. |.+|..+...... ..
T Consensus 89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999988876533 247889999999999999999984 4455443221110 00
Q ss_pred ccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC-CCh
Q 038466 441 RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP-VDR 514 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~ 514 (572)
.....|++.|+|||++. ...++.++|||||||++|||+||+.|+..... ............+.. ...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCccCCCCc
Confidence 12235788999999874 34468899999999999999999999753211 111111111111110 001
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
... ..+..+...||+.+|++||++++|+++.+...
T Consensus 240 ~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 240 KWS---MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ccC---HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 110 12345667899999999999999999877543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=231.96 Aligned_cols=222 Identities=24% Similarity=0.321 Sum_probs=160.2
Q ss_pred cccccCeeEEEEEEcC--C--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQLP--N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~--~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.+|.|+||.||+|... + +..+|+|.+...... ...+++.+|++++++++|||||++++++. .+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 5789999999999743 2 368999999866543 23467899999999999999999999876 456899999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------C------c
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------N------R 441 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------~------~ 441 (572)
+|+|.+++.... .+++..+..++.+++.|++|||. |.+|..+....+.. . .
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999998643 57899999999999999999974 45554432211100 0 0
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....++..|+|||......++.++|||||||++|||++ |+.||+.... . .....+....+.+......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~~~~--- 224 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------A-EVIAMLESGERLPRPEECP--- 224 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------H-HHHHHHHcCCcCCCCCCCC---
Confidence 01113457999999988899999999999999999998 9999864321 0 0111111111111111110
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+.+++.+||+.+|++||++.+|.+.+..
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 123456779999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=232.88 Aligned_cols=227 Identities=19% Similarity=0.284 Sum_probs=165.5
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++.+.+|.|+||.||+++.. ++..+|+|.++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 455678999999999999854 6899999998644322 2246788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++.... ...++......++.++++|+.|||. |.+|..+...... ....
T Consensus 80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999998886532 2346778888999999999999984 4455433221110 0011
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|++.|+|||+..+..++.++||||||+++|||++|+.||+... ..............+ .+..... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~---~ 227 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQGSYKP-LPSHYSY---E 227 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhcCCCCC-CCcccCH---H
Confidence 2457888999999988889999999999999999999999986321 111111111111111 1111111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQE 547 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~ 547 (572)
+..+..+||+.||++||++.+|+..
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2355668999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=236.93 Aligned_cols=237 Identities=22% Similarity=0.276 Sum_probs=171.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++....+|.|+||.||++... +++.+|+|.+...... ...+++.+|++++++++||||+++++++..++..++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4556678999999999999865 6899999998765433 234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC------------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS------------------------N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~------------------------~ 440 (572)
|+++++|.+++.... ..++......++.++++|++|||.. ..++|.+.+.. .
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999987643 3577788888999999999999962 12232211100 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|+..|+|||+..+..++.++||||||++++||++|+.|+........ .............. +....... .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~--~ 230 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQYIVNEPP-PRLPSGKF--S 230 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHHHhcCCC-CCCChhhc--C
Confidence 0114578899999999888999999999999999999999999853311000 00001111111111 11111101 1
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+..+...||..||++|||+.+++.+.+..+.
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 113456668999999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=239.00 Aligned_cols=241 Identities=21% Similarity=0.302 Sum_probs=174.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+++.+.+|.|+||.||+|.. .++..||+|.+....... .+.+.+|+.++++++|||+++++++|..++..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH---HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4566677899999999999975 468899999986543222 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++.+. .+++.++..++.+++.|++|||. |.+|..+..... ...
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999988743 36788889999999999999984 333332211100 011
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|++.|+|||+.....++.++|||||||++||+++|+.||....... ..........+.........
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-- 242 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPELQNPEKLS-- 242 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heeehhcCCCCCCCCccccC--
Confidence 122357888999999988889999999999999999999999986332100 00001000001000001011
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccccc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAA 561 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~~~ 561 (572)
.....+...||+.+|++||++.+++.+.+.....+..+.+.
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~ 283 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP 283 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence 11235666899999999999999999988877776665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=260.04 Aligned_cols=235 Identities=21% Similarity=0.238 Sum_probs=170.1
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK---- 377 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 377 (572)
..+.+.+...+|.|+||+||+|+. .+|+.||||++......+ .....+.+|+.++..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345677888999999999999984 579999999987543322 22467889999999999999999988775432
Q ss_pred ----eEEEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------
Q 038466 378 ----CMFLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------- 437 (572)
Q Consensus 378 ----~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------- 437 (572)
..++||||+++|+|.++++... ....+++.....++.+++.||.||| +|++|.++..+..
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3689999999999999987532 2335788888889999999999997 4566654432111
Q ss_pred ----------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 438 ----------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 438 ----------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ............
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTLAGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhcCC
Confidence 001123468999999999999999999999999999999999999985321 111111111111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+ .+..... .+..+...||+.||++||++.+++++.+
T Consensus 262 ~~~-~~~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 262 YDP-LPPSISP---EMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred CCC-CCCCCCH---HHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 111 1111111 1235666899999999999999998754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=232.84 Aligned_cols=225 Identities=20% Similarity=0.269 Sum_probs=157.5
Q ss_pred cccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEEEEEecc
Q 038466 312 IWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIYEYM 386 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 386 (572)
.+|.|+||.||+|... ++..+|+|++...... ...+.|.+|+.+++.++||||++++++|.. ++..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 5789999999999753 2467999998643221 224678899999999999999999998864 55688999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------------
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------------- 439 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------------- 439 (572)
++|+|.+++.... ..+.+...+.++.+++.|++|||. |.+|..+.......
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999997543 236777888899999999999984 45554432211100
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC-CCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......+++.|+|||+.....++.++|||||||++|||+|| .+|+.... ............. ++.+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~ 229 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGRR-LLQPEYCPD 229 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCCC-CCCCCcCCH
Confidence 00122346689999999888999999999999999999995 55553221 1111111111111 111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..++..||+.+|++||++.+|++++...
T Consensus 230 ---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 230 ---PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 234567789999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=246.34 Aligned_cols=222 Identities=23% Similarity=0.293 Sum_probs=159.6
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||+||+|+. .+|+.+|+|++...........+++..|.. +++.++||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 579999999999985 579999999997543322223345556654 577899999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|..++.... .+++.....++.++++|++|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9998886533 47788888899999999999984 444443322110 111223468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... .++.... .+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~-------~~~ 224 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHKPLVLRPGASL-------TAW 224 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcCCccCCCCCCH-------HHH
Confidence 999999999999999999999999999999999999985321 111111222221 1222211 123
Q ss_pred HHHHHccccCCCCCCCHH----HHHHHHhh
Q 038466 525 TISFACLQSNPKSRPTMQ----YVSQEFLI 550 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~----~V~~~l~~ 550 (572)
.+...|++.+|++||++. +++.+.+.
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 225 SILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred HHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 455689999999999874 66665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=238.93 Aligned_cols=237 Identities=20% Similarity=0.298 Sum_probs=164.3
Q ss_pred CccccccccccCeeEEEEEEcC-----------------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCccc
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-----------------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~ 368 (572)
.+++.+.+|.|+||.||+++.. ++..+|+|++...... ...++|.+|++++++++|+||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcce
Confidence 4667788999999999998532 2457999999754322 22468899999999999999999
Q ss_pred EEEEEEeCCeEEEEEecccCCChhhhhhcCCC--------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee
Q 038466 369 LYGFCLHRKCMFLIYEYMKRGSLFCNLHNNED--------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST 434 (572)
Q Consensus 369 l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~ 434 (572)
+++++..++..++||||+++|+|.+++..... ...+++.+...++.++++|++|||. |++|..+..
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 99999999999999999999999999876321 1247788899999999999999974 455554332
Q ss_pred CCCC--------CC-----------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc--CCCCCCccccccCC
Q 038466 435 CPDS--------SN-----------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSLSSS 493 (572)
Q Consensus 435 ~~~~--------~~-----------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt--G~~P~~~~~~~~~~ 493 (572)
.... .. .....+++.|+|||+...+.++.++|||||||++|||+| |..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 1100 00 001123567999999888889999999999999999998 67777432110000
Q ss_pred CCcchhhhhhcc-cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 494 SDPKIMLIDVLD-QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 494 ~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
............ ...+.+. ... ..+.+++..||+.||++||+|.+|.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 244 ENTGEFFRDQGRQVYLPKPA--LCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHhhccccccCCCCC--CCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000000000000 0111111 000 12345777999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.21 Aligned_cols=235 Identities=22% Similarity=0.287 Sum_probs=166.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++...+|.|+||.||+++.. +++.+|+|.+...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 346777889999999999999864 5899999998754333323345688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++... .++......++.+++.|++||| +|++|..+..+...
T Consensus 122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999988643 3566777789999999999997 45666544321110
Q ss_pred CCccccccccCccccccccCC----CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPV 512 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~----~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~ 512 (572)
.......||++|+|||++... .++.++||||+||++|||+||+.||..... ......+.+.. +..+.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcccCCCC
Confidence 011235699999999998653 378999999999999999999999853211 11112222211 11111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCC--CCCCHHHHHHHHhhcc
Q 038466 513 DRKVIRDILLASTISFACLQSNPK--SRPTMQYVSQEFLITR 552 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~--~RPsm~~V~~~l~~~~ 552 (572)
....... +..+...|++.+|. .||+++++++|.+...
T Consensus 271 ~~~~s~~---~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 271 DVEISKH---AKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cccCCHH---HHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 1111111 12334467765544 3899999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-27 Score=234.33 Aligned_cols=230 Identities=25% Similarity=0.388 Sum_probs=169.2
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|.. .+++.||+|........ ...+.|.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45567789999999999985 46899999998754432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++|+|.+++... .+++.....++.+++.|+.|||+ |.+|..+...... ....
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999988642 47888899999999999999985 3333332221110 0111
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...|+..|+|||+......+.++|||||||++|||++|+.|+..... .. ....+....++........ .
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~---~ 228 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MK-VLFLIPKNNPPTLEGNYSK---P 228 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HH-HHHHHhcCCCCCCCcccCH---H
Confidence 23578899999999888899999999999999999999999853211 10 1111111111111111111 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.+++..||+.+|++||++++++++.+..+.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 2356668999999999999999999776654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=245.65 Aligned_cols=179 Identities=26% Similarity=0.344 Sum_probs=143.0
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+.+.+|.|+||.||+++.. +++.+|+|.+...........+.|.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4567788999999999999865 578999999875443333334568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~~ 440 (572)
|+++|+|.+++++... .+++.....++.+++.|+.||| +|++|..+..+.+. ..
T Consensus 82 y~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999975322 4778888889999999999997 45666544321110 01
Q ss_pred ccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 12346899999999985 34688999999999999999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=231.53 Aligned_cols=230 Identities=23% Similarity=0.319 Sum_probs=167.0
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 384 (572)
+++.+.+|.|+||.||++... +++.+|+|++....... ...+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 456678899999999999854 57899999987543222 224578899999999999999999998764 446899999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++|+|.+++.... ...+++.+...++.+++.|++|||+ |.+|..+..... ....
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999997632 2347899999999999999999984 444443322110 0011
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|++.|+|||+..+..++.++||||||++++||++|+.|++... ............++. .......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~--- 228 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRIIEGKLPP-MPKDYSP--- 228 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCCC-CccccCH---
Confidence 22457889999999999999999999999999999999999985321 111111111222211 1111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+++..|++.+|++||++.+++++.|
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 2345677999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=240.87 Aligned_cols=233 Identities=22% Similarity=0.301 Sum_probs=168.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++.+..+|.|+||.||++.. .++..||||++...... ..+.+.+|+.++++++||||+++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 345567789999999999985 46899999998754432 23578899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++++|.+++... .+++.....++.+++.|++|||+ |++|..+..+.+ ....
T Consensus 100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999988542 37888899999999999999974 444443322111 0111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|+..|+|||+..+..++.++|||||||++|||++|+.|+....... ..........+..+... ....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~--~~~~--- 246 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRRIRDNLPPRVKDSH--KVSS--- 246 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCcccccc--ccCH---
Confidence 22457889999999988889999999999999999999999985321100 00001111112111110 0001
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+..+...||+.||++|||+++++++.+.....
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 123455589999999999999999987665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=230.25 Aligned_cols=223 Identities=22% Similarity=0.356 Sum_probs=164.0
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
.+|.|+||.||++...+++.||+|.+...... ...+.|.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 57899999999999777999999998765443 2346799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------------Ccccccc
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------------NRTLLAG 446 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------------~~~~~~g 446 (572)
.+++..... .+++.....++.+++.|+.|||+ |.+|..+..+.+.. ......+
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999975432 47888889999999999999984 45555433221100 0001123
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 525 (572)
+..|+|||++.+..++.++|||||||++|||+| |..|+..... ....+.+......+.+.... ..+.+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~---~~~~~ 226 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQLCP---EEIYR 226 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCccCC---HHHHH
Confidence 456999999988889999999999999999999 8888743211 01111111111111111111 12345
Q ss_pred HHHHccccCCCCCCCHHHHHHHHh
Q 038466 526 ISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 526 i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
++.+|++.+|++|||+++|++.|.
T Consensus 227 li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhccChhhCcCHHHHHHHhh
Confidence 777999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=233.10 Aligned_cols=233 Identities=22% Similarity=0.328 Sum_probs=164.9
Q ss_pred ccccccccccCeeEEEEEEcCC--CcEEEEEecCCcch-------HHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeC
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPN--GKVFALKKLHTSET-------EELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHR 376 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~--g~~vAvK~l~~~~~-------~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~ 376 (572)
+++...+|.|+||.||+|.... ++.+|+|.+..... ......+++.+|++++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4456678999999999998754 78999998863321 122334677889998875 7999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC-----------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD----------- 437 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~----------- 437 (572)
+..++||||+++++|.+++... .....+++..+..++.+++.|+.|||.. .+|..+....+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999887542 2233578888899999999999999952 22222111100
Q ss_pred -----CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 438 -----SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 438 -----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
........|+..|+|||+..+..++.++||||||+++|||++|+.|+.... .........+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLATKIVEAVYEPLP 234 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHHHHHhhccCCcCC
Confidence 001223458889999999998889999999999999999999999975321 11111111122111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...... .+..++.+||+.||++||++.||..++.
T Consensus 235 ~~~~~~---~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 235 EGMYSE---DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cccCCH---HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 101111 2345666899999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=238.69 Aligned_cols=232 Identities=21% Similarity=0.259 Sum_probs=167.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++.+.+|.|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4566778999999999999864 588999999876544333445678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------C----------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------S---------- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------~---------- 439 (572)
|+++|+|.+++.... .+++.....++.++++|+.|||+ |.+|..+...... .
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999997543 47888888899999999999984 3444433221100 0
Q ss_pred -------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 440 -------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 440 -------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
......|+..|+|||++....++.++|+|||||++|||+||+.||.... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-------~~~~~~~~~~~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-------PEELFGQVISD 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhc
Confidence 0011346788999999988889999999999999999999999984211 11111111111
Q ss_pred CCCCCCCh-HHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhh
Q 038466 507 RLPPPVDR-KVIRDILLASTISFACLQSNPKSRPT---MQYVSQEFLI 550 (572)
Q Consensus 507 ~l~~~~~~-~~~~~~~~~~~i~~~Cl~~dP~~RPs---m~~V~~~l~~ 550 (572)
....+... .... .+..++.+||+.||++||+ +.+++++.+.
T Consensus 232 ~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 232 DIEWPEGDEALPA---DAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred ccCCCCccccCCH---HHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 11111110 0011 1245667999999999998 5677776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=234.74 Aligned_cols=225 Identities=24% Similarity=0.302 Sum_probs=153.1
Q ss_pred cccccCeeEEEEEEcCC---CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~---g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||+||+|...+ ...+|+|.+....... ....|.+|+++++.++||||++++|+|.+.+..++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD--EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChH--HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 47899999999997543 4578999876543222 235788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC--cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------------------Cc
Q 038466 389 GSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------------NR 441 (572)
Q Consensus 389 GsL~~~l~~~~~--~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------------~~ 441 (572)
|+|.+++..... ....++.....++.++++|++|||+ |.+|..+..+.+.. ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999976432 1234677778899999999999984 45554332211100 00
Q ss_pred cccccccCccccccccC-------CCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh---cccCCCC
Q 038466 442 TLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV---LDQRLPP 510 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-------~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~---~~~~l~~ 510 (572)
....+++.|+|||+... ..++.++|||||||++|||++ |..||..... .. ..... .+..++.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQ-VLKQVVREQDIKLPK 232 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HH-HHHHHhhccCccCCC
Confidence 11234567999998642 356889999999999999999 7888753211 00 01111 1112222
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
+........ ....+...|| .||++|||+++|.+.+
T Consensus 233 ~~~~~~~~~--~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQLDLKYSD--RWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CcccccCCH--HHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111100100 1123445688 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=232.87 Aligned_cols=229 Identities=22% Similarity=0.285 Sum_probs=160.6
Q ss_pred ccccccccCeeEEEEEEcCC-Cc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CeE
Q 038466 309 VFSIWNYDGYGSVYKAQLPN-GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KCM 379 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~-g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 379 (572)
+.+.+|.|+||.||+|+..+ +. .+|+|.++...... ...+.|.+|++++++++||||++++++|... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999998654 33 58999887543222 2346889999999999999999999988542 246
Q ss_pred EEEEecccCCChhhhhhcCC---CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------ 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------ 438 (572)
+++|||+++|+|.+++.... ....++|.....++.+++.|++|||. |.+|..+......
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 89999999999988874321 22347899899999999999999984 4455443221100
Q ss_pred --CC-----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCC
Q 038466 439 --SN-----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510 (572)
Q Consensus 439 --~~-----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~ 510 (572)
.. .....+++.|+|||+.....++.++||||||+++|||++ |+.||..... ......+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 234 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQGNRLK 234 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCCC
Confidence 00 011234668999999998899999999999999999999 7888753211 11111111111111
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....... .+..++..||+.||++|||+.++++++.
T Consensus 235 -~~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 235 -QPPDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred -CCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111111 1346677999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=245.44 Aligned_cols=178 Identities=24% Similarity=0.341 Sum_probs=143.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+.+.+|.|+||.||+++.. +++.||+|.+...........+.|.+|..++..++|+||+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4667788999999999999864 688999999976443333345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~~ 440 (572)
|+++|+|.++++.... .+++.....++.+++.|++||| +|++|..+..+... ..
T Consensus 82 y~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 82 YYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999975322 4677788889999999999997 45565544321110 01
Q ss_pred ccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 441 RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.....||++|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 123468999999999865 467899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=233.43 Aligned_cols=233 Identities=23% Similarity=0.354 Sum_probs=168.2
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
.+++....+|.|+||.||+|+.. +.+.||+|.+...... ...+.|.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 34666778999999999999853 3568999998765432 235689999999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCc------ccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDA------VELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------- 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~------~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------- 439 (572)
.++||||+++|+|.++++..... ..++|..+..++.+++.|++|||. |++|..+....+..
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 99999999999999999764421 258999999999999999999974 45555432211100
Q ss_pred -----------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccC
Q 038466 440 -----------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 440 -----------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
......++..|+|||.+.+...+.++||||||+++|||++ |..|+..... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~~ 235 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAGK 235 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcCC
Confidence 0111235677999999988888999999999999999998 7888743211 11111111111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...+....... .+..++.+||+.+|++||++.++++++.
T Consensus 236 ~~~~~~~~~~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVPEGCPS---RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCCCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111000001 2345667899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=238.76 Aligned_cols=177 Identities=21% Similarity=0.257 Sum_probs=137.1
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+.+.+|.|+||.||+|+.. +|+.||||++......+ ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 345567899999999999864 68999999987543221 1235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
++ |+|.+++........+++.....++.++++||.|||. |.+|..+....+. ....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 6888888754443468888999999999999999985 3333322211110 0011
Q ss_pred ccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 443 LLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
...+++.|+|||++.+ ..++.++|||||||+++||+||+.|+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2246789999998765 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=239.11 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=164.5
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++....+|.|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3556678999999999999975 58999999987543322 234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++++|..+..... .++|.+...++.++++|++|||+. .+|..+..+.+ ....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999999987765432 378999999999999999999853 33332221110 0111
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcch-hh---hhhcccC
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-ML---IDVLDQR 507 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~-~~---~~~~~~~ 507 (572)
....|+..|+|||+..+ ..++.++|||||||++|||+||++|+....... ....... .. ....+..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 12347889999998865 457889999999999999999999875321100 0000000 00 0000000
Q ss_pred -CCCCCChHHH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 -LPPPVDRKVI-----RDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 -l~~~~~~~~~-----~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+........ .-...+..++..||+.+|++||++++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 0000000000 00112446777999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=233.76 Aligned_cols=232 Identities=20% Similarity=0.340 Sum_probs=167.0
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcc---hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSE---TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~---~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+....+|.|+||.||+|.. .+++.||+|.+.... .......+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3456789999999999985 578999999987433 122234578999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------- 438 (572)
||+++|+|.+++.+.. .+++.....++.+++.|+.|||. +++|..+..+...
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999987543 47888889999999999999984 3444332221110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
.......||..|+|||+..+..++.++||||+|++++||++|+.|+..... ................+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCCCCchh
Confidence 001123578899999999888899999999999999999999999853211 0001111111111111111111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... .+..+...|++.+|++||++.+++++.+
T Consensus 236 ~~~---~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 236 LSP---GLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred hCH---HHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 111 2234667899999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=233.34 Aligned_cols=228 Identities=25% Similarity=0.380 Sum_probs=165.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
.+++...+|.|+||.||+|... +|. .+|+|.+...... ....++.+|++++++++||||++++|+|.. +..+
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4566678999999999999854 333 6899988765432 234678899999999999999999999987 7889
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.++++.... .+++.....++.++++|++|||. |.+|..+....+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999976433 47899999999999999999984 34444332211100
Q ss_pred -Cc---cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc--CCCCCC
Q 038466 440 -NR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 512 (572)
Q Consensus 440 -~~---~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~ 512 (572)
.. ....++..|+|||+.....++.++||||||+++||++| |+.|++.... . ...+.+.. ..+.+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------V-EIPDLLEKGERLPQPP 234 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------H-HHHHHHhCCCCCCCCC
Confidence 00 00112467999999988889999999999999999998 9999863211 1 11111111 111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
... ..+..++..||..+|.+||++.++++.+...
T Consensus 235 ~~~-----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 235 ICT-----IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC-----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 101 1234556689999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=255.49 Aligned_cols=230 Identities=22% Similarity=0.317 Sum_probs=172.8
Q ss_pred CccccccccccCeeEEEEEEcCCC-cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEE-EEEe---C---
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYG-FCLH---R--- 376 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g-~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g-~~~~---~--- 376 (572)
...+.+++.+|||+.||.|+...+ ..+|+|++-..+. ...+...+|+++|++|+ |||||.+++ .... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667899999999999997655 9999999976643 33578889999999998 999999999 3322 1
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCCccc-------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTL------------- 443 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~~~~------------- 443 (572)
-+++|.||||++|+|-+++..+... .|+..+.++|+.++++|+++||. ++|+++|++.+..+..+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 3688999999999999999865443 38899999999999999999994 67778877654332111
Q ss_pred ----------------------cccccCccccccc---cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcch
Q 038466 444 ----------------------LAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI 498 (572)
Q Consensus 444 ----------------------~~gt~~y~APE~~---~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~ 498 (572)
..-|+.|.|||.+ .+..+++|+|||++||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 1247899999975 467799999999999999999999999974311
Q ss_pred hhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 499 MLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
..+++....-|..+.-... +..++..||+.||++||++-+|+.+++.....
T Consensus 264 --laIlng~Y~~P~~p~ys~~---l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDR---LKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --eeEEeccccCCCCccHHHH---HHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1222322221111111121 23455589999999999999999998776544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=233.12 Aligned_cols=231 Identities=24% Similarity=0.398 Sum_probs=166.5
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCeEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 382 (572)
++....+|.|+||.||+|.. .+++.||+|.++...... ..+++.+|++++++++ |||++++++++..++..++|
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 44556789999999999985 578999999987543221 2457889999999997 99999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~ 439 (572)
|||+++++|.++++.. .+++.....++.+++.|+.|||. +.+|..+..... ..
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999988643 57888899999999999999985 333332221110 01
Q ss_pred CccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......|+..|+|||+..++ .++.++|||||||++|||++|+.|++...... . ........++......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~-~~~~~~~~~~~~~~~~-- 226 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------A-MMLIPKSKPPRLEDNG-- 226 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------h-hhccccCCCCCCCccc--
Confidence 11223588899999988654 46899999999999999999999986432110 0 0011111111111100
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
....+.+++..||+.||++||++.+++.+.+..+.
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 01123456668999999999999999998877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=233.96 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=167.9
Q ss_pred ccccccccccCeeEEEEEEcC-----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCM 379 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 379 (572)
+...+.+|.|+||.||+|.+. ++..+|||.+...... ...+.|.+|++++++++||||+++++++.. +...
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 455677899999999999853 3789999999866543 234689999999999999999999999987 5578
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------- 439 (572)
++||||+++|+|.+++..... .++|..+..++.+++.|++|||. |.+|..+....+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999976432 48899999999999999999984 44444332211100
Q ss_pred --C----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCC----C---Ccchhhhhhccc
Q 038466 440 --N----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS----S---DPKIMLIDVLDQ 506 (572)
Q Consensus 440 --~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~----~---~~~~~~~~~~~~ 506 (572)
. .....++..|+|||+.....++.++||||||++++||+||+.|+......... . .......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 0 00112345699999998889999999999999999999999987532110000 0 000011111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
....+...... ..+..++.+||+.+|++||||.+|++++..
T Consensus 242 ~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 242 GERLPRPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred CCcCCCCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11111111111 124567779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=230.60 Aligned_cols=226 Identities=20% Similarity=0.329 Sum_probs=162.4
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEE-eCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-HRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E 384 (572)
++.+...+|.|+||.||+|... |..+|+|.+..... .+.|.+|+.++++++|+|+++++|++. .++..++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4566778999999999999765 67889999865432 357889999999999999999999865 4567899999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------Ccccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------NRTLL 444 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------~~~~~ 444 (572)
|+++|+|.++++.... ..++|.....++.+++.|++|||. |.+|..+..+.+.. .....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 159 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence 9999999999876432 347899999999999999999984 44444332211110 01112
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
.++..|+|||+.....++.++|||||||++|||++ |+.|+..... .. ....+....++........ .+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~---~~ 228 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KD-VVPRVEKGYKMDAPDGCPP---VV 228 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCCCCCCCCCCCH---HH
Confidence 34567999999988889999999999999999997 9999752210 00 0111111111110000001 22
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+..+||+.+|++|||++++.+.|.
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 35666899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=247.21 Aligned_cols=235 Identities=20% Similarity=0.273 Sum_probs=166.3
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++.+.+.+|.|+||.||+++.. +++.+|+|.+...........+.+.+|+++++.++||||+++++.+.+++..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 356778889999999999999864 6899999998754333333345688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++... .++......++.+++.|++||| +|++|..+....+.
T Consensus 122 ~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999988653 2566667778999999999997 45565544321110
Q ss_pred CCccccccccCccccccccCC----CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 512 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~----~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~ 512 (572)
.......||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+... .+..+.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCcccCCC
Confidence 011235699999999998653 378999999999999999999999853211 1111111111 111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhhcc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKS--RPTMQYVSQEFLITR 552 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~--RPsm~~V~~~l~~~~ 552 (572)
...... .+..+...|+..++.+ ||+++++.++.+...
T Consensus 271 ~~~~s~---~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 271 DNDISK---EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred cCCCCH---HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 111111 1233445788744433 789999999887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=234.80 Aligned_cols=235 Identities=22% Similarity=0.284 Sum_probs=165.5
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR---- 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~---- 376 (572)
..+++.+...+|.|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 456678888999999999999986 56899999998754322 24577899999999 899999999998754
Q ss_pred -CeEEEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------
Q 038466 377 -KCMFLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 377 -~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------- 438 (572)
+..++||||+++|+|.++++... ....+.+.....++.+++.|++|||. |++|..+....+.
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 35899999999999999886421 22357888999999999999999984 3333322211100
Q ss_pred -------CCccccccccCccccccccCC-----CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 439 -------SNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
.......|+..|+|||++... .++.++|||||||++|||++|+.|+..... .....+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~~~~~~~~~ 248 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFKIPRN 248 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HHHHHHHhcC
Confidence 011224578899999987543 368999999999999999999999853211 1111111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+........ ...+..++.+||+.+|++||++++++++.+.
T Consensus 249 ~~~~~~~~~~~--~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 249 PPPTLLHPEKW--CRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred CCCCCCccccc--CHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 11100000000 1123456779999999999999999988653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=230.81 Aligned_cols=230 Identities=20% Similarity=0.271 Sum_probs=161.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcc--hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 380 (572)
++.+...+|.|+||.||+|.. .+|..||||.+.... .......+.+.+|++++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 456677899999999999986 458999999886322 11223356888999999999999999999998764 4688
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.+++.... .+++.....++.+++.|++|||+ |++|..+....+.
T Consensus 83 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999999987542 36777788999999999999984 3444333221100
Q ss_pred ----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......|+..|+|||+..+..++.++|||||||++|||++|+.|+..... .............+..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPVLPP 232 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHHHHHhcCCCCCCCch
Confidence 011224578899999999888899999999999999999999999853211 111111111111111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.... .+..+...|+. +|++||++++|+++.+
T Consensus 233 ~~~~---~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 233 HVSD---HCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred hhCH---HHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 1111 12233446774 8999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=244.43 Aligned_cols=241 Identities=19% Similarity=0.184 Sum_probs=165.4
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----eEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 380 (572)
++..+.+|.|+||.||+|.. .+|+.||||++....... ...+++.+|+++++.++||||+++++++..++ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 45667899999999999985 579999999986542221 22467889999999999999999999998776 789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------- 437 (572)
+||||+. ++|.+.+... ..+++.....++.+++.|+.|||. |++|..+..+.+
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 5787777543 247888889999999999999974 555554322111
Q ss_pred -CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcch------hh
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI------ML 500 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~------~~ 500 (572)
........+|+.|+|||++.+. .++.++|||||||++|||++|+.||+...... ....... ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 0011223578899999998764 57999999999999999999999986332100 0000000 00
Q ss_pred h-hhcccCCCCCCChHHH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 I-DVLDQRLPPPVDRKVI----RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~-~~~~~~l~~~~~~~~~----~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. .+......++...... .....+.++..+|++.||++|||+++++++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0 0000000010000000 00112346777999999999999999999987654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=237.33 Aligned_cols=235 Identities=20% Similarity=0.315 Sum_probs=166.6
Q ss_pred CCccccccccccCeeEEEEEEcC--------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~--------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+.+.+.+|.|+||.||+|+.. ....+|+|.++..... ....++.+|+++++++ +||||++++++|.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 34566788999999999999631 2567999998754332 2246788999999999 69999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP 436 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~ 436 (572)
++..++||||+++|+|.+++..... ...++|.+.+.++.+++.|+.|||. |.+|..+....
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 9999999999999999999975321 2348899999999999999999984 45554433221
Q ss_pred CCC----C---------------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCc
Q 038466 437 DSS----N---------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 ~~~----~---------------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~ 496 (572)
+.. + .....++..|+|||++....++.++|||||||++|||++ |..|+.... .
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-------~ 242 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-------V 242 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-------H
Confidence 110 0 001123357999999988889999999999999999999 888875321 0
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. ..+.+.............. .+..++.+||+.+|++|||+.++++.+....
T Consensus 243 ~~-~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 EE-LFKLLREGHRMDKPSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH-HHHHHHcCCCCCCCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 10 1111111111000001011 1235667999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=234.52 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=170.4
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++..+.+|.|++|.||+|.. .+++.+|+|+++...... .+.+.+|+.++++++||||+++++++..++..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 345567899999999999985 568999999986543322 3568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++++|.+++.. ..+++.....++.+++.|++|||. +++|..+..+.+ ....
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999999998875 247888889999999999999984 444443322111 0011
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|++.|+|||+..+..++.++|||||||+++||++|+.|+.... +....... ....++..... .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~~~~-~~~~~~~~~~~-~~~~~ 243 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAMKRI-RDNLPPKLKNL-HKVSP 243 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHH-HhcCCCCCccc-ccCCH
Confidence 12358889999999988889999999999999999999999985321 11111111 11111100000 00001
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.+..++.+||+.+|++||++++++++.+.....+
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 2345666899999999999999999887765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=242.71 Aligned_cols=235 Identities=21% Similarity=0.261 Sum_probs=178.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 382 (572)
..+++...+|.|.||.||+++.+ +|+.+|+|.+.+.........+.+.+|+++|+++. |||||.+++.+.+.+..++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 44666789999999999999865 49999999998665433223467889999999999 99999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------------- 437 (572)
||++.||.|++.+... .++......++.++++++.|+|. |.+|..+.....
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999865 26777788899999999999974 555543322111
Q ss_pred -CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCCh
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDR 514 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~ 514 (572)
.......+||++|+|||++....|+..+||||.||++|.|++|.+||..... ......+..... ..+.-.
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHHHHHHHcCCCCCCCCCcc
Confidence 1123446799999999999999999999999999999999999999864321 111112222221 111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+ .+..+...++..||.+|+|..++++|+|....
T Consensus 264 ~is~---~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 DISE---SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCH---HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 1111 23345568999999999999999999987754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=236.98 Aligned_cols=237 Identities=23% Similarity=0.279 Sum_probs=167.7
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
....+|.|+||.||+|.. .+|+.||+|++...........+.+.+|++++++++|||++++++++.+++..|+||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 345689999999999985 4689999999875433333334678899999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-------------CCCcccccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------SSNRTLLAGTY 448 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------~~~~~~~~gt~ 448 (572)
|++.+.+.... ..++|.++..++.++++|+.|||. +.+|..+..... ........|+.
T Consensus 105 -~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 181 (313)
T cd06633 105 -GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP 181 (313)
T ss_pred -CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccc
Confidence 57777776432 247899999999999999999984 344433322110 01112345788
Q ss_pred Ccccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHH
Q 038466 449 GYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 449 ~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 525 (572)
.|+|||++. ...++.++|||||||++|||++|+.|+...... ...........+......... ....
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~---~l~~ 251 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNEWTD---SFRG 251 (313)
T ss_pred cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccccCH---HHHH
Confidence 999999974 456889999999999999999999997532110 001111111111100000001 1234
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhhccCCCccc
Q 038466 526 ISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK 558 (572)
Q Consensus 526 i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~ 558 (572)
+...||+.+|++||++.+++++.+....++...
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~ 284 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDRPARV 284 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence 566899999999999999999988776654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=251.83 Aligned_cols=244 Identities=18% Similarity=0.228 Sum_probs=166.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC------CcccEEEEEEeC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR------NIVKLYGFCLHR 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~~ 376 (572)
.+.+.+...+|.|+||+||+|.. .+++.||||+++..... .+++..|++++.+++|. +++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 35577788999999999999985 46889999999643221 23456677777777654 588899988764
Q ss_pred -CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCCC----------
Q 038466 377 -KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 377 -~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~~---------- 438 (572)
...++|||++ +|+|.+++.+.. .+.+.....|+.|++.||+|||+ |++|..+......
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 5688999988 678888887542 47888889999999999999985 3344433221110
Q ss_pred --------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc------C
Q 038466 439 --------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------S 492 (572)
Q Consensus 439 --------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~------~ 492 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||+...... .
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred cCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 01123568999999999999999999999999999999999999996432100 0
Q ss_pred --CCCcchh--------hhhhccc--CCCCCCChHH------------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 493 --SSDPKIM--------LIDVLDQ--RLPPPVDRKV------------IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 493 --~~~~~~~--------~~~~~~~--~l~~~~~~~~------------~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
...+... ..+..+. .+.+...... ......+.++...||+.||++|||++|+++|.
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 0000000 0000000 0000000000 00012245677899999999999999999999
Q ss_pred hhccCCC
Q 038466 549 LITRKTP 555 (572)
Q Consensus 549 ~~~~~~~ 555 (572)
|.....+
T Consensus 440 ~~~~~~~ 446 (467)
T PTZ00284 440 YVLKYYP 446 (467)
T ss_pred cccccCC
Confidence 8877554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=229.49 Aligned_cols=234 Identities=25% Similarity=0.355 Sum_probs=171.5
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+|+.. +|+.||||++...... ...+.|.+|++.+.+++|+|++++++++..++..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4566778999999999999875 5999999998866432 234689999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-C------CCCCceeeCCC-----------------CCC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-D------CSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-~------~~~~i~~~~~~-----------------~~~ 440 (572)
|+++++|.+++... ..++...+..++.++++|++|||. . ..|..+..... ...
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999754 347888899999999999999997 2 22222111110 000
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH-HHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK-VIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~ 519 (572)
.....|+..|+|||......++.++||||||+++|||+||+.|+..... .........+.....+. .+.. ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~- 230 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPPS-LPAEEFSP- 230 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCCCCC-CCcccCCH-
Confidence 1123578899999999888999999999999999999999999864321 00011111111111111 1111 011
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+..+...|++.+|++||++.+++++.+...
T Consensus 231 --~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 231 --EFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred --HHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 2234556899999999999999999877643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=231.14 Aligned_cols=224 Identities=23% Similarity=0.359 Sum_probs=164.7
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcch------HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET------EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~------~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
+...+|.|+||.||+|.. .+++.+|+|.+..... ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 345789999999999985 4688999998864322 122345678999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------- 438 (572)
||||+++++|.+++.... .+++.....++.+++.|++|||. |++|..+......
T Consensus 84 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred EEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999999999997542 47788888999999999999984 3444332211100
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh---hcccCCC
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID---VLDQRLP 509 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~---~~~~~l~ 509 (572)
.......|+..|+|||++.+..++.++|||||||++|||+||+.||+..... ..... ...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 233 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGENASPEIP 233 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhccCCCcCC
Confidence 0011235788999999998888999999999999999999999998632210 11111 1112222
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...+ . .+..+..+||+.||++||++.+|+++.+
T Consensus 234 ~~~~----~---~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 234 SNIS----S---EAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred cccC----H---HHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 2111 1 1234556899999999999999988754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=230.00 Aligned_cols=228 Identities=22% Similarity=0.322 Sum_probs=166.3
Q ss_pred ccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||.||+|+.. +++.+|+|.+...........+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 478999999999865 5899999999765443333457899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccccccccC
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTLLAGTYG 449 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~~~gt~~ 449 (572)
.+++.+.. .+++..+..++.++++|++|||. +.+|..+..+.+ ........|+..
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99997643 37788888999999999999984 333332221110 001122457889
Q ss_pred ccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHH
Q 038466 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFA 529 (572)
Q Consensus 450 y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~ 529 (572)
|+|||+.....++.++|+||||+++|||++|+.|+..... .+......+.+.......+..... .+..+...
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~ 229 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNYIDK---AAKDLIKQ 229 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCcccCH---HHHHHHHH
Confidence 9999999888899999999999999999999999853321 111111222211111111111111 23456678
Q ss_pred ccccCCCCCCC-----HHHHHHHHhhc
Q 038466 530 CLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 530 Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
||+.+|++||+ ++|+.++.+..
T Consensus 230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 230 LLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HccCChhhCcCCcccCHHHHhcChhhh
Confidence 99999999999 88998887654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=233.65 Aligned_cols=228 Identities=23% Similarity=0.342 Sum_probs=170.0
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++.+...+|.|+||.||++... +++.+|+|.+...........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 3556678999999999999864 689999999876544333445778999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCcccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNRTLL 444 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~~~~ 444 (572)
|+++|+|.+++.... .++...+..++.+++.|+.|||. +.+|..+..+.+. ......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 999999999987542 47888888999999999999984 3333332221110 111234
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILL 522 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~ 522 (572)
.|++.|+|||.......+.++||||||+++|||+||+.|+.... ............ ++...+ ..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~------ 224 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKILEGKVRFPSFFS-PD------ 224 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCccCCccCC-HH------
Confidence 58899999999988888999999999999999999999985321 111111222222 222221 11
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHHHHhh
Q 038466 523 ASTISFACLQSNPKSRP-----TMQYVSQEFLI 550 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~ 550 (572)
...+..+||+.||++|| +.++++++.+.
T Consensus 225 l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred HHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 23455689999999999 88888877654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=237.19 Aligned_cols=230 Identities=20% Similarity=0.307 Sum_probs=167.7
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++.+..+|.|+||.||+|.. .+++.||+|.+....... .+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 345566889999999999985 468999999986543322 3568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++|+|..++.. ..+++.....++.+++.|++|||. |++|..+..+.+ ....
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9999999887754 247888999999999999999984 344433322110 0111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC-C-ChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP-V-DRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~-~~~~~~~ 519 (572)
....|+..|+|||++.+..++.++|||||||++|||++|+.|+..... ... ...+.....+. . ......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~~~~~~~~~~~~~~- 245 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQA-MKRLRDSPPPKLKNAHKISP- 245 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHhccCCCCccccCCCCH-
Confidence 234588999999999888899999999999999999999999853211 000 01111111000 0 000001
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.+|++||++++++++.+....
T Consensus 246 --~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 246 --VLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred --HHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 12345568999999999999999998766544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=231.64 Aligned_cols=233 Identities=23% Similarity=0.317 Sum_probs=165.6
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK---- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~---- 377 (572)
.+.+++.+.+|.|+||.||+|... +++.+|+|.+...... .++|.+|+++++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 456778889999999999999864 5889999998765432 25788999999999 6999999999997644
Q ss_pred --eEEEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------
Q 038466 378 --CMFLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------- 437 (572)
Q Consensus 378 --~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------- 437 (572)
..++||||+++++|.+++.... ....+++.....++.++++|+.|||. +..|..+....+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4899999999999998887532 12357888889999999999999984 333333222110
Q ss_pred ------CCCccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 438 ------SSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 438 ------~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
........|+..|+|||++.. ..++.++|||||||+++||+||+.|+..... ......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~ 233 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFKIPRN 233 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHHhhcc
Confidence 001122457889999998753 3478899999999999999999999853211 1111111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+........ ...+..+..+||..||++|||+++++++.|
T Consensus 234 ~~~~~~~~~~~--~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 234 PPPTLKSPENW--SKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred CCCCCCchhhc--CHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 11110001100 112345667899999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=229.29 Aligned_cols=223 Identities=22% Similarity=0.324 Sum_probs=163.8
Q ss_pred cccccccCeeEEEEEEcC-CCcEEEEEecCCcch--HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 310 FSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
.+.+|.|+||+||+|... +++.||+|.+..... ...+..+.+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 456899999999999875 789999999865331 11223467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------CCcccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------SNRTLL 444 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~~~~~~ 444 (572)
++++|.+++.... .+++.....++.++++|++|||. +.+|..+....+. ......
T Consensus 85 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 161 (258)
T cd06632 85 PGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161 (258)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccccc
Confidence 9999999987542 47888888999999999999984 3333332211100 011234
Q ss_pred ccccCccccccccCCC-cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc----cCCCCCCChHHHHH
Q 038466 445 AGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD----QRLPPPVDRKVIRD 519 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~~~~~~~~~~~ 519 (572)
.|+..|+|||...... ++.++|+|||||++|||++|+.|++.... ......... +..++..+ .
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~-~---- 229 (258)
T cd06632 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDHLS-D---- 229 (258)
T ss_pred CCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCcCCCcC-H----
Confidence 5788999999987766 89999999999999999999999854321 000111111 11111111 1
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..+..+||+.+|++||++++++.+.+
T Consensus 230 --~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 230 --EAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred --HHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 1234556899999999999999988754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=231.31 Aligned_cols=228 Identities=18% Similarity=0.221 Sum_probs=152.8
Q ss_pred cccccCeeEEEEEEcCC---CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~---g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||.||+|+..+ ...+++|.+....... ..+.|.+|+++++.++||||++++|+|.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK--EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH--HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 47899999999997543 3456777776543322 246899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC-cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------------CCcc
Q 038466 389 GSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------------SNRT 442 (572)
Q Consensus 389 GsL~~~l~~~~~-~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------------~~~~ 442 (572)
|+|.+++++... ....++.....++.++++|++|||. |++|..+..+.+. ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 999999986432 2345666677899999999999984 4555443221100 0011
Q ss_pred ccccccCccccccccC-------CCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCC-cchhhhhhcccCCCCCCC
Q 038466 443 LLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD-PKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-------~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~ 513 (572)
...|+..|+|||+... ..++.++|||||||++|||++ |+.|++.......... .........++.++.+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 2346788999998753 245789999999999999997 5667743211000000 000001112222222221
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
. . ...+...|| .+|++||++++|++.+.
T Consensus 240 ~-~------~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 240 E-R------WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred H-H------HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 1 123445799 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=234.76 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=164.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++....+|.|+||.||+|+.. +|+.||+|++....... ...+.+.+|++++++++|||++++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3566678899999999999865 58999999986443211 123567899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~ 441 (572)
|+++++|..++... ..++|..+..++.++++|+.|||. |.+|..+..+... ...
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99999888776543 247899999999999999999985 3444333221110 001
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC---------CCCcc-hhhh---hhcc-c
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK-IMLI---DVLD-Q 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~---------~~~~~-~~~~---~~~~-~ 506 (572)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+. .... .... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 12346788999999865 5688999999999999999999999853221000 00000 0000 0000 0
Q ss_pred CCCCCCChHHHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 RLPPPVDRKVIRD-----ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 ~l~~~~~~~~~~~-----~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.+........ ...+.++...||+.+|++||++.+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0111100000000 112346777999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=244.04 Aligned_cols=223 Identities=21% Similarity=0.279 Sum_probs=159.9
Q ss_pred ccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 313 WNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
+|.|+||+||+|+. .+|+.||||++.............+..|..++.+. +||||+++++++.+++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 58899999999985 46899999999754333222334566777777766 699999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCccccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNRTLLA 445 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~~~~~ 445 (572)
|+|.+++.... .+++.....++.|++.|++||| +|++|..+..+.. ........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998887533 4778888889999999999997 4555544322110 01112346
Q ss_pred cccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHH
Q 038466 446 GTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILL 522 (572)
Q Consensus 446 gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~ 522 (572)
||+.|+|||++.+. .++.++||||+||++|||+||+.||.... .......+.. ..++.......
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~------ 224 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAFGKVRFPKNVLSDE------ 224 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCccCCHH------
Confidence 89999999998754 48999999999999999999999985321 1111111111 12222111111
Q ss_pred HHHHHHHccccCCCCCC----CHHHHHHHHhhc
Q 038466 523 ASTISFACLQSNPKSRP----TMQYVSQEFLIT 551 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RP----sm~~V~~~l~~~ 551 (572)
...+...||+.||++|| ++.+++++.+..
T Consensus 225 ~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred HHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 23455689999999998 688888877654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=254.14 Aligned_cols=223 Identities=24% Similarity=0.366 Sum_probs=163.0
Q ss_pred ccccccCeeEEEEEEc-CCC----cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQL-PNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~-~~g----~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++|.|+||+||||.+ +.| .+||||++......+ ..++|..|+-.|++++|||+++++|+|.... +.||++|
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 5789999999999975 544 479999997655433 2368999999999999999999999998877 8899999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-----------------CCCCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-----------------PDSSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-----------------~~~~~~~ 442 (572)
||.|+|.++++.+++. +.-...+.+..|||+||.||| +|.....+... .+.....
T Consensus 779 mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred cccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999986653 455667889999999999996 34333222110 0000111
Q ss_pred c--cccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHH
Q 038466 443 L--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVI 517 (572)
Q Consensus 443 ~--~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~ 517 (572)
. ..-.+.|||=|.+....|+.++|||||||++||++| |..|++.+.. ..+.+.+ ..+++.|...
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsqPpiC--- 925 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQPPIC--- 925 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCCCCCc---
Confidence 1 112356999999999999999999999999999997 9999875421 1122222 2234433211
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+.+-.++++||..|++.||++++...++...
T Consensus 926 --tiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 926 --TIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred --cHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 11223456789999999999999999888543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=240.10 Aligned_cols=221 Identities=22% Similarity=0.293 Sum_probs=156.1
Q ss_pred cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHH-HHHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEA-QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|+.. +++.||+|++...........+.+..|. .+++.++||||+++++++.+++..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5799999999999864 6789999999754332222223444444 4578899999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLLAG 446 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~~g 446 (572)
+|.+++.... .+.......++.++++|++|||. |++|..+..+.+ ........|
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999887533 35566667789999999999974 555544322111 011223468
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLAS 524 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~ 524 (572)
|+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.... .++..+ .. +.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~-~~------~~ 224 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKPNIT-NS------AR 224 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCcCCCCCCC-HH------HH
Confidence 999999999999999999999999999999999999985321 111111122111 112121 11 23
Q ss_pred HHHHHccccCCCCCCCHH----HHHHHHh
Q 038466 525 TISFACLQSNPKSRPTMQ----YVSQEFL 549 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~----~V~~~l~ 549 (572)
++...|++.||++||+.. ++.++.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 455589999999999876 4554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=240.84 Aligned_cols=175 Identities=26% Similarity=0.250 Sum_probs=135.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------ 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 377 (572)
+.+.+.+.+|.|+||.||++.. .+|+.||||++....... ...+.+.+|+.++++++||||+++++++...+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4566778899999999999985 468999999997543222 22457889999999999999999999986543
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------- 437 (572)
..++||||+++ ++.+.++. .+++.....++.++++|+.|||+ |++|..+....+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 46555542 36777778899999999999974 455544332211
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 0011224578999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=230.14 Aligned_cols=229 Identities=23% Similarity=0.308 Sum_probs=163.2
Q ss_pred CccccccccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
++.+...+|.|+||.||+|...+ ...||||........ ...+.|.+|++++++++||||++++++|.+ +..++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35566789999999999998543 347899988755422 234678999999999999999999999875 45789
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------- 438 (572)
||||+++|+|.+++.... ..+++..+..++.++++|++|||. |.+|..+......
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999999999997543 247899999999999999999984 4444433221100
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChH
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRK 515 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~ 515 (572)
.......++..|+|||++....++.++|||||||+++|+++ |+.||..... .. ....+.. ...+.+. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~-~~~~~~~~~~~~~~~--~ 232 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------ND-VIGRIENGERLPMPP--N 232 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH------HH-HHHHHHcCCcCCCCC--C
Confidence 00011123467999999988889999999999999999996 9999853221 01 0111111 1111111 1
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
... .+..++.+|+..+|++|||+.+++..+...
T Consensus 233 ~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 233 CPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 234566689999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=233.35 Aligned_cols=232 Identities=22% Similarity=0.315 Sum_probs=162.9
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe-----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----- 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----- 375 (572)
..+.+++...+|.|+||.||+|.. .+++.+|+|.+...... ..++..|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 345567778899999999999986 56899999998654322 24677899999998 69999999999863
Q ss_pred -CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC-----------
Q 038466 376 -RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD----------- 437 (572)
Q Consensus 376 -~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~----------- 437 (572)
.+..+++|||+++|+|.+++..... ..+++.....++.++++|+.|||.. .+|..+.....
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 4578999999999999998875332 2467777888999999999999853 33332211110
Q ss_pred ------CCCccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 438 ------SSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 438 ------~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
........|++.|+|||++. ...++.++|||||||++|||+||+.|+...... .........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~ 241 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRN 241 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hhhhhHhhC
Confidence 01112345888999999875 346788999999999999999999998533210 001111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+......... .+.++...||+.||++||++.|++++.+
T Consensus 242 ~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 242 PPPKLKSKKWSK---KFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCCcccccCH---HHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 111100000011 2345666899999999999999988754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=234.35 Aligned_cols=237 Identities=21% Similarity=0.291 Sum_probs=165.2
Q ss_pred ccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCM 379 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 379 (572)
+...+.+|.|+||.||.++. .++..||+|.++...... ..+.|.+|++++++++|||++++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH--HHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45667899999999999973 357899999987553322 246799999999999999999999999875 568
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------- 439 (572)
++||||+++|+|.+++.... ..++|..+..++.+++.|++|||. |.+|..+....+..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 99999999999999986532 247999999999999999999974 45554433211100
Q ss_pred ------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc-c---cCCCCcc---hhhhhhccc
Q 038466 440 ------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-L---SSSSDPK---IMLIDVLDQ 506 (572)
Q Consensus 440 ------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~-~---~~~~~~~---~~~~~~~~~ 506 (572)
......|+..|+|||+..+..++.++|||||||++|||+|++.|...... . ....... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 00123356679999999888899999999999999999998876421100 0 0000000 000111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
....+..... ...+.+++..||+.+|++||++++|++.+..
T Consensus 242 ~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 242 GKRLPRPPNC---PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred CccCCCCCCC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111111111 1123467779999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=236.63 Aligned_cols=238 Identities=24% Similarity=0.316 Sum_probs=169.1
Q ss_pred CccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 382 (572)
.|+....+|+|.||.||||+ ..+|++||+|++......+ ++..-..+||.+|++++||||++|.+...+. ..+|||
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45666789999999999998 6789999999998665332 3455677899999999999999999998876 689999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------S 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~ 438 (572)
+|||++ ||.-.+.. ....++..+...++.|+.+||+|+| +|++..++..+.. .
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999997 67766654 2346888899999999999999986 5666655433211 1
Q ss_pred CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc---------cCCCCcchh------hhh
Q 038466 439 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL---------SSSSDPKIM------LID 502 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~---------~~~~~~~~~------~~~ 502 (572)
...+..+-|..|.|||.+.+ ..|+...|+||.||||.||++|++.+.....+ ...-.++.+ ...
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 11334456899999998776 57999999999999999999999987532211 000000000 001
Q ss_pred hcccCCCCCCChHHHHHH-----HHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 503 VLDQRLPPPVDRKVIRDI-----LLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 503 ~~~~~l~~~~~~~~~~~~-----~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+.+. .+. +..+.+. ..++.+.-..+..||++|.|+.++++.-+.
T Consensus 354 ~~kp~--~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 354 IFKPQ--QPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccCCC--Ccc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 11111 111 1112221 123456667889999999999999987665
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=249.14 Aligned_cols=239 Identities=18% Similarity=0.213 Sum_probs=160.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------- 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 376 (572)
..+.+...+|.|+||.||+|.. .+++.||||++..... ...+|+.++++++|||||++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4577788899999999999986 4689999998864321 234699999999999999999987532
Q ss_pred -CeEEEEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------
Q 038466 377 -KCMFLIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------- 438 (572)
Q Consensus 377 -~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------- 438 (572)
...++||||+++ ++.+++... .....+++.....++.+++.||+||| +|++|..+......
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 246799999985 676666432 22335788888889999999999997 46666544332111
Q ss_pred -------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcchhhhhh
Q 038466 439 -------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIMLIDV 503 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~~~~~~ 503 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||++||........ ...+.......
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 01122457899999998765 4689999999999999999999999853211000 00000000000
Q ss_pred ccc-----CCCCCCChHHHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 504 LDQ-----RLPPPVDRKVIR-----DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 504 ~~~-----~l~~~~~~~~~~-----~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+ ..+......... ....+..+...||+.||++|||+.|+++|.+..
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 000 011000000000 011245677799999999999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=232.10 Aligned_cols=233 Identities=18% Similarity=0.279 Sum_probs=180.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+++...+|.|.||+|-+|.. ..|++||||.++++...+...+-..++|+++|+.++||||+.+|.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3467778999999999999985 679999999999877666555678899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC----------------CCCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP----------------DSSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~----------------~~~~~ 441 (572)
||..+|.|++++.+.+ .|+......+..||..++.|+|. |.+-..+..+. +..-.
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999998754 47777778899999999999984 33332222211 11112
Q ss_pred cccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
++++|++-|.+||+..+..| ++..|-||+||+||-|+.|..|||..+ .+..+.++.......|..+....
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~GaYrEP~~PSdA~-- 280 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISRGAYREPETPSDAS-- 280 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhcccccCCCCCchHH--
Confidence 45789999999999988877 478999999999999999999998432 23333344443333332222222
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.++.+++-.+|++|.|+.+|..|.|....
T Consensus 281 ----gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 281 ----GLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred ----HHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 23346778999999999999999987654
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=246.24 Aligned_cols=168 Identities=19% Similarity=0.212 Sum_probs=135.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+...+|.|+||.||+|... +++.||||.... ..+.+|++++++++|+|||++++++..++..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 34667778999999999999865 588999996432 34568999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------C---
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------S--- 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------~--- 439 (572)
||+. |+|.+++.... ..++|.++..++.|+++||.|||+ |++|.++...... .
T Consensus 240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9995 78888886532 258999999999999999999974 4555443221100 0
Q ss_pred -CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 440 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 011246899999999999999999999999999999999988764
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=228.99 Aligned_cols=228 Identities=28% Similarity=0.385 Sum_probs=165.4
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
+....+|.|+||.||+|.. .+++.||+|.++..... ....+.+..|++++++++|+||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 4456789999999999985 46899999998866543 234578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC----------------CC----
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS----------------SN---- 440 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~----------------~~---- 440 (572)
++++|.++++... .+++..+..++.++++|+.|||.. .+|..+...... ..
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999987532 367888889999999999999853 333222111000 00
Q ss_pred -ccccccccCccccccccCCC---cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchh--hhhhcccCCCCCCCh
Q 038466 441 -RTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM--LIDVLDQRLPPPVDR 514 (572)
Q Consensus 441 -~~~~~gt~~y~APE~~~~~~---~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~ 514 (572)
.....++..|+|||++.... ++.++||||||++++||++|+.||..... ..... ......+.++...
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~-- 231 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGAGHKPPIPDSL-- 231 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhcCCCCCCCccc--
Confidence 01235778999999988766 88999999999999999999999853210 00000 0001111122111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.... ....+...||+.+|++||++.+++.+.|
T Consensus 232 ~~~~---~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 232 QLSP---EGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred ccCH---HHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0011 1234566899999999999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=237.81 Aligned_cols=234 Identities=21% Similarity=0.312 Sum_probs=166.9
Q ss_pred CccccccccccCeeEEEEEEcC--------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR 376 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~--------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 376 (572)
.+.+.+.+|.|+||.||+|+.. .+..||+|.++..... ...+++.+|+++++++ +||||++++++|.++
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3566778999999999999642 1347899988754322 2246789999999999 899999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD 437 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~ 437 (572)
+..+++|||+++|+|.+++.... ....+.|..++.++.++++|+.|||. |++|..+....+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999987532 12348899999999999999999984 455554432211
Q ss_pred CC-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcc
Q 038466 438 SS-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK 497 (572)
Q Consensus 438 ~~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~ 497 (572)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..|+.... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~ 243 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------VE 243 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------HH
Confidence 00 0011123457999999999999999999999999999998 888874321 01
Q ss_pred hhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 498 IMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 498 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. ....+......+....... .+..++..||+.+|++||++.++++++....
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 E-LFKLLKEGHRMDKPANCTH---ELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred H-HHHHHHcCCCCCCCCCCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1 1111111111111111111 2345667899999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=243.85 Aligned_cols=234 Identities=20% Similarity=0.298 Sum_probs=174.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+...+|.|+-|.|-.|+. .+|+.+|||.+...............+|+-+|+-+.|||++++|+.+.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4456778899999999999985 689999999998763322233456778999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~~ 441 (572)
||+++|.|++++..++. +...+..+...||..|+.|+| ||.+|.....+.+ +.-.
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999987653 555566667777777777775 6777764432211 1112
Q ss_pred cccccccCccccccccCCCcC-cccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIR 518 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s-~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~ 518 (572)
.+-+|++.|.|||++.+..|. .++||||+|||||-|+||+.|||+.. -...+..+-.. .+|.....+ .+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~MPs~Is~e-aQ 240 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFEMPSNISSE-AQ 240 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcccCCCcCCHH-HH
Confidence 345799999999999998874 78999999999999999999997321 01111222222 233322222 22
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.+..+++..||+.|-|++||++|+|....+.
T Consensus 241 ------dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 241 ------DLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ------HHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 3334688999999999999999999876653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.07 Aligned_cols=223 Identities=24% Similarity=0.342 Sum_probs=161.7
Q ss_pred cccccccCeeEEEEEEcC---CC--cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 310 FSIWNYDGYGSVYKAQLP---NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~---~g--~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
...+|.|-||.||+|.+. .| -.||||..+.....+. .+.|..|+-+|++++|||||+++|.|.+. ..|+|||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 357899999999999753 23 3689999987655443 47899999999999999999999999765 5899999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CC--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SS--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~--~ 440 (572)
.++-|.|..+|+.+.. .++......++.|++.+|+||| +|+...++..+.. .. .
T Consensus 471 L~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred cccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999987554 5777778889999999999985 5654443322110 00 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHH-cCCCCCCccccccCCCCcchhhhhh-cccCCCCCC-ChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDV-LDQRLPPPV-DRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ell-tG~~P~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~-~~~~~ 517 (572)
.+...-.+.|||||.+...+++.+||||-|||.+||++ .|..||..... ...+..+ -..++|.|. .+...
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-------sDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-------SDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-------cceEEEecCCCCCCCCCCCChHH
Confidence 11112245699999999999999999999999999998 59999863321 1111111 122343322 22222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
-.++.+||+.+|.+||.+.++...+..
T Consensus 622 ------YslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 622 ------YSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred ------HHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 245568999999999999998876643
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=234.23 Aligned_cols=230 Identities=23% Similarity=0.371 Sum_probs=164.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+++..+.+|.|+||.||+|.. .+|+ .||+|.+....... ...+|.+|+.++++++||||++++|+|..+ ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK--ANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3456677899999999999985 3444 57999887544322 234688999999999999999999999764 46
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------- 439 (572)
++++||+++|+|.+++.... ..+++.....++.++++|+.|||. |++|..+....+..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 79999999999999987543 247888889999999999999984 45554432211000
Q ss_pred -----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCCCC
Q 038466 440 -----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPP 511 (572)
Q Consensus 440 -----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~ 511 (572)
......++..|+|||++.+..++.++|||||||++|||+| |+.|+..... ....+.+. ...+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGERLPQP 233 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCC
Confidence 0011224668999999988889999999999999999997 8899753210 00111111 111111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. . ...+..++..||..+|++||+++++++.+....
T Consensus 234 ~~-~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 234 PI-C----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CC-C----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 10 0 012345667899999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=236.75 Aligned_cols=242 Identities=16% Similarity=0.172 Sum_probs=165.0
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+...+.+|.|+||.||+|+.. +++.||+|+++...... ....+.+|++++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4566778999999999999864 68899999987543222 12457789999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++ +|.+++.... ..+++.....++.+++.|++|||. |++|..+..... ....
T Consensus 85 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9985 8888776543 246788888899999999999984 445443322110 0011
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhh------hhccc
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLI------DVLDQ 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~------~~~~~ 506 (572)
....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ......... +..+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 12357889999998764 5689999999999999999999999853211000 000000000 00000
Q ss_pred CCCCCCChHHH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 507 RLPPPVDRKVI----RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 507 ~l~~~~~~~~~----~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..+........ .-.....++...|++.||++|||+.|++++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00000000000 00012345667899999999999999999988764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=226.22 Aligned_cols=238 Identities=22% Similarity=0.308 Sum_probs=167.1
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|+|+||+|||++.+ +|+.||||++..+..+ ....+--.+|+++|++++|+|+|.++.+|......+||+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 455678899999999999975 5999999999866542 22334556899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee--------CC---------CCCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST--------CP---------DSSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~--------~~---------~~~~~~ 442 (572)
|+.--|.+ |..... .++.....+++.|+++|+.|+| +|++|..+.. |. .+...+
T Consensus 83 ~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99754443 333222 3566667789999999999986 6777765432 11 112223
Q ss_pred ccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchhhhhhc-------c
Q 038466 443 LLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDVL-------D 505 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~~~~~~-------~ 505 (572)
-.+.|..|.|||.+.+ .+|+...|||+.||++.||+||.+-|...++.. ....+. ...++ .
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr--hq~iF~~N~~F~G 237 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR--HQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH--HHHHhccCCceee
Confidence 3457889999999877 689999999999999999999998653221110 000000 00111 1
Q ss_pred cCCCCCCChHHHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 506 QRLPPPVDRKVIRD-----ILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 506 ~~l~~~~~~~~~~~-----~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
-++|.+.+.+..+. ...+++++..|++.||++|++-+|++.|...
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 12333322222111 1234678889999999999999999987543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=229.52 Aligned_cols=228 Identities=23% Similarity=0.279 Sum_probs=163.4
Q ss_pred ccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||+||++.. .+|+.+|+|.+...........+.+.+|++++++++||||+++++.+...+..++||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 47899999999975 46899999998754433333345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCccccccccC
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTLLAGTYG 449 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~~~gt~~ 449 (572)
.+++..... ..+++.....++.+++.|+.|||. |.+|..+....+ ........|+..
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 999876442 357888899999999999999984 333333322111 011122356789
Q ss_pred ccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHHHHHHHHHH
Q 038466 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLASTIS 527 (572)
Q Consensus 450 y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~i~ 527 (572)
|+|||+..+..++.++|||||||+++||++|+.||...... ............ ...+...+ .. +..+.
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~------~~~li 229 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK---VEKEELKRRTLEMAVEYPDKFS-PE------AKDLC 229 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc---ccHHHHHhccccccccCCccCC-HH------HHHHH
Confidence 99999998888999999999999999999999998533210 000000001111 11111111 11 23455
Q ss_pred HHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 528 FACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 528 ~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
..||+.||++|| +..+++.+.+..
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHhChhhh
Confidence 689999999999 777788776553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=224.25 Aligned_cols=229 Identities=25% Similarity=0.353 Sum_probs=168.7
Q ss_pred cccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEEEEe
Q 038466 308 DVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYE 384 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 384 (572)
...+.+|.|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+.+. +..++|||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 44567899999999999865 6899999998765432 22357889999999999999999999999988 88999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC----------------CC---
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD----------------SS--- 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~----------------~~--- 439 (572)
|+++++|.+++.... .++|..+..++.++++|++|||+. ..|..+..... ..
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999999999987643 689999999999999999999853 23322211110 00
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
......++..|+|||.......+.++||||||++++||++|+.|++... ...............+..+.....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~- 231 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPEHLSE- 231 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCcccCH-
Confidence 0223457889999999988889999999999999999999999986432 011111111111111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....++.+|++.+|++||++.+++++.+
T Consensus 232 --~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 232 --EAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred --HHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 2345666899999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=232.71 Aligned_cols=229 Identities=22% Similarity=0.333 Sum_probs=167.6
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.+..+|.|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++++++|+|++++++++..++..++||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 346789999999999986 57899999998654332 23578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCcccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTLL 444 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~~ 444 (572)
+++|.+++... .+++.....++.+++.|++|||+ |.+|..+..+.+ .......
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99999887532 37888888999999999999985 333333222110 0011224
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKVIRDILL 522 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~ 522 (572)
.|+++|+|||+..+..++.++|||||||++|||++|+.|+..... ......+....++... ..... .
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~---~ 245 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPKLKNLHKVSP---S 245 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhCCcccCCcccCCH---H
Confidence 578899999999888899999999999999999999999742210 0011111111111100 00001 1
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
+..+..+||+.+|.+||++++++++.+..+..+
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 234556899999999999999999988776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=230.78 Aligned_cols=233 Identities=24% Similarity=0.328 Sum_probs=162.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++++.+.+|.|+||.||+|+.. +|+.||+|+++.....+. ..++..|+.. ++..+||||+++++++..++..++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4566778999999999999864 699999999876532221 1345556554 67789999999999999999999999
Q ss_pred ecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC----------------CC
Q 038466 384 EYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD----------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~----------------~~ 439 (572)
||++ |+|.+++... .....+++.....++.+++.|+.|||.. ++|..+..+.+ ..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 6887777642 2234588999999999999999999953 22322211110 00
Q ss_pred CccccccccCccccccccC----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc---cCCCCCC
Q 038466 440 NRTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPV 512 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 512 (572)
......|+..|+|||++.+ ..++.++|+||||+++|||++|+.|++.... .......... +..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~- 231 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEEPSPQLPAE- 231 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhcCCCCCCcc-
Confidence 1122457889999998764 4568999999999999999999999853211 0011111111 111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... .+..+...||+.+|++||++++|+++.+....
T Consensus 232 --~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 232 --KFSP---EFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --ccCH---HHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0011 12356668999999999999999998776654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=234.72 Aligned_cols=171 Identities=22% Similarity=0.298 Sum_probs=133.6
Q ss_pred cccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChh
Q 038466 314 NYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLF 392 (572)
Q Consensus 314 ~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 392 (572)
|+|+||+||+++. .+|+.||+|.+......+ ...+.+.+|+.+++.++||||++++++|..++..++||||+.+|++.
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~ 87 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHH
Confidence 4558999999986 479999999987554332 23478899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCc-------c
Q 038466 393 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNR-------T 442 (572)
Q Consensus 393 ~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~-------~ 442 (572)
+++..... ..+++.....++.+++.||+|||. |++|..+....+. ... .
T Consensus 88 ~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (328)
T cd08226 88 SLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166 (328)
T ss_pred HHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccc
Confidence 98876432 247888888999999999999974 4555443221110 000 0
Q ss_pred ccccccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 443 LLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
...++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11245679999998763 478999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=232.41 Aligned_cols=233 Identities=27% Similarity=0.380 Sum_probs=169.2
Q ss_pred cccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
++.+.+|.|+||+||+++.. +++.+|+|.+......... .....+|+.++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccccccccc
Confidence 34578999999999999865 5779999999877655433 234456999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNRTL 443 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~~~ 443 (572)
++|+|.+++.. ...+++..+..++.++++|+.|||+ |++|..+..+.+ ......
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999982 2347889999999999999999974 555554432211 111223
Q ss_pred cccccCcccccccc-CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 444 LAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 444 ~~gt~~y~APE~~~-~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
..+|..|+|||+.. ...++.++||||+|++++||++|+.|+...... ..................... ......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD----DQLEIIEKILKRPLPSSSQQS-REKSEE 232 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH----HHHHHHHHHHHTHHHHHTTSH-TTSHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccch----hhhhhhhhccccccccccccc-chhHHH
Confidence 45788999999998 888999999999999999999999998643100 000011111111110000000 000023
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..+...||+.||++||++.+++++.|
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 345667899999999999999998876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=226.71 Aligned_cols=225 Identities=21% Similarity=0.358 Sum_probs=161.9
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
.+.+.+.+|.|+||.||+|.. +++.||+|.++.... .+.|.+|+.++++++|||++++++++..+ ..++||||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 355667899999999999974 577899999865432 25788999999999999999999998765 47999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------Cccccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------NRTLLA 445 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------~~~~~~ 445 (572)
+++|+|.+++.... ...+++..+..++.++++|+.|||+ |.+|..+....... ......
T Consensus 80 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (254)
T cd05083 80 MSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158 (254)
T ss_pred CCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence 99999999997643 2357888999999999999999984 45554433221110 001122
Q ss_pred cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHH
Q 038466 446 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524 (572)
Q Consensus 446 gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 524 (572)
.+..|+|||++....++.++|||||||++|||++ |+.|+..... .. ..+.+......+....... .+.
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~---~~~ 227 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KE-VKECVEKGYRMEPPEGCPA---DVY 227 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HH-HHHHHhCCCCCCCCCcCCH---HHH
Confidence 3467999999988899999999999999999997 9999753211 00 1111111111111111111 223
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHh
Q 038466 525 TISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 525 ~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.++..||+.+|++||++++++..+.
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHc
Confidence 5667999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=233.16 Aligned_cols=245 Identities=22% Similarity=0.232 Sum_probs=167.4
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchH--HHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++..+.+|.|+||.||+|... +|+.||||++...... .....+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 344567899999999999864 6899999999765432 1223356778999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+ +|+|.+++.... ..+++.....++.++++|+.|||. |++|..+...... ..
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 999999997543 258899999999999999999974 3444433221110 00
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc-------CCCCc-chh------hhhhcc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSSDP-KIM------LIDVLD 505 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------~~~~~-~~~------~~~~~~ 505 (572)
.....+++.|+|||++.+ ..++.++|||||||+++||++|.+|+....... ....+ ... ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 111235678999998754 457899999999999999999987764321100 00000 000 000000
Q ss_pred cCCCCCCChHH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 506 QRLPPPVDRKV--IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 506 ~~l~~~~~~~~--~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
....++..... ......+.+++..||+.||++|||++||+++.+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00000000000 00012234677799999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=234.23 Aligned_cols=169 Identities=22% Similarity=0.363 Sum_probs=129.5
Q ss_pred ccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey 385 (572)
..+|.|+||.||+|+.. +++.+|+|.+...... ..+.+|++++++++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 47899999999999854 4688999998754322 346689999999999999999998864 4568999999
Q ss_pred ccCCChhhhhhcCC------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------
Q 038466 386 MKRGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------- 437 (572)
Q Consensus 386 ~~~GsL~~~l~~~~------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------- 437 (572)
+.+ +|.+++.... ....+++.....++.|++.|++|||+ |++|..+.....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 874 7877765321 12347788888999999999999974 555544332100
Q ss_pred ---C-----CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 438 ---S-----SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 438 ---~-----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
. .......||+.|+|||++.+ ..++.++||||+||++|||+||++||.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 0 01123467899999999876 458999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=234.50 Aligned_cols=169 Identities=22% Similarity=0.359 Sum_probs=129.2
Q ss_pred ccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey 385 (572)
..+|.|+||.||+|+.. ++..||+|.+...... ..+.+|++++++++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 46899999999999864 4578999998754322 356789999999999999999999854 5678999999
Q ss_pred ccCCChhhhhhcC------CCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 386 MKRGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 386 ~~~GsL~~~l~~~------~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
+++ +|.+++... .....+++.....++.|+++||.|||+ |.+|..+......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 676666432 122347888888999999999999974 5555543321000
Q ss_pred ---------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 439 ---------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 439 ---------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||++||.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 01122457899999999876 458999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=232.71 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=173.0
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHH-----------HHHHHHHHHHHHHHhcCCCCcccEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEEL-----------AFIKSFRNEAQVLSQVLHRNIVKLY 370 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~-----------~~~~~f~~E~~~l~~l~H~niv~l~ 370 (572)
..+++.+...+|.|.||.|-+|+. .+++.||||++.+...... .-.+..++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 456788888999999999999985 5799999999976542211 1135788999999999999999999
Q ss_pred EEEEeC--CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----
Q 038466 371 GFCLHR--KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---- 438 (572)
Q Consensus 371 g~~~~~--~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---- 438 (572)
.+.-++ +.+|||+|||..|.+...= .+...+...+..++..++..||+||| +|++|.......+.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 987654 5799999999999874221 12223888888899999999999996 67888754332110
Q ss_pred ----------------C--CccccccccCccccccccCCC----cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCc
Q 038466 439 ----------------S--NRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 439 ----------------~--~~~~~~gt~~y~APE~~~~~~----~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~ 496 (572)
. .....+|||.|||||.+.++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------- 324 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------- 324 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-------
Confidence 0 011257999999999987632 45789999999999999999999842211
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
-.....++...+.-|..++.-+ ...++..+.+++||+.|.+..+|..|+|..+.
T Consensus 325 ~~l~~KIvn~pL~fP~~pe~~e---~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPENPEINE---DLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHhcCcccCCCcccccH---HHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 0112233333333332221111 22356678999999999999999999998766
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=231.93 Aligned_cols=176 Identities=22% Similarity=0.285 Sum_probs=135.9
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
|+....+|.|+||.||+|+.. +|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 455677899999999999864 68999999987543221 1235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~-----------------~~~~ 442 (572)
+. ++|..++.... ...+++.....++.++++|++|||+. .+|..+..+.+. ....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 96 68988887543 23588999999999999999999843 333322111100 0111
Q ss_pred ccccccCccccccccCCC-cCcccchHHHHHHHHHHHcCCCCCC
Q 038466 443 LLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
...+++.|+|||+..+.. ++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 234678899999876644 6889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=232.08 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=167.5
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|+. .+++.+|+|.+...........+++.+|++++++++|+|++++++++..++..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55567889999999999986 46889999998643222223346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------CCcccccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------SNRTLLAG 446 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------~~~~~~~g 446 (572)
+. |++.+.+.... ..+++.++..++.+++.|+.|||. |.+|..+....+. .......|
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG 173 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccC
Confidence 97 68877775432 247888889999999999999984 3333332221110 01122457
Q ss_pred ccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 447 TYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 447 t~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
++.|+|||++. ...++.++|||||||++|||++|+.|+..... ............+........ ..+
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~---~~~ 243 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWS---EYF 243 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhhcCCCCcCccccc---HHH
Confidence 88999999874 35688999999999999999999999753211 011111111111111100111 112
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
..+..+||+.+|++||++++|+.+.+.....+.
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 356668999999999999999999887765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=228.22 Aligned_cols=225 Identities=24% Similarity=0.351 Sum_probs=164.8
Q ss_pred ccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||.||+++.. +|+.+|+|.+...........+.+.+|++++++++||||+++++.+..++..++||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 477899999999976 4999999999766544344567889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------------------CC
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------------------SN 440 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------------------~~ 440 (572)
.+++.... .+++..+..++.++++|++|||. |..|..+..+.+. ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99987543 57888999999999999999984 3333322111100 01
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....++..|+|||+......+.++||||||++++|++||+.||+... ...............+......
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~--- 227 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNILNGKIEWPEDVEVS--- 227 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCcCCCccccCC---
Confidence 122357788999999988889999999999999999999999985321 1111111222222222111001
Q ss_pred HHHHHHHHHccccCCCCCCCH---HHHHHHHhh
Q 038466 521 LLASTISFACLQSNPKSRPTM---QYVSQEFLI 550 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm---~~V~~~l~~ 550 (572)
..+..+...||+.+|++|||+ .+++++.+.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 123456668999999999999 776666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=240.97 Aligned_cols=168 Identities=21% Similarity=0.218 Sum_probs=134.2
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+...+|.|+||.||+|+.. +++.||+|..... ....|+.++++++|||||++++++.+++..++||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 35777889999999999999865 5789999975432 2346899999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~~ 441 (572)
||+. |+|.+++.... ..++|..+..++.+++.|+.||| +|++|..+..... ....
T Consensus 137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 9995 68888886533 35889999999999999999997 4555544322110 0111
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2346899999999999999999999999999999999865553
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=224.05 Aligned_cols=226 Identities=25% Similarity=0.370 Sum_probs=163.8
Q ss_pred ccccccccCeeEEEEEEcCC-----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 309 VFSIWNYDGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~-----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+|.|+||.||++...+ +..||+|++......+ ..+.+.+|++++.+++|+||+++++++.+.+..+++|
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 45678999999999998653 4889999997654332 3468899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------S 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------~ 439 (572)
||+++|+|.+++..... ..+++.+...++.++++|++|||+ |++|..+..+... .
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999999875432 127899999999999999999984 4444433221110 0
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......+++.|+|||......++.++||||+|++++||++ |+.|++... .............. +.......
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~ 231 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-------NEEVLEYLKKGYRL-PKPENCPP 231 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCCC-CCCCcCCH
Confidence 0001226688999999988889999999999999999998 788875321 11111111111111 11011111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+.+++.+|+..||++|||+.++++.+
T Consensus 232 ---~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 232 ---EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 234566799999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=218.32 Aligned_cols=235 Identities=21% Similarity=0.317 Sum_probs=170.0
Q ss_pred cCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 377 (572)
.+.+.+...+|+|||.-||.++ ..++..+|+|++.....++ .+.-.+|++.-++++|||++++++++..+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456677889999999999998 6789999999998776443 356778999999999999999999886543
Q ss_pred eEEEEEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceeeCCCCCCc-------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH--------HDCSPSIASTCPDSSNR------- 441 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH--------~~~~~~i~~~~~~~~~~------- 441 (572)
+.|+++.|...|||.+.+.... ++..++..+.+.|..++++|+.+|| +|.+|.++.........
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 4999999999999999998643 3346888999999999999999887 45555544321110000
Q ss_pred -------------------cccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchh
Q 038466 442 -------------------TLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499 (572)
Q Consensus 442 -------------------~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~ 499 (572)
..-.-|..|.|||.+.. ...++++||||+||+||+|+.|..||+..-. .... .
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgS----l 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGS----L 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCe----E
Confidence 00123778999998754 4578999999999999999999999975422 1110 0
Q ss_pred hhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 500 LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 500 ~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...+..+.+..|......+. ..++..+|++.||.+||+..+++.++.
T Consensus 252 aLAv~n~q~s~P~~~~yse~---l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEA---LHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred EEeeeccccccCCCCCccHH---HHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 11122222222221111122 235667899999999999999988763
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=241.57 Aligned_cols=237 Identities=22% Similarity=0.216 Sum_probs=165.1
Q ss_pred CccccccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+...+|.|+||.||++... .+..||+|.+.... .+.+|++++++++|||||++++++...+..++|
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4667788999999999999743 46789999886432 345799999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------------- 437 (572)
|||+. ++|.+++... ..++|..+..++.+++.|+.|||. |++|..+.....
T Consensus 165 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99996 6888888432 358899999999999999999974 455543322110
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCC---------------CCc---chh
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS---------------SDP---KIM 499 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~---------------~~~---~~~ 499 (572)
........||+.|+|||++....++.++|||||||++|||++|+.|+......... ..+ ...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 00112346899999999999999999999999999999999999998532110000 000 000
Q ss_pred hhh---hcccCCCCCCC-hHHHH---HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 500 LID---VLDQRLPPPVD-RKVIR---DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 500 ~~~---~~~~~l~~~~~-~~~~~---~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
... .......++.. +.... ....+..+..+|+..||++|||+.+++.+.+..+.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000 00000000000 00000 001223455689999999999999999998876553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=232.44 Aligned_cols=230 Identities=23% Similarity=0.342 Sum_probs=164.3
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh--cCCCCcccEEEEEEeCC----eEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCLHRK----CMFL 381 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l 381 (572)
.+.+.+|.|.||.|++|.+. |+.||||++...+. +++.+|.++.+. +||+||..+++.-..+. .+||
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34457899999999999986 67899999976542 567788888775 59999999999765433 5899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceeeCCCCCCc---------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-----DCSPSIASTCPDSSNR--------------- 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-----~~~~~i~~~~~~~~~~--------------- 441 (572)
|.||-++|||+++|... .++-..-++++..+|.||++||. ..+|.|+|++.++.+.
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999863 46777788999999999999995 4578888876655432
Q ss_pred ---------------cccccccCccccccccCCC----c--CcccchHHHHHHHHHHHcC----------CCCCCccccc
Q 038466 442 ---------------TLLAGTYGYIAPELAYTMV----M--TEKCDVYSFGVVTLEVLMG----------KHPRDLLSSL 490 (572)
Q Consensus 442 ---------------~~~~gt~~y~APE~~~~~~----~--s~ksDVySfGvvl~ElltG----------~~P~~~~~~~ 490 (572)
...+||-.|||||++.... + -..+||||||.|+||+.-+ +.||..+..
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp- 441 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP- 441 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-
Confidence 1246999999999986532 2 2469999999999998742 356654321
Q ss_pred cCCCCcchhhhhhcccCCCCCCCh--HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 491 SSSSDPKIMLIDVLDQRLPPPVDR--KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 491 ~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..-..+.+..-+-.+++.|..+. ...+.+..+.+++..||..+|..|-|+--|-+.+..
T Consensus 442 -~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 442 -SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred -CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 11111112222223333333221 122344456688889999999999998877766643
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=229.37 Aligned_cols=227 Identities=22% Similarity=0.273 Sum_probs=167.4
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++.+.+|.|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456678999999999999865 5899999999765433333457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC----------------CCCccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD----------------SSNRTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~----------------~~~~~~ 443 (572)
+++++|.+++... ..+++.....++.++++|+.|||.. .+|..+..+.+ ......
T Consensus 82 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 9999999998754 2578888899999999999999852 33322211100 001123
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc---cCCCCCCChHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPVDRKVIRDI 520 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~ 520 (572)
..|+..|+|||+.....++.++||||||+++|||++|+.|++..... ... ....... +..++..+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~------- 226 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRD-QIRAKQETADVLYPATWS------- 226 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHH-HHHHHhccccccCcccCc-------
Confidence 45788999999998888999999999999999999999998643210 011 1111111 11111111
Q ss_pred HHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 038466 521 LLASTISFACLQSNPKSRPTM--QYVSQEF 548 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm--~~V~~~l 548 (572)
..+..+..+||+.||++||++ +|+..+.
T Consensus 227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 227 TEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred HHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 122355668999999999999 7776554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=238.53 Aligned_cols=234 Identities=21% Similarity=0.288 Sum_probs=171.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe-EEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC-MFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV 382 (572)
++++....+|.|+||.++..+.+ ++..+++|++......+.. .+.-.+|+.++++++|||||.+++.+.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 45667788999999999988754 5789999999876544433 3466789999999999999999999998888 9999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-----------------CCCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-----------------PDSS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-----------------~~~~ 439 (572)
||||+||++.+.+.+.+ ...++..+...+..|+..|+.||| ||.+...+... .+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999998754 344666666778888888888887 45444332110 0111
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
-....+||+.||.||.+.+..|+.|+|+||+||++|||++=+++|...+. ...+..+......| .+.....+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~~~~P-lp~~ys~e 233 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRGLYSP-LPSMYSSE 233 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhccCCC-CCccccHH
Confidence 23457899999999999999999999999999999999999999863221 11122222222221 11111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+...|++.+|+.||+..+++.++...
T Consensus 234 ---l~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 234 ---LRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---HHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 12345589999999999999999986555
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=236.28 Aligned_cols=242 Identities=19% Similarity=0.208 Sum_probs=165.5
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------ 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 376 (572)
.+.+.....+|.|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34567778899999999999985 568899999997543322 2245677899999999999999999987543
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------ 438 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------ 438 (572)
...++++||+ +++|.+++... .+++.....++.|+++|+.||| +|++|..+....+.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3578999998 78898777532 4788888999999999999997 45555544322110
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc--------CCCCcchhhhhh----
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKIMLIDV---- 503 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~--------~~~~~~~~~~~~---- 503 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........+
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred cCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 11123468999999999876 568999999999999999999999985321100 000000000000
Q ss_pred ---cccCCCCCCChHHHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 504 ---LDQRLPPPVDRKVIRD-----ILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 504 ---~~~~l~~~~~~~~~~~-----~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
....++.. +...... ...+.++...|++.||++|||++++++|.+...
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 248 ARKYIQSLPHM-PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHhhccccc-cchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00000000 0000000 012346677999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=228.77 Aligned_cols=226 Identities=20% Similarity=0.228 Sum_probs=157.7
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHH---HHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ---VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
++|.|+||.||++.. .+|+.+|+|.+...........+.+.+|.. ++...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 368999999999986 468999999886543221111223344443 3444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------CCCcccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------SSNRTLLAG 446 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------~~~~~~~~g 446 (572)
+|+|.+++.... .++|.....++.|++.|+.|||. |.+|..+..+.. ........|
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCC
Confidence 999998887543 48899999999999999999974 444443322110 011122358
Q ss_pred ccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh---hcccCCCCCCChHHHHHHHH
Q 038466 447 TYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID---VLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 447 t~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~ 522 (572)
|..|+|||.... ..++.++|||||||++|||+||+.||..... . .. ..... .....+++..+. .
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~-~~-~~~~~~~~~~~~~~~~~~~~-------~ 225 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---K-DK-HEIDRMTLTVNVELPDSFSP-------E 225 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC---c-CH-HHHHHHhhcCCcCCccccCH-------H
Confidence 999999998864 5689999999999999999999999853211 0 00 01111 111222222211 1
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 523 ASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
+..+...|++.||++|| +++++++|.+...
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 23455689999999999 6999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-26 Score=228.10 Aligned_cols=239 Identities=19% Similarity=0.239 Sum_probs=163.7
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|+.. +|+.||||+++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 456678899999999999975 68999999987654321 134677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++ +|.+++........+++.....++.+++.|+.|||. |.+|..+...... ....
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 888888765434468999999999999999999984 3333322211100 0011
Q ss_pred ccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCc-chhh-----hhhcccCC
Q 038466 443 LLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDP-KIML-----IDVLDQRL 508 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~-~~~~-----~~~~~~~l 508 (572)
...+|+.|++||++.+ ..++.++|||||||++|||++|+.|+........ ...+ .... ........
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 2346788999998765 4578999999999999999999999853221000 0000 0000 00000111
Q ss_pred CCCCChHHHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 509 PPPVDRKVIRD-----ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 509 ~~~~~~~~~~~-----~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+.... ..... ...+.++...|++.||++||++++++++.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 239 PRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred cCCCh-HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 11000 00000 112345667899999999999999987654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=237.79 Aligned_cols=176 Identities=24% Similarity=0.220 Sum_probs=136.6
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------ 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 376 (572)
.+.+...+.+|.|+||.||++.. ..++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 34567778899999999999985 468899999997543222 2246778899999999999999999988643
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------- 437 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------- 437 (572)
...++||||+++ ++.+.+.. .+++.....++.++++||+|||+ |++|..+....+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999975 56665542 36788888899999999999974 555554332111
Q ss_pred ---CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
........||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0011234689999999999988999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=231.55 Aligned_cols=237 Identities=19% Similarity=0.177 Sum_probs=158.2
Q ss_pred cccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhh
Q 038466 314 NYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFC 393 (572)
Q Consensus 314 ~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~ 393 (572)
|.++++.||++.. +|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..+++|||+++|+|.+
T Consensus 11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred cCCceEEEEEecC-CCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 3445555555554 68999999987652222 235689999999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------------CCccc
Q 038466 394 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------------SNRTL 443 (572)
Q Consensus 394 ~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------------~~~~~ 443 (572)
++..... ..+++.....++.+++.|+.|||. |.+|..+....+. .....
T Consensus 89 ~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 9875422 246777788899999999999984 4455443221100 00112
Q ss_pred cccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccccC------CCCcch-----------hhhh--
Q 038466 444 LAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS------SSDPKI-----------MLID-- 502 (572)
Q Consensus 444 ~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~------~~~~~~-----------~~~~-- 502 (572)
..++..|+|||++.. ..++.++|||||||++|||++|+.||........ ...+.. ....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 346778999999865 3588999999999999999999999863321000 000000 0000
Q ss_pred --hcccCCCCCCCh-HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 503 --VLDQRLPPPVDR-KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 503 --~~~~~l~~~~~~-~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..++......+. ....-...+..++..||+.||++|||+++++++.+...-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000000000000 000001123457778999999999999999999876533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=222.83 Aligned_cols=227 Identities=26% Similarity=0.389 Sum_probs=167.3
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||++... +++.+++|++..... ...+.+.+|++.+++++|+|++++++++..++..++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 345567899999999999875 689999999986554 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------CCC-ccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------SSN-RTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------~~~-~~~ 443 (572)
+++++|.+++.... ..+++..+..++.++++++.|||. |..|..+..... ... ...
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99999999887643 358899999999999999999985 333333221110 000 133
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcch-hhhhhcccCCCCCCChHHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI-MLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
..|+..|+|||+.....++.++||||||++++||++|+.|++..... ... .......+..+.+.. -...
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~ 226 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATNGPPGLRNPEK-----WSDE 226 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcCCCCcCcccc-----cCHH
Confidence 45788999999998888999999999999999999999998533110 000 000000111111110 0012
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
+.++...||+.||++|||+.+++++.
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCC
Confidence 34556689999999999999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=230.87 Aligned_cols=240 Identities=23% Similarity=0.257 Sum_probs=157.7
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEEe-----CC
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH-----RK 377 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 377 (572)
+++...+|.|+||.||+|+.. +|+.||+|.++.....+ .....+.+|+++++++ +||||+++++++.. ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 445677899999999999864 68999999987543211 1113445677766655 79999999999865 24
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------- 437 (572)
..++||||++ ++|.+++.... ...+++.....++.+++.|+.|||+ |.+|..+....+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 5899999998 48888887533 2347888899999999999999974 455543322111
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhh-------
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML------- 500 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~------- 500 (572)
........||..|+|||++.+..++.++||||+||++|||++|++||........ ........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 0111224578899999999888999999999999999999999999743211000 00000000
Q ss_pred hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 501 IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 501 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.....+..+.+.......-...+.++..+|++.||++|||+.+++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0000000000000000000012346677999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=232.96 Aligned_cols=241 Identities=17% Similarity=0.177 Sum_probs=163.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+...+.+|.|+||.||+|+.. +++.||+|.+....... ....+.+|++++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 4566778999999999999864 68899999987543221 12456789999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~ 441 (572)
|++ |+|.+++..... .+++.....++.++++|++|||. |.+|..+....+. ...
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 997 589888875432 47788888899999999999984 3444333221110 001
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc----------cCCCC---cchhhh-hhccc
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSD---PKIMLI-DVLDQ 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~~~~~---~~~~~~-~~~~~ 506 (572)
....+++.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..... +..... .....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 12346889999998765 45788999999999999999999998532110 00000 000000 00000
Q ss_pred CCCCCCChHH--H--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 507 RLPPPVDRKV--I--RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 507 ~l~~~~~~~~--~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+....... . .-...+.++..+|++.||++|||++||+++.|..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000000000 0 0001124566799999999999999999987764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=229.88 Aligned_cols=177 Identities=20% Similarity=0.268 Sum_probs=136.4
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.++....+|.|+||.||+|... +++.||||.+....... ....+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 34666778999999999999865 68999999987543221 1235678999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||++ |+|.+++..... .+++.....++.++++|+.|||+ |++|..+..+... ..
T Consensus 83 e~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9998 499988875432 57888888899999999999984 3333322211100 00
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.....++..|+|||+..+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 111236788999998865 4588999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=237.48 Aligned_cols=175 Identities=23% Similarity=0.226 Sum_probs=136.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 377 (572)
+.+.+.+.+|.|+||.||+|.. ..++.||||++....... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4566778899999999999985 468899999997543222 2235778899999999999999999987643 3
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------- 437 (572)
..++||||+++ +|.+.+.. .+++.....++.|++.|++|||. |++|..+....+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999975 66666642 36788888899999999999974 555544322111
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 0011234689999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=228.53 Aligned_cols=240 Identities=22% Similarity=0.244 Sum_probs=164.6
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+.+.+|.|+||.||+|.. .+|+.||+|++......+ ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 44567889999999999986 468999999987654322 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------CC---Cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------SS---NR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------~~---~~ 441 (572)
+ +++|.+++.... ..+++.++..++.++++|++|||. |++|..+..+.. .. ..
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 999999987543 358899999999999999999984 333332211100 00 01
Q ss_pred cccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc-------CCCCcch-hhh------hhccc
Q 038466 442 TLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSSDPKI-MLI------DVLDQ 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------~~~~~~~-~~~------~~~~~ 506 (572)
....|+..|+|||++.+. .++.++||||+|++++||+||++|+....... ....+.. ... +....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 224578899999988654 46899999999999999999987764221100 0000000 000 00000
Q ss_pred CCC--CCCCh-HH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 507 RLP--PPVDR-KV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 507 ~l~--~~~~~-~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+ .+... .. ......+..+..+|++.+|++||++++++++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 000 00000 00 0001233456679999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=231.15 Aligned_cols=233 Identities=23% Similarity=0.248 Sum_probs=162.1
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 384 (572)
++....+|.|+||.||++.. .+|+.+|+|++...... .....+.+|+.++.++. ||||++++|++..++..+++||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 44556789999999999985 46899999998754432 22467889999999996 9999999999999999999999
Q ss_pred cccCCChhh---hhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC----------------C
Q 038466 385 YMKRGSLFC---NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD----------------S 438 (572)
Q Consensus 385 y~~~GsL~~---~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~----------------~ 438 (572)
|+.. ++.+ .+... ....+++.....++.+++.|++|||+. .+|..+..... .
T Consensus 84 ~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 84 LMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9874 4433 33222 123578888899999999999999853 23322211110 0
Q ss_pred CCccccccccCccccccccCC---CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc---cCCCCCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPV 512 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~---~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 512 (572)
.......|++.|+|||++... .++.++|||||||++|||++|+.||..... .......... +.++...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcCCCCCcCCCcC
Confidence 011223578899999998766 689999999999999999999999853210 0001111111 1111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.... ...+.+++.+||+.+|++|||+++|+.+.+..+
T Consensus 236 ~~~~---~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 236 EREF---SPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCcc---CHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0001 112345667999999999999999999877654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=230.97 Aligned_cols=239 Identities=20% Similarity=0.198 Sum_probs=161.4
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
+..+.+|.|++|.||+|.. .+|+.||+|++......+ ...+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 3456789999999999985 479999999987543221 22356788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC-----------------CCccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS-----------------SNRTL 443 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~-----------------~~~~~ 443 (572)
+ ++|.+++..... ..+++..+..++.++++|++|||+. ..|..+..+.+. .....
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 789988875432 3588999999999999999999853 333222111100 00112
Q ss_pred cccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc-------CCCCcc-hh------hhhhc--cc
Q 038466 444 LAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSSDPK-IM------LIDVL--DQ 506 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------~~~~~~-~~------~~~~~--~~ 506 (572)
..+++.|+|||++.+. .++.++||||||+++|||+||+.||....... ....+. .. ..+.. -+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 2457889999987654 57899999999999999999999985321100 000000 00 00000 00
Q ss_pred CCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 RLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 ~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....+...... .-...+.++..+|++.||++|||+++|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 00000000000 00012346777999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=237.03 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=172.4
Q ss_pred ccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC-eEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK-CMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~ 383 (572)
+.+...+|.|.||.||+|+ ..+|+.||||+++..-....+.. =.+|++.|+++. |||||++...+.+.+ .+|+||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 3445678999999999998 45799999999986654333222 257999999999 999999999999988 999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------C-CCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------S-SNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~-~~~ 441 (572)
|||+. +|++.++++ ...++..+...|+.||.+||+|+| ||.+|..+..... + ...
T Consensus 90 E~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred Hhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 99985 799999876 346888999999999999999986 6777765543210 0 111
Q ss_pred cccccccCcccccccc-CCCcCcccchHHHHHHHHHHHcCCCCCCccccc----------c---CCCCcc-hhhhhhccc
Q 038466 442 TLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------S---SSSDPK-IMLIDVLDQ 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~-~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~---~~~~~~-~~~~~~~~~ 506 (572)
+-.+.|..|.|||++. .+.|+.+.|+|++|||++|+.+-++-|-...+. . ....++ ..+...+.-
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 3346789999999875 577999999999999999999877655322110 0 001111 112222222
Q ss_pred CCCCCCC---hHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 507 RLPPPVD---RKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 507 ~l~~~~~---~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
++|.-.. ... ......+..+...|++-||++|||++|.+++.+.....+
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 2221110 000 011223456777899999999999999999987664443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=232.46 Aligned_cols=240 Identities=25% Similarity=0.282 Sum_probs=164.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||.||+|... +++.||+|+++...... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc-cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3566778999999999999865 58899999987543222 234678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC----------------CC--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD----------------SS--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~----------------~~--~ 440 (572)
|++++.+....... ..+++.....++.+++.|++|||.. .+|..+..+.. .. .
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99987776655432 2478888899999999999999853 33322211100 00 1
Q ss_pred ccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchhhhhhccc----
Q 038466 441 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDVLDQ---- 506 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~~~~~~~~---- 506 (572)
.....|+..|+|||++.+. .++.++||||||+++|||++|+.|+....... ....+........++
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 1224567889999999887 88999999999999999999999875321100 000000000000000
Q ss_pred -CCCCCCChHHHHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 507 -RLPPPVDRKVIRD------ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 507 -~l~~~~~~~~~~~------~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+.......... ...+..++..||+.+|++||++++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 0001000000000 123456777999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=225.93 Aligned_cols=239 Identities=21% Similarity=0.207 Sum_probs=160.9
Q ss_pred cccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEEeCCe-----
Q 038466 308 DVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLHRKC----- 378 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 378 (572)
++...+|.|+||.||+|+.. +++.||+|++......+ .....+.+|+++++++ +|||++++++++.+.+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 45567899999999999976 48999999997543322 2234566788777666 59999999999998776
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~--------------- 437 (572)
.+++|||++ ++|.+++..... ..++|.....++.++++|+.|||.. .+|..+..+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999997 489888875432 3589999999999999999999853 33332211111
Q ss_pred -CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCC---cchhh-----h
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSD---PKIML-----I 501 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~---~~~~~-----~ 501 (572)
........++..|+|||+..+..++.++|||||||++|||+||++|++....... ... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 0011123467889999999988999999999999999999999998753221000 000 00000 0
Q ss_pred hhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 502 DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 502 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.......+.+.......-...+.+++..||+.||++||++++++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 000000011000000011123446777999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=223.04 Aligned_cols=231 Identities=21% Similarity=0.251 Sum_probs=168.7
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++...++.|+||.||+++. .+++.+|+|.+......+ ....++.+|++++++++|+||+++++++.+....++||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 44566789999999999975 468899999987544322 2245778899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------CCccc
Q 038466 386 MKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------SNRTL 443 (572)
Q Consensus 386 ~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------~~~~~ 443 (572)
+++++|.+++.... ....+++.....++.+++.|++|||. +.+|..+....+. .....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 99999999887532 22457888999999999999999984 3444433221110 01112
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
..|++.|+|||+..+..++.++|+||+|+++|||++|+.|++.... ............++ ...... ..+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~---~~~ 229 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKVQRGKYPP-IPPIYS---QDL 229 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCC-CchhhC---HHH
Confidence 3478899999999988899999999999999999999999853221 11111111112111 111111 123
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..+...|++.+|++||++.+++++++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 230 QNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 46677999999999999999988753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=229.07 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=164.0
Q ss_pred cCCccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 381 (572)
.+++++...+|.|+||.||+|...+ ++.||||.++...... ..+++..|++++.+.. ||||++++|+|.++...++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3556777899999999999999764 8999999997543322 1345667887777775 9999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~----------------~ 438 (572)
||||++ +++...+.... ..+++..+..++.++++|++|||.. ++|..+..+.+ .
T Consensus 92 v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999985 46666554422 2588999999999999999999952 22222111110 0
Q ss_pred CCccccccccCccccccccCCC----cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC-CCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVD 513 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~----~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~ 513 (572)
.......|+..|+|||++.+.. ++.++||||||+++|||++|+.|+..... .......+.....+. +..
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCCCCCC
Confidence 0111234678899999987554 78999999999999999999999853210 001111122221111 100
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
..... .+.+++.+||+.||++||++++++++.+..+..
T Consensus 243 ~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 243 EGFSP---DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCH---HHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00111 234566789999999999999999998766543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=231.44 Aligned_cols=239 Identities=18% Similarity=0.213 Sum_probs=160.2
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++..+.+|.|+||.||+|+.. +|+.+|+|+++.....+ ...+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 345567899999999999864 68999999987543221 2235677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
++ |+|.+++.... ..+++.....++.++++|+.|||. |.+|..+....+. ....
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 97 57887776432 247888999999999999999985 3333322211100 0011
Q ss_pred ccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC----------CCCcch--hhhhhcccCCC
Q 038466 443 LLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS----------SSDPKI--MLIDVLDQRLP 509 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~----------~~~~~~--~~~~~~~~~l~ 509 (572)
...+++.|+|||++.+. .++.++|||||||++|||+||+.|+........ ...... ......+....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 23467889999988664 478999999999999999999988632111000 000000 00000000000
Q ss_pred CCCChH-H-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 PPVDRK-V-----IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~~~~~~-~-----~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+..... . ..-...+.++...||+.||++|||+++++.+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 000000 0 000112345677999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=222.50 Aligned_cols=228 Identities=21% Similarity=0.278 Sum_probs=157.6
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
.+|.|+||.||+|.. .+|+.||||.+.............+..|..+ ....+|+|++++++++.+++..++||||+++|
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 578899999999986 4689999999876543222223445555554 44568999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------CCccccccccCc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------SNRTLLAGTYGY 450 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------~~~~~~~gt~~y 450 (572)
+|.+++.... .+++.....++.+++.|+.|||. +.+|..+...... .......|++.|
T Consensus 83 ~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y 159 (260)
T cd05611 83 DCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDY 159 (260)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCc
Confidence 9999987543 36777788899999999999985 3333322211110 011234578899
Q ss_pred cccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHHHHHHHHH
Q 038466 451 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLASTISF 528 (572)
Q Consensus 451 ~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~i~~ 528 (572)
+|||...+..++.++||||||+++|||+||+.|+.... ............ .+........ ..+..++.
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~i~ 229 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRRINWPEEVKEFCS---PEAVDLIN 229 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcccCCCCcccccCC---HHHHHHHH
Confidence 99999988889999999999999999999999985321 111111111111 1111110001 12345667
Q ss_pred HccccCCCCCCCH---HHHHHHHhhcc
Q 038466 529 ACLQSNPKSRPTM---QYVSQEFLITR 552 (572)
Q Consensus 529 ~Cl~~dP~~RPsm---~~V~~~l~~~~ 552 (572)
+||+.+|++||++ +|++.+.+..+
T Consensus 230 ~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 230 RLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHccCCHHHccCCCcHHHHHcChHhhc
Confidence 9999999999955 67777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=242.18 Aligned_cols=229 Identities=18% Similarity=0.296 Sum_probs=168.8
Q ss_pred cccccccCeeEEEEEEcC-CCcEEEEEecCCcch-HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe--EEEEEec
Q 038466 310 FSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSET-EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC--MFLIYEY 385 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey 385 (572)
..++|.|.|=+||||... +|..||=-.++..+. ......++|..|+++|+.|+|||||++|.+..+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 458899999999999864 577777333322111 122345899999999999999999999999887654 7899999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC-------------------------C
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS-------------------------N 440 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~-------------------------~ 440 (572)
|..|+|..|+++++. ++.....+.++||.+||.|||+. .|+|+|++.+-. .
T Consensus 125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999987653 55566778999999999999985 567777653321 1
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
...+.|||.|||||.+. ..|++..||||||+.|+||+|+..||.. ...+......+.....|.... .+. .
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~--kV~-d 270 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALS--KVK-D 270 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhh--ccC-C
Confidence 22367999999999876 8899999999999999999999999842 223333333333333222111 001 1
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+..++.+|+.. .++|||..|++.+.|....
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2234566799999 9999999999998877654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.54 Aligned_cols=177 Identities=23% Similarity=0.268 Sum_probs=137.5
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 382 (572)
+++....+|.|+||.||+|... +++.+|+|.++.....+ .....+.+|++++++++||||+++++++..+ +..++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4666778999999999999865 58999999997554322 2334677899999999999999999999877 889999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~-----------------~~ 439 (572)
|||++ ++|.+.+..... .+++.....++.+++.||+|||.. .+|..+..+.. ..
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99998 589888875432 588999999999999999999853 33332211110 01
Q ss_pred CccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
......+++.|+|||++.+. .++.++|+||||++++||++|+.|+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11223467889999988654 468999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.42 Aligned_cols=177 Identities=21% Similarity=0.229 Sum_probs=135.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+.+.+|.|+||.||+|.. .+|+.||+|.+....... ....+.+|++++++++|+||+++++++.+++..++||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4566778899999999999985 468899999986543221 1235678999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+. +++.+++.... ..+.+.....++.++++|+.|||+ |++|..+...... ..
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9996 67776665432 246777788899999999999984 4444433221100 01
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.....+++.|+|||+..+ ..++.++|||||||++|||+||+.||+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 112346889999999865 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=222.55 Aligned_cols=230 Identities=23% Similarity=0.341 Sum_probs=160.7
Q ss_pred cccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q 038466 308 DVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------ 377 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 377 (572)
.+.+++|.|+||.||+|... +++.||||++....... ...+++.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 34567899999999999753 36889999987643322 22467889999999999999999999986542
Q ss_pred eEEEEEecccCCChhhhhhcCC---CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------- 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------- 439 (572)
..++++||+++|+|.+++.... ....+++.....++.+++.|++|||+ |.+|..+.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999999988875321 22347888889999999999999984 34444332211100
Q ss_pred ----------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-C
Q 038466 440 ----------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-R 507 (572)
Q Consensus 440 ----------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~ 507 (572)
......+++.|++||+.....++.++||||||+++|||++ |+.|+..... ... ...+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~-~~~~~~~~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEI-YNYLIKGNR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHH-HHHHHcCCc
Confidence 0011123567999999988889999999999999999999 8888742211 010 1111111 1
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...+.. .. ..+.+++..||+.+|++||++.++.+.+..
T Consensus 234 ~~~~~~--~~---~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 234 LKQPPD--CL---EDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCCCCC--CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111111 11 123467779999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=220.43 Aligned_cols=230 Identities=20% Similarity=0.273 Sum_probs=162.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcc--hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 380 (572)
++++.+.+|.|+||.||+|.. .+|..||+|.+.... .......+.|.+|++++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 456677899999999999985 468999999875321 11223356899999999999999999999998764 4688
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+|+||+++++|.+++.... .+++.....++.+++.|+.|||. +.+|..+..+...
T Consensus 83 ~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999887532 36778888999999999999984 3343332221100
Q ss_pred ----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......|+..|+|||+..+...+.++|||||||+++||++|+.||..... .....+......++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~p~ 232 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTKPMLPD 232 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCCCCCCCc
Confidence 011124578899999999888899999999999999999999999853211 111112221111111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...++ +..+...|++ +|..||+..+++.|++
T Consensus 233 ~~~~~---~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 233 GVSDA---CRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred ccCHH---HHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 11111 2344557888 5799999999887754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=225.14 Aligned_cols=237 Identities=19% Similarity=0.181 Sum_probs=158.7
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeC--CeEEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR--KCMFLIY 383 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 383 (572)
.+.+.+|.|+||.||+|.. .+++.||+|+++........ ....+|+..+.++. |||++++++++.++ +..++||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 3456789999999999985 46899999998754322211 23457889999986 99999999999987 8899999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC---------------CCCCcc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP---------------DSSNRT 442 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~---------------~~~~~~ 442 (572)
||++ |++.+.+.... ..++|.+...++.+++.|++|||. +.+|..+..+. ......
T Consensus 80 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcC
Confidence 9997 58888876533 258899999999999999999984 33333322111 000112
Q ss_pred ccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc------C--CCCcchhhhh-----hcccCC
Q 038466 443 LLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------S--SSDPKIMLID-----VLDQRL 508 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~------~--~~~~~~~~~~-----~~~~~l 508 (572)
...++..|+|||+... ..++.++|||||||++|||++|+.||....... . .......... ..+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 2347889999997654 557899999999999999999999985321100 0 0000000000 000000
Q ss_pred CCCCChHH----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 509 PPPVDRKV----IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 509 ~~~~~~~~----~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+....... ......+.+++.+||+.+|++||++++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 10000000 001123456777999999999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=219.22 Aligned_cols=231 Identities=23% Similarity=0.361 Sum_probs=169.1
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+++.+.+|.|+||.||++... ++..+|+|++....... ...+++.+|++++++++|||++++++.+..++..++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh-HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 445667899999999999864 68999999997654322 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCCc
Q 038466 386 MKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 386 ~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~~ 441 (572)
+++++|.+++.... ....+++.....++.+++.|+.|||. +.+|..+..... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999987642 13468999999999999999999985 333332221110 0011
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|++.|+|||......++.++||||+|++++||++|+.|++... .............++ .+.....
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~--- 229 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKGQYPP-IPSQYSS--- 229 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcCCCCC-CCCCCCH---
Confidence 12357888999999988889999999999999999999999985321 111111111111111 1111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++..||..+|++||++.+++++.+
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 1235666899999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=247.83 Aligned_cols=230 Identities=26% Similarity=0.408 Sum_probs=167.0
Q ss_pred ccccccccccCeeEEEEEEcC----C----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP----N----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~----~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
..+.+.+|.|.||.|++|... . ...||||.++..... ...+.+..|+++|+.+ +|+|||.++|+|..++
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 345568999999999999742 1 457999999866544 2357899999999998 5999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCC-----Cc--------ccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCC--
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE-----DA--------VELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCP-- 436 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~-----~~--------~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~-- 436 (572)
..++|+||+..|+|.++|+..+ .. ..+.-.+.+.++.|||.||+|| |+|.....+....
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999998765 00 1377888999999999999998 5665544332110
Q ss_pred -------------CCCCccc---ccc--ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcc
Q 038466 437 -------------DSSNRTL---LAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK 497 (572)
Q Consensus 437 -------------~~~~~~~---~~g--t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~ 497 (572)
....... ..| ...|||||.+....|+.|||||||||+||||+| |..||.... ...+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-----~~~~ 530 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-----PTEE 530 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----cHHH
Confidence 0101111 112 234999999999999999999999999999997 888885311 0111
Q ss_pred hhhhhhccc--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 498 IMLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 498 ~~~~~~~~~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+.+.+.+ ++..|.. ...++ -.++..||+.+|++||++.+++..+..
T Consensus 531 --l~~~l~~G~r~~~P~~--c~~ei---Y~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 --LLEFLKEGNRMEQPEH--CSDEI---YDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred --HHHHHhcCCCCCCCCC--CCHHH---HHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1222332 3333322 12222 356778999999999999999887754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=221.28 Aligned_cols=237 Identities=22% Similarity=0.289 Sum_probs=173.3
Q ss_pred cCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++..++|.|.|+.||+.. -++|+.+|+|.++....... ..++..+|+++.+.++|||||++...+.+....|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567788899999999999986 46799999998876544333 246788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-------------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP-------------------D 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~-------------------~ 437 (572)
+|+|.||+|..-+-.+ .-.+....-..+.||.+++.|.| +|.+|....... +
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 9999999997655432 12333444567889999999997 566665432211 1
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRK 515 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~ 515 (572)
.......+|||+|||||++....|+..+|||+.||+||-++.|.+||...+ .......+. +...+++.-+.
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhccccCCCCcccCc
Confidence 222334679999999999999999999999999999999999999985321 111111111 22233322111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
..+ .+..+.-+++..||++|-|..|.+.|.|+..+.
T Consensus 239 is~---~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 239 VTP---EAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CCH---HHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 111 123455578999999999999999999986554
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.58 Aligned_cols=243 Identities=19% Similarity=0.169 Sum_probs=161.3
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCe-----
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKC----- 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 378 (572)
+++....+|.|+||.||+|... +|+.||+|++......+ .....+.+|++++++++ ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4566678999999999999864 68999999987543221 12356788999999995 5999999999987665
Q ss_pred EEEEEecccCCChhhhhhcCCC--cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-----------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----------- 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~--~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----------- 439 (572)
.|+||||+++ +|.+++..... ...+++.....++.++++|+.|||. +.+|..+..+....
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999985 78888765322 2357899999999999999999984 34444332221000
Q ss_pred -------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcch-hhhhh
Q 038466 440 -------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKI-MLIDV 503 (572)
Q Consensus 440 -------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~-~~~~~ 503 (572)
......+++.|+|||++.+ ..++.++||||||+++|||+||+.||........ ...+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 0011235778999998765 4579999999999999999999999853211000 000000 00000
Q ss_pred ------c-ccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 504 ------L-DQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 504 ------~-~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. -+...+....... .....+..+...|++.||++||++++++.+.|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 0 0000000000000 001123456779999999999999999988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=226.43 Aligned_cols=236 Identities=21% Similarity=0.315 Sum_probs=179.2
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..-+++.+.+|.|.|++|-.|+. -+|+.||||++.+...++.. ...+.+|++.|+-++|||||++|.+.-....+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34577888999999999999984 58999999999987665433 34677899999999999999999999888999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-----------------CCCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-----------------PDSS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-----------------~~~~ 439 (572)
+|.-.+|+|+++|-++..+ +...-..++..||.+++.|+| +|.+|..+... ..+.
T Consensus 96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999999876654 444444567778888888875 78888765321 1122
Q ss_pred CccccccccCccccccccCCCcC-cccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s-~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
..+..+|+..|-|||++.+..|+ +..||||+|||||-|++|++||+... ....+..++|-+...|. ....
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------DSETLTmImDCKYtvPs--hvS~ 244 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------DSETLTMIMDCKYTVPS--HVSK 244 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------chhhhhhhhcccccCch--hhhH
Confidence 33567899999999999998886 68999999999999999999996332 11223334444433321 1212
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
+ +.+++..++..||.+|.+.++|+.+.|....+
T Consensus 245 e---CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 245 E---CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred H---HHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 1 23455578999999999999999988876544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=225.70 Aligned_cols=227 Identities=22% Similarity=0.302 Sum_probs=168.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 383 (572)
++.+.+.+|.|+||.||+|... +|+.||+|++...........+.+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 4556678999999999999864 69999999987643322233467889999999999 999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------C--
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------S-- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~-- 438 (572)
||+++|+|.+++.... .+++.....++.+++.|+.|||. |.+|..+....+ .
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999997543 58999999999999999999984 233322211100 0
Q ss_pred ------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhh
Q 038466 439 ------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 439 ------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~ 500 (572)
.......|+..|+|||+.....++.++||||||++++|+++|+.|+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~ 231 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------YLTF 231 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------HHHH
Confidence 011123468899999999888899999999999999999999999863321 1111
Q ss_pred hhhccc--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHHh
Q 038466 501 IDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTM----QYVSQEFL 549 (572)
Q Consensus 501 ~~~~~~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm----~~V~~~l~ 549 (572)
....+. ..+...+. .+..+...||+.+|++||++ ++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 232 QKILKLEYSFPPNFPP-------DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHhcCCCCCCccCH-------HHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 111111 12221211 13456668999999999999 88887654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=222.83 Aligned_cols=229 Identities=20% Similarity=0.203 Sum_probs=158.1
Q ss_pred cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHH---HHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
++|.|+||.||+|.. .+|+.||+|.+.............+..|. +.++...||||+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 368899999999985 46899999998754322111112233443 44555689999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------CCCcccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------SSNRTLLAG 446 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------~~~~~~~~g 446 (572)
+|+|.+++.... .++|..+..++.+++.|++|||. |.+|..+....+ ........|
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCC
Confidence 999998886432 58999999999999999999984 344433221110 011123458
Q ss_pred ccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHH
Q 038466 447 TYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525 (572)
Q Consensus 447 t~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 525 (572)
+..|+|||++.++ .++.++||||+||++|||++|+.||+........ ............++...+ . .+..
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~s-~------~~~~ 228 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSFS-P------ELRS 228 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhccCCCCCCcCC-H------HHHH
Confidence 9999999998754 6899999999999999999999998643110000 000001111122222111 1 2234
Q ss_pred HHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 526 ISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 526 i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
+...|+..+|++|| ++.+++++.+...
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 55689999999999 9999998876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=226.35 Aligned_cols=237 Identities=22% Similarity=0.247 Sum_probs=161.2
Q ss_pred ccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEecc
Q 038466 309 VFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
+...+|.|+||.||+|... +++.||||++........ .....+|++.+++++ |||++++++++.+++..++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567899999999999975 588999999875432211 123457899999999 999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCCcccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSNRTLL 444 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~~~~~ 444 (572)
+|+|.+++.... ...++|.+...++.+++.++.|||+ |.+|..+..+.. .......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 889998887643 2357899999999999999999985 333333221110 0011223
Q ss_pred ccccCcccccccc-CCCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCc----c-hhhhhhcccCCC
Q 038466 445 AGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP----K-IMLIDVLDQRLP 509 (572)
Q Consensus 445 ~gt~~y~APE~~~-~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~----~-~~~~~~~~~~l~ 509 (572)
.|+..|+|||++. ...++.++||||||++++||++|+.|+....... ..... + .......+...+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 4788899999875 4457899999999999999999999874321100 00000 0 000000111111
Q ss_pred CCCCh--HH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 PPVDR--KV--IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~~~~~--~~--~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
..... .. ......+..++..||+.+|++|||++|++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 10000 00 000123456778999999999999999988754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=225.40 Aligned_cols=243 Identities=21% Similarity=0.225 Sum_probs=162.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++....+|.|+||.||+|... +|+.||+|++......+ ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4566778899999999999864 68999999986543221 223568889999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------~~ 440 (572)
|++ ++|.+++..... ...++.....++.+++.|++|||+ +++|..+..+... ..
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 996 578777754332 235666777889999999999984 4444433221110 00
Q ss_pred ccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcchh-------hhhh--
Q 038466 441 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIM-------LIDV-- 503 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~~-------~~~~-- 503 (572)
.....|++.|+|||++.+. .++.++|||||||++|||+||+.|+........ ...+... ..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 1122467889999988654 578999999999999999999999853211000 0000000 0000
Q ss_pred cccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 504 LDQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 504 ~~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+..+........ .....+.++..+|++.+|++||++++++++.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 00000000000000 0001234566789999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=209.01 Aligned_cols=248 Identities=22% Similarity=0.264 Sum_probs=170.6
Q ss_pred cccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
...+.+|+|.||.||+|+ ..+|+.||||+++..+..+. ....-.+|++.|++++|+||+.+++.|.+.+.+.||+|||
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 345678999999999998 56799999999987654322 1235568999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNRTL 443 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~~~ 443 (572)
+. +|...++++. ..+.-.+...++.++.+|++|+| +|.+|.+.....++ ...+.
T Consensus 84 ~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred cc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 86 7888887643 35777888889999999999986 68888765432111 11122
Q ss_pred cccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc----------c---CCCCcchh-hhhhccc-C
Q 038466 444 LAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------S---SSSDPKIM-LIDVLDQ-R 507 (572)
Q Consensus 444 ~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~---~~~~~~~~-~~~~~~~-~ 507 (572)
.+-|..|.|||.+.+ ..|+...|+||.|||+.||+-|.+-+...++. . ....++.. +.+...- .
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 246788999998776 56999999999999999999987644211110 0 01111110 0011000 1
Q ss_pred CCCC-CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccc
Q 038466 508 LPPP-VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559 (572)
Q Consensus 508 l~~~-~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~ 559 (572)
.|.+ ...-.......++++....+..||.+|+|.+|++++.+....+++...
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPP 293 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCCh
Confidence 1111 110000111123456668999999999999999999877655444333
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=222.29 Aligned_cols=226 Identities=24% Similarity=0.282 Sum_probs=155.2
Q ss_pred Cccccccc--cccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFSIW--NYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~~~--~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~l 381 (572)
.+++...+ |.|+||.||+++. .++..+|+|.+........ |+..... .+|||++++++++..++..++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34444444 9999999999985 4688999999875432211 2222221 279999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~ 441 (572)
||||+++|+|.+++.... .++|.....++.++++|+.|||+ |++|..+...... ...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997643 58999999999999999999985 3344332221111 011
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....|+..|+|||++.+..++.++|||||||+++||+||+.||...... ...... .........+.+ ... ..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~--~~~---~~ 235 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLES-LLKRQQKKLPFI--KNV---SK 235 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHH-HHHhhcccCCcc--ccc---CH
Confidence 1235788999999999888999999999999999999999998632110 000000 111111111111 000 01
Q ss_pred HHHHHHHHccccCCCCCCC-HHHHHHHHhh
Q 038466 522 LASTISFACLQSNPKSRPT-MQYVSQEFLI 550 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPs-m~~V~~~l~~ 550 (572)
.+..+...|++.+|++||+ +++++++.|.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 1234556899999999996 7999987654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=225.85 Aligned_cols=179 Identities=22% Similarity=0.331 Sum_probs=134.3
Q ss_pred ccccccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFL 381 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 381 (572)
+++.+.+|.|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 455677899999999999864 5899999999864322222235677899999999999999999999988 78999
Q ss_pred EEecccCCChhhhhhcCC--CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC----CC-----------
Q 038466 382 IYEYMKRGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP----DS----------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~--~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~----~~----------- 438 (572)
||||+++ ++.+.+.... ....++......++.|++.|++|||. |++|..+..+. ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999985 6666664322 12257777888899999999999974 44443332221 00
Q ss_pred ---------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 ---------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 ---------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.......+|+.|+|||++.+ ..++.++|||||||+++||++|+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 00112346788999998765 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=232.36 Aligned_cols=233 Identities=22% Similarity=0.354 Sum_probs=168.1
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++..+.+|.||-..|||+...+.+.+|+|++.....+ ......|.+|+++|.+++ |.+||++|+|-..++.+|||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45667789999999999999988899999988755433 344678999999999995 9999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC----------------CCCC--C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC----------------PDSS--N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~----------------~~~~--~ 440 (572)
|=+ -+|..+|...... ..+| .+..+-.++..++.++| .|.+|...... .++. -
T Consensus 441 ~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred ccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCcccccee
Confidence 864 5899999865432 3445 34556777778887775 57777643210 1111 1
Q ss_pred ccccccccCccccccccCC-----------CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC-
Q 038466 441 RTLLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL- 508 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~-----------~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l- 508 (572)
...-+||+.||+||.+... +++.+|||||+|||||+|+.|+.||...... -..+..+.+|.-
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAKLHAITDPNHE 591 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHHHHhhcCCCcc
Confidence 1235799999999987532 3678999999999999999999998543210 001222334422
Q ss_pred -CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 509 -PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 509 -~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+-|..... .+ +..++..|++.||.+|||..+++++.+.+-
T Consensus 592 Iefp~~~~~-~~---li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPEN-DE---LIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCc-hH---HHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11111111 11 456778999999999999999999987654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=230.81 Aligned_cols=240 Identities=25% Similarity=0.291 Sum_probs=161.7
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC--CeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 380 (572)
+.+.+...+|.|+||.||+|... +|+.+|+|++....... ...+.+.+|+++++++ +||||++++|+|... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45666778999999999999865 68899999986432111 1235677899999999 999999999998654 3689
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||++ ++|..++... .++|..+..++.+++.|++|||. |.+|..+..+.+.
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5898888643 57888889999999999999984 3444332211100
Q ss_pred ------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcch-----
Q 038466 439 ------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI----- 498 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~----- 498 (572)
.......||..|+|||++.. ..++.++||||||+++|||+||+.||........ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 01112357889999998754 5678999999999999999999999853211000 000000
Q ss_pred ---hhhhhccc---CCCCCCChHHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 499 ---MLIDVLDQ---RLPPPVDRKVIR-DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 499 ---~~~~~~~~---~l~~~~~~~~~~-~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+.++. .-..+. ..... ....+..++.+||+.||++|||+.+++++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~ 299 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299 (337)
T ss_pred HhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence 00000000 000000 00000 011234677799999999999999999986553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=222.71 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=162.0
Q ss_pred cccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEEEEe
Q 038466 308 DVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYE 384 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 384 (572)
++...+|.|+||.||+|... +|+.+|+|++..... .....+.+.+|++++++++|||++++++++.+. +..++|||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 34567899999999999865 589999999986641 122345788999999999999999999999988 88999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC---------------CC---C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD---------------SS---N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~---------------~~---~ 440 (572)
|+++ +|.+++.... ..+++.....++.++++|++|||.. .+|..+..+.+ .. .
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9985 8888886542 3578899999999999999999853 33322211100 00 1
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCC----Ccchhhh-hhcc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSS----DPKIMLI-DVLD 505 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~----~~~~~~~-~~~~ 505 (572)
.....++..|+|||.+.+ ..++.++||||||+++|||+||+.|++...... ... .+..... ....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 122346788999997654 467899999999999999999999986322100 000 0000000 0000
Q ss_pred cCCCCCCCh---HHHHH--HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 506 QRLPPPVDR---KVIRD--ILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 506 ~~l~~~~~~---~~~~~--~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.....+... ..... .....+++..||+.+|++||++++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 000000000 00011 123456778999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=225.02 Aligned_cols=247 Identities=23% Similarity=0.262 Sum_probs=164.9
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 380 (572)
.++++..+.+|.|+||.||+|.. .+|+.||+|+++.....+ .....+.+|++++++++|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34577788899999999999986 469999999987543221 1123456799999999999999999998765 5689
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||+.+ +|.+++.... ..+++.+...++.++++|++|||. |++|..+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999974 7887776532 358899999999999999999985 3344322211100
Q ss_pred -CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcchhhh-h--hc--
Q 038466 439 -SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIMLI-D--VL-- 504 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~~~~-~--~~-- 504 (572)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.|+........ ...+..... . ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 01111235678999998865 4578999999999999999999999853221000 000000000 0 00
Q ss_pred --ccCCCC-CCC--hHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 505 --DQRLPP-PVD--RKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 505 --~~~l~~-~~~--~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
....+. +.. .... .....+.++...|++.||++|||+++++++.+..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 000000 000 0000 0011234566789999999999999999998876553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.68 Aligned_cols=232 Identities=20% Similarity=0.225 Sum_probs=160.6
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchH--HHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+.+|.|+||.||++... .+..+++|.++..... ......++..|++++++++||||+++++++.+.+..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 345577899999999999754 3444555555432110 1111245678999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------CCC
Q 038466 384 EYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~~~ 440 (572)
||+++++|.++++.. .....+++.....++.++++|+.|||+ +.+|..+..... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~~ 161 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDL 161 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCccc
Confidence 999999999888752 223468999999999999999999985 333332211100 001
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
.....|++.|+|||+.....++.++||||||+++|||++|..|++... .............+. .+.....
T Consensus 162 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~-- 231 (260)
T cd08222 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTPS-LPETYSR-- 231 (260)
T ss_pred ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCCCC-CcchhcH--
Confidence 112457889999999888888999999999999999999999975221 111111111111111 1111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+++.+||+.+|++||++.+++++.+
T Consensus 232 -~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 232 -QLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -HHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 2345666899999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=215.17 Aligned_cols=224 Identities=25% Similarity=0.363 Sum_probs=166.6
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+.+.+|.|+||.||+|... +++.||+|.+......+ ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 345567899999999999864 68899999998665422 2356899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++++|.+++... ..+++..+..++.+++.|+.|||+ |.+|..+....+. ....
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999998754 358899999999999999999985 3333332221110 0012
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKVIRD 519 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~ 519 (572)
...|+..|+|||+..+..++.++||||+|++++||++|+.|+..... ........ .+..+...+ .
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~---- 225 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRIVQDDHPPLPEGIS-P---- 225 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhccCCCCCCCCCC-H----
Confidence 34578899999998887889999999999999999999999853221 00011111 111222111 1
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+..+..+|++.+|++||++.+++.+.
T Consensus 226 --~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 226 --ELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred --HHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 123456689999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=223.74 Aligned_cols=241 Identities=20% Similarity=0.275 Sum_probs=158.7
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------ 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 377 (572)
+.++....+|.|+||.||+|... +++.||||++......+ .....+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34666788999999999999864 68999999986443221 11235668999999999999999999987654
Q ss_pred --eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC-----------
Q 038466 378 --CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS----------- 438 (572)
Q Consensus 378 --~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~----------- 438 (572)
..++||||+.+ ++.+.+.... ..+++.+...++.+++.|+.|||.. .+|..+......
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 35999999974 7877776432 2578889999999999999999853 333322111000
Q ss_pred ----------CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccc---------cCCCC---
Q 038466 439 ----------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL---------SSSSD--- 495 (572)
Q Consensus 439 ----------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~---------~~~~~--- 495 (572)
.......++..|+|||+..+. .++.++||||||+++|||+||+.|+...... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 001123467889999987664 4788999999999999999999987532110 00000
Q ss_pred -cchhhhhhccc-CCCCCCChHHHH------HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 496 -PKIMLIDVLDQ-RLPPPVDRKVIR------DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 496 -~~~~~~~~~~~-~l~~~~~~~~~~------~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+.....+..+. ..+......... ....+.+++..||..||++|||+++++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 00000000000 000000000000 0112346777999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=228.98 Aligned_cols=244 Identities=21% Similarity=0.215 Sum_probs=164.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 379 (572)
.++++...+|.|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3566677899999999999985 46999999998754321 1234677789999999999999999998763 3468
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
++||||+. |+|.+++.... .+++.....++.++++|++|||. +++|..+....+.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999996 68988886432 37888899999999999999984 3333322111100
Q ss_pred ------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc--------CCCCcch-----
Q 038466 439 ------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKI----- 498 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~--------~~~~~~~----- 498 (572)
.......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 00112357889999998765 468999999999999999999999985432100 0000000
Q ss_pred ---hhhhh---cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 499 ---MLIDV---LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 499 ---~~~~~---~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..... .....+.+...........+..+...|++.+|++||++++++.+.+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00000 00000100000000001223467779999999999999999999877544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=215.46 Aligned_cols=222 Identities=25% Similarity=0.316 Sum_probs=163.7
Q ss_pred ccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|+||.||++... +++.+|+|.+.............+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 478999999999865 5899999998765543333456889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CCcccccccc
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SNRTLLAGTY 448 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~~~~~~gt~ 448 (572)
.+++.... .+++.....++.+++.|+.|||. +.+|..+...... .......|+.
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99987543 47888899999999999999984 3444333221110 0122345788
Q ss_pred CccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHH
Q 038466 449 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF 528 (572)
Q Consensus 449 ~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~ 528 (572)
.|+|||...+...+.++|+||||+++||+++|+.||+.... ......+.....+.+.. ... ...++..
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~~---~l~~~i~ 225 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLRFPEF--LSP---EARDLIS 225 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCCCCCC--CCH---HHHHHHH
Confidence 99999999888889999999999999999999999853211 11111222222221111 001 1234666
Q ss_pred HccccCCCCCCCH---HHHHHHHh
Q 038466 529 ACLQSNPKSRPTM---QYVSQEFL 549 (572)
Q Consensus 529 ~Cl~~dP~~RPsm---~~V~~~l~ 549 (572)
.||..||++||++ +++..+.+
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHhCCC
Confidence 8999999999999 67766543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=236.55 Aligned_cols=235 Identities=23% Similarity=0.346 Sum_probs=178.7
Q ss_pred ccCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe-----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----- 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----- 375 (572)
.+..+++..++|.|.+|.|||++ .++|+.+|+|++......+ ++...|.++++.. .|||++.+||++..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34557778899999999999998 4679999999998776554 3445678888776 69999999999874
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC--------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC-------------- 435 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~-------------- 435 (572)
++.+|||||||.+||.-+.+++.. ...+.|....-|+++++.|+.+||. |.+...+...
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 578999999999999999998765 5568999888999999999999984 4443332210
Q ss_pred ---CCCCCccccccccCccccccccCC-----CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 436 ---PDSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 436 ---~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
..-..+.+.+||+.|||||++... .|+.++|+||+||+..||.-|.+|..++. +. ..-+.-++
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------Pm--raLF~IpR 242 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------PM--RALFLIPR 242 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-------hh--hhhccCCC
Confidence 111234457899999999998643 47889999999999999999999975432 11 11222344
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
-|||.-.........+.+.+..|+.+|-++||++.+.+++.++.
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 45544333334444566778899999999999999999998877
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=227.12 Aligned_cols=243 Identities=21% Similarity=0.193 Sum_probs=161.6
Q ss_pred cccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH-----------HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 310 FSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL-----------AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~-----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
...+|.|+||.||+|... +++.||||++........ .....+.+|++++++++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 456899999999999854 689999999865432110 00124778999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------- 437 (572)
..++||||++ |+|.+++.... .+++.....++.++++|++|||. |++|..+.....
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 9999999997 68988886432 47788888999999999999984 233322211100
Q ss_pred -----------------CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc--------
Q 038466 438 -----------------SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------- 491 (572)
Q Consensus 438 -----------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------- 491 (572)
........++..|+|||++.+. .++.++||||+||++|||+||+.|+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~ 249 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 0001112357789999998754 47899999999999999999999985322100
Q ss_pred --CCCC---cchh---hhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 492 --SSSD---PKIM---LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 492 --~~~~---~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
.... +... .........+.............+.++...|++.+|++||++++++.+.+.......
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 0000 0000 000000000000000000001123467779999999999999999999887655433
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=228.40 Aligned_cols=240 Identities=21% Similarity=0.230 Sum_probs=161.5
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----e
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----C 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 378 (572)
+++.+.+.+|.|+||.||+|.. .+|+.||||++...... ....++.+|++++++++||||+++++++.... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4567778899999999999985 57899999998643222 22456888999999999999999999876543 5
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------- 438 (572)
.++||||+++ ++.+.+... .+++.....++.+++.|++|||. |++|..+......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 7999999974 787776532 47888888999999999999984 3444332211100
Q ss_pred ------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhhh
Q 038466 439 ------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDV 503 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~~ 503 (572)
.......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 00112357889999998654 5689999999999999999999999853210000 00000000000
Q ss_pred ccc-------CCCC--CCChH-H-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 504 LDQ-------RLPP--PVDRK-V-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 504 ~~~-------~l~~--~~~~~-~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+. ..+. ..... . ......+..++..||+.+|++|||+.+++++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 000 0000 00000 0 00011245677799999999999999999997664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=220.02 Aligned_cols=237 Identities=22% Similarity=0.249 Sum_probs=163.0
Q ss_pred ccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
..+.+|.|++|.||+|... +|+.+|+|++....... .....+.+|++++++++|+||+++++++.+++..++||||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4567899999999999864 68999999987654332 234678889999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C-Ccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S-NRTLL 444 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~-~~~~~ 444 (572)
+ ++.+++.... ..+++..+..++.+++.|+.|||. |.+|..+..+.+. . .....
T Consensus 82 ~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 82 T-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred C-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 5 8888877533 358899999999999999999984 3333322211100 0 01123
Q ss_pred ccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcchhh-hhhcc------cCCC
Q 038466 445 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIML-IDVLD------QRLP 509 (572)
Q Consensus 445 ~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~~~-~~~~~------~~l~ 509 (572)
.++..|+|||...+. .++.++||||+|+++|||+||+.||........ ...+.... ....+ ...+
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 467889999998776 789999999999999999999998853221000 00000000 00000 0000
Q ss_pred C---CCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 P---PVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~---~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
. ....... .....+..++..||+.||.+||++++++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0 0000000 01123456777999999999999999998765
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=224.18 Aligned_cols=174 Identities=24% Similarity=0.250 Sum_probs=134.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 377 (572)
+.++..+.+|.|+||.||+|.. .+|+.||||++....... ...+.+.+|++++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4466677899999999999985 479999999986432221 2235677899999999999999999988643 3
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------- 438 (572)
..++||||+. |+|.+.+... ++..+...++.+++.|++|||. |++|..+....+.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999996 5787777532 6777888899999999999984 4444433221110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 01122357889999999999899999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=224.54 Aligned_cols=179 Identities=27% Similarity=0.345 Sum_probs=134.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 377 (572)
.+++++...+|.|+||.||+|... +|+.||+|+++.....+ .....+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 445677788999999999999865 58999999997543221 12346778999999999999999999987655
Q ss_pred -----eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------
Q 038466 378 -----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------- 438 (572)
Q Consensus 378 -----~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------- 438 (572)
..++|+||+++ ++...+... ...+++.....++.+++.|++|||. +.+|..+......
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 666666543 2358899999999999999999984 3333322111100
Q ss_pred --------C--CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 --------S--NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 --------~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
. ......++..|+|||++.. ..++.++|||||||+++||++|++|++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 0 0011235778999998754 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=226.15 Aligned_cols=240 Identities=20% Similarity=0.195 Sum_probs=165.4
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----eEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 380 (572)
+++...+|.|+||.||+|+.. +|+.||||++...... ....+.+.+|++++++++||||+++++++...+ ..|
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 456678999999999999865 5899999998764321 223467899999999999999999999998775 789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~ 438 (572)
+||||++ ++|.+++.... .+++.....++.+++.|++|||. |.+|..+..+.. .
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999998 58888887533 58899999999999999999984 333332221110 0
Q ss_pred ----CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCc-------c
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP-------K 497 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~-------~ 497 (572)
.......+|..|+|||++.+. .++.++||||||++++||+||+.||....... ....+ .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 011223578889999999877 78999999999999999999999985322100 00000 0
Q ss_pred hhhhhhccc-CCCCCCChH-HH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 498 IMLIDVLDQ-RLPPPVDRK-VI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 498 ~~~~~~~~~-~l~~~~~~~-~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
....+.+.. ....+.... .. .....+..+...||+.+|++||++++++++.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 000000000 000000000 00 0011234567789999999999999999987664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=223.18 Aligned_cols=245 Identities=20% Similarity=0.225 Sum_probs=163.0
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 381 (572)
.+.++....+|.|+||.||+|.. .+|+.||||++....... ...+.+.+|++++++++||||++++++|.. .+..++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 45577778899999999999985 479999999886432211 223677889999999999999999999876 567899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~ 441 (572)
||||+ +++|.++++.. .+++.....++.++++|+.|||+ +.+|..+..+... ...
T Consensus 88 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 88 VTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred Eeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 99998 56888877642 35666777899999999999985 3333322221100 011
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc------C--CCCcchhh--------hhh-
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------S--SSDPKIML--------IDV- 503 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~------~--~~~~~~~~--------~~~- 503 (572)
....++..|+|||++.+ ..++.++|||||||++|||+||+.|+....... . ...+.... .+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 12346788999998765 568999999999999999999999985321100 0 00000000 000
Q ss_pred --cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 504 --LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 504 --~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.....+.+...........+..++.+|++.+|++||++++++.+.+..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000000010000000011234566789999999999999999997665443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=216.93 Aligned_cols=227 Identities=22% Similarity=0.311 Sum_probs=159.4
Q ss_pred ccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+.+.+.+|.|+||.||+++. .+++.||||.++..... .....+.+.+|++++.++ +||||+++++.+..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 44567889999999999874 35789999998754322 223346788999999999 5999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.+++.... .+.+.....++.++++|+.|||. |.+|..+..+.+.
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999887532 47788888899999999999984 3333322221110
Q ss_pred --CCccccccccCccccccccCCC--cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCC
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPV 512 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~--~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~ 512 (572)
.......|+..|+|||+..+.. .+.++||||||+++|||+||+.|+...... .........+.... .+...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKSKPPFPKTM 235 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHccCCCCCccc
Confidence 0011235788999999987655 788999999999999999999998432110 00011111111111 11111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQ 546 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~ 546 (572)
+ . .+.++..+||+.||++|||+++|..
T Consensus 236 ~-~------~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 236 S-A------EARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred C-H------HHHHHHHHHhcCCHhhccCcchHHH
Confidence 1 1 1234566899999999999876644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=216.19 Aligned_cols=235 Identities=22% Similarity=0.308 Sum_probs=162.7
Q ss_pred ccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+++...+|.|+||.||+++. .+|+.||+|.+...... .....+.+.+|++++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45567889999999999975 46899999998754322 122345788899999999 5999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.+++.... .+.+.....++.++++|+.|||. |.+|..+..+.+.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999987543 46777777888899999999984 3344332221110
Q ss_pred --CCccccccccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 --SNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......|+..|+|||+.... .++.++||||||+++|||+||+.|+...... .........+.....+.+ .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~--~ 233 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPPYP--Q 233 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccCCCCC--c
Confidence 011124578899999998753 4788999999999999999999998532110 000111111111111111 1
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
... ..+..+...||+.||++|| +.+++..+.+..+
T Consensus 234 ~~~---~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 234 EMS---ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred cCC---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 100 1123556689999999997 7888888765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=253.88 Aligned_cols=225 Identities=25% Similarity=0.369 Sum_probs=160.7
Q ss_pred cccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.+|.|-||.||-|. .++|+..|||.+...... ....+...+|+.++..++|||+|++||.-.+++..+|.||||++|+
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 46777799999998 567999999998765544 3345677899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------------CCccc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------------SNRTL 443 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------------~~~~~ 443 (572)
|.+.+...+. .+..--..+..|++.|++||| +|++|..+..+..+ .....
T Consensus 1321 La~ll~~gri---~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred HHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 9998875322 233333346778999999997 56666544321110 00122
Q ss_pred cccccCccccccccCC---CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 444 LAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~---~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
..||+.|||||++.+. ....+.||||+|||.+||+||++||..++ .+..+...+...-.|..+.....
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-------ne~aIMy~V~~gh~Pq~P~~ls~-- 1468 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-------NEWAIMYHVAAGHKPQIPERLSS-- 1468 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-------chhHHHhHHhccCCCCCchhhhH--
Confidence 4699999999998754 35678999999999999999999985432 12222222222111222222211
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...++...|++.||+.|++..|++.+-+.
T Consensus 1469 -~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1469 -EGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred -hHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 12345558999999999999999887654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=224.33 Aligned_cols=182 Identities=25% Similarity=0.316 Sum_probs=152.6
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+.|..+.++|.||||.||-++. .+|+.+|.|++.+..........--.+|-.+|.++..+.||.+--.|...+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 345678888999999999999986 4699999999976654443333455689999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SS 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~ 439 (572)
|+..|.||+|.-+|.+.+. ..++..+.+-+|.+|+.||++|| +|++|.++..+.. ..
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999999987654 45888888889999999999999 4788877654322 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.....+||.||||||++..+.|+...|+||+||++|||+.|+.||.
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 2223479999999999999999999999999999999999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=224.81 Aligned_cols=241 Identities=20% Similarity=0.172 Sum_probs=161.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 379 (572)
.+.+...+|.|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 456677899999999999985 568999999987542221 1235677899999999999999999988654 348
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
++||||+. ++|.+++.... .+++.....++.+++.|+.|||. +.+|..+......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 68888886432 47888889999999999999984 3444333211100
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc----------cCCCCcc------hh
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDPK------IM 499 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~~~~~~~------~~ 499 (572)
.......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 01122357888999998764 46899999999999999999999998532100 0000000 00
Q ss_pred hhhhccc--CCCCCCChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 500 LIDVLDQ--RLPPPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 500 ~~~~~~~--~l~~~~~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
....+.. ..+.+..... ......+.+++.+||+.+|++|||+++++++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 0000000 0000000000 00012234677799999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=218.15 Aligned_cols=237 Identities=23% Similarity=0.255 Sum_probs=162.9
Q ss_pred ccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
....+|.|+||.||+|... +++.+|+|.+...... ....+.+..|++++++++|+|++++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3456899999999999865 5999999999865422 2234577889999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCCC-----------------CCcccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPDS-----------------SNRTLL 444 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~~-----------------~~~~~~ 444 (572)
++|.+++.... ..+++..+..++.++++|+.|||.. .+|..+...... ......
T Consensus 82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 58999998643 3588999999999999999999853 333322211100 001122
Q ss_pred ccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchh--hhhh--cccCCCC
Q 038466 445 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM--LIDV--LDQRLPP 510 (572)
Q Consensus 445 ~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~--~~~~--~~~~l~~ 510 (572)
.++..|+|||++... .++.++|||||||+++||++|+.|+....... ........ ..+. .+...+.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 346779999998766 78999999999999999999999985321100 00000000 0000 0111110
Q ss_pred CCCh---HHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 511 PVDR---KVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 511 ~~~~---~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.... ... .....+.+++..||+.||++||++++|+.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 0000 000 00123456777999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=225.05 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=163.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 377 (572)
+.+.....+|.|+||.||+|+. .+|+.||||++......+ ...+.+.+|++++++++||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4566778899999999999985 468999999987543222 2235688999999999999999999998754 3
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------- 438 (572)
..++|+||+.. ++..+.. ..+++.....++.++++|++|||. +++|..+....+.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46999999974 6665542 147788888899999999999985 3333322211110
Q ss_pred -CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcch-------hh
Q 038466 439 -SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-------ML 500 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~-------~~ 500 (572)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.. ..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 01122356888999999866 468999999999999999999999986321100 0000000 00
Q ss_pred hhhcc--cCCCCCCChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccc
Q 038466 501 IDVLD--QRLPPPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559 (572)
Q Consensus 501 ~~~~~--~~l~~~~~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~ 559 (572)
..... +..+....... ......+.++...||+.||++||++++++.+.+.....+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 00000 00000000000 0000123456678999999999999999998766554444333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.84 Aligned_cols=239 Identities=20% Similarity=0.178 Sum_probs=160.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------- 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 376 (572)
..+.....+|.|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3466677899999999999985 56899999998765432 246788899999999999999999876543
Q ss_pred -------CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----
Q 038466 377 -------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---- 439 (572)
Q Consensus 377 -------~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---- 439 (572)
...++||||++ ++|.+++... .+++.....++.|++.|+.|||. +++|..+.......
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 5888777532 37788888999999999999984 33443322211100
Q ss_pred -----------------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC---------
Q 038466 440 -----------------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------- 492 (572)
Q Consensus 440 -----------------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------- 492 (572)
......|+..|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 0011246788999998654 5688899999999999999999999853211000
Q ss_pred CCCcch--hh----hhhcc-cCCCCCCC-hHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 493 SSDPKI--ML----IDVLD-QRLPPPVD-RKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 493 ~~~~~~--~~----~~~~~-~~l~~~~~-~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...... .. ..... ........ .... .....+..+...|++.||++|||+++++.+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000000 00 00000 00000000 0000 0001234567799999999999999999988775
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=221.75 Aligned_cols=244 Identities=20% Similarity=0.224 Sum_probs=163.7
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR----- 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----- 376 (572)
..+.+...+.+|.|+||.||+|.. .+|+.||+|++....... ...+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 345677788899999999999984 579999999997543222 2235688899999999999999999988643
Q ss_pred -CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------
Q 038466 377 -KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------- 438 (572)
Q Consensus 377 -~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------- 438 (572)
...++++|++ +++|.+++... .+++..+..++.++++|++|||+ +.+|..+....+.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3467888876 78998877532 37888999999999999999984 3344332221110
Q ss_pred ---CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhhh---
Q 038466 439 ---SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDV--- 503 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~~--- 503 (572)
.......||..|+|||+..+ ..++.++|||||||++|||++|+.|+........ ...+.......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 11122457889999998765 5688999999999999999999999853211000 00000000000
Q ss_pred -----cc--cCCCCC-CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 504 -----LD--QRLPPP-VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 504 -----~~--~~l~~~-~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+. +..+.. ...........+.++...|++.||++||++.+++.+.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 000000 00000000112346777899999999999999999887653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=221.68 Aligned_cols=242 Identities=20% Similarity=0.236 Sum_probs=159.0
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 377 (572)
.+++.+...+|.|+||.||+|... +++.+|||++......+. ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 356777788999999999999854 689999999864432211 1235678999999999999999999875433
Q ss_pred ---eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------
Q 038466 378 ---CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 378 ---~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------- 438 (572)
..++||||+.+ ++...+.... ..+++.....++.++++|++|||. |.+|..+....+.
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999975 6766665432 358888999999999999999985 3333322111000
Q ss_pred ------------------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc--------
Q 038466 439 ------------------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------- 491 (572)
Q Consensus 439 ------------------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------- 491 (572)
...+...|++.|+|||+..+ ..++.++|||||||++|||++|++|+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 00012346788999998765 458999999999999999999999985322100
Q ss_pred -CCCCcch-h----hhh----hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 492 -SSSDPKI-M----LID----VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 492 -~~~~~~~-~----~~~----~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....+.. . ... ......++............+.++...|++.||++|||+.+++.+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 0000000 0 000 00011111000000000122346777999999999999999988754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=239.66 Aligned_cols=118 Identities=23% Similarity=0.337 Sum_probs=100.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||.||+|... +++.||||+++..........+.+..|+++++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 45667788999999999999865 68999999997654333344567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~ 425 (572)
||+++|+|.++++... .+++.....++.+++.||.|||.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~ 122 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR 122 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999987543 46777888999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=212.52 Aligned_cols=224 Identities=20% Similarity=0.288 Sum_probs=156.8
Q ss_pred cccccCeeEEEEEEcCC------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-CeEEEEEe
Q 038466 312 IWNYDGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KCMFLIYE 384 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 384 (572)
.+.+|.||.||+|.+.+ .+.|-||.++....+- +...|..|.-.+..+.|||+..+.|.+.++ ...+..|.
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 45678899999996542 3456677776544322 346788999999999999999999999764 56889999
Q ss_pred cccCCChhhhhh-----cCCCcccCCHHHHHHHHHHHHHHHHHHhcCC------CCCcee--------eCCCCCCccccc
Q 038466 385 YMKRGSLFCNLH-----NNEDAVELDWAKRVNIVKAMAHALAYLHHDC------SPSIAS--------TCPDSSNRTLLA 445 (572)
Q Consensus 385 y~~~GsL~~~l~-----~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~------~~~i~~--------~~~~~~~~~~~~ 445 (572)
|+.-|+|..+|. +......++-.+.+.++.|++.|++|||+.. ...... .+...-.+..+.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP 448 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence 999999999998 3333344666677889999999999998531 111100 000000111111
Q ss_pred -----------cccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCC
Q 038466 446 -----------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPV 512 (572)
Q Consensus 446 -----------gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~ 512 (572)
....||+||.+....|+..+|||||||+||||+| |+.|+-.+ ++..+.....|. ++..|.
T Consensus 449 ~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-------DPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 449 GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-------DPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-------CHHHHHHHHhccceecCCC
Confidence 1356999999999999999999999999999997 99998432 333333333332 444443
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
... . +...++..||...|++||+++|++.-+.
T Consensus 522 NCP--D---eLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 522 NCP--D---ELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred CCc--H---HHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 211 1 1245666899999999999999988663
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-25 Score=230.90 Aligned_cols=176 Identities=28% Similarity=0.377 Sum_probs=146.2
Q ss_pred ccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CeEEE
Q 038466 309 VFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KCMFL 381 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 381 (572)
.-..+|.||||.||+|+ -.+|+.||||.++...... ..+..-+|+++|++++|+|||+++|.=.+. +...+
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34578999999999999 4579999999998644222 245677899999999999999999975443 35679
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeC--------------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTC-------------------- 435 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~-------------------- 435 (572)
|||||.+|||+..|...+....|+..+.+.+..+++.||.|| |||++|.++...
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999999877777899999999999999999999 578888765321
Q ss_pred CCCCCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 436 PDSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 436 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.+.+....+.||..|.+||.+.. ..|+.-+|.|||||++||.+||..||..
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 12233456789999999999985 7899999999999999999999999853
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=220.61 Aligned_cols=244 Identities=20% Similarity=0.216 Sum_probs=164.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC---- 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 378 (572)
.++++....+|.|+||.||+|+.. +++.||||++....... ...+.+.+|+.++++++|||++++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456777889999999999999865 58899999987543222 223567789999999999999999998876554
Q ss_pred --EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------
Q 038466 379 --MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------ 438 (572)
Q Consensus 379 --~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------ 438 (572)
.++|+||+ +++|.+++.. ..+++.....++.++++|++|||. +.+|..+....+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 5699888864 248888999999999999999985 3333322211100
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhh------
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLI------ 501 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~------ 501 (572)
.......++..|+|||.... ..++.++|||||||++|||+||+.||........ ...+.....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 01122357888999998765 3678999999999999999999999853211000 000000000
Q ss_pred --hhcc---cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 502 --DVLD---QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 502 --~~~~---~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+. ....+............+.++...|++.||++|||+++|+++.+..+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0000 000000000000001234567779999999999999999999877544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.17 Aligned_cols=241 Identities=24% Similarity=0.254 Sum_probs=163.5
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 377 (572)
.+.++....+|.|+||.||+|.. .+|+.||||++...... ....+.+.+|++++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 34567778899999999999984 57999999998653322 223456889999999999999999999987653
Q ss_pred -eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------
Q 038466 378 -CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------ 438 (572)
Q Consensus 378 -~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------ 438 (572)
..++||||+ +++|.+++... .+++.....++.++++|++|||+ |++|..+......
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 67898877532 47888889999999999999985 3444332221110
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhhhcc--
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDVLD-- 505 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~~~~-- 505 (572)
.......+++.|+|||++.. ..++.++||||+||++||+++|+.||........ ...+.. ..+.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 246 (343)
T cd07880 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSE 246 (343)
T ss_pred cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhhcch
Confidence 11122357889999998865 4588999999999999999999999853211000 000000 000000
Q ss_pred ------cCCCCCCChHHHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 506 ------QRLPPPVDRKVIRD-----ILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 506 ------~~l~~~~~~~~~~~-----~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..++.... ..... ...+..+..+|++.||++|||+.+++.+.+...
T Consensus 247 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 247 DAKNYVKKLPRFRK-KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hHHHHHHhccccCc-chHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 00000000 00000 012346677899999999999999999876653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=207.13 Aligned_cols=245 Identities=20% Similarity=0.211 Sum_probs=163.4
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 382 (572)
+|+....+++|.||.||+|+. .++++||+|+++..... ..+--.-.+||.+|.+++|||||.+-.+... -+.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 455566789999999999986 46999999999876532 2222345689999999999999999887653 4679999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~ 439 (572)
||||+. +|...++.-. ..+.-.+...+..|+.+|+.||| +|.++++.....+ ..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999987 7888887644 24666777889999999999997 4666654322111 01
Q ss_pred CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc-------------cCCCCcchhhhhhcc
Q 038466 440 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSSDPKIMLIDVLD 505 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~-------------~~~~~~~~~~~~~~~ 505 (572)
..+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++-|...... .....+.......+.
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 1334556889999998776 56999999999999999999999765322110 000111110000000
Q ss_pred -cCCCC-CCC--hHHHHHH---HHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 506 -QRLPP-PVD--RKVIRDI---LLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 506 -~~l~~-~~~--~~~~~~~---~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
-..+. |.. +...... .....+.-..+..||.+|-|++|.+++-+....+
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 00000 000 0000000 1223445567889999999999999987766543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=230.22 Aligned_cols=179 Identities=17% Similarity=0.163 Sum_probs=127.0
Q ss_pred cCCccccccccccCeeEEEEEEcCC--CcEEEEEec--------------CCcchHHHHHHHHHHHHHHHHHhcCCCCcc
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN--GKVFALKKL--------------HTSETEELAFIKSFRNEAQVLSQVLHRNIV 367 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~--g~~vAvK~l--------------~~~~~~~~~~~~~f~~E~~~l~~l~H~niv 367 (572)
.+.+++...+|.|+||+||++.... +..+++|.+ ...........+.|.+|++++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3467788899999999999986532 322332211 110011112345788999999999999999
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhhhhcCCC--cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS- 438 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~- 438 (572)
++++++.+.+..|+|+||+. +++.+++..... .......+...++.|++.||.||| +|++|.++....+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999985 567776654221 111223445678999999999997 45565544321110
Q ss_pred -----------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCC
Q 038466 439 -----------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483 (572)
Q Consensus 439 -----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P 483 (572)
.......||+.|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 011124689999999999999999999999999999999998754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=220.98 Aligned_cols=230 Identities=20% Similarity=0.237 Sum_probs=169.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
...+.+..++|.|.|++|..|+. .+|..||||.+++....... .+.+.+|+++|..++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34567778999999999999985 46999999999877655433 45588999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCC-------------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPD------------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~------------------------- 437 (572)
|||+.+|.+++++.+++.... .....+..|+.++++|+|.++ ++|.+.+
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e---~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE---KEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcccchh---hhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999997654322 344457789999999998653 2222211
Q ss_pred CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC-hH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RK 515 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~ 515 (572)
.......+|++.|.|||+..+..| ++.+|+||+||++|-|+.|..|||.-.-. .. ...++..+...+.. ..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--~L-----r~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--EL-----RPRVLRGKYRIPFYMSC 280 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--cc-----cchheeeeecccceeec
Confidence 111234679999999999988776 57999999999999999999999843210 01 11222222222221 11
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+. +..+.+..+|.+|++++++.++.|.-..
T Consensus 281 dce~------lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 281 DCED------LLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hhHH------HHHHhhccCccccCCHHHhhhhcccchh
Confidence 1122 2235678999999999999998776533
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=207.59 Aligned_cols=206 Identities=22% Similarity=0.210 Sum_probs=147.0
Q ss_pred cCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhhh
Q 038466 316 DGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCN 394 (572)
Q Consensus 316 ~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~ 394 (572)
|.||.||+++. .+|+.+|+|++..... +..|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 78999999986 4689999999976432 23455556667799999999999999999999999999999999
Q ss_pred hhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------CccccccccCccccc
Q 038466 395 LHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS--------------NRTLLAGTYGYIAPE 454 (572)
Q Consensus 395 l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~--------------~~~~~~gt~~y~APE 454 (572)
+.... .+++.....++.+++.|+.|||. |.+|..+..+.+.. ......++..|+|||
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 87543 37888999999999999999984 44444333221110 001123466799999
Q ss_pred cccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccC
Q 038466 455 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSN 534 (572)
Q Consensus 455 ~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~d 534 (572)
+.....++.++||||+|+++|||++|+.|++..... ........++...+. .+..+..+|++.|
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~~~~~~-------~~~~li~~~l~~d 216 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIPEWVSE-------EARSLLQQLLQFN 216 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCcccCCH-------HHHHHHHHHccCC
Confidence 998888999999999999999999999886422100 000001112221111 1234556899999
Q ss_pred CCCCCCH-----HHHHHHH
Q 038466 535 PKSRPTM-----QYVSQEF 548 (572)
Q Consensus 535 P~~RPsm-----~~V~~~l 548 (572)
|++||++ ++++.|.
T Consensus 217 p~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 217 PTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred HHHhcCCCccchHHHHcCC
Confidence 9999996 5555443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=203.62 Aligned_cols=218 Identities=26% Similarity=0.351 Sum_probs=159.5
Q ss_pred CeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhhhh
Q 038466 317 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNL 395 (572)
Q Consensus 317 ~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l 395 (572)
+||.||+|... +|+.+|+|++........ .+.|.+|++.+++++|+|+++++|++..+...+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999976 589999999986554321 468899999999999999999999999999999999999999999998
Q ss_pred hcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCCC----------------CCCccccccccCcccc
Q 038466 396 HNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCPD----------------SSNRTLLAGTYGYIAP 453 (572)
Q Consensus 396 ~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~~----------------~~~~~~~~gt~~y~AP 453 (572)
..... +++.....++.++++++.|||.. +.|..+..... ........|+..|++|
T Consensus 79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGR---LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccC---CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 75432 78888999999999999999853 33322211110 0012234578899999
Q ss_pred ccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChH-HHHHHHHHHHHHHHcc
Q 038466 454 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRK-VIRDILLASTISFACL 531 (572)
Q Consensus 454 E~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~-~~~~~~~~~~i~~~Cl 531 (572)
|+.....++.++||||||++++||++|+.|++... ... ...+... .......... ... .+..++.+|+
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~l 225 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD------QLL-ELFKKIGKPKPPFPPPEWKISP---EAKDLIRKLL 225 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHH-HHHHHHhccCCCCccccccCCH---HHHHHHHHHc
Confidence 99988889999999999999999999999985321 111 1111111 1111110000 111 2345667999
Q ss_pred ccCCCCCCCHHHHHHHHh
Q 038466 532 QSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 532 ~~dP~~RPsm~~V~~~l~ 549 (572)
..+|++||++.+++++.+
T Consensus 226 ~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 226 VKDPEKRLTAEEALQHPF 243 (244)
T ss_pred cCCchhccCHHHHhhCCC
Confidence 999999999999988643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-25 Score=240.17 Aligned_cols=183 Identities=24% Similarity=0.384 Sum_probs=152.1
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++|++.+++|.|+||.|..++.. ++++||+|++++..........-|..|-.+|.--+.+-||+++-.|.++..+|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3467899999999999999999875 589999999987655544445689999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHH----HHHHHHHHHHHHHhcCCCCCceeeCCC-----------------C-C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRV----NIVKAMAHALAYLHHDCSPSIASTCPD-----------------S-S 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~----~i~~~ia~gl~yLH~~~~~~i~~~~~~-----------------~-~ 439 (572)
|||||+||+|...+.+.. ..+-+|++.+ -+|++-.|.|.|+|+|++|.++..+.. + .
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999999998776 4556787543 356677799999999999987643211 1 1
Q ss_pred CccccccccCcccccccc----C-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 NRTLLAGTYGYIAPELAY----T-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~----~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
...+.+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 123467999999999874 2 6799999999999999999999999863
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.35 Aligned_cols=240 Identities=20% Similarity=0.229 Sum_probs=159.0
Q ss_pred ccccccccccCeeEEEEEEcC-C--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC----Ce
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR----KC 378 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 378 (572)
+++...+|.|+||.||+++.. + +..||+|++...... ....+.+.+|+++++++ .||||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 445667899999999999854 4 789999998743221 12245678899999999 599999999976533 45
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------- 438 (572)
.++++||+. ++|.+++.... .+++.....++.|++.|++|||+ |++|..+..+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999986 68988886432 47888899999999999999984 4444433211100
Q ss_pred -------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhh
Q 038466 439 -------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLID 502 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~ 502 (572)
.......||..|+|||+..+ ..++.++||||+||++|||++|+.|+........ ...+......
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 00122358899999998765 4689999999999999999999999853211000 0000000000
Q ss_pred hccc----------CCC-CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 503 VLDQ----------RLP-PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 503 ~~~~----------~l~-~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..++ ..+ .+........-..+..+..+|++.||++|||+++++.+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 0000 000 000000000011234677799999999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=199.20 Aligned_cols=232 Identities=23% Similarity=0.291 Sum_probs=167.9
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcc-----hHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 378 (572)
.++...++|.|+-++|-++.. ++|..+|+|++.... ..-.+..+.-.+|+.+|+++ .||+|+++.++|..+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 345556788888888888764 568899999986322 11234456777899999998 59999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------- 437 (572)
.++|+|.|+.|.|+++|... ..++..+-.+|+.++.+|++||| +|.+|.++..+..
T Consensus 98 ~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999753 35777777789999999999986 6777776543211
Q ss_pred -CCCccccccccCccccccccC------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--
Q 038466 438 -SSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-- 508 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l-- 508 (572)
+....-++|||||.|||.+.. ..|+...|.|+.||+||.++.|.+||.-. .+-.++..+.....
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLRMIMEGKYQF 247 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHHHHHhccccc
Confidence 111233689999999998754 35788999999999999999999998411 11112222222211
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..|.-.. -...+.+++.+|++.||++|-|.+|+++|.+.
T Consensus 248 ~speWad---is~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 248 RSPEWAD---ISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred CCcchhh---ccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 1111000 11123456668999999999999999999876
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-23 Score=202.19 Aligned_cols=244 Identities=21% Similarity=0.229 Sum_probs=168.3
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCC-cccEEEEEEeCC------e
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRK------C 378 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 378 (572)
++.+..+|+|.||+||+|+. .+|+.||+|++.....++. .-..-.+|+.++++++|+| ||++++++...+ .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 44556799999999999985 5799999999986644211 1123457999999999999 999999999877 7
Q ss_pred EEEEEecccCCChhhhhhcCCCc-ccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDA-VELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------ 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~-~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------ 439 (572)
.++|+||+.. +|.+++...... ..++-.....++.|+.+|++||| ||.+|.++..+.+..
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 8999999975 788888764421 23555567789999999999996 678887765543211
Q ss_pred -----CccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccc----------c---CCCCcchhh
Q 038466 440 -----NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------S---SSSDPKIML 500 (572)
Q Consensus 440 -----~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~---~~~~~~~~~ 500 (572)
..+..++|..|.|||++.+. .|++..|+||+||++.||+++++-|....+. . ....+....
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 12234578899999998776 7999999999999999999988766432210 0 011111110
Q ss_pred hhhcccCCCC---CCChHH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 IDVLDQRLPP---PVDRKV--IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~~~~~~~l~~---~~~~~~--~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..-.+...+. +.+-.. ........++..+|++.+|.+|.|.+.++.|.+...
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 0000111111 111000 000123456777999999999999999999865543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=202.28 Aligned_cols=236 Identities=20% Similarity=0.320 Sum_probs=165.5
Q ss_pred ccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEecccC
Q 038466 311 SIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.++|+|+||+|--+. +.+|..+|||++.+..... +.+..+|++++.+.+ |+||++++.||.++...|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs---R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS---RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchH---HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 378999999999886 6889999999998775443 457778999999885 99999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee-----------C---CC-----------
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST-----------C---PD----------- 437 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~-----------~---~~----------- 437 (572)
|+|..+|+++. .+...+.-+++.+||.||.||| +|.+|.++.- | ..
T Consensus 161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99999998754 3555666779999999999997 5666654321 0 00
Q ss_pred --CCCccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCcccc----c-cCCC---Ccchhhhh
Q 038466 438 --SSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS----L-SSSS---DPKIMLID 502 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~----~-~~~~---~~~~~~~~ 502 (572)
......-+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||-..-. | +... -++.....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 00112346888899999753 24588999999999999999999999853211 1 1110 01111111
Q ss_pred hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 503 VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 503 ~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+-+....-|. .+...-...+.++...-+..|+.+|-+..+|++++|..+-
T Consensus 318 IQEGkYeFPd-kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 318 IQEGKYEFPD-KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HhccCCcCCh-hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 2222222111 1111111122344445677999999999999998887643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-23 Score=200.05 Aligned_cols=233 Identities=20% Similarity=0.281 Sum_probs=168.0
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++|+..+++|.|.||+|-.++- .+|+.+|+|++++...-....+..-..|-++|+..+||.+..+--.|+..+.++.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457889999999999999999985 4699999999987654444445566789999999999999999989999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCcee-------------eC----CCC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIAS-------------TC----PDS 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~-------------~~----~~~ 438 (572)
||||+.||.|+-+|...+ .++..+..-+...|..||.|||+. .+-.... .| ...
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999999998887543 244444445678899999999963 2111111 11 123
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.....++|||.|.|||++....|+...|+|..|||||||++|+.||...+. ..-..+.-+-+-+.|....++. .
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLIl~ed~kFPr~ls~eA-k 396 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELILMEDLKFPRTLSPEA-K 396 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHHHhhhccCCccCCHHH-H
Confidence 345678999999999999999999999999999999999999999853321 0000111122223333322221 1
Q ss_pred HHHHHHHHHHHccccCCCCCC----C-HHHHHHHHhh
Q 038466 519 DILLASTISFACLQSNPKSRP----T-MQYVSQEFLI 550 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RP----s-m~~V~~~l~~ 550 (572)
.+ ...-+.+||.+|- . +.||.++-+.
T Consensus 397 tL------LsGLL~kdP~kRLGgGpdDakEi~~h~FF 427 (516)
T KOG0690|consen 397 TL------LSGLLKKDPKKRLGGGPDDAKEIMRHRFF 427 (516)
T ss_pred HH------HHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence 11 1245789999994 2 6788776543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=204.36 Aligned_cols=234 Identities=16% Similarity=0.159 Sum_probs=148.6
Q ss_pred CCccccccccccCeeEEEEEEcCC----CcEEEEEecCCcchH---HHHH-----HHHHHHHHHHHHhcCCCCcccEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETE---ELAF-----IKSFRNEAQVLSQVLHRNIVKLYGF 372 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~---~~~~-----~~~f~~E~~~l~~l~H~niv~l~g~ 372 (572)
+.+.+...+|.|+||.||+|+..+ +..+|+|........ +... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 456777889999999999998643 456677754322211 0000 1122334455667899999999998
Q ss_pred EEeCC----eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----
Q 038466 373 CLHRK----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----- 437 (572)
Q Consensus 373 ~~~~~----~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----- 437 (572)
+.... ..++++|++.. ++.+.+.... ..++.....++.++++|++||| +|.+|..+..+..
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 76543 34678887653 4544444321 2456777889999999999996 4666654432110
Q ss_pred -------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCC-cc
Q 038466 438 -------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-PK 497 (572)
Q Consensus 438 -------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~-~~ 497 (572)
........||+.|+|||+..+..++.++|||||||+++||+||+.||........... ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 0011234699999999999999999999999999999999999999864321100000 00
Q ss_pred h-hhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 498 I-MLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 498 ~-~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
. ....+..+....+.... .+.++...|++.+|++||++.++.+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANK------FIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhhccCCCCH------HHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 00111111111111111 123455689999999999999998754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=202.19 Aligned_cols=237 Identities=21% Similarity=0.218 Sum_probs=162.1
Q ss_pred cccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-----CCeEEEEE
Q 038466 310 FSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----RKCMFLIY 383 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~ 383 (572)
.+.+|.|+||.|.+|.. .+|+.||||++...-.... ..++-.+|+++|+.++|+||+.+++.+.. -+.+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 56789999999999985 5799999999973322222 23667789999999999999999998865 34699999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-------------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP-------------------DS 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~-------------------~~ 438 (572)
|+|+ -+|.+.++... .++-....-+..|+.+|+.|+| +|++|.+...+. ..
T Consensus 106 elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 9994 57888887543 2555555567889999999996 688887553211 11
Q ss_pred CCccccccccCcccccccc-CCCcCcccchHHHHHHHHHHHcCCCCCCcccccc--------CCCCcchh--------hh
Q 038466 439 SNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKIM--------LI 501 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~-~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~--------~~~~~~~~--------~~ 501 (572)
...+-.+.|..|.|||.+. ...|+...||||.||++.||++|++-|...+.+. ..+..+.. ..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 2234456789999999875 4679999999999999999999998664322110 00001100 00
Q ss_pred hhcc---cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 502 DVLD---QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 502 ~~~~---~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+. +..+.+........-..++++..+++..||.+|+|.+|.++|++..
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 1111 1111111000001112345666789999999999999999998765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=205.44 Aligned_cols=236 Identities=23% Similarity=0.283 Sum_probs=153.9
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC---e--EE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK---C--MF 380 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---~--~~ 380 (572)
+....++|.|+||.||+|.+. +++.||||+.-...... .+|+++|++++|||||++.-+|.... + ..
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 344568999999999999864 57999999987654321 26999999999999999999887532 2 35
Q ss_pred EEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------CCcccc
Q 038466 381 LIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------SNRTLL 444 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------~~~~~~ 444 (572)
+||||||. +|.+.++.. .....++-....-+..|+.+|++||| +|++|.+...+.+. +.....
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99999996 788888742 11122333334447889999999995 67888766544332 111122
Q ss_pred c--------cccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc----------cCCCCcchh-----h
Q 038466 445 A--------GTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDPKIM-----L 500 (572)
Q Consensus 445 ~--------gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----------~~~~~~~~~-----~ 500 (572)
. -|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+.. .....+++. .
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 2 3567999998765 57999999999999999999999866422110 000000000 0
Q ss_pred hhhcccCCCC-CCCh-HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 501 IDVLDQRLPP-PVDR-KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 501 ~~~~~~~l~~-~~~~-~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+...+.+.+ +..+ ..-.......++..++++.+|.+|.+..|++.|.+.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 0011111111 0000 000011123466778999999999999999998654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=196.39 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=166.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 382 (572)
++.+....+|.|..|+|+|++.. +|...|||.+......+. .++....++++.+-. .|.||+.+|||..+..+++.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 34556677899999999999864 699999999987654332 467777787776654 89999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH-------hcCCCCCceeeCC----------------CCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL-------HHDCSPSIASTCP----------------DSS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL-------H~~~~~~i~~~~~----------------~~~ 439 (572)
||.|.. .....++.-.. +++..-.=++...+.+||.|| |+|.+|.++..+. ++.
T Consensus 170 MelMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 999964 23444443222 232222225677788999998 8899998765432 122
Q ss_pred CccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 440 NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
..+..+|.+.|||||-+.- ..|+.++|||||||.++||.||+.||..-. .+ -..+..+++ ..||..+...
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-----td-Fe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-----TD-FEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-----cc-HHHHHHHHh-cCCCCCCccc
Confidence 2344578999999998863 479999999999999999999999985311 11 112233333 2222221111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
.-...+.++...|+.+|+.+||.-.++++|.+..+..++.
T Consensus 320 -gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 320 -GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred -CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 0011234555689999999999999999998877665543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-23 Score=225.68 Aligned_cols=229 Identities=23% Similarity=0.360 Sum_probs=155.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------- 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 376 (572)
.+|+....+|.||||.|||++.+ ||+.+|||++.... .+. ......+|+.++++++|||||++|....+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~-~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDK-LYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHH-HHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 34666778999999999999965 89999999998765 222 235677899999999999999997543210
Q ss_pred --------------------------------------------------------------------------------
Q 038466 377 -------------------------------------------------------------------------------- 376 (572)
Q Consensus 377 -------------------------------------------------------------------------------- 376 (572)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh
Q 038466 377 --------------------------------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424 (572)
Q Consensus 377 --------------------------------~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH 424 (572)
..+||-||||+.-.+.++++.+.... .-..-.++..+|++|+.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 12467788888777777776543211 11122357889999999996
Q ss_pred ------cCCCCCceeeCC-----------------------------------CCCCccccccccCccccccccCC---C
Q 038466 425 ------HDCSPSIASTCP-----------------------------------DSSNRTLLAGTYGYIAPELAYTM---V 460 (572)
Q Consensus 425 ------~~~~~~i~~~~~-----------------------------------~~~~~~~~~gt~~y~APE~~~~~---~ 460 (572)
||.+|.++..+. ...+.+..+||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 678886542210 01123456799999999998754 4
Q ss_pred cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCC
Q 038466 461 MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540 (572)
Q Consensus 461 ~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPs 540 (572)
|+.|.|+||+|||++||+.- |.. .+.....+...-++.+|.+.+ -...++.....+..+.+++||.+|||
T Consensus 795 Yn~KiDmYSLGIVlFEM~yP---F~T------sMERa~iL~~LR~g~iP~~~~-f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLYP---FGT------SMERASILTNLRKGSIPEPAD-FFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred ccchhhhHHHHHHHHHHhcc---CCc------hHHHHHHHHhcccCCCCCCcc-cccccchHHHHHHHHHhcCCCccCCC
Confidence 99999999999999999964 321 111112223333445554411 01111222234556889999999999
Q ss_pred HHHHHHH
Q 038466 541 MQYVSQE 547 (572)
Q Consensus 541 m~~V~~~ 547 (572)
+.|++..
T Consensus 865 A~eLL~s 871 (1351)
T KOG1035|consen 865 ATELLNS 871 (1351)
T ss_pred HHHHhhc
Confidence 9999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=212.14 Aligned_cols=246 Identities=12% Similarity=0.126 Sum_probs=151.3
Q ss_pred cCCccccccccccCeeEEEEEEc-----------------CCCcEEEEEecCCcchHHH-H----------HHHHHHHHH
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-----------------PNGKVFALKKLHTSETEEL-A----------FIKSFRNEA 355 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-----------------~~g~~vAvK~l~~~~~~~~-~----------~~~~f~~E~ 355 (572)
.++|++...+|.|+||.||+|.. .+++.||||++........ . ..+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45788888999999999999963 2356899999875432211 0 012334577
Q ss_pred HHHHhcCCCCc-----ccEEEEEEe--------CCeEEEEEecccCCChhhhhhcCCC---------------------c
Q 038466 356 QVLSQVLHRNI-----VKLYGFCLH--------RKCMFLIYEYMKRGSLFCNLHNNED---------------------A 401 (572)
Q Consensus 356 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~ 401 (572)
..+.+++|.++ ++++|+|.. .+..++||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888877765 778888764 3568999999999999999875311 1
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------CCcc--ccccccCcccccccc
Q 038466 402 VELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------SNRT--LLAGTYGYIAPELAY 457 (572)
Q Consensus 402 ~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~~~~--~~~gt~~y~APE~~~ 457 (572)
..++|.....++.++++|+.|||. |.+|..+....+. .... ...+|+.|+|||.+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 135677888899999999999974 4555443221110 0001 122478999999875
Q ss_pred CCC--------------------c--CcccchHHHHHHHHHHHcCCC-CCCccccccCCC---Ccchh-hhhhcccCCCC
Q 038466 458 TMV--------------------M--TEKCDVYSFGVVTLEVLMGKH-PRDLLSSLSSSS---DPKIM-LIDVLDQRLPP 510 (572)
Q Consensus 458 ~~~--------------------~--s~ksDVySfGvvl~ElltG~~-P~~~~~~~~~~~---~~~~~-~~~~~~~~l~~ 510 (572)
... + ..+.||||+||+++||++|.. |+.......... ..... ..........-
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 432 1 135799999999999999985 654321111000 00000 00000011110
Q ss_pred CCChHHHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHhhcc
Q 038466 511 PVDRKVIRDILLASTISFACLQSNP---KSRPTMQYVSQEFLITR 552 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP---~~RPsm~~V~~~l~~~~ 552 (572)
+..... -....+++.+++..+| .+|+|++|+++|.|...
T Consensus 464 ~~~d~~---s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRN---KEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccc---ChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000000 0112345556777655 78999999999987643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=208.79 Aligned_cols=172 Identities=22% Similarity=0.370 Sum_probs=137.3
Q ss_pred ccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-C-----CCcccEEEEEEeCCeE
Q 038466 307 IDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-H-----RNIVKLYGFCLHRKCM 379 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~ 379 (572)
+++.+++|.|.||+|-||. ..+++.||||+++.... +..+-..|+.+|..++ | -|+|++++||...++.
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 4567789999999999998 46799999999986542 3345567999999997 3 5899999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCCc------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSNR------------ 441 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~~------------ 441 (572)
+||+|.... +|.++|+.+. ...++......++.||++||.+|| -|.+|.++..+......
T Consensus 264 ciVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999975 8999998754 335788888889999999999996 46677666543222111
Q ss_pred ----cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 442 ----TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 442 ----~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
-...-+..|.|||++.+..|+.+.||||||||+.||.||.+-|
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 1122356699999999999999999999999999999997533
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=191.55 Aligned_cols=228 Identities=25% Similarity=0.304 Sum_probs=162.7
Q ss_pred ccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe----CCeEEEEEe
Q 038466 311 SIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----RKCMFLIYE 384 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E 384 (572)
.++|.|--|+|-.+.. .+|+.+|+|++..+.. -++|+++.=+. .|||||++++.|.. ...+.+|||
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K--------ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK--------ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHH--------HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 4789999999998875 4689999999976532 23677764444 69999999998764 456889999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------S 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------~ 439 (572)
+|+||.|+..+..++. ..++..+.-.|+.+|+.|+.||| +|.+|.+....... .
T Consensus 140 ~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred cccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999999987654 35777778899999999999997 56666543221111 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 517 (572)
....-+=|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... . ...+...+... ..|.+.-.+..
T Consensus 219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--i-spgMk~rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--I-SPGMKRRIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--C-ChhHHhHhhccCccCCChhHhHHH
Confidence 1122345889999999999999999999999999999999999986432211 1 11122222222 22322211111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+ .+.+++...+..+|++|-|+++++.+.|+...
T Consensus 296 e---~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 296 E---AAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred H---HHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 2 12345556789999999999999999987654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-23 Score=202.56 Aligned_cols=219 Identities=21% Similarity=0.305 Sum_probs=155.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++++..++|.|+||+|..|..+ +.+.+|||++++...-+...++--..|-++|+-- +-|.+|+++.+++.-+.+|.||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 4667789999999999999765 4789999999865432222223333466666544 5789999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC-----------------CCCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP-----------------DSSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~-----------------~~~~ 440 (572)
||+.+|+|.-+++..+. +..+..+-+|.+||-||-|||. |.+-..+..+. +...
T Consensus 430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 99999999988886543 3445567789999999999995 33332222111 1223
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
..+++|||.|+|||++....|+...|+|||||+||||+.|++||+.. +++.....+.+....-|. ....+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-------DE~elF~aI~ehnvsyPK--slSkE- 576 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-------DEDELFQAIMEHNVSYPK--SLSKE- 576 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHHccCcCcc--cccHH-
Confidence 34578999999999999999999999999999999999999999743 222223334444433321 22222
Q ss_pred HHHHHHHHHccccCCCCCC
Q 038466 521 LLASTISFACLQSNPKSRP 539 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RP 539 (572)
+..|...-+.+.|.+|-
T Consensus 577 --Av~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 577 --AVAICKGLLTKHPGKRL 593 (683)
T ss_pred --HHHHHHHHhhcCCcccc
Confidence 22344455678888874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=191.82 Aligned_cols=228 Identities=21% Similarity=0.376 Sum_probs=163.7
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
++..++.+..-|..|+|+++.+.+ ++|++...+... ...++|..|.-.|+-+.||||..++|.|..+.++.++..||+
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDI-VAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCcccccccccCcch-hhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344566677789999999986554 456665443222 234689999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCce---------eeCCCCCCc------------ccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIA---------STCPDSSNR------------TLLAG 446 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~---------~~~~~~~~~------------~~~~g 446 (572)
.|||+..||+... ...+-.+.++.|.++|+|++|||+- .|-+. ..+.+-... ....=
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAY 348 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeecccccc
Confidence 9999999997543 3467788899999999999999963 12111 111110000 00112
Q ss_pred ccCccccccccCCCcC---cccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMT---EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 447 t~~y~APE~~~~~~~s---~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
.+.||+||.+....-+ ..+|+|||.|++||+.|.+.||.....+..... ...+-+...+||...+..
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---ialeglrv~ippgis~hm------- 418 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---IALEGLRVHIPPGISRHM------- 418 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---hhhccccccCCCCccHHH-------
Confidence 5789999998766533 579999999999999999999975543332221 123445566666654332
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+++.-|+.+||.+||.+..|+--++
T Consensus 419 ~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHH
Confidence 23445699999999999999876654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-23 Score=195.34 Aligned_cols=237 Identities=24% Similarity=0.280 Sum_probs=159.0
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+....+|.|.||+|+|-.. +.|+..|||++.....+. ..++|..|.+. ++.-+-||||++||.+...+..|+-|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 334456789999999999986 569999999998765432 24678888875 55557899999999999999999999
Q ss_pred ecccCCChhhh---hhcCCCcccCCHHHHHHHHHHHHHHHHHH-------hcCCCCCceeeCCC----------------
Q 038466 384 EYMKRGSLFCN---LHNNEDAVELDWAKRVNIVKAMAHALAYL-------HHDCSPSIASTCPD---------------- 437 (572)
Q Consensus 384 Ey~~~GsL~~~---l~~~~~~~~l~~~~r~~i~~~ia~gl~yL-------H~~~~~~i~~~~~~---------------- 437 (572)
|.|.- |++.+ .+... ...++..-.-.|......||.|| |+|.+|+.+..+..
T Consensus 143 ELMd~-SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHhh-hHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99964 55332 22211 11233333334445556777776 99999987754221
Q ss_pred CCCccccccccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC-Ch
Q 038466 438 SSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV-DR 514 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~ 514 (572)
+...+..+|...|||||-+... .|+.+|||||+||+|||+.||+.|+..+.+. .+ .+..++....|.-. +.
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----fe--ql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FE--QLCQVVIGDPPILLFDK 294 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HH--HHHHHHcCCCCeecCcc
Confidence 1223456788999999988643 4899999999999999999999998644321 00 11222222222111 11
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+..+-...+....-.|+-+|-++||...++..+.+...
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 11111223345555899999999999999988765443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=202.40 Aligned_cols=175 Identities=22% Similarity=0.358 Sum_probs=139.6
Q ss_pred ccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
..+.+|.|+||.|..++ .++...+|+|.+.+.+.-....+...+.|-.||++.+.+-||+||-.|.+++.+|.||||++
T Consensus 633 kik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIP 712 (1034)
T KOG0608|consen 633 KIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 712 (1034)
T ss_pred EEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccC
Confidence 35678999999999996 56688999999998877666667788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHH-----HHHHHHHHHHHHhcCCCCCceeeCCCC------------------------
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVN-----IVKAMAHALAYLHHDCSPSIASTCPDS------------------------ 438 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~-----i~~~ia~gl~yLH~~~~~~i~~~~~~~------------------------ 438 (572)
||++...|-+.+-.. -+ ..|.- .|++-+|-|.|+|+|++|..+..+.++
T Consensus 713 GGDmMSLLIrmgIFe-E~-LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 713 GGDMMSLLIRMGIFE-ED-LARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred CccHHHHHHHhccCH-HH-HHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 999988876543211 11 12332 345556778888999999755321100
Q ss_pred ------------------CC-----------------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCC
Q 038466 439 ------------------SN-----------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483 (572)
Q Consensus 439 ------------------~~-----------------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P 483 (572)
+. ...++||+.|+|||++....|+.-+|+||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 00 0125799999999999999999999999999999999999999
Q ss_pred CC
Q 038466 484 RD 485 (572)
Q Consensus 484 ~~ 485 (572)
|-
T Consensus 871 f~ 872 (1034)
T KOG0608|consen 871 FL 872 (1034)
T ss_pred cc
Confidence 85
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=190.24 Aligned_cols=229 Identities=20% Similarity=0.335 Sum_probs=163.7
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
..++|++..++|.|+|++|..+++. +.+.+|+|++++.-..+.+.+...+.|-.+..+. +||.+|.+..+|.....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4567888999999999999999974 6899999999865544444455666777777665 6999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee-------------C----CC
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST-------------C----PD 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~-------------~----~~ 437 (572)
.|.||+++|+|.-+++..+ .++.....-+..+|.-+|.|||. |.+-..+.. | ..
T Consensus 328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999987776543 35554445577889999999995 333222211 1 12
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCC-cchhhhhhcccCCCCCCChHH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-PKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~ 516 (572)
......++|||.|+|||.+.+..|+...|+|++||+|+||+.|+.|||....-..... .+....-++...+..|..-.
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls- 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS- 483 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee-
Confidence 2334578999999999999999999999999999999999999999986542111111 12222223333333332111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 038466 517 IRDILLASTISFACLQSNPKSRP 539 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RP 539 (572)
..+..+...-+.+||.+|.
T Consensus 484 ----vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 484 ----VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----hhhHHHHHHhhcCCcHHhc
Confidence 1123344467899999884
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=204.45 Aligned_cols=222 Identities=21% Similarity=0.242 Sum_probs=157.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh-cCCCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV 382 (572)
+.+++...+|.|+|++|-++.. ++++..|||++..... +-.+|+.++.. -+||||+++.+.|.++.+.|+|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 3445555689999999999875 5689999999986622 12346655544 4799999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-CCCCCc--------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-PDSSNR-------------- 441 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-~~~~~~-------------- 441 (572)
||++.+|-+.+.+..... .. ..+..++.+++.++.||| +|.+|.++... ....-.
T Consensus 395 ~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred ehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 999999988877765432 22 566678899999999997 56777766553 111000
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
..-+=|..|.|||+.....|++.+|+||+||+||||++|+.|+..-. . ...+...+ ..++.......
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P------~-~~ei~~~i---~~~~~s~~vS~--- 537 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP------A-GIEIHTRI---QMPKFSECVSD--- 537 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC------c-hHHHHHhh---cCCccccccCH---
Confidence 01123677999999999999999999999999999999999974211 1 11111111 11111111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+..+...|++.||.+||+|+++..+.|.
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcch
Confidence 12345558999999999999999999887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=195.41 Aligned_cols=230 Identities=24% Similarity=0.347 Sum_probs=157.4
Q ss_pred cccccccCeeEEEEEE-cCCCcEEEEEecCCcchHH----HHHHHHHHHHHHHHHhcCCCCcccEEEEEE-eCCeEEEEE
Q 038466 310 FSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-HRKCMFLIY 383 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 383 (572)
...+|.|||+.||||. +...+.||||+-....... ..+.+.-.+|-++.+.++||.||++|+|+. +.+..+-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 4578999999999997 5667889999865433221 223455667899999999999999999986 456788999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceee--------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--------HDCSPSIAST--------------------C 435 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH--------~~~~~~i~~~--------------------~ 435 (572)
|||+|.+|+-+|+.++ .++......|+.+|+.+|.||. -|.+|+.+.. +
T Consensus 548 EYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred eecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 9999999999998654 3566777889999999999995 3444443321 0
Q ss_pred CCCCC-------ccccccccCccccccccC----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc
Q 038466 436 PDSSN-------RTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 436 ~~~~~-------~~~~~gt~~y~APE~~~~----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
.++.+ ....+||+.|++||.+.- .+++.|.||||.||++|.-+.|+.||.....-....... .+...-
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN-TIlkAt 703 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN-TILKAT 703 (775)
T ss_pred CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-chhcce
Confidence 01111 123579999999998754 368999999999999999999999985321100000000 011111
Q ss_pred ccCCCC-CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 505 DQRLPP-PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 505 ~~~l~~-~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.-..|+ |.-... +..++.+|++..-++|-...++..+..
T Consensus 704 EVqFP~KPvVsse------AkaFIRRCLaYRKeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 704 EVQFPPKPVVSSE------AKAFIRRCLAYRKEDRIDVQQLACDPY 743 (775)
T ss_pred eccCCCCCccCHH------HHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence 111221 211111 223445899999999998888876643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-20 Score=174.56 Aligned_cols=189 Identities=28% Similarity=0.462 Sum_probs=149.8
Q ss_pred ccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCCh
Q 038466 313 WNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL 391 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 391 (572)
+|.|++|.||++...+ |+.+++|++....... ..+.+.+|++.+++++|++++++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4678999999999754 8999999998665432 236788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCC-CCC-----------------Cccccccc
Q 038466 392 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCP-DSS-----------------NRTLLAGT 447 (572)
Q Consensus 392 ~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~-~~~-----------------~~~~~~gt 447 (572)
.+++.... ..+++..+..++.++++++.|||.. ..|..+.... ... ......+.
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 99987542 2478889999999999999999853 3333332222 100 01123467
Q ss_pred cCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHH
Q 038466 448 YGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTI 526 (572)
Q Consensus 448 ~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i 526 (572)
..|++||..... .++.++|+|++|++++|| .....+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~~~~ 193 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PELKDL 193 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHHHHH
Confidence 789999998877 888999999999999998 112345
Q ss_pred HHHccccCCCCCCCHHHHHHHH
Q 038466 527 SFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 527 ~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
...|++.+|++||++.++++++
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 5689999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=208.65 Aligned_cols=245 Identities=17% Similarity=0.177 Sum_probs=143.9
Q ss_pred ccCCccccccccccCeeEEEEEEcC-C----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEE-----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-N----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF----- 372 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~----- 372 (572)
..+++++...+|.|+||.||+|+.. + +..||||++......+. +..| .+.+..+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3456777889999999999999864 4 78999999865432211 1111 1222223333322221
Q ss_pred -EEeCCeEEEEEecccCCChhhhhhcCCCcc-----------------cCCHHHHHHHHHHHHHHHHHHh------cCCC
Q 038466 373 -CLHRKCMFLIYEYMKRGSLFCNLHNNEDAV-----------------ELDWAKRVNIVKAMAHALAYLH------HDCS 428 (572)
Q Consensus 373 -~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~-----------------~l~~~~r~~i~~~ia~gl~yLH------~~~~ 428 (572)
+..++..++||||+++|+|.++++...... .........++.|+++||+||| +|++
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 245678999999999999999887532100 0111223468899999999997 4566
Q ss_pred CCceeeCCCCC-------------------CccccccccCccccccccCC----------------------CcCcccch
Q 038466 429 PSIASTCPDSS-------------------NRTLLAGTYGYIAPELAYTM----------------------VMTEKCDV 467 (572)
Q Consensus 429 ~~i~~~~~~~~-------------------~~~~~~gt~~y~APE~~~~~----------------------~~s~ksDV 467 (572)
|.++..+.+.. ......||++|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 65443321110 01234578999999965321 24457799
Q ss_pred HHHHHHHHHHHcCCCCCCccc-c----ccCCCCcchhhhhhcccCCCCCCChHHHH----HHHHHHHHHHHccccCCCCC
Q 038466 468 YSFGVVTLEVLMGKHPRDLLS-S----LSSSSDPKIMLIDVLDQRLPPPVDRKVIR----DILLASTISFACLQSNPKSR 538 (572)
Q Consensus 468 ySfGvvl~ElltG~~P~~~~~-~----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~~~i~~~Cl~~dP~~R 538 (572)
|||||++|||+++..|.+... . +...............+...+.. ....+ +.....++...|++.||++|
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDL-RRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhh-hhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999877754210 0 00000000001111111111100 00000 00012256678999999999
Q ss_pred CCHHHHHHHHhhccCCC
Q 038466 539 PTMQYVSQEFLITRKTP 555 (572)
Q Consensus 539 Psm~~V~~~l~~~~~~~ 555 (572)
||++++++|.+..+..+
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999998876554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-22 Score=199.80 Aligned_cols=229 Identities=20% Similarity=0.312 Sum_probs=169.8
Q ss_pred CccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+....+|.||||.|=...... ...+|+|.+++....+..+.+....|-++|-+.+.|.||++|--|.+...+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 34556789999999998887654 33589999987766666666788899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC----------------CCCCCcc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC----------------PDSSNRT 442 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~----------------~~~~~~~ 442 (572)
-|-||.|...|++++. ++-....-++..+.+|++|||+ |.+|.+...+ ..+....
T Consensus 501 aClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 9999999999987653 4434444577788999999995 6777654322 1233445
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchh---hhhhccc-CCCCCCChHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM---LIDVLDQ-RLPPPVDRKVIR 518 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~---~~~~~~~-~l~~~~~~~~~~ 518 (572)
+++|||.|.|||++....++..+|.||+||++|||+||++||...+ +-.. +..-+|. .+|.-..+.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-------pmktYn~ILkGid~i~~Pr~I~k~--- 647 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-------PMKTYNLILKGIDKIEFPRRITKT--- 647 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHHHHhhhhhhhcccccchh---
Confidence 6899999999999999999999999999999999999999985322 2111 1111221 112111111
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+..++.+-+..+|.+|-. +.+|-+|-|..
T Consensus 648 ----a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 648 ----ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ----HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 223344555789999976 77888877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-22 Score=207.20 Aligned_cols=237 Identities=22% Similarity=0.329 Sum_probs=166.4
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..++++....+|.|.||.|||++. ..++..|||.++.....+. +-.++|+-+++..+|||||.++|.+...+..|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 345788888999999999999985 5699999999987655442 456689999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC------CCCceeeCC----------CC-------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC------SPSIASTCP----------DS------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~------~~~i~~~~~----------~~------- 438 (572)
.||||.+|+|.+.-|..+ .+...+..-+++...+|++|||... +...+.... .+
T Consensus 90 cMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999988777543 3555566667888999999998543 333322110 00
Q ss_pred CCccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC-CCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-PPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~ 514 (572)
..+..+.||+.|||||+.. .+.|..++|||+.|+...|+---++|......++ . ........ .+|.-+
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~-l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------A-LFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------H-HHHhhccCCCCCccc
Confidence 1123467999999999864 5679999999999999999988888743221000 0 00111111 111100
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.-.....+-.++..|+-++|++||+.+..++|.+....
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 000111122345567999999999999988877655433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=175.15 Aligned_cols=156 Identities=19% Similarity=0.116 Sum_probs=108.3
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC----------CccccccccCccccccccC
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS----------NRTLLAGTYGYIAPELAYT 458 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~----------~~~~~~gt~~y~APE~~~~ 458 (572)
|+|.++++.++ ..++|.+...++.|+++|+.|||+..+|..+....+.. ......||+.|||||++.+
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~fG~~~~~~~~~~~g~~~y~aPE~~~~ 78 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRVDPYFMAPEVIQG 78 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceeeccceEeeccccCCCcccccChHHhcC
Confidence 78999997543 25899999999999999999999988777654322110 0112358999999999999
Q ss_pred CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCCCC-CChHHHHHHHHHHHHHHHccccC
Q 038466 459 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPP-VDRKVIRDILLASTISFACLQSN 534 (572)
Q Consensus 459 ~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~-~~~~~~~~~~~~~~i~~~Cl~~d 534 (572)
..++.++|||||||++|||+||+.|+....... ......... ..+.. .......+...+..++..||+.+
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 152 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRL 152 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcc
Confidence 999999999999999999999999985332110 011111111 11110 01111111113467778999999
Q ss_pred CCCCCCHHHHHHHHhhcc
Q 038466 535 PKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 535 P~~RPsm~~V~~~l~~~~ 552 (572)
|++||++.+++++++...
T Consensus 153 p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 153 PQRREAANHYLAHCRALF 170 (176)
T ss_pred cccccCHHHHHHHHHHHH
Confidence 999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=195.97 Aligned_cols=230 Identities=21% Similarity=0.251 Sum_probs=161.6
Q ss_pred ccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 311 SIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
+++|.|-||+||-|.. ++|+.||||++.+...... ...++++|+.+|++++||.||.+.-.|...+.+|.|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999985 5799999999986543321 1257889999999999999999999999999999999999765
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee-------------------CCCCCCcccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST-------------------CPDSSNRTLL 444 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~-------------------~~~~~~~~~~ 444 (572)
-|.-.|....+ .++...-.-++.||..||+|||. |.+|..+.. ..+.+-+..+
T Consensus 649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 55555543322 35444444578899999999985 455544322 1122223456
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIRDILLA 523 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~~~~ 523 (572)
+||+.|.|||++....|...-|+||.||++|--++|.-||....+.. .++-.. -+-|+.+-..+. ..+
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaFMyPp~PW~eis--~~A 795 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAFMYPPNPWSEIS--PEA 795 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhccccccCCCchhhcC--HHH
Confidence 89999999999999999999999999999999999999986322110 011111 111111111111 122
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
++++-.-++..=++|-|..+-+.+.|....+
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 3444455667777899998888888776554
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=181.24 Aligned_cols=180 Identities=23% Similarity=0.310 Sum_probs=136.7
Q ss_pred cCCccccccccccCeeEEEEEEcC---C--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP---N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~---~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~ 377 (572)
...++....+|.|.||.||||.-. + ...+|+|+++...... ....+-.+|+.++++++|||+|.+..++.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 345667778899999999999532 2 3479999998653221 223455689999999999999999998877 78
Q ss_pred eEEEEEecccCCChhhhhhcCC--CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCC---------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSN--------- 440 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~--~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~--------- 440 (572)
.+++++||++. +|...++-++ ....++-.....|..||..|+.||| +|.+|..+....+...
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999987 7888876543 2235666667789999999999996 6888887654332111
Q ss_pred ---------------ccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 441 ---------------RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 441 ---------------~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
..-++-|+.|.|||.+.+. .||.+.|||+.||+..||+|-++-|.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 1123458999999998775 48999999999999999999776553
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=213.32 Aligned_cols=177 Identities=37% Similarity=0.653 Sum_probs=105.5
Q ss_pred ChhhhHHHHhhhcCCC----CCCCCCCCCCCCCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCC
Q 038466 61 ALSPIQLEKKALINTG----WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136 (572)
Q Consensus 61 ~~~~l~~~~~~~~~~~----~~~~~~~~~~~c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n 136 (572)
+..+++.+++++..+. .|+. ..++|.|.||+|+..++|+.|++++..... .+ ...|..+++|+.|+|++|
T Consensus 30 ~~~~l~~~~~~~~~~~~~~~~w~~---~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~--~~-~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 30 ELELLLSFKSSINDPLKYLSNWNS---SADVCLWQGITCNNSSRVVSIDLSGKNISG--KI-SSAIFRLPYIQTINLSNN 103 (968)
T ss_pred HHHHHHHHHHhCCCCcccCCCCCC---CCCCCcCcceecCCCCcEEEEEecCCCccc--cC-ChHHhCCCCCCEEECCCC
Confidence 3457888888874332 2332 368999999999877899999998532111 01 123556666677777776
Q ss_pred cccccCchhcc-CCccCCEEEccCCcCCCC----------------------CCcCCcCCCCcceeecccccccCCCCcc
Q 038466 137 ALTGSIPPEIS-ALSKLQLLDLSSNGLTGT----------------------IPPEIGNLKNLIELNVGSNSLIGPIPSA 193 (572)
Q Consensus 137 ~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~----------------------ip~~~~~l~~L~~L~Ls~N~l~g~ip~~ 193 (572)
.+.|.+|..+. ++++|++|+|++|+++|. +|..++++++|++|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 66666666544 555666666655555554 4444555555555555555555555555
Q ss_pred ccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCC
Q 038466 194 LGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243 (572)
Q Consensus 194 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s 243 (572)
++++++|++|+|++|.+++.+|..++++++|+.|++++|+++|.+|..++
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 233 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHh
Confidence 55555555555555555555555555555555555555555555555443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.9e-19 Score=169.88 Aligned_cols=173 Identities=29% Similarity=0.399 Sum_probs=137.9
Q ss_pred ccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
....++.|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 44567899999999999765 899999999866543 134688899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeeCC----------------CCC--Cccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIASTCP----------------DSS--NRTL 443 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~------~~~~i~~~~~----------------~~~--~~~~ 443 (572)
+++|.+++..... .+++.....++.++++++.|||.. +.+..+..+. ... ....
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 9999999876432 178888899999999999999853 2222211110 000 1123
Q ss_pred cccccCccccccc-cCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 444 LAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 444 ~~gt~~y~APE~~-~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
..++..|++||.. ....++.++||||||++++||++|+.||+
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 4577889999998 66778889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=179.72 Aligned_cols=245 Identities=19% Similarity=0.275 Sum_probs=167.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC--C----cccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR--N----IVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~--n----iv~l~g~~~~~~ 377 (572)
+.+.+.+.+|+|.||.|-++.. ..+..||||+++.-.. +.+.-.-|+++++++.+. + +|.+.++|.-.+
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3456778899999999999975 3489999999975432 234455799999999432 2 678888888889
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC---------C-----
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP---------D----- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~---------~----- 437 (572)
..++|+|.+ |-|+.+++.++. ..+++......|+.|++++++||| .|.+|.++.... +
T Consensus 165 hiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 999999988 348999998643 345777788899999999999997 467776542210 0
Q ss_pred -----C---------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccc------ccc
Q 038466 438 -----S---------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS------SLS 491 (572)
Q Consensus 438 -----~---------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~------~~~ 491 (572)
+ .....++.|.-|.|||++.+...+.++||||+||||.|+.||..-|..-+ .+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 0 01123457888999999999999999999999999999999987553111 000
Q ss_pred C--CCCcchhhhhh------cccCC-----------------CCCCCh---HHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 038466 492 S--SSDPKIMLIDV------LDQRL-----------------PPPVDR---KVIRDILLASTISFACLQSNPKSRPTMQY 543 (572)
Q Consensus 492 ~--~~~~~~~~~~~------~~~~l-----------------~~~~~~---~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~ 543 (572)
. ...|.-++... ...++ +.|... ..-.+.....++...++..||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 0 00000000000 00000 011100 01123334567788899999999999999
Q ss_pred HHHHHhhccCCC
Q 038466 544 VSQEFLITRKTP 555 (572)
Q Consensus 544 V~~~l~~~~~~~ 555 (572)
+++|.+..+..+
T Consensus 403 AL~HpFF~~~~~ 414 (415)
T KOG0671|consen 403 ALSHPFFARLTP 414 (415)
T ss_pred HhcCHHhhcCCC
Confidence 999998776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-20 Score=196.19 Aligned_cols=214 Identities=25% Similarity=0.307 Sum_probs=146.3
Q ss_pred cccccCee-EEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 312 IWNYDGYG-SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 312 ~~~~~~fG-~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
++|.|.-| .||+|... |+.||||++-.... .--.+|+..|+.- +|||||++|+.-.+++..|+..|.|. -
T Consensus 516 ilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred HcccCCCCcEEEEEeeC-CceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 45666655 48999875 67999999864332 2335799999887 59999999999889999999999996 5
Q ss_pred ChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCCC------------------------
Q 038466 390 SLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPDS------------------------ 438 (572)
Q Consensus 390 sL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~~------------------------ 438 (572)
+|.+++.... +.....-..-..+..|++.|+++| |||.+|.++.....+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 8999987641 111011011233455555565555 688888866432110
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC-CCCCCccccccCCCCcchhhhhhccc-----CCCCC
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 511 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~-----~l~~~ 511 (572)
.......||-||+|||++....-+...|++|+|||+|..+|| +.||...-.. . ..++.. .+.+.
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------~---~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------Q---ANILTGNYTLVHLEPL 738 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------h---hhhhcCccceeeeccC
Confidence 012235699999999999999889999999999999999986 8998632111 0 111111 11111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
. .+ .+.+++..++.++|..||++.+|+.|++
T Consensus 739 ~-d~------eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 739 P-DC------EAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred c-hH------HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 1 11 3455666899999999999999998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=191.94 Aligned_cols=147 Identities=33% Similarity=0.522 Sum_probs=118.7
Q ss_pred hhhHHHHhhhcCCCCCCCCCCCCCCC-----CccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCc
Q 038466 63 SPIQLEKKALINTGWWNSSFWTTDHC-----KWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFA 137 (572)
Q Consensus 63 ~~l~~~~~~~~~~~~~~~~~~~~~~c-----~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~ 137 (572)
.++...|.++..+..++| ..++| .|.||.|..... .....++.|+|++|.
T Consensus 375 ~aL~~~k~~~~~~~~~~W---~g~~C~p~~~~w~Gv~C~~~~~----------------------~~~~~v~~L~L~~n~ 429 (623)
T PLN03150 375 SALQTLKSSLGLPLRFGW---NGDPCVPQQHPWSGADCQFDST----------------------KGKWFIDGLGLDNQG 429 (623)
T ss_pred HHHHHHHHhcCCcccCCC---CCCCCCCcccccccceeeccCC----------------------CCceEEEEEECCCCC
Confidence 456677776543221122 24566 799999963110 001135788999999
Q ss_pred ccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchh
Q 038466 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217 (572)
Q Consensus 138 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~ 217 (572)
+.|.+|..+++|++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++|.++|.+|..
T Consensus 430 L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred ccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhc-cccCccccCCCcc
Q 038466 218 IAGM-KNLTWLDLSNNNI 234 (572)
Q Consensus 218 ~~~l-~~L~~L~ls~N~l 234 (572)
++.+ .++..+++++|..
T Consensus 510 l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 510 LGGRLLHRASFNFTDNAG 527 (623)
T ss_pred HhhccccCceEEecCCcc
Confidence 8764 4566777776654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=159.42 Aligned_cols=175 Identities=23% Similarity=0.305 Sum_probs=131.5
Q ss_pred cccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 310 FSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
...+|.|+||.|=|-++ .+|+..|+|++...-..+ ..++...|+.+ ++....|.+|.+||.+.+....|+.||.|.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 45689999999988885 679999999998654322 23567778876 455679999999999999999999999997
Q ss_pred CCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh-------cCCCCCceeeCCC----------------CCCccc
Q 038466 388 RGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH-------HDCSPSIASTCPD----------------SSNRTL 443 (572)
Q Consensus 388 ~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH-------~~~~~~i~~~~~~----------------~~~~~~ 443 (572)
. ||+.+-++- ......+..-.=+||..|.+||.||| +|.+|+++..+.+ +...+.
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 4 665544321 11223444445578999999999985 7888887654321 122344
Q ss_pred cccccCccccccccC----CCcCcccchHHHHHHHHHHHcCCCCCCcc
Q 038466 444 LAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRDLL 487 (572)
Q Consensus 444 ~~gt~~y~APE~~~~----~~~s~ksDVySfGvvl~ElltG~~P~~~~ 487 (572)
.+|.-.|||||.+.. ..|+-||||||+||++.||.+++.||+..
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 568889999998753 36899999999999999999999999743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-19 Score=204.42 Aligned_cols=177 Identities=21% Similarity=0.281 Sum_probs=121.7
Q ss_pred hcCC-CCcccEEEEE-------EeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------c
Q 038466 360 QVLH-RNIVKLYGFC-------LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------H 425 (572)
Q Consensus 360 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~ 425 (572)
.++| +||++++++| .+.+..+.++||+ +++|.++|.... ..+++.+...++.||++||+||| +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3445 6888888887 3334677889987 569999997532 34888899999999999999997 5
Q ss_pred CCCCCceeeCC-----------------C-CC----------------------------------CccccccccCcccc
Q 038466 426 DCSPSIASTCP-----------------D-SS----------------------------------NRTLLAGTYGYIAP 453 (572)
Q Consensus 426 ~~~~~i~~~~~-----------------~-~~----------------------------------~~~~~~gt~~y~AP 453 (572)
|++|..+.... + .. ......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 67776554311 0 00 00113478889999
Q ss_pred ccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHcccc
Q 038466 454 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQS 533 (572)
Q Consensus 454 E~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~ 533 (572)
|++.+..++.++|||||||+||||++|.+|+..... ..........++.. .........++..||++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHRVLPPQI----LLNWPKEASFCLWLLHP 251 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHhhcChhh----hhcCHHHHHHHHHhCCC
Confidence 999999999999999999999999999988642110 00011111111110 01111223556689999
Q ss_pred CCCCCCCHHHHHHHHhhcc
Q 038466 534 NPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 534 dP~~RPsm~~V~~~l~~~~ 552 (572)
+|.+||+|.||+++.+...
T Consensus 252 ~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 252 EPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ChhhCcChHHHhhchhhhh
Confidence 9999999999999987754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=151.17 Aligned_cols=174 Identities=21% Similarity=0.279 Sum_probs=128.2
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++-...+|+|.||+||||+. .+++.||+|+++..+..+ ..-.+-.+|+.++++++|+|||++++....+..+-+|+||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34456789999999999985 568999999998654332 1224556899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCC-----------------cc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSN-----------------RT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~-----------------~~ 442 (572)
|.. +|..+...-. ..++-......+.|+.+|+.|.| +|.+|........+.- ..
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 974 5655554322 24666666677888888887764 6788875543221110 01
Q ss_pred ccccccCccccccccCCC-cCcccchHHHHHHHHHHHc-CCCCC
Q 038466 443 LLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLM-GKHPR 484 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~Ellt-G~~P~ 484 (572)
.-+-|..|.+|.++.+.+ |++.-|+||-||++.|+.. |++-|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 123477899999987754 8999999999999999985 55433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-19 Score=164.36 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=156.2
Q ss_pred cccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--------CCeEE
Q 038466 310 FSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--------RKCMF 380 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~ 380 (572)
...+|.|.||.||||+.. +|+.||+|++-..... ..+-..-.+|+++|..++|+|++.++..|.. ....|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 346789999999999975 5788898876542211 1122334579999999999999999998864 23489
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------S 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------~ 439 (572)
+||++|+. +|.-.|.+.. ..++.....+++.++..||.|+| +|.++..+....+. +
T Consensus 101 lVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 99999986 6777776532 35777788889999999998876 56666544322110 0
Q ss_pred ------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccc-------------cccCCCCcch-
Q 038466 440 ------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLS-------------SLSSSSDPKI- 498 (572)
Q Consensus 440 ------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~-------------~~~~~~~~~~- 498 (572)
..+..+-|..|.+||.+.+ ..|+.+.|||.-|||+.||.||.+-+..-. +......++.
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 0112234889999998765 569999999999999999999987653211 1111111111
Q ss_pred --hhhhhcc-cCCCCCCChHHHHHHH------HHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 499 --MLIDVLD-QRLPPPVDRKVIRDIL------LASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 499 --~~~~~~~-~~l~~~~~~~~~~~~~------~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+.+.+. +.++...-+.....+. .++++....+..||.+|++..+++.|.+.-++.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 1111110 1111111011111111 244566678899999999999999987665543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.5e-18 Score=174.65 Aligned_cols=174 Identities=20% Similarity=0.251 Sum_probs=134.0
Q ss_pred ccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHH-----HHHHHHHHHHhcC---CCCcccEEEEEEeCCeE
Q 038466 309 VFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIK-----SFRNEAQVLSQVL---HRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~-----~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 379 (572)
..+.+|.|+||.|..|..+. ...|+||.+.+.+.-....++ ..-.|+++|..++ |+||++++++|.+++..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 34578999999999998754 678999998866543222222 3457999999998 99999999999999999
Q ss_pred EEEEeccc-CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC---------------CC
Q 038466 380 FLIYEYMK-RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC---------------PD 437 (572)
Q Consensus 380 ~lV~Ey~~-~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~---------------~~ 437 (572)
||+||--. +-+|++++..+. .++.....-|..||+.|+++||. |++...+-.+ .+
T Consensus 645 yl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 99999754 558999987543 46667777799999999999973 3333222111 11
Q ss_pred CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCC
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
+....+++||.+|.|||++.+..| +..-|||++||+||.++..+-||.
T Consensus 722 sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 223345789999999999999887 456999999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-16 Score=158.21 Aligned_cols=115 Identities=19% Similarity=0.292 Sum_probs=90.5
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-----C---CCcccEEEEEEe-
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----H---RNIVKLYGFCLH- 375 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~- 375 (572)
.+.+++++|-|.|++||.+.. .+.+.||+|+.+....- .+.-..||++|++++ | ..||+|+++|..
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 355677899999999999984 56889999999865432 344567999999985 2 459999999975
Q ss_pred ---CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 376 ---RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 376 ---~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
+..++||+||. |-+|..+|.... ...++.....+|+.||..||.|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~e 206 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRE 206 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence 45799999998 457777777542 34577788889999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=151.20 Aligned_cols=174 Identities=27% Similarity=0.295 Sum_probs=128.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 379 (572)
+++...-+|+|+||+||....+ +|+.||.|++..--. .....+++.+|+++|.-++|.|+...++..... +++
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3445567899999999999864 699999999864322 223357888999999999999999998877654 357
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP----------------- 436 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~----------------- 436 (572)
|.+.|.|.. +|.+.+-.. ..++-....-...||.+|+.||| +|++|++...+.
T Consensus 133 YV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 888998864 666666532 23444444456789999999986 688887543211
Q ss_pred -CCCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCC
Q 038466 437 -DSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 437 -~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
+..+++.-+-|-.|.|||.+++. .|+...||||.||++.|++-++.-|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 11223334567889999999875 5899999999999999998776544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-15 Score=157.42 Aligned_cols=188 Identities=28% Similarity=0.444 Sum_probs=128.0
Q ss_pred HHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCC
Q 038466 358 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPD 437 (572)
Q Consensus 358 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~ 437 (572)
|+.+.|.|+.+++|.+.+++..+.|.+||..|+|.+.+.. ....++|.-+...+.++++||+|+|..... .|....
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~--~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIG--YHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcce--eeeeec
Confidence 3568899999999999999999999999999999999986 345689999999999999999999964221 222111
Q ss_pred CCC------cc----------------------ccccccCccccccccCC-------CcCcccchHHHHHHHHHHHcCCC
Q 038466 438 SSN------RT----------------------LLAGTYGYIAPELAYTM-------VMTEKCDVYSFGVVTLEVLMGKH 482 (572)
Q Consensus 438 ~~~------~~----------------------~~~gt~~y~APE~~~~~-------~~s~ksDVySfGvvl~ElltG~~ 482 (572)
+.+ +. ...-..-|.|||.+... ..+.++|||||||+++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 111 00 01122348999988753 14678999999999999999999
Q ss_pred CCCccccccCCCCcchhhhhhcc-c--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 483 PRDLLSSLSSSSDPKIMLIDVLD-Q--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 483 P~~~~~~~~~~~~~~~~~~~~~~-~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
||+..... ..+...+..+.+ . ...|...... +.......++..||.++|++||++++|-..+.....
T Consensus 157 ~~~~~~~~---~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLV---EDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccc---CChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99753221 111112222222 1 1122111110 111124567779999999999999999887755443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.7e-16 Score=149.64 Aligned_cols=216 Identities=24% Similarity=0.255 Sum_probs=140.8
Q ss_pred CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CeEEEEEecccCCChhhhhhcCCCc
Q 038466 328 NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KCMFLIYEYMKRGSLFCNLHNNEDA 401 (572)
Q Consensus 328 ~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~Ey~~~GsL~~~l~~~~~~ 401 (572)
.++.||+|++........ ..++-.+|..++..+.|+||++++.++.-. .+.|+|||||. ++|...++.
T Consensus 40 ~~~~v~ikk~~~pf~n~~-~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~---- 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQT-HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM---- 113 (369)
T ss_pred ccCceehhhhcCccccCc-cchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH----
Confidence 478899999865432221 124566899999999999999999998753 35899999997 477777763
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCCccccccccCccccccccCC
Q 038466 402 VELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSNRTLLAGTYGYIAPELAYTM 459 (572)
Q Consensus 402 ~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~ 459 (572)
+++-...-.|..|+..|+.||| +|.+|..+....+ ....+-.+.|..|.|||++.+.
T Consensus 114 -elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~ 192 (369)
T KOG0665|consen 114 -ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGM 192 (369)
T ss_pred -hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheecc
Confidence 3555555678889999999986 5677765432110 0112234577889999999988
Q ss_pred CcCcccchHHHHHHHHHHHcCCCCCCccc---ccc------CCCCc------------------chhhhhhcccCCCC--
Q 038466 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLS---SLS------SSSDP------------------KIMLIDVLDQRLPP-- 510 (572)
Q Consensus 460 ~~s~ksDVySfGvvl~ElltG~~P~~~~~---~~~------~~~~~------------------~~~~~~~~~~~l~~-- 510 (572)
.+.+++||||.||++.||++|+.-|.... .+. ...++ .... .-+....|.
T Consensus 193 ~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~ 271 (369)
T KOG0665|consen 193 GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA-ISFSELFPDSL 271 (369)
T ss_pred CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc-cchhhhCCccc
Confidence 89999999999999999999986442111 000 00000 0000 000011110
Q ss_pred --CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 511 --PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 511 --~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+.......+.-.+..++.+++..||++|-+.+++++|+...
T Consensus 272 f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 272 FPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00001101122344666789999999999999999998763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.4e-15 Score=141.91 Aligned_cols=173 Identities=20% Similarity=0.286 Sum_probs=125.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEE-EEEeCCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYG-FCLHRKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g-~~~~~~~~~l 381 (572)
+.+++...+|+|.||.+-.++.+ ..+.+++|.+...... .++|.+|...--.+ .|.||+.-|+ .|...+....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45677788999999999999975 5788999999876543 36788887654444 4899998877 4677788889
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC-CCC-------CCccccc--
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC-PDS-------SNRTLLA-- 445 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~-~~~-------~~~~~~~-- 445 (572)
++||+|.|+|...+... .+....-..++.|++.|+.|+|+ |++...+..- .+. ...+...
T Consensus 100 ~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999998777543 34555566789999999999984 4443332210 000 0011112
Q ss_pred ------cccCccccccccC---C--CcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 446 ------GTYGYIAPELAYT---M--VMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 446 ------gt~~y~APE~~~~---~--~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
-+..|-|||.... + ...+.+|||.|||+++-.+||+.||.
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 2456899997643 2 35788999999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.5e-15 Score=152.82 Aligned_cols=174 Identities=20% Similarity=0.228 Sum_probs=129.7
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC------CCCcccEEEEEEeCCe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL------HRNIVKLYGFCLHRKC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~ 378 (572)
.+.+....|.|-|+.|.+|... .|..||||++....... +.=.+|+++|.+|. --|+++++-.|...++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3455556778889999999864 48899999998776443 33457999999995 4578999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCH------HHHHHHHHHHHHHHHHHhcCCCCCceeeCCC---------CCCc--
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDW------AKRVNIVKAMAHALAYLHHDCSPSIASTCPD---------SSNR-- 441 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~------~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~---------~~~~-- 441 (572)
++||+|-.. -+|.+.|.+.+....|.. ++++-+|....+-..+||.|++|..+..... ++..
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999775 478889988766555554 4445555555666667899999987654211 1100
Q ss_pred -----cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 442 -----TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 442 -----~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
+-..-+.-|.|||++.+..|+..-|+||.||+|||+-||+.-|
T Consensus 588 ~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 588 SENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred ccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 0011133599999999999999999999999999999998654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-15 Score=137.83 Aligned_cols=170 Identities=18% Similarity=0.275 Sum_probs=125.6
Q ss_pred cCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC--eE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK--CM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 379 (572)
.+++++...+|.|.|+.||.|. ..+.+.++||.++.-.. +...+|+.+|..++ ||||+++++...++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4556777889999999999997 56678899999986542 56778999999998 999999999988754 46
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHH------HhcCCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY------LHHDCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~y------LH~~~~~~i~~~~~~~--------------- 438 (572)
.||+||+.|-+....-. .++-....-+..++.+||.| +|+|.+|..+..+...
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 79999999988654332 12222333344455555554 5678888876543221
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
..-...+.+..|-.||.+.. ..|+..-|+|||||++.+|+..+.||.
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 11123345677889998765 568999999999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=144.99 Aligned_cols=170 Identities=27% Similarity=0.330 Sum_probs=131.0
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 379 (572)
+.+.....+|+|.|++||+|.+. ..+.||+|.+...... .+..+|+++|..+. |.||+++.+++..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 44566778999999999999753 4678999999866543 35778999999985 99999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceee-------------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIAST------------------- 434 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~------------------- 434 (572)
.+|+||++.-+-.++... ++......+...+..||.++ |+|.+|+....
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999888777763 44555556667777777766 57777764310
Q ss_pred ----------------CC-CCC--------------------------CccccccccCccccccccC-CCcCcccchHHH
Q 038466 435 ----------------CP-DSS--------------------------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSF 470 (572)
Q Consensus 435 ----------------~~-~~~--------------------------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySf 470 (572)
.. ... ..-..+||+||.|||++.. ..-+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 000 0011369999999999764 567899999999
Q ss_pred HHHHHHHHcCCCCCC
Q 038466 471 GVVTLEVLMGKHPRD 485 (572)
Q Consensus 471 Gvvl~ElltG~~P~~ 485 (572)
||+++-+++++.||.
T Consensus 265 GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFF 279 (418)
T ss_pred cceeehhhccccccc
Confidence 999999999999974
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-12 Score=131.46 Aligned_cols=234 Identities=26% Similarity=0.328 Sum_probs=159.8
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC-CcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
.....+|.|+||.||++... ..+|+|.+...........+.|.+|+.+++.+.|+ +++++++++......++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34556789999999999876 78899999866544333457899999999999999 7999999997777789999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CC----
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SS---- 439 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~---- 439 (572)
.++++.+.+........+.......+..+++.++.|+|. |.+|..+..... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 999999666643211246667778899999999999874 444432211100 00
Q ss_pred ---CccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC----CC
Q 038466 440 ---NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR----LP 509 (572)
Q Consensus 440 ---~~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----l~ 509 (572)
......||..|+|||.... ..++...|+||+|++++++++|..|+...... .......+.+... ..
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCcccc
Confidence 1244578999999999987 67899999999999999999999996533210 0000011111111 11
Q ss_pred CCCChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038466 510 PPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQE 547 (572)
Q Consensus 510 ~~~~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~ 547 (572)
....... .........+...|+..+|..|.++.+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111100 0001122345557888999999998877665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=135.45 Aligned_cols=143 Identities=15% Similarity=0.080 Sum_probs=97.8
Q ss_pred cCCccccccccccCeeEEEEEEcC--CCcEEEEEecCCcch--HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP--NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~--~g~~vAvK~l~~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
...+.+...+|.|+||+||+|+.. +++++|||++..... ......+.|.+|+++|++++|+|+|+.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345777889999999999999864 588899998753311 112234679999999999999999963322 2458
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCC-CCCceeeCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDC-SPSIASTCPDS-------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~-~~~i~~~~~~~-------------- 438 (572)
|+||||+++++|.. .... . ...++.++++++.||| +|. +|.++....+.
T Consensus 94 ~LVmE~~~G~~L~~-~~~~-~--------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARPH-G--------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hCcc-c--------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 99999999999963 2111 1 1345677888888886 577 67655432110
Q ss_pred -----------CCccccccccCccccccccCC
Q 038466 439 -----------SNRTLLAGTYGYIAPELAYTM 459 (572)
Q Consensus 439 -----------~~~~~~~gt~~y~APE~~~~~ 459 (572)
.......|++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 001234577889999987643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=8e-13 Score=147.39 Aligned_cols=125 Identities=35% Similarity=0.630 Sum_probs=103.6
Q ss_pred cCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccC
Q 038466 151 KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLS 230 (572)
Q Consensus 151 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls 230 (572)
.++.|+|++|.++|.+|..++.|++|+.|+|++|++.|.+|..++++++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCccccCC------------CCCCCCCCCccCCCCCCCCCCccceeeeehhhhh
Q 038466 231 NNNIKGSIPVRLS------------PNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAI 277 (572)
Q Consensus 231 ~N~l~g~ip~~~s------------~n~~l~~~~~~~l~~c~~~~~~~~~~~i~~~~~~ 277 (572)
+|+++|.+|..+. .|.++|+.. .++.|.........+.+++++++
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p--~l~~C~~~~~~~~~i~~~~~~~~ 555 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP--GLRACGPHLSVGAKIGIAFGVSV 555 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC--CCCCCcccCCCceEEEEEhHHHH
Confidence 9999999998763 333466532 24567543333334444444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-13 Score=150.39 Aligned_cols=234 Identities=21% Similarity=0.260 Sum_probs=149.2
Q ss_pred cccccccCeeEEEEEEc-CCCcEEEEEecCC---cchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 310 FSIWNYDGYGSVYKAQL-PNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~---~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
..++|.|.+|.|+.... ...+.++.|.... ....+......+..|..+-..++|||++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 34678888897777653 3344445554331 1222223334477888888999999998888877777766667999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC-------------------CC--
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP-------------------DS-- 438 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~-------------------~~-- 438 (572)
|++ +|+..+.... .+.-.++..+..|+.+|+.|+|. |.++....... +.
T Consensus 403 ~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred ccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999 9998887542 35555677889999999999984 44443221100 00
Q ss_pred CCccccccccCccccccccCCCcCc-ccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTE-KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~-ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.......|+-+|+|||++....|+. ..||||.||++..|++|+.||..... .++......-.++.-.........
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~----~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK----SDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc----cccchhhhccccccccccChHHHH
Confidence 1122356889999999999999886 59999999999999999999843211 000000000000000000011122
Q ss_pred HHHH-HHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDIL-LASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~-~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+. ....+..+.++.||.+|-||++|++.-|+.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~ 589 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR 589 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence 2211 123455678999999999999999988764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=5e-12 Score=122.02 Aligned_cols=165 Identities=13% Similarity=0.098 Sum_probs=106.1
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHH------HHHHHHHHHhcCCCCcccEEEEEEeC-
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS------FRNEAQVLSQVLHRNIVKLYGFCLHR- 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~------f~~E~~~l~~l~H~niv~l~g~~~~~- 376 (572)
.+.+....+++.||||.||.+.. ++..+|||.+...........+. |.+|++.+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 45567778899999999999765 56689999998655444444444 67999999999999999999986643
Q ss_pred -------CeEEEEEecccCCChhhhhhcCCCcccCCHHH--HHHHHHHHHHHHHHHhcCCCCCceeeCCCCCCcccccc-
Q 038466 377 -------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLLAG- 446 (572)
Q Consensus 377 -------~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~--r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~~~~~~g- 446 (572)
+..++||||++|.+|.++.. ++... .+.-+.+-+|...++|+|.+|+++....+. -..+..|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~ 180 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG 180 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence 35789999999999977632 11111 111122223444455667777766554322 1111111
Q ss_pred ccCcccc----ccccCCCcCcccchHHHHHHHHHH
Q 038466 447 TYGYIAP----ELAYTMVMTEKCDVYSFGVVTLEV 477 (572)
Q Consensus 447 t~~y~AP----E~~~~~~~s~ksDVySfGvvl~El 477 (572)
+..+..+ .+.....++.++|+||||+++.-.
T Consensus 181 ~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 181 KRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred cccccchhhHHHHHHHhHhcccccccceeEeehHH
Confidence 1111111 123344577899999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.8e-11 Score=112.67 Aligned_cols=123 Identities=17% Similarity=0.151 Sum_probs=85.8
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHH---H--------------------HHHHHHHHHHHHhcCCCCcc
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA---F--------------------IKSFRNEAQVLSQVLHRNIV 367 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~---~--------------------~~~f~~E~~~l~~l~H~niv 367 (572)
..+|.|+||.||+|..++|+.||||+++........ . ......|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 468999999999999889999999999754321000 0 11223599999999988875
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN 440 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~ 440 (572)
....+... ..++||||++++++....... ..++..+...++.+++.++.|+||+. .++|.+.+..|
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~--giiHrDlkP~N 148 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC--RLVHADLSEYN 148 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHH
Confidence 54443222 238999999998775443221 24777888899999999999995432 35666655544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.8e-10 Score=114.48 Aligned_cols=177 Identities=21% Similarity=0.213 Sum_probs=132.9
Q ss_pred CccccccccccCeeEEEEEEcCC--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC----CCcccEEEEE-EeCCe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH----RNIVKLYGFC-LHRKC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~ 378 (572)
.+.+...+|.|+||.||++.... ...+|+|.......... ..+..|..++..+.+ +++.++++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 56778899999999999998654 35788888765432211 146678888888873 6888999988 47778
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~~~~--------------- 437 (572)
.|+||+.+ |.+|.+...... ...++-...++|+.|+..++.++ |+|++|.+......
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99999977 568888765544 34577788889999999888755 57777753321100
Q ss_pred --------CC--------C-ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcc
Q 038466 438 --------SS--------N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL 487 (572)
Q Consensus 438 --------~~--------~-~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~ 487 (572)
.. . .....||..|+++.+..+...+.+.|+||++-++.|+..|..||...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 00 0 12355999999999999999999999999999999999999998543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-11 Score=130.74 Aligned_cols=168 Identities=24% Similarity=0.323 Sum_probs=119.5
Q ss_pred ccccCeeEEEEEE----cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEeccc
Q 038466 313 WNYDGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 313 ~~~~~fG~Vyk~~----~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
.|.|.||.|+..+ .+.|..+|+|.+++....... ......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5788899988653 345888999998765432211 124556888889888 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHH------HhcCCCCCceeeCCCCC-------------Ccccccccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY------LHHDCSPSIASTCPDSS-------------NRTLLAGTY 448 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~y------LH~~~~~~i~~~~~~~~-------------~~~~~~gt~ 448 (572)
+|++...+.+... .+...-......+|-++++ +|++.++..+..+..+. .....+||.
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 9999988875432 2222222223333444444 45677666554332210 012237899
Q ss_pred CccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 449 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 449 ~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
-|||||+.. .+...+|.|||||+++||+||-.||..
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999987 677899999999999999999999853
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.5e-12 Score=113.88 Aligned_cols=111 Identities=29% Similarity=0.496 Sum_probs=65.3
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccC-CCCccccCCCc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTN 199 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~ 199 (572)
++..+.+|+.|++++|++. .+|.++++|++|+.|+++-|++. ..|..||.++.|++|||.+|++.. .+|..|-.++.
T Consensus 51 nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~t 128 (264)
T KOG0617|consen 51 NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTT 128 (264)
T ss_pred cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHH
Confidence 3455666666666666665 34666666666666666666665 566666666666666666666642 34555555555
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcc
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 234 (572)
|+.|+|+.|.|. .+|..++++++|+.|.+..|.+
T Consensus 129 lralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 129 LRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred HHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 555555555554 3455555555555555555544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.7e-11 Score=123.02 Aligned_cols=156 Identities=24% Similarity=0.347 Sum_probs=107.9
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHH---HhcCCCCCceeeCC----------------CC
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---LHHDCSPSIASTCP----------------DS 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~y---LH~~~~~~i~~~~~----------------~~ 438 (572)
..|+.|++|..++|.+||..+......+|..-..++.+++.|+.| +|+|.+|..+.... +.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 478999999999999999876666677888888999999998875 79998887553211 11
Q ss_pred -------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCC
Q 038466 439 -------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~ 510 (572)
...+.-.||..||+||.+.+..|+.|+|+||+|++|+|+++ -..+++... ...++-+..+|+
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIRDGIIPP 479 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhhcCCCCh
Confidence 12344579999999999999999999999999999999997 343432111 112222333332
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~ 547 (572)
..- .+-..-..+..+.+.+.|++||++.++.-+
T Consensus 480 ~~~----~d~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 480 EFL----QDYPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred HHh----hcCcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 110 000111233346889999999976665444
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-11 Score=129.49 Aligned_cols=121 Identities=23% Similarity=0.257 Sum_probs=99.6
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+.+++.|+|+.|+++..--..+.+|++|+.||||+|.+...-++.+...++|++|+|++|+++..-+.+|..|..|
T Consensus 264 ~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L 343 (873)
T KOG4194|consen 264 AFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL 343 (873)
T ss_pred ceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHh
Confidence 46777888888888888887766778888888888888888887777888888888888888888888888888888888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
++|+|++|+++..--..|..+++|+.|||++|.+++.|-.+
T Consensus 344 e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa 384 (873)
T KOG4194|consen 344 EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA 384 (873)
T ss_pred hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence 88888888887655666778888889999999888777654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-11 Score=110.15 Aligned_cols=120 Identities=33% Similarity=0.523 Sum_probs=105.3
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+.++++++.|.||+|.++. +|+.|..|.+|+.|++++|+++ .+|.++++|+.|+.|+++-|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 4556778899999999985 6778999999999999999998 78999999999999999999986 6899999999999
Q ss_pred eeEeccCcCCC-CCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 202 NLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 202 ~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
.|||++|+++. .+|..|..+..|+.|+|+.|.|. -+|..++..
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~l 149 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKL 149 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhh
Confidence 99999999974 68999999999999999999985 466665443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-09 Score=101.76 Aligned_cols=122 Identities=15% Similarity=0.162 Sum_probs=85.6
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchH-----------------------HHHHHHHHHHHHHHHHhcCCCCcc
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETE-----------------------ELAFIKSFRNEAQVLSQVLHRNIV 367 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~-----------------------~~~~~~~f~~E~~~l~~l~H~niv 367 (572)
..+|.|+||+||+|...+|+.||||+++..... .......+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 467999999999999878999999998764211 000122356899999999999986
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhh-hhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN 440 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~-l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~ 440 (572)
....+.... .++||||++++++... +.. ..++......++.+++.++.|+|+. .+++|.+.+..|
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~N 148 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYN 148 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhh
Confidence 555544332 4899999999865433 322 2355667788999999999999861 145555544443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-10 Score=112.76 Aligned_cols=179 Identities=26% Similarity=0.379 Sum_probs=115.5
Q ss_pred HHHhcCCCCcccEEEEEEeC-----CeEEEEEecccCCChhhhhhcCCC-cccCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 038466 357 VLSQVLHRNIVKLYGFCLHR-----KCMFLIYEYMKRGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPS 430 (572)
Q Consensus 357 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~GsL~~~l~~~~~-~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~ 430 (572)
-+-++.|.|||+++.|..+. .....+.|||..|++..+|++.+. ...+....-.+.+.||..|+.|||. |.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 35566799999999987653 457899999999999999986432 1222222223578999999999995 6676
Q ss_pred ceeeCC--------------------CCCC----------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC
Q 038466 431 IASTCP--------------------DSSN----------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 480 (572)
Q Consensus 431 i~~~~~--------------------~~~~----------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG 480 (572)
++|... +..+ .....|-+||.|||+-.....+..+|||+||...+||..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 665321 0000 1123456899999998888889999999999999999887
Q ss_pred CCC-CCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 481 KHP-RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 481 ~~P-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..- .+.... ...+..+..++ ..+..+.+. .....|++..|..||+|.+.+.|+...
T Consensus 279 Eiq~tnseS~----~~~ee~ia~~i-~~len~lqr----------~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESK----VEVEENIANVI-IGLENGLQR----------GSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcce----eehhhhhhhhe-eeccCcccc----------CcCcccccCCCCCCcchhhhhcCceee
Confidence 643 221110 00111111111 001111111 112269999999999999998876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.6e-09 Score=100.10 Aligned_cols=118 Identities=14% Similarity=0.184 Sum_probs=89.1
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcch-----HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~-----~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
..+|.|++|.||+|.. +|..+++|+...... .......++.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3578999999999987 566788887653221 1111234688999999999999998888888888889999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS 439 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~ 439 (572)
+++++|.+.+... .+ .+..++.++++++.++|.. +++|.+....
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~ 124 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTS 124 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcc
Confidence 9999999888642 12 6788999999999999853 3444444433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=128.31 Aligned_cols=221 Identities=21% Similarity=0.262 Sum_probs=136.6
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcc-hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~-~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++..+.+|.+.|=+|.+|+.++|. |+||++-... .-.....++-..|++ ..-++|||.+++--.-..+.-.|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 3455677888899999999999997 7888875443 111111122334555 667799999998766555666778888
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee--------------------CCCC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST--------------------CPDS 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~--------------------~~~~ 438 (572)
|..+ +|++.|..+. -+...+..=|+-|+..|+.-+|+ |++-.++.. ....
T Consensus 102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8865 6777776432 24444455578888888877764 444333211 0011
Q ss_pred CCccccccc----cCccccccccCC-----------CcCcccchHHHHHHHHHHHc-CCCCCCccccc--cC--CCCcch
Q 038466 439 SNRTLLAGT----YGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSL--SS--SSDPKI 498 (572)
Q Consensus 439 ~~~~~~~gt----~~y~APE~~~~~-----------~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~--~~--~~~~~~ 498 (572)
...+.+..| .+|+|||-+... ..+++.||||.||++.||++ |++||+...-+ +. ..+++.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 111222223 369999976431 25789999999999999996 78888753311 11 111111
Q ss_pred hhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 038466 499 MLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547 (572)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~ 547 (572)
.+..+-|. .. ..+.+.+++.||++|-++++.++.
T Consensus 258 ~Le~Ied~---------~~------Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDV---------SL------RNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCc---------cH------HHHHHHHHccCchhccCHHHHHHh
Confidence 11111111 11 223446889999999999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-10 Score=121.23 Aligned_cols=111 Identities=39% Similarity=0.545 Sum_probs=96.6
Q ss_pred cCCCCCCcEEEccCCccc-ccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCC-ccccCCCc
Q 038466 122 FSCFPNLVKLTIQFFALT-GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP-SALGSLTN 199 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~ 199 (572)
++.++.|+.+.+..|++. .-||+.|..|..|+.||||+|++. ..|..+..-+++-+|+||+|++.. || +.+-+++.
T Consensus 74 Ls~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet-IPn~lfinLtD 151 (1255)
T KOG0444|consen 74 LSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET-IPNSLFINLTD 151 (1255)
T ss_pred hccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc-CCchHHHhhHh
Confidence 667888888888888886 358999999999999999999998 789999999999999999999864 55 55788999
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
|-.||||+|++. .+|+.+..|.+|++|+||+|.|.
T Consensus 152 LLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 152 LLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred Hhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 999999999998 68888999999999999999763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-10 Score=116.21 Aligned_cols=114 Identities=33% Similarity=0.494 Sum_probs=92.5
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++...-|+.+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 667788888888877665 57888888888888888888887 6777776666677766666777655555599999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCccc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 240 (572)
+|||.+|.+. .+|+.++++.+|++|++++|.|+ .|.
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 9999999998 68999999999999999999997 554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.3e-09 Score=101.93 Aligned_cols=114 Identities=15% Similarity=0.138 Sum_probs=80.4
Q ss_pred cccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-----CCCCcccEEEEEEeCC---eEE-
Q 038466 310 FSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-----LHRNIVKLYGFCLHRK---CMF- 380 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~- 380 (572)
...+|.|+||.||. .++....+||++....... .+++.+|+++++++ +||||++++|++.++. ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~---~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGG---DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccch---HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 35789999999996 4433334799887543222 35789999999999 6799999999998863 434
Q ss_pred EEEec--ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHH-HHHh------cCCCCCceee
Q 038466 381 LIYEY--MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL-AYLH------HDCSPSIAST 434 (572)
Q Consensus 381 lV~Ey--~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl-~yLH------~~~~~~i~~~ 434 (572)
+|+|| +++|+|.+++.+. .++.. ..++.++..++ +||| +|++|.++..
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl 138 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILC 138 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 88999 6689999999653 13433 24456666666 7887 4555554433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-08 Score=97.05 Aligned_cols=102 Identities=16% Similarity=0.208 Sum_probs=77.9
Q ss_pred ccccCeeEEEEEEcCCCcEEEEEecCCcc-----hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 313 WNYDGYGSVYKAQLPNGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~-----~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
+|.|+||.||+|.+ +|..+++|+..... .+.....+++.+|++++..++|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 68899999999985 56778888854321 1111223578899999999999987776667777777899999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~ 425 (572)
+++|.+.+..... .++.++++++.++|.
T Consensus 81 g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~ 108 (199)
T TIGR03724 81 GKPLKDVIEEGND----------ELLREIGRLVGKLHK 108 (199)
T ss_pred CccHHHHHhhcHH----------HHHHHHHHHHHHHHH
Confidence 9999887754210 678888999999884
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.4e-10 Score=120.03 Aligned_cols=117 Identities=34% Similarity=0.518 Sum_probs=78.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCC-------------------------CCCCcCCcCCCCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLT-------------------------GTIPPEIGNLKNL 176 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~-------------------------g~ip~~~~~l~~L 176 (572)
|-++..|-.|+||+|.+. .+|+.+..|..|+.|+||+|.+. ..+|.++.+|.+|
T Consensus 146 finLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL 224 (1255)
T KOG0444|consen 146 FINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL 224 (1255)
T ss_pred HHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence 555666667777777765 45667777777777777777542 1256667777777
Q ss_pred ceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 177 IELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 177 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
..+|||.|++. .+|..+-++++|+.|+||+|+++ .+.-..+...+|++|++|.|+|+ .+|..+
T Consensus 225 ~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~av 287 (1255)
T KOG0444|consen 225 RDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAV 287 (1255)
T ss_pred hhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHH
Confidence 77777777765 56777777777777777777776 34444555667777777777776 355443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.8e-10 Score=117.19 Aligned_cols=116 Identities=24% Similarity=0.255 Sum_probs=94.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
|..+++|+.|.|..|.+...-...|..|.++++|+|+.|+++..--.++-+|+.|+.|+||+|.+...-++++..+++|+
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 33344444444444444444445577788899999999999876667788999999999999999999999999999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
.|+|++|+++...+.+|..|..|+.|+|++|.++.-
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l 356 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHL 356 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHH
Confidence 999999999988888999999999999999998643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.5e-08 Score=93.70 Aligned_cols=162 Identities=14% Similarity=0.068 Sum_probs=104.9
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHH-HHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEec
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEEL-AFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
.+...++.|+||+||.+.- ++..++.+.+........ -....|.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456788999999997766 567778787775543211 11235889999999995 4889999886 447999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCC-CCCceeeCCCCCCcc----------------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC-SPSIASTCPDSSNRT---------------- 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~-~~~i~~~~~~~~~~~---------------- 442 (572)
+.|++|.+.+.. . . ..+..+++.++.|+ |+|. +|.++....+..-..
T Consensus 80 I~G~~L~~~~~~--~--~------~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR--G--D------LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh--h--h------HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998654321 1 1 12344555555555 5677 565544322110000
Q ss_pred --------------ccccccCccccccccCC-CcC-cccchHHHHHHHHHHHcCCCCC
Q 038466 443 --------------LLAGTYGYIAPELAYTM-VMT-EKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 443 --------------~~~gt~~y~APE~~~~~-~~s-~ksDVySfGvvl~ElltG~~P~ 484 (572)
....++.|++|+-..-. ..+ ...+.++-|.-+|+++||+.|.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 01135667777643221 333 5678999999999999999885
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-08 Score=110.01 Aligned_cols=117 Identities=16% Similarity=0.156 Sum_probs=85.1
Q ss_pred cccccccCeeEEEEEEcCCCcEEEEEecCCc----chHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 310 FSIWNYDGYGSVYKAQLPNGKVFALKKLHTS----ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~----~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
...+|.|+||.||+|.+.+...++.++.... ........+++.+|++++++++|++++..+.++.+++..++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4578999999999998765544333322211 111112235788999999999999999988888888888999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN 440 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~ 440 (572)
+++++|.+++. .+..++.++++++.|||.. .++|.+.+..|
T Consensus 418 ~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~N 458 (535)
T PRK09605 418 IGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSN 458 (535)
T ss_pred cCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHH
Confidence 99999988775 3456888999999999842 34444444333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.7e-08 Score=99.15 Aligned_cols=176 Identities=19% Similarity=0.237 Sum_probs=105.0
Q ss_pred cccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-----------CCcccEEEEEE---
Q 038466 310 FSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-----------RNIVKLYGFCL--- 374 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-----------~niv~l~g~~~--- 374 (572)
...+|.|+|+.||.++.. +|+.+|||+............+++++|.-....+.+ +-++++ +...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEETT
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEEcC
Confidence 457899999999999865 599999999865443333345778777755555332 222222 2111
Q ss_pred ------eC--C------eEEEEEecccCCChhhhhh---cCCC-cccCCHHHHHHHHHHHHHHHHHHhc------CCCCC
Q 038466 375 ------HR--K------CMFLIYEYMKRGSLFCNLH---NNED-AVELDWAKRVNIVKAMAHALAYLHH------DCSPS 430 (572)
Q Consensus 375 ------~~--~------~~~lV~Ey~~~GsL~~~l~---~~~~-~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~ 430 (572)
.. . +.+++|+-+ .+||.+.+. .... ...+....|+.+..|+.+-+++||+ |++|.
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~ 174 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE 174 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence 11 1 235667766 467766543 2221 2235566778888888999999874 44554
Q ss_pred ceeeCCCCCC--------------ccccccccCccccccccC--------CCcCcccchHHHHHHHHHHHcCCCCCCcc
Q 038466 431 IASTCPDSSN--------------RTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLMGKHPRDLL 487 (572)
Q Consensus 431 i~~~~~~~~~--------------~~~~~gt~~y~APE~~~~--------~~~s~ksDVySfGvvl~ElltG~~P~~~~ 487 (572)
....+.++.- ......+.+|.+||.... -.++.+.|.|++|+++|.|.+|+.|++..
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4333222110 000123467899997643 25789999999999999999999999754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.2e-09 Score=95.67 Aligned_cols=109 Identities=28% Similarity=0.382 Sum_probs=41.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhcc-CCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccc-cCCCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEIS-ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSAL-GSLTN 199 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~ 199 (572)
+.+..+++.|+|++|.++-. +.++ .+.+|+.|||++|.++. ++ .+..+++|++|++++|.++. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 45566788999999998753 3455 57899999999999984 43 57788999999999999875 44444 46899
Q ss_pred cCeeEeccCcCCCC-CchhhhhccccCccccCCCccc
Q 038466 200 LSNLDLSSNKLSGK-IPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 200 L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
|+.|++++|++... --..+..+++|+.|++.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999998742 1245678899999999999875
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.2e-09 Score=78.32 Aligned_cols=59 Identities=44% Similarity=0.584 Sum_probs=30.2
Q ss_pred cCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCc
Q 038466 151 KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209 (572)
Q Consensus 151 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~ 209 (572)
+|++|++++|+++...+..|.++++|++|++++|++....|..|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555553333445555555555555555554444455555555555555554
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.5e-08 Score=116.45 Aligned_cols=69 Identities=32% Similarity=0.388 Sum_probs=49.0
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP 191 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 191 (572)
++.+++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|...+.+|
T Consensus 653 ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 653 LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence 5667788888888877777788888888888888888876555677655 56666666666654444333
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-08 Score=114.24 Aligned_cols=42 Identities=21% Similarity=0.347 Sum_probs=22.7
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
|+.|++++|+++ .+|..+.++++|+.|+|++|.|+|.+|..+
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 334444444444 355555556666666666666666555544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-09 Score=109.44 Aligned_cols=115 Identities=37% Similarity=0.526 Sum_probs=91.3
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCcccc-CCCccCee
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALG-SLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L 203 (572)
+..|+.||...|-+ +.+|+.++.|.+|.-|+|..|.+. .+| +|+++..|.+|.++.|++. .+|.+.+ ++.+|..|
T Consensus 182 m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vL 257 (565)
T KOG0472|consen 182 MKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVL 257 (565)
T ss_pred HHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceee
Confidence 45566676666655 467888888888888888888887 566 7888888888888888765 6777666 89999999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
||..|+++ +.|+++..+++|+.||+|+|.+++ +|.++++.
T Consensus 258 DLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 258 DLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred eccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 99999998 689999999999999999999986 56566544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-09 Score=117.75 Aligned_cols=105 Identities=35% Similarity=0.507 Sum_probs=53.8
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCc-CCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPP-EIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
.|+.|.+.+|.|+...=+-+-+..+|+.|+|++|++. .+|+ .+.+|..|++|+||+|+|+ .+|..+.++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 3455555555555554444555555555555555554 2332 2445555555555555554 34555555555555555
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
.+|++. ..| ++.+++.|+.+|+|.|+|+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhh
Confidence 555554 344 4455555555555555543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-08 Score=77.21 Aligned_cols=61 Identities=41% Similarity=0.519 Sum_probs=56.6
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccc
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 186 (572)
|+|+.|++++|.+....+..|.++++|++|++++|.++...|..|.++++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999988778899999999999999999987788899999999999999975
|
... |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-07 Score=91.83 Aligned_cols=125 Identities=14% Similarity=0.097 Sum_probs=85.8
Q ss_pred ccccccccccCeeEEEEEE--cCCCcEEEEEecCCcchH---------------------HHHHHHHHHHHHHHHHhcCC
Q 038466 307 IDVFSIWNYDGYGSVYKAQ--LPNGKVFALKKLHTSETE---------------------ELAFIKSFRNEAQVLSQVLH 363 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~--~~~g~~vAvK~l~~~~~~---------------------~~~~~~~f~~E~~~l~~l~H 363 (572)
+.+.+.+|.|+||.||+|. ..+|+.||||.++..... .......+..|++.+.++.|
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4456789999999999998 578999999998754210 00012346789999999986
Q ss_pred CC--cccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC
Q 038466 364 RN--IVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN 440 (572)
Q Consensus 364 ~n--iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~ 440 (572)
.. +.+++++ ...++||||++++++........ .....+...++.+++.++.|||... .++|.+.+..+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 43 3344443 23589999999998876543221 2344445678999999999999543 25666655544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.5e-07 Score=94.82 Aligned_cols=168 Identities=21% Similarity=0.283 Sum_probs=97.8
Q ss_pred CCCCcccEEEEEEe---------------------------CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHH
Q 038466 362 LHRNIVKLYGFCLH---------------------------RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVK 414 (572)
Q Consensus 362 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~ 414 (572)
+|||||++.++|.+ +..+|+||.-.+. +|.+++..+. .+...+.-|..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 58999988887753 2347888876654 6777776432 23334455778
Q ss_pred HHHHHHHHHhc------CCCCCceeeCCCC---------------------------CCccccccccCccccccccCCC-
Q 038466 415 AMAHALAYLHH------DCSPSIASTCPDS---------------------------SNRTLLAGTYGYIAPELAYTMV- 460 (572)
Q Consensus 415 ~ia~gl~yLH~------~~~~~i~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~~- 460 (572)
|+.+|+.|||+ |.+...+....+. +...-..|.-.-||||+.....
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999974 4443333211110 0111123555689999875321
Q ss_pred -----cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCC
Q 038466 461 -----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNP 535 (572)
Q Consensus 461 -----~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP 535 (572)
--.|+|-|+.|.+.||+++..-||.....+.-... ...+.--|.++...+ .. +.++...-++.||
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---~Yqe~qLPalp~~vp-p~------~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---TYQESQLPALPSRVP-PV------ARQLVFDLLKRDP 498 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---hhhhhhCCCCcccCC-hH------HHHHHHHHhcCCc
Confidence 24699999999999999999999863211110000 011111122222221 11 2244456789999
Q ss_pred CCCCCHHHH
Q 038466 536 KSRPTMQYV 544 (572)
Q Consensus 536 ~~RPsm~~V 544 (572)
++||+..-.
T Consensus 499 skRvsp~iA 507 (598)
T KOG4158|consen 499 SKRVSPNIA 507 (598)
T ss_pred cccCCccHH
Confidence 999995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.9e-08 Score=111.50 Aligned_cols=167 Identities=23% Similarity=0.242 Sum_probs=119.7
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCeEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+.+|.|+||+||+|...+|+.||+|+-+.....+ |+--.+++.||+ -+-|..+...+.-.+.-++|+
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 44556889999999999998889999999988766543 333344555555 233444555555677788999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHH------HHHHHHhcCCCCCceeeC----------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMA------HALAYLHHDCSPSIASTC---------------------- 435 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia------~gl~yLH~~~~~~i~~~~---------------------- 435 (572)
||.+.|+|.+++...+ .++|.-.+.++.+++ |+...+|.|++|......
T Consensus 774 ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999998433 366666666666655 445555667887644221
Q ss_pred ----CCCCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCC
Q 038466 436 ----PDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 482 (572)
Q Consensus 436 ----~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~ 482 (572)
++........+|-++-.+|...+..-+...|-|.+.-+++-|+.|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 01111223456788899999999999999999999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.3e-08 Score=110.33 Aligned_cols=139 Identities=24% Similarity=0.364 Sum_probs=89.6
Q ss_pred cCCccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+|+.++.+..|+||.||..+.+. .+.+|+ ++++.... .+ + ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lR---n---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LR---N---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hh---c---cccccCCccee---------------
Confidence 4567888899999999999998764 678888 44433211 00 0 23333333333
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceee----------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIAST---------------------- 434 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~---------------------- 434 (572)
|+-...++.-+. .+. +.+.+++|||+ |.+|.....
T Consensus 136 ------gDc~tllk~~g~-lPv----------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGP-LPV----------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCC-Ccc----------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 444444443221 111 11567788874 555542210
Q ss_pred -CCCC---------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 435 -CPDS---------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 435 -~~~~---------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
+.+. .....++||+.|+||||+....|+...|+|++|+++||.+-|..||+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 0000 01233679999999999999999999999999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.6e-07 Score=91.16 Aligned_cols=174 Identities=20% Similarity=0.218 Sum_probs=127.5
Q ss_pred CccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 383 (572)
++.+.+.+|+|.||+.+.|. +-+++.||||.-...... -++..|-+..+.| .-+.|-.+|-|..++-.-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 35666789999999999997 678999999976543321 1233455544444 4688888888878888888999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee-----------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST----------------------- 434 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~----------------------- 434 (572)
|.. |.||.+...-.+ ..++....+.||+|+..-++|+| +|++|.....
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 988 568877665433 24667778889999999999999 4777764321
Q ss_pred CCCC------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcc
Q 038466 435 CPDS------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL 487 (572)
Q Consensus 435 ~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~ 487 (572)
+++. .....+.||..||+=---.+..-+.+-|.=|+|-+++..+-|..||..+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 1111 1123467999999876666677788999999999999999999998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.2e-07 Score=87.85 Aligned_cols=178 Identities=15% Similarity=0.180 Sum_probs=126.3
Q ss_pred ccCCccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCeEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 380 (572)
....+.+...+|.|+||.+|.|. ..+|+.||||.-...... -++..|.++.+.++| ..|-.+..|..+...-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 34556778899999999999997 578999999987654332 245568888888875 45556666777888888
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH------hcCCCCCceee--------------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSIAST-------------------- 434 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL------H~~~~~~i~~~-------------------- 434 (572)
+|||.. |.||.+...-... .++..+.+-+|-|+..-++|+ |+|++|.....
T Consensus 88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999988 5688776653222 355556666777777666665 57888865421
Q ss_pred -CCC------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccc
Q 038466 435 -CPD------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS 488 (572)
Q Consensus 435 -~~~------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~ 488 (572)
+.. -.......||..|.+--...+..-+.+-|+=|.|-+|+..--|+.||..+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 000 011123568999987665556666788999999999999999999997553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.3e-07 Score=82.26 Aligned_cols=114 Identities=16% Similarity=0.110 Sum_probs=90.1
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC--CCcccEEEEEEeCCeEEEEEecccC
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
..++.|+++.||++...+ ..+++|....... ..++.+|+.++..++| .++.++++++..++..+++|||+++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457889999999999765 6789999876543 2468889999999987 4999999988888889999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN 440 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~ 440 (572)
+++... ++..+..++.+++++++++|......+.|.+....+
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~N 119 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcce
Confidence 877543 445667788999999999997655566666655444
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.3e-09 Score=117.68 Aligned_cols=108 Identities=37% Similarity=0.544 Sum_probs=94.9
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+-++.+|+.|+|++|.|..-....+.++..|+.|+||+|.++ .+|..+..+..|++|...+|++. .+| .+..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 667889999999999998665567899999999999999999 89999999999999999999987 577 899999999
Q ss_pred eeEeccCcCCCC-CchhhhhccccCccccCCCc
Q 038466 202 NLDLSSNKLSGK-IPPEIAGMKNLTWLDLSNNN 233 (572)
Q Consensus 202 ~L~ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~ 233 (572)
.+|+|.|+++.. +|.... -++|++||+++|.
T Consensus 456 ~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred EEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 999999999854 444332 3899999999997
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-07 Score=105.29 Aligned_cols=98 Identities=26% Similarity=0.431 Sum_probs=50.1
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
+|+.|++++|.|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|++. .+|..+. ++|+.|+++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 4555555555554 2343332 24555555555555 4444432 35566666666655 3454442 356666666
Q ss_pred cCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 207 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
+|+|++ +|..+. .+|+.|++++|++++
T Consensus 292 ~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 292 DNSIRT-LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred CCcccc-Ccccch--hhHHHHHhcCCcccc
Confidence 666653 444332 356666666666653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-07 Score=87.56 Aligned_cols=116 Identities=14% Similarity=0.072 Sum_probs=78.3
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHH-------------------HHHHHHHHHHHHHHhcCCCC--
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEEL-------------------AFIKSFRNEAQVLSQVLHRN-- 365 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~-------------------~~~~~f~~E~~~l~~l~H~n-- 365 (572)
+.+...++.|+||.||+|..++|+.||||++........ .....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 344567899999999999988899999998764321100 01124678999999998884
Q ss_pred cccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCC
Q 038466 366 IVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDS 438 (572)
Q Consensus 366 iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~ 438 (572)
+.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+++|.+...
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 4555543 346899999999998765321 1233567788888888875 2344444333
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-07 Score=106.22 Aligned_cols=102 Identities=26% Similarity=0.514 Sum_probs=71.6
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++|+.|+|++|.++. +|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|++
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 467788888888774 565543 47888888888887 4666543 36788888888876 5676654 47888888
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCccc
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 240 (572)
++|+++ .+|..+. .+|+.|++++|+|++ +|.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCcccc-Ccc
Confidence 888887 4666553 478888888888774 443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.4e-07 Score=110.96 Aligned_cols=116 Identities=28% Similarity=0.401 Sum_probs=96.3
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|+|++|...+.+|..+++|++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~ 852 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLN 852 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeE
Confidence 4688999999999889999999999999999999987666888776 7899999999998777777754 36789999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
|++|.++ .+|.++..+++|+.|++++|+--..+|..++..
T Consensus 853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L 892 (1153)
T PLN03210 853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKL 892 (1153)
T ss_pred CCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccc
Confidence 9999998 689999999999999999854434577655433
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.4e-08 Score=100.39 Aligned_cols=110 Identities=25% Similarity=0.379 Sum_probs=99.0
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeeccc-ccccCCCCccccCCCccCeeE
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGS-NSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ 204 (572)
+....++|..|.++...|..|+.+.+|+.||||+|+++..-|+.|.+|++|..|-+.+ |+++...-..|++|.+|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3567899999999998889999999999999999999999999999999998887766 888765557899999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+.-|++.-...+.|..+++|..|.+..|.+.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q 177 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQ 177 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhh
Confidence 9999999878888999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.6e-08 Score=109.03 Aligned_cols=232 Identities=18% Similarity=0.227 Sum_probs=149.9
Q ss_pred CCccccccccccCeeEEEEEEcC--CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~--~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 381 (572)
..+.++..+|.|.|+.|-..... ....+|+|.+...... ....++...|..+=..+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~-~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS-EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc-cchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34556667889999998777643 3456777777655321 122344455777766776 9999999999999999999
Q ss_pred EEecccCCChhhhh-hcCCCcccCCHHHHHHHHHHHHHHHHHHh-------cCCCCCceeeCCC----------------
Q 038466 382 IYEYMKRGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLH-------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 382 V~Ey~~~GsL~~~l-~~~~~~~~l~~~~r~~i~~~ia~gl~yLH-------~~~~~~i~~~~~~---------------- 437 (572)
+.||..+|++++.+ +.......- ...-.+..++..++.|+| ++.+|.+......
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~--~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSS--SSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCC--cchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999888 433212122 223346788889999999 2444442211100
Q ss_pred ---CC--Ccccccc-ccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC---
Q 038466 438 ---SS--NRTLLAG-TYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--- 507 (572)
Q Consensus 438 ---~~--~~~~~~g-t~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 507 (572)
.. ......| ++.|+|||...+. ......|+||.|+++.-+++|..|++........ ...+....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~ 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKGRF 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeeccccccc
Confidence 00 0112457 9999999998874 5578899999999999999999998744321100 00111110
Q ss_pred -C--CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 508 -L--PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 508 -l--~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. ....... ...+..+++..+|+.|.+.+++..+.+...
T Consensus 251 ~~~~~~~~~~~-------~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 TQLPWNSISDQ-------AHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCccccCChh-------hhhcccccccCCchhccccccccccccccc
Confidence 1 1111111 122334677799999999999887766555
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-08 Score=102.67 Aligned_cols=115 Identities=28% Similarity=0.343 Sum_probs=66.9
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCcc---CCEEEccCCcCCC----CCCcCCcCC-CCcceeecccccccCC----
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSK---LQLLDLSSNGLTG----TIPPEIGNL-KNLIELNVGSNSLIGP---- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~---L~~L~Ls~N~l~g----~ip~~~~~l-~~L~~L~Ls~N~l~g~---- 189 (572)
+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.
T Consensus 77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 444666677777777666555555555444 7777777776652 222334445 6667777777766632
Q ss_pred CCccccCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccC
Q 038466 190 IPSALGSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 190 ip~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 233445556677777777766642 22333444567777777766653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-07 Score=86.87 Aligned_cols=102 Identities=29% Similarity=0.344 Sum_probs=51.8
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCC-cCCCCcceeecccccccCCCC-ccccCCCccC
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIP-SALGSLTNLS 201 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~ 201 (572)
.+.+|+.|+|++|.+... +.+..++.|+.|++++|+++. +++.+ ..+++|++|+|++|++...-- ..+..+++|+
T Consensus 40 ~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~ 116 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLR 116 (175)
T ss_dssp T-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--
T ss_pred hhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcc
Confidence 578999999999999864 257889999999999999994 54444 468999999999999964221 5678899999
Q ss_pred eeEeccCcCCCCCch----hhhhccccCcccc
Q 038466 202 NLDLSSNKLSGKIPP----EIAGMKNLTWLDL 229 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~----~~~~l~~L~~L~l 229 (572)
.|+|.+|.++.. +. -+..+++|+.||-
T Consensus 117 ~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 117 VLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred eeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 999999999843 33 3567889998874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-06 Score=81.55 Aligned_cols=118 Identities=14% Similarity=0.098 Sum_probs=72.7
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHH---------------------HHHHHHHHHHhcCCCC--cc
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------------------SFRNEAQVLSQVLHRN--IV 367 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~---------------------~f~~E~~~l~~l~H~n--iv 367 (572)
+.+|.|+||+||+|...+|+.||||++...........+ ....|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 467999999999999888999999998754321111111 1135666677765543 44
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhh-hhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS 439 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~-l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~ 439 (572)
+.+++ ...++||||+++|++... +.... .. .+...++.+++.++.++|.. ..++|.+....
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~ 144 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEY 144 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChh
Confidence 44443 235899999999654321 21111 01 34556888899999988852 23455544433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.8e-08 Score=92.78 Aligned_cols=104 Identities=27% Similarity=0.313 Sum_probs=68.3
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
+.|+.||||+|.++ .+..+..-++.++.|++|+|.++. + ..+..|++|+.||||+|.++. +-..-..+-+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence 35677777777776 345566666777778888877762 2 236667777777887777652 3333445566677777
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+.|.+.. -+.++.+-+|..||+++|++.
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchh
Confidence 7776642 234566677777777777764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.1e-08 Score=98.53 Aligned_cols=115 Identities=28% Similarity=0.327 Sum_probs=87.0
Q ss_pred cCCCCCCcEEEccCCcccc------cCchhccCCccCCEEEccCCcCCCCCCcCCcCCCC---cceeecccccccC----
Q 038466 122 FSCFPNLVKLTIQFFALTG------SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN---LIELNVGSNSLIG---- 188 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g------~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~---L~~L~Ls~N~l~g---- 188 (572)
+...++++.|+++++.+.+ .++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++
T Consensus 47 l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~ 126 (319)
T cd00116 47 LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR 126 (319)
T ss_pred HhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH
Confidence 4566778889998888762 34456778889999999999998766666665555 9999999998873
Q ss_pred CCCccccCC-CccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccC
Q 038466 189 PIPSALGSL-TNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 189 ~ip~~~~~l-~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.+...+..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 127 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 334456667 8899999999998853 33345566789999999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.1e-07 Score=90.46 Aligned_cols=112 Identities=31% Similarity=0.349 Sum_probs=90.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
..-+|.++.|++|+|.+... ..+..|++|+.||||+|.++ .+-..-..|.+.+.|+|++|.+.. -+.++.+-+|.
T Consensus 303 vKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLv 377 (490)
T KOG1259|consen 303 VKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLV 377 (490)
T ss_pred hhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhhe
Confidence 33468999999999999854 34888999999999999998 444555678899999999998742 24578889999
Q ss_pred eeEeccCcCCCC-CchhhhhccccCccccCCCcccCCc
Q 038466 202 NLDLSSNKLSGK-IPPEIAGMKNLTWLDLSNNNIKGSI 238 (572)
Q Consensus 202 ~L~ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~i 238 (572)
.||+++|++... --..+|+++-|+++.|.+|.+.+..
T Consensus 378 nLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 378 NLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999999998732 1245889999999999999998743
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.6e-07 Score=96.98 Aligned_cols=105 Identities=37% Similarity=0.541 Sum_probs=81.6
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
-|+.|-+++|.++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.+++ .-.|..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecc
Confidence 4677777777765 46777787778888888888877 67777888888888888888876 4666676 3457788888
Q ss_pred cCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 207 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|+++ .||-.|.+|+.|++|-|.+|.|..
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 88888 688888888888888888888863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-07 Score=98.70 Aligned_cols=114 Identities=35% Similarity=0.567 Sum_probs=64.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+.++..|++|+|+.|.++- +|..+..| -|+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|+.++++.+|+
T Consensus 117 i~~L~~lt~l~ls~NqlS~-lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr 192 (722)
T KOG0532|consen 117 ICNLEALTFLDLSSNQLSH-LPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR 192 (722)
T ss_pred hhhhhHHHHhhhccchhhc-CChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH
Confidence 3344455555555555542 34444433 2455555555555 55666665566666666666654 4556666666666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.|++..|++. .+|+++..| .|..||+|+|+++ .||..|
T Consensus 193 ~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 193 DLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred HHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhh
Confidence 6666666665 355555533 4556677777764 466555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.8e-06 Score=90.06 Aligned_cols=120 Identities=22% Similarity=0.188 Sum_probs=73.5
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHH-------------------------------H------HHHHHHH
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA-------------------------------F------IKSFRNE 354 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~-------------------------------~------~~~f~~E 354 (572)
.++.+++|+||+|++.+|+.||||+.+........ + .-+|.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 47889999999999999999999998764211100 0 0135667
Q ss_pred HHHHHhcC----CCCcccEEEEEEe-CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHH-------HHHH
Q 038466 355 AQVLSQVL----HRNIVKLYGFCLH-RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH-------ALAY 422 (572)
Q Consensus 355 ~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~-------gl~y 422 (572)
++.+.+++ |.+-|.+-..+.+ ....+|||||++|++|.+....... ..+ +..++..+++ .-.+
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 76666653 3333443333322 3457899999999999887653211 122 2233333332 3345
Q ss_pred HhcCCCCCceeeCC
Q 038466 423 LHHDCSPSIASTCP 436 (572)
Q Consensus 423 LH~~~~~~i~~~~~ 436 (572)
+|.|.+|+++....
T Consensus 279 ~H~D~hPgNilv~~ 292 (437)
T TIGR01982 279 FHADLHPGNIFVLK 292 (437)
T ss_pred eeCCCCcccEEECC
Confidence 67788887776543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-06 Score=94.90 Aligned_cols=126 Identities=17% Similarity=0.085 Sum_probs=73.7
Q ss_pred ccccccCeeEEEEEEcCC-CcEEEEEecCCcchHH-------------------------------HHHHH------HHH
Q 038466 311 SIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEE-------------------------------LAFIK------SFR 352 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~-------------------------------~~~~~------~f~ 352 (572)
.-++.|++|+||+|++++ |+.||||+++..-... .++.+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 467889999999999987 9999999997542110 01122 244
Q ss_pred HHHHHHHhcC----CCCcccEEEEEEe-CCeEEEEEecccCCChhhh--hhcCC-CcccCCHHHHHHHHHHHHHHHHHHh
Q 038466 353 NEAQVLSQVL----HRNIVKLYGFCLH-RKCMFLIYEYMKRGSLFCN--LHNNE-DAVELDWAKRVNIVKAMAHALAYLH 424 (572)
Q Consensus 353 ~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~GsL~~~--l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH 424 (572)
+|+.-+.+++ +.+.|.+-..+.+ ....+|||||++|+++.+. +...+ +...+.-.....+..|+.+ -.+.|
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-~GffH 283 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-DGFFH 283 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-CCeee
Confidence 4554444443 4444444343333 3456799999999999764 22211 1011111111123334432 46789
Q ss_pred cCCCCCceeeCCC
Q 038466 425 HDCSPSIASTCPD 437 (572)
Q Consensus 425 ~~~~~~i~~~~~~ 437 (572)
.|.+|+++....+
T Consensus 284 aDpHPGNIlv~~~ 296 (537)
T PRK04750 284 ADMHPGNIFVSYD 296 (537)
T ss_pred CCCChHHeEEecC
Confidence 9999998866543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-06 Score=96.36 Aligned_cols=86 Identities=29% Similarity=0.356 Sum_probs=68.4
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
+|+.|+|++|.|.+ +|.. .++|+.|++++|++++ +|.. ..+|+.|+|++|+++ .+|..++++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 57777777777775 4433 3578888888888874 6653 346788999999987 789999999999999999
Q ss_pred cCcCCCCCchhhhhc
Q 038466 207 SNKLSGKIPPEIAGM 221 (572)
Q Consensus 207 ~N~l~g~~p~~~~~l 221 (572)
+|.|+|.+|..+..+
T Consensus 454 ~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 454 GNPLSERTLQALREI 468 (788)
T ss_pred CCCCCchHHHHHHHH
Confidence 999999988877554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.8e-07 Score=89.70 Aligned_cols=98 Identities=23% Similarity=0.261 Sum_probs=75.1
Q ss_pred ccccCch-hccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCch
Q 038466 138 LTGSIPP-EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP 216 (572)
Q Consensus 138 l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~ 216 (572)
..+..|. .|..|++|+.|+|++|.+++.-+..|.++..+++|.|..|++...--..|.++.+|+.|+|.+|+++-..|.
T Consensus 261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~ 340 (498)
T KOG4237|consen 261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG 340 (498)
T ss_pred cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence 3334443 377888888888888888877778888888888888888887665566777888888888888888877788
Q ss_pred hhhhccccCccccCCCccc
Q 038466 217 EIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 217 ~~~~l~~L~~L~ls~N~l~ 235 (572)
.|..+..|..|+|-.|.+.
T Consensus 341 aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 341 AFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cccccceeeeeehccCccc
Confidence 8888888888888777653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.4e-05 Score=75.50 Aligned_cols=109 Identities=19% Similarity=0.200 Sum_probs=83.0
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC--CcccEEEEEEeCC---eEEEEEecc
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR--NIVKLYGFCLHRK---CMFLIYEYM 386 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~Ey~ 386 (572)
.++.|.++.||+++..+|+.+++|........ .....+.+|+++++.+++. ++.++++++.... ..++||||+
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 45678899999999877788999998654321 1124678899999999864 4567888776542 568999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
+++++.+.+.. ..++..++..++.++++.+.+||+-
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~ 118 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSV 118 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99988765532 1367778889999999999999974
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.7e-05 Score=74.93 Aligned_cols=114 Identities=16% Similarity=0.158 Sum_probs=76.0
Q ss_pred ccc-ccCeeEEEEEEcCCCcEEEEEecCCcch-----H-----HHHHHHHHHHHHHHHHhcCCCCc--ccEEEEEEeCC-
Q 038466 312 IWN-YDGYGSVYKAQLPNGKVFALKKLHTSET-----E-----ELAFIKSFRNEAQVLSQVLHRNI--VKLYGFCLHRK- 377 (572)
Q Consensus 312 ~~~-~~~fG~Vyk~~~~~g~~vAvK~l~~~~~-----~-----~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~- 377 (572)
++| .||.|+||+.... +..++||....... . .......+.+|++++.+++|+++ .+.+++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred eeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 565 7899999999876 56788888753211 0 01123567889999999999885 67777754432
Q ss_pred e---EEEEEecccC-CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee
Q 038466 378 C---MFLIYEYMKR-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST 434 (572)
Q Consensus 378 ~---~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~ 434 (572)
. .++||||+++ ++|.+++... .++.. ...++++++.+|| +|++|.++..
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 2 3599999997 6898887642 23322 2456777788776 4555555444
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4e-06 Score=96.43 Aligned_cols=109 Identities=28% Similarity=0.368 Sum_probs=86.8
Q ss_pred CCCCCcEEEccCCc--ccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 124 CFPNLVKLTIQFFA--LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 124 ~l~~L~~L~l~~n~--l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
..+.|++|-+..|. +.-..+..|..++.|++||||+|.--+.+|.++++|-+|++|+|++..+. .+|..++++..|.
T Consensus 543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 34578888888886 33333344777899999999988887889999999999999999988876 7888999999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNN 233 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 233 (572)
+|++..+.-...+|.....|.+|++|.+....
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccc
Confidence 99998887766677777778889888876554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.8e-06 Score=88.37 Aligned_cols=108 Identities=44% Similarity=0.641 Sum_probs=79.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCc-cCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALS-KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
+..++.++.|++.+|.++. +|+....+. +|+.|++++|.+. .+|..++.+++|+.|++++|++. .+|...+.+++|
T Consensus 112 ~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 112 LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 3344667788888887774 455566664 8888888888887 56666778888888888888876 466666677888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNN 233 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 233 (572)
+.|++++|+++ .+|...+.+..|+.+++++|.
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 88888888887 577766666678888888885
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.5e-06 Score=86.89 Aligned_cols=106 Identities=33% Similarity=0.545 Sum_probs=80.5
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
+|+.|++++|.+.- +|..+.++++|+.|++++|.++ .+|...+.+++|+.|++++|++. .+|..+..+..|+.|.++
T Consensus 141 nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 78888888888874 4566788888888888888888 66766667888888888888875 577766666778888888
Q ss_pred cCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 207 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
+|... .++..+..+.++..+.+.+|++..
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeee
Confidence 88543 456667777777777777777653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.3e-05 Score=92.35 Aligned_cols=87 Identities=33% Similarity=0.510 Sum_probs=80.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
|..++.|+.|||++|.=.+.+|.+|++|-+|++|+|+...+. .+|..+++|+.|.+||+..+.-...+|.....|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 777999999999999988999999999999999999999999 8999999999999999999887777788888899999
Q ss_pred eeEeccCc
Q 038466 202 NLDLSSNK 209 (572)
Q Consensus 202 ~L~ls~N~ 209 (572)
+|.+..-.
T Consensus 646 ~L~l~~s~ 653 (889)
T KOG4658|consen 646 VLRLPRSA 653 (889)
T ss_pred EEEeeccc
Confidence 99987655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00011 Score=79.41 Aligned_cols=92 Identities=17% Similarity=0.220 Sum_probs=66.0
Q ss_pred cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCC
Q 038466 326 LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELD 405 (572)
Q Consensus 326 ~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~ 405 (572)
..++.+|.|...+.+.... .....+-++-|+.+|||||++++......+..|+|+|-+.- |..++.+.. .
T Consensus 34 k~~~~~vsVF~~~~~~~~~---~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~-~---- 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEV---TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG-K---- 103 (690)
T ss_pred eccCCceEEEEEeCCCchh---hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH-H----
Confidence 4467788888877655411 23345667889999999999999999999999999998753 444454322 1
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCC
Q 038466 406 WAKRVNIVKAMAHALAYLHHDCS 428 (572)
Q Consensus 406 ~~~r~~i~~~ia~gl~yLH~~~~ 428 (572)
....-.+.+|+.||.|||++|.
T Consensus 104 -~~v~~Gl~qIl~AL~FL~~d~~ 125 (690)
T KOG1243|consen 104 -EEVCLGLFQILAALSFLNDDCN 125 (690)
T ss_pred -HHHHHHHHHHHHHHHHHhccCC
Confidence 1122246789999999998875
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.6e-06 Score=72.52 Aligned_cols=83 Identities=28% Similarity=0.403 Sum_probs=47.2
Q ss_pred CccCCEEEccCCcCCCCCCcCCcC-CCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCcc
Q 038466 149 LSKLQLLDLSSNGLTGTIPPEIGN-LKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWL 227 (572)
Q Consensus 149 l~~L~~L~Ls~N~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L 227 (572)
...|+..+|++|.|. .+|+.|.. .+.++.|+|++|.++ .+|.++..++.|+.|+++.|.+. ..|.-+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 334444566666665 34444432 335666666666654 45656666666666666666665 455555556666666
Q ss_pred ccCCCcc
Q 038466 228 DLSNNNI 234 (572)
Q Consensus 228 ~ls~N~l 234 (572)
|.-+|..
T Consensus 129 ds~~na~ 135 (177)
T KOG4579|consen 129 DSPENAR 135 (177)
T ss_pred cCCCCcc
Confidence 6665554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=7.9e-06 Score=91.91 Aligned_cols=169 Identities=22% Similarity=0.244 Sum_probs=99.0
Q ss_pred ccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCCChhh
Q 038466 315 YDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFC 393 (572)
Q Consensus 315 ~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~ 393 (572)
.+.++.++-+.- ..|...++|.......-.....++...+-.+.-..+||-+++..--+.-....+||++|..+|+|..
T Consensus 814 S~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~S 893 (1205)
T KOG0606|consen 814 SGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPS 893 (1205)
T ss_pred CCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchh
Confidence 345666665542 2244444444432221111111222233333334456776665554455677899999999999999
Q ss_pred hhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCce------e-----------------eC-C----C--
Q 038466 394 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIA------S-----------------TC-P----D-- 437 (572)
Q Consensus 394 ~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~------~-----------------~~-~----~-- 437 (572)
.||+..... ..+.|. ....+..+.+|||. +.+|... | .. . .
T Consensus 894 kl~~~~~~s--aepaRs-~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~ 970 (1205)
T KOG0606|consen 894 KLHNSGCLS--AEPARS-PILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSG 970 (1205)
T ss_pred hhhcCCCcc--cccccc-hhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccC
Confidence 998754211 111222 22334456677653 3222100 0 00 0 0
Q ss_pred ------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 438 ------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 438 ------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
........||+.|.|||...+......+|+|++|++++|.++|.+|++.
T Consensus 971 ~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 971 TPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred ccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0001235689999999999999999999999999999999999999863
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=2.3e-06 Score=92.20 Aligned_cols=107 Identities=31% Similarity=0.352 Sum_probs=80.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcC-CcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
+.-++.|+.|||++|.++.. ..+..|++|++|||++|.+. .+|.- ..+++ |+.|+|.+|.++.. ..+.+|.+|
T Consensus 183 Lqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL 256 (1096)
T KOG1859|consen 183 LQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSL 256 (1096)
T ss_pred HHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhhh
Confidence 44467888999999998864 37888899999999999988 55542 23444 89999999987643 347788899
Q ss_pred CeeEeccCcCCCCC-chhhhhccccCccccCCCcc
Q 038466 201 SNLDLSSNKLSGKI-PPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 201 ~~L~ls~N~l~g~~-p~~~~~l~~L~~L~ls~N~l 234 (572)
+.||++.|-+.+.- -..+..|..|+.|+|.+|.+
T Consensus 257 ~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 257 YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 99999999887632 12345677888889988876
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.6e-05 Score=54.82 Aligned_cols=33 Identities=52% Similarity=0.797 Sum_probs=11.6
Q ss_pred CCEEEccCCcCCCCCCcCCcCCCCcceeeccccc
Q 038466 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185 (572)
Q Consensus 152 L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~ 185 (572)
|++|++++|+++ .+|+.+++|++|++|++++|+
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~ 35 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNP 35 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSC
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCC
Confidence 333333333333 233333333333333333333
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=5.1e-06 Score=72.27 Aligned_cols=117 Identities=19% Similarity=0.212 Sum_probs=90.0
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+.....|+..+|++|.|..-.+..-...+.++.|+|++|.++ .+|.++..|+.|+.||++.|.+. ..|..+..|.+|-
T Consensus 49 l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 49 LSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLD 126 (177)
T ss_pred HhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHH
Confidence 344456778899999998654444456678999999999999 78999999999999999999987 4677777799999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
.|+..+|... .||-.+-.-.+.-..++.++.+.+.-|..
T Consensus 127 ~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 127 MLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred HhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 9999999887 56666544444555566777776655543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.63 E-value=5.4e-05 Score=53.22 Aligned_cols=37 Identities=38% Similarity=0.618 Sum_probs=32.3
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCC
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLT 163 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 163 (572)
++|++|++++|.++ .+|+.+++|++|+.|++++|.++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47899999999999 57878999999999999999998
|
... |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00047 Score=63.53 Aligned_cols=112 Identities=16% Similarity=0.109 Sum_probs=73.5
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCccc-EEEEEEeCCeEEEEEecccCCC
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK-LYGFCLHRKCMFLIYEYMKRGS 390 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~Gs 390 (572)
.++.|.++.||+++.. |..+++|........ ...+.+|++++..+.+.++++ ++++. .+..++||||+++.+
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 3566778999999865 667999987654321 124678999999987766654 44433 334589999999988
Q ss_pred hhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeeCCCCCCc
Q 038466 391 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIASTCPDSSNR 441 (572)
Q Consensus 391 L~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--~~~i~~~~~~~~~~ 441 (572)
+... . .. ...+..++++.++.||... ...++|.+....|.
T Consensus 78 l~~~--~-----~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Ni 119 (170)
T cd05151 78 LLTE--D-----FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNF 119 (170)
T ss_pred cccc--c-----cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcE
Confidence 7542 0 00 1234567888888888654 23346666555544
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=4.1e-06 Score=90.43 Aligned_cols=103 Identities=27% Similarity=0.352 Sum_probs=82.9
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCc-cccCCCccCeeEe
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS-ALGSLTNLSNLDL 205 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~l 205 (572)
.|...+.++|.|.- +..++.-++.|+.|||++|+++.. +.+..|+.|++|||+.|.+.. +|. ....+. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeee
Confidence 46677788888874 466788899999999999999843 378889999999999999874 443 233344 999999
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.+|.++. -..+.+|.+|..||+++|-|++
T Consensus 240 rnN~l~t--L~gie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 240 RNNALTT--LRGIENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred cccHHHh--hhhHHhhhhhhccchhHhhhhc
Confidence 9999874 3457899999999999999876
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=4.1e-05 Score=81.81 Aligned_cols=108 Identities=32% Similarity=0.345 Sum_probs=65.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+.+|+.|++..|.+.+.-. .+..+++|++|+|++|.++... .+..++.|+.|++++|.+... ..+..+++|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence 5556667777777777665322 2556677777777777776432 245556677777777766531 2344466777
Q ss_pred eeEeccCcCCCCCchh-hhhccccCccccCCCccc
Q 038466 202 NLDLSSNKLSGKIPPE-IAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~ 235 (572)
.+++++|.+...-+ . ...+.+++.+++.+|.+.
T Consensus 166 ~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 166 LLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR 199 (414)
T ss_pred cccCCcchhhhhhh-hhhhhccchHHHhccCCchh
Confidence 77777777663322 1 355666777777766653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.48 E-value=2.1e-05 Score=80.60 Aligned_cols=16 Identities=25% Similarity=0.366 Sum_probs=7.2
Q ss_pred CCCCCcEEEccCCccc
Q 038466 124 CFPNLVKLTIQFFALT 139 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~ 139 (572)
.||+|+.|+|+.|.+.
T Consensus 170 qLp~Le~LNls~Nrl~ 185 (505)
T KOG3207|consen 170 QLPSLENLNLSSNRLS 185 (505)
T ss_pred hcccchhccccccccc
Confidence 3444444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.47 E-value=1.9e-05 Score=80.96 Aligned_cols=113 Identities=27% Similarity=0.262 Sum_probs=58.2
Q ss_pred CCCCCCcEEEccCCcccccCc--hhccCCccCCEEEccCCcCCCCCCcCC-cCCCCcceeecccccccCC-CCccccCCC
Q 038466 123 SCFPNLVKLTIQFFALTGSIP--PEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGP-IPSALGSLT 198 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~ 198 (572)
..|++++.|||+.|-|...-| .-...|++|+.|+|+.|++.-..-... ..+++|+.|.|++|.|+-. +-.....++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 345666666666666554322 223456666666666666653222222 2345666666666665421 112233456
Q ss_pred ccCeeEeccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 199 NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 199 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+|..|+|..|...+.--.+..-+..|+.|||++|++-
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 6666666666422222222334456666666666653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=5e-05 Score=81.56 Aligned_cols=168 Identities=16% Similarity=0.131 Sum_probs=112.0
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCC-cccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey 385 (572)
.+.|..++.+.++++||.+-...+....+.+... ..-.-++++|.+++||| .|..++-+..++..+++++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 4556677888999999998433333336665543 12335789999999999 78888877778889999999
Q ss_pred ccCC-ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCc--eeeC---------------CCCCCccccccc
Q 038466 386 MKRG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI--ASTC---------------PDSSNRTLLAGT 447 (572)
Q Consensus 386 ~~~G-sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i--~~~~---------------~~~~~~~~~~gt 447 (572)
+.+| +-..-... ....+...+...+.+.-.++++|+|+..+.+. +... ..........+|
T Consensus 316 ~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 316 CSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred hcCCccccccCCh--hhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCcccccccCCCC
Confidence 9988 32211110 01112222223344555688999998643221 1100 001123456789
Q ss_pred cCccccccccCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 448 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 448 ~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
+.|+|||+.....+..+.|+||.|+--.+|.-|-+|.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999999999999999999999888888887774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.001 Score=70.13 Aligned_cols=155 Identities=18% Similarity=0.299 Sum_probs=95.2
Q ss_pred eEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeEEEEEecccC-CChh
Q 038466 319 GSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLIYEYMKR-GSLF 392 (572)
Q Consensus 319 G~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-GsL~ 392 (572)
.+.||+.. .||..|++|+++..+.... ..-..-++.++++.|+|+|++..++.. +..+.+||+|.|+ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 36899974 5899999999953332211 011234678899999999999998762 4568999999996 6776
Q ss_pred hhhhcCCC------------cccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCCccccccc-------cCcccc
Q 038466 393 CNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLLAGT-------YGYIAP 453 (572)
Q Consensus 393 ~~l~~~~~------------~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~~~~~~gt-------~~y~AP 453 (572)
+.-..... ....+......++.|+..||.++|+..-.. ...+. ...++.|+ .+.|
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAc---k~L~~-~kIlv~G~~RIriS~C~i~-- 440 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLAC---KTLDL-KKILVTGKMRIRISGCGIM-- 440 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCcee---ecccH-hHeEeeCcceEEEecccce--
Confidence 65433211 122344555678999999999999752111 00000 00111111 1111
Q ss_pred ccccCCC-----cCcccchHHHHHHHHHHHcCCC
Q 038466 454 ELAYTMV-----MTEKCDVYSFGVVTLEVLMGKH 482 (572)
Q Consensus 454 E~~~~~~-----~s~ksDVySfGvvl~ElltG~~ 482 (572)
+++.... --.+-|.--+|.+++-|.||..
T Consensus 441 Dvl~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 441 DVLQEDPTEPLESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eeecCCCCcchhHHhhhhHHHHHHHHHHHhhccc
Confidence 1111111 1246799999999999999954
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=6e-05 Score=80.58 Aligned_cols=110 Identities=30% Similarity=0.354 Sum_probs=86.5
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.+..++.+++..|.+.- +-..+..+.+|+.|+|..|.+.+ +...+..+++|++|+|++|.++... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 45667777788887764 33447888999999999999984 4444788999999999999997654 36777889999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++++|.++. ...+..+.+|+.+++++|.++..-+
T Consensus 146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~ 179 (414)
T KOG0531|consen 146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEN 179 (414)
T ss_pred eeccCcchh--ccCCccchhhhcccCCcchhhhhhh
Confidence 999999984 3345568999999999999875433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00026 Score=75.73 Aligned_cols=226 Identities=17% Similarity=0.150 Sum_probs=132.1
Q ss_pred CCccccccccccCeeEEEEEEc--CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~--~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.++.....++.+.|+.||+... .++..+++|.+..........+..+ .|+-+...+ .|.++++++......+..|+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccccccccC
Confidence 3456667788899999998753 4688999998875543322222222 233333333 48888888777777777889
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------CC-------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------SN------- 440 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------~~------- 440 (572)
--|||.++++...+.- ...++...++++..+++.++.|+| .|.+|..+.....+ ..
T Consensus 344 p~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 9999999998765521 122444556667777777777766 45555544321110 00
Q ss_pred ccccccccCcc--ccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC-CCChHHH
Q 038466 441 RTLLAGTYGYI--APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~--APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~ 517 (572)
.....++-++. +|+......+-.+.|+||||..+.|.++|..--+... . ...+.....+. +.....
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~---~~~i~~~~~p~~~~~~~~- 489 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------Q---SLTIRSGDTPNLPGLKLQ- 489 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------c---ceeeecccccCCCchHHh-
Confidence 01122333445 4444455667889999999999999999875321100 0 01111111211 111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...++.....+++..||.+.+...+...
T Consensus 490 -----~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 490 -----LQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----hhhhhhhhcCCccccchhhhhhcccchh
Confidence 1223334568999999998887665543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00047 Score=73.83 Aligned_cols=222 Identities=25% Similarity=0.224 Sum_probs=128.3
Q ss_pred ccccccc--cCeeEEEEEEc---CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEE
Q 038466 309 VFSIWNY--DGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 309 ~~~~~~~--~~fG~Vyk~~~---~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+|. |.+|.||+++. .++..+|+|+-+........ ..+=.+|.....++ .|+|.|+.+......+..|+-
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcceee
Confidence 3445677 99999999986 46888999984322110000 11223455555555 499999988888889999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHH----HHHHHhcC------CCCCceeeCCC---------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLHHD------CSPSIASTCPD--------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~----gl~yLH~~------~~~~i~~~~~~--------------- 437 (572)
.|++. .+|..+.+..... +.-.....+..+... |+..+|.+ .+|..+....+
T Consensus 197 tE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 99997 6787777653321 111222233444444 88888853 33322211110
Q ss_pred -CCC-------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcc--ccccCCCCcchhhhhhcccC
Q 038466 438 -SSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL--SSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 438 -~~~-------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~--~~~~~~~~~~~~~~~~~~~~ 507 (572)
..+ .....|..-|++||.. .+.++..+|+||+|.+.+|..+|..+.-.- ..+. . +++.
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~---------~r~~ 341 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--Q---------LRQG 341 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--c---------cccc
Confidence 000 0111466779999975 455788999999999999999987653211 1110 0 0111
Q ss_pred -CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 -LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 -l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
++.......-.+. .......++++|-.|++.+.+..+-.
T Consensus 342 ~ip~e~~~~~s~~l---~~~~~~~~d~~~~~~~~~q~~~~l~~ 381 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSL---RSVTSQMLDEDPRLRLTAQILTALNV 381 (524)
T ss_pred cCchhhhcCcchhh---hhHHHHhcCcchhhhhHHHHHhcccc
Confidence 1111100000001 11334678999999999988876543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00058 Score=47.72 Aligned_cols=34 Identities=38% Similarity=0.753 Sum_probs=20.7
Q ss_pred hhhhHHHHhhhcCCC-----CCCCCCCCCCCCCccceeeC
Q 038466 62 LSPIQLEKKALINTG-----WWNSSFWTTDHCKWEGITCN 96 (572)
Q Consensus 62 ~~~l~~~~~~~~~~~-----~~~~~~~~~~~c~w~Gv~c~ 96 (572)
..+|+.+|+++..+. .|+.+. ..+||+|.||+|+
T Consensus 5 ~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 5 RQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred HHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence 356888999887422 344431 3799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00068 Score=65.59 Aligned_cols=65 Identities=32% Similarity=0.412 Sum_probs=32.8
Q ss_pred ccCCccCCEEEccCC--cCCCCCCcCCcCCCCcceeecccccccCCCCcc---ccCCCccCeeEeccCcCCC
Q 038466 146 ISALSKLQLLDLSSN--GLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSA---LGSLTNLSNLDLSSNKLSG 212 (572)
Q Consensus 146 ~~~l~~L~~L~Ls~N--~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~---~~~l~~L~~L~ls~N~l~g 212 (572)
+..|++|+.|++|.| +.++.++.....+++|++|+|++|++.- +++ +..+.+|..|++.+|.-+.
T Consensus 61 ~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~pl~~l~nL~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 61 FPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLRPLKELENLKSLDLFNCSVTN 130 (260)
T ss_pred CCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccchhhhhcchhhhhcccCCccc
Confidence 344555666666666 4444444444444566666666665531 222 2334445556666555443
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0012 Score=63.97 Aligned_cols=91 Identities=26% Similarity=0.358 Sum_probs=68.2
Q ss_pred CchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccc--cccCCCCccccCCCccCeeEeccCcCCCCCchh--
Q 038466 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN--SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-- 217 (572)
Q Consensus 142 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N--~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-- 217 (572)
+..-.-.+..|+.|++.+..++.. ..+..|++|+.|.+|.| ...+.++....++++|++|++++|++.- ++.
T Consensus 35 ~~gl~d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~ 110 (260)
T KOG2739|consen 35 LGGLTDEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLR 110 (260)
T ss_pred cccccccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccc
Confidence 444444556777778888877732 34667889999999999 7777788778888999999999999872 333
Q ss_pred -hhhccccCccccCCCcccC
Q 038466 218 -IAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 218 -~~~l~~L~~L~ls~N~l~g 236 (572)
+..+.+|..||+.+|.-++
T Consensus 111 pl~~l~nL~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 111 PLKELENLKSLDLFNCSVTN 130 (260)
T ss_pred hhhhhcchhhhhcccCCccc
Confidence 4566778888888877543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0054 Score=64.22 Aligned_cols=32 Identities=22% Similarity=0.304 Sum_probs=13.8
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCC
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSN 160 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N 160 (572)
+|+.|+++++.--..+|..+. ++|++|++++|
T Consensus 73 sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~C 104 (426)
T PRK15386 73 ELTEITIENCNNLTTLPGSIP--EGLEKLTVCHC 104 (426)
T ss_pred CCcEEEccCCCCcccCCchhh--hhhhheEccCc
Confidence 355555544322223333221 34555555555
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0023 Score=59.73 Aligned_cols=101 Identities=24% Similarity=0.215 Sum_probs=55.6
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccC--CCCccccCCCccCeeE
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG--PIPSALGSLTNLSNLD 204 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ 204 (572)
+...++|++|.+.-. ..|..+..|..|.|++|+++..-|.--.-+++|+.|.|.+|++.. .+ .-+..|++|++|.
T Consensus 43 ~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl-~pLa~~p~L~~Lt 119 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDL-DPLASCPKLEYLT 119 (233)
T ss_pred ccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhc-chhccCCccceee
Confidence 345666777766532 245566777777777777774444333345667777777776642 11 1244556666666
Q ss_pred eccCcCCCCCch---hhhhccccCccccC
Q 038466 205 LSSNKLSGKIPP---EIAGMKNLTWLDLS 230 (572)
Q Consensus 205 ls~N~l~g~~p~---~~~~l~~L~~L~ls 230 (572)
+-+|..+..--- .+..+++|+.||..
T Consensus 120 ll~Npv~~k~~YR~yvl~klp~l~~LDF~ 148 (233)
T KOG1644|consen 120 LLGNPVEHKKNYRLYVLYKLPSLRTLDFQ 148 (233)
T ss_pred ecCCchhcccCceeEEEEecCcceEeehh
Confidence 666665422110 12345555555544
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0049 Score=64.49 Aligned_cols=10 Identities=40% Similarity=0.401 Sum_probs=4.7
Q ss_pred CCcEEEccCC
Q 038466 127 NLVKLTIQFF 136 (572)
Q Consensus 127 ~L~~L~l~~n 136 (572)
+|+.|++++|
T Consensus 95 nLe~L~Ls~C 104 (426)
T PRK15386 95 GLEKLTVCHC 104 (426)
T ss_pred hhhheEccCc
Confidence 4444444444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.00053 Score=68.75 Aligned_cols=113 Identities=23% Similarity=0.354 Sum_probs=67.4
Q ss_pred cCCCCCCcEEEccCCcccc----cCchhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeecccccccCCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGPIPSA 193 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~ip~~ 193 (572)
|...+.|+.+.++.|.+.- .+-..+..+++|++|||..|.|+-. +...+..+++|++|+++++.+...-..+
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a 260 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA 260 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH
Confidence 4445677777777776642 1223456777777777777777632 2233556667777777777765433322
Q ss_pred c-----cCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcc
Q 038466 194 L-----GSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 194 ~-----~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l 234 (572)
| ...++|+.|.+.+|.++.. +-..+...+.|..|+|++|.+
T Consensus 261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 261 FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 2 2246777777777776532 222334456677777777776
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.00093 Score=67.05 Aligned_cols=114 Identities=23% Similarity=0.257 Sum_probs=82.5
Q ss_pred cCCCCCCcEEEccCCcccccCchh----ccCCccCCEEEccCCcCCCC-------------CCcCCcCCCCcceeecccc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPE----ISALSKLQLLDLSSNGLTGT-------------IPPEIGNLKNLIELNVGSN 184 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~----~~~l~~L~~L~Ls~N~l~g~-------------ip~~~~~l~~L~~L~Ls~N 184 (572)
+..++.|+.|+||.|.|.-.-++. +.+++.|++|.|.+|.+.-. ...-.++-++|+++..+.|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 455678999999999987554443 56788999999999988521 1122345578999999998
Q ss_pred cccCC----CCccccCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCccc
Q 038466 185 SLIGP----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 185 ~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
++... +...|...+.|+.+.+++|.+... +-..+..+++|+.|||..|.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 87432 223466678899999999987521 2234677889999999999886
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0016 Score=73.51 Aligned_cols=115 Identities=23% Similarity=0.270 Sum_probs=81.4
Q ss_pred CCCCCCcEEEccCCccccc-CchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccC-CCCccccCCCcc
Q 038466 123 SCFPNLVKLTIQFFALTGS-IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTNL 200 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L 200 (572)
..||+|+.|.+.+-.+... .-.-..++++|..||+|+.+++.. ..++.|++|++|-+.+=.+.. ..=..+.+|++|
T Consensus 145 ~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L 222 (699)
T KOG3665|consen 145 TMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKL 222 (699)
T ss_pred hhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCC
Confidence 3478999999988777543 233456889999999999998843 567889999988775443321 111356789999
Q ss_pred CeeEeccCcCCCCC--chh----hhhccccCccccCCCcccCCcc
Q 038466 201 SNLDLSSNKLSGKI--PPE----IAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 201 ~~L~ls~N~l~g~~--p~~----~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+.||+|........ ... -..|++|+.||.|++.+.+.+=
T Consensus 223 ~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~l 267 (699)
T KOG3665|consen 223 RVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEIL 267 (699)
T ss_pred CeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHH
Confidence 99999987765322 211 1248899999999888876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0096 Score=64.76 Aligned_cols=137 Identities=18% Similarity=0.166 Sum_probs=78.9
Q ss_pred ccccCeeEEEEEEcCCCcEEEEEecCCcchHHH-------------------------------HH------HHHHHHHH
Q 038466 313 WNYDGYGSVYKAQLPNGKVFALKKLHTSETEEL-------------------------------AF------IKSFRNEA 355 (572)
Q Consensus 313 ~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~-------------------------------~~------~~~f~~E~ 355 (572)
++..+-|+||+|++++|+.||||+.+..-.... ++ .-+|.+|+
T Consensus 133 iAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA 212 (517)
T COG0661 133 IASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREA 212 (517)
T ss_pred hhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHH
Confidence 345678999999999999999999875422110 01 11345566
Q ss_pred HHHHhcC----CCCcccEEEEEEe-CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHH-------HHHHH
Q 038466 356 QVLSQVL----HRNIVKLYGFCLH-RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH-------ALAYL 423 (572)
Q Consensus 356 ~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~-------gl~yL 423 (572)
.-+.+++ +..=|++=..|.+ .....|+|||++|-.+.+...-... ..+ +..++..+++ --.|.
T Consensus 213 ~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~q~~~dgff 287 (517)
T COG0661 213 ANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhcCcc
Confidence 5555553 2222333333433 3456799999999888777432221 233 1222222222 14577
Q ss_pred hcCCCCCceeeCCCCCCccccccccCccccc
Q 038466 424 HHDCSPSIASTCPDSSNRTLLAGTYGYIAPE 454 (572)
Q Consensus 424 H~~~~~~i~~~~~~~~~~~~~~gt~~y~APE 454 (572)
|.|..|+++....+..-.-...|..+.+.|+
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999998877655543333344555555554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 572 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-26 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-61
Identities = 86/289 (29%), Positives = 127/289 (43%), Gaps = 57/289 (19%)
Query: 301 ERATNNIDVFSIWNY---DGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 357
+ A++N FS N G+G VYK +L +G + A+K+L E F+ E ++
Sbjct: 26 QVASDN---FSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTEVEM 80
Query: 358 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE-LDWAKRVNIVKAM 416
+S +HRN+++L GFC+ L+Y YM GS+ L ++ LDW KR I
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 417 AHALAYLHHDCSPSI-------------------------ASTCPDSSNR--TLLAGTYG 449
A LAYLH C P I A T + GT G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID------- 502
+IAPE T +EK DV+ +GV+ LE++ G+ DL ++D +ML+D
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLDWVKGLLK 257
Query: 503 ------VLDQRLPPPVDRK-VIRDILLASTISFACLQSNPKSRPTMQYV 544
++D L + V + I +A C QS+P RP M V
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVAL----LCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-53
Identities = 78/279 (27%), Positives = 117/279 (41%), Gaps = 42/279 (15%)
Query: 301 ERATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 360
E ATNN D + + +G VYK L +G ALK+ ++ I+ F E + LS
Sbjct: 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEEFETEIETLSF 91
Query: 361 VLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLH-NNEDAVELDWAKRVNIVKAMAHA 419
H ++V L GFC R M LIY+YM+ G+L +L+ ++ + + W +R+ I A
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 420 LAYLHHDC-------SPSI---------------ASTCPDSSNR---TLLAGTYGYIAPE 454
L YLH S +I + + T++ GT GYI PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
Query: 455 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS--------DPKIMLIDVLDQ 506
+TEK DVYSFGVV EVL + + L ++D
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 507 RLPPPVDRK-VIRDILLASTISFACLQSNPKSRPTMQYV 544
L + + + + A CL + + RP+M V
Sbjct: 272 NLADKIRPESLRKFGDTAV----KCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 72/290 (24%), Positives = 109/290 (37%), Gaps = 59/290 (20%)
Query: 301 ERATNNIDVFSIWNYD------GYGSVYKAQLPNGKVFALKKLHTSETEE-LAFIKSFRN 353
+ TNN D I G+G VYK + N A+KKL + F
Sbjct: 21 KNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 354 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIV 413
E +V+++ H N+V+L GF + L+Y YM GSL L + L W R I
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 414 KAMAHALAYLHHDC-----------------SPSI-----ASTCPDSSNR---TLLAGTY 448
+ A+ + +LH + + I A + + + GT
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 449 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID------ 502
Y+APE A +T K D+YSFGVV LE++ G D +L+D
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-------EHREPQLLLDIKEEIE 251
Query: 503 --------VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYV 544
+D+++ V +AS CL RP ++ V
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVAS----QCLHEKKNKRPDIKKV 297
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 78 WNSSFWTTDHC--KWEGITCNSAG---SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLT 132
W + TD C W G+ C++ + L LSG N S NL L
Sbjct: 27 WLPT---TDCCNRTWLGVLCDTDTQTYRVNNLDLSG----LNLPKPYPIPSSLANLPYLN 79
Query: 133 IQFFA----LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG 188
+ L G IPP I+ L++L L ++ ++G IP + +K L+ L+ N+L G
Sbjct: 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139
Query: 189 PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL-TWLDLSNNNIKGSIP 239
+P ++ SL NL + N++SG IP L T + +S N + G IP
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 53/169 (31%), Positives = 73/169 (43%), Gaps = 40/169 (23%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKL-QLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
PNLV +T ++G+IP + SKL + +S N LTG IPP NL NL +++ N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS- 243
L G GS N + L+ N L+ + ++ KNL LDL NN I G++P L+
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 244 ------------------P---------------NKGLCGGNFLDLPSC 259
P NK LCG LP+C
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 139 TGSIPPEISALSKLQLLDLSSNGLTGT--IPPEIGNLKNLIELNV-GSNSLIGPIPSALG 195
G + + ++ LDLS L IP + NL L L + G N+L+GPIP A+
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 196 SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
LT L L ++ +SG IP ++ +K L LD S N + G++P +S
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 14/55 (25%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 190 IPSALGSLTNLSN----LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
I LG+ T LS+ D + G + + LDLS N+ P+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 61/302 (20%), Positives = 108/302 (35%), Gaps = 70/302 (23%)
Query: 301 ERATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--L 358
+ + + + +G V+KAQL N V A+K + +S++NE +V L
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDK------QSWQNEYEVYSL 72
Query: 359 SQVLHRNIVKLYGFCLH----RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVK 414
+ H NI++ G ++LI + ++GSL L N + W + +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAE 128
Query: 415 AMAHALAYLHHD-------CSPSIA----------------------------STCPDSS 439
MA LAYLH D P+I+ +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 440 NRTLLAGTYGYIAPELA-----YTMVMTEKCDVYSFGVVTLEVLMGKHPRD-------LL 487
+ GT Y+APE+ + + D+Y+ G+V E+ D L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 488 SSLSSSSDPKI--MLIDVLDQRLPPPVDRKVIRDI---LLASTISFACLQSNPKSRPTMQ 542
P + M V+ ++ P + + +L TI C + ++R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE-ECWDHDAEARLSAG 307
Query: 543 YV 544
V
Sbjct: 308 CV 309
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-41
Identities = 62/174 (35%), Positives = 81/174 (46%), Gaps = 14/174 (8%)
Query: 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158
G E + +G F S+ I G P + LD+S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNR-LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N L+G IP EIG++ L LN+G N + G IP +G L L+ LDLSSNKL G+IP +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 219 AGMKNLTWLDLSNNNIKGSIPV-----RLSP-----NKGLCGGNFLDLPSCDTT 262
+ + LT +DLSNNN+ G IP P N GLCG LP CD +
Sbjct: 701 SALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-39
Identities = 49/130 (37%), Positives = 68/130 (52%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
L L + L G IP E+ + L+ L L N LTG IP + N NL +++ +N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244
L G IP +G L NL+ L LS+N SG IP E+ ++L WLDL+ N G+IP +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 245 NKGLCGGNFL 254
G NF+
Sbjct: 561 QSGKIAANFI 570
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-39
Identities = 49/122 (40%), Positives = 66/122 (54%)
Query: 118 SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI 177
L + L +L +Q TG IPP +S S+L L LS N L+GTIP +G+L L
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
+L + N L G IP L + L L L N L+G+IP ++ NL W+ LSNN + G
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 238 IP 239
IP
Sbjct: 506 IP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-39
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 15/176 (8%)
Query: 78 WNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLN--FSCFPNLVKLTIQF 135
W+S+ + C ++G+TC + + LS N S ++ L L +
Sbjct: 33 WSSN---KNPCTFDGVTCRD-DKVTSIDLSS--KPLNVGFSAVSSSLLSLTGLESLFLSN 86
Query: 136 FALTGSIPPEISALSKLQLLDLSSNGLTGTIPP--EIGNLKNLIELNVGSNSLIGPIP-S 192
+ GS+ + L LDLS N L+G + +G+ L LNV SN+L P S
Sbjct: 87 SHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145
Query: 193 ALGSLTNLSNLDLSSNKLSGKIPPEIA---GMKNLTWLDLSNNNIKGSIPVRLSPN 245
L +L LDLS+N +SG G L L +S N I G + V N
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVN 201
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-37
Identities = 51/137 (37%), Positives = 74/137 (54%), Gaps = 5/137 (3%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI--SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
+ +L+ L + +G I P + + + LQ L L +NG TG IPP + N L+ L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
++ N L G IPS+LGSL+ L +L L N L G+IP E+ +K L L L N++ G IP
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
Query: 240 VRLSPNKGLCGGNFLDL 256
LS L N++ L
Sbjct: 484 SGLSNCTNL---NWISL 497
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-36
Identities = 56/131 (42%), Positives = 78/131 (59%), Gaps = 3/131 (2%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
LV L + F L+G+IP + +LSKL+ L L N L G IP E+ +K L L + N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
L G IPS L + TNL+ + LS+N+L+G+IP I ++NL L LSNN+ G+IP L
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 246 KGLCGGNFLDL 256
+ L +LDL
Sbjct: 538 RSL---IWLDL 545
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-35
Identities = 52/157 (33%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALS-KLQLLDLSSNG 161
L LS F+ L L L + F +G +P ++ LS L LDLSSN
Sbjct: 322 SLALSS--NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 162 LTGTIPPEIGN--LKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219
+G I P + L EL + +N G IP L + + L +L LS N LSG IP +
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 220 GMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
+ L L L N ++G IP L K L L L
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTL---ETLIL 473
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-35
Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 5/133 (3%)
Query: 116 RLSQLNFSCFPNLVKLTIQ-----FFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI 170
++ + N G +++ LS +++S G P
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLS 230
N +++ L++ N L G IP +GS+ L L+L N +SG IP E+ ++ L LDLS
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 231 NNNIKGSIPVRLS 243
+N + G IP +S
Sbjct: 689 SNKLDGRIPQAMS 701
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-35
Identities = 44/119 (36%), Positives = 58/119 (48%), Gaps = 3/119 (2%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
L L I L+G IS ++L+LL++SSN G IPP LK+L L++
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 182 GSNSLIGPIPSAL-GSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
N G IP L G+ L+ LDLS N G +PP L L LS+NN G +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-34
Identities = 45/125 (36%), Positives = 59/125 (47%), Gaps = 4/125 (3%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
S L L I G IPP L LQ L L+ N TG IP + G L L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IAGMKNLTWLDLSNNNIKGSI 238
++ N G +P GS + L +L LSSN SG++P + + M+ L LDLS N G +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 239 PVRLS 243
P L+
Sbjct: 360 PESLT 364
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-34
Identities = 40/128 (31%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 118 SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI 177
+ L L I ++G + +S L+ LD+SSN + IP +G+ L
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQ 226
Query: 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
L++ N L G A+ + T L L++SSN+ G IPP +K+L +L L+ N G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284
Query: 238 IPVRLSPN 245
IP LS
Sbjct: 285 IPDFLSGA 292
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-33
Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 7/135 (5%)
Query: 126 PNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEIGNLK-NLIELNVGS 183
L L + +G +P + + + L++LDLS N +G +P + NL +L+ L++ S
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 184 NSLIGPIPSALG--SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241
N+ GPI L L L L +N +GKIPP ++ L L LS N + G+IP
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 242 LSPNKGLCGGNFLDL 256
L L L L
Sbjct: 438 LGSLSKL---RDLKL 449
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-32
Identities = 43/123 (34%), Positives = 61/123 (49%), Gaps = 4/123 (3%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
L L + F LTG IP +S + L + LS+N LTG IP IG L+NL L + +NS
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
G IP+ LG +L LDL++N +G IP + ++ N I G V + +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKND 581
Query: 246 KGL 248
Sbjct: 582 GMK 584
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 9/121 (7%)
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
LTG IP I L L +L LS+N +G IP E+G+ ++LI L++ +N G IP+A+
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN--NIKGSIPVRLSPNKGLCGGNFLD 255
+ +++N ++GK I + N +G +L+ N +
Sbjct: 562 S----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR---NPCN 614
Query: 256 L 256
+
Sbjct: 615 I 615
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 64/261 (24%), Positives = 107/261 (40%), Gaps = 51/261 (19%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V KA+ K A+K++ + K+F E + LS+V H NIVKLYG CL+
Sbjct: 20 AFGVVCKAKW-RAKDVAIKQIESESER-----KAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIA---- 432
C+ + EY + GSL+ LH E A ++ + +AYLH ++
Sbjct: 74 VCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 433 --------------------STCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
+ C ++ T G+ ++APE+ +EKCDV+S+G+
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-----PPVDRKVIRDILLASTIS 527
+ EV+ + P D + + IM R P P ++
Sbjct: 192 ILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRPPLIKNLPKPIESLMTR-------- 239
Query: 528 FACLQSNPKSRPTMQYVSQEF 548
C +P RP+M+ + +
Sbjct: 240 --CWSKDPSQRPSMEEIVKIM 258
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 60/267 (22%), Positives = 105/267 (39%), Gaps = 54/267 (20%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELA-FIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G VY+A G A+K E+++ I++ R EA++ + + H NI+ L G CL
Sbjct: 19 GFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI---- 431
+ L+ E+ + G L L + VN +A + YLH + I
Sbjct: 78 EPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 432 ----------ASTCPDSSNRTL------------------LAGTYGYIAPELAYTMVMTE 463
D SN+ L AG Y ++APE+ + ++
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSK 193
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR---KVIRDI 520
DV+S+GV+ E+L G+ P + L+ + V +L P+ + +
Sbjct: 194 GSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 521 LLASTISFACLQSNPKSRPTMQYVSQE 547
+ C +P SRP+ + +
Sbjct: 247 ME------DCWNPDPHSRPSFTNILDQ 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 66/275 (24%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLH----TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
G+G V+K + + + V A+K L ETE + + F+ E ++S + H NIVKLYG
Sbjct: 31 GFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 431
+ M + E++ G L+ L + + W+ ++ ++ +A + Y+ + +P I
Sbjct: 91 LMHNPPRM--VMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN-QNPPI 145
Query: 432 A----------------------------STCPDSSNRTLLAGTYGYIAPEL------AY 457
+ + + L G + ++APE +Y
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESY 205
Query: 458 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD---- 513
TEK D YSF ++ +L G+ P D S I +I R P D
Sbjct: 206 ----TEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FINMIREEGLRPTIPEDCPPR 258
Query: 514 -RKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547
R VI C +PK RP Y+ +E
Sbjct: 259 LRNVIEL----------CWSGDPKKRPHFSYIVKE 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 63/285 (22%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+V++A+ +G A+K L + + F E ++ ++ H NIV G
Sbjct: 49 SFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI----- 431
+ ++ EY+ RGSL+ LH + +LD +R+++ +A + YLH+ +P I
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165
Query: 432 -----------------------ASTCPDSSNRTLLAGTYGYIAPEL----AYTMVMTEK 464
++ SS AGT ++APE+ EK
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPS----NEK 219
Query: 465 CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-----RKVIRD 519
DVYSFGV+ E+ + P L+ + + +RL P + +I
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 520 ILLASTISFACLQSNPKSRPTMQYVSQ--EFLITRKTPLVKHAAI 562
C + P RP+ + LI P + +
Sbjct: 275 ----------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 50/262 (19%), Positives = 85/262 (32%), Gaps = 56/262 (21%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH- 375
G ++K + G +K L + + F E L H N++ + G C
Sbjct: 22 HSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79
Query: 376 -RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI--- 431
LI +M GSL+ LH + V +D ++ V MA +A+LH P I
Sbjct: 80 PAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHT-LEPLIPRH 137
Query: 432 ---------------------ASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDV 467
S ++APE D+
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKF---SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-----RKVIRDILL 522
+SF V+ E++ + P LS++ M + + R P K+++
Sbjct: 195 WSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGLRPTIPPGISPHVSKLMKI--- 246
Query: 523 ASTISFACLQSNPKSRPTMQYV 544
C+ +P RP +
Sbjct: 247 -------CMNEDPAKRPKFDMI 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 47/266 (17%), Positives = 88/266 (33%), Gaps = 55/266 (20%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G VY + +G+V A++ + E +K+F+ E Q H N+V G C+
Sbjct: 45 RFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP 101
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H------ 425
+ +I K +L+ + + + LD K I + + + YLH H
Sbjct: 102 PHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK 159
Query: 426 ----------------DCSPSIASTCPDSSNRTLLAGTYGYIAPEL---------AYTMV 460
+ + G ++APE+ +
Sbjct: 160 NVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 461 MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR--KVIR 518
++ DV++ G + E+ + P + + I+ + K I
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGTGMKPNLSQIGMGKEIS 273
Query: 519 DILLASTISFACLQSNPKSRPTMQYV 544
DILL C + RPT +
Sbjct: 274 DILL------FCWAFEQEERPTFTKL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 53/274 (19%), Positives = 94/274 (34%), Gaps = 62/274 (22%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G K G+V +K+L + E ++F E +V+ + H N++K G
Sbjct: 23 FGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIGVLYKD 79
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H------ 425
K + I EY+K G+L + + + + W++RV+ K +A +AYLH H
Sbjct: 80 KRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 426 --------------------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTM 459
+ PD R + G ++APE+
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-----R 514
EK DV+SFG+V E++ + + L P +
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----MDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ C +P+ RP+ +
Sbjct: 254 PITVR----------CCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 55/261 (21%), Positives = 112/261 (42%), Gaps = 52/261 (19%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G+VYK + +G V A+K L+ + +++F+NE VL + H NI+ G+
Sbjct: 37 FGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 92
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSPS- 430
+ ++ ++ + SL+ +LH +E + + K ++I + A + YLH H D +
Sbjct: 93 QLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 431 ------------------IASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYS 469
S S L+G+ ++APE+ + + + DVY+
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR------KVIRDILLA 523
FG+V E++ G+ P +++ ++ V L P + + K ++ ++
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDLSKVRSNCPKRMKRLMA- 263
Query: 524 STISFACLQSNPKSRPTMQYV 544
CL+ RP+ +
Sbjct: 264 -----ECLKKKRDERPSFPRI 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 55/297 (18%), Positives = 94/297 (31%), Gaps = 81/297 (27%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVLHRNIVKLYGFCL 374
YG+VYK L + + A+K + ++F NE + + + H NI +
Sbjct: 25 RYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 375 HRKC-----MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD--- 426
L+ EY GSL L + DW + ++ LAYLH +
Sbjct: 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 427 ---CSPSIA----------------------------------STCPDSSNRTLLAGTYG 449
P+I+ + + GT
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 450 YIAPELAYTMV-------MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------S 493
Y+APE+ V ++ D+Y+ G++ E+ M S+
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253
Query: 494 SDPKI--MLIDVLDQRLPPPVDRKVIRDIL----LASTISFACLQSNPKSRPTMQYV 544
+ P M + V ++ P + L L TI C + ++R T Q
Sbjct: 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE-DCWDQDAEARLTAQXA 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 58/290 (20%), Positives = 99/290 (34%), Gaps = 70/290 (24%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVLHRNIVKLYGFCL 374
YG V++ G+ A+K + + KS+ E ++ + H NI+ +
Sbjct: 20 RYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 375 HRKC----MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---- 426
+ ++LI Y + GSL+ L LD + IV ++A LA+LH +
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 427 -CSPSIA------------------------------STCPDSSNRTLLAGTYGYIAPEL 455
P+IA ST GT Y+APE+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 456 ------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------SSSDPKI--MLI 501
++ D+++FG+V EV ++ +DP M
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 502 DVLDQRLPPPVDRKVIRDI---LLASTISFACLQSNPKSRPTMQYVSQEF 548
V + P + + D LA + C NP +R T + +
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMK-ECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/286 (19%), Positives = 93/286 (32%), Gaps = 70/286 (24%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVLHRNIVKLYGFCL 374
YG V+ + G+ A+K T+E S+ E ++ + H NI+ +
Sbjct: 49 RYGEVWMGKW-RGEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADI 101
Query: 375 HRKC----MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H 425
++LI +Y + GSL+ L + LD + + + L +LH
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 426 DCSPSIA------------------------------STCPDSSNRTLLAGTYGYIAPE- 454
P+IA T GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 455 LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------SSSDPKI--MLI 501
L ++ D+YSFG++ EV ++ SDP M
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 502 DVLDQRLPPPVDRKVIRDIL---LASTISFACLQSNPKSRPTMQYV 544
V ++L P + D + ++ C NP SR T V
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMT-ECWAHNPASRLTALRV 322
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 54/286 (18%), Positives = 101/286 (35%), Gaps = 70/286 (24%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVLHRNIVKLYGFCL 374
+G V++ + G+ A+K + E +S+ EA++ + H NI+
Sbjct: 54 RFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 375 HRK----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---- 426
++L+ +Y + GSLF L+ + + + + A LA+LH +
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 427 -CSPSIA------------------------------STCPDSSNRTLLAGTYGYIAPE- 454
P+IA +T GT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 455 LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDLLS------SLSSSSDPKI--MLI 501
L ++ M ++ D+Y+ G+V E+ + SDP + M
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 502 DVLDQRLPPPVDRKVIRDIL---LASTISFACLQSNPKSRPTMQYV 544
V +Q+L P + + +A + C +N +R T +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGAARLTALRI 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 15/163 (9%)
Query: 86 DHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPE 145
+ + A + Y + + L +L + + +P
Sbjct: 214 GNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL-----KDLTDVEVYNCPNLTKLPTF 268
Query: 146 ISALSKLQLLDLSSNGLT--------GTIPPEIGNLKNLIELNVGSNSLI-GPIPSALGS 196
+ AL ++QL++++ N + + + + +G N+L P+ ++L
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+ L L+ N+L G P L L+L+ N I
Sbjct: 329 MKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPA 370
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 139 TGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLT 198
T + + + KL +L+ N L G P G+ L LN+ N + + G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 199 NLSNLDLSSNKLSGKIPP--EIAGMKNLTWLDLSNNNIKGSIPVRLSP 244
+ NL + NKL IP + + ++ +D S N I P
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 31/204 (15%), Positives = 54/204 (26%), Gaps = 22/204 (10%)
Query: 69 KKALINTGWWNSSFWTTDHCKW------------EGITCNSAGSIFELYLSGYYAGFNWR 116
AL W F T W G++ NS G + L L G+ G + R
Sbjct: 39 WDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGF--GASGR 96
Query: 117 LSQLNFSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLSSNGLTGTIPPEIGN 172
+ L L + P ISA + T
Sbjct: 97 VPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155
Query: 173 LK--NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLS 230
+LI+ + S+ I + + + SN ++ + + + L +
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214
Query: 231 NNNIKGSIPVRLSPNKGLCGGNFL 254
N+ N+
Sbjct: 215 NSPFVAENICEAWENENSEYAQQY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 18/149 (12%), Positives = 48/149 (32%), Gaps = 20/149 (13%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL 176
+ F +L+K I SI K + SN +T + + L L
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL 208
Query: 177 IELNVGSNSLIGP-------------------IPSALGSLTNLSNLDLSSNKLSGKIPPE 217
+ +G++ + +L +L+++++ + K+P
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
Query: 218 IAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246
+ + + ++++ N ++
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQA 297
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 18/150 (12%), Positives = 51/150 (34%), Gaps = 29/150 (19%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG----------------- 164
++ +T + + L+KL+ + ++
Sbjct: 179 SRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 165 --TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKL--------SGKI 214
T + NLK+L ++ V + + +P+ L +L + ++++ N+ +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 215 PPEIAGMKNLTWLDLSNNNIK-GSIPVRLS 243
+ + + + + NN+K + L
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 28/139 (20%), Positives = 52/139 (37%), Gaps = 18/139 (12%)
Query: 122 FSCFPNLVKLTIQFFALTG-------SIPPEISALSKLQLLDLSSNGLTGTIPPEI--GN 172
FS L + + LT L +DL N LT + +
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATT 511
Query: 173 LKNLIELNVGSNSLIGPIPSALGSLTNL------SNLDLSSNKLSGKIPPEIAGMKNLTW 226
L L+ +++ NS P+ + + L + D N+ + P I +LT
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570
Query: 227 LDLSNNNIKGSIPVRLSPN 245
L + +N+I+ + +++PN
Sbjct: 571 LQIGSNDIR-KVNEKITPN 588
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 23/157 (14%), Positives = 54/157 (34%), Gaps = 28/157 (17%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPP--EISALSKLQLLD 156
L L+ N +++++ + ++ + + IP + ++S + +D
Sbjct: 357 SLNLAY-----N-QITEIPANFCGFTEQV--ENLSFAHNKLKYIPNIFDAKSVSVMSAID 408
Query: 157 LSSNGLTG-------TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209
S N + + P N+ +N+ +N + + + LS+++L N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468
Query: 210 LSG-------KIPPEIAGMKNLTWLDLSNNNIKGSIP 239
L+ LT +DL N +
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSD 505
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 24/146 (16%), Positives = 46/146 (31%), Gaps = 21/146 (14%)
Query: 118 SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLL------DLSSNGLTGTIPPEIG 171
+ P LV + + + + + P + S L+ D N P I
Sbjct: 505 DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
+L +L +GSN + + + N+S LD+ N + L
Sbjct: 564 LCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 232 NNIKGSIPVRLSPNKGLCGGNFLDLP 257
+ + + G + LD+
Sbjct: 621 DK-----------TQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 4/120 (3%)
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP 189
+ I+ I ++ L+ + G N EL+
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD----MWGAQ 72
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLC 249
+L S ++ L L SG++P I + L L L ++ K + +
Sbjct: 73 PGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISAN 132
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 24/124 (19%), Positives = 46/124 (37%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
++ + + L + F L + +LQ+LDLS + +L +
Sbjct: 18 NFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L + N + A L++L L L+ I +K L L++++N I+
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 236 GSIP 239
Sbjct: 138 SFKL 141
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 34/138 (24%), Positives = 46/138 (33%), Gaps = 5/138 (3%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
NF L L Q L + +L L LD+S L +L L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 180 NVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238
+ NS P L NL+ LDLS +L P + +L L++S+NN
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 239 PVRLSPNKGLCGGNFLDL 256
L LD
Sbjct: 511 TFPYKCLNSL---QVLDY 525
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 31/147 (21%), Positives = 53/147 (36%), Gaps = 11/147 (7%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLT---IQFFALTGSIPPEI-SALSKLQLL 155
++ L +S F L L + + + P+I + L L L
Sbjct: 422 NLIYLDISH-----T-HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
DLS L P +L +L LN+ N+ L +L LD S N +
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 216 PEIAGM-KNLTWLDLSNNNIKGSIPVR 241
E+ +L +L+L+ N+ + +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 5/123 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
+ +L L + + S LS LQ L L IG+LK L ELNV
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 182 GSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLT----WLDLSNNNIKG 236
N + +P +LTNL +LDLSSNK+ ++ + + LDLS N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 237 SIP 239
P
Sbjct: 192 IQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 34/157 (21%), Positives = 59/157 (37%), Gaps = 9/157 (5%)
Query: 86 DHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT--GSIP 143
+CK+ S+ L + N + + P+L L + L+ G
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 144 PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP-SALGSLTNLSN 202
+ L+ LDLS NG+ T+ L+ L L+ ++L S SL NL
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
LD+S G+ +L L ++ N+ + +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 33/166 (19%), Positives = 56/166 (33%), Gaps = 19/166 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFA----LTGSIPPEISALSKLQLLDLS 158
+L L+ L +L L A + +P S L+ L+ LDLS
Sbjct: 104 KLVAV-----ET-NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 159 SNGLTGTIPPEIGNLKNL----IELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
SN + ++ L + + L++ N + P A + L L L +N S +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNV 216
Query: 215 PPE-IAGMKNLTWLDLSNNNIKGSIPVRLSPN---KGLCGGNFLDL 256
I G+ L L + + +GLC +
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 32/173 (18%), Positives = 48/173 (27%), Gaps = 29/173 (16%)
Query: 94 TCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT------GSIPPEIS 147
+ L L + + S L LTI+ F L I +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 148 ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL-------------------IG 188
L+ + L S + + L + + G
Sbjct: 280 CLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 189 PIPSALGSLTNLSNLDLSSNKLS--GKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+ L +L LDLS N LS G G +L +LDLS N +
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 31/170 (18%), Positives = 53/170 (31%), Gaps = 27/170 (15%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT------GSIPPEISALSKLQLLD 156
L LS ++ + + L ++ + +L I P +L L
Sbjct: 153 HLDLSSN------KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 157 LSSNGLTGTIPPE-IGNLKNLIELNV------GSNSLIGPIPSALGSLTNLSNLDLSSNK 209
L +N + + I L L + +L SAL L NL+ +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 210 LS---GKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
L I + N++ L + I+ S N G L+L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGW---QHLEL 311
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 29/187 (15%), Positives = 51/187 (27%), Gaps = 37/187 (19%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSI---PPEISALSKLQLLD 156
+ +L L + + + L + + SAL L L
Sbjct: 201 RLHKLTLR--NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 157 LSSNGLT------GTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 210
+ L I L N+ ++ S ++ + +L+L + K
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKF 316
Query: 211 S-------------------GKIPPEIAGMKNLTWLDLSNNNI--KGSIPVRLSPNKGLC 249
G + +L +LDLS N + KG L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL- 375
Query: 250 GGNFLDL 256
+LDL
Sbjct: 376 --KYLDL 380
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 33/133 (24%), Positives = 50/133 (37%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
+L+Q+ N+ L + L + S+L LD+ N ++ P L
Sbjct: 15 KLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L LN+ N L TNL+ L L SN + KNL LDLS+N +
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 236 GSIPVRLSPNKGL 248
+ + L
Sbjct: 135 STKLGTQVQLENL 147
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 38/124 (30%), Positives = 54/124 (43%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
RL NF+ + L L + F ++ P L L++L+L N L+ N
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L EL++ SNS+ + NL LDLS N LS ++NL L LSNN I+
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 236 GSIP 239
Sbjct: 159 ALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 35/120 (29%), Positives = 47/120 (39%), Gaps = 2/120 (1%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
P L L +Q L+ + + L L L SN + KNLI L++
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKN--LTWLDLSNNNIKGSIP 239
N L L NL L LS+NK+ E+ N L L+LS+N IK P
Sbjct: 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 35/159 (22%), Positives = 50/159 (31%), Gaps = 19/159 (11%)
Query: 100 SIFELYLSGYYAGFNWRLSQLN-----FSCFPNLVKLTIQFFALTGSIPPEISALSKLQL 154
S+ L L L ++ F NL L + + + L KL++
Sbjct: 455 SLQRLMLRR-----V-ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 155 LDLSSNGLT--------GTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206
LDL N L G + L +L LN+ SN L L +DL
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
N L+ +L L+L N I P
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 100 SIFELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTG--SIPPEISALSKLQL 154
+IFE+YLS N + QL F+ P+L +L ++ AL S P L L +
Sbjct: 431 NIFEIYLSY-----N-KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL--------IGPIPSALGSLTNLSNLDLS 206
LDLS+N + + L+ L L++ N+L G L L++L L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
SN + L +DL NN+ + L L+L
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL---KSLNL 591
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKL-----------TIQFFALTGSIPPEISA 148
++ L LS N ++ +N L KL + A G +
Sbjct: 481 NLTILDLSN-----N-NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
Query: 149 LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208
LS L +L+L SNG +L L +++G N+L S + +L +L+L N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 209 KLSGKIPPEI--AGMKNLTWLDLSNNNIKGSIP 239
++ + ++ +NLT LD+ N +
Sbjct: 595 LITS-VEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 34/163 (20%), Positives = 58/163 (35%), Gaps = 17/163 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLT--------IQFFALTGSIPPEISALSKLQL 154
L + N + + + F L+ L LT ++ S L +
Sbjct: 333 HLNMED-----N-DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA-HSPLHI 385
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGK 213
L+L+ N ++ L +L L++G N + + L N+ + LS NK
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 214 IPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
A + +L L L +K + SP + L LDL
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILDL 487
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 42/164 (25%), Positives = 63/164 (38%), Gaps = 19/164 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEISAL--SKLQLLDL 157
L LS N LS NL +L + + E+ S L+ L+L
Sbjct: 125 TLDLSH-----N-GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALG---SLTNLSNLDLSSNKLSGKI 214
SSN + P + L L + + L + L + T++ NL LS+++LS
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 215 PPEIAGMK--NLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
G+K NLT LDLS NN+ + L + L
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL---EYFFL 279
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 32/168 (19%), Positives = 58/168 (34%), Gaps = 14/168 (8%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISAL--SKLQLLDL 157
+F L+L+ G + ++ L++ L+ + L + L +LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN--------- 208
S N L L L + N++ +L L N+ L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
L +K L L++ +N+I G + L +L L
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL---KYLSL 360
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 20/88 (22%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
++ D S LT +P ++ N+ LN+ N L + + L++LD+ N +S
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 212 GKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
P + L L+L +N +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSD 90
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 30/138 (21%), Positives = 48/138 (34%), Gaps = 17/138 (12%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFA---LTGSIPPEISALSKLQLLDLSS 159
L L N ++ F +L +L I L + L+ L+L
Sbjct: 540 ILNLES-----N-GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 160 NGLTGTIPPEIG-NLKNLIELNVGSNSLIGPIPSALG-----SLTNLSNLDLSSNKLSGK 213
N +T G +NL EL++ N S + T+ + +LSS+ L
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN- 652
Query: 214 IPPEIAGMKNLTWLDLSN 231
PP G + D S+
Sbjct: 653 TPPHYHGFP-VRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 13/128 (10%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG---------TIPPEIGN 172
+S +L + + +P + L +LQ L+++ N + +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 173 LKNLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
+ +G N+L P ++L + L LD NK+ LT L L
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDY 604
Query: 232 NNIKGSIP 239
N I+ IP
Sbjct: 605 NQIE-EIP 611
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 23/156 (14%), Positives = 51/156 (32%), Gaps = 30/156 (19%)
Query: 117 LSQLNFSCFPNLVKLTIQ-FFALTGSIPPEISALSKLQLLDLSSNGLTG----------- 164
+ + +L I I I L+KLQ++ +++ T
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473
Query: 165 --------TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG---- 212
NLK+L ++ + + + +P L L L +L+++ N+
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 213 -----KIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
++ + + + NN++ P S
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 26/138 (18%), Positives = 49/138 (35%), Gaps = 15/138 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI--GNL 173
+S + S N +T L +DL N LT ++ + L
Sbjct: 698 PISTIILSN--N--LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTL 752
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNL------SNLDLSSNKLSGKIPPEIAGMKNLTWL 227
L ++V N P+ + + L D N++ + P I +L L
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 228 DLSNNNIKGSIPVRLSPN 245
+ +N+I+ + +L+P
Sbjct: 812 QIGSNDIR-KVDEKLTPQ 828
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 9e-20
Identities = 30/146 (20%), Positives = 54/146 (36%), Gaps = 18/146 (12%)
Query: 103 ELYLSGYYAGFNWRLSQLN-FSCFPNLVKLTIQFFALTGSIPPEISA-LSKLQLLDLSSN 160
L N ++ L F L L + + + IP + A +++ L S N
Sbjct: 577 LLDCVH-----N-KVRHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629
Query: 161 GLTGTIPP--EIGNLKNLIELNVGSNSLIGPIPSALGSL-----TNLSNLDLSSNKLSGK 213
L IP ++ + ++ N + + S+ N S + LS N++
Sbjct: 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF 688
Query: 214 IPPEIAGMKNLTWLDLSNNNIKGSIP 239
A ++ + LSNN + SIP
Sbjct: 689 PTELFATGSPISTIILSNNLM-TSIP 713
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-19
Identities = 18/149 (12%), Positives = 47/149 (31%), Gaps = 20/149 (13%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL 176
L +L++ I I + K + +N +T I I L L
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL 450
Query: 177 IELNVGSNSL-------------------IGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
+ ++ + +L +L++++L + ++P
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
Query: 218 IAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246
+ + L L+++ N + ++ +
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 23/146 (15%), Positives = 46/146 (31%), Gaps = 21/146 (14%)
Query: 118 SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL------SSNGLTGTIPPEIG 171
+ P L + + + + S P + S+L+ + N + P I
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
+LI+L +GSN + + L L LD++ N + L
Sbjct: 804 TCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 232 NNIKGSIPVRLSPNKGLCGGNFLDLP 257
+ + + G + L +
Sbjct: 861 DK-----------TQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 23/152 (15%), Positives = 45/152 (29%), Gaps = 8/152 (5%)
Query: 112 GFNWRLSQLNFSCFPNLV--KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE 169
G NWR + + + + ++ ++ L L+ G G +P
Sbjct: 283 GKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 170 IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM-KNLTWLD 228
IG L L L+ G++S + +++ + L D
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 229 LSNNNIKGSIPVRLSPNKGLCGGNFLDLPSCD 260
L + I R K + + + L
Sbjct: 403 LLQDAIN-----RNPEMKPIKKDSRISLKDTQ 429
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 9e-15
Identities = 24/165 (14%), Positives = 51/165 (30%), Gaps = 36/165 (21%)
Query: 77 WWNSSFWTTDHCKW---EGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTI 133
WN + + W G+ ++ G + L L+G+
Sbjct: 301 NWNFN---KELDMWGDQPGVDLDNNGRVTGLSLAGFG----------------------- 334
Query: 134 QFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS- 192
G +P I L++L++L ++ T + + +
Sbjct: 335 ----AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 193 ALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
L L+ DL + ++ PE+ +K + + L + I
Sbjct: 391 FLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNL 433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 52/256 (20%), Positives = 96/256 (37%), Gaps = 51/256 (19%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-- 374
+ +VYK A +L + + + + F+ EA++L + H NIV+ Y
Sbjct: 39 FKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97
Query: 375 --HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI- 431
+KC+ L+ E M G+L L + + + + + L +L H +P I
Sbjct: 98 VKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFL-HTRTPPII 153
Query: 432 ------------------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
+T +S + GT ++APE+ Y E DV
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM-YEEKYDESVDV 212
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR---KVIRDILLAS 524
Y+FG+ LE+ ++P + + I V P D+ +++I+
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAAQ-----IYRR-VTSGVKPASFDKVAIPEVKEIIE-- 264
Query: 525 TISFACLQSNPKSRPT 540
C++ N R +
Sbjct: 265 ----GCIRQNKDERYS 276
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 3/114 (2%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
S NL +L I +T P +S L+ L LLD+S + +I +I L + ++
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ N I I L +L L +L++ + + I L L + I
Sbjct: 143 LSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
N+ LTI T + P IS LS L+ L + +T P + L +L L+
Sbjct: 61 GIEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ ++ I + + +L ++++DLS N I P + + L L++ + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 8/142 (5%)
Query: 118 SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI 177
+ + + +L +T+ +T + I ++ L +++ T P I L NL
Sbjct: 36 ANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLE 91
Query: 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
L + + L LT+L+ LD+S + I +I + + +DLS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 238 IPVRLSPNKGLCGGNFLDLPSC 259
I P K L L++
Sbjct: 152 I----MPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-18
Identities = 22/134 (16%), Positives = 53/134 (39%), Gaps = 7/134 (5%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
+ + + ++ L + L++ +T I N+ +L + +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
+ + L+NL L + ++ P ++G+ +LT LD+S++ SI +++
Sbjct: 78 ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 246 KGLCGGNFLDLPSC 259
+ N +DL
Sbjct: 136 PKV---NSIDLSYN 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
+L +TI L +P + + L+ L L+ N L +P I +L L EL++ +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 187 IGPIPSALGS---------LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
+ +P L S L NL +L L + +P IA ++NL L + N+ + +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220
Query: 238 IP 239
+
Sbjct: 221 LG 222
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 30/117 (25%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL 186
NL L I+ L+ ++ P I L KL+ LDL PP G L L + S
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 187 IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
+ +P + LT L LDL ++P IA + + + + R
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 13/121 (10%), Positives = 27/121 (22%), Gaps = 23/121 (19%)
Query: 140 GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI--------- 190
GS S + L + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 191 ----------PSALGSLT--NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238
L T L+L S L + P + + +L + + + +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 239 P 239
P
Sbjct: 120 P 120
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 10/100 (10%)
Query: 103 ELYLSGYYAGFNWRLSQL--NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSN 160
EL L G L F L +L ++ + ++P +I L++L+ LDL
Sbjct: 233 ELDLRG-----CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 161 GLTGTIPPEIGNLKNLIELNVGSNS---LIGPIPSALGSL 197
+P I L + V + L P A +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 32/162 (19%), Positives = 53/162 (32%), Gaps = 14/162 (8%)
Query: 100 SIFELYLSGYYAGFNWRLSQLN----FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLL 155
+ L + L ++ F L+ L I + L+ L L
Sbjct: 400 ELQHLDFQH-----S-TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
Query: 156 DLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
++ N + N NL L++ L +L L L++S N L
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513
Query: 215 PPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
+ +L+ LD S N I+ S + K L F +L
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL---AFFNL 552
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 39/159 (24%), Positives = 57/159 (35%), Gaps = 11/159 (6%)
Query: 103 ELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
+ LS FN L L FS F L L + + L L L L+
Sbjct: 36 NIDLS-----FN-PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89
Query: 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEI 218
N + P L +L L L +G L L L+++ N + K+P
Sbjct: 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 219 AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNF-LDL 256
+ + NL +DLS N I+ L + N LD+
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-22
Identities = 29/121 (23%), Positives = 48/121 (39%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
+LS++ + + + F L S S+LQ LDLS + L +
Sbjct: 22 KLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L + N + P + LT+L NL KL+ I + L L++++N I
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 236 G 236
Sbjct: 142 S 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 1/114 (0%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
F +L L + + + + + + L LDLS L L L LN
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ N+L+ S L +LS LD S N++ K+L + +L+NN++
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 35/144 (24%), Positives = 52/144 (36%), Gaps = 9/144 (6%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP--PEIGNL 173
+L Q P L LT+ SI + AL L LDLS N L+ +
Sbjct: 318 QLKQFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IAGMKNLTWLDLSNN 232
+L L++ N I + + L L +LD + L ++ L +LD+S
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 233 NIKGSIPVRLSPNKGLCGGNFLDL 256
N K L N L +
Sbjct: 435 NTKIDFDGIFLGLTSL---NTLKM 455
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 5/119 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
+ +L L + + P S L+ L+ L L IG L L +LNV
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 182 GSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTW----LDLSNNNIK 235
N + +P+ +LTNL ++DLS N + ++ ++ LD+S N I
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 21/100 (21%), Positives = 42/100 (42%), Gaps = 4/100 (4%)
Query: 140 GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
GS+ P I + + L+ +P +I + + +++ N L + + +
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
L LDLS ++ G+ +L+ L L+ N I+ P
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 23/148 (15%), Positives = 45/148 (30%), Gaps = 21/148 (14%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT------GSIPPEISALSKLQLLD 156
+ LS + + + L + +L I + KL L
Sbjct: 157 HVDLSYN------YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELT 210
Query: 157 LSSNGLTGTIPPE-IGNLKNLIELN------VGSNSLIGPIPSALGSLTNLS--NLDLSS 207
L N + I + NL L +L PS + L +++ L+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 208 NKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ + N++ + L+ +IK
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 29/161 (18%), Positives = 58/161 (36%), Gaps = 27/161 (16%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
+I E L+ ++ + F C N+ +++ ++ ++ K Q L +
Sbjct: 262 TIDEFRLTY---TNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIR 316
Query: 160 NGLT-------------------GTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL--T 198
L G+I + L +L L++ N+L + L
Sbjct: 317 CQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 199 NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+L +LDLS N + G++ L LD ++ +K
Sbjct: 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 27/183 (14%), Positives = 55/183 (30%), Gaps = 29/183 (15%)
Query: 96 NSAGSIFELYLSGYYAGFNWRLSQLNFSCF--PNLVKLTIQFFALTGSIPPE-ISALSKL 152
+ L +S + + F L +LT++ + +I + L+ L
Sbjct: 178 ENPQVNLSLDMSLN------PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 153 QLLDLSSNGLTGTI------PPEIGNLKNL--IELNVGSNSLIGPIPSALGSLTNLSNLD 204
+ L P + L ++ E + + L N+S +
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP---------VRLSPNKGLCGGNFLD 255
L+ + ++ L + +K P + L+ NKG +
Sbjct: 292 LAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKVA 348
Query: 256 LPS 258
LPS
Sbjct: 349 LPS 351
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 56/268 (20%), Positives = 93/268 (34%), Gaps = 62/268 (23%)
Query: 318 YGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V+ +L N V A+K + +L F EA++L Q H NIV+L G C
Sbjct: 127 FGEVFSGRLRADNTLV-AVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQ 183
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP 429
++ ++++ E ++ G L + + + +V A + YL H D +
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESKCCIHRDLA- 240
Query: 430 SIASTCPDSSN-----------RTLLAGTY------GYI-----APELAYTMVMTEKCDV 467
A C + R G Y + APE + + DV
Sbjct: 241 --ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 468 YSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDI 520
+SFG++ E G P P + + RLP P + +
Sbjct: 299 WSFGILLWETFSLGASPY-----------PNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 521 LLASTISFACLQSNPKSRPTMQYVSQEF 548
+ C P RP+ + QE
Sbjct: 348 ME------QCWAYEPGQRPSFSTIYQEL 369
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 34/147 (23%), Positives = 58/147 (39%), Gaps = 11/147 (7%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
L+ + N +S+++ S + + +T + S++Q LDL N +
Sbjct: 103 TLHAAN-----N-NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 163 TG-TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
+ L LN+ N + + L LDLSSNKL+ + PE
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSA 213
Query: 222 KNLTWLDLSNNNIKGSIPVRLSPNKGL 248
+TW+ L NN + I L ++ L
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNL 239
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 24/114 (21%), Positives = 51/114 (44%), Gaps = 10/114 (8%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
N+ +L + L+ +++ +KL+LL+LSSN L ++ +L L L++
Sbjct: 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDL 87
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+N + L ++ L ++N +S ++ + + L+NN I
Sbjct: 88 NNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 4/96 (4%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIG-NLKNLIELNVGSNSLIGPIPSALGSLTN 199
+I ++ ++ ++ + L + + N+ EL++ N L + L T
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L+LSSN L ++ + L LDL+NN ++
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 8/120 (6%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
+ +L ++ + ++ LDLS N L+ ++ L LN+ SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
L L SL+ L LDL++N + E+ ++ L +NNNI +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 19/136 (13%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG---SIPPEISALSKLQLLDLSS 159
EL LSG N LSQ++ + KL + L+ ++ +LS L+ LDL++
Sbjct: 38 ELDLSG-----N-PLSQISAADLAPFTKL--ELLNLSSNVLYETLDLESLSTLRTLDLNN 89
Query: 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219
N + E+ ++ L+ +N+ I + N+ L++NK++ +
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNN-ISRVSC--SRGQGKKNIYLANNKITMLRDLDEG 141
Query: 220 GMKNLTWLDLSNNNIK 235
+ +LDL N I
Sbjct: 142 CRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 32/137 (23%), Positives = 55/137 (40%), Gaps = 15/137 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF----PNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158
L L N + +NF+ L L +Q+ + + ++ +KL+ LDLS
Sbjct: 148 YLDLKL-----N-EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLS 199
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
SN L + PE + + +++ +N L+ I AL NL + DL N
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRD 256
Query: 219 AGMKNLTWLDLSNNNIK 235
KN ++ +K
Sbjct: 257 FFSKNQRVQTVAKQTVK 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 26/124 (20%), Positives = 42/124 (33%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
L+++ + + L F L S L L LDL+ + +
Sbjct: 23 GLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L + +N LI +AL L +L +S + K L L L +N+I
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 236 GSIP 239
Sbjct: 143 SIKL 146
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 42/164 (25%), Positives = 61/164 (37%), Gaps = 17/164 (10%)
Query: 100 SIFELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLL 155
+ L LS N L F P L L + F L L L++L
Sbjct: 377 HLQSLNLSY-----N-EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI---PSALGSLTNLSNLDLSSNKLSG 212
+LS + L + L L LN+ N ++L +L L L LS LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 213 KIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
+K + +DLS+N + S LS KG+ +L+L
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI----YLNL 530
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 34/160 (21%), Positives = 52/160 (32%), Gaps = 11/160 (6%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTI-----QFFALTGSIPPEISALSKLQLLDL 157
L + G N + +L C NL L + ++ LS LQ L+L
Sbjct: 329 HLSIKG-----NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPP 216
S N L L++ L S +L L L+LS + L
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 217 EIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
G+ L L+L N+ + + + L L L
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 4/139 (2%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL--LDLSSN 160
L G L S +L T + P L ++ + ++L +
Sbjct: 206 SLNFGGTQNLLVI-FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 161 GLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAG 220
L EL++ + L +PS L L+ L L LS+NK +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 221 MKNLTWLDLSNNNIKGSIP 239
+LT L + N + +
Sbjct: 324 FPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 14/156 (8%)
Query: 100 SIFELYLSGYYAGFNWRLSQLN----FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLL 155
+ L L+ RL + F L L + L S L LQ L
Sbjct: 401 QLELLDLAF-----T-RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
Query: 156 DLSSNGLTGTI---PPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG 212
+L N + L L L + L A SL ++++DLS N+L+
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 213 KIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL 248
++ +K + L+L++N+I +P L
Sbjct: 515 SSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 25/117 (21%), Positives = 43/117 (36%), Gaps = 2/117 (1%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
F L L + L +S L+ L G++ + N K L L +
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTW--LDLSNNNIKG 236
GSN + L LD +N + +++ ++ T L+L+ N+I G
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 26/162 (16%), Positives = 46/162 (28%), Gaps = 18/162 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLS 158
L + L+ +L + T L G I P + Q L+
Sbjct: 157 VLDFQNN------AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210
Query: 159 SNGLTGTIPPEIGN--LKNLIELNVGSNSLIGPIPSALGSLTNLS--NLDLSSNKLSGKI 214
I + N +++L P+ L +S +++L +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 215 PPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
L LDL+ ++ +P L L L L
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL---KKLVL 308
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 29/139 (20%), Positives = 51/139 (36%), Gaps = 5/139 (3%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
L L G + + L L + F L+ ++L + +DLS N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 163 TGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMK 222
T + + +LK + LN+ SN + +PS L L+ ++L N L
Sbjct: 513 TSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC--TCSNIYF- 568
Query: 223 NLTWLDLSNNNIKGSIPVR 241
L W + ++ +
Sbjct: 569 -LEWYKENMQKLEDTEDTL 586
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
N +++ + + L L I +T P ++ LS+L L++ +N
Sbjct: 203 YFTAYV-----N-QITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
++ + +L L LNVGSN + S L +L+ L++L L++N+L + I G+
Sbjct: 255 ISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 222 KNLTWLDLSNNNIKGSIPV 240
NLT L LS N+I P+
Sbjct: 311 TNLTTLFLSQNHITDIRPL 329
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 4e-21
Identities = 29/119 (24%), Positives = 53/119 (44%), Gaps = 7/119 (5%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
S L L I +T + L+ L+ L L+ + ++ + NL + LN
Sbjct: 83 PLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+G+N + S L ++T L+ L ++ +K+ IA + +L L L+ N I+ P
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 33/134 (24%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
L + N +++ L + L L I ++ + L+KL++L++ SN
Sbjct: 225 SLKIGN-----N-KITDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
++ + NL L L + +N L +G LTNL+ L LS N ++ P +A +
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL 332
Query: 222 KNLTWLDLSNNNIK 235
+ D +N IK
Sbjct: 333 SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 14/138 (10%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
ELYL+ + +S + + + L + S +S ++ L L ++ +
Sbjct: 114 ELYLNE-----D-NISDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
+ I NL +L L++ N + P L SLT+L N+++ P +A M
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220
Query: 222 KNLTWLDLSNNNIKGSIP 239
L L + NN I P
Sbjct: 221 TRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 30/120 (25%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
NL L + +T P +S L KL L + +N +T + NL NL EL
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+ +++ P L +LT + +L+L +N ++ M L +L ++ + +K P+
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPI 173
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 26/119 (21%), Positives = 49/119 (41%), Gaps = 8/119 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ ++ +Q ++T + L + L ++ + I L NL LN
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+ N + P L +L L+NL + +NK++ + + NL L L+ +NI P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 7/60 (11%), Positives = 16/60 (26%), Gaps = 4/60 (6%)
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L I I L L ++ ++++T L ++ +
Sbjct: 2 AATLATLPAP-INQI-FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 49/294 (16%), Positives = 101/294 (34%), Gaps = 76/294 (25%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G V++A+ + +A+K++ E + E + L+++ H IV+ + L
Sbjct: 17 GFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLE 74
Query: 376 RKCM------------FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 423
+ ++ + ++ +L ++ E + + ++I +A A+ +L
Sbjct: 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 424 H-----H---------------------------DCSPSIASTC---PDSSNRTLLAGTY 448
H H D + P + T GT
Sbjct: 135 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 449 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508
Y++PE + + K D++S G++ E LL S+ + L DV + +
Sbjct: 195 LYMSPEQIHGNSYSHKVDIFSLGLILFE---------LLYPFSTQMERVRTLTDVRNLKF 245
Query: 509 PP------PVDRKVIRDILLASTISFACLQSNPKSRPTMQYV-SQEFLITRKTP 555
PP P + +++D L +P RP + P
Sbjct: 246 PPLFTQKYPCEYVMVQD----------MLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 67/252 (26%), Positives = 108/252 (42%), Gaps = 47/252 (18%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ + + ALK L ++ E+ R E ++ S + H NI++LYG+
Sbjct: 22 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSPS 430
++LI EY G+++ L E + +A+AL+Y H H D P
Sbjct: 82 TRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT--YITELANALSYCHSKRVIHRDIKPE 138
Query: 431 -----------IA----STCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475
IA S SS RT L GT Y+ PE+ + EK D++S GV+
Sbjct: 139 NLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 476 EVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPPPVD---RKVIRDILLASTISFAC 530
E L+GK P + ++ + I ++ P V R +I +
Sbjct: 199 EFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEGARDLISRL---------- 241
Query: 531 LQSNPKSRPTMQ 542
L+ NP RP ++
Sbjct: 242 LKHNPSQRPMLR 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 46/270 (17%), Positives = 92/270 (34%), Gaps = 68/270 (25%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR 376
G++ + + + A+K++ E Q+L + H N+++ + R
Sbjct: 37 EGTIVYRGMFDNRDVAVKRIL------PECFSFADREVQLLRESDEHPNVIRYFCTEKDR 90
Query: 377 KCMFLIYEYMKRGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----- 425
+ ++ E +L H + + +++ LA+LH
Sbjct: 91 QFQYIAIELC-AATLQEYVEQKDFAHLGLEPI--------TLLQQTTSGLAHLHSLNIVH 141
Query: 426 -DCSPS---IASTCPDSSNRTLLA----------------------GTYGYIAPEL---A 456
D P I+ + +++ GT G+IAPE+
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 457 YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDV-LDQRLPPPVDR 514
T D++S G V V+ G HP S I+L LD P +
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFG----KSLQRQANILLGACSLDCLHPEKHED 257
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYV 544
+ R+++ + +P+ RP+ ++V
Sbjct: 258 VIARELIE------KMIAMDPQKRPSAKHV 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 50/264 (18%), Positives = 103/264 (39%), Gaps = 53/264 (20%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLYGFCL 374
G V++ +++A+K ++ E + + S+RNE L+++ + I++LY + +
Sbjct: 40 GSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCS 428
+ ++++ E L L + +++ K K M A+ +H H D
Sbjct: 99 TDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIHQHGIVHSDLK 154
Query: 429 PS---------------IASTCPDSSNRTLL---AGTYGYIAPEL-----------AYTM 459
P+ IA+ + + GT Y+ PE
Sbjct: 155 PANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIR 518
++ K DV+S G + + GK P + + K+ I + + P + K ++
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 519 DILLASTISFACLQSNPKSRPTMQ 542
D+L CL+ +PK R ++
Sbjct: 271 DVLK------CCLKRDPKQRISIP 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 50/279 (17%), Positives = 104/279 (37%), Gaps = 65/279 (23%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF--- 372
G+G V+KA+ +GK + +K++ + + E + L+++ H NIV G
Sbjct: 23 GFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 373 -------------CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 419
KC+F+ E+ +G+L +LD + + + +
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLALELFEQITKG 134
Query: 420 LAYLH-----H-DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAY 457
+ Y+H + D PS + ++ + RT GT Y++PE
Sbjct: 135 VDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS 194
Query: 458 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516
+ ++ D+Y+ G++ E+L + + D+ D + D+K
Sbjct: 195 SQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDLRDGIISDIFDKK- 243
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
+ + L P+ RP + + + +K+P
Sbjct: 244 -----EKTLLQ-KLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 35/148 (23%), Positives = 61/148 (41%), Gaps = 13/148 (8%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
L+ + N +S+++ S + + +T + S++Q LDL N +
Sbjct: 103 TLHAAN-----N-NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 163 TGTIPPE--IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAG 220
T+ + L LN+ N + + + L LDLSSNKL+ + PE
Sbjct: 157 D-TVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQS 212
Query: 221 MKNLTWLDLSNNNIKGSIPVRLSPNKGL 248
+TW+ L NN + I L ++ L
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNL 239
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 24/121 (19%), Positives = 47/121 (38%), Gaps = 5/121 (4%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTG-SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLK 174
L L+ C + L ++ + + ++ L+ L+L N + + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 175 NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
L L++ SN L + S ++ + L +NKL I + +NL DL N
Sbjct: 192 KLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 235 K 235
Sbjct: 250 H 250
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
+I ++ ++ ++ + L + + N+ EL++ N L + L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L+LSSN L ++ + L LDL+NN ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
N+ +L + L+ +++ +KL+LL+LSSN L ++ +L L L++
Sbjct: 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDL 87
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241
+N + L ++ L ++N +S ++ + + L+NN I +
Sbjct: 88 NNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLD 139
Query: 242 LSPNKGLCGGNFLDL 256
+ +LDL
Sbjct: 140 EGCRSRV---QYLDL 151
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 8/120 (6%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
+ +L ++ + ++ LDLS N L+ ++ L LN+ SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
L L SL+ L LDL++N + E+ ++ L +NNNI +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 19/136 (13%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG---SIPPEISALSKLQLLDLSS 159
EL LSG N LSQ++ + KL + L+ ++ +LS L+ LDL++
Sbjct: 38 ELDLSG-----N-PLSQISAADLAPFTKL--ELLNLSSNVLYETLDLESLSTLRTLDLNN 89
Query: 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219
N + E+ ++ L+ +N+ I + N+ L++NK++ +
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNN-ISRVSC--SRGQGKKNIYLANNKITMLRDLDEG 141
Query: 220 GMKNLTWLDLSNNNIK 235
+ +LDL N I
Sbjct: 142 CRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 22/140 (15%), Positives = 46/140 (32%), Gaps = 19/140 (13%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
L LS N L + + L L + + E+ ++ L ++N
Sbjct: 62 LLNLSS-----N-VLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE--IA 219
++ + + + + +N + G + + LDL N++ + A
Sbjct: 111 IS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166
Query: 220 GMKNLTWLDLSNNNIKGSIP 239
L L+L N I +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVK 185
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 15/136 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF----PNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158
L L N + +NF+ L L +Q+ + + ++ +KL+ LDLS
Sbjct: 148 YLDLKL-----N-EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLS 199
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE- 217
SN L + PE + + +++ +N L+ I AL NL + DL N +
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 218 IAGMKNLTWLDLSNNN 233
+ + + +
Sbjct: 258 FSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 20/76 (26%), Positives = 31/76 (40%)
Query: 170 IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDL 229
N V +SL + S S N+ LDLS N LS ++A L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 230 SNNNIKGSIPVRLSPN 245
S+N + ++ +
Sbjct: 66 SSNVLYETLDLESLST 81
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 17/171 (9%), Positives = 38/171 (22%), Gaps = 12/171 (7%)
Query: 100 SIFELYLSGYYAGFN-WRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158
++ L G N + L N T+ + + L
Sbjct: 238 NLEHFDLRG-----NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 159 SNGLTGTIPPEIGNLKNL----IELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
+ P L L L G S + + +D + +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TV 351
Query: 215 PPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPSCDTTKP 264
++ + L+ + + + L G + +
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 13/67 (19%), Positives = 22/67 (32%), Gaps = 3/67 (4%)
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLC 249
I + ++ + L + N+ LDLS N + L+P L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL- 60
Query: 250 GGNFLDL 256
L+L
Sbjct: 61 --ELLNL 65
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 25/282 (8%), Positives = 57/282 (20%), Gaps = 63/282 (22%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC-- 373
V+ + + FALK + ++ +++L + +
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 374 ------------------------LHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LD 405
L+ L +
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEG 192
Query: 406 WAKRVNIVKAMAHALAYLHH-----------------DCSPSIA---STCPDSSNRTLLA 445
+ + A L D + + + +
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS 252
Query: 446 GTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV 503
Y E A T T + + G+ V P L++ S + L
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
Query: 504 LDQRLPPPVDRKV---IRDILLASTISFACLQSNPKSRPTMQ 542
L + ++ ++ L + + R
Sbjct: 313 GTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPL 348
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 53/283 (18%), Positives = 99/283 (34%), Gaps = 78/283 (27%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V KA+ + + +A+KK+ +E + + + +E +L+ + H+ +V+ Y L
Sbjct: 18 AFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 376 R-------------KCMFLIYEYMKRGSLF-----CNLHNNEDAVELDWAKRVNIVKAMA 417
R +F+ EY + G+L+ NL+ D + + +
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-------WRLFRQIL 126
Query: 418 HALAYLH-----H--------------------------------DCSPSIASTCPDSSN 440
AL+Y+H H + S N
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 441 RTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499
T GT Y+A E L T EK D+YS G++ E++ ++ K+
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK----KLR 242
Query: 500 LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
+ + PP D ++ I + +P RP +
Sbjct: 243 SVSI---EFPPDFDDNKMKV--EKKIIR-LLIDHDPNKRPGAR 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 56/271 (20%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ KV A+K + E FI+ EA+V+ ++ H +V+LYG CL +
Sbjct: 21 FGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD---- 426
+ L+ E+M+ G L L + + + +AYL H D
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 133
Query: 427 -CSPSIASTCPDS---SNRTLLAGTY-----GYI-----APELAYTMVMTEKCDVYSFGV 472
C S R +L Y +PE+ + K DV+SFGV
Sbjct: 134 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 193
Query: 473 VTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLAST 525
+ EV GK P +V++ RL P + I+
Sbjct: 194 LMWEVFSEGKIPY-----------ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN--- 239
Query: 526 ISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556
C + P+ RP + ++ ++ L
Sbjct: 240 ---HCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 63/289 (21%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+ V + L +G +ALK++ E ++ + EA + H NI++L +CL
Sbjct: 41 GFSYVDLVEGLHDGHFYALKRILCHEQQDREEA---QREADMHRLFNHPNILRLVAYCLR 97
Query: 376 RK----CMFLIYEYMKRGSLFCNLHNNEDAVE-------LDWAKRVNIVKAMA--HALAY 422
+ +L+ + KRG+L+ + +D L + I + + HA Y
Sbjct: 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL--LGICRGLEAIHAKGY 155
Query: 423 LHHD-------------------CSPSIASTCPDSSNRTLLA-------GTYGYIAPEL- 455
H D S + A + S + L T Y APEL
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 456 ---AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512
++ ++ E+ DV+S G V ++ G+ P D++ S + L V +Q P
Sbjct: 216 SVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS----VALA-VQNQLSIPQS 269
Query: 513 DR--KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559
R + +L + + +P RP + + + + +H
Sbjct: 270 PRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 50/264 (18%), Positives = 102/264 (38%), Gaps = 53/264 (20%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCL 374
G V++ +++A+K ++ E + + S+RNE L+++ I++LY + +
Sbjct: 21 GSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCS 428
+ ++++ E L L + +++ K K M A+ +H H D
Sbjct: 80 TDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIHQHGIVHSDLK 135
Query: 429 PS---------------IASTCPDSSNRTLL---AGTYGYIAPEL-----------AYTM 459
P+ IA+ + + GT Y+ PE
Sbjct: 136 PANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIR 518
++ K DV+S G + + GK P + + K+ I + + P + K ++
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAIIDPNHEIEFPDIPEKDLQ 251
Query: 519 DILLASTISFACLQSNPKSRPTMQ 542
D+L CL+ +PK R ++
Sbjct: 252 DVLK------CCLKRDPKQRISIP 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 50/276 (18%), Positives = 96/276 (34%), Gaps = 71/276 (25%)
Query: 318 YGSVYKAQLPNGKVFA-----------LKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 366
+ ++K + L K H + +E F A ++S++ H+++
Sbjct: 21 FTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES------FFEAASMMSKLSHKHL 74
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL--- 423
V YG C+ L+ E++K GSL L N++ + + W ++ + K +A A+ +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEEN 132
Query: 424 ---HHD-----CSPSIASTCPDSSN-----------RTLLAGTYGYI-----APE-LAYT 458
H + + T+L PE +
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENP 192
Query: 459 MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPV 512
+ D +SFG E+ G P LS+L S L +LP P
Sbjct: 193 KNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQ--------RKLQFYEDRHQLPAP- 240
Query: 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ +++ C+ P RP+ + + ++
Sbjct: 241 KAAELANLIN------NCMDYEPDHRPSFRAIIRDL 270
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 52/254 (20%), Positives = 86/254 (33%), Gaps = 63/254 (24%)
Query: 317 GYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
G G +Y A + NG+ LK L S E E Q L++V+H +IV+++ F
Sbjct: 92 GLGWIYLALDRNV-NGRPVVLKGLVHSGDAE--AQAMAMAERQFLAEVVHPSIVQIFNFV 148
Query: 374 LH-----RKCMFLIYEYMKRGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHALAYLHH- 425
H +++ EY+ SL + + L A+ + + + AL+YLH
Sbjct: 149 EHTDRHGDPVGYIVMEYVGGQSL-------KRSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 426 -----DCSPS---------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P S L GT G+ APE+ T T
Sbjct: 202 GLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG---YLYGTPGFQAPEIVRTGP-TVAT 257
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525
D+Y+ G + + R+ + D + R + R
Sbjct: 258 DIYTVGRTLAALTLDLPTRN-------GRYVDGLPEDDPVLKTYDSYGRLLRR------- 303
Query: 526 ISFACLQSNPKSRP 539
+ +P+ R
Sbjct: 304 ----AIDPDPRQRF 313
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 54/266 (20%), Positives = 93/266 (34%), Gaps = 61/266 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V + A+K + E FI+ EA+V+ + H +V+LYG C ++
Sbjct: 37 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGVCTKQR 92
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
+F+I EYM G L L + + + K + A+ YL H D +
Sbjct: 93 PIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA--- 147
Query: 432 ASTCPDSSN-----------RTLLAGTY-----GYI-----APELAYTMVMTEKCDVYSF 470
A C + R +L Y PE+ + K D+++F
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 471 GVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLA 523
GV+ E+ GK P + + + RL P + + I+
Sbjct: 208 GVLMWEIYSLGKMPY-----------ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY- 255
Query: 524 STISFACLQSNPKSRPTMQYVSQEFL 549
+C RPT + + +
Sbjct: 256 -----SCWHEKADERPTFKIL-LSNI 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 49/264 (18%), Positives = 101/264 (38%), Gaps = 53/264 (20%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCL 374
G V++ +++A+K ++ E + + S+RNE L+++ I++LY + +
Sbjct: 68 GSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCS 428
+ ++++ E L L + +++ K K M A+ +H H D
Sbjct: 127 TDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIHQHGIVHSDLK 182
Query: 429 PS---------------IASTCPDSSNRTLL---AGTYGYIAPEL-----------AYTM 459
P+ IA+ + + G Y+ PE
Sbjct: 183 PANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIR 518
++ K DV+S G + + GK P + + K+ I + + P + K ++
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 519 DILLASTISFACLQSNPKSRPTMQ 542
D+L CL+ +PK R ++
Sbjct: 299 DVLK------CCLKRDPKQRISIP 316
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 8/120 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
S L +L + ++ P ++ L+ L L+L+ N L P I NLKNL L
Sbjct: 260 PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+ N++ P + SLT L L +NK+S +A + N+ WL +N I P+
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 371
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 38/120 (31%), Positives = 56/120 (46%), Gaps = 6/120 (5%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ S L L F + ++ L+ L+ LD+SSN ++ + L NL L
Sbjct: 148 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLI 205
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+N + P LG LTNL L L+ N+L +A + NLT LDL+NN I P+
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL 261
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 9/125 (7%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ NL LT+ +T P + L+ L L+LSSN ++ + L +L +L+
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
N + P L +LT L LD+SSNK+S +A + NL L +NN I P+
Sbjct: 163 F-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL 217
Query: 241 RLSPN 245
+ N
Sbjct: 218 GILTN 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
+AL++ L +T T+ +L + L + + L NL+ ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
S+N+L+ P + + L + ++NN I P+
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPL 108
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 19/116 (16%), Positives = 40/116 (34%), Gaps = 8/116 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
S L +L ++ ++ L+ + L N ++ P + NL + +L
Sbjct: 326 PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIAGMKNLTWLDLSNNNIK 235
+ + + N+S + N I P I+ + T D++ N
Sbjct: 382 LNDQAWTNAPVN---YKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 13/89 (14%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
L ++ + I L ++ +G ++ + L ++ L +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 212 GKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+ + NLT ++ SNN + P+
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITPL 86
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 50/260 (19%), Positives = 87/260 (33%), Gaps = 59/260 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VY L N A+K++ ++ + E + + H+NIV+ G
Sbjct: 35 YGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYLGSFSEN 91
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-D---- 426
+ + E + GSL L + ++ + K + L YLH H D
Sbjct: 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151
Query: 427 -----------------CSPSIASTCPDSSNRTLLAGTYGYIAPEL------AYTMVMTE 463
S +A + GT Y+APE+ Y
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGI---NPCTETFTGTLQYMAPEIIDKGPRGYGK---- 204
Query: 464 KCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522
D++S G +E+ GK P +L ++ + + + P I + +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGMFKV--HPE-----IPESMS 252
Query: 523 ASTISF--ACLQSNPKSRPT 540
A +F C + +P R
Sbjct: 253 AEAKAFILKCFEPDPDKRAC 272
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 55/262 (20%), Positives = 99/262 (37%), Gaps = 58/262 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V KV A+K + T + +F EA V++Q+ H N+V+L G + K
Sbjct: 34 FGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGVIVEEK 87
Query: 378 -CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
++++ EYM +GSL L + + L + + A+ YL H D +
Sbjct: 88 GGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA-- 144
Query: 431 IASTCPDSSNRTL------LA-----GTYG------YIAPELAYTMVMTEKCDVYSFGVV 473
A S + L + APE + K DV+SFG++
Sbjct: 145 -ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203
Query: 474 TLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLASTI 526
E+ G+ P P+I L DV+ + ++ P + +++
Sbjct: 204 LWEIYSFGRVPY-----------PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK---- 248
Query: 527 SFACLQSNPKSRPTMQYVSQEF 548
C + RP+ + ++
Sbjct: 249 --NCWHLDAAMRPSFLQLREQL 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 55/282 (19%)
Query: 296 KPKLEERATNNIDVFSIWNYD--------GYGSVYKAQ-LPNGKVFALKKLHTSETEELA 346
+ T N+ S+ Y +G + +G+ + +K+++ S
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-K 65
Query: 347 FIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNN------ED 400
+ R E VL+ + H NIV+ ++++ +Y + G LF ++ ED
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 401 AVELDWAKRVNIVKAMA--HALAYLHHDCSPS----------------IASTCPDSSNRT 442
+ LDW V I A+ H LH D IA +
Sbjct: 126 QI-LDWF--VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182
Query: 443 L-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDLLSSLSSSSDPKI 498
GT Y++PE+ K D+++ G V E+ KH + + + KI
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL-----KI 237
Query: 499 MLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
+ PPV D L S +S + NP+ RP+
Sbjct: 238 I------SGSFPPVSLHYSYD--LRSLVS-QLFKRNPRDRPS 270
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 54/263 (20%)
Query: 318 YGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VY+ + A+K L E F+K EA V+ ++ H N+V+L G C
Sbjct: 26 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD---- 426
++I E+M G+L L E+ + + ++ A+ YL H D
Sbjct: 82 PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 427 -CSPSIASTCPDSS---NRTLLAGTYG----------YIAPELAYTMVMTEKCDVYSFGV 472
C + +R + TY + APE + K DV++FGV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 473 VTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLAST 525
+ E+ G P P I L V + R+ P + + +++
Sbjct: 201 LLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMR--- 246
Query: 526 ISFACLQSNPKSRPTMQYVSQEF 548
AC Q NP RP+ + Q F
Sbjct: 247 ---ACWQWNPSDRPSFAEIHQAF 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 61/274 (22%), Positives = 98/274 (35%), Gaps = 71/274 (25%)
Query: 318 YGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G+VYK KV A+K+L TS + EA V++ V + ++ +L
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPHVCRLL 83
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA---YL 423
G CL + LI + M G L + ++D + L+W V I K M + L +
Sbjct: 84 GICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMNY-LEDRRLV 139
Query: 424 HHDCSPSIASTCPDSSN-----------RTLLAGTYGY-----------IAPELAYTMVM 461
H D + A + + L A Y +A E +
Sbjct: 140 HRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 462 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-R 514
T + DV+S+GV E++ G P I ++ RLP P
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY-----------DGIPASEISSILEKGERLPQPPICT 245
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ I+ C + SRP + + EF
Sbjct: 246 IDVYMIMR------KCWMIDADSRPKFRELIIEF 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 48/273 (17%), Positives = 88/273 (32%), Gaps = 71/273 (26%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+ VY+A L +G ALKK+ + + E +L Q+ H N++K Y +
Sbjct: 45 FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 104
Query: 377 KCMFLIYEYMKRGSLFCNLHNN--------EDAVELDWAKRVNIVKAMAHALAYLH---- 424
+ ++ E G L + + E V + AL ++H
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQLCSALEHMHSRRV 157
Query: 425 -H---------------------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELA 456
H + A + GT Y++PE
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---------VGTPYYMSPERI 208
Query: 457 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDR- 514
+ K D++S G + E+ + P + + + PP P D
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 515 -KVIRDILLASTISFACLQSNPKSRPTMQYVSQ 546
+ +R ++ C+ +P+ RP + YV
Sbjct: 264 SEELRQLVN------MCINPDPEKRPDVTYVYD 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 64/256 (25%), Positives = 104/256 (40%), Gaps = 55/256 (21%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ N + ALK L S+ E+ R E ++ S + H NI+++Y + R
Sbjct: 27 FGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86
Query: 377 KCMFLIYEYMKRGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHALAYLH-----H-D 426
K ++L+ E+ RG L+ L + E + ++ +A AL Y H H D
Sbjct: 87 KRIYLMLEFAPRGELYKELQKHGRFDEQR-----SAT--FMEELADALHYCHERKVIHRD 139
Query: 427 CSPS-----------IA----STCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
P IA S S R + GT Y+ PE+ EK D++ G
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPPPVD---RKVIRDILLASTI 526
V+ E L+G P D S I +D + PP + + +I +
Sbjct: 200 VLCYEFLVGMPPFD-------SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKL------ 246
Query: 527 SFACLQSNPKSRPTMQ 542
L+ +P R ++
Sbjct: 247 ----LRYHPPQRLPLK 258
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 13/144 (9%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
EL S N ++ + L L +Q LT + L +DLS N L
Sbjct: 209 ELDASH-----N-SINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 260
Query: 163 TGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
I ++ L L + +N L+ + + L LDLS N L +
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317
Query: 222 KNLTWLDLSNNNIKGSIPVRLSPN 245
L L L +N+I ++ +
Sbjct: 318 DRLENLYLDHNSIV-TLKLSTHHT 340
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 28/163 (17%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEIS--------------- 147
L LS N RL+ ++ S P+L + + L+ ++ I+
Sbjct: 169 NLQLSS-----N-RLTHVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSINVVR 221
Query: 148 --ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
+L +L L N LT + N L+E+++ N L + + L L +
Sbjct: 222 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL 248
S+N+L + + L LDLS+N++ + L
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 21/139 (15%), Positives = 50/139 (35%), Gaps = 12/139 (8%)
Query: 113 FNWRLSQLNFSCFPN-------LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGT 165
+N + Q + C + + I E L+ +++ ++ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-K 59
Query: 166 IPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKN 223
+P + + + + LN+ + A + L + N + +PP + +
Sbjct: 60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118
Query: 224 LTWLDLSNNNIKGSIPVRL 242
LT L L N++ S+P +
Sbjct: 119 LTVLVLERNDLS-SLPRGI 136
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 31/116 (26%), Positives = 57/116 (49%), Gaps = 7/116 (6%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F+ + KL + F A+ +PP + + L +L L N L+ ++P I N L L
Sbjct: 89 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
++ +N+L + T+L NL LSSN+L+ + + + +L ++S N +
Sbjct: 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 20/151 (13%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLS 158
E+ LS N L ++ + F + +L + ++ ++ + L++LDLS
Sbjct: 252 EVDLSY-----N-ELEKIMYHPFVKMQRL--ERLYISNNRLVALNLYGQPIPTLKVLDLS 303
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N L + L L + NS I + L + L NL LS N
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNS-IVTLK--LSTHHTLKNLTLSHNDWDC--NSLR 357
Query: 219 AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLC 249
A +N+ + + + I +L GLC
Sbjct: 358 ALFRNVARPAVDDADQHCKIDYQLE--HGLC 386
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 58/262 (22%), Positives = 101/262 (38%), Gaps = 58/262 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V KV A+K + T + AF+ EA V++Q+ H N+V+L G + K
Sbjct: 206 FGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHSNLVQLLGVIVEEK 259
Query: 378 -CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
++++ EYM +GSL L + + L + + A+ YL H D +
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA-- 316
Query: 431 IASTCPDSSNRTL------LA-----GTYG------YIAPELAYTMVMTEKCDVYSFGVV 473
A S + L + APE + K DV+SFG++
Sbjct: 317 -ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 474 TLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLASTI 526
E+ G+ P P+I L DV+ + ++ P + D++
Sbjct: 376 LWEIYSFGRVPY-----------PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK---- 420
Query: 527 SFACLQSNPKSRPTMQYVSQEF 548
C + +RPT + ++
Sbjct: 421 --NCWHLDAATRPTFLQLREQL 440
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 11/163 (6%)
Query: 87 HCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT--GSIPP 144
+CK+ S+ L + N + + P+L L + L+ G
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 145 EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTNLSNL 203
+ L+ LDLS NG+ T+ L+ L L+ ++L S SL NL L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 204 DLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPN 245
D+S I G+ +L L ++ N+ + + +
Sbjct: 427 DISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 47/180 (26%), Positives = 69/180 (38%), Gaps = 12/180 (6%)
Query: 100 SIFELYLSGYYAGFN--WRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL 157
S L LS FN L +F FP L L + + +LS L L L
Sbjct: 29 STKNLDLS-----FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 158 SSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIP 215
+ N + ++ L +L +L +L +G L L L+++ N + S K+P
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 216 PEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNF-LDLPSCD-TTKPATLFVEIFL 273
+ + NL LDLS+N I+ L + N LDL F EI L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 24/111 (21%), Positives = 43/111 (38%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
+ L + F L + +LQ+LDLS + +L +L L + N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ A L++L L L+ I +K L L++++N I+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 33/144 (22%), Positives = 53/144 (36%), Gaps = 15/144 (10%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLT---IQFFALTGSIPPEI-SALSKLQLL 155
++ L +S F L L + + + P+I + L L L
Sbjct: 422 NLIYLDISH-----T-HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 156 DLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
DLS L + P +L +L LN+ SN L LT+L + L +N
Sbjct: 476 DLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC-S 533
Query: 215 PPEIAGMKNLTWLDLSNNNIKGSI 238
P I + WL+ ++ +GS
Sbjct: 534 CPRIDYLSR--WLNKNSQKEQGSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 27/157 (17%), Positives = 51/157 (32%), Gaps = 24/157 (15%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
++ Y + F+C N+ ++ + + S Q L+L +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVN 313
Query: 160 NGLTG-------------------TIPPEIGNLKNLIELNVGSNSL--IGPIPSALGSLT 198
+L +L L++ N L G + T
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 199 NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+L LDLS N + + G++ L LD ++N+K
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 30/173 (17%), Positives = 55/173 (31%), Gaps = 27/173 (15%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT------GSIPPEISALSKLQLLD 156
L LS ++ + + L ++ + +L I P +L L
Sbjct: 153 HLDLSSN------KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 157 LSSNGLTGTIPPE-IGNLKNLIELN------VGSNSLIGPIPSALGSLTNLS--NLDLSS 207
L +N + + I L L +L SAL L NL+ L+
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 208 NKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPSC 259
++ + N++ L + I+ R+ G L+L +C
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-----RVKDFSYNFGWQHLELVNC 314
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 56/265 (21%), Positives = 108/265 (40%), Gaps = 60/265 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A A+K + AF+ EA V+ + H +VKL+ ++
Sbjct: 201 FGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLHAVVT-KE 255
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
+++I E+M +GSL L ++E + + K ++ +A +A++ H D
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR--- 311
Query: 432 ASTCPDSSN-----------RTLLAGTY-----GYI-----APELAYTMVMTEKCDVYSF 470
A+ S++ R + Y APE T K DV+SF
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371
Query: 471 GVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLA 523
G++ +E++ G+ P P + +V+ R+P P + + + +I++
Sbjct: 372 GILLMEIVTYGRIPY-----------PGMSNPEVIRALERGYRMPRPENCPEELYNIMM- 419
Query: 524 STISFACLQSNPKSRPTMQYVSQEF 548
C ++ P+ RPT +Y+
Sbjct: 420 -----RCWKNRPEERPTFEYIQSVL 439
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 36/196 (18%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V G+ A+K + + ++ +S E Q+L Q+ H NI+KLY F
Sbjct: 38 SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---------- 425
+ +L+ E G LF + + + E+D A+ I++ + + Y+H
Sbjct: 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKNKIVHRDLKP 154
Query: 426 ----------DCSPSI-----ASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDV 467
D + I ++ S GT YIAPE+ Y EKCDV
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD----EKCDV 210
Query: 468 YSFGVVTLEVLMGKHP 483
+S GV+ +L G P
Sbjct: 211 WSTGVILYILLSGCPP 226
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 2e-18
Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 13/144 (9%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
EL S N ++ + L L +Q LT + L +DLS N L
Sbjct: 215 ELDASH-----N-SINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266
Query: 163 TGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
I ++ L L + +N L+ + + L LDLS N L +
Sbjct: 267 E-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
Query: 222 KNLTWLDLSNNNIKGSIPVRLSPN 245
L L L +N+I ++ +
Sbjct: 324 DRLENLYLDHNSIV-TLKLSTHHT 346
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 5e-18
Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 28/163 (17%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEIS--------------- 147
L LS N RL+ ++ S P+L + + L+ ++ I+
Sbjct: 175 NLQLSS-----N-RLTHVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSINVVR 227
Query: 148 --ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
+L +L L N LT + N L+E+++ N L + + L L +
Sbjct: 228 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL 248
S+N+L + + L LDLS+N++ + L
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 9e-15
Identities = 31/138 (22%), Positives = 62/138 (44%), Gaps = 16/138 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLT---IQFFALTGSIPPEI-SALSKLQLLDLS 158
L L+ ++ +++ F + + F A+ +PP + + L +L L
Sbjct: 79 LLNLND-----L-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 131
Query: 159 SNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
N L+ ++P I N L L++ +N+L + T+L NL LSSN+L+ +
Sbjct: 132 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL- 188
Query: 218 IAGMKNLTWLDLSNNNIK 235
+ + +L ++S N +
Sbjct: 189 -SLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 20/151 (13%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLS 158
E+ LS N L ++ + F + +L + ++ ++ + L++LDLS
Sbjct: 258 EVDLSY-----N-ELEKIMYHPFVKMQRL--ERLYISNNRLVALNLYGQPIPTLKVLDLS 309
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N L + L L + NS I + L + L NL LS N
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNS-IVTLK--LSTHHTLKNLTLSHNDWDC--NSLR 363
Query: 219 AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLC 249
A +N+ + + + I +L GLC
Sbjct: 364 ALFRNVARPAVDDADQHCKIDYQL--EHGLC 392
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 14/103 (13%), Positives = 34/103 (33%), Gaps = 3/103 (2%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
I + + + E L N + ++++ + L S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 201 SNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPVRL 242
L+L+ ++ +I A + L + N I+ +P +
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 60/265 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V + A+K + E F + EAQ + ++ H +VK YG C
Sbjct: 21 FGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGVCSKEY 76
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
++++ EY+ G L L ++ L+ ++ + + + +A+L H D +
Sbjct: 77 PIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA--- 131
Query: 432 ASTCPDSSN-----------RTLLAGTY-----GYI-----APELAYTMVMTEKCDVYSF 470
A C + R +L Y APE+ + + K DV++F
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191
Query: 471 GVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLA 523
G++ EV GK P +V+ + RL P I I+
Sbjct: 192 GILMWEVFSLGKMPY-----------DLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY- 239
Query: 524 STISFACLQSNPKSRPTMQYVSQEF 548
+C P+ RPT Q +
Sbjct: 240 -----SCWHELPEKRPTFQQLLSSI 259
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 53/283 (18%), Positives = 97/283 (34%), Gaps = 73/283 (25%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR 376
G+V G+ A+K++ + F E ++L++ H N+++ Y
Sbjct: 28 SGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 377 KCMFLIYEYMKRGSLF----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-- 425
+ +++ E +L ++E+ +++++ +A +A+LH H
Sbjct: 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD 140
Query: 426 ---------DCSPSIASTCPDSSNRTLL------------------------AGTYGYIA 452
S A + N +L +GT G+ A
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200
Query: 453 PEL-------AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVL 504
PEL +T D++S G V +L GKHP S + I+
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG----DKYSRESNIIRGIFS 256
Query: 505 DQRLPPPVDRKVI---RDILLASTISFACLQSNPKSRPTMQYV 544
+ DR +I D+ IS + +P RPT V
Sbjct: 257 LDEMKCLHDRSLIAEATDL-----IS-QMIDHDPLKRPTAMKV 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 59/266 (22%), Positives = 88/266 (33%), Gaps = 64/266 (24%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLH 375
YGSV K P+G++ A+K++ ++ E+ K + V + IV+ YG
Sbjct: 35 YGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHH---- 425
++ E M S V + I A AL +L
Sbjct: 93 EGDCWICMELMS-TSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 426 ---DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPE--------LAYT 458
D PS I+ DS +T AG Y+APE Y
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 459 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKV 516
+ DV+S G+ E+ G+ P +S + D L Q + PP
Sbjct: 208 ----VRSDVWSLGITLYELATGRFPYPKWNS----------VFDQLTQVVKGDPPQLSNS 253
Query: 517 IRDILLASTISF--ACLQSNPKSRPT 540
S I+F CL + RP
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPK 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 58/280 (20%), Positives = 91/280 (32%), Gaps = 64/280 (22%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G V+K P+G V A K +H E QVL + IV YG
Sbjct: 46 GGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSD 103
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSP 429
+ + E+M GSL L E K + A+ L YL D P
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
S ++ DS + GT Y++PE + + D++S G+
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLS 219
Query: 474 TLEVLMGKHP-------------------------------RDLLSSLSSSSDPKIMLID 502
+E+ +G++P L+ S P + + +
Sbjct: 220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279
Query: 503 VLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPT 540
+LD PPP + + ++ CL NP R
Sbjct: 280 LLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERAD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 62/267 (23%)
Query: 318 YGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG VY+ + V A+K L E F+K EA V+ ++ H N+V+L G C
Sbjct: 233 YGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLGVCTR 287
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP 429
++I E+M G+L L E+ + + ++ A+ YL H + +
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRNLA- 345
Query: 430 SIASTCPDSSN-----------RTLLAGTYG----------YIAPELAYTMVMTEKCDVY 468
A C N R + TY + APE + K DV+
Sbjct: 346 --ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 469 SFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDIL 521
+FGV+ E+ G P P I L V + R+ P + + +++
Sbjct: 404 AFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452
Query: 522 LASTISFACLQSNPKSRPTMQYVSQEF 548
AC Q NP RP+ + Q F
Sbjct: 453 R------ACWQWNPSDRPSFAEIHQAF 473
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 3e-18
Identities = 36/155 (23%), Positives = 57/155 (36%), Gaps = 31/155 (20%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
L + L+ L ++ L I LT S+P +L+ L++S N L
Sbjct: 44 VLNVG------ESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQL 93
Query: 163 TGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL--------------TNLSNLDLSSN 208
T ++P L L + L +PS L L L L +S N
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDN 151
Query: 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
+L+ +P + L L NN + S+P+ S
Sbjct: 152 QLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPS 181
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-16
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 28/137 (20%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL-----------------LDLS 158
+L+ L L +L++ L S+P S L KL L +S
Sbjct: 172 QLTSLP-MLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVS 229
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N LT ++P LK L V N L +P L +L + N+L+ ++P +
Sbjct: 230 GNRLT-SLPVLPSELKEL---MVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESL 280
Query: 219 AGMKNLTWLDLSNNNIK 235
+ + T ++L N +
Sbjct: 281 IHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 18/91 (19%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 149 LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208
+ +L++ +GLT T+P + ++ L + N+L +P+ L L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGN 91
Query: 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+L+ +P G+ L+ ++
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 6e-14
Identities = 29/123 (23%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 116 RLSQLNFSCFP----NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIG 171
+ P L +L + LT S+P S +L+ L +S N LT ++P
Sbjct: 207 WAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPS 261
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
L L+V N L +P +L L++ + ++L N LS + + ++ +T +
Sbjct: 262 GLL---SLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPGYS 314
Query: 232 NNI 234
I
Sbjct: 315 GPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 38/175 (21%), Positives = 60/175 (34%), Gaps = 52/175 (29%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL-------- 154
L + + L+ L + P L L + LT S+P L +L +
Sbjct: 65 TLVIP------DNNLTSLP-ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL 116
Query: 155 ---------LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLT------- 198
L + N LT ++P L+ EL+V N L +P+ L
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLAS-LPALPSELCKLWAYNN 171
Query: 199 ----------NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
L L +S N+L+ +P + L L NN + S+P S
Sbjct: 172 QLTSLPMLPSGLQELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPS 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 55/265 (20%), Positives = 97/265 (36%), Gaps = 60/265 (22%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
+G V+ A+K L AF+ EA ++ Q+ H+ +V+LY
Sbjct: 26 FGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYAVVTQEP 81
Query: 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPSI 431
+++I EYM+ GSL L +L K +++ +A +A++ H D
Sbjct: 82 -IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHRDLR--- 136
Query: 432 ASTCPDSSN-----------RTLLAGTY-----GYI-----APELAYTMVMTEKCDVYSF 470
A+ S R + Y APE T K DV+SF
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 471 GVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLA 523
G++ E++ G+ P P + +V+ R+ P + + + ++
Sbjct: 197 GILLTEIVTHGRIPY-----------PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR- 244
Query: 524 STISFACLQSNPKSRPTMQYVSQEF 548
C + P+ RPT Y+
Sbjct: 245 -----LCWKERPEDRPTFDYLRSVL 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 57/291 (19%), Positives = 100/291 (34%), Gaps = 62/291 (21%)
Query: 318 YGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+GSV + G + A+K+L S ++ + F+ E Q+L + IVK G
Sbjct: 36 FGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIVKYRGV 92
Query: 373 CLH--RKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMA--HALAYLH 424
R+ + L+ EY+ G L L + ++ L ++ I K M + +H
Sbjct: 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEYLGSRRCVH 150
Query: 425 HDCSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVM 461
D + A S + L Y+ APE +
Sbjct: 151 RDLA---ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 462 TEKCDVYSFGVVTLEVLM-GKHP---RDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPV 512
+ + DV+SFGVV E+ + L +L+ RLP P
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF--LITRKTPLVKHA 560
+ +++ C +P+ RP+ + + L + HA
Sbjct: 268 ACPAEVHELMK------LCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 54/264 (20%), Positives = 87/264 (32%), Gaps = 65/264 (24%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRNIVKLYGFCLH 375
G V+K + G V A+K++ S +E K + V+ IV+ +G +
Sbjct: 38 CGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCS 428
+F+ E M + E K + A+ AL YL D
Sbjct: 96 NTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---MTVAIVKALYYLKEKHGVIHRDVK 152
Query: 429 PS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE-----KCDV 467
PS I+ D + AG Y+APE T+ + DV
Sbjct: 153 PSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLAST 525
+S G+ +E+ G+ P + +VL + + PP LL
Sbjct: 213 WSLGISLVELATGQFPYKNCKT----------DFEVLTKVLQEEPP---------LLPGH 253
Query: 526 ISF---------ACLQSNPKSRPT 540
+ F CL + + RP
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPK 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 60/271 (22%), Positives = 93/271 (34%), Gaps = 64/271 (23%)
Query: 318 YGSVYKAQL---PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
G V +L V A+K L TE + F +EA ++ Q H NI++L G
Sbjct: 62 SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDHPNIIRLEGVV 119
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC 427
+ ++ EYM+ GSL L ++ + + V +++ + + YL H D
Sbjct: 120 TRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDL 177
Query: 428 SPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTEK 464
+ A SN R L APE +
Sbjct: 178 A---ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA 234
Query: 465 CDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVI 517
DV+SFGVV EVL G+ P + DV+ RLP P+ +
Sbjct: 235 SDVWSFGVVMWEVLAYGERPY-----------WNMTNRDVISSVEEGYRLPAPMGCPHAL 283
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548
++L C + RP +
Sbjct: 284 HQLML------DCWHKDRAQRPRFSQIVSVL 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 34/143 (23%), Positives = 48/143 (33%), Gaps = 9/143 (6%)
Query: 111 AGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTI---- 166
A + L++L P L L+I ++ L LDLS N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 167 ---PPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMK 222
P + L+ L N G + G + + L LDLS N L
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 223 NLTWLDLSNNNIKGSIPVRLSPN 245
L L+LS +K +P L
Sbjct: 254 QLNSLNLSFTGLK-QVPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 35/125 (28%), Positives = 46/125 (36%), Gaps = 9/125 (7%)
Query: 117 LSQLNFSCFPNLVKLTI---QFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GN 172
+S L FP L L + +G +A +LQ LDLS N L
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 173 LKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232
L LN+ L +P L + LS LDLS N+L P + + L L N
Sbjct: 252 PSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGN 306
Query: 233 NIKGS 237
S
Sbjct: 307 PFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 24/134 (17%), Positives = 46/134 (34%), Gaps = 11/134 (8%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTG--SIPPEISALSK--LQLLDLSSNGLTGTIPPEIGN 172
L + P+L L ++ + + E+ K L++L ++ ++
Sbjct: 112 PPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171
Query: 173 LKNLIELNVGSNSLIGPIP----SALGSLTNLSNLDLSSNK---LSGKIPPEIAGMKNLT 225
L L++ N +G L L L + SG A L
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 226 WLDLSNNNIKGSIP 239
LDLS+N+++ +
Sbjct: 232 GLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 31/139 (22%), Positives = 51/139 (36%), Gaps = 13/139 (9%)
Query: 127 NLVKLTIQFFALTGSIPPEISAL---SKLQLLDLSSNGLTGTIPPEIGNL--KNLIELNV 181
+L +LT++ + I + S LQ L L + +TGT PP + +L LN+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 182 GSNSLIGPIPSALG----SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237
+ S L L ++ ++ L+ LDLS+N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 238 IPVRLSPNKGLCGGNFLDL 256
+ + LC F L
Sbjct: 189 RGLISA----LCPLKFPTL 203
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 2/87 (2%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
L+ +D ++ T + +LK L S I + ++ L L L + +++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 212 GKIPPEIA--GMKNLTWLDLSNNNIKG 236
G PP + +L L+L N +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT 135
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 63/266 (23%), Positives = 107/266 (40%), Gaps = 62/266 (23%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ +V A+K L AF++ EAQV+ ++ H +V+LY
Sbjct: 197 FGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYAVVS-E 250
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
+ ++++ EYM +GSL L L + V++ +A +AY+ H D
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLR-- 307
Query: 431 IASTCPDSSN-----------RTLLAGTYG----------YIAPELAYTMVMTEKCDVYS 469
A+ N R + Y + APE A T K DV+S
Sbjct: 308 -AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 470 FGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILL 522
FG++ E+ G+ P P ++ +VLDQ R+P P + + + D++
Sbjct: 367 FGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEF 548
C + P+ RPT +Y+
Sbjct: 416 ------QCWRKEPEERPTFEYLQAFL 435
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 62/266 (23%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ +V A+K L AF++ EAQV+ ++ H +V+LY
Sbjct: 280 FGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYAVVSEE 334
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSPS 430
++++ EYM +GSL L L + V++ +A +AY+ H D
Sbjct: 335 P-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLR-- 390
Query: 431 IASTCPDSSN-----------RTLLAGTYG----------YIAPELAYTMVMTEKCDVYS 469
A+ N R + Y + APE A T K DV+S
Sbjct: 391 -AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 470 FGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILL 522
FG++ E+ G+ P P ++ +VLDQ R+P P + + + D++
Sbjct: 450 FGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEF 548
C + P+ RPT +Y+
Sbjct: 499 ------QCWRKEPEERPTFEYLQAFL 518
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 56/277 (20%), Positives = 95/277 (34%), Gaps = 59/277 (21%)
Query: 318 YGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G V + G+ A+K L I + E ++L + H NIVK G
Sbjct: 34 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIVKYKGI 91
Query: 373 CLH--RKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMA--HALAYLH 424
C + LI E++ GSL L N++ + L +A V I K M + Y+H
Sbjct: 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA--VQICKGMDYLGSRQYVH 149
Query: 425 HDCSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVM 461
D + A S + + Y APE
Sbjct: 150 RDLA---ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF 206
Query: 462 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD---PKIMLIDVLDQ-----RLPPPV 512
DV+SFGV E+L ++ ++ + +++ RLP P
Sbjct: 207 YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPP 266
Query: 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ + ++ C + P +R + Q + + F
Sbjct: 267 NCPDEVYQLMR------KCWEFQPSNRTSFQNLIEGF 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 69/272 (25%), Positives = 101/272 (37%), Gaps = 65/272 (23%)
Query: 318 YGSVYKAQL--PNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G VYK L +GK A+K L TE+ F EA ++ Q H NI++L G
Sbjct: 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSHHNIIRLEGV 114
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
K M +I EYM+ G+L L + E + V +++ +A + YL H D
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRD 172
Query: 427 CSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTE 463
+ A +SN R L APE T
Sbjct: 173 LA---ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
DV+SFG+V EV+ G+ P LS+ +V+ RLP P+D
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSN-----------HEVMKAINDGFRLPTPMDCPSA 278
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
I +++ C Q RP +
Sbjct: 279 IYQLMM------QCWQQERARRPKFADIVSIL 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 53/201 (26%), Positives = 75/201 (37%), Gaps = 47/201 (23%)
Query: 317 GYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
YG V A+K + TS +L E VL + H NI+KLY
Sbjct: 49 AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL------LEEVAVLKLLDHPNIMKLY 102
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----- 425
F ++ +L+ E K G LF + + E+D A I+K + + YLH
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLHKHNIVH 159
Query: 426 ---------------DCSPSI-----ASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMT 462
D I ++ + GT YIAPE+ Y
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD---- 215
Query: 463 EKCDVYSFGVVTLEVLMGKHP 483
EKCDV+S GV+ +L G P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/278 (21%), Positives = 102/278 (36%), Gaps = 61/278 (21%)
Query: 318 YGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+GSV + G+V A+KKL S E L + F E ++L + H NIVK G
Sbjct: 23 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIVKYKGV 79
Query: 373 CLH--RKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMA--HALAYLH 424
C R+ + LI EY+ GSL L +++ ++ L + I K M Y+H
Sbjct: 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGMEYLGTKRYIH 137
Query: 425 HDCSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVM 461
D + + + L + APE
Sbjct: 138 RDLA---TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 462 TEKCDVYSFGVV-----TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 511
+ DV+SFGVV T P + + + + ++++ +++ RLP P
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 512 VD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
I I+ C +N RP+ + ++
Sbjct: 255 DGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 64/271 (23%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V +L P+ K A+K L TE+ + F EA ++ Q H NI++L G
Sbjct: 58 FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRLEGVV 115
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDC 427
K + ++ EYM+ GSL L ++ + + V +++ +A + YL H D
Sbjct: 116 TKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 173
Query: 428 SPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTEK 464
+ A +SN R L +PE T
Sbjct: 174 A---ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA 230
Query: 465 CDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVI 517
DV+S+G+V EV+ G+ P ++ DV+ RLPPP+D +
Sbjct: 231 SDVWSYGIVLWEVMSYGERPY-----------WEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548
++L C Q + +RP + +
Sbjct: 280 YQLML------DCWQKDRNNRPKFEQIVSIL 304
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 20/138 (14%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
L +S N +L +L L + + +L +P L+ + +N
Sbjct: 135 YLGVSN-----N-QLEKLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQ 184
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221
L PE+ NL L + +NSL +P +L ++ +N L PE+ +
Sbjct: 185 LE--ELPELQNLPFLTAIYADNNSLKK-LPD---LPLSLESIVAGNNILE--ELPELQNL 236
Query: 222 KNLTWLDLSNNNIKGSIP 239
LT + NN +K ++P
Sbjct: 237 PFLTTIYADNNLLK-TLP 253
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 27/152 (17%), Positives = 53/152 (34%), Gaps = 34/152 (22%)
Query: 120 LNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL-------------LDLSSNGLTGTI 166
+ + + + + PP ++ + L+L++ GL+ ++
Sbjct: 28 VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86
Query: 167 PPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP----------- 215
P +L+ L NSL +P SL +L + + LS P
Sbjct: 87 PELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 142
Query: 216 ----PEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
PE+ L +D+ NN++K +P
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 19/111 (17%)
Query: 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL---- 197
I P + + LQ S+ LT +P E N+K+ E + P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 198 ---------TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
L+L++ LS +P +L L S N++ +P
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELP 107
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 18/112 (16%), Positives = 36/112 (32%), Gaps = 18/112 (16%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNL-------------KNLIELNVGSNSLI 187
+P E + + + PP G + EL + + L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL- 83
Query: 188 GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+P +L +L S N L+ ++P +K+L + + + P
Sbjct: 84 SSLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 27/133 (20%), Positives = 43/133 (32%), Gaps = 30/133 (22%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVG 182
PNL L + S+ L+ L++S+N L +P L+ L
Sbjct: 294 ELPPNLYYLNASSNEIR-SLCDL---PPSLEELNVSNNKLI-ELPALPPRLE---RLIAS 345
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMK----------------NLTW 226
N L +P NL L + N L + P ++ NL
Sbjct: 346 FNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQ 400
Query: 227 LDLSNNNIKGSIP 239
L + N ++ P
Sbjct: 401 LHVETNPLR-EFP 412
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 32/166 (19%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
+Y N L L P+L L ++ LT +P +L+ L + + +GL
Sbjct: 241 TIYADN-----N-LLKTLPDLP-PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL 292
Query: 163 TGTIPPEIGNL--------------KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208
+ +PP + L +L ELNV +N LI +P+ L L S N
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFN 347
Query: 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFL 254
L+ ++P +NL L + N ++ P + L + L
Sbjct: 348 HLA-EVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHL 388
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 28/146 (19%), Positives = 55/146 (37%), Gaps = 24/146 (16%)
Query: 95 CNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL 154
C+ S+ EL +S N +L +L + P L +L F L +P L+
Sbjct: 313 CDLPPSLEELNVSN-----N-KLIEL-PALPPRLERLIASFNHLA-EVPELPQ---NLKQ 361
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
L + N L P ++++L + + +P NL L + +N L +
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDLRMNS-----HLAEVPE---LPQNLKQLHVETNPLR-EF 411
Query: 215 PPEIAGMKNLTWLDLSNNNIKGSIPV 240
P +++ L +++ +
Sbjct: 412 PDIP---ESVEDLRMNSERVVDPYEF 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 12/68 (17%), Positives = 25/68 (36%), Gaps = 4/68 (5%)
Query: 196 SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLD 255
S T L S+ L+ ++P E +K+ T + + + + P + +
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM---AVSR 64
Query: 256 LPSCDTTK 263
L C +
Sbjct: 65 LRDCLDRQ 72
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELN 180
F L L I + ++ P L L ++ LT +P + +L L LN
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ N + S L L L + L +L+ + P G+ L L++S N + ++
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLE 312
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNL 173
L+Q F+ FP+L +L + ++ ++ P + L L+ L L SN L IP + L
Sbjct: 46 TLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGL 103
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNN 232
NL +L++ N ++ + L NL +L++ N L I +G+ +L L L
Sbjct: 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKC 162
Query: 233 NIKGSIP 239
N+ SIP
Sbjct: 163 NLT-SIP 168
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 14/142 (9%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
+L +S N ++ L F NL L + L I S L+ L+ L L
Sbjct: 108 KLDISE-----N-KIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLE 160
Query: 159 SNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
LT +IP E +L LI L + ++ + L L L++S + P
Sbjct: 161 KCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 218 IAGMKNLTWLDLSNNNIKGSIP 239
NLT L +++ N+ ++P
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVP 240
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 11/46 (23%), Positives = 21/46 (45%), Gaps = 4/46 (8%)
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNI 234
+P + T LDL N++ + + A +L L+L+ N +
Sbjct: 26 VPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV 68
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 64/272 (23%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V + + P+GK A+K L + + F E + + HRN+++LYG
Sbjct: 31 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAH--ALAYLHHDC 427
L M ++ E GSL L ++ +A V + + M + + ++H D
Sbjct: 91 L-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMGYLESKRFIHRDL 147
Query: 428 SPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTEK 464
+ A ++ R L Y+ APE T +
Sbjct: 148 A---ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 204
Query: 465 CDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ------RLPPPVD-RKV 516
D + FGV E+ G+ P + +L + RLP P D +
Sbjct: 205 SDTWMFGVTLWEMFTYGQEPW-----------IGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
I ++++ C P+ RPT +
Sbjct: 254 IYNVMV------QCWAHKPEDRPTFVALRDFL 279
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 36/147 (24%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI-SALSKLQLLDL 157
+L LS N +L ++ + F L +L L + P + L+ LQ L L
Sbjct: 84 QLDLSD-----NAQLRSVDPATFHGLGRL--HTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 158 SSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP 216
N L +P + +L NL L + N + A L +L L L N+++ + P
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHP 194
Query: 217 EI-AGMKNLTWLDLSNNNIKGSIPVRL 242
+ L L L NN+ ++P
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 25/122 (20%), Positives = 48/122 (39%), Gaps = 8/122 (6%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVG 182
++ + ++ +P A L +L L SN L I L L +L++
Sbjct: 31 PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLS 88
Query: 183 SNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPV 240
N+ + + L L L L L ++ P + G+ L +L L +N ++ ++P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
Query: 241 RL 242
Sbjct: 147 DT 148
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 6/101 (5%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTN 199
++P I A Q + L N ++ +P +NL L + SN L +A L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 200 LSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
L LDLS N + P G+ L L L ++ +
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG 121
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
GL +P I + + N + ++ + NL+ L L SN L+ +I
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RI 71
Query: 215 PPEI-AGMKNLTWLDLSNNNIKGSIP 239
G+ L LDLS+N S+
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVD 97
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 32/211 (15%), Positives = 57/211 (27%), Gaps = 47/211 (22%)
Query: 317 GYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+ VY+A N + F LK + E + L + +K Y
Sbjct: 77 AFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLKPSMQHMFMKFY 133
Query: 371 GFCLHRKCMFLIYEYMKRGSLF--CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH---- 424
L + L+ E G+L NL+ N + ++ M + + +H
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 425 ----------------------HDCSPSIA----------STCPDSSNRTLLAGTYGYIA 452
D S +A P + T T G+
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 453 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483
E+ + D + +L G +
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 54/276 (19%), Positives = 104/276 (37%), Gaps = 51/276 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+ VY+A+ + G A+K + + ++ +NE ++ Q+ H +I++LY +
Sbjct: 23 SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
++L+ E G + L N + A+ + + + YLH H D +
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLHSHGILHRDLTL 140
Query: 430 ------------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
+ P + T L GT YI+PE+A + DV+S G
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPPPVD---RKVIRDILLASTI 526
+ +L+G+ P D + K L + + D +P + + +I +
Sbjct: 200 CMFYTLLIGRPPFD-------TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL------ 246
Query: 527 SFACLQSNPKSRPTMQYVSQ-EFLITRKTPLVKHAA 561
L+ NP R ++ V F+ + K
Sbjct: 247 ----LRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 53/264 (20%), Positives = 93/264 (35%), Gaps = 67/264 (25%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G +VY A+ A+K + E+ +K F E SQ+ H+NIV +
Sbjct: 23 GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
C +L+ EY++ +L + ++ L +N + + + H D P
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139
Query: 430 S----------------IASTCPDSS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
IA ++S N L GT Y +PE A E D+YS
Sbjct: 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQAKGEATDECTDIYS 197
Query: 470 FGVVTLEVLMG--------------KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515
G+V E+L+G KH +D + ++++ I P +
Sbjct: 198 IGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI----------PQSLSNV 247
Query: 516 VIRDILLASTISFACLQSNPKSRP 539
++R + + +R
Sbjct: 248 ILR-----------ATEKDKANRY 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 61/274 (22%), Positives = 99/274 (36%), Gaps = 71/274 (25%)
Query: 318 YGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G+VYK KV A+K+L TS + EA V++ V + ++ +L
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPHVCRLL 83
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA---YL 423
G CL + LI + M G L + ++D + L+W V I K M + L +
Sbjct: 84 GICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMNY-LEDRRLV 139
Query: 424 HHDCSPSIASTCPDSSN-----------RTLLAGTYGY-----------IAPELAYTMVM 461
H D + A + + L A Y +A E +
Sbjct: 140 HRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 462 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-R 514
T + DV+S+GV E++ G P I ++ RLP P
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY-----------DGIPASEISSILEKGERLPQPPICT 245
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ I++ C + SRP + + EF
Sbjct: 246 IDVYMIMV------KCWMIDADSRPKFRELIIEF 273
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 8e-17
Identities = 38/123 (30%), Positives = 56/123 (45%), Gaps = 6/123 (4%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLK 174
L+Q+ +L + F + ++ L +LQLL+L S TI E NL
Sbjct: 16 LTQV-PQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 175 NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE--IAGMKNLTWLDLSNN 232
NL L++GS+ + P A L +L L L LS + + +K LT LDLS N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 233 NIK 235
I+
Sbjct: 134 QIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 27/126 (21%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI-SALSKLQLLDLSSNGLTGTIPPEI 170
+ + + F L + +++ L+ S+ + L L++L+L+ N +
Sbjct: 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310
Query: 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDL 229
L NL LN+ N L S L ++ +DL N ++ I + ++ L LDL
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDL 369
Query: 230 SNNNIK 235
+N +
Sbjct: 370 RDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 16/160 (10%)
Query: 100 SIFELYLSGYYAGFNW--RLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLD 156
S+ L LS + L+ F +L L + + + I E L LQ+L+
Sbjct: 267 SVRHLDLS-----HGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLN 320
Query: 157 LSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
LS N L + L + +++ N + L L LDL N L+
Sbjct: 321 LSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT---- 375
Query: 216 PEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLD 255
I + ++ + LS N + + L+ N N L+
Sbjct: 376 -TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 31/128 (24%), Positives = 55/128 (42%), Gaps = 7/128 (5%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPE--IGNLKNLIE 178
F PNL L + + + P+ L L L L GL+ + + NLK L
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 179 LNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAG--MKNLTWLDLSNNNIK 235
L++ N + + + G L +L ++D SSN++ E+ K L++ L+ N++
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 236 GSIPVRLS 243
+ V
Sbjct: 188 SRVSVDWG 195
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 18/161 (11%)
Query: 94 TCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG-SIPPEISALSKL 152
T + SI +++LS +L L + + L I + + L
Sbjct: 376 TIHFIPSIPDIFLS------GNKLVTLPKINL-TANLIHLSENRLENLDILYFLLRVPHL 428
Query: 153 QLLDLSSNGLTGTIPPE--IGNLKNLIELNVGSNSLIGPI-----PSALGSLTNLSNLDL 205
Q+L L+ N + + + +L +L +G N L L++L L L
Sbjct: 429 QILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 206 SSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPN 245
+ N L+ +PP + + + L L L++N + L N
Sbjct: 488 NHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 39/170 (22%), Positives = 61/170 (35%), Gaps = 15/170 (8%)
Query: 95 CNSAGSIFELYLSGYYAGFNW-RLSQLNFSCF----PNLVKLTIQFFALTGSIPPE--IS 147
N ++ ++ L+ + RL L+ F P+L L + + S + S
Sbjct: 390 GNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPS 448
Query: 148 ALSKLQLLDLSSNGLTGTIPPEI-----GNLKNLIELNVGSNSLIGPIPSALGSLTNLSN 202
L+ L L N L E+ L +L L + N L P LT L
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGN 252
L L+SN+L+ + NL LD+S N + P L +
Sbjct: 509 LSLNSNRLT-VLSHNDL-PANLEILDISRNQLLAPNPDVFVSLSVLDITH 556
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 32/161 (19%), Positives = 51/161 (31%), Gaps = 22/161 (13%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTG-SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNL-- 173
L F L +L + + + P L+ L+ +D SSN + E+ L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTN------LSNLDLSSNKLSGKIP------------ 215
K L ++ +NSL + G N L LD+S N + I
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 216 PEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
+ ++ +NIK LDL
Sbjct: 234 FSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDL 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 62/278 (22%), Positives = 102/278 (36%), Gaps = 61/278 (21%)
Query: 318 YGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+GSV + G+V A+KKL S E L + F E ++L + H NIVK G
Sbjct: 54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIVKYKGV 110
Query: 373 CLH--RKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMA--HALAYLH 424
C R+ + LI EY+ GSL L +++ ++ L + I K M Y+H
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGMEYLGTKRYIH 168
Query: 425 HDCSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVM 461
D + + + L Y APE
Sbjct: 169 RDLA---TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 462 TEKCDVYSFGVV-----TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 511
+ DV+SFGVV T P + + + + ++++ +++ RLP P
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
Query: 512 VD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
I I+ C +N RP+ + ++
Sbjct: 286 DGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 317
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 37/196 (18%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V K + +A+K ++ + + + E ++L ++ H NI+KL+
Sbjct: 34 SFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H----- 425
+++ E G LF + + E D A+ I+K + + Y+H H
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHNIVHRDLKP 149
Query: 426 ----------DCSPSI-----ASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDV 467
DC I ++ ++ GT YIAPE+ Y EKCDV
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY----DEKCDV 205
Query: 468 YSFGVVTLEVLMGKHP 483
+S GV+ +L G P
Sbjct: 206 WSAGVILYILLSGTPP 221
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 62/294 (21%), Positives = 102/294 (34%), Gaps = 78/294 (26%)
Query: 318 YGSVYKA-QLPNGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
V A P + A+K L +T + E Q +SQ H NIV Y +
Sbjct: 28 TAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 375 HRKCMFLIYEYMKRGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD--- 426
+ ++L+ + + GS+ + LD + I++ + L YLH +
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI 143
Query: 427 -----------------------CSPSIASTCPDSSN--RTLLAGTYGYIAPELAYTMVM 461
S +A+ + N R GT ++APE VM
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-----VM 198
Query: 462 TE------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLIDVLDQRLPPPVD 513
+ K D++SFG+ +E+ G P P +ML + PP
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPY-------HKYPPMKVLMLT----LQNDPPSL 247
Query: 514 RKVIRDILLASTIS--F-----ACLQSNPKSRPTMQYVSQEFLITRKTPLVKHA 560
++D + F CLQ +P+ RPT + E L + + A
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELL---RHKFFQKA 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 62/263 (23%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLH 375
YG V K + +P+G++ A+K++ + + K + + + V V YG
Sbjct: 20 YGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALFR 77
Query: 376 RKCMFLIYEYMKRGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------- 425
+++ E M SL + + + + D + I ++ AL +LH
Sbjct: 78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSKLSVIHR 134
Query: 426 DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPE--------LAYTMVM 461
D PS I+ D + + AG Y+APE Y++
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV-- 192
Query: 462 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRD 519
K D++S G+ +E+ + + P S P L Q P P ++ D
Sbjct: 193 --KSDIWSLGITMIELAILRFP------YDSWGTP----FQQLKQVVEEPSP---QLPAD 237
Query: 520 ILLASTISF--ACLQSNPKSRPT 540
A + F CL+ N K RPT
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPT 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 37/190 (19%), Positives = 73/190 (38%), Gaps = 16/190 (8%)
Query: 62 LSPIQLEKKALINTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLN 121
LS ++ + L G +N S + +I L++ +Y +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDV----VSELGKVETVTIRRLHIPQFYL---FYDLSTV 305
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPE---IGNLKNLI 177
+S + ++T++ + +P L L+ LDLS N + G +L
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 178 ELNVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L + N L + L +L NL++LD+S N +P + + +L+LS+ I+
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
Query: 236 GSIPVRLSPN 245
+ +
Sbjct: 424 -VVKTCIPQT 432
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 5/127 (3%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEI-GNL 173
+ + + L + F +T I + A + LQ+L L S+ + TI + +L
Sbjct: 16 SFTSIPSGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSL 73
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNN 232
+L L++ N L S G L++L L+L N + + NL L + N
Sbjct: 74 GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
Query: 233 NIKGSIP 239
I
Sbjct: 134 ETFSEIR 140
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 15/161 (9%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTI------QFFALTGSIPPEISALSKLQLLD 156
L LS N LS L+ S F L L + L + L+ LQ L
Sbjct: 78 HLDLSD-----N-HLSSLSSSWFGPLSSLKYLNLMGNPYQTL--GVTSLFPNLTNLQTLR 129
Query: 157 LSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
+ + I L +L EL + + SL +L S+ ++ +L L ++ + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 216 PEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDL 256
+ ++ +L+L + N+ L ++ L
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 24/147 (16%), Positives = 46/147 (31%), Gaps = 4/147 (2%)
Query: 113 FNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGN 172
+ LS++ F ++ L + L +
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 173 LKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE---IAGMKNLTWLDL 229
L+ + + V ++ + S L +L LDLS N + + +L L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 230 SNNNIKGSIPVRLSPNKGLCGGNFLDL 256
S N+++ S+ L LD+
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDI 394
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 27/141 (19%), Positives = 50/141 (35%), Gaps = 11/141 (7%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNL 176
S + F V F L + I LS+++ D + NGL P E + L
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280
Query: 177 I--------ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWL 227
L++ L + + L + + + ++K+ +P +K+L +L
Sbjct: 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFL 339
Query: 228 DLSNNNIKGSIPVRLSPNKGL 248
DLS N + +
Sbjct: 340 DLSENLMVEEYLKNSACKGAW 360
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 12/117 (10%)
Query: 94 TCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQ 153
+C + L LS + + L L + L S L +LQ
Sbjct: 405 SCQWPEKMRFLNLSS-----T-GIRVVKTCIPQTLEVLDVSNNNLD-SFSLF---LPRLQ 454
Query: 154 LLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 210
L +S N L T+P L+ + + N L LT+L + L +N
Sbjct: 455 ELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 15/114 (13%), Positives = 38/114 (33%), Gaps = 1/114 (0%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
F NL L I I + L+ L L++ + L + +++++ L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ + + L+++ L+L L+ + + + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 29/89 (32%)
Query: 148 ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207
+ + D S T +IP + + +LDLS
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--------------------------TAAMKSLDLSF 35
Query: 208 NKLSGKIPPE-IAGMKNLTWLDLSNNNIK 235
NK++ I + NL L L ++ I
Sbjct: 36 NKIT-YIGHGDLRACANLQVLILKSSRIN 63
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 51/272 (18%), Positives = 93/272 (34%), Gaps = 68/272 (25%)
Query: 318 YGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+GSV + ++ A+K L T + + ++ EAQ++ Q+ + IV+L G
Sbjct: 23 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPYIVRLIGV 78
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
C + + L+ E G L L + E+ + ++ ++ + YL H D
Sbjct: 79 CQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 427 CSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTE 463
+ A + + L A Y APE +
Sbjct: 136 LA---ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
+ DV+S+GV E L G+ P K+ +V+ R+ P +
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY-----------KKMKGPEVMAFIEQGKRMECPPECPPE 241
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C + RP V Q
Sbjct: 242 LYALMS------DCWIYKWEDRPDFLTVEQRM 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 57/289 (19%)
Query: 291 KRKYKKPKLEERATNNIDVFSIWNYD--------GYGSVYKAQ-LPNGKVFALKKLHTSE 341
P +E +D S Y G+ ++ +VFA K + S
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 342 TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDA 401
+ + E + + H+++V +GF +F++ E +R SL LH A
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA 137
Query: 402 VELDWAKRVNIVKAMAHALAYLH-----H-DCSPS-----------IA----STCP--DS 438
+ A+ ++ + YLH H D I +T D
Sbjct: 138 LTEPEARY--YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
Query: 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI 498
+ +L GT YIAPE+ + + DV+S G + +L+GK P + +S K
Sbjct: 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKE 248
Query: 499 ML--IDVLDQRLPPPVD---RKVIRDILLASTISFACLQSNPKSRPTMQ 542
I + +P ++ +I+ + LQ++P +RPT+
Sbjct: 249 TYLRIKKNEYSIPKHINPVAASLIQKM----------LQTDPTARPTIN 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 8/115 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
NL+ L ++ +T + P + L+K+ L+LS N L + I L+++ L+
Sbjct: 58 GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLD 113
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ S + P L L+NL L L N+++ I P +AG+ NL +L + N +
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVG 182
N +K+ +T ++ + L + L G+T TI + L NLI L +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
N + + L +LT ++ L+LS N L + IAG++++ LDL++ I
Sbjct: 72 DNQITD--LAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ + L+ +T +I + L+ L L+L N +T + P + NL + EL
Sbjct: 36 TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELE 91
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ N L SA+ L ++ LDL+S +++ + P +AG+ NL L L N I
Sbjct: 92 LSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 30/115 (26%), Positives = 52/115 (45%), Gaps = 8/115 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ +L + L ++ I+ L ++ LDL+S +T + P + L NL L
Sbjct: 80 PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLY 135
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ N + S L LTNL L + + ++S + P +A + LT L +N I
Sbjct: 136 LDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 29/127 (22%), Positives = 55/127 (43%), Gaps = 9/127 (7%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ NL L+I ++ + P ++ LSKL L N ++ I P + +L NLIE++
Sbjct: 146 PLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVH 201
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+ +N + S L + +NL + L++ ++ P NL ++ I
Sbjct: 202 LKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVFY--NNNLVVPNVVKGPSGAPIAP 256
Query: 241 RLSPNKG 247
+ G
Sbjct: 257 ATISDNG 263
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 52/274 (18%), Positives = 94/274 (34%), Gaps = 71/274 (25%)
Query: 318 YGSVYKAQL----PNGKVF-ALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G+V+K + K+ +K + + A + + H +IV+L
Sbjct: 26 FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD----HMLAIGSLDHAHIVRLL 81
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA---YL 423
G C + L+ +Y+ GSL ++ + A+ L+W V I K M + L +
Sbjct: 82 GLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMYY-LEEHGMV 137
Query: 424 HHDCSPSIASTCPDSSN-----------RTLLAGTYGY-----------IAPELAYTMVM 461
H + + A S L +A E +
Sbjct: 138 HRNLA---ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 462 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-R 514
T + DV+S+GV E++ G P + L +V D RL P
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPY-----------AGLRLAEVPDLLEKGERLAQPQICT 243
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ +++ C + RPT + ++ EF
Sbjct: 244 IDVYMVMV------KCWMIDENIRPTFKELANEF 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/253 (18%), Positives = 83/253 (32%), Gaps = 54/253 (21%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375
YG V+K + +G+++A+K+ + E +V H V+L
Sbjct: 70 YGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
++L E SL + ++ ++ ALA+LH H D P
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVW--GYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSF 470
+ + + + G Y+APEL +Y DV+S
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG----TAADVFSL 241
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTIS 527
G+ LEV ++ LPP + +R +L+
Sbjct: 242 GLTILEVACNMELPHGGEGW-----QQLR-----QGYLPPEFTAGLSSELRSVLV----- 286
Query: 528 FACLQSNPKSRPT 540
L+ +PK R T
Sbjct: 287 -MMLEPDPKLRAT 298
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 3e-16
Identities = 55/271 (20%), Positives = 87/271 (32%), Gaps = 48/271 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY----- 370
G+G V + G+ A+K+ + + + + E Q++ ++ H N+V
Sbjct: 26 GFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 371 -GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----- 424
L EY + G L L+ E+ L ++ ++ AL YLH
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRII 143
Query: 425 H------------DCSPSI--------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
H I A T GT Y+APEL T
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 465 CDVYSFGVVTLEVLMGK-------HPRDLLSSLSSSSDPKIMLIDVLDQR------LPPP 511
D +SFG + E + G P + S+ I++ D L LP P
Sbjct: 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263
Query: 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
I L + L + + R T
Sbjct: 264 NHLSGILAGKLERWLQCM-LMWHQRQRGTDP 293
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 4e-16
Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 68/272 (25%)
Query: 318 YGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+GSV + ++ A+K L T + + ++ EAQ++ Q+ + IV+L G
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPYIVRLIGV 404
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
C + + L+ E G L L + E+ + ++ ++ + YL H +
Sbjct: 405 CQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 427 CSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTE 463
+ A + + L A Y APE +
Sbjct: 462 LA---ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
+ DV+S+GV E L G+ P K+ +V+ R+ P +
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPY-----------KKMKGPEVMAFIEQGKRMECPPECPPE 567
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C + RP V Q
Sbjct: 568 LYALMS------DCWIYKWEDRPDFLTVEQRM 593
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 54/270 (20%), Positives = 90/270 (33%), Gaps = 64/270 (23%)
Query: 318 YGSVYKAQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+G+V K KV A+K L +E + A EA V+ Q+ + IV++ G C
Sbjct: 30 FGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 88
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCS 428
+ L+ E + G L L N + + +V ++ + YL H D +
Sbjct: 89 -AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 429 PSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVMTEKC 465
A + + L A Y APE + K
Sbjct: 145 ---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 466 DVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIR 518
DV+SFGV+ E G+ P + +V R+ P + +
Sbjct: 202 DVWSFGVLMWEAFSYGQKPY-----------RGMKGSEVTAMLEKGERMGCPAGCPREMY 250
Query: 519 DILLASTISFACLQSNPKSRPTMQYVSQEF 548
D++ C + ++RP V
Sbjct: 251 DLMN------LCWTYDVENRPGFAAVELRL 274
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 24/129 (18%), Positives = 52/129 (40%), Gaps = 13/129 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNL 173
++ + P+L +L + +T + L+ L L LS N ++ + N
Sbjct: 182 NITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANT 239
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-------IAGMKNLTW 226
+L EL++ +N L+ +P L + + L +N +S I + +
Sbjct: 240 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 297
Query: 227 LDLSNNNIK 235
+ L +N ++
Sbjct: 298 VSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 8/127 (6%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
F NL L + ++ I P + L KL+ L LS N L +P ++ K L EL
Sbjct: 72 FKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELR 127
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
V N + S L + ++L +N L S I GMK L+++ +++ NI +I
Sbjct: 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 186
Query: 239 PVRLSPN 245
P L P+
Sbjct: 187 PQGLPPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 29/142 (20%), Positives = 62/142 (43%), Gaps = 20/142 (14%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
EL+L G N ++++++ + NL KL + F +++ ++ + L+ L L+
Sbjct: 196 ELHLDG-----N-KITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSL--IGP----IPSALGSLTNLSNLDLSSNKLS- 211
+N L +P + + K + + + +N++ IG P + S + L SN +
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307
Query: 212 GKIPPEI-AGMKNLTWLDLSNN 232
+I P + + L N
Sbjct: 308 WEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 20/120 (16%), Positives = 43/120 (35%), Gaps = 22/120 (18%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLS 158
+L LS N +S ++ N L + L +P ++ +Q++ L
Sbjct: 220 KLGLSF-----N-SISAVDNGSLANTPHL--RELHLNNNKLVKVPGGLADHKYIQVVYLH 271
Query: 159 SNGLTGTIPPE-------IGNLKNLIELNVGSNSL-IGPI-PSALGSLTNLSNLDLSSNK 209
+N ++ I + +++ SN + I PS + + + L + K
Sbjct: 272 NNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 29/84 (34%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
L+++ S GL +P ++ + + LDL +NK++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--------------------------PDTALLDLQNNKIT 65
Query: 212 GKIPPEI-AGMKNLTWLDLSNNNI 234
+I +KNL L L NN I
Sbjct: 66 -EIKDGDFKNLKNLHTLILINNKI 88
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 48/260 (18%), Positives = 83/260 (31%), Gaps = 50/260 (19%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG-FCLH 375
YG K + +GK+ K+L E A + +E +L ++ H NIV+ Y
Sbjct: 19 YGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77
Query: 376 RKCMFLIY-EYMKRGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--- 430
I EY + G L + ++ LD + ++ + AL H
Sbjct: 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137
Query: 431 ------------------------IASTC-PDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
+A D+S GT Y++PE M EK
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS 197
Query: 466 DVYSFGVVTLEVLMGKHP---RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522
D++S G + E+ P L + + + + + L
Sbjct: 198 DIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREGKFRRIPYRYSDE--L 244
Query: 523 ASTISFACLQSNPKSRPTMQ 542
I+ L RP+++
Sbjct: 245 NEIIT-RMLNLKDYHRPSVE 263
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 6/120 (5%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELN 180
P L L + L S+P L L +LD+S N LT ++P L L EL
Sbjct: 73 DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ N L P L L L L++N L+ ++P + G++NL L L N++ +IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 33/119 (27%), Positives = 52/119 (43%), Gaps = 9/119 (7%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELN 180
S + +++ LT ++PP++ +L LS N L T L +LN
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRLTQLN 61
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+ L + G+L L LDLS N+L +P + LT LD+S N + S+P
Sbjct: 62 LDRAEL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP 116
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 36/113 (31%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
P L L + F LT S+P L +LQ L L N L T+PP + L +L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232
++ +N+L L L NL L L N L IP G L + L N
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 51/291 (17%), Positives = 86/291 (29%), Gaps = 75/291 (25%)
Query: 318 YGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+G V++ + G A+KK L EEL + + IV LYG
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----------ACAGLSSPRIVPLYGAVR 120
Query: 375 HRKCMFLIYEYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH-----H 425
+ + E ++ GSL + ED + + L YLH H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-------LYYLGQALEGLEYLHTRRILH 173
Query: 426 -D---------------------CSPSIASTCPDSS--NRTLLAGTYGYIAPELAYTMVM 461
D + + S + GT ++APE +VM
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE----VVM 229
Query: 462 ----TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517
K D++S + L +L G HP + + L + I
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP------WTQYFRGPLCLKIASEPPPIRE-----I 278
Query: 518 RDILLASTISF--ACLQSNPKSRPT-MQYVSQEFLITRKTPLVKHAAIQDI 565
T L+ P R + M+ + ++ +K +
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 65/289 (22%), Positives = 106/289 (36%), Gaps = 72/289 (24%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+K KV A+K + E E+ I+ + E VLSQ + K YG L
Sbjct: 35 FGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKD 92
Query: 377 KCMFLIYEYMKRGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHALAYLHHD------- 426
+++I EY+ GS L +E + I++ + L YLH +
Sbjct: 93 TKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLHSEKKIHRDI 145
Query: 427 -------------------CSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
+ + T R GT ++APE+ K D+
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLIDVLDQRLPPPVDR----KVIRDIL 521
+S G+ +E+ G+ P S P + LI + PP K +++ +
Sbjct: 203 WSLGITAIELARGEPPH-------SELHPMKVLFLI----PKNNPPTLEGNYSKPLKEFV 251
Query: 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISISEL 570
ACL P RPT ++E L K + A + ++EL
Sbjct: 252 E------ACLNKEPSFRPT----AKELL---KHKFILRNAKKTSYLTEL 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 51/206 (24%), Positives = 76/206 (36%), Gaps = 46/206 (22%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTS----------ETEELAFIKSFRNEAQVLSQVLHRN 365
YG V + A+K + S F + NE +L + H N
Sbjct: 48 AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107
Query: 366 IVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH- 424
I+KL+ +K +L+ E+ + G LF + N E D A I+K + + YLH
Sbjct: 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGICYLHK 164
Query: 425 ----H-----------DCSPS---------IASTCPDSSNRTLLAGTYGYIAPEL---AY 457
H + + ++S GT YIAPE+ Y
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY 224
Query: 458 TMVMTEKCDVYSFGVVTLEVLMGKHP 483
EKCDV+S GV+ +L G P
Sbjct: 225 N----EKCDVWSCGVIMYILLCGYPP 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 52/277 (18%), Positives = 93/277 (33%), Gaps = 61/277 (22%)
Query: 318 YGSVYKAQLPN-----GKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G V G++ A+K L + + E +L + H +I+K
Sbjct: 44 FGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ----EIDILRTLYHEHIIKYK 99
Query: 371 GFCLHRKC--MFLIYEYMKRGSLFCNLHNNEDAVE--LDWAKRVNIVKAMA--HALAYLH 424
G C + L+ EY+ GSL L + + L +A I + MA HA Y+H
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMAYLHAQHYIH 157
Query: 425 HDCSPSIASTCPDSSN-----------RTLLAGTYGYI------------APELAYTMVM 461
D + A ++ + + G Y APE
Sbjct: 158 RDLA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF 214
Query: 462 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD---PKIMLIDVLD-----QRLPPPV 512
DV+SFGV E+L + + ++ ++ + + +RLP P
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD 274
Query: 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C ++ RPT + +
Sbjct: 275 KCPAEVYHLMK------NCWETEASFRPTFENLIPIL 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 6/121 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F NL+ L I I + LS L++L ++ N P+I L+NL L
Sbjct: 122 FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
++ L P+A SL++L L++S N + + +L LD S N+I +
Sbjct: 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TS 238
Query: 239 P 239
Sbjct: 239 K 239
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 9/120 (7%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLT--GTIPPEIGNLKNLIELNV 181
+ +L ++ L S+P + L++L L LSSNGL+ G +L L++
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA--GMKNLTWLDLSNNNIKGSIP 239
N +I + S L L +LD + L ++ ++NL +LD+S+ + +
Sbjct: 86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAF 142
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 28/126 (22%), Positives = 47/126 (37%), Gaps = 9/126 (7%)
Query: 116 RLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI- 170
F +L L + + + P+I + L L LDLS L + P
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI--AGMKNLTWLD 228
+L +L LN+ N+ L +L LD S N + + +L +L+
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLN 254
Query: 229 LSNNNI 234
L+ N+
Sbjct: 255 LTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 32/106 (30%), Positives = 45/106 (42%), Gaps = 17/106 (16%)
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
+ +S GLT ++P I + L + SN L LT L+ L LSSN LS K
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 215 PPEIA--GMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPS 258
+ G +L +LDLS N + ++ NFL L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMS-----------SNFLGLEQ 102
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 13/115 (11%)
Query: 103 ELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
L ++G N F+ NL L + L + P ++LS LQ+L++S
Sbjct: 154 VLKMAG-----NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 159 SNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSL-TNLSNLDLSSNKLS 211
N ++ L +L L+ N ++ L ++L+ L+L+ N +
Sbjct: 208 HNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/252 (20%), Positives = 88/252 (34%), Gaps = 45/252 (17%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G G VY+A+ ++ ALK + + + + F + EA+ ++ ++V ++ F
Sbjct: 46 GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
+++ + L L L + V IV+ + AL H H D P
Sbjct: 106 DGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKP 162
Query: 430 S----------------IASTCPDSS-NRT-LLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
IAS D + GT Y+APE T + D+Y+
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 472 VVTLEVLMGKHP--RDLLSSLSS--SSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
V E L G P D LS + + + + +P D + R
Sbjct: 223 CVLYECLTGSPPYQGDQLSVMGAHINQAIP--RPSTVRPGIPVAFDAVIAR--------- 271
Query: 528 FACLQSNPKSRP 539
+ NP+ R
Sbjct: 272 --GMAKNPEDRY 281
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 64/272 (23%), Positives = 95/272 (34%), Gaps = 69/272 (25%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V++ P A+K TS++ F++ EA + Q H +IVKL G
Sbjct: 28 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ----EALTMRQFDHPHIVKLIG 83
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HH 425
+++I E G L L + LD A + ++ ALAYL H
Sbjct: 84 VIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 426 DCSPSIASTCPDSSN-----------RTLLAGTYGYI-----------APELAYTMVMTE 463
D + A SSN R + TY Y APE T
Sbjct: 141 DIA---ARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTS 196
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
DV+ FGV E+LM G P + DV+ + RLP P +
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPF-----------QGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C +P RP + +
Sbjct: 246 LYSLMT------KCWAYDPSRRPRFTELKAQL 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 57/255 (22%), Positives = 100/255 (39%), Gaps = 49/255 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+ ++ +VFA K + S + + E + + H+++V +GF
Sbjct: 27 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
+F++ E +R SL LH A+ A+ ++ + YLH H D
Sbjct: 87 NDFVFVVLELCRRRSLL-ELHKRRKALTEPEARY--YLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 430 S-----------IA----STCP--DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
I +T D + +L GT YIAPE+ + + DV+S G
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 203
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPP---PVDRKVIRDILLASTIS 527
+ +L+GK P + +S K I + +P PV +I+ +
Sbjct: 204 IMYTLLVGKPPFE-------TSCLKETYLRIKKNEYSIPKHINPVAASLIQKM------- 249
Query: 528 FACLQSNPKSRPTMQ 542
LQ++P +RPT+
Sbjct: 250 ---LQTDPTARPTIN 261
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 56/272 (20%), Positives = 96/272 (35%), Gaps = 69/272 (25%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G VY+ G+ A+K + + F+ EA ++ + H +IVKL G
Sbjct: 25 FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----EAVIMKNLDHPHIVKLIG 80
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAH--ALAYLHH 425
+ ++I E G L L N+++++ + ++ + I KAMA+ ++ +H
Sbjct: 81 IIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAMAYLESINCVHR 137
Query: 426 DCSPSIASTCPDSSN-----------RTLLAGTYGYI-----------APELAYTMVMTE 463
D + +S R + Y Y +PE T
Sbjct: 138 DIA---VRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTT 193
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
DV+ F V E+L GK P L + DV+ RLP P V
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENK-----------DVIGVLEKGDRLPKPDLCPPV 242
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C +P RP +
Sbjct: 243 LYTLMT------RCWDYDPSDRPRFTELVCSL 268
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 2e-15
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 4/92 (4%)
Query: 144 PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203
+ L + LDLS N L +PP + L+ L L N+L + + +L L L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQEL 513
Query: 204 DLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNI 234
L +N+L + L L+L N++
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 4e-14
Identities = 26/120 (21%), Positives = 43/120 (35%), Gaps = 5/120 (4%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
S L L + +++L L+ LT + + L
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLL 464
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ L++ N L +P AL +L L L S N L + +A + L L L NN ++
Sbjct: 465 VTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 6/111 (5%)
Query: 116 RLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLK 174
L+ L + + L + L ++PP ++AL L++L S N L + + NL
Sbjct: 452 DLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLP 508
Query: 175 NLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL 224
L EL + +N L L S L L+L N L + + +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 25/130 (19%), Positives = 51/130 (39%), Gaps = 13/130 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPE--ISALSKLQLLD--------LSSNGLTGT 165
L +L L+ + + AL + + + S L+ +D +
Sbjct: 373 ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLE 432
Query: 166 IPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLT 225
++ L++ L + L L +++LDLS N+L +PP +A ++ L
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489
Query: 226 WLDLSNNNIK 235
L S+N ++
Sbjct: 490 VLQASDNALE 499
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 40/204 (19%), Positives = 72/204 (35%), Gaps = 39/204 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF--C 373
+V++ + G +FA+K + + E +VL ++ H+NIVKL+
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H--- 425
+ LI E+ GSL+ L +A L ++ + +++ + + +L H
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 426 -----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPELAYTMVM------ 461
D A D L GT Y+ P++ V+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198
Query: 462 --TEKCDVYSFGVVTLEVLMGKHP 483
D++S GV G P
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 65/272 (23%), Positives = 97/272 (35%), Gaps = 69/272 (25%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V++ P A+K TS++ F++ EA + Q H +IVKL G
Sbjct: 403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ----EALTMRQFDHPHIVKLIG 458
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HH 425
+++I E G L L + LD A + ++ ALAYL H
Sbjct: 459 VIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 426 DCSPSIAST-CPDSSN-----------RTLLAGTY-----GYI-----APELAYTMVMTE 463
D IA+ SSN R + TY G + APE T
Sbjct: 516 D----IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 516
DV+ FGV E+LM G P + DV+ + RLP P +
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPF-----------QGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C +P RP + +
Sbjct: 621 LYSLMT------KCWAYDPSRRPRFTELKAQL 646
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 52/263 (19%), Positives = 85/263 (32%), Gaps = 62/263 (23%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G VY L +GK A+K L+ + F E ++ H N++ L G C
Sbjct: 102 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGIC 159
Query: 374 LHRKC-MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
L + ++ YMK G L + N + +A + +L H D
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217
Query: 427 -----CSPSIASTC-----------PDSSNRTLLAGTYGYI-----APELAYTMVMTEKC 465
C T D ++ T + A E T T K
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 277
Query: 466 DVYSFGVVTLEVLM-------GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVI 517
DV+SFGV+ E++ + D+ L +RL P +
Sbjct: 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRLLQPEYCPDPL 325
Query: 518 RDILLASTISFACLQSNPKSRPT 540
+++L C + RP+
Sbjct: 326 YEVML------KCWHPKAEMRPS 342
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 74/277 (26%)
Query: 318 YGSVYKAQLPNG-----KVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G VY + + + A+K L T + AF++ E ++ + H N++ L
Sbjct: 34 FGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLR----EGLLMRGLNHPNVLALI 88
Query: 371 GFCLHRKCM-FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------ 423
G L + + ++ YM G L + + + ++ +A + YL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 424 HHDCSPSIASTCPDSSNRTL------LA-------------GTYGYI-----APELAYTM 459
H D + A C + T+ LA + + A E T
Sbjct: 147 HRDLA---ARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 460 VMTEKCDVYSFGVVTLEVLM-------GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512
T K DV+SFGV+ E+L P DL L+ +RLP P
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------------GRRLPQPE 251
Query: 513 D-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ ++ C +++P RPT + + E
Sbjct: 252 YCPDSLYQVMQ------QCWEADPAVRPTFRVLVGEV 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 39/268 (14%), Positives = 83/268 (30%), Gaps = 63/268 (23%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375
+GSV+K +G ++A+K+ ++ E + + H ++V+ +
Sbjct: 24 FGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82
Query: 376 RKCMFLIYEYMKRGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLH---------- 424
M + EY GSL + N A+ +++ + L Y+H
Sbjct: 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK 142
Query: 425 -------HDCSPSIASTCPDS---------------------SNRTLLAGTYGYIAPE-L 455
P+ AS D S+ + G ++A E L
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVL 202
Query: 456 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR- 514
K D+++ + + + +I Q P + +
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-----EIR------QGRLPRIPQV 251
Query: 515 --KVIRDILLASTISFACLQSNPKSRPT 540
+ ++L + +P+ RP+
Sbjct: 252 LSQEFTELLK------VMIHPDPERRPS 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 55/274 (20%), Positives = 88/274 (32%), Gaps = 68/274 (24%)
Query: 318 YGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G VY L +GK A+K L+ + F E ++ H N++ L G C
Sbjct: 38 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGIC 95
Query: 374 LHRKC-MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
L + ++ YMK G L + N + +A + YL H D
Sbjct: 96 LRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153
Query: 427 CSPSIASTCPDSSNRTL------LA-------------GTYGYI-----APELAYTMVMT 462
+ A C T+ LA T + A E T T
Sbjct: 154 LA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 463 EKCDVYSFGVVTLEVLM-------GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-R 514
K DV+SFGV+ E++ + D+ L +RL P
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRLLQPEYCP 258
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ +++L C + RP+ +
Sbjct: 259 DPLYEVML------KCWHPKAEMRPSFSELVSRI 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 58/285 (20%), Positives = 101/285 (35%), Gaps = 81/285 (28%)
Query: 318 YGSVYKAQLPNGKVF---ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYG 371
+G V KA++ + A+K++ + S+ + F E +VL ++ H NI+ L G
Sbjct: 38 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLCKLGHHPNIINLLG 93
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN-----------------IVK 414
C HR ++L EY G+L L + N + +
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 415 AMAHALA---YLHHDCSPSIASTCPDSSNRTL--------------LAGTYGYI-----A 452
M + L+ ++H D + A N + T G + A
Sbjct: 154 GMDY-LSQKQFIHRDLA---ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 209
Query: 453 PE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPKIMLIDVL 504
E L Y+ V T DV+S+GV+ E++ +G P +L L
Sbjct: 210 IESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------------ 256
Query: 505 DQRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
RL P++ + D++ C + P RP+ +
Sbjct: 257 GYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 63/284 (22%), Positives = 99/284 (34%), Gaps = 80/284 (28%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368
+G VY+ Q+ +V A+K L SE +EL F+ EA ++S+ H+NIV+
Sbjct: 43 FGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLM----EALIISKFNHQNIVR 97
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHALAYL- 423
G L F++ E M G L F L +++ + +A YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 424 -----HHDCSPSIAS----TCPDSSNRTL------LA-----------GTYGYI-----A 452
H D IA+ R +A G +
Sbjct: 158 ENHFIHRD----IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 453 PE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ---- 506
PE + T K D +SFGV+ E+ +G P P +VL+
Sbjct: 214 PEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEVLEFVTSG 261
Query: 507 -RLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
R+ PP + + I+ C Q P+ RP + +
Sbjct: 262 GRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 15/142 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
EL+L N + + F P+L++L + I L L+ L+L
Sbjct: 151 ELWLRN-----N-PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE- 217
+ P + L L EL + N P + L++L L + ++++S I
Sbjct: 205 MCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNA 261
Query: 218 IAGMKNLTWLDLSNNNIKGSIP 239
G+ +L L+L++NN+ S+P
Sbjct: 262 FDGLASLVELNLAHNNLS-SLP 282
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 18/138 (13%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNV 181
SC K+ L+ +P I + + L+L N + I + +L +L L +
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQL 106
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPV 240
G NS+ A L +L+ L+L N L+ IP + L L L NN I+ SIP
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIP- 163
Query: 241 RLSPNKGLCGGNFLDLPS 258
F +PS
Sbjct: 164 ---------SYAFNRVPS 172
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 26/112 (23%), Positives = 39/112 (34%), Gaps = 6/112 (5%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVG 182
N L + + I + L L++L L N + I L +L L +
Sbjct: 74 PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELF 131
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNN 233
N L A L+ L L L +N + IP + +L LDL
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 14/135 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
L L +L ++ F NL L + + +P ++ L L+ L++S
Sbjct: 175 RLDLGEL----K-KLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 160 NGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N I P L +L +L V ++ + +A L +L L+L+ N LS +P ++
Sbjct: 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 219 -AGMKNLTWLDLSNN 232
++ L L L +N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 34/115 (29%), Positives = 46/115 (40%), Gaps = 7/115 (6%)
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNS 185
L L I LT IP + L L L N + I E L L +G N
Sbjct: 173 KLNYLRISEAKLT-GIPKD--LPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240
+ +L L L L L +NKLS ++P + +K L + L NNI + V
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV 281
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 13/129 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNL 173
+L+ + L +L + + +I E SKL L L N + I L
Sbjct: 183 KLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFL 240
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-------AGMKNLTW 226
L EL++ +N L +P+ L L L + L +N ++ K+
Sbjct: 241 PTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 227 LDLSNNNIK 235
+ L NN +
Sbjct: 299 ISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 20/142 (14%)
Query: 103 ELYLSGYYAGFN--WRLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSS 159
EL+L N + + + L +L + + I S L L+ L L +
Sbjct: 197 ELHLDH-----NKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDN 250
Query: 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS-------ALGSLTNLSNLDLSSNKLS- 211
N L+ +P + +LK L + + +N+ I + + + L +N +
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308
Query: 212 GKIPPEI-AGMKNLTWLDLSNN 232
++ P + + + N
Sbjct: 309 WEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 25/117 (21%), Positives = 55/117 (47%), Gaps = 9/117 (7%)
Query: 124 CFPNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNV 181
P+ L +Q ++ + + L L L L +N ++ I + L+ L +L +
Sbjct: 52 ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYI 109
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGS 237
N L+ IP ++L L + N++ K+P + +G++N+ +++ N ++ S
Sbjct: 110 SKNHLVE-IPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 18/119 (15%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
++P EIS LLDL +N ++ + + L++L L + +N + A L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPS 258
L L +S N L +IPP + +L L + +N I+ +P G F L +
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVP----------KGVFSGLRN 148
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 17/119 (14%), Positives = 42/119 (35%), Gaps = 20/119 (16%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
L L + ++ + P L +L + L+ +P + L LQ++ L +
Sbjct: 221 RLGLG------HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 160 NGLTGTIPPEI-------GNLKNLIELNVGSNSL-IGPI-PSALGSLTNLSNLDLSSNK 209
N +T + +++ +N + + P+ +T+ + + K
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 19/84 (22%), Positives = 33/84 (39%), Gaps = 29/84 (34%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
L+++ S GL +P EI + + LDL +N +S
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--------------------------PDTTLLDLQNNDIS 67
Query: 212 GKIPPE-IAGMKNLTWLDLSNNNI 234
++ + G+++L L L NN I
Sbjct: 68 -ELRKDDFKGLQHLYALVLVNNKI 90
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 40/204 (19%), Positives = 72/204 (35%), Gaps = 39/204 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF--C 373
+V++ + G +FA+K + + E +VL ++ H+NIVKL+
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H--- 425
+ LI E+ GSL+ L +A L ++ + +++ + + +L H
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 426 -----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPELAYTMVM------ 461
D A D L GT Y+ P++ V+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198
Query: 462 --TEKCDVYSFGVVTLEVLMGKHP 483
D++S GV G P
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 41/172 (23%), Positives = 66/172 (38%), Gaps = 38/172 (22%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL-------- 154
EL L+ LS L + P + L I AL S+P ++L L
Sbjct: 63 ELQLNR-----L-NLSSLPDNLPPQITVLEITQNALI-SLPELPASLEYLDACDNRLSTL 115
Query: 155 ---------LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
LD+ +N LT +P L+ +N +N L +P T+L L +
Sbjct: 116 PELPASLKHLDVDNNQLT-MLPELPALLE---YINADNNQLTM-LPE---LPTSLEVLSV 167
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL-CGGNFLDL 256
+N+L+ +P ++L LD+S N ++ S+P N F
Sbjct: 168 RNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 31/159 (19%)
Query: 122 FSCFPNLVKLTIQFFALTG--SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
FS + K + S+ E +++ L L+ L+ ++P + + L
Sbjct: 30 FSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLS-SLPDNLP--PQITVL 85
Query: 180 NVGSNSLIGPIPSALGSLT-----------------NLSNLDLSSNKLSGKIPPEIAGMK 222
+ N+LI +P SL +L +LD+ +N+L+ +P A
Sbjct: 86 EITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLT-MLPELPA--- 140
Query: 223 NLTWLDLSNNNIKGSIPVRLSPNKGL-CGGNFL-DLPSC 259
L +++ NN + +P + + L N L LP
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPEL 178
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 19/122 (15%), Positives = 33/122 (27%), Gaps = 10/122 (8%)
Query: 116 RLSQLNFSCFP----NLVKLTIQFFALTGSIPPEISALSKLQ----LLDLSSNGLTGTIP 167
+ + P +L L + L S+P + N +T IP
Sbjct: 166 SVRNNQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223
Query: 168 PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWL 227
I +L + + N L I +L T + S + + L
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADA 283
Query: 228 DL 229
Sbjct: 284 VT 285
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 15/82 (18%), Positives = 28/82 (34%), Gaps = 3/82 (3%)
Query: 165 TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP-PEIAGMKN 223
+I I N +L N N++ G + L + + + +
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 224 LTWLDLSNNNIKGSIPVRLSPN 245
+ L L+ N+ S+P L P
Sbjct: 61 FSELQLNRLNLS-SLPDNLPPQ 81
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 64/291 (21%), Positives = 101/291 (34%), Gaps = 80/291 (27%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368
+G VY+ Q+ +V A+K L SE +EL F+ EA ++S+ H+NIV+
Sbjct: 84 FGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFL----MEALIISKFNHQNIVR 138
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHALAYL- 423
G L F++ E M G L F L +++ + +A YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 424 -----HHDCSPSIAS----TCPDSSNRTL------LA-----------GTYGYI-----A 452
H D IA+ R +A G +
Sbjct: 199 ENHFIHRD----IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 453 PE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ---- 506
PE + T K D +SFGV+ E+ +G P P +VL+
Sbjct: 255 PEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEVLEFVTSG 302
Query: 507 -RLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
R+ PP + + I+ C Q P+ RP + + + P
Sbjct: 303 GRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 60/282 (21%), Positives = 100/282 (35%), Gaps = 76/282 (26%)
Query: 318 YGSVYKAQL-------PNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368
+G VY+ P +V A+K + S E + F+ EA V+ + ++V+
Sbjct: 38 FGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLN----EASVMKEFNCHHVVR 92
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL--F-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 421
L G + +I E M RG L + + NN +K + + +A +A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 422 YL------HHDCSPSIASTCPDSSNRTL------LA-----------GTYGYI-----AP 453
YL H D + A C + + T+ + G G + +P
Sbjct: 153 YLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 454 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----R 507
E V T DV+SFGVV E+ + P + VL
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----------QGLSNEQVLRFVMEGGL 258
Query: 508 LPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
L P + ++ +++ C Q NPK RP+ +
Sbjct: 259 LDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSI 294
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 44/299 (14%), Positives = 94/299 (31%), Gaps = 83/299 (27%)
Query: 316 DGYGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+ +V A+ P G+ +++ L E + F+ + E V H NIV
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL---QGELHVSKLFNHPNIVPYRAT 94
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------- 425
+ ++++ +M GS +L ++ I++ + AL Y+HH
Sbjct: 95 FIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRS 153
Query: 426 -----------------DCSPSIASTCPDSSNRTLLAGTYGYI------APELAYTMVMT 462
+++ R + + +PE V+
Sbjct: 154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-----VLQ 208
Query: 463 E-------KCDVYSFGVVTLEVLMGK------HPRDLLSSLSSSSDPKIMLIDVLDQRLP 509
+ K D+YS G+ E+ G +L + + P ++ +
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268
Query: 510 PPVDRKVIRDILLASTISFA----------------------------CLQSNPKSRPT 540
+ + + L+ +++ + CLQ NP +RP+
Sbjct: 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 6/136 (4%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTG--SIP-PEISALSKLQLLDLSSNGLTGTIPPEIGN 172
+ + I+ F ++G + S +S LD S+N LT T+ G+
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 173 LKNLIELNVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDL 229
L L L + N L + I + +L LD+S N +S + K+L L++
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 230 SNNNIKGSIPVRLSPN 245
S+N + +I L P
Sbjct: 407 SSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 43/230 (18%), Positives = 76/230 (33%), Gaps = 6/230 (2%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSN 184
L I ++ +I +LSKL++L +S N + + + + L L++ N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
L I NL +LDLS N + I E M L +L LS +++ S + ++
Sbjct: 80 KL-VKISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 244 PNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEERA 303
L + P L L IV +L LE
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 353
+ + +Y P L + T+ + ++ +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 33/130 (25%), Positives = 57/130 (43%), Gaps = 10/130 (7%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTG--SIPPEISA---LSKLQLLDLSSNGLTGTIPPEI 170
L+ F +L +L + + + LQ LD+S N ++
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 171 -GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDL 229
K+L+ LN+ SN L I L + LDL SNK+ IP ++ ++ L L++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451
Query: 230 SNNNIKGSIP 239
++N +K S+P
Sbjct: 452 ASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 25/165 (15%), Positives = 55/165 (33%), Gaps = 6/165 (3%)
Query: 80 SSFWTTDHCKWEGITCNSAGSIFELYLSG--YYAGFNWRLSQLNFSCFPNLVKLTIQFFA 137
++ TT + + +++ +S ++R + + L +
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 138 LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSL 197
S + + + + +G + + L+ +N L + G L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 198 TNLSNLDLSSNKLSGKIPPEI---AGMKNLTWLDLSNNNIKGSIP 239
T L L L N+L ++ MK+L LD+S N++
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 6/99 (6%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
+P ++S K +L++S N ++ +I +L L L + N + S L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
LDLS NKL KI NL LDLS N ++P
Sbjct: 72 EYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALP 106
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 16/150 (10%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLT---IQFFALTGSIPPEI-SALSKLQLL 155
L +S N +S+L S +L KL I + + + +L+ L
Sbjct: 22 KTTILNIS-----QN-YISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYL 74
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKI 214
DLS N L I NL L++ N+ PI G+++ L L LS+ L
Sbjct: 75 DLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 215 PPEIAGMKNLT-WLDLSNNNIKGSIPVRLS 243
IA + L L + P L
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 15/142 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
EL+L N + + F P+L +L + I LS L+ L+L+
Sbjct: 140 ELWLRN-----N-PIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE- 217
L IP + L L EL++ N L P + L +L L + +++ I
Sbjct: 194 MCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNA 250
Query: 218 IAGMKNLTWLDLSNNNIKGSIP 239
+++L ++L++NN+ +P
Sbjct: 251 FDNLQSLVEINLAHNNLT-LLP 271
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 38/139 (27%), Positives = 55/139 (39%), Gaps = 18/139 (12%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELN 180
SC K+ L +P IS +LL+L N + I +L++L L
Sbjct: 39 CSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQ 94
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ N + A L NL+ L+L N+L+ IP + L L L NN I+ SIP
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIP 152
Query: 240 VRLSPNKGLCGGNFLDLPS 258
F +PS
Sbjct: 153 ----------SYAFNRIPS 161
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 29/112 (25%), Positives = 40/112 (35%), Gaps = 6/112 (5%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVG 182
N L + + I L L++L LS N + TI L NL L +
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELF 120
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNN 233
N L A L+ L L L +N + IP + +L LDL
Sbjct: 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 103 ELYLSGYYAGFNWRLSQLN---FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159
L L RLS ++ F NL L + L IP ++ L KL LDLS
Sbjct: 164 RLDLGEL----K-RLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 160 NGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
N L+ I P L +L +L + + + +A +L +L ++L+ N L+ +P ++
Sbjct: 217 NHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 219 -AGMKNLTWLDLSNN 232
+ +L + L +N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 72/269 (26%)
Query: 317 GYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY--GF 372
G V+ A+ + V A+K L + +F FR EAQ + + H IV +Y G
Sbjct: 24 GMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82
Query: 373 --CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H 425
+++ EY+ +L +H + + + ++ AL + H H
Sbjct: 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIH 139
Query: 426 -DCSPS----------------IASTCPDSSNRT----LLAGTYGYIAPELAYTMVMTEK 464
D P+ IA DS N + GT Y++PE A + +
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 465 CDVYSFGVVTLEVLMG--------------KHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510
DVYS G V EVL G +H R+ S+ + L
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-----------RHEGLSA 248
Query: 511 PVDRKVIRDILLASTISFACLQSNPKSRP 539
+D V++ L NP++R
Sbjct: 249 DLDAVVLK-----------ALAKNPENRY 266
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 31/115 (26%), Positives = 51/115 (44%), Gaps = 8/115 (6%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
PN+ KL + LT I P ++ L L L L N + + + +LK L L+
Sbjct: 63 GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLS 118
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ N + + L L L +L L +NK++ I ++ + L L L +N I
Sbjct: 119 LEHNGIS--DINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 26/117 (22%), Positives = 53/117 (45%), Gaps = 12/117 (10%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ F +K ++ ++T ++ + L+ + + +++ + ++ I L N+ +L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLF 74
Query: 181 VGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ N L I P L +L NL L L NK+ + + +K L L L +N I
Sbjct: 75 LNGNKLTDIKP----LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 19/145 (13%)
Query: 103 ELYLSGYYAGFNWRLSQL-NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG 161
L+L ++ L + L L+++ ++ I + L +L+ L L +N
Sbjct: 94 WLFLD------ENKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNK 145
Query: 162 LTGTIPPEIGNLKNLIELNVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219
+T I + L L L++ N + I L LT L NL LS N +S + +A
Sbjct: 146 IT-DITV-LSRLTKLDTLSLEDNQISDI----VPLAGLTKLQNLYLSKNHIS-DLRA-LA 197
Query: 220 GMKNLTWLDLSNNNIKGSIPVRLSP 244
G+KNL L+L + S
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSN 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 6/114 (5%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
P L L + +T I +S L+KL L L N ++ I P + L L L
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ N + AL L NL L+L S + K + + + ++ ++
Sbjct: 185 LSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 54/290 (18%), Positives = 95/290 (32%), Gaps = 70/290 (24%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCL 374
G+ VY+AQ + +G+ +ALK+L ++E E+ ++ E + ++ H NIV+
Sbjct: 40 GFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 375 HRK-------CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 427
K FL+ + +G L L E L + I A+ ++H
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-Q 155
Query: 428 SPSIA-----------------------STCPDSSNRTLLA---------------GTYG 449
P I S S T
Sbjct: 156 KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215
Query: 450 YIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506
Y PE+ + EK D+++ G + + +HP + D + I
Sbjct: 216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---------DGAKLRIVNGKY 266
Query: 507 RLPPPVDR-KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
+PP + V ++ A LQ NP+ R ++ V +
Sbjct: 267 SIPPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 58/283 (20%), Positives = 101/283 (35%), Gaps = 77/283 (27%)
Query: 318 YGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+GSV +AQL V LK + ++ F++ EA + + H ++ KL
Sbjct: 36 FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR----EAACMKEFDHPHVAKLV 91
Query: 371 GFCL------HRKCMFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALA 421
G L +I +MK G L L + E+ L V + +A +
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 422 YL------HHDCSPSIAS-TCPDSSNRTL------LA-----------GTYGYI-----A 452
YL H D +A+ C + + T+ L+ G + A
Sbjct: 152 YLSSRNFIHRD----LAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 453 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ----- 506
E + T DV++FGV E++ G+ P I ++ +
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-----------AGIENAEIYNYLIGGN 256
Query: 507 RLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
RL P + + + D++ C ++PK RP+ + E
Sbjct: 257 RLKQPPECMEEVYDLMY------QCWSADPKQRPSFTCLRMEL 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 37/186 (19%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V K + +A+K ++ + + + E ++L ++ H NI+KL+
Sbjct: 35 FGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDS 93
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSPS 430
+++ E G LF + + E D A+ I+K + + Y+H H D P
Sbjct: 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHNIVHRDLKPE 150
Query: 431 ---IASTCPDSS--------------NRTL--LAGTYGYIAPEL---AYTMVMTEKCDVY 468
+ S D N + GT YIAPE+ Y EKCDV+
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY----DEKCDVW 206
Query: 469 SFGVVT 474
S GV+
Sbjct: 207 SAGVIL 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 318 YGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ V K + G +A K K + + + E +L QVLH NI+ L+
Sbjct: 25 FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--------- 424
+R + LI E + G LF L E E + + +K + + YLH
Sbjct: 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTKKIAHFDL 141
Query: 425 ----------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
+ P I A D + GT ++APE + Y + + D
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEAD 200
Query: 467 VYSFGVVT 474
++S GV+T
Sbjct: 201 MWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 36/192 (18%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V++ + G+VF K ++T + + +NE +++Q+ H ++ L+ +
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------------ 424
M LI E++ G LF + + ++ A+ +N ++ L ++H
Sbjct: 121 YEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 425 -----HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFG 471
+ S+ A+ + T + APE + V D+++ G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIG 237
Query: 472 VVTLEVLMGKHP 483
V+ +L G P
Sbjct: 238 VLGYVLLSGLSP 249
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 48/190 (25%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
VY+ Q K +ALK L + ++ R E VL ++ H NI+KL
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAV-------ELDWAKRVNIVKAMAHALAYLH----- 424
+ L+ E + G LF D + E D A VK + A+AYLH
Sbjct: 121 TEISLVLELVTGGELF-------DRIVEKGYYSERDAAD---AVKQILEAVAYLHENGIV 170
Query: 425 H-D--------CSPS-----------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
H D +P+ ++ + GT GY APE+ +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 465 CDVYSFGVVT 474
D++S G++T
Sbjct: 231 VDMWSVGIIT 240
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 15/135 (11%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALT---------GSIPPEI-SALSKLQLLDLSSNGLTGTI 166
NF N ++ + ++ + S + L+ L L+ N + I
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 167 PPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNL 224
L +L++LN+ N L +L L LDLS N + + + G+ NL
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNL 373
Query: 225 TWLDLSNNNIKGSIP 239
L L N +K S+P
Sbjct: 374 KELALDTNQLK-SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 19/156 (12%)
Query: 126 PNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGS 183
++ + + ++ + S L LQ L + I L +LI L +
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 184 NSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEI-AGMKNLTWLDLSNNNIKGSIP-- 239
N + A L NL L L+ L + + +L L L +NNIK P
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 240 ----------VRLSPNK--GLCGGNFLDLPSCDTTK 263
+ L+ NK +C + L+ T
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 11/101 (10%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPS-ALGSLT 198
+P + +DLS N + + L++L L V + I + L+
Sbjct: 27 ELPAHV------NYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 199 NLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
+L L L N+ ++ G+ NL L L+ N+ G++
Sbjct: 80 SLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 39/180 (21%), Positives = 75/180 (41%), Gaps = 18/180 (10%)
Query: 60 SALSPIQLEKKALINTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQ 119
+ + + L + + + +++F D+ ++G+ + + LS + ++
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG---VKTCDLSK-----S-KIFA 289
Query: 120 LN---FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLK 174
L FS F +L +LT+ + I L+ L L+LS N L +I + NL
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 175 NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNN 233
L L++ N + + L NL L L +N+L +P I + +L + L N
Sbjct: 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 35/170 (20%), Positives = 56/170 (32%), Gaps = 33/170 (19%)
Query: 122 FSCFPNLVKLTIQFFALTGS-IPPEI-SALSKLQLLDLSSNGLTGTIPPEI--GNLKNLI 177
F+ NL LT+ L G+ + L+ L++L L N + I P N++
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFH 157
Query: 178 ELNVGSNSLIGPIPSALGSLT--NLSNLDLSSNKL--------SGKIPPEIAGMKNLTWL 227
L++ N + L + + + L LSS L + ++T L
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 228 DLSNNNIKGSIPVRLS------------------PNKGLCGGNFLDLPSC 259
DLS N K S+ R NF D +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 56/269 (20%), Positives = 109/269 (40%), Gaps = 51/269 (18%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G+VY A + G+ A+++++ + + I NE V+ + + NIV L
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSYLVG 89
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------SP 429
++++ EY+ GSL + +D + + + AL +LH + S
Sbjct: 90 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 430 SI----------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
+I A P+ S R+ + GT ++APE+ K D++S G++
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF--ACL 531
+E++ G+ P + L + + LI P + + L A F CL
Sbjct: 206 AIEMIEGEPPYLNENPLRA-----LYLI----ATNGTPELQN--PEKLSAIFRDFLNRCL 254
Query: 532 QSNPKSRPTMQYVSQEFLITRKTPLVKHA 560
+ + + R + ++E L + +K A
Sbjct: 255 EMDVEKRGS----AKELL---QHQFLKIA 276
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 37/287 (12%), Positives = 74/287 (25%), Gaps = 78/287 (27%)
Query: 317 GYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--------------- 360
+ +A G+ F + + +E IK + E L
Sbjct: 90 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149
Query: 361 -------VLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAV--------ELD 405
V K+ L + M+++ + + NL + + L
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 406 WAKRVNIVKAMAHALAYLHH------DCSPS----------------IASTCPDSSNRTL 443
R+ + + LA LHH P +S +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSP 268
Query: 444 LAGTYG---YIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 495
+ + A + +MT D ++ G+ + P ++L
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG--- 325
Query: 496 PKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
I + +P PV R ++ L+ + R
Sbjct: 326 --SEWIFRSCKNIPQPV-RALLE----------GFLRYPKEDRLLPL 359
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 33/194 (17%), Positives = 67/194 (34%), Gaps = 44/194 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTS--ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
+ V + G+ FA+K + + + + + EA + + H +IV+L
Sbjct: 37 FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV-------NIVKAMAHALAYLH--- 424
+++++E+M L + V+ A V + ++ + AL Y H
Sbjct: 97 SDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 425 --H--------------DCSP--------SIASTCPDSSNRTLLAGTYGYIAPELAYTMV 460
H + +P +I GT ++APE+
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVKREP 209
Query: 461 MTEKCDVYSFGVVT 474
+ DV+ GV+
Sbjct: 210 YGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 41/197 (20%), Positives = 72/197 (36%), Gaps = 42/197 (21%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V++ + G FA K + T + ++ R E Q +S + H +V L+
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 377 KCMFLIYEYMKRGSLFCNL-----HNNEDAVELDWAKRVNIVKAMAHALAYLH------- 424
M +IYE+M G LF + +ED V ++ + L ++H
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------VEYMRQVCKGLCHMHENNYVHL 279
Query: 425 ----------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
S + + + + GT + APE V D
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTD 338
Query: 467 VYSFGVVTLEVLMGKHP 483
++S GV++ +L G P
Sbjct: 339 MWSVGVLSYILLSGLSP 355
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 31/119 (26%), Positives = 42/119 (35%), Gaps = 8/119 (6%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI--SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNV 181
L + L+ + E + L+ L L LS N L I E + NL L++
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL 95
Query: 182 GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
SN L L L L L +N + + M L L LS N I P
Sbjct: 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 13/121 (10%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI--GNLKNLIELN 180
C N++ + Q L ++P + + LLDLS N L+ + E L NL L
Sbjct: 17 LCASNILSCSKQ--QLP-NVPQSLPSY--TALLDLSHNNLS-RLRAEWTPTRLTNLHSLL 70
Query: 181 VGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
+ N + I S A + NL LDLSSN L + + + ++ L L L NN+I +
Sbjct: 71 LSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VV 127
Query: 239 P 239
Sbjct: 128 D 128
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 36/124 (29%), Positives = 58/124 (46%), Gaps = 10/124 (8%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
+ NL L + L I E + L+ LDLSSN L T+ + +L+ L L
Sbjct: 60 PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI----AGMKNLTWLDLSNNNIK 235
+ +N ++ +A + L L LS N++S + P E+ + L LDLS+N +K
Sbjct: 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 236 GSIP 239
+P
Sbjct: 177 -KLP 179
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 9/118 (7%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F PNL L + L ++ + S L L++L L +N + + ++ L +L
Sbjct: 84 FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141
Query: 180 NVGSNSLIGPIPSA---LGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTW--LDLSNN 232
+ N + L L LDLSSNKL ++ + L L NN
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 29/133 (21%), Positives = 54/133 (40%), Gaps = 14/133 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
+L++L+ S P L L LT I +S ++L LD N ++
Sbjct: 117 KLTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQ 171
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L+ N + + + L+ L+ +N ++ ++ LT+LD S+N +
Sbjct: 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
Query: 236 GSIPVRLSPNKGL 248
I ++P L
Sbjct: 226 -EID--VTPLTQL 235
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 17/131 (12%), Positives = 44/131 (33%), Gaps = 10/131 (7%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
L +++ + L+ + +++ ++L LLD + G+T + +
Sbjct: 265 DLLEIDLTHNTQLIYFQAE--GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPK 319
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L+ L + + L + + T L +L + + + + L +
Sbjct: 320 LVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI 374
Query: 236 GSIPVRLSPNK 246
L+ N
Sbjct: 375 TMPKETLTNNS 385
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 34/162 (20%), Positives = 64/162 (39%), Gaps = 35/162 (21%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
+L + N ++ L+ S NL L LT ++ ++ L+KL L+ +N L
Sbjct: 68 KLICTS-----N-NITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118
Query: 163 TGTIPP-------------------EIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203
T + ++ + L EL+ N I + + T L+ L
Sbjct: 119 T-KLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175
Query: 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
D S NK++ ++ ++ K L L+ NNI + + +
Sbjct: 176 DCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQ 213
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 11/120 (9%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
L++L+ S L L L EI QL+ + G ++ +
Sbjct: 244 PLTELDVSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L+ + + + L L L L++ +L+ ++ ++ L L N +I+
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 9/120 (7%)
Query: 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185
N F + + L+ L LD ++ +T I L L +L SN+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
+ + L TNL+ L SNKL+ + + + LT+L+ N + + V +P
Sbjct: 76 ITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPL 128
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 29/156 (18%), Positives = 54/156 (34%), Gaps = 24/156 (15%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGL 162
L S ++++L+ S L +L +T + ++ +L LD SSN L
Sbjct: 174 TLDCS------FNKITELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224
Query: 163 TGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMK 222
T I + L L + N L + + +L+ L+ L L +I +
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNT 275
Query: 223 NLTWLDLSNNNIKGSIPVRLSPNKGL----CGGNFL 254
L + + ++ N L C +
Sbjct: 276 QLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 14/130 (10%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
+++L+ S P LV L + LT + +S +KL+ L + + +G +
Sbjct: 308 GITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPA 362
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSN------LDLSSNKLSGKIPPEIAGMKNLTWLDL 229
L I +P + +L+ LD N ++ I P G+ + +
Sbjct: 363 LNNNFEAEGQTIT-MPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTI 419
Query: 230 SNNNIKGSIP 239
+ N+ P
Sbjct: 420 TWENLSTDNP 429
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 40/195 (20%), Positives = 63/195 (32%), Gaps = 46/195 (23%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
G V A + K A++ K E + E ++L ++ H I+K+
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 372 FCLHRKCMFLIYEYMKRGSLF----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--- 424
F + +++ E M+ G LF N E K M A+ YLH
Sbjct: 208 FF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-----CKL--YFYQMLLAVQYLHENG 259
Query: 425 ---------------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVM 461
+ I + ++S L GT Y+APE L
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 462 --TEKCDVYSFGVVT 474
D +S GV+
Sbjct: 320 GYNRAVDCWSLGVIL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-14
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 318 YGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ V K Q GK +A K K S + + E +L ++ H NI+ L+
Sbjct: 18 FAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF 77
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H--- 425
++ + LI E + G LF L E E + +K + + YLH H
Sbjct: 78 ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---QFLKQILDGVHYLHSKRIAHFDL 134
Query: 426 -----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
+P I A + + GT ++APE + Y + + D
Sbjct: 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEAD 193
Query: 467 VYSFGVVT 474
++S GV+T
Sbjct: 194 MWSIGVIT 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 39/190 (20%), Positives = 73/190 (38%), Gaps = 46/190 (24%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+K + G A K + T ++ + +NE V++Q+ H N+++LY +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESK 158
Query: 377 KCMFLIYEYMKRGSLF-------CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----- 424
+ L+ EY+ G LF NL E + +K + + ++H
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESYNL--TELDT-------ILFMKQICEGIRHMHQMYIL 209
Query: 425 ------------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEK 464
+ + I A + GT ++APE + Y V +
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV-SFP 268
Query: 465 CDVYSFGVVT 474
D++S GV+
Sbjct: 269 TDMWSVGVIA 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 45/189 (23%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+ V+ Q GK+FALK + S S NE VL ++ H NIV L
Sbjct: 22 FSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYEST 78
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAV-------ELDWAKRVNIVKAMAHALAYLH----- 424
+L+ + + G LF D + E D + +++ + A+ YLH
Sbjct: 79 THYYLVMQLVSGGELF-------DRILERGVYTEKDASL---VIQQVLSAVKYLHENGIV 128
Query: 425 H-D--------CSPS------IA----STCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
H D +P I S + + GT GY+APE+ ++
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 466 DVYSFGVVT 474
D +S GV+T
Sbjct: 189 DCWSIGVIT 197
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 33/125 (26%), Positives = 54/125 (43%), Gaps = 12/125 (9%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ L L+++ ++ I + L +L+ L L +N +T I + L L L+
Sbjct: 104 SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLS 159
Query: 181 VGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238
+ N + I L LT L NL LS N +S + +AG+KNL L+L +
Sbjct: 160 LEDNQISDI----VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKP 213
Query: 239 PVRLS 243
S
Sbjct: 214 INHQS 218
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
I P A ++ +L +T + L ++ ++ ++ I + + L N+
Sbjct: 13 QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-IKSV-QGIQYLPNV 67
Query: 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ L L+ NKL+ I P + +KNL WL L N IK
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 13/84 (15%), Positives = 31/84 (36%), Gaps = 6/84 (7%)
Query: 152 LQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211
+ S + I P I+ N+ S+ + L ++ + +++ +
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 212 GKIPPEIAGMKNLTWLDLSNNNIK 235
+ I + N+T L L+ N +
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 6/114 (5%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
P L L + +T I +S L+KL L L N ++ I P + L L L
Sbjct: 126 GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 181
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ N + AL L NL L+L S + K + + + ++ ++
Sbjct: 182 LSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 44/149 (29%), Positives = 61/149 (40%), Gaps = 23/149 (15%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI-SALSKLQLLDL 157
L LS + + + +L L+ LTG S+ S LS LQ L
Sbjct: 56 VLDLSR-----C-EIQTIEDGAYQSLSHLST--LILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 158 SSNGLTGTIPPEI-GNLKNLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIP 215
L ++ G+LK L ELNV N + +P +LTNL +LDLSSNK+ I
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 216 PEI-AGMKNLTW----LDLSNNNIKGSIP 239
+ + LDLS N + I
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 39/147 (26%), Positives = 57/147 (38%), Gaps = 20/147 (13%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI-SALSKLQLLDL 157
L L+G N + L F L L Q S+ L L+ L++
Sbjct: 80 TLILTG-----N-PIQSLALGAFSGLSSL--QKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 158 SSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNL----SNLDLSSNKLSG 212
+ N + PE NL NL L++ SN + + L L + +LDLS N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 213 KIPPEIAGMKNLTWLDLSNNNIKGSIP 239
I P L L L N +K S+P
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLK-SVP 216
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 10/118 (8%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNL--- 176
L +L + + PE S L+ L+ LDLSSN + +I L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
Query: 177 -IELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNN 232
+ L++ N + I L L L +N+L +P I + +L + L N
Sbjct: 179 NLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 6/84 (7%)
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
IP + + L++ N L + S L LDLS ++ I
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 218 I-AGMKNLTWLDLSNNNIKGSIPV 240
+ +L+ L L+ N I+ S+ +
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLAL 93
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 88/298 (29%)
Query: 318 YGSVYKAQLPNG-------KVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVKL 369
+G V+ A+ N V A+K L + F + EA++L+ + H +IVK
Sbjct: 28 FGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAARKDFQR----EAELLTNLQHEHIVKF 82
Query: 370 YGFCLHRKCMFLIYEYMKRGSL-------------FCNLHNNEDAVELDWAKRVNIVKAM 416
YG C + +++EYMK G L + + EL ++ ++I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 417 AHALAYL------HHDCSPSIAS-TCPDSSNRTL------LA-----------GTYGYI- 451
A + YL H D +A+ C +N + ++ G + +
Sbjct: 143 ASGMVYLASQHFVHRD----LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 452 ----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD 505
PE + Y T + DV+SFGV+ E+ GK P ++ +V++
Sbjct: 199 IRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPW-----------FQLSNTEVIE 246
Query: 506 Q-----RLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL--ITRKTP 555
L P K + D++L C Q P+ R ++ + + L + + TP
Sbjct: 247 CITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEI-YKILHALGKATP 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 318 YGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ V K + G +A K K + + + E +L QVLH N++ L+
Sbjct: 25 FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--------- 424
+R + LI E + G LF L E E + + +K + + YLH
Sbjct: 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLHTKKIAHFDL 141
Query: 425 ----------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
+ P I A D + GT ++APE + Y + + D
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEAD 200
Query: 467 VYSFGVVT 474
++S GV+T
Sbjct: 201 MWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 40/188 (21%), Positives = 70/188 (37%), Gaps = 35/188 (18%)
Query: 318 YGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ V K + G +A K K T + + E +L ++ H N++ L+
Sbjct: 24 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H--- 425
++ + LI E + G LF L E E + +K + + + YLH H
Sbjct: 84 ENKTDVILILELVAGGELFDFLAEKESLTEEEAT---EFLKQILNGVYYLHSLQIAHFDL 140
Query: 426 -----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
P I A + + GT ++APE + Y + + D
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEAD 199
Query: 467 VYSFGVVT 474
++S GV+T
Sbjct: 200 MWSIGVIT 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 29/238 (12%), Positives = 71/238 (29%), Gaps = 43/238 (18%)
Query: 317 GYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
++A L + AL + ++ + LS++ + ++
Sbjct: 43 PPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHALAYLHH------ 425
R ++ E+++ GSL ++ + + ++++A A H
Sbjct: 101 HTRAGGLVVAEWIRGGSL-------QEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALS 153
Query: 426 DCSPS---IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 482
PS + S + ++ + + D+ G +L+ +
Sbjct: 154 IDHPSRVRV------SIDGDVVLAYPATMPDA-------NPQDDIRGIGASLYALLVNRW 200
Query: 483 PRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA-STISFACLQSNPKSRP 539
P S + + P + RDI S ++ +Q + R
Sbjct: 201 PLPEAGVRSGLA----PAERDTAGQPIEP--ADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 57/282 (20%), Positives = 98/282 (34%), Gaps = 76/282 (26%)
Query: 318 YGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+GSV + L V +K ++S+ E F+ EA + H N+++L
Sbjct: 47 FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS----EAACMKDFSHPNVIRLL 102
Query: 371 GFCL-----HRKCMFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAY 422
G C+ +I +MK G L L + + + + +A + Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 423 L------HHDCSPSIAS-TCPDSSNRTL------LA-----------GTYGYI-----AP 453
L H D +A+ C + T+ L+ G + A
Sbjct: 163 LSNRNFLHRD----LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 454 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----R 507
E V T K DV++FGV E+ G P P + ++ D R
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----------PGVQNHEMYDYLLHGHR 267
Query: 508 LPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
L P D + +I+ +C +++P RPT + +
Sbjct: 268 LKQPEDCLDELYEIMY------SCWRTDPLDRPTFSVLRLQL 303
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 52/249 (20%), Positives = 102/249 (40%), Gaps = 44/249 (17%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
G V A+ +G+ A+K + + + + NE ++ H N+V++Y L
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQHFNVVEMYKSYLVG 114
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------SP 429
+ ++++ E+++ G+L ++ + E A + +A+ ALAYLH S
Sbjct: 115 EELWVLMEFLQGGAL-TDIVSQVRLNEEQIAT---VCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 430 SI----------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
SI A D R L GT ++APE+ + + D++S G++
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF--ACL 531
+E++ G+ P S + + + + + PPP + + F L
Sbjct: 231 VIEMVDGEPPYFSDSPVQA-----MKRL----RDSPPPKLKN--SHKVSPVLRDFLERML 279
Query: 532 QSNPKSRPT 540
+P+ R T
Sbjct: 280 VRDPQERAT 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 61/296 (20%), Positives = 105/296 (35%), Gaps = 77/296 (26%)
Query: 294 YKKPKLEERATNNIDVFSIWNYDG------YGSVYKAQ-LPNGKVFALKKLHTSETEELA 346
+K + E ++D +W G +G VYKA+ G + A K + T EEL
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 347 FIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSL-----FCNLHNNEDA 401
E ++L+ H IVKL G H ++++ E+ G++ + E
Sbjct: 62 DYI---VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ 118
Query: 402 VELDWAKRVNIVKAMAHALAYLHHD--------------------------CSPSIASTC 435
+++ + + M AL +LH S T
Sbjct: 119 IQV-------VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170
Query: 436 PDSSNRTLLAGTYGYIAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSL 490
R GT ++APE+ M + K D++S G+ +E+ + P L+ +
Sbjct: 171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 491 SSSSDPKIMLIDVLDQRLPPPVDR------KVIRDILLASTISFACLQSNPKSRPT 540
++ I + PP RD L L NP++RP+
Sbjct: 229 RV-----LLKI----AKSDPPTLLTPSKWSVEFRDFLK------IALDKNPETRPS 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 37/214 (17%), Positives = 73/214 (34%), Gaps = 54/214 (25%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKS--------------FRNEAQVLSQVLH 363
+ + + + K +ALKK S E+ F+NE Q+++ + +
Sbjct: 44 FNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102
Query: 364 RNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA------MA 417
+ G + +++IYEYM+ S+ + ++ + I +
Sbjct: 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVL 161
Query: 418 HALAYLH------H-DCSPS-----------IA----STCPDSSNRTLLAGTYGYIAPEL 455
++ +Y+H H D PS ++ S GTY ++ PE
Sbjct: 162 NSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPE- 220
Query: 456 AYTMVMTE------KCDVYSFGVVTLEVLMGKHP 483
E K D++S G+ + P
Sbjct: 221 ---FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 46/197 (23%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375
+ V L + +A+K + E ++L Q HRN+++L F
Sbjct: 26 HARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEE 82
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H----- 425
+L++E M+ GS+ ++H EL+ + +V+ +A AL +LH H
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKGIAHRDLKP 139
Query: 426 ---------DCSP------------SIASTCPDSSNRTLL--AGTYGYIAPELAYTMVMT 462
SP + C S LL G+ Y+APE+
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199
Query: 463 -----EKCDVYSFGVVT 474
++CD++S GV+
Sbjct: 200 ASIYDKRCDLWSLGVIL 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/195 (22%), Positives = 65/195 (33%), Gaps = 46/195 (23%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
G V A + K A+K K E + E ++L ++ H I+K+
Sbjct: 23 CGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82
Query: 372 FCLHRKCMFLIYEYMKRGSLF----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH--- 424
F + +++ E M+ G LF N E K M A+ YLH
Sbjct: 83 FF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-----CKL--YFYQMLLAVQYLHENG 134
Query: 425 --H---------------DCSPSI-----ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVM 461
H DC I + ++S L GT Y+APE L
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 462 --TEKCDVYSFGVVT 474
D +S GV+
Sbjct: 195 GYNRAVDCWSLGVIL 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 54/288 (18%), Positives = 102/288 (35%), Gaps = 84/288 (29%)
Query: 318 YGSVYKAQLPNG-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G V+ A+ N V A+K L + + F+ EA++L+ + H++IV+ +
Sbjct: 54 FGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQHIVRFF 109
Query: 371 GFCLHRKCMFLIYEYMKRGSL------------FCNLHNNEDAVELDWAKRVNIVKAMAH 418
G C + + +++EYM+ G L + L + + + +A
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 419 ALAYL------HHDCSPSIAS-TCPDSSNRTL------LA-----------GTYGYI--- 451
+ YL H D +A+ C + ++ G +
Sbjct: 170 GMVYLAGLHFVHRD----LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 452 --APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPKIMLI 501
PE + Y T + DV+SFGVV E+ GK P + + ++
Sbjct: 226 WMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ--------- 275
Query: 502 DVLDQRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ L P + I+ C Q P+ R +++ V
Sbjct: 276 ---GRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARL 314
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 48/192 (25%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+ V + G FA K KL + ++L EA++ ++ H NIV+L+
Sbjct: 19 FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------EREARICRKLQHPNIVRLHD 72
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H- 425
+L+++ + G LF ++ E E D + ++ + ++AY H H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNGIVHR 129
Query: 426 D--------CSPS-----------IASTCPDSSNRTLLAGTYGYIAPEL----AYTMVMT 462
+ S + +A DS AGT GY++PE+ Y +
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY----S 185
Query: 463 EKCDVYSFGVVT 474
+ D+++ GV+
Sbjct: 186 KPVDIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 39/186 (20%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V A Q A KK+ E+ + F+ E +++ + H NI++LY
Sbjct: 22 WGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSPS 430
++L+ E G LF + + E D A+ I+K + A+AY H H D P
Sbjct: 79 TDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 431 ---IASTCPDS---------SNR-------TLLAGTYGYIAPEL---AYTMVMTEKCDVY 468
+ PDS + R GT Y++P++ Y +CD +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY----GPECDEW 191
Query: 469 SFGVVT 474
S GV+
Sbjct: 192 SAGVMM 197
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 13/117 (11%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ + + S+ + + L+ L LS N ++ + P + +L L EL+
Sbjct: 36 SQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELS 91
Query: 181 VGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
V N L + I LS L L +N+L + +KNL L + NN +K
Sbjct: 92 VNRNRLKNLNGI-----PSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
L+ +L +T + L + N ++++ + + TNL L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
S N++S + P + + L L ++ N +K
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 17/119 (14%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL--LDLSSNGLTGTIPPEIGNLKNLIE 178
L +L++ L ++ + L L L +N L + +LKNL
Sbjct: 80 PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEI 132
Query: 179 LNVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L++ +N L I LG L+ L LDL N+++ + +K + W+DL+
Sbjct: 133 LSIRNNKLKSI----VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 6/44 (13%), Positives = 15/44 (34%), Gaps = 2/44 (4%)
Query: 192 SALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L N +L ++ + + + + N+NI+
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ 54
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ + +G +K ++ ++ ++ E +VL + H NI+K++
Sbjct: 35 FGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAV----ELDWAKRVNIVKAMAHALAYLH-----H-D 426
M+++ E + G L + + + E A+ ++K M +ALAY H H D
Sbjct: 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE---LMKQMMNALAYFHSQHVVHKD 149
Query: 427 CSPS---IASTCPDS---------SNR-------TLLAGTYGYIAPEL---AYTMVMTEK 464
P T P S + T AGT Y+APE+ T K
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV----TFK 205
Query: 465 CDVYSFGVVT 474
CD++S GVV
Sbjct: 206 CDIWSAGVVM 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 62/199 (31%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+ V + G FA K KL + ++L EA++ ++ H NIV+L+
Sbjct: 42 FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------EREARICRKLQHPNIVRLHD 95
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAV-------ELDWAKRVNIVKAMAHALAYLH 424
+L+++ + G LF + + E D + + ++ + ++AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELF-------EDIVAREFYSEADAS---HCIQQILESIAYCH 145
Query: 425 -----H-D--------CSPS-----------IASTCPDSSNRTLLAGTYGYIAPEL---- 455
H + S + +A DS AGT GY++PE+
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 456 AYTMVMTEKCDVYSFGVVT 474
Y ++ D+++ GV+
Sbjct: 206 PY----SKPVDIWACGVIL 220
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 7/118 (5%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVG 182
+ KL +Q L+ S+P + L+KL+LL L+ N L T+P I LKNL L V
Sbjct: 36 PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
N L L NL+ L L N+L +PP + + LT+L L N ++ S+P
Sbjct: 94 DNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLP 149
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 7/121 (5%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F NL L + L ++P + L L L L N L ++PP + +L L L
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
++G N L LT+L L L +N+L ++P + L L L NN +K +
Sbjct: 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RV 196
Query: 239 P 239
P
Sbjct: 197 P 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 35/114 (30%), Positives = 53/114 (46%), Gaps = 6/114 (5%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F NL +L + L S+PP + +L+KL L L N L ++P + L +L EL
Sbjct: 105 FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNN 232
+ +N L A LT L L L +N+L ++P ++ L L L N
Sbjct: 163 RLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
D SS LT IP I + +L++ SN L A LT L L L+ NKL +P
Sbjct: 22 DCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77
Query: 216 PEI-AGMKNLTWLDLSNNNIKGSIP 239
I +KNL L +++N ++ ++P
Sbjct: 78 AGIFKELKNLETLWVTDNKLQ-ALP 101
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 37/200 (18%), Positives = 76/200 (38%), Gaps = 63/200 (31%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+ V + ++ G+ +A KL + ++L EA++ + H NIV+L+
Sbjct: 24 FSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------EREARICRLLKHPNIVRLHD 77
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAV-------ELDWAKRVNIVKAMAHALAYLH 424
+LI++ + G LF + + E D + ++ + A+ + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELF-------EDIVAREYYSEADASH---CIQQILEAVLHCH 127
Query: 425 -----H-DCSPS---IASTCPDSS---------------NRTL--LAGTYGYIAPEL--- 455
H + P +AS ++ + AGT GY++PE+
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 456 -AYTMVMTEKCDVYSFGVVT 474
Y + D+++ GV+
Sbjct: 188 DPY----GKPVDLWACGVIL 203
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 63/290 (21%), Positives = 97/290 (33%), Gaps = 86/290 (29%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNIV 367
+G V +A KV A+K L E+ A + E +++S + H NIV
Sbjct: 59 FGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMS----ELKIMSHLGQHENIV 113
Query: 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN---------------I 412
L G C H + +I EY G L L +E D A + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 413 VKAMAHALA---YLHHDCSPSIASTCPDSSNRTLLAGTYG----------YI-------- 451
+ MA LA +H D + A ++ G +G YI
Sbjct: 174 AQGMAF-LASKNCIHRDVA---ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 452 ----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-------RDLLSSLSSSSDPKIM 499
APE + V T + DV+S+G++ E+ +G +P +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG------ 283
Query: 500 LIDVLDQRLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
++ P K I I+ AC P RPT Q +
Sbjct: 284 ------YQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICSFL 321
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 43/197 (21%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V++ + + K + K + T+ + E +L+ HRNI+ L+
Sbjct: 18 FGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESM 73
Query: 377 KCMFLIYEYMKRGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------- 424
+ + +I+E++ +F NE + V+ V + AL +LH
Sbjct: 74 EELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVCEALQFLHSHNIGHF 126
Query: 425 ----------HDCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 466
S +I A N LL Y APE + +V + D
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATD 185
Query: 467 VYSFGVVTLEVLMGKHP 483
++S G + +L G +P
Sbjct: 186 MWSLGTLVYVLLSGINP 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 10/120 (8%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNV 181
C + + IP S Q L L L TIP NL N+ + V
Sbjct: 9 ECHQE-EDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYV 62
Query: 182 GSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ + + S + +L+ ++++++ + + I P+ + L +L + N +K P
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 32/170 (18%), Positives = 57/170 (33%), Gaps = 40/170 (23%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
+Y+S + L QL F + + I+ I P+ L L+ L +
Sbjct: 59 RIYVSI-----DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 159 SNGLTGTIPPE--IGNLKNLIELNVGSNSLIGPIPS-ALGSLTN---------------- 199
+ GL P + + L + N + IP A L N
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ 172
Query: 200 --------LSNLDLSSNKLSGKIPPEI-AGMKN-LTWLDLSNNNIKGSIP 239
L + L+ NK I + G+ + + LD+S ++ ++P
Sbjct: 173 GYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 37/288 (12%), Positives = 80/288 (27%), Gaps = 79/288 (27%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQ------------------- 356
+ +A G+ F + + +E IK + E
Sbjct: 85 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144
Query: 357 ------VLSQVLHRNIVKLYGFCLHRKCM--FLIYEYMK--RGSLFCNLHNNEDAVE-LD 405
++ + ++++ + F +Y M+ + L ++ + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 406 WAKRVNIVKAMAHALAYLHH------DCSPS-----------IA--STCPDSSNRTLLAG 446
R+ + + LA LHH P + R + +
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSV 264
Query: 447 TYGYIAPEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 495
+ G+ PEL +MT D ++ G+V + P ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP------ITKDAA 318
Query: 496 PKIM-LIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
I + +P PV R ++ L+ + R
Sbjct: 319 LGGSEWIFRSCKNIPQPV-RALLEG----------FLRYPKEDRLLPL 355
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 53/271 (19%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VY A+ + N +V A+KK+ S + + E + L ++ H N ++ G L
Sbjct: 67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------------ 424
+L+ EY GS L ++ ++ + LAYLH
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLHSHNMIHRDVKAG 183
Query: 425 -----HDCSPSIA--STCPDSSNRTLLAGTYGYIAPELAYTMVMTE---KCDVYSFGVVT 474
+ + + GT ++APE+ M + K DV+S G+
Sbjct: 184 NILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243
Query: 475 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-----KVIRDILLASTISFA 529
+E+ K P ++++S+ + I + P + + R+ + +
Sbjct: 244 IELAERKPPLFNMNAMSA-----LYHI----AQNESPALQSGHWSEYFRNFVD------S 288
Query: 530 CLQSNPKSRPTMQYVSQEFLITRKTPLVKHA 560
CLQ P+ RPT S+ L K V
Sbjct: 289 CLQKIPQDRPT----SEVLL---KHRFVLRE 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 37/283 (13%), Positives = 92/283 (32%), Gaps = 56/283 (19%)
Query: 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 364
+ F+ W K Q +++ + + + + + + + +
Sbjct: 65 GIVRYFNAWLETPP---EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 365 NIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
N V + +++ + ++ +L ++ + + ++I +A A+ +LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 425 -----H------------------------------DCSPSIASTCPDSSNRTLLAGTYG 449
H + ++ + P + T GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509
Y++PE + + K D++S G++ E LL S S+ + ++ DV + + P
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFE---------LLYSFSTQMERVRIITDVRNLKFP 292
Query: 510 PPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQ-EFL 549
+K ++ L +P RP + +
Sbjct: 293 LLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 3/85 (3%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G V++A+ + +A+K++ E + E + L+++ H IV+ + L
Sbjct: 18 GFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLE 75
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNED 400
E + +
Sbjct: 76 TPPEKWQEEMDEIWLKDESTDWPLS 100
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 55/304 (18%), Positives = 107/304 (35%), Gaps = 86/304 (28%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375
YG VYK + + G++ A+K + + E + + E +L + HRNI YG +
Sbjct: 37 YGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIK 92
Query: 376 RKC------MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYL 423
+ ++L+ E+ GS+ D ++ + I + + L++L
Sbjct: 93 KNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 424 HHDC--------------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAY 457
H S + T R GT ++APE+
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIA 202
Query: 458 TMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512
+ K D++S G+ +E+ G P + + + + LI R P P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLI----PRNPAPR 253
Query: 513 DR-----KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISI 567
+ K + + +CL N RP +++ + K P ++ +
Sbjct: 254 LKSKKWSKKFQSFIE------SCLVKNHSQRPA----TEQLM---KHPFIRDQPNERQVR 300
Query: 568 SELR 571
+L+
Sbjct: 301 IQLK 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 52/199 (26%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 370
V + G FA+K S + ++ R E +L QV H +I+ L
Sbjct: 107 SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAV-------ELDWAKRVNIVKAMAHALAYL 423
MFL+++ M++G LF D + E + I++++ A+++L
Sbjct: 167 DSYESSSFMFLVFDLMRKGELF-------DYLTEKVALSEKETRS---IMRSLLEAVSFL 216
Query: 424 H-----H----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMV 460
H H D + I + L GT GY+APE L +M
Sbjct: 217 HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 461 MTEK-----CDVYSFGVVT 474
T D+++ GV+
Sbjct: 277 ETHPGYGKEVDLWACGVIL 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 39/185 (21%), Positives = 65/185 (35%), Gaps = 37/185 (20%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375
+ K + + FA+K + + E L H NIVKL+
Sbjct: 24 FSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITALKLCEGHPNIVKLHEVFHD 77
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
+ FL+ E + G LF + + E + + I++ + A++++H H D P
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 430 S---IASTCPDSS---------------NRTL--LAGTYGYIAPELAYTMVMTEKCDVYS 469
+ N+ L T Y APEL E CD++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 470 FGVVT 474
GV+
Sbjct: 195 LGVIL 199
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 20/93 (21%), Positives = 31/93 (33%), Gaps = 2/93 (2%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
+ L L + + + + L L L + + L P A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232
LS L+LS N L + + +L L LS N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGK 213
L + +G + +NL EL + + + + L L L NL + + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-F 70
Query: 214 IPPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLP-SCD 260
+ P+ L+ L+LS N ++ S+ + L P C
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 141 SIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLT 198
IPP S KL+ +DLS+N ++ + P+ L++L L + N + S L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLF 104
Query: 199 NLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+L L L++NK++ + + + NL L L +N ++ +I
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIA 144
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
GLT IP + + + E+ + N++ P A L +DLS+N++S ++ P+
Sbjct: 19 RGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 218 I-AGMKNLTWLDLSNNNIKGSIPVRL 242
G+++L L L N I +P L
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSL 99
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 4/89 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F +L L + +T +P + L LQLL L++N + + + +L NL L
Sbjct: 76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLL 133
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSN 208
++ N L L + + L+ N
Sbjct: 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 57/273 (20%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YGSVYKA G++ A+K++ ++ E ++ Q ++VK YG
Sbjct: 41 SYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------- 427
++++ EY GS+ + + D I+++ L YLH
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHFMRKIHRDIKA 153
Query: 428 ------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
+ + T + R + GT ++APE+ + D++S
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF- 528
G+ +E+ GK P + + + I +I PPP RK ++ + F
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRA-----IFMI----PTNPPPTFRK--PELWSDNFTDFV 259
Query: 529 -ACLQSNPKSRPTMQYVSQEFLITRKTPLVKHA 560
CL +P+ R T + + L + P V+ A
Sbjct: 260 KQCLVKSPEQRAT----ATQLL---QHPFVRSA 285
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 62/289 (21%), Positives = 94/289 (32%), Gaps = 80/289 (27%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNIV 367
+G V +A V A+K L TE A + E +VLS + H NIV
Sbjct: 36 FGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMS----ELKVLSYLGNHMNIV 90
Query: 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVN---------------- 411
L G C +I EY G L L D+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 412 ---IVKAMAHALA---YLHHDCSPSIASTCPDSSNRTLLAGTYG----------YI---- 451
+ K MA LA +H D + A + R +G Y+
Sbjct: 151 SYQVAKGMAF-LASKNCIHRDLA---ARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 452 --------APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLID 502
APE + V T + DV+S+G+ E+ +G P + S
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSK----FYK 259
Query: 503 VLDQ--RLPPPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
++ + R+ P + DI+ C ++P RPT + + Q
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLI 302
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 28/127 (22%), Positives = 50/127 (39%), Gaps = 3/127 (2%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
+S F + + + S L+ + N T ++ LK L L +
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 182 GSNSL--IGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEIAGMKNLTWLDLSNNNIKGSI 238
N L + ++++L LD+S N L S A +++ L+LS+N + GS+
Sbjct: 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 239 PVRLSPN 245
L P
Sbjct: 445 FRCLPPK 451
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 25/100 (25%), Positives = 42/100 (42%), Gaps = 8/100 (8%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPP-EIGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
+P ++ + + L LS N ++ + +I L L L + N + +
Sbjct: 45 HVPKDLPP--RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD 101
Query: 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
L LD+S N+L I M +L LDLS N+ +P
Sbjct: 102 LEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLP 137
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 9/123 (7%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLT----GTIPPEIGNLKNL 176
S L L +Q L + + L+ L +++
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 177 IELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236
+ LN+ SN L G + L + LDL +N++ IP ++ ++ L L++++N +K
Sbjct: 431 LVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK- 486
Query: 237 SIP 239
S+P
Sbjct: 487 SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 122 FSCFPNLVKLTIQFFALT----GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI 177
N+ L +L + + + +L+LSSN LTG++ + +
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVK 453
Query: 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNN 233
L++ +N ++ IP + L L L+++SN+L +P + + +L ++ L +N
Sbjct: 454 VLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 25/184 (13%), Positives = 55/184 (29%), Gaps = 8/184 (4%)
Query: 63 SPIQLEKKALINTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNF 122
+ + AL + N + + L ++ + W+ S F
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 123 SCF--PNLVKLTIQFFALTGSIPPEI-----SALSKLQLLDLSSNGLTGTIPPEIGNLKN 175
F + L I +T I E +AL L + + + +
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+ + + S ++ + L+ + N + + + +K L L L N +K
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 236 GSIP 239
+
Sbjct: 391 -NFF 393
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 9/208 (4%)
Query: 116 RLSQLNFSCFPNLVKLTIQFFALTGSIPP--EISALSKLQLLDLSSNGLTGTIPPEIGNL 173
RL ++ +L L + F +P E L+KL L LS+ + +L
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 174 K-NLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232
+ I L++ S + G +L N + L L + S + L L LSN
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 233 NIK----GSIPVRLSPNKGLCGGNFLDLPSCDTTKPATLFVEIFLPLAIVLSVIVFACLL 288
+ + LS + L +TT ++ + F V + ++ +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 289 LAKRKYKKPKLEERATNNIDVFSIWNYD 316
+ ++ E A ++ + + N
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQV 316
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 21/125 (16%)
Query: 123 SCFPNLV-----KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIG--NLKN 175
C V KL IP I L L++N T + L
Sbjct: 10 RCEGTTVDCSNQKLN--------KIPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQ 58
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNI 234
L ++N +N + A + ++ + L+SN+L + ++ G+++L L L +N I
Sbjct: 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRI 117
Query: 235 KGSIP 239
+
Sbjct: 118 T-CVG 121
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 21/93 (22%), Positives = 42/93 (45%), Gaps = 5/93 (5%)
Query: 149 LSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207
L +L+ ++ S+N +T I + E+ + SN L L +L L L S
Sbjct: 56 LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114
Query: 208 NKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
N+++ + + G+ ++ L L +N I ++
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 6/114 (5%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIEL 179
F P L K+ +T I S + + L+SN L + ++ L++L L
Sbjct: 53 FKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTL 110
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNN 232
+ SN + + L+++ L L N+++ + P + +L+ L+L N
Sbjct: 111 MLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 29/83 (34%), Positives = 39/83 (46%), Gaps = 14/83 (16%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368
+G V KA + V A+K L + S +E + E VL QV H +++K
Sbjct: 36 FGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLS----EFNVLKQVNHPHVIK 90
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL 391
LYG C + LI EY K GSL
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSL 113
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 37/190 (19%), Positives = 65/190 (34%), Gaps = 47/190 (24%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375
Y + FA+K + S+ + E ++L + H NI+ L
Sbjct: 35 YSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-----H-DCSP 429
K ++++ E MK G L + + E + + ++ + + YLH H D P
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYLHAQGVVHRDLKP 144
Query: 430 S---IASTCPDSS----------------NRTL--LAGTYGYIAPEL----AYTMVMTEK 464
S + N L T ++APE+ Y
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY----DAA 200
Query: 465 CDVYSFGVVT 474
CD++S GV+
Sbjct: 201 CDIWSLGVLL 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 21/163 (12%)
Query: 93 ITCNSAGSIFE--LYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI 146
S+F L G +++ F L L + + S P+
Sbjct: 136 YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL--EELEIDASDLQSYEPKS 193
Query: 147 -SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGS-------- 196
++ + L L + ++ L + L S L +
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
N+ ++ L ++ + + L L+ S N +K S+P
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVP 293
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 7/122 (5%)
Query: 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVG 182
+ L + +T I LQ L L+SNG+ TI + +L +L L++
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS 108
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA--GMKNLTWLDLSNNNIKGSIPV 240
N L S L++L+ L+L N + + L L + N + I
Sbjct: 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 241 RL 242
+
Sbjct: 168 KD 169
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 20/122 (16%), Positives = 38/122 (31%), Gaps = 13/122 (10%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI--------GN 172
N+ L + + S ++ L+L L E+
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 173 LKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSN 231
+ + SL + L ++ L L+ S N+L +P I + +L + L
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHT 310
Query: 232 NN 233
N
Sbjct: 311 NP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 6/116 (5%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
+ V I + S + + + SS L +IP + + + L++ +N
Sbjct: 6 WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNN 62
Query: 185 SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ S L NL L L+SN ++ I + + + +L LDLS N + ++
Sbjct: 63 RITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLS 116
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 16/100 (16%), Positives = 31/100 (31%), Gaps = 1/100 (1%)
Query: 111 AGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI 170
F S + + T F L+ + + + ++ L + +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL 273
Query: 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 210
+ L+EL N L LT+L + L +N
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 43/189 (22%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFC-- 373
G V + G+ ALK L+ S R E Q +IV +
Sbjct: 42 NGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 374 --LHRKCMFLIYEYMKRGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLH----- 424
++C+ +I E M+ G LF + D E + A+ I++ + A+ +LH
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE---IMRDIGTAIQFLHSHNIA 150
Query: 425 H-DCSPS---IASTCPDSS-------------NRTL--LAGTYGYIAPELAYTMVMTEKC 465
H D P S D+ L T Y+APE+ + C
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSC 210
Query: 466 DVYSFGVVT 474
D++S GV+
Sbjct: 211 DMWSLGVIM 219
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
+P I + L L N T +P E+ N K+L +++ +N + + ++T L
Sbjct: 24 VLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 201 SNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
L LS N+L IPP G+K+L L L N+I +P
Sbjct: 81 LTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTN 199
+P E+S L L+DLS+N ++ T+ + N+ L+ L + N L P L +
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103
Query: 200 LSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNN 232
L L L N +S +P + L+ L + N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 217
S+ GL +P I +++ EL + N +P L + +L+ +DLS+N++S + +
Sbjct: 18 SNKGLK-VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 218 I-AGMKNLTWLDLSNNNIKGSIPVR 241
+ M L L LS N ++ IP R
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPR 96
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 12/121 (9%)
Query: 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNV 181
C + +T IP ++ L L I +L ++ +
Sbjct: 8 HCSNRVFLCQES--KVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEI 61
Query: 182 GSNSLIGPIPS-ALGSLTNLSNLDLS-SNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSI 238
N ++ I + +L L + + +N L I PE + NL +L +SN IK +
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HL 119
Query: 239 P 239
P
Sbjct: 120 P 120
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 38/168 (22%)
Query: 103 ELYLSGYYAGFNWRLSQLNFSCF---PNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLS 158
++ +S N L + F P L ++ I+ I PE L LQ L +S
Sbjct: 58 KIEISQ-----NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 159 SNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPS-ALGSLT-NLSNLDLSSNKLSG--- 212
+ G+ +P + + L++ N I I + L+ L L+ N +
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 171
Query: 213 --------------------KIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
++P ++ G LD+S I S+P
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 218
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 19/145 (13%), Positives = 41/145 (28%), Gaps = 17/145 (11%)
Query: 94 TCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTG----SIPPEI-SA 148
+ L + N + + + F L + L I +
Sbjct: 123 HKIHSLQKVLLDIQD-----NINIHTIERNSFVGLSFES-VILWLNKNGIQEIHNSAFNG 176
Query: 149 LSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207
+L +N L +P ++ + L++ + L +L L +
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235
Query: 208 NKLSGKIPPEIAGMKNLTWLDLSNN 232
K K+P + + L L+
Sbjct: 236 LK---KLPT-LEKLVALMEASLTYP 256
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 37/196 (18%), Positives = 67/196 (34%), Gaps = 53/196 (27%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLY 370
+ V + G+ +A K + E+ +E VL ++ L+
Sbjct: 42 FAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI------LHEIAVLELAKSCPRVINLH 95
Query: 371 GFCLHRKCMFLIYEYMKRGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424
+ + LI EY G +F +E+ V + ++K + + YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-------IRLIKQILEGVYYLH 148
Query: 425 -----H-DCSPS---IASTCPDS----------------SNRTLLAGTYGYIAPE-LAYT 458
H D P ++S P + GT Y+APE L Y
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 459 MVMTEKCDVYSFGVVT 474
+ T D+++ G++
Sbjct: 209 PI-TTATDMWNIGIIA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 42/193 (21%), Positives = 74/193 (38%), Gaps = 39/193 (20%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIK-SFRNEAQVLSQV-LHRNIVKL 369
V + P K +A+K + EE+ ++ + E +L +V H NI++L
Sbjct: 30 SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----- 424
FL+++ MK+G LF L E + K I++A+ + LH
Sbjct: 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEVICALHKLNIV 146
Query: 425 H----------DCSPSI-------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVM----- 461
H D +I + + GT Y+APE + +M
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 462 TEKCDVYSFGVVT 474
++ D++S GV+
Sbjct: 207 GKEVDMWSTGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 52/194 (26%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFC-- 373
G V + + FALK L R E ++ + +IV++
Sbjct: 75 NGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYEN 126
Query: 374 --LHRKCMFLIYEYMKRGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLH----- 424
RKC+ ++ E + G LF + + D E + + I+K++ A+ YLH
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLHSINIA 183
Query: 425 H-DCSPS---IASTCPDSS--------------NRTL--LAGTYGYIAPEL----AYTMV 460
H D P S P++ + +L T Y+APE+ Y
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY--- 240
Query: 461 MTEKCDVYSFGVVT 474
+ CD++S GV+
Sbjct: 241 -DKSCDMWSLGVIM 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 12/82 (14%)
Query: 318 YGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 369
+G V++A+ P + A+K L S + F + EA ++++ + NIVKL
Sbjct: 60 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----EAALMAEFDNPNIVKL 115
Query: 370 YGFCLHRKCMFLIYEYMKRGSL 391
G C K M L++EYM G L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDL 137
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
+G V +L KVFA+K L+ E + A FR E VL + I L Y F
Sbjct: 86 AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPS 430
++L+ +Y G L L ED + + A+ +V A+ H L Y+H D P
Sbjct: 146 DNN-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 431 ---------IAST----C----PDSSNRTLLA-GTYGYIAPELAYTMVMTEK-----CDV 467
I C D + ++ +A GT YI+PE+ M + CD
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 468 YSFGVVTLEVLMGKHP 483
+S GV E+L G+ P
Sbjct: 265 WSLGVCMYEMLYGETP 280
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 10/130 (7%)
Query: 116 RLSQLNFSCFPNLVKLT---IQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI- 170
L+ L+ + F L KLT + + L ++ + L++L L L++N L ++P +
Sbjct: 46 GLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVF 103
Query: 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDL 229
+L L +L +G N L LT L L L++N+L IP + NL L L
Sbjct: 104 DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 230 SNNNIKGSIP 239
S N ++ S+P
Sbjct: 163 STNQLQ-SVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 32/112 (28%), Positives = 47/112 (41%), Gaps = 5/112 (4%)
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIG 188
KL +Q L L+KL L+L N L T+ + +L L L + +N L
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97
Query: 189 PIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
LT L L L N+L +P + + L L L+ N ++ SIP
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 31/100 (31%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
S+P I A + + LDL S GL L L LN+ N L LT L
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 201 SNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
L L++N+L+ +P + + L L L N +K S+P
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLP 123
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 21/88 (23%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
D L ++P I + +L++ S L + LT L+ L+L N+L +
Sbjct: 20 DCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS 75
Query: 216 PEI-AGMKNLTWLDLSNNNIKGSIPVRL 242
+ + L L L+NN + S+P+ +
Sbjct: 76 AGVFDDLTELGTLGLANNQLA-SLPLGV 102
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 5/94 (5%)
Query: 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201
+ +S L + L LS+N + I + ++NL L++G N LI I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRN-LIKKIENLDAVADTLE 96
Query: 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L +S N+++ + I + NL L +SNN I
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 33/149 (22%), Positives = 53/149 (35%), Gaps = 12/149 (8%)
Query: 89 KWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISA 148
+E A ++ L G S L + + I +S
Sbjct: 13 IFEERKSVVATEAEKVELHGMIP--PIEKMDATLSTLKACKHLALSTNNIE-KISS-LSG 68
Query: 149 LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208
+ L++L L N + I L EL + N I + S + L NL L +S+N
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYN-QIASL-SGIEKLVNLRVLYMSNN 125
Query: 209 KLSGKIPPEI---AGMKNLTWLDLSNNNI 234
K++ EI A + L L L+ N +
Sbjct: 126 KITN--WGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 20/60 (33%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 176 LIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+EL+ I + + L +L +L LS+N + KI ++GM+NL L L N IK
Sbjct: 27 KVELHGMIPP-IEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 16/120 (13%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ S NL L++ + I + L+ L +S N + ++ I L NL L
Sbjct: 65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLY 121
Query: 181 VGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPE----------IAGMKNLTWLD 228
+ +N + G I L +L L +L L+ N L + + NL LD
Sbjct: 122 MSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 21/83 (25%), Positives = 32/83 (38%), Gaps = 14/83 (16%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 368
+G VYK L V A+K L F EA + +++ H N+V
Sbjct: 22 FGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRH----EAMLRARLQHPNVVC 76
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL 391
L G + + +I+ Y G L
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDL 99
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 13/83 (15%)
Query: 318 YGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNIVK 368
+G V A A+K L +E A + E ++++Q+ H NIV
Sbjct: 58 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSHENIVN 113
Query: 369 LYGFCLHRKCMFLIYEYMKRGSL 391
L G C ++LI+EY G L
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDL 136
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 49/244 (20%), Positives = 81/244 (33%), Gaps = 85/244 (34%)
Query: 318 YGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
YG V A + + A+K K+ ++ ++ + E +++ ++ H NI +LY
Sbjct: 39 YGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTEVRLMKKLHHPNIARLYE 95
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRV--------------------- 410
+ + L+ E G L L+ D A V
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 411 ----------------NIVKAMAHALAYLH-----H-DCSP------------------- 429
NI++ + AL YLH H D P
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 430 -SIASTCPDSSNRTLL---AGTYGYIAPEL------AYTMVMTEKCDVYSFGVVTLEVLM 479
S ++ + AGT ++APE+ +Y KCD +S GV+ +LM
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY----GPKCDAWSAGVLLHLLLM 271
Query: 480 GKHP 483
G P
Sbjct: 272 GAVP 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 32/197 (16%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH- 375
+ V ++ G+V+A+K ++ + + + FR E VL R I +L+ F
Sbjct: 74 FSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQD 132
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPS- 430
++L+ EY G L L + + + A+ IV A+ H L Y+H D P
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDN 192
Query: 431 --------IAST----C----PDSSNRTLLA-GTYGYIAPELAYTMVMTEK-------CD 466
I C D + R+L+A GT Y++PE+ + CD
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 467 VYSFGVVTLEVLMGKHP 483
++ GV E+ G+ P
Sbjct: 253 WWALGVFAYEMFYGQTP 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 15/85 (17%)
Query: 318 YGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNI 366
+G V A+ A+K L +E + I E +++ + H+NI
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----EMEMMKMIGKHKNI 137
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSL 391
+ L G C +++I EY +G+L
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNL 162
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 15/85 (17%)
Query: 318 YGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNI 366
+G V A+ A+K L +E + + E +++ + H+NI
Sbjct: 94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIGKHKNI 149
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSL 391
+ L G C +++I EY +G+L
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNL 174
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 15/85 (17%)
Query: 318 YGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNI 366
+G V A+ A+K L +E + + E +++ + H+NI
Sbjct: 48 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIGKHKNI 103
Query: 367 VKLYGFCLHRKCMFLIYEYMKRGSL 391
+ L G C +++I EY +G+L
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 8/102 (7%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPE--IGNLKNLIELNVGSNSLIGPIPSALGSLT 198
IP +I L L+ N L I + G L +L++L + N L G P+A +
Sbjct: 22 EIPRDIPL--HTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 199 NLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
++ L L NK+ +I ++ G+ L L+L +N I +
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 42/182 (23%), Positives = 67/182 (36%), Gaps = 49/182 (26%)
Query: 318 YGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFC-- 373
G V + + FALK L R E ++ + +IV++
Sbjct: 31 NGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYEN 82
Query: 374 --LHRKCMFLIYEYMKRGSLF------CNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH 424
RKC+ ++ E + G LF + E +A E I+K++ A+ YLH
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEAIQYLH 134
Query: 425 -----H-DCSPS---IASTCPDSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGV 472
H D P S P++ L +G A E Y + CD++S GV
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAI---LKLTDFG-FAKETTGEKY----DKSCDMWSLGV 186
Query: 473 VT 474
+
Sbjct: 187 IM 188
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 16/85 (18%)
Query: 318 YGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNIV 367
+G V +A V A+K L + +E A + E ++L + H N+V
Sbjct: 40 FGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMS----ELKILIHIGHHLNVV 94
Query: 368 KLYGFCLHRKC-MFLIYEYMKRGSL 391
L G C + +I E+ K G+L
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNL 119
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 39/124 (31%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 125 FPNLVKLT---IQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEIGN-LKNLIEL 179
L LT + L S+P + L+ L+ L L N L ++P + + L NL L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM----KNLTWLDLSNNNIK 235
N+ N L LTNL+ LDLS N+L +P G+ L L L N +K
Sbjct: 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLP---EGVFDKLTQLKDLRLYQNQLK 194
Query: 236 GSIP 239
S+P
Sbjct: 195 -SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 21/123 (17%), Positives = 41/123 (33%), Gaps = 33/123 (26%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL--IGPIPSALGSLT 198
P + A + +L +T + L ++ ++ ++ + + I L
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LP 63
Query: 199 NLSNLDLSSNKLSG---------------------KIPPEI-AGMKNLTWLDLSNNNIKG 236
N+ L L NKL +P + + NL L L N ++
Sbjct: 64 NVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 237 SIP 239
S+P
Sbjct: 123 SLP 125
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 21/70 (30%), Positives = 40/70 (57%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG V K + G++ A+KK S+ +++ + R E ++L Q+ H N+V L C +
Sbjct: 38 YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKK 96
Query: 377 KCMFLIYEYM 386
K +L++E++
Sbjct: 97 KRWYLVFEFV 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 4/111 (3%)
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIG 188
L + +T P +L L+ L L SN L +P + +L L L++G+N L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 189 PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
+ L +L L + NKL+ ++P I + +LT L L N +K SIP
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
S+P I + Q+L L N +T P +L NL EL +GSN L SLT L
Sbjct: 33 SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 201 SNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ LDL +N+L+ +P + + +L L + N + +P
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELP 128
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
D S ++P I N L + N + P SL NL L L SN+L +P
Sbjct: 25 DCRSKRHA-SVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP 80
Query: 216 PEI-AGMKNLTWLDLSNNNIKGSIPVR 241
+ + LT LDL N + +P
Sbjct: 81 VGVFDSLTQLTVLDLGTNQLT-VLPSA 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
F L L + LT +P + L L+ L + N LT +P I L +L L
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 181 VGSNSLIGPIPSALGSLTNLSNLDLSSN 208
+ N L A L++L++ L N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 59/260 (22%), Positives = 101/260 (38%), Gaps = 62/260 (23%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-YGFCL 374
+G V Q K++A+K ++ + E +++ E Q++ + H +V L Y F
Sbjct: 27 SFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNN----EDAVELDWAKRVNIVKA-MAHALAYLHH---- 425
MF++ + + G L +L N E+ V+L + + AL YL +
Sbjct: 87 EED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FI-------CELVMALDYLQNQRII 137
Query: 426 --DCSP----------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
D P +IA+ P + T +AGT Y+APE M + K
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE----MFSSRKGAG 193
Query: 468 Y-------SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIR 518
Y S GV E+L G+ P + SS+ K ++ + P ++ +
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYH----IRSSTSSKEIVHTFETTVVTYPSAWSQE-MV 248
Query: 519 DILLASTISFACLQSNPKSR 538
+L L+ NP R
Sbjct: 249 SLLK------KLLEPNPDQR 262
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 23/69 (33%), Positives = 38/69 (55%), Gaps = 1/69 (1%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
YG VYKA+ G++ ALK++ +E + R E +L ++ H NIV L +
Sbjct: 34 YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSER 92
Query: 378 CMFLIYEYM 386
C+ L++E+M
Sbjct: 93 CLTLVFEFM 101
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 27/69 (39%), Positives = 41/69 (59%), Gaps = 1/69 (1%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377
YG VYKAQ G+ FALKK+ + +E + R E +L ++ H NIVKLY +K
Sbjct: 15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKK 73
Query: 378 CMFLIYEYM 386
+ L++E++
Sbjct: 74 RLVLVFEHL 82
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 148 ALSKLQLLDLSSNGLT-GTIPPEIGNLKNLIELNVGSNSL--IGPIPSALGSLTNLSNLD 204
+ ++ L L + G I NL L++ + L + +P L L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLE 77
Query: 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
LS N++ G + + NLT L+LS N +K
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 12/122 (9%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
+ F NL L++ L S+ + L KL+ L+LS N + G + L NL LN
Sbjct: 44 LTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 181 VGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-----IAGMKNLTWLDLSNNN 233
+ N L I + L L L +LDL + +++ + + LT+LD +
Sbjct: 102 LSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNL--NDYRESVFKLLPQLTYLDGYDRE 158
Query: 234 IK 235
+
Sbjct: 159 DQ 160
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 22/88 (25%), Positives = 32/88 (36%), Gaps = 8/88 (9%)
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
++ L+ N SN G I NL L L + L + + + L L+LS
Sbjct: 25 AVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 232 NNIKGSIPVRLSPNKGLC----GGNFLD 255
N I G + + L GN L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
Y +VYK G ALK++ ++EE + R E ++ ++ H NIV+LY
Sbjct: 18 YATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTE 75
Query: 377 KCMFLIYEYM 386
+ L++E+M
Sbjct: 76 NKLTLVFEFM 85
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGN-LKNLIELNVGSNSLIG 188
L ++ +L L+ L L L N L ++P + N L +L LN+ +N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 189 PIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
LT L L L++N+L +P + + L L L N +K S+P
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
S+P I A + LDL +N L L +L +L +G N L LT+L
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 201 SNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
+ L+LS+N+L +P + + L L L+ N ++ S+P
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLP 116
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
+ S G T ++P I L++ +NSL LT+L+ L L NKL +P
Sbjct: 13 ECYSQGRT-SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP 68
Query: 216 PEI-AGMKNLTWLDLSNNNIKGSIPVR 241
+ + +LT+L+LS N ++ S+P
Sbjct: 69 NGVFNKLTSLTYLNLSTNQLQ-SLPNG 94
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 21/70 (30%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG V+K + G++ A+KK SE + + + R E ++L Q+ H N+V L +
Sbjct: 16 YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRK 74
Query: 377 KCMFLIYEYM 386
+ + L++EY
Sbjct: 75 RRLHLVFEYC 84
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA+ G+V ALKK+ E + R E +L ++ H NIVKL
Sbjct: 16 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTE 74
Query: 377 KCMFLIYEYM 386
++L++E++
Sbjct: 75 NKLYLVFEFL 84
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 3/92 (3%)
Query: 144 PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203
+ + + + LDL + I L ++ N I + L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-IRKL-DGFPLLRRLKTL 69
Query: 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
+++N++ + +LT L L+NN++
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 148 ALSKLQLLDLSSNGLT-GTIPPEIGNLKNLIELNVGSNSL--IGPIPSALGSLTNLSNLD 204
S ++ L L ++ G + + L L+ + L I +P L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLE 70
Query: 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
LS N++SG + NLT L+LS N IK
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 140 GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTN 199
G + +L+ L + GLT +I + L L +L + N + G + N
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 200 LSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNI 234
L++L+LS NK+ + ++NL LDL N +
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 8/88 (9%)
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
++K L+ N SN G + L L + L+ I + + L L+LS+
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 232 NNIKGSIPVRLSPNKGLC----GGNFLD 255
N + G + V L GN +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 10/114 (8%)
Query: 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180
F L L+ LT SI + L+KL+ L+LS N ++G + NL LN
Sbjct: 37 LTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 181 VGSNSLIGP-IPSALGSLTNLSNLDLSSNKLSGKIPPE-----IAGMKNLTWLD 228
+ N + L L NL +LDL + +++ + + LT+LD
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL--NDYRENVFKLLPQLTYLD 146
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKA + A+K++ EE + R E +L ++ HRNI++L H
Sbjct: 47 YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHN 105
Query: 377 KCMFLIYEYM 386
+ LI+EY
Sbjct: 106 HRLHLIFEYA 115
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 20/70 (28%), Positives = 40/70 (57%), Gaps = 2/70 (2%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG+V+KA+ ++ ALK++ + +E + R E +L ++ H+NIV+L+
Sbjct: 15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSD 73
Query: 377 KCMFLIYEYM 386
K + L++E+
Sbjct: 74 KKLTLVFEFC 83
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 18/73 (24%), Positives = 37/73 (50%), Gaps = 5/73 (6%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ +VYKA+ ++ A+KK+ E + R E ++L ++ H NI+ L
Sbjct: 23 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAF 81
Query: 374 LHRKCMFLIYEYM 386
H+ + L++++M
Sbjct: 82 GHKSNISLVFDFM 94
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 23/70 (32%), Positives = 36/70 (51%), Gaps = 3/70 (4%)
Query: 318 YGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
Y +VYK + + ALK++ E EE A + R E +L + H NIV L+
Sbjct: 15 YATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTE 72
Query: 377 KCMFLIYEYM 386
K + L++EY+
Sbjct: 73 KSLTLVFEYL 82
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 44/193 (22%), Positives = 78/193 (40%), Gaps = 29/193 (15%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V + KV+A+K L E + + F E +++ +V+L+
Sbjct: 82 FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPS-- 430
+ ++++ EYM G L + N + V WA+ +V A+ H++ ++H D P
Sbjct: 142 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199
Query: 431 -------IAST----C----PDSSNRT-LLAGTYGYIAPEL----AYTMVMTEKCDVYSF 470
+ C + R GT YI+PE+ +CD +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 471 GVVTLEVLMGKHP 483
GV E+L+G P
Sbjct: 260 GVFLYEMLVGDTP 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 38/194 (19%), Positives = 67/194 (34%), Gaps = 49/194 (25%)
Query: 318 YGSVYKAQ---LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374
YG VYKA+ + K +ALK++ E S E +L ++ H N++ L L
Sbjct: 34 YGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 375 HR--KCMFLIYEYM----KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLH 424
+ ++L+++Y H A + +VK++ + + YLH
Sbjct: 89 SHADRKVWLLFDYAEHDLWH---IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 425 H------DCSPS-IASTCPDSSNRTL------LAGTYGYIAPELAYTMVMTEKCDVYSFG 471
D P+ I + A + +P +
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--SPLKPLADLDPV-------- 195
Query: 472 VVTL-----EVLMG 480
VVT E+L+G
Sbjct: 196 VVTFWYRAPELLLG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 31/170 (18%), Positives = 62/170 (36%), Gaps = 16/170 (9%)
Query: 318 YGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 370
+G V +A + A+K L T ++ +E ++L + H N+V L
Sbjct: 35 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL 92
Query: 371 GFCLHRKC-MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 429
G C + +I E+ K G+L L + + K + + + + D
Sbjct: 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY-VGAIPVDLKR 151
Query: 430 SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 479
+ S S+ + G++ + + E + +TLE L+
Sbjct: 152 RLDSITSSQSSA-----SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTN 199
S+P I + L+L SN L ++P + L L +L++ N + LT
Sbjct: 21 SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK 77
Query: 200 LSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIP 239
L+ L L NKL +P + + L L L N +K S+P
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 149 LSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPS-ALGSLTNLSNLDLS 206
L++L L LS N + ++P + L L L + N L +P+ LT L L L
Sbjct: 51 LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKLTQLKELALD 108
Query: 207 SNKLSGKIPPEIA--GMKNLTWLDLSNN 232
+N+L K P+ + +L + L N
Sbjct: 109 TNQL--KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 215
+S GLT ++P I + + L + SN L LT L+ L LS N++ +P
Sbjct: 13 RCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLP 68
Query: 216 PEI-AGMKNLTWLDLSNNNIKGSIP 239
+ + LT L L N ++ S+P
Sbjct: 69 DGVFDKLTKLTILYLHENKLQ-SLP 92
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 45/196 (22%), Positives = 71/196 (36%), Gaps = 35/196 (17%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKL-YG 371
G+G VY + GK++A+K L + NE +LS V IV + Y
Sbjct: 201 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHH----- 425
F K + I + M G L +L + E + A + L ++H+
Sbjct: 261 FHTPDK-LSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMHNRFVVY 315
Query: 426 -DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDV 467
D P+ +A GT+GY+APE L + D
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 468 YSFGVVTLEVLMGKHP 483
+S G + ++L G P
Sbjct: 375 FSLGCMLFKLLRGHSP 390
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 19/78 (24%), Positives = 38/78 (48%), Gaps = 10/78 (12%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG----- 371
+G V+KA+ G+ ALKK+ +E I + R E ++L + H N+V L
Sbjct: 30 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTK 88
Query: 372 ---FCLHRKCMFLIYEYM 386
+ + ++L++++
Sbjct: 89 ASPYNRCKGSIYLVFDFC 106
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 46/195 (23%), Positives = 74/195 (37%), Gaps = 34/195 (17%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G V Q+ GK++A KKL ++ NE Q+L +V R +V L +
Sbjct: 196 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYE 254
Query: 376 RK-CMFLIYEYMKRGSLFCNLHNNEDAV--ELDWAKRVNIVKA-MAHALAYLHH------ 425
K + L+ M G L ++++ A E R A + L LH
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCGLEDLHRERIVYR 310
Query: 426 DCSPS---------IAST----C----PDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVY 468
D P I + + + GT GY+APE+ T D +
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 469 SFGVVTLEVLMGKHP 483
+ G + E++ G+ P
Sbjct: 370 ALGCLLYEMIAGQSP 384
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 17/107 (15%), Positives = 32/107 (29%), Gaps = 18/107 (16%)
Query: 146 ISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSL----------IGPIP 191
+ ++ + LS N + + I + K+L + +
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 192 SALGSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNI 234
AL L + LS N + ++ L L L NN +
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 17/100 (17%), Positives = 30/100 (30%), Gaps = 15/100 (15%)
Query: 150 SKLQLLDLSSNGLTG----TIPPEIGNLKNLIELNVGSNSLIGP------IPSALGSLTN 199
L+ + N L + + L + + N I P + L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG-IRPEGIEHLLLEGLAYCQE 217
Query: 200 LSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIK 235
L LDL N + + + NL L L++ +
Sbjct: 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 20/105 (19%), Positives = 34/105 (32%), Gaps = 17/105 (16%)
Query: 146 ISALSKLQLLDLSSNGLT-----GTIPPEIGNLKNLIELNVGSNSLIGP-----IPSALG 195
+ L + + NG+ + + + L L++ N+ + AL
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-FTHLGSSALAIALK 241
Query: 196 SLTNLSNLDLSSNKLSGKIPPEIAGM------KNLTWLDLSNNNI 234
S NL L L+ LS + + L L L N I
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 17/105 (16%)
Query: 146 ISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGP-----IPSALGS 196
++ +L++LDL N T + + + NL EL + L+ + A
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC-LLSARGAAAVVDAFSK 270
Query: 197 LTN--LSNLDLSSNKLSGKIPPEIA-----GMKNLTWLDLSNNNI 234
L N L L L N++ + M +L +L+L+ N
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 17/110 (15%), Positives = 32/110 (29%), Gaps = 24/110 (21%)
Query: 149 LSKLQLLDLSSNGLTGTIPPEIGNL-------KNLIELNVGSNSL----IGPIPSALGSL 197
L + D+ + + IP + L L + + N+ P+ L
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 198 TNLSNLDLSSNKLS-------------GKIPPEIAGMKNLTWLDLSNNNI 234
T L +L L +N L + + L + N +
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 42/194 (21%), Positives = 77/194 (39%), Gaps = 29/194 (14%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+G V+ Q+ GK++A KKL+ ++ + E ++L++V R IV L +
Sbjct: 197 GFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFE 255
Query: 376 RKC-MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHH------DC 427
K + L+ M G + +++N ++ R A + L +LH D
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 428 SP------------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
P ++ + + AGT G++APEL D ++
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 470 FGVVTLEVLMGKHP 483
GV E++ + P
Sbjct: 375 LGVTLYEMIAARGP 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 35/198 (17%), Positives = 64/198 (32%), Gaps = 41/198 (20%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+ +V A+ + +A+K L + + E V+S++ H VKLY
Sbjct: 43 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 102
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH----- 425
+ ++ Y K G L + + + AL YLH
Sbjct: 103 EKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 426 -DCSP-------------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P + S + GT Y++PEL +
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 466 DVYSFGVVTLEVLMGKHP 483
D+++ G + +++ G P
Sbjct: 214 DLWALGCIIYQLVAGLPP 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 51/258 (19%), Positives = 83/258 (32%), Gaps = 55/258 (21%)
Query: 317 GYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHR--NIVKLY 370
G+GSVY + + A+K K S+ EL E +L +V +++L
Sbjct: 55 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 371 GFCLHRKCMFLIYEYMK-RGSLFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYLHH 425
+ LI E + LF + E + A+ +++A+ H LH
Sbjct: 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQE-ELARSFFWQVLEAVRHCHNCGVLHR 173
Query: 426 DCSPS------------IA----STCPDSSNRTLLAGTYGYIAPEL----AYTMVMTEKC 465
D + + T GT Y PE Y
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH---GRSA 230
Query: 466 DVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAS 524
V+S G++ L ++ G P + D +I+ V V + L+
Sbjct: 231 AVWSLGIL-LYDMVCGDIPFE--------HDEEIIRGQV---FFRQRVSSECQH--LIRW 276
Query: 525 TISFACLQSNPKSRPTMQ 542
CL P RPT +
Sbjct: 277 -----CLALRPSDRPTFE 289
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 24/129 (18%), Positives = 43/129 (33%), Gaps = 21/129 (16%)
Query: 150 SKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGP----IPSALGSLT-NL 200
+L+ L L L+ + + + EL V +N + + L L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 201 SNLDLSSNKLSGKIPPEIAGM----KNLTWLDLSNNNIKGS-----IPVRLSPNKGLCGG 251
L L S ++ ++ G+ +L L L +N + P L P+ L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR-- 259
Query: 252 NFLDLPSCD 260
L + C
Sbjct: 260 -TLWIWECG 267
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 13/105 (12%)
Query: 146 ISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSL----IGPIPSALGSL 197
+ L + Q++ L GLT I + L ELN+ SN L + + L +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 198 -TNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKGS 237
+ L L + L+G + + + L L LS+N + +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 10/95 (10%)
Query: 150 SKLQLLDLSSNGLTGTIPPEIG-NLKNLIELNVGSNSL----IGPIPSALGSLTNLSNLD 204
+Q LD+ L+ E+ L+ + + L I SAL L+ L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 205 LSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
L SN+L + + L L N +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 13/101 (12%)
Query: 150 SKLQLLDLSSNGLT----GTIPPEIGNLKNLIELNVGSNSL----IGPIPSALGS-LTNL 200
S+L+ L + G+T G + + ++L EL++ N L + L L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 201 SNLDLSSNKLSGKIPPEIAGM----KNLTWLDLSNNNIKGS 237
+L + S + + + + L L +SNN ++ +
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 29/153 (18%), Positives = 49/153 (32%), Gaps = 20/153 (13%)
Query: 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT----GSIPPEISALSKLQLL 155
I L + + R ++L + + LT I + L L
Sbjct: 4 DIQSLDIQCEELS-DARWAEL-LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 156 DLSSNGLTGTIPPEIGN-LKN----LIELNVGSNSL----IGPIPSALGSLTNLSNLDLS 206
+L SN L + L+ + +L++ + L G + S L +L L L LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 207 SNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
N L + L L L ++
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 14/103 (13%)
Query: 146 ISALSKLQLLDLSSNGLTGT-----IPPEIGNLKNLIELNVGSNSL----IGPIPSALGS 196
+++ + L+ L L SN L P + L L + + G + L +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
+L L L+ N+L + + L L + + +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 22/103 (21%), Positives = 34/103 (33%), Gaps = 14/103 (13%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNL-----KNLIELNVGSNSL----IGPIPSALGS 196
+ A L+ L L+ N L + L L V S S S L
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
L L +S+N+L E+ L L L++ ++
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 17/105 (16%)
Query: 147 SALSK---LQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSL----IGPIPSAL 194
S L LQ L LS N L + L +L + SL P+ S L
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 195 GSLTNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
+ + L +S+N ++ + L L L + +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 19/103 (18%), Positives = 33/103 (32%), Gaps = 14/103 (13%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSL----IGPIPSALGS 196
+ A + L +S+N + + + L L + S + + + S
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
+L L L SNKL E+ L L + I
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 21/109 (19%), Positives = 35/109 (32%), Gaps = 26/109 (23%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSL----IGPIPSALGS 196
++ L L +S+N L E+ L L + + + + L +
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 396
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMK-----------NLTWLDLSNNNI 234
+L LDLS+N L AG+ L L L +
Sbjct: 397 NHSLRELDLSNNCLGD------AGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 57/260 (21%)
Query: 317 GYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQV----LHRNIVK 368
G+G+V+ L + A+K + L+ + E +L +V H +++
Sbjct: 43 GFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102
Query: 369 LYGFCLHRKCMFLIYEYMKRGS-LFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYL 423
L + ++ L+ E LF + E ++ +V A+ H+ +
Sbjct: 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-GPSRCFFGQVVAAIQHCHSRGVV 161
Query: 424 HHDCSPS------------IA----STCPDSSNRTLLAGTYGYIAPEL----AYTMVMTE 463
H D + T GT Y PE Y
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYH---AL 218
Query: 464 KCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522
V+S G++ L ++ G P + D +I+ ++ P V L+
Sbjct: 219 PATVWSLGIL-LYDMVCGDIPFE--------RDQEILEAEL---HFPAHVSPDCCA--LI 264
Query: 523 ASTISFACLQSNPKSRPTMQ 542
CL P SRP+++
Sbjct: 265 RR-----CLAPKPSSRPSLE 279
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 42/197 (21%), Positives = 71/197 (36%), Gaps = 42/197 (21%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V + +G +A+K L + +L I+ NE ++L V +VKL
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 376 RKCMFLIYEYMKRGSLFCNLHN----NED-----AVELDWAKRVNIVKAMAHALAYLHH- 425
++++ EY+ G +F +L +E A ++ YLH
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI------------VLTFEYLHSL 160
Query: 426 --------------DCSPSIAST----CPDSSNRTL-LAGTYGYIAPELAYTMVMTEKCD 466
D I T RT L GT +APE+ + + D
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 467 VYSFGVVTLEVLMGKHP 483
++ GV+ E+ G P
Sbjct: 221 WWALGVLIYEMAAGYPP 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 89/564 (15%), Positives = 151/564 (26%), Gaps = 210/564 (37%)
Query: 1 LKCLYKLRKSLLNPIAQSTEKLIISMDPASSIFRLAALVWVAIFTCDNVAVR----SG-T 55
L+ KLR++LL + PA NV + SG T
Sbjct: 134 LQPYLKLRQALLE------------LRPA-----------------KNVLIDGVLGSGKT 164
Query: 56 IVTASALSPIQLEKKALINTGWWNSSFWTTDHCKWEGIT---CNSAGSIFELYLSGYYAG 112
V +++ K FW + CNS ++ E+
Sbjct: 165 WVALDVCLSYKVQCKMD------FKIFW---------LNLKNCNSPETVLEM-------- 201
Query: 113 FNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGN 172
L +L + PN + + I + L +L N L + + N
Sbjct: 202 ----LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQN 255
Query: 173 LKNLIELNVGSNSLI------------------GPIPSALGSLTNLSNLDLSSNKLS--- 211
K N+ L+ + +LT L L
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 212 GKIPPEI------------AGMKN--LTW-------LDLSNNNIKGSIPVRLSPN--KGL 248
+P E+ +++ TW D I+ S+ V L P + +
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV-LEPAEYRKM 374
Query: 249 CGGNFLDLPSCDTTKPATLF---VEIFLPLAIVLSVIVFACLLLAKRKYKKPKLEERATN 305
F L ++F I P I+L L+ N
Sbjct: 375 ----FDRL---------SVFPPSAHI--P-TILL------SLIWFDVIKSDV---MVVVN 409
Query: 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 365
+ +S+ S +P+ ++ L NE LHR+
Sbjct: 410 KLHKYSLVEKQPKESTI--SIPS--------IY------LELKVKLENEYA-----LHRS 448
Query: 366 IVKLY----GFCLHRK---------CMFLIY-----EYMKRGSLFCNLHNNEDAVELDWA 407
IV Y F + + E+ +R +LF + + +
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFL 503
Query: 408 KRVNIVKAMAHALAYLHHDCSPSIASTCPDSSNRTLL-AGTY-GYIAPELAYTMVMTEKC 465
++ K + HD + A S TL Y YI +
Sbjct: 504 EQ----K--------IRHDST---AWNASGSILNTLQQLKFYKPYI----------CDND 538
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSS 489
Y V + + K +L+ S
Sbjct: 539 PKYERLVNAILDFLPKIEENLICS 562
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 21/81 (25%), Positives = 35/81 (43%), Gaps = 13/81 (16%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEA---QVLSQVLHRNIVKLY 370
YG+VYKA+ +G ALK + I + R E + L H N+V+L
Sbjct: 22 YGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLM 80
Query: 371 GFCLHRKC-----MFLIYEYM 386
C + + L++E++
Sbjct: 81 DVCATSRTDREIKVTLVFEHV 101
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 11/79 (13%)
Query: 318 YGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIVKLY-- 370
YG V+KA+ G+ ALK++ EE + + R E VL H N+V+L+
Sbjct: 24 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDV 82
Query: 371 ---GFCLHRKCMFLIYEYM 386
+ L++E++
Sbjct: 83 CTVSRTDRETKLTLVFEHV 101
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 66/209 (31%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G VY+A+L +G++ A+KK+ + + R E Q++ ++ H NIV+L F
Sbjct: 67 FGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQIMRKLDHCNIVRLRYFFYSS 119
Query: 377 ------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----------AL 420
+ L+ +Y+ ++ R + + +L
Sbjct: 120 GEKKDEVYLNLVLDYVP-----ETVYR-----VARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 421 AYLH-----H-DCSPS---IASTCPD------SSNRTLLAGTY--GYI------APEL-- 455
AY+H H D P + S + L+ G YI APEL
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229
Query: 456 ---AYTMVMTEKCDVYSFGVVTLEVLMGK 481
YT + DV+S G V E+L+G+
Sbjct: 230 GATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 14/98 (14%)
Query: 150 SKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGP-----IPSALGSLTNL 200
++ L LS+N LT + + ++ L++ +G + + L L
Sbjct: 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTG-LGDEGLELLAAQLDRNRQL 213
Query: 201 SNLDLSSNKLSGKIPPEIAGM----KNLTWLDLSNNNI 234
L+++ N +A +L L L N +
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 16/102 (15%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSL----IGPIPSALGS 196
+ + + L L N L ++ + + L + +N L + + L
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGM----KNLTWLDLSNNNI 234
T++++L L L + +A + L L+++ N
Sbjct: 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 17/105 (16%)
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSLIGP-----IPSALG 195
S + LDLS N L E+ ++ LN+ NS +G + L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS-LGFKNSDELVQILA 76
Query: 196 SL-TNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
++ N+++L+LS N LS K E+ +T LDL N+
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 17/101 (16%)
Query: 150 SKLQLLDLSSNGLTGTIPPEIGNL-----KNLIELNVGSNSLIGP-----IPSALGSL-T 198
+ +LDL N + E ++ LN+ N +G + L ++
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND-LGIKSSDELIQILAAIPA 167
Query: 199 NLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
N+++L+L N L+ K E+A ++T LDLS N +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 13/101 (12%), Positives = 35/101 (34%), Gaps = 16/101 (15%)
Query: 150 SKLQLLDLSSNGLTGTIPPEIGNL----KNLIELNVGSNSL--IGP-----IPSALGSLT 198
+ + L+L N L G + L K+L + + + + + + +A ++
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 199 NLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNI 234
+ +D + ++ I+ + L N +
Sbjct: 285 KIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCL 325
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 27/140 (19%), Positives = 44/140 (31%), Gaps = 30/140 (21%)
Query: 114 NWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISAL---SKLQLLDLSSNGLTGTIPPEI 170
+ L ++N + N+ T++ A AL + ++ + + +
Sbjct: 35 DPDLEEVNLNNIMNIPVPTLKACA---------EALKTNTYVKKFSIVGTRSNDPVAFAL 85
Query: 171 GNL----KNLIELNVGSNSLIGP-----IPSAL---GSLTNLSNLDLSSNKLSGKIPPEI 218
+ L LNV SN I + AL SL L +D S L + EI
Sbjct: 86 AEMLKVNNTLKSLNVESNF-ISGSGILALVEALQSNTSLIEL-RIDNQSQPLGNNVEMEI 143
Query: 219 AGM----KNLTWLDLSNNNI 234
A M L
Sbjct: 144 ANMLEKNTTLLKFGYHFTQQ 163
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 14/72 (19%), Positives = 28/72 (38%), Gaps = 9/72 (12%)
Query: 172 NLKNLIELNVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM----K 222
N +L E+N+ + I AL + T + + + + + +A M
Sbjct: 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNN 93
Query: 223 NLTWLDLSNNNI 234
L L++ +N I
Sbjct: 94 TLKSLNVESNFI 105
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 4e-05
Identities = 18/134 (13%), Positives = 46/134 (34%), Gaps = 17/134 (12%)
Query: 117 LSQLNFSCFPNLVKLTIQFFALTGSIPPEISALS---------KLQLLDLSSNGLTGTIP 167
+ + S PNL KL + +++ L+ L + +
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 168 PEIGN---LKNLIELNVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAG 220
L L +++ + L + + + +L +++ N LS ++ E+
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
Query: 221 MKNLTWLDLSNNNI 234
+ +D+S++
Sbjct: 330 SLPMK-IDVSDSQE 342
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 58/266 (21%), Positives = 93/266 (34%), Gaps = 64/266 (24%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+ V A+ + G+ A+K + ++ + K FR E +++ + H NIVKL+
Sbjct: 27 NFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIET 85
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---------- 425
K ++LI EY G +F L + E A+ + + A+ Y H
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS--KFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 426 -----DCSPSI--------ASTCPDSSNRTLLAGTYGYIAPEL----AYTMVMTEKCDVY 468
D +I G Y APEL Y + DV+
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYD---GPEVDVW 198
Query: 469 SFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
S GV+ L L+ G P D + K + VL + P +S
Sbjct: 199 SLGVI-LYTLVSGSLPFD-------GQNLKELRERVLRGKYRIP------------FYMS 238
Query: 528 FAC-------LQSNPKSRPTMQYVSQ 546
C L NP R T++ + +
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
+D S L ++P I L + N + P LT L+ LDL +N+L+ +
Sbjct: 14 VDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VL 69
Query: 215 PPEI-AGMKNLTWLDLSNNNIKGSIP 239
P + + LT L L++N +K SIP
Sbjct: 70 PAGVFDKLTQLTQLSLNDNQLK-SIP 94
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 44/200 (22%), Positives = 68/200 (34%), Gaps = 46/200 (23%)
Query: 318 YGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G V + G+ +A LKK +E+A + E +VL H + L +
Sbjct: 161 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNSRHPFLTALK-YS 216
Query: 374 LH-RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD----- 426
+ + EY G LF +L E R A + AL YLH +
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSEKNVVY 272
Query: 427 -----------------------CSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE 463
C I ++ +T GT Y+APE+
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKTFC-GTPEYLAPEVLEDNDYGR 328
Query: 464 KCDVYSFGVVTLEVLMGKHP 483
D + GVV E++ G+ P
Sbjct: 329 AVDWWGLGVVMYEMMCGRLP 348
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 50/264 (18%), Positives = 87/264 (32%), Gaps = 69/264 (26%)
Query: 318 YGSVYKAQ-LPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G V+ A K +K K+ E + E +LS+V H NI+K+
Sbjct: 37 FGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96
Query: 372 FCLHRKCMFLIYEYMKRGS-LFCNLHNNEDAVELDWAKRV--NIVKAMA--HALAYLHHD 426
++ L+ E G LF + + E A + +V A+ +H D
Sbjct: 97 IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-PLASYIFRQLVSAVGYLRLKDIIHRD 155
Query: 427 CSP-----------SIASTCPD--SSN----RTLL---AGTYGYIAPEL----AYTMVMT 462
+ D S+ L GT Y APE+ Y
Sbjct: 156 IKDENIVIAEDFTIKLI----DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR---G 208
Query: 463 EKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD---RKVIR 518
+ +++S GV L L+ ++P L + + + P V ++
Sbjct: 209 PELEMWSLGVT-LYTLVFEENPFCELE--------ETVEAAI---HPPYLVSKELMSLVS 256
Query: 519 DILLASTISFACLQSNPKSRPTMQ 542
+ LQ P+ R T++
Sbjct: 257 GL----------LQPVPERRTTLE 270
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI 214
++ + L ++P I + L + +N + P L NL L +SNKL+ I
Sbjct: 17 VNCQNIRLA-SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AI 72
Query: 215 PPEI-AGMKNLTWLDLSNNNIKGSIP 239
P + + LT LDL++N++K SIP
Sbjct: 73 PTGVFDKLTQLTQLDLNDNHLK-SIP 97
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 19/75 (25%), Positives = 33/75 (44%), Gaps = 13/75 (17%)
Query: 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR- 376
+G V++A+L A+KK+ + + R E Q++ V H N+V L F
Sbjct: 53 FGVVFQAKLVESDEVAIKKVLQDKRFKN------R-ELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 377 -----KCMFLIYEYM 386
+ L+ EY+
Sbjct: 106 DKKDEVFLNLVLEYV 120
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 42/196 (21%)
Query: 318 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ + NG+ +A+K L L ++ +E +LS V H I++++G
Sbjct: 19 FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78
Query: 377 KCMFLIYEYMKRGSLFCNLHN----NED-----AVELDWAKRVNIVKAMAHALAYLHH-- 425
+ +F+I +Y++ G LF L A E+ AL YLH
Sbjct: 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------------CLALEYLHSKD 126
Query: 426 -------------DCSPSIAST----CPDSSNRTL-LAGTYGYIAPELAYTMVMTEKCDV 467
D + I T + T L GT YIAPE+ T + D
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 186
Query: 468 YSFGVVTLEVLMGKHP 483
+SFG++ E+L G P
Sbjct: 187 WSFGILIYEMLAGYTP 202
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 9/72 (12%), Positives = 29/72 (40%), Gaps = 9/72 (12%)
Query: 172 NLKNLIELNVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM----K 222
+ +L E+N+ + + + A + ++ L++ +S + +
Sbjct: 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSP 98
Query: 223 NLTWLDLSNNNI 234
+L L++ +N +
Sbjct: 99 SLRVLNVESNFL 110
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 45/194 (23%)
Query: 329 GKVFALKKLHTSETEELAFIKSFR-------------NEAQVLSQVLHRNIVKL-YGFCL 374
GKVF +KK+ S+ +L +K + E +L +V H IVKL Y F
Sbjct: 38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHH-------- 425
K ++LI ++++ G LF L E + V A +A AL +LH
Sbjct: 98 EGK-LYLILDFLRGGDLFTRLSKEVMFTE----EDVKFYLAELALALDHLHSLGIIYRDL 152
Query: 426 -------DCSPSIAST----C-----PDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 469
D I T + + GT Y+APE+ T+ D +S
Sbjct: 153 KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWS 211
Query: 470 FGVVTLEVLMGKHP 483
FGV+ E+L G P
Sbjct: 212 FGVLMFEMLTGTLP 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 9e-04
Identities = 21/76 (27%), Positives = 33/76 (43%), Gaps = 1/76 (1%)
Query: 318 YGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V + G A+K L+ + L + + E Q L H +I+KLY
Sbjct: 24 FGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83
Query: 377 KCMFLIYEYMKRGSLF 392
F++ EY+ G LF
Sbjct: 84 TDFFMVMEYVSGGELF 99
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 572 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.98 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.98 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.89 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.83 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.83 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.82 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.75 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.68 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.68 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.62 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.6 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.6 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.59 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.59 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.58 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.58 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.58 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.57 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.57 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.56 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.56 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.54 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.54 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.53 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.52 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.51 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.51 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.5 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.5 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.49 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.48 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.48 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.47 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.46 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.46 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.45 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.45 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.45 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.45 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.44 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.44 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.43 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.43 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.43 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.42 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.41 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.41 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.4 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.4 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.38 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.38 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.37 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.37 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.36 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.35 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.35 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.35 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.34 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.33 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.33 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.33 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.33 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.3 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.29 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.28 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.25 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.25 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.23 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.22 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.2 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.2 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.2 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.17 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.17 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.15 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.08 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.06 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.03 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.99 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.97 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.94 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.84 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.77 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.77 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.52 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.4 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.39 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.39 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.39 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.38 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.29 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.96 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.74 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.49 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.4 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.36 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.21 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.37 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.08 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.98 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 94.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 94.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 94.34 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 94.05 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 92.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 90.18 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 83.46 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.59 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=178.1
Q ss_pred hhccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 038466 301 ERATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374 (572)
Q Consensus 301 ~~~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 374 (572)
+.....+++.+.+|.|+||+||+|++. +++.||||+++...... ..++|.+|++++++++|||||+++|+|.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--HHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 334455667788999999999999863 47899999997543322 2468999999999999999999999999
Q ss_pred eCCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC
Q 038466 375 HRKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC 435 (572)
Q Consensus 375 ~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~ 435 (572)
+++..++|||||++|||.++|+.+.. ...++|.+++.|+.|||+||+||| +|++|.++..+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999999975421 235899999999999999999996 56676655331
Q ss_pred CC-------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCC
Q 038466 436 PD-------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD 495 (572)
Q Consensus 436 ~~-------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~ 495 (572)
.+ ........||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------- 252 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------- 252 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------
Confidence 10 011223568999999999999999999999999999999998 899986432
Q ss_pred cchhhhhhccc-CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 496 PKIMLIDVLDQ-RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 496 ~~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.......+... .++.|. .... .+.+++..||+.||++||||+||+++|..
T Consensus 253 ~~~~~~~i~~~~~~~~p~--~~~~---~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 253 NQDVVEMIRNRQVLPCPD--DCPA---WVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHHHTTCCCCCCT--TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCCCcc--cchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111122222 222221 1111 23457779999999999999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=358.75 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=178.4
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
+++.+...+|.|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++|||||+++|+|.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34555678999999999999853 4789999999865433 34789999999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCC------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---
Q 038466 379 MFLIYEYMKRGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--- 437 (572)
.+||||||++|+|.++++.... ...++|.+++.|+.|||+||+||| +|++|.++..+.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 9999999999999999986432 235899999999999999999996 5666665533111
Q ss_pred ----------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhh
Q 038466 438 ----------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 438 ----------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~ 500 (572)
........||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 001123568999999999999999999999999999999999 8999864321 1111
Q ss_pred hhhcc-cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 501 IDVLD-QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 501 ~~~~~-~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
..+.. .+++.|. .... .+..++..||+.||++||||+||+++|......|
T Consensus 271 ~~i~~g~~~~~p~--~~~~---~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 271 DCITQGRELERPR--ACPP---EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHTCCCCCCT--TCCH---HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHcCCCCCCcc--cccH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11111 1222221 1111 1345677999999999999999999997655444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=354.50 Aligned_cols=232 Identities=24% Similarity=0.373 Sum_probs=175.1
Q ss_pred CCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
+++.+.+.+|.|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH---HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45566778999999999999853 4789999999865432 24789999999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCC----------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----
Q 038466 379 MFLIYEYMKRGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~----------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---- 438 (572)
.++|||||++|+|.++|+..+ ....++|.+++.|+.|||+||+||| +|++|.++..+.+.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999999998642 2346999999999999999999997 46666655332110
Q ss_pred -----------C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhh
Q 038466 439 -----------S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLID 502 (572)
Q Consensus 439 -----------~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~ 502 (572)
. ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.... .......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Confidence 0 0112358999999999999999999999999999999999 899986432 1111222
Q ss_pred hcccC-CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 503 VLDQR-LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 503 ~~~~~-l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+.... ++.|. .... .+.+++..||+.||++||||++|++.|...
T Consensus 243 i~~~~~~~~p~--~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVLQRPR--TCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCCCCCT--TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCc--cchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22221 22221 1111 234567799999999999999999887543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.99 Aligned_cols=234 Identities=20% Similarity=0.364 Sum_probs=172.8
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+++.+.+.+|.|+||+||+|++.+ .||||+++...... ...++|.+|+++|++++|||||+++|+|.+ +..+||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34456677889999999999999764 48999997544332 235789999999999999999999999865 568999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
||||++|+|.++|+... ..++|.+++.|+.|||+||+||| +|++|.++..+.+
T Consensus 110 mEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999998643 35899999999999999999997 5677765532110
Q ss_pred CCCccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc-----ccCCC
Q 038466 438 SSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL-----DQRLP 509 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-----~~~l~ 509 (572)
.......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... .......+ .+.++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------RDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHTTCCCCCST
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCCcc
Confidence 011234579999999999863 4689999999999999999999999863321 11111111 11111
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. ....... .+..++..||+.||++||||.||++++...+.
T Consensus 261 ~-~~~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 261 K-LYKNCPK---AMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp T-SCTTSCH---HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c-ccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 1111111 23456779999999999999999999876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.23 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=167.7
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----eEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMFLI 382 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 382 (572)
+.+.+.+|.|+||+||+|++ +|+.||||+++.....+ ..+..|+..+.+++|||||+++|+|.+++ .+|||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 34456799999999999987 58999999997654221 23345677778899999999999998754 58999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceeeCCCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIASTCPDSSN----------------- 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~i~~~~~~~~~----------------- 440 (572)
||||++|+|.++|+.. .++|..+++++.++|+||+|||+.+ .++++|++.+..|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999854 4899999999999999999998652 3455554432211
Q ss_pred -------------ccccccccCccccccccCC------CcCcccchHHHHHHHHHHHcCCCCCCccccccC----C--CC
Q 038466 441 -------------RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS----S--SD 495 (572)
Q Consensus 441 -------------~~~~~gt~~y~APE~~~~~------~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~----~--~~ 495 (572)
.....||+.|||||++.+. .++.++|||||||++|||+||++|+........ . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 1124699999999998654 478899999999999999999988643221100 0 00
Q ss_pred c--chhhhhhcccCCCCCCChH--HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 496 P--KIMLIDVLDQRLPPPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 496 ~--~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+ ......+.+..+.++.+.. ..+....+.+++..||+.||++||||.||+++|....
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0 1111122333333322211 1122223457888999999999999999999986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=333.47 Aligned_cols=231 Identities=21% Similarity=0.290 Sum_probs=169.8
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeEEEEE
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLIY 383 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 383 (572)
+...+|.|+||+||+|.. .++..||||++....... ...++|.+|+++|++++|||||+++++|.+ ++.+|+||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 345699999999999985 468999999997554332 235789999999999999999999999875 34589999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------CCCCCceeeCCC----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------DCSPSIASTCPD----------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------~~~~~i~~~~~~----------------~~ 439 (572)
|||++|+|.+++++.. .+++.....++.|++.||+|||+ |++|.++..+.. ..
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999998543 58899999999999999999974 455554433211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ........+.....++..+.....
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~~- 257 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKVAIP- 257 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGCCCH-
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cHHHHHHHHHcCCCCCCCCccCCH-
Confidence 1234579999999998864 69999999999999999999999985321 111111112121111111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+..+||+.||++|||++|+++|.|..++
T Consensus 258 --~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 258 --EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp --HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred --HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 13456678999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.48 Aligned_cols=236 Identities=18% Similarity=0.299 Sum_probs=176.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+ ...++|.+|+++|++++|||||++++++.+++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577788999999999999985 579999999997654333 23578999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-----------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-----------------N 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-----------------~ 440 (572)
|||++|+|.++|...+ ...+++.+...++.|++.||+||| +|++|.++..+.+.. .
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999999999997543 234678888899999999999996 677777665432211 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.....++. ......
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~~-~~~~s~-- 251 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPPV-SLHYSY-- 251 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCC-CTTSCH--
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCC-CccCCH--
Confidence 123469999999999999999999999999999999999999996321 1122223333333221 111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+.++...||+.||++|||++|+++|.|..+.
T Consensus 252 -~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 252 -DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -HHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 12356668999999999999999999877543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.07 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=182.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..++.+..+|.|+||+||+|+. .+|+.||||+++...... .+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577788999999999999986 579999999997544322 256889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~ 440 (572)
|||++|+|.+++.+. .+++.+...++.|++.||+||| +|++|.++..+.+ ...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999998753 4888899999999999999996 6788776543211 112
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC-CCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~ 519 (572)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.+...+. +.......
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~~~~~~~~~s~- 298 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDNLPPRLKNLHKVSP- 298 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSSCCCCSCGGGSCH-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCCccccCCH-
Confidence 345689999999999999999999999999999999999999985321 111111111111111 11011111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCccc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK 558 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~ 558 (572)
.+.++..+||+.||++|||++|+++|.|..+..++..
T Consensus 299 --~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~ 335 (346)
T 4fih_A 299 --SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 335 (346)
T ss_dssp --HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred --HHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcc
Confidence 1235666899999999999999999999887665443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=340.48 Aligned_cols=234 Identities=20% Similarity=0.291 Sum_probs=175.3
Q ss_pred hccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCcccEEEEEE
Q 038466 302 RATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCL 374 (572)
Q Consensus 302 ~~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~ 374 (572)
...+++++.+.+|.|+||+||+|++. .++.||||+++...... ..++|.+|+++|++++| ||||+++|+|.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~--~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH--HHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 34456777889999999999999743 24689999998654432 24689999999999976 89999999997
Q ss_pred eC-CeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee
Q 038466 375 HR-KCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST 434 (572)
Q Consensus 375 ~~-~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~ 434 (572)
++ +..++|||||++|+|.++|+.... ...++|.+++.++.|||+||+||| +|++|.++..
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 65 568999999999999999986421 234899999999999999999996 5777765533
Q ss_pred CCC----------------CC---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCC
Q 038466 435 CPD----------------SS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS 494 (572)
Q Consensus 435 ~~~----------------~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~ 494 (572)
+.+ .. ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----- 293 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----- 293 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-----
Confidence 110 00 1123568999999999999999999999999999999998 9999863311
Q ss_pred Ccchhhhhhccc--CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 495 DPKIMLIDVLDQ--RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 495 ~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.. .....+.. +++.|. .... .+.+++..||+.||++||||+||+++|.
T Consensus 294 -~~-~~~~~i~~g~~~~~p~--~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 294 -DE-EFCRRLKEGTRMRAPD--YTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp -SH-HHHHHHHHTCCCCCCT--TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HH-HHHHHHHcCCCCCCCc--cCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 11 11122211 222221 1111 1345667899999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=332.06 Aligned_cols=228 Identities=18% Similarity=0.231 Sum_probs=178.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.....+....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688889999999999999985 579999999998654333334568999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------------S 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------------~ 438 (572)
|||++|+|.+++.+.+ .++......++.|++.|++||| ||++|.++..+.+ .
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999998643 4788888889999999999997 6788876543211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~ 516 (572)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.... .+....+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~~p~~~s~-- 259 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFAKIIKLEYDFPEKFFP-- 259 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTTCCH--
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCcccCH--
Confidence 11234679999999999999999999999999999999999999995321 111222222222 2222221
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.++..+|++.||++|||++|+..+.+
T Consensus 260 -----~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 260 -----KARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp -----HHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred -----HHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 1235666899999999999998755443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.88 Aligned_cols=232 Identities=19% Similarity=0.257 Sum_probs=170.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.....+....++|.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4677888999999999999985 579999999998665444444568999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~~ 441 (572)
||| +|+|.+++.... .++......++.|++.|++||| +|++|.++..+.+ ....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 999 689999997643 4888888999999999999996 6788876644221 1112
Q ss_pred cccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIR 518 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~ 518 (572)
...+||+.|||||++.+..+ +.++||||+||++|||+||+.||+... .......+..... +...++
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~~~~p~~~s~---- 237 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGVYTLPKFLSP---- 237 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTTSCH----
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH----
Confidence 34679999999999988776 579999999999999999999996321 1111222222222 222221
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+.++..+||+.||++|||++|+++|.|....-
T Consensus 238 ---~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 238 ---GAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp ---HHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred ---HHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 123456689999999999999999999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.56 Aligned_cols=235 Identities=22% Similarity=0.301 Sum_probs=182.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.++....+|.|+||+||+|+. .+|+.||||++....... .+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 4577788999999999999985 569999999997554332 256889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~ 440 (572)
|||++|+|.++++.. .+++.+...++.|++.||+||| +|++|.++..+.+ ...
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999998753 3788888999999999999996 6888876643211 112
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~ 517 (572)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+. .+.++.+. ...
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~~~~~~~--~~s 374 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDNLPPRLKNLH--KVS 374 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCSCTT--SSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCcccc--cCC
Confidence 345679999999999999999999999999999999999999985321 111111111 11221111 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCccc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK 558 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~ 558 (572)
. .+.++..+||+.||++|||++|+++|.|..+..+...
T Consensus 375 ~---~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~ 412 (423)
T 4fie_A 375 P---SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 412 (423)
T ss_dssp H---HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCcc
Confidence 1 1234566899999999999999999999887655443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=328.16 Aligned_cols=219 Identities=20% Similarity=0.226 Sum_probs=170.3
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.....+|.|+||+||+|+. .+|+.||||+++.... +.+|+++|++++|||||++++++.+++..||||||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 44556799999999999985 5699999999975432 24699999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------------------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------------- 439 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------------- 439 (572)
|++|+|.++++..+ .+++.+...++.|++.||+||| +|++|.++..+.+..
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999998643 4889999999999999999997 578877664432211
Q ss_pred ---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc-----CCCCC
Q 038466 440 ---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 511 (572)
Q Consensus 440 ---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~-----~l~~~ 511 (572)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+... .+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-------GPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-------SCCHHHHHHSCCGGGGSCTT
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHcCCCCchhcCcc
Confidence 01124699999999999999999999999999999999999999863211 1111112111 12222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.++ .+.++..+||+.||++|||+.|+++++..
T Consensus 282 ~s~-------~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 282 CAP-------LTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 211 12345568999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=323.85 Aligned_cols=231 Identities=22% Similarity=0.306 Sum_probs=172.0
Q ss_pred CCccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++++.+.+|.|+||+||+|+. .+++.||||+++........ ..++.+|+++|++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5688889999999999999974 24789999999754322111 236788999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
+|||||++|+|.+++.+.. .+++.+...++.|++.||+||| +|++|.++..+.+
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999998643 4788888899999999999996 6778776543221
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.....+.|.. ..
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~p~~--~s 250 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-------RKETMTMILKAKLGMPQF--LS 250 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--SC
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-------HHHHHHHHHcCCCCCCCc--CC
Confidence 112234679999999999999999999999999999999999999996321 111222233333222211 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
. .+.++..+||+.||++||| ++|+++|.|..
T Consensus 251 ~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 251 P---EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp H---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred H---HHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 1 1235666899999999998 67898887754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.89 Aligned_cols=232 Identities=20% Similarity=0.321 Sum_probs=169.6
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-------
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------- 377 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 377 (572)
+|++.+.+|.|+||+||+|+. .+|+.||||+++...... ..++|.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 467778999999999999985 579999999997554322 3467999999999999999999999987654
Q ss_pred -----eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------
Q 038466 378 -----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------- 438 (572)
Q Consensus 378 -----~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------- 438 (572)
..|+|||||++|+|.+++.........++.....++.|++.||+||| +|++|.++....+.
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 37999999999999999987665556778778889999999999986 67888765432110
Q ss_pred ---------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcc
Q 038466 439 ---------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK 497 (572)
Q Consensus 439 ---------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~ 497 (572)
...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~~ 234 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ERV 234 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HHH
Confidence 00122469999999999999999999999999999999997 664211 000
Q ss_pred hhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 498 IMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 498 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.....+.+...|+ ...........+..+||+.||++|||+.|++++.+...
T Consensus 235 ~~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 235 RTLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 1111222222221 11111112345667899999999999999999877653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.61 Aligned_cols=243 Identities=20% Similarity=0.238 Sum_probs=174.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe------CC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------RK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~ 377 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++...... ...+++.+|+++|++++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4578888999999999999985 579999999997554322 234678899999999999999999999764 35
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
.+|+|||||+ |+|.+++.... .+++.....++.|++.||.||| +|++|.++..+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999996 78999997543 5888889999999999999996 6788876543211
Q ss_pred -------CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc--------CCCCcch---
Q 038466 438 -------SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKI--- 498 (572)
Q Consensus 438 -------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~--------~~~~~~~--- 498 (572)
.......+||+.|||||++.+. .++.++||||+||++|||+||++||....... ....+..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 0112346799999999998765 56999999999999999999999985321100 0000000
Q ss_pred -----hh---hhhcccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 499 -----ML---IDVLDQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 499 -----~~---~~~~~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.. .....+..+.+. .... .....+.++..+||+.||++|||++|+++|.|..+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPW-ETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCH-HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 000111111100 0000 000123456679999999999999999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.80 Aligned_cols=235 Identities=20% Similarity=0.279 Sum_probs=180.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.|++.+.+|.|+||+||+|+. .+|+.||||++......+ .+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4677888999999999999985 579999999997655433 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~~ 439 (572)
|||++|+|.+++..... .+++.+...++.||+.||.||| +|++|.++....+ ..
T Consensus 234 E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999975432 4788888899999999999997 5777776544321 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 517 (572)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+... ..+.+......
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHhCCCCCCcccccCCC
Confidence 1234579999999999999999999999999999999999999985321 11111222221 11111101111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
. .+.++...||+.||++|||+.|+++|.|.....
T Consensus 385 ~---~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 385 E---DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp H---HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 1 123566689999999999999999998876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=293.05 Aligned_cols=246 Identities=32% Similarity=0.506 Sum_probs=185.2
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+.....+|.|+||.||+|+..+|+.||||++........ ...|.+|++++++++||||++++++|.+++..++|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 4567888889999999999999988899999999986543221 23688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC---------------------
Q 038466 383 YEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN--------------------- 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~--------------------- 440 (572)
|||+++|+|.++++... ....++|..+..++.+++.|++|||+.+.++++|.+.+..+
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 99999999999998754 23458999999999999999999998766666654332111
Q ss_pred ------ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC----------CCCcchhhhhhc
Q 038466 441 ------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS----------SSDPKIMLIDVL 504 (572)
Q Consensus 441 ------~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~----------~~~~~~~~~~~~ 504 (572)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+....... ............
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred cccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 1123489999999999888899999999999999999999999863211100 000011112223
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+........... ...+..++..||+.||++|||+++|+++|.....
T Consensus 266 ~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 266 DVDLQGNYKDEE---VEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CTTCTTSCCHHH---HHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred ChhhccccCHHH---HHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 333333332222 2344577889999999999999999999976544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.80 Aligned_cols=235 Identities=20% Similarity=0.240 Sum_probs=175.4
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH---HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
..++|++..++|.|+||+||+|+. .+|+.||||+++...... .......+.++++++.++|||||++++++.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 346788899999999999999985 569999999997543221 1122333455778888999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------- 437 (572)
+|+|||||+||+|.++|...+ .++......++.+|+.||+||| ||++|.++..+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999998643 4788888889999999999997 5777776543221
Q ss_pred CCCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCCh
Q 038466 438 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDR 514 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~ 514 (572)
.......+||+.|||||++.. ..|+.++||||+||++|||+||+.||..... .........+... ..+...+.
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcCCCCCCCccCCH
Confidence 112234689999999999965 5799999999999999999999999953211 1111111122222 22222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
. +..+...|++.||++|++ ++||.+|.|..
T Consensus 420 ~-------a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 420 E-------LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp H-------HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred H-------HHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 1 235566899999999998 79999888764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.97 Aligned_cols=171 Identities=23% Similarity=0.252 Sum_probs=140.8
Q ss_pred cCCccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 378 (572)
.+.+++.+.+|.|+||+||+|+. .+++.||||++...... .++.+|+++|+++ +|||||++++++.+++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34578888999999999999974 35789999998765432 3577899999998 69999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------- 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------- 439 (572)
.|+|||||++|+|.+++. .+++.+...++.|++.|++||| +|++|.++..+.+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999884 3778888899999999999996 688887654321100
Q ss_pred ---------------------------------CccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 440 ---------------------------------NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 440 ---------------------------------~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
.....+||+.|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 01124699999999998765 58999999999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=283.40 Aligned_cols=243 Identities=31% Similarity=0.444 Sum_probs=183.9
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..++++....+|.|+||.||+|+..+|+.||||++....... .+.|.+|++++++++||||++++++|.+++..++|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH---HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH---HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 456788888999999999999998889999999987654332 46789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCC-cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~-~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------- 438 (572)
|||+++|+|.+++..... ...++|..+..++.+++.|+.||| +|++|..+....+.
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999976432 235899999999999999999997 46666655332110
Q ss_pred --CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCc--------chhhhhhcccCC
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--------KIMLIDVLDQRL 508 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~--------~~~~~~~~~~~l 508 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.|+............ .......+++..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 0112345899999999998889999999999999999999999998532211000000 000112233333
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
........ ...+..++..||+.||++|||+++|++++...
T Consensus 274 ~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 274 ADKIRPES---LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTCSCHHH---HHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHH---HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 33222222 22345677799999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=279.61 Aligned_cols=236 Identities=21% Similarity=0.310 Sum_probs=179.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.....+|.|+||+||+|.. .+|+.||||++....... .+.+.+|+.++++++|||||++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34577788999999999999985 579999999987544332 25688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~ 439 (572)
|||+++|+|.+++... .+++.....++.+++.|++||| +|++|.++....+ ..
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999753 3788889999999999999997 4666655433211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~ 516 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........ .+....+ ...
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~--~~~ 242 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPELQNP--EKL 242 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCSCCCSCG--GGS
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCc--ccc
Confidence 12345699999999999999999999999999999999999999853211 11111111 1111111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCccc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVK 558 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~ 558 (572)
.. .+..+...||+.||++|||++|++++.+.....+...
T Consensus 243 ~~---~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 281 (297)
T 3fxz_A 243 SA---IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281 (297)
T ss_dssp CH---HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred CH---HHHHHHHHHccCChhHCcCHHHHhhChhhcccCcccc
Confidence 11 1235666899999999999999999988876655443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=281.68 Aligned_cols=232 Identities=24% Similarity=0.365 Sum_probs=172.4
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..++++...+|.|+||+||+|+. +|+.||||++....... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 34566778899999999999986 57889999997654332 23468999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC--------CCCCceeeCCCC-----------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD--------CSPSIASTCPDS----------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~--------~~~~i~~~~~~~----------------- 438 (572)
||+++|+|.+++........+++..+..++.+++.|++|||.. ++|..+....+.
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999998754444589999999999999999999864 233322221110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhh--c--ccCCCCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV--L--DQRLPPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~--~--~~~l~~~~~~ 514 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+ . ....+...+.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCCCCccCCH
Confidence 01123468999999999999999999999999999999999999986331 11111111 1 1112222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..+...||+.||++|||+++|++.+...
T Consensus 267 -------~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 267 -------QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 123566689999999999999999987544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-32 Score=276.49 Aligned_cols=234 Identities=24% Similarity=0.381 Sum_probs=177.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++.+...+|.|+||.||+|.. .+|+.||+|++...... ..+.|.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4566678899999999999986 46999999998665432 2468999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------------ 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------------ 439 (572)
||+++|+|.+++.... ..++|..+..++.+++.|++||| +|++|..+....+..
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999998643 25899999999999999999997 466666553321100
Q ss_pred -------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 440 -------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 440 -------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ..........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--DFGLNVRGFLDR 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--TSSBCHHHHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--HHhhhhhccccc
Confidence 00134689999999999999999999999999999999999999753221111 001111222222
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..++..+.. +..++..||+.||++|||+.++++.+...+
T Consensus 243 ~~~~~~~~~-------l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 YCPPNCPPS-------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp TCCTTCCTT-------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCHH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 223222222 234566899999999999999999876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=279.68 Aligned_cols=235 Identities=20% Similarity=0.241 Sum_probs=178.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||.||+|... +|+.||+|.+...... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 45677788999999999999864 6899999999765432 256889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~~ 439 (572)
||+++|+|.+++.... ..+++.....++.+++.|+.||| +|++|..+..... ..
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999997543 35888999999999999999997 4666665543321 01
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH-H
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI-R 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~ 518 (572)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.......+ .... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~--~~~~~~ 229 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFD--EEAFKE 229 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCC--HHHHTT
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHcCCCCCC--hhhhcc
Confidence 1123468999999999998889999999999999999999999985321 1111222222222211 0000 0
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
-...+..+...|++.||++|||+.|++++.|.....
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 011234566799999999999999999999887554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=278.55 Aligned_cols=233 Identities=21% Similarity=0.290 Sum_probs=178.3
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++.+...+|.|+||.||+|+. .+|+.||||++....... ...+++.+|++++++++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 345678888999999999999986 679999999997654322 234678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SS 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~ 439 (572)
||||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|.++..+.+ ..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999997543 4788888999999999999997 4666665433211 11
Q ss_pred CccccccccCccccccccCCCcC-cccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC-hHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s-~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~ 517 (572)
......||+.|+|||++.+..++ .++||||+||++|||+||+.||+... .......+.......|.. ...
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~~s~~- 240 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRGKYRIPFYMSTD- 240 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCHH-
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCHH-
Confidence 12345699999999999887765 79999999999999999999986321 111112222222222211 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+..+...||+.||++|||++|+++|.|...
T Consensus 241 -----~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 241 -----CENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -----HHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -----HHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 234566899999999999999999987754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-32 Score=277.31 Aligned_cols=231 Identities=22% Similarity=0.315 Sum_probs=174.1
Q ss_pred ccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
++....+|.|+||.||+|+.. +|+.||||++....... .+.|.+|++++++++||||+++++++..++..++||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 445568999999999999865 79999999987554332 35688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~~ 442 (572)
+++|+|.+++... .++|..+..++.+++.|+.||| +|.+|..+....+ .....
T Consensus 124 ~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 9999999988642 4899999999999999999997 4566654433211 11123
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC-hHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDIL 521 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~ 521 (572)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.+...+.... .....
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~--- 269 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-------PVQAMKRLRDSPPPKLKNSHKVSP--- 269 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSSCCCCTTGGGSCH---
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCCcCccccCCH---
Confidence 3568999999999999999999999999999999999999985321 111111111111111000 01111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+..+...||+.||++|||+++++++.+..+..
T Consensus 270 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 270 VLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 123556689999999999999999998876554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-32 Score=281.41 Aligned_cols=234 Identities=21% Similarity=0.325 Sum_probs=174.1
Q ss_pred cCCccccccccccCeeEEEEEEc--------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL 374 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~--------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 374 (572)
.+.+.+...+|.|+||.||+|+. .++..||||+++..... ...++|.+|+++++++ +|||||+++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34567778899999999999974 24568999999865432 2356899999999999 8999999999999
Q ss_pred eCCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC
Q 038466 375 HRKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC 435 (572)
Q Consensus 375 ~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~ 435 (572)
+++..|+||||+++|+|.+++..... ...++|..+..++.+++.||+||| +|++|.++...
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 99999999999999999999986432 234789999999999999999997 46666655432
Q ss_pred CCC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCC
Q 038466 436 PDS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD 495 (572)
Q Consensus 436 ~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~ 495 (572)
.+. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~------- 310 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 310 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-------
Confidence 110 01122346788999999999999999999999999999999 999985321
Q ss_pred cchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 496 PKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 496 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
... ....+.....++.+..... .+..++..||+.||++|||+.|++++|..
T Consensus 311 ~~~-~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 311 VEE-LFKLLKEGHRMDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp GGG-HHHHHHTTCCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HHHHHhcCCCCCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 1111111111111111111 12356668999999999999999998854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=277.12 Aligned_cols=231 Identities=18% Similarity=0.293 Sum_probs=171.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-------
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------- 377 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 377 (572)
++++...+|.|+||.||+|+.. +|+.||||++....... ..+.+.+|++++++++|||||+++++|.+.+
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4667788999999999999865 79999999997544322 2467899999999999999999999986643
Q ss_pred --------------------------------------------------eEEEEEecccCCChhhhhhcCCCcccCCHH
Q 038466 378 --------------------------------------------------CMFLIYEYMKRGSLFCNLHNNEDAVELDWA 407 (572)
Q Consensus 378 --------------------------------------------------~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~ 407 (572)
..++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 289999999999999999887666667888
Q ss_pred HHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------------------CCccccccccCccc
Q 038466 408 KRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------------------SNRTLLAGTYGYIA 452 (572)
Q Consensus 408 ~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------------------~~~~~~~gt~~y~A 452 (572)
....++.+++.|++||| +|.+|.++....+. .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 88999999999999997 46666554332110 01122458999999
Q ss_pred cccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccc
Q 038466 453 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQ 532 (572)
Q Consensus 453 PE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~ 532 (572)
||++.+..++.++|||||||++|||+||..|+.... ...........+. ...........+...||+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLKFPL----LFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTCCCH----HHHHHCHHHHHHHHHHHC
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccCCCc----ccccCChhHHHHHHHHcc
Confidence 999999999999999999999999999988753110 0111111111111 111111223456779999
Q ss_pred cCCCCCCCHHHHHHHHhhc
Q 038466 533 SNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 533 ~dP~~RPsm~~V~~~l~~~ 551 (572)
.||++|||++|++++.+..
T Consensus 312 ~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 312 PSPTERPEATDIIENAIFE 330 (332)
T ss_dssp SSGGGSCCHHHHHHSTTCC
T ss_pred CCCCcCCCHHHHhhchhhh
Confidence 9999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=269.61 Aligned_cols=232 Identities=21% Similarity=0.309 Sum_probs=172.3
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 381 (572)
.+.+.+...+|.|+||.||+|+.. |+.||||++....... ...+.|.+|++++++++||||+++++++.++ +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 345677789999999999999975 8889999998654332 2346799999999999999999999999887 77899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC--------CCCCceeeCCCC------------CCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD--------CSPSIASTCPDS------------SNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~--------~~~~i~~~~~~~------------~~~ 441 (572)
||||+++|+|.++++... ...+++..+..++.++++|+.|||+. .+|..+..+.+. ...
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999998643 23589999999999999999999953 333333222111 111
Q ss_pred cccccccCccccccccCCCcCc---ccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc----ccCCCCCCCh
Q 038466 442 TLLAGTYGYIAPELAYTMVMTE---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL----DQRLPPPVDR 514 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~---ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~----~~~l~~~~~~ 514 (572)
....||+.|+|||++.+..++. ++||||||+++|||+||+.||+.... ........ .+..+...+.
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCCCCCCTTCCH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCCCCCCCCCCH
Confidence 2345899999999988765544 89999999999999999999863321 11111111 1222222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. +..+...||+.||++|||++++++.+....
T Consensus 239 ~-------~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 239 H-------VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp H-------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred H-------HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 235566899999999999999999886543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=280.31 Aligned_cols=236 Identities=22% Similarity=0.290 Sum_probs=176.1
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.....+|.|+||.||+|+. .+|+.||||++...........++|.+|++++++++|||||++++++.+++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 356667899999999999985 6799999999976543333445789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-------------CCCccccc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-------------SSNRTLLA 445 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-------------~~~~~~~~ 445 (572)
|+. |++.+.+.... ..+++..+..++.+++.||.|||. |++|..+....+ ........
T Consensus 135 ~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 211 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211 (348)
T ss_dssp CCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred cCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence 998 68888776432 258899999999999999999974 556654432211 01123356
Q ss_pred cccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC---CCCCCChHHHHH
Q 038466 446 GTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR---LPPPVDRKVIRD 519 (572)
Q Consensus 446 gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~ 519 (572)
||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+.... .........
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~--- 281 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWSEY--- 281 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCCTTSCHH---
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCCCCCCHH---
Confidence 899999999874 56789999999999999999999999853211 11111111111 111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
+..+...||+.||++|||+++++++.+..+..+..
T Consensus 282 ---l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 282 ---FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp ---HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred ---HHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 23456689999999999999999999887765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=276.40 Aligned_cols=230 Identities=20% Similarity=0.275 Sum_probs=176.4
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+.. +|+.||||+++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 45777889999999999999864 69999999997543322223467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|..++.... .+++.....++.+++.||+||| +|++|.++..+.+ ...
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 9999999999987532 4788888899999999999997 4666665433211 112
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.... .+...+..
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~~--- 231 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRTLSPE--- 231 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCHH---
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCHH---
Confidence 234579999999999999999999999999999999999999985321 111111222222 22222211
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+..+...||+.||++|| ++++|++|.+..
T Consensus 232 ----~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 232 ----AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ----HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ----HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 23455689999999999 899999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=272.79 Aligned_cols=236 Identities=21% Similarity=0.311 Sum_probs=174.2
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+.+.+|.|+||.||+|+. .+++.||+|++...........+.|.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 34577788999999999999985 56899999998654433344567899999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+..+.+.
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999997543 4889999999999999999997 45666554332110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC---CChH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP---VDRK 515 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~ 515 (572)
.......||+.|+|||++.+..++.++||||+|+++|||+||+.||+.... .......+....+.. ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHHHSSCCCCHHHHSCTT
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhccCCCcchhcccC
Confidence 011224589999999999999999999999999999999999999863221 111111111111110 0000
Q ss_pred HHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhcc
Q 038466 516 VIRDILLASTISFACLQSNPKSRP-TMQYVSQEFLITR 552 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RP-sm~~V~~~l~~~~ 552 (572)
... .+..+..+|++.||++|| +++++.+.+....
T Consensus 240 ~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 240 IPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp SCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 001 123566689999999999 7898888886543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=284.37 Aligned_cols=231 Identities=24% Similarity=0.365 Sum_probs=170.1
Q ss_pred cCCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
...+.+...+|.|+||.||+|+.. ++..||||+++..... ...++|.+|++++++++|||||+++|+|.+++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 345777789999999999999864 5778999999865432 2346899999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------------- 439 (572)
++||||+++|+|.++++... ..+++.++..++.+++.||+||| +|++|..+..+.+..
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999998643 35899999999999999999997 456665543321110
Q ss_pred ------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccC--CCC
Q 038466 440 ------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPP 510 (572)
Q Consensus 440 ------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~ 510 (572)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .. .....+... .+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-------~~-~~~~~i~~~~~~~~ 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQ-DVIKAVDEGYRLPP 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-------HH-HHHHHHHTTEECCC
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-------HH-HHHHHHHcCCCCCC
Confidence 0011234678999999998999999999999999999998 999985321 11 111122211 222
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+. .... .+..++..||+.||++||++++|++.+...
T Consensus 272 ~~--~~~~---~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 272 PM--DCPA---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp CT--TCBH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc--cccH---HHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11 1111 134566789999999999999999988654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=273.99 Aligned_cols=229 Identities=28% Similarity=0.451 Sum_probs=167.5
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+++...+|.|+||.||+|+.. ++.||||++..... .+.|.+|++++++++||||++++|++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTH-----HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhH-----HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45667788999999999999875 68899999975432 3678899999999999999999998863 4789999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCC------------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSS------------------------N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~------------------------~ 440 (572)
|+++|+|.++++.......+++...+.++.++++|+.|||+.....++|.+.+.. .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999987655456788899999999999999999733223333321111 1
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhh-hhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI-DVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~ 519 (572)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||+.... ...... ....... ++.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~- 231 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVHNGTR-PPLIKNLPK- 231 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHHTTCC-CCCBTTCCH-
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHhcCCC-CCcccccCH-
Confidence 1223589999999999999999999999999999999999999863211 111111 1111111 111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..++..||+.||++|||++++++++...
T Consensus 232 --~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 232 --PIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 123566689999999999999999988653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=278.24 Aligned_cols=238 Identities=21% Similarity=0.261 Sum_probs=169.1
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----eEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 380 (572)
+.+++...+|.|+||.||+|+.. ++.||||++....... ..+..|+.++++++|||||++++++.+.. ..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHH----HHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34667789999999999999875 7899999997654322 35567999999999999999999998754 479
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC----------------CCCCceeeCCC-------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD----------------CSPSIASTCPD------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~----------------~~~~i~~~~~~------- 437 (572)
+||||+++|+|.++++.. .++|..+..++.+++.|++|||.. ++|..+....+
T Consensus 99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999999753 389999999999999999999964 33333221110
Q ss_pred ------------CCCccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCC-------
Q 038466 438 ------------SSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS------- 493 (572)
Q Consensus 438 ------------~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~------- 493 (572)
........||+.|+|||++.+ ..++.++|||||||++|||+||+.||+........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 001122468999999999876 45678999999999999999999998643211000
Q ss_pred C--CcchhhhhhcccCCCCCCCh--HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 494 S--DPKIMLIDVLDQRLPPPVDR--KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 494 ~--~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. ...............+.... ........+..++..||+.||++|||+++|++.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00011111112222221111 0111122345677899999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=282.45 Aligned_cols=237 Identities=23% Similarity=0.315 Sum_probs=177.5
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+++.+...+|.|+||.||+|+.. +++.||||+++...... ...+|.+|+.++++++|||||++++++.+++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 455677889999999999999842 46789999997543332 2357889999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCC----CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-------- 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~----~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-------- 439 (572)
..++||||+++|+|.+++.... ....+++..+..++.+++.||+||| +|++|.++....+..
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999998643 2235899999999999999999997 466776655432211
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .......+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-------~~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence 1112346889999999988899999999999999999998 999985321 111111111
Q ss_pred cc-CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 505 DQ-RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 505 ~~-~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. ....+. .... .+..++..||+.||++|||+.+|+++++.....
T Consensus 301 ~~~~~~~~~--~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMDPPK--NCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCCCCT--TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCc--cCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 111111 1111 123566789999999999999999998766443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=269.10 Aligned_cols=231 Identities=24% Similarity=0.419 Sum_probs=164.6
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHH-HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+.+.+|.|+||.||+|... |+.||||++....... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 345677789999999999999975 8899999987544322 22346789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC---------CCCceeeCCC-------C--------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC---------SPSIASTCPD-------S-------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~---------~~~i~~~~~~-------~-------- 438 (572)
|||+++|+|.+++... .+++.....++.+++.|+.|||+.. +|..+..... .
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999988642 4788899999999999999998643 3433322210 0
Q ss_pred --------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC
Q 038466 439 --------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510 (572)
Q Consensus 439 --------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~ 510 (572)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||..... ..............
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAMNKLAL 233 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHTSCCCC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhcCCCCC
Confidence 001123589999999999888899999999999999999999999853221 11111111111111
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+.+..... .+..+...||+.||++|||+.|+++++.
T Consensus 234 ~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 234 PIPSTCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 11111111 1235666899999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=271.89 Aligned_cols=233 Identities=22% Similarity=0.310 Sum_probs=163.1
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh--cCCCCcccEEEEEEeC----C
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCLHR----K 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~ 377 (572)
.+.+.+.+.+|.|+||.||+|+. +|+.||||++..... +.+..|.+++.. ++||||+++++++... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34677788999999999999987 688999999975432 345567777766 8999999999997653 4
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------------CCCCCceeeCCCC-----
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------------DCSPSIASTCPDS----- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------------~~~~~i~~~~~~~----- 438 (572)
..++||||+++|+|.++++.. .+++..+..++.+++.|++|||. |++|.++....+.
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 589999999999999999642 48899999999999999999992 3444433221110
Q ss_pred -----------CC-----ccccccccCccccccccCC------CcCcccchHHHHHHHHHHHcC----------CCCCCc
Q 038466 439 -----------SN-----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------KHPRDL 486 (572)
Q Consensus 439 -----------~~-----~~~~~gt~~y~APE~~~~~------~~s~ksDVySfGvvl~ElltG----------~~P~~~ 486 (572)
.. .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 00 1123689999999998876 566899999999999999999 666642
Q ss_pred cccccCCCCcchhhhhhc-ccCCCCCCChH--HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 487 LSSLSSSSDPKIMLIDVL-DQRLPPPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~--~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.... .. ......... .....+..+.. .......+.+++..||+.||++|||+.+|++.|..
T Consensus 236 ~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPN--DP-SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCS--SC-CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC--Cc-chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2110 00 000111111 11111111110 11112234567789999999999999999998853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=276.39 Aligned_cols=236 Identities=22% Similarity=0.245 Sum_probs=175.2
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH---HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.+++...+|.|+||.||+|+.. +|+.||||.+........ ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4667788999999999999864 699999999875432110 013578899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------- 438 (572)
||||+++|+|.+++... ..+++.....++.+++.|+.||| +|++|..+......
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999753 25889999999999999999997 46666654332111
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
.......||+.|+|||++....++.++|||||||++|||+||+.||.... .......+.......+ ..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~--~~ 239 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYEFE--DE 239 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHTCCCCC--HH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHhcCCCcC--cc
Confidence 11123468999999999998999999999999999999999999985321 1111111111111110 00
Q ss_pred HH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 516 VI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 516 ~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.. .....+..+...||+.||++|||+++++++.+....
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 00 000123456668999999999999999999887644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=280.47 Aligned_cols=237 Identities=22% Similarity=0.258 Sum_probs=177.2
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH---HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+.+++...+|.|+||.||+|+.. +|+.||+|.++....... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 345777889999999999999864 699999999975432210 0135788999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------- 438 (572)
++||||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999997532 5889999999999999999997 46666654332111
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~-- 238 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITAVSYDFD-- 238 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCC--
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCC--
Confidence 11223469999999999999899999999999999999999999985321 1111112222211111
Q ss_pred hHHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 514 RKVIR-DILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 514 ~~~~~-~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..... ....+..+...||+.||++|||+.|+++|.|...
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 00000 0012345667899999999999999999988753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=266.40 Aligned_cols=227 Identities=22% Similarity=0.337 Sum_probs=173.4
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++++...+|.|+||.||+|+..+++.||+|++....... ++|.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4567778899999999999998888899999998655433 468899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~ 440 (572)
|+++|+|.+++..... .+++..+..++.+++.|++|||+ |++|..+....+.. .
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999975432 57889999999999999999974 55555443311100 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc---CCCCCCChHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPVDRKV 516 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~~ 516 (572)
.....||+.|+|||++....++.++||||+|+++|||+| |+.||+... .......+... ..+...+ .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~-~- 234 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKPRLAS-T- 234 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCCCCTTSC-H-
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhcCccCCCCCcCC-H-
Confidence 112345678999999998899999999999999999999 999985321 11111111111 1111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..+...||+.||++|||++++++++...
T Consensus 235 -----~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 235 -----HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 123566689999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=285.60 Aligned_cols=231 Identities=22% Similarity=0.357 Sum_probs=173.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++.+...+|.|+||.||+|+.. +++.||||.++..... ...++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 345667788999999999999975 7899999999754322 2346789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC--------------C--
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS--------------N-- 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~--------------~-- 440 (572)
|||+++|+|.++++... ..+++.....++.+++.||+||| +|++|.++....+.. .
T Consensus 191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999997532 34889999999999999999997 466666554322110 0
Q ss_pred ---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc--CCCCCCCh
Q 038466 441 ---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDR 514 (572)
Q Consensus 441 ---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~ 514 (572)
.....+++.|+|||++....++.++|||||||++|||+| |+.||..... . ...+.+.. +++.+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~-- 338 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------Q-QTREFVEKGGRLPCPE-- 338 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------H-HHHHHHHTTCCCCCCT--
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHcCCCCCCCC--
Confidence 011224678999999998899999999999999999998 9999864321 1 11111211 122111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.... .+..++..||+.||++|||+++|++.+...
T Consensus 339 ~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 339 LCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111 123566789999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=278.97 Aligned_cols=234 Identities=21% Similarity=0.287 Sum_probs=177.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3467778899999999999986 468999999997654322 23467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999887542 4788999999999999999997 46666655432111
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~ 516 (572)
.......||++|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... +.+.....
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTTGGGGS
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCcccccCC
Confidence 11123569999999999999899999999999999999999999985321 1111111222211 11110111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. .+..+...||+.||++|||+.+++++.|...
T Consensus 258 ~~---~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 258 TP---EAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CH---HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CH---HHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11 1345666899999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.66 Aligned_cols=234 Identities=21% Similarity=0.287 Sum_probs=172.5
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++...+|.|+||.||+|+.. +++.||||++......+ ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46778889999999999999864 79999999987554322 2357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+..+...
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999987542 4889999999999999999997 46666554332110
Q ss_pred CCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.......||+.|+|||++.+..+ +.++|||||||++|||+||+.||+.... ...............+......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 235 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPWKKID 235 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT------TSHHHHHHHTTCTTSTTGGGSC
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHhcccccCCccccCC
Confidence 01123468999999999987765 7899999999999999999999863221 1111111111111111001111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. .+..+...||+.||++|||++|++++.|...
T Consensus 236 ~---~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 236 S---APLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp H---HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred H---HHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1 1235666899999999999999999988754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.62 Aligned_cols=234 Identities=22% Similarity=0.295 Sum_probs=173.0
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+.+...+|.|+||.||+|+.. .+..||||+++...... ..+.|.+|++++++++||||+++++++.+++..+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 45667789999999999999863 35579999998654322 2468999999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.++++... ..+++..+..++.+++.|+.||| +|++|.++..+.+..
T Consensus 127 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999999999997543 25889999999999999999997 466666544321110
Q ss_pred -----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 440 -----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 440 -----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. .....+.+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~ 276 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-------NRDVISSVE-EGYRLPAP 276 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHHHHHHH-TTCCCCCC
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHH-cCCCCCCC
Confidence 0011235678999999998899999999999999999999 999985321 111111111 11111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..... .+..++..||+.||++|||+.+|++.+.....
T Consensus 277 ~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 277 MGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 12356678999999999999999999866543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.78 Aligned_cols=232 Identities=20% Similarity=0.295 Sum_probs=172.1
Q ss_pred ccCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+.+.+...+|.|+||.||+|+. .+++.||||+++...... ..+.|.+|++++.++ +|||||+++|+|.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH--HHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 445677888999999999999962 357899999998654332 246799999999999 79999999999988
Q ss_pred CCe-EEEEEecccCCChhhhhhcCCC------------------------------------------------------
Q 038466 376 RKC-MFLIYEYMKRGSLFCNLHNNED------------------------------------------------------ 400 (572)
Q Consensus 376 ~~~-~~lV~Ey~~~GsL~~~l~~~~~------------------------------------------------------ 400 (572)
.+. .++||||+++|+|.++++....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 654 8999999999999999986432
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C---CCcccccc
Q 038466 401 ---------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S---SNRTLLAG 446 (572)
Q Consensus 401 ---------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~---~~~~~~~g 446 (572)
...+++.....++.+++.||+|||+ |++|.++....+ . .......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1128889999999999999999974 566654432110 0 01123457
Q ss_pred ccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc----cCCCCCCChHHHHHHH
Q 038466 447 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD----QRLPPPVDRKVIRDIL 521 (572)
Q Consensus 447 t~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~~~~~~~~~~~~~ 521 (572)
|+.|+|||++.+..++.++|||||||++|||+| |+.||..... ... ....+. ...+...+.
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~------- 323 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEE-FCRRLKEGTRMRAPDYTTP------- 323 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHH-HHHHHHHTCCCCCCTTCCH-------
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch------hHH-HHHHHHcCCCCCCCCCCCH-------
Confidence 889999999998999999999999999999998 9999853211 111 111111 111211111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+..++..||+.||++|||+++|++++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 12356668999999999999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=268.85 Aligned_cols=234 Identities=20% Similarity=0.235 Sum_probs=166.5
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH-----------------------HHHHHHHHHHHHHHH
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE-----------------------LAFIKSFRNEAQVLS 359 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~-----------------------~~~~~~f~~E~~~l~ 359 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++....... ....++|.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35677788999999999999985 568999999997543211 112357899999999
Q ss_pred hcCCCCcccEEEEEEe--CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCc
Q 038466 360 QVLHRNIVKLYGFCLH--RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSI 431 (572)
Q Consensus 360 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i 431 (572)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++.....++.+++.|++||| +|++|..
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999987 5689999999999999876543 25889999999999999999997 4666665
Q ss_pred eeeCCCC-----------------CCccccccccCccccccccCCC---cCcccchHHHHHHHHHHHcCCCCCCcccccc
Q 038466 432 ASTCPDS-----------------SNRTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 491 (572)
Q Consensus 432 ~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~---~s~ksDVySfGvvl~ElltG~~P~~~~~~~~ 491 (572)
+....+. .......||+.|+|||++.+.. ++.++|||||||++|||+||+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 4332110 0112346899999999987654 47899999999999999999999853211
Q ss_pred CCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 492 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 492 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+.......+.......+ +..+...||+.||++|||+.|+++|.|..
T Consensus 246 -----~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 -----MCLHSKIKSQALEFPDQPDIAED---LKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp -----HHHHHHHHHCCCCCCSSSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred -----HHHHHHHhcccCCCCCccccCHH---HHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 11111111111111111111111 23556689999999999999999988754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=277.70 Aligned_cols=182 Identities=16% Similarity=0.224 Sum_probs=149.7
Q ss_pred ccCCcccccccccc--CeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 303 ATNNIDVFSIWNYD--GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 303 ~~~~~~~~~~~~~~--~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
..+.+++.+.+|.| +||.||+|+.. +|+.||||++....... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34567788899999 99999999865 79999999997654322 3457888999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------- 438 (572)
++|||||++|+|.+++..... ..+++.....++.+++.|++||| +|++|.++..+.+.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999999976422 24889999999999999999997 46666655432111
Q ss_pred ---------CCccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 ---------SNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 ---------~~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 00112368889999999987 5799999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=279.19 Aligned_cols=238 Identities=16% Similarity=0.211 Sum_probs=174.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHH--HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++...+|.|+||.||+|.. .+|+.||||++........ ...+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 466778899999999999985 5699999999864321110 0135788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC----------------
Q 038466 383 YEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS---------------- 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~---------------- 439 (572)
|||+++|+|.+.+.... ....+++.....++.+++.|++||| +|++|.++....+..
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 99999999988876432 2234788889999999999999997 466666554321110
Q ss_pred ----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 440 ----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 440 ----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ......+.......+. ..
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~~~-~~ 255 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKMNP-RQ 255 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCCCH-HH
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCCCc-cc
Confidence 1123468999999999999999999999999999999999999985321 1111122222211110 00
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...-...+..+...||+.||++|||+.++++|.+...
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 0000012345667899999999999999999987754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.35 Aligned_cols=230 Identities=23% Similarity=0.333 Sum_probs=177.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++...+|.|+||.||+|+. .+|+.||+|+++..........+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 4577788999999999999986 469999999997654332233467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCccc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNRTL 443 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~~~ 443 (572)
||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+..+.+. .....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 9999999999998643 4788888899999999999997 45666554432111 11223
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~~ 521 (572)
..||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..... ++..+. .
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~~~~-~----- 229 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNAELRFPPFFNE-D----- 229 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHCCCCCCTTSCH-H-----
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCH-H-----
Confidence 579999999999999999999999999999999999999985321 1111222333222 222221 1
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 522 LASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+..+...|++.||++|| ++++|.+|.+..
T Consensus 230 -~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 230 -VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp -HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred -HHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 23455689999999999 899999988764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=273.27 Aligned_cols=235 Identities=18% Similarity=0.217 Sum_probs=157.5
Q ss_pred ccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEecccC
Q 038466 311 SIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
+.+|.|+||.||+|+.. +|+.||||++.... ...+.+|++++.++. |||||++++++.+++..++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 56899999999999864 68999999996542 245678999999997 99999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------------CCcc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------------SNRT 442 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------------~~~~ 442 (572)
|+|.+++.... .+++.....++.+++.|++||| +|++|..+....+. ....
T Consensus 91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 99999998643 5889999999999999999997 46666554332111 1112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 522 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 522 (572)
...||+.|+|||++.+..++.++||||+||++|||+||+.||..................+.....+.+. .........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~ 246 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG-EAWKNVSQE 246 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-HHHHTSCHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-ccccCCCHH
Confidence 3457999999999999999999999999999999999999986432111111111111222222222211 110000112
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
+..+...||+.||++|||+++++++.|.....+
T Consensus 247 ~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred HHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 345667899999999999999999998876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=283.46 Aligned_cols=234 Identities=19% Similarity=0.237 Sum_probs=176.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|.. .+|+.+|+|++........ ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH-HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 3466778899999999999975 5799999999976553332 2467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------------- 437 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------------- 437 (572)
||+++|+|.+.+.... .+++.....++.+++.|+.||| +|++|.++....+
T Consensus 90 E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999987643 4788899999999999999997 5777776544211
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRK 515 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~ 515 (572)
........||++|+|||++.+..++.++||||+||++|||++|+.||.... .......+.... .+.+....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 239 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAYDFPSPEWDT 239 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCTTTTTT
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCCCcccccc
Confidence 001123568999999999999999999999999999999999999985321 111111121111 11111011
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
... .+..+...||+.||++|||+.|+++|.|...
T Consensus 240 ~s~---~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 240 VTP---EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SCH---HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCH---HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 111 1235666899999999999999999987753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.62 Aligned_cols=229 Identities=20% Similarity=0.249 Sum_probs=168.9
Q ss_pred cccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 310 FSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
...+|.|+||.||+|+. .+|+.||+|+++...... .+.|.+|++++++++|||||+++++|.+.+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 35689999999999985 569999999998755332 36789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC--C----------------CCCCcccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC--P----------------DSSNRTLL 444 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~--~----------------~~~~~~~~ 444 (572)
|+|.+++.... ..+++..+..++.+++.||+||| +|++|..+... . ........
T Consensus 171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 99999887532 35889999999999999999997 46666655321 1 01112234
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHHHHHHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKVIRDILL 522 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~ 522 (572)
.||++|+|||++....++.++|||||||++|||+||+.||.... .......+.......+.. ..... .
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~---~ 318 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-------DAETLNNILACRWDLEDEEFQDISE---E 318 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCSCSGGGTTSCH---H
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccCCCChhhhccCCH---H
Confidence 58999999999999999999999999999999999999985321 111122222222111100 00111 2
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 523 ~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..+...||+.||++|||++|++++.+....
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 3456679999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.01 Aligned_cols=234 Identities=19% Similarity=0.243 Sum_probs=176.7
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34577788999999999999985 67999999998754332222235788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~ 440 (572)
|||+ +|+|.+++.... .+++.....++.+++.|+.||| +|++|..+..+.+ ...
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999 789998887543 4888999999999999999997 5777766543211 111
Q ss_pred ccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~ 517 (572)
.....||+.|+|||++.+..+ +.++||||+||++|||+||+.||+...... ....+.. ...+...+. .
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~p~~~s~-~- 234 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------LFKKVNSCVYVMPDFLSP-G- 234 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------CBCCCCSSCCCCCTTSCH-H-
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCCCCCcccCCH-H-
Confidence 233568999999999988776 789999999999999999999986432100 0001111 111221211 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
+..+...||+.||++|||++|++++.|.....|
T Consensus 235 -----~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 235 -----AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp -----HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred -----HHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 234566899999999999999999988765433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=268.81 Aligned_cols=240 Identities=18% Similarity=0.245 Sum_probs=175.7
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--eEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l 381 (572)
+.+.+...+|.|+||.||+|+.. +|+.||||++........ .+.+.+|++++++++||||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34667789999999999999865 599999999975443221 356789999999999999999999998765 7899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee----CC---------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST----CP--------------- 436 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~----~~--------------- 436 (572)
||||+++|+|.+++........+++.....++.+++.|++||| +|++|..+.. ..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999987554445899999999999999999997 4677765532 10
Q ss_pred -CCCCccccccccCcccccccc--------CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---
Q 038466 437 -DSSNRTLLAGTYGYIAPELAY--------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--- 504 (572)
Q Consensus 437 -~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--- 504 (572)
.........||+.|+|||++. ...++.++|||||||++|||+||+.||........ .......+.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 243 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKIITGK 243 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHHHHHHC
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHHhcCC
Confidence 011112346899999999875 57789999999999999999999999853221000 000011111
Q ss_pred ------------------ccCCCCC--CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 505 ------------------DQRLPPP--VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 505 ------------------~~~l~~~--~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+.++.. ..... . ..+..+...||+.||++|||++|+++++....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGL-Q--VLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHH-H--HHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhH-H--HHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111211 11111 1 12345667999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.51 Aligned_cols=231 Identities=23% Similarity=0.379 Sum_probs=174.9
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+.+...+|.|+||.||+|+..++..||||++....... +++.+|++++.+++||||+++++++.+++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34567778899999999999998888899999998655432 46889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC---------------C--
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---------------N-- 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---------------~-- 440 (572)
||+++|+|.+++.... ..+++..+..++.+++.|++|||. |++|..+....+.. .
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999999997542 358899999999999999999974 55665443321110 0
Q ss_pred -ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCC-CCCChHH
Q 038466 441 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP-PPVDRKV 516 (572)
Q Consensus 441 -~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~-~~~~~~~ 516 (572)
.....||+.|+|||++.+..++.++||||+|+++|||+| |+.||+.... ......+... ... +.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~- 232 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHRLYRPHLASD- 232 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCCTTSCH-
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCCCCCCCcChH-
Confidence 011235667999999988889999999999999999999 9999863321 1111111111 111 111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.||++|||+.++++++...++
T Consensus 233 -----~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 233 -----TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 12356668999999999999999999976544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=268.08 Aligned_cols=243 Identities=19% Similarity=0.233 Sum_probs=172.1
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+++.+.+|.|+||+||+|+..+|+.||+|++...... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4567778899999999999999888999999999754332 223467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++ +|.+.+.... ..+++.....++.+++.|+.||| +|++|..+....+. ..
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 99985 7888777543 34788889999999999999997 46666654332111 11
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC------------
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR------------ 507 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~------------ 507 (572)
.....||+.|+|||++.+ ..++.++||||+||++|||+||+.||...... .....+.......
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHHCCCChHHhhhhhccc
Confidence 223468999999999876 56899999999999999999999998633210 0000000000000
Q ss_pred ------CC--CCCChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 508 ------LP--PPVDRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 508 ------l~--~~~~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. ........ .....+.++...|++.||++|||++|+++|.|...-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 00 00000000 0001234566799999999999999999998876544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.12 Aligned_cols=236 Identities=19% Similarity=0.303 Sum_probs=173.2
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC--CCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 382 (572)
+.+.+...+|.|+||.||+|...+++.||||++....... ...+.|.+|++++.+++| |||+++++++.+++..++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4567788999999999999999889999999987554322 234789999999999987 9999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC--------C----------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP--------D----------S 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~--------~----------~ 438 (572)
|| +.+|+|.+++.... .+++..+..++.+++.|+.||| +|++|..+.... . .
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCccccc
Confidence 99 56889999998643 4788899999999999999997 466665543210 0 0
Q ss_pred CCccccccccCccccccccC-----------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 439 SNRTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
.......||++|+|||++.+ ..++.++|||||||++|||+||+.||.... .........+++.
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPN 237 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHCTT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHhcCC
Confidence 01123469999999999854 678999999999999999999999985321 1111122233322
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.....+..... .+..++..||+.||++|||+.|++++.|.....
T Consensus 238 ~~~~~~~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 238 HEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SCCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cccCCcccCCH---HHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 22111111111 123566689999999999999999998876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=274.88 Aligned_cols=232 Identities=19% Similarity=0.249 Sum_probs=179.3
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++...+|.|+||.||+|+.. +|+.||||++...........+.+.+|++++++++||||+++++++.+++..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456778889999999999999864 699999999976543333335678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCc
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNR 441 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~ 441 (572)
||||+++|+|.+++.... .+++.....++.+++.||+||| +|++|..+..+.+. ...
T Consensus 119 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999999999998643 4788889999999999999997 46666655432111 112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~ 519 (572)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... +...+. .
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~~~-~--- 264 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPSHFSS-D--- 264 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTCCH-H---
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCH-H---
Confidence 34579999999999999999999999999999999999999985321 1111222222222 222221 1
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 520 ILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+..+...||+.||++||+ +++|.+|.+..
T Consensus 265 ---~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 265 ---LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp ---HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred ---HHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 234566899999999998 99999988764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.86 Aligned_cols=234 Identities=26% Similarity=0.285 Sum_probs=168.5
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++...+|.|+||.||+|+.. +++.||||+++.... .+.+.+|++++++++||||++++++|.+++..++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345777889999999999999865 588999999975432 25688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC---CC---------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP---DS--------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~---~~--------------- 438 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+.... +.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999987543 4788999999999999999997 466666554321 00
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC--CCCChH
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--PPVDRK 515 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~ 515 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........+...... .+....
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER------GDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT------CHHHHHHHHHTTCCCCCTTTTTT
T ss_pred ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc------ccHHHHHHHHhCCCccCCchhhh
Confidence 01123468999999999999999999999999999999999999985321 111111222222111 111011
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
... .+..+...||+.||++|||+.+++++.+.....
T Consensus 278 ~~~---~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 278 VSL---NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp SCH---HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CCH---HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 111 123566699999999999999999998876554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=264.18 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=179.3
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++...+|.|+||.||+|.. .+|+.||+|++....... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35677788999999999999985 468999999997654332 2346788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+.+.... .+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999988887542 4788899999999999999997 45666554432111
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChH
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRK 515 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~ 515 (572)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... .......+.... .+.+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSPEWDT 233 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTTTTTT
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-------hhHHHHHHHhccccCCchhhcc
Confidence 11123468999999999999999999999999999999999999985321 111111111111 11111011
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
... .+..+...||+.||++|||++|++++.+........
T Consensus 234 ~~~---~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 234 VTP---EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp SCH---HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred cCH---HHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 111 123566689999999999999999998876654333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=277.44 Aligned_cols=233 Identities=20% Similarity=0.311 Sum_probs=175.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++.+.+|.|+||+||+|+. .+|+.||||+++..........+.+.+|.++++.+ +|||||++++++.+++..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 45678888999999999999986 46899999999865433333456788999999998 69999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++|+|.+++.... .+++.....++.+++.|++||| +|++|.++..+.+ .
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999999997543 4888889999999999999997 4666665533211 0
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......+||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.......+.. ...
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--~~~ 249 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDEVVYPTW--LHE 249 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--SCH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--CCH
Confidence 11234569999999999998899999999999999999999999985321 111222233332222211 011
Q ss_pred HHHHHHHHHHHccccCCCCCCCH------HHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTM------QYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm------~~V~~~l~~~ 551 (572)
.+..+...|++.||++||++ +++++|.+..
T Consensus 250 ---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 250 ---DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp ---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred ---HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 12345668999999999998 8899887764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=265.61 Aligned_cols=233 Identities=22% Similarity=0.357 Sum_probs=156.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++.+...+|.|+||.||+|+. .+|+.||||.+......+....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3466778899999999999985 579999999997544333233467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++|+|.+++.... ..+++..+..++.++++|+.||| +|++|..+....+. ..
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999999998643 35889999999999999999997 45666544332110 11
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||+...... ...... +...+...+ .
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~-~--- 237 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TLNKVVLADYEMPSFLS-I--- 237 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCCCCCTTSC-H---
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HHHHHhhcccCCccccC-H---
Confidence 123468999999999998899999999999999999999999986432110 001111 111222111 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.||++|||+++++++.+..+.
T Consensus 238 ---~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 238 ---EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ---HHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ---HHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 12356668999999999999999999876654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=268.54 Aligned_cols=229 Identities=21% Similarity=0.213 Sum_probs=164.0
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.++....+|.|+||+||+|+.. +|+.||||++......... ..++..|+..+.++ +|||||+++++|.+++..++||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 4566778999999999999865 7999999998754333222 23455566555555 9999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCCc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSNR 441 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~~ 441 (572)
||+ +|+|.+++.... ..++|..+..++.+++.||+||| +|++|.++..+.+ ....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 999 779988887643 35899999999999999999997 4566655432110 1112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
....||++|+|||++.+ .++.++|||||||++|||++|..|+..... ...+.....++....... .
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~ 279 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAGLS---S 279 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHHHHTTSC---H
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCcccccCCC---H
Confidence 33468999999998875 789999999999999999999776532111 111111111110000000 1
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+..+...||+.||++|||++|++++.|..+
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 2345666899999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.01 Aligned_cols=238 Identities=19% Similarity=0.336 Sum_probs=176.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++.+++|.|+||+||+|+.. +++.||||+++..........+.+.+|..++.++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 346777889999999999999864 6899999999865443333445688899999887 89999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++|+|..++.... .+++.....++.+++.||+||| +|++|.++..+.+ .
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999999999987543 4888899999999999999997 4667665533211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--CCCcchhhhhhcccCC--CCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--SSDPKIMLIDVLDQRL--PPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~l--~~~~~~ 514 (572)
......+||+.|+|||++.+..++.++||||+||++|||+||+.||+....... ..........+....+ +...+.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 287 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence 122346799999999999999999999999999999999999999964321110 0111111122222222 222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHhhc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPT------MQYVSQEFLIT 551 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPs------m~~V~~~l~~~ 551 (572)
.+..+...||+.||++||+ ++||.+|.|..
T Consensus 288 -------~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 288 -------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp -------HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred -------HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 1235566899999999998 47999987764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=267.20 Aligned_cols=235 Identities=27% Similarity=0.429 Sum_probs=172.7
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcch-HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccCC
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSET-EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRG 389 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 389 (572)
..+|.|+||.||+|.. +++.||||++..... ......+.|.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 6789999999999987 578999999875321 11223467899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------------C---Ccccc
Q 038466 390 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------S---NRTLL 444 (572)
Q Consensus 390 sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------~---~~~~~ 444 (572)
+|.+++........++|..+..++.+++.|+.|||. |++|..+....+. . .....
T Consensus 116 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 195 (307)
T 2nru_A 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI 195 (307)
T ss_dssp BHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSC
T ss_pred cHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccccc
Confidence 999999764444568999999999999999999974 5566544332110 0 01224
Q ss_pred ccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCC-------cchhhhhhcccCCCCCCChHHH
Q 038466 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-------PKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 445 ~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.||+.|+|||++.+ .++.++||||||+++|||+||+.||+.......... ......+.+++.++.. ....
T Consensus 196 ~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 272 (307)
T 2nru_A 196 VGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTS- 272 (307)
T ss_dssp CSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC-CHHH-
T ss_pred CCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc-chHH-
Confidence 68999999998765 589999999999999999999999864321110000 0001122333333221 1222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+..++..||+.||++|||+++|++++...
T Consensus 273 --~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 273 --VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22344677799999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=272.42 Aligned_cols=237 Identities=23% Similarity=0.323 Sum_probs=175.9
Q ss_pred cCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+++.+.+.+|.|+||.||+|+.. +++.||||+++..... ...+.|.+|++++++++||||++++++|.+++
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 456777889999999999999863 4589999999865432 23468999999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC---------------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCC
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPS 430 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~ 430 (572)
..++||||+++|+|.+++..... ...+++.++..++.++++|+.|||+ |++|.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 99999999999999999976421 1458999999999999999999974 55665
Q ss_pred ceeeCCCC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccc
Q 038466 431 IASTCPDS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSL 490 (572)
Q Consensus 431 i~~~~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~ 490 (572)
.+..+.+. .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-- 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC--
Confidence 44332110 01122457889999999988889999999999999999999 999985321
Q ss_pred cCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 491 SSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 491 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.......+.+...+. .+..... .+..++..||+.||++|||+.+|++++.....
T Consensus 282 -----~~~~~~~~~~~~~~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 -----HEEVIYYVRDGNILA-CPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp -----HHHHHHHHHTTCCCC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hHHHHHHHhCCCcCC-CCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 111111222222111 0011111 12356668999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.80 Aligned_cols=232 Identities=22% Similarity=0.353 Sum_probs=173.5
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+.+...+|.|+||.||+|...++..||||+++..... .++|.+|+++|++++|||||++++++. .+..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 34556777899999999999999988899999999865432 367899999999999999999999986 5678999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS----------------- 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~----------------- 439 (572)
||||++|+|.++++... ...+++..+..++.+++.||+||| +|++|.++....+..
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999997532 224788899999999999999997 456665544322110
Q ss_pred -CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChHH
Q 038466 440 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRKV 516 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~ 516 (572)
......+|+.|+|||++....++.++|||||||++|||+| |+.||.... .......+.. .+++.+. ..
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~~~--~~ 410 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPE--NC 410 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHHTCCCCCCT--TS
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--CC
Confidence 0011235678999999998899999999999999999999 999985331 1111111111 1222221 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. .+..++..||+.||++||||++|++.|....
T Consensus 411 ~~---~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 411 PE---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CH---HHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 1235667899999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=264.29 Aligned_cols=228 Identities=21% Similarity=0.360 Sum_probs=171.1
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+.+.+.+|.|+||.||+|...++..||||++....... ++|.+|++++.+++||||+++++++.+++..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34567778999999999999999888899999998655433 46889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------ 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------ 439 (572)
||+++|+|.+++.... ..+++..+..++.+++.|+.|||+ |++|..+....+..
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999997632 348899999999999999999974 55555543322110
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc---cCCCCCCChH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPVDRK 515 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~ 515 (572)
......||+.|+|||++....++.++||||+|+++|||+| |+.||..... ......+.. ...+...+ .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~ 248 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLYRPHLAS-E 248 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCCTTCC-H
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhcccCCCCCCcCC-H
Confidence 0111235678999999998889999999999999999998 9999863321 111111111 11111111 1
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..+...||+.||++|||++++++++...
T Consensus 249 ------~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 249 ------KVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 123566689999999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=277.17 Aligned_cols=234 Identities=19% Similarity=0.246 Sum_probs=177.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|.. .+|+.||+|.+......+ ...+.+|++++++++|||||++++++.+++..++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 4567778899999999999986 468999999997654332 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------S 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~ 439 (572)
||+++|+|.+++.... ..+++.....++.+++.||+||| +|++|.++....+. .
T Consensus 128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999987542 35889999999999999999997 46676655442110 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 517 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+... ..+........
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccccccCC
Confidence 11234689999999999999999999999999999999999999853211 1111111111 11111101111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. .+..+...||+.||++|||+.+++++.+....
T Consensus 279 ~---~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 279 P---EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp H---HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1 12356679999999999999999999887644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=274.46 Aligned_cols=237 Identities=18% Similarity=0.239 Sum_probs=170.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++.+.+|.|+||+||+++.. +|+.||||++....... +.+.+|+.++++++|||||++++++.+++..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 345778889999999999999864 79999999997654332 4577999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+......
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999987533 4888999999999999999997 45666554332111
Q ss_pred CCccccccccCccccccccCCCcCcc-cchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~k-sDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.......||+.|+|||++.+..++.+ +||||+||++|||+||+.||...... .........+.......+......
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCCCCCCCcCCCC
Confidence 01123468999999999988877665 89999999999999999998643210 000111112222222111110111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. .+..+..+||+.||++|||+.|+++|.|..+.
T Consensus 249 ~---~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 P---ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp H---HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 1 12356668999999999999999999887544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.44 Aligned_cols=238 Identities=20% Similarity=0.333 Sum_probs=177.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++...+|.|+||.||+|+.. +|+.||||+++..........+.+.+|.+++.++ +|||||++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 345777889999999999999864 6899999999865433334456788999999988 89999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+..+.+ .
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999987543 4788889999999999999997 4666665433211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCC--CCcchhhhhhcccC--CCCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS--SDPKIMLIDVLDQR--LPPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~--~~~~~~~~~~~~~~--l~~~~~~ 514 (572)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||+........ .........+.... .+...+.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 244 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCH
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCH
Confidence 1223457999999999999999999999999999999999999999643211000 01111111222222 2222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHhhc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTM------QYVSQEFLIT 551 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm------~~V~~~l~~~ 551 (572)
.+..+...||+.||++||+. +++.+|.+..
T Consensus 245 -------~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 245 -------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp -------HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred -------HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 12345668999999999994 7999887764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=277.09 Aligned_cols=233 Identities=18% Similarity=0.300 Sum_probs=172.5
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC--CCCcccEEEEEEeCCeEEEEEe
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+...+|.|+||.||+|...+|+.||||++....... ...+.|.+|++++++++ |||||++++++..++..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 66678899999999999998889999999987544322 23578999999999997 4999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------C---CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------S---SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~---~~ 440 (572)
+.+|+|.+++.... .+++..+..++.+++.||.||| +|++|.++..... . ..
T Consensus 137 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC--------
T ss_pred -cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCcccc
Confidence 67899999998643 5788889999999999999997 4566655433110 0 00
Q ss_pred ccccccccCccccccccC-----------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC
Q 038466 441 RTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-----------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~ 509 (572)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... ........++++...
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPNHE 286 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHCTTSC
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhCcccc
Confidence 123469999999999864 468999999999999999999999985321 111122233333222
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+.+..... .+..++..||+.||++|||+.||+++.+....
T Consensus 287 ~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 287 IEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCCCccchH---HHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 111111111 12356668999999999999999999887644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=271.01 Aligned_cols=231 Identities=22% Similarity=0.328 Sum_probs=164.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcE----EEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~----vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
+++...+.+|.|+||.||+|+. .+|+. ||+|.+...... ...++|.+|++++++++|||||+++++|.+++ .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 4567778999999999999985 34543 688888644322 22468999999999999999999999998765 7
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------- 437 (572)
++|+||+++|+|.++++.... .+++..+..++.+++.|+.||| +|++|.++....+
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999986433 5889999999999999999997 4556654432110
Q ss_pred ---CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
........||++|+|||++.+..++.++|||||||++|||+| |+.||+.... . .....+......+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------S-EISSILEKGERLPQP 241 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------G-GHHHHHHTTCCCCCC
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-------H-HHHHHHHcCCCCCCC
Confidence 001122346789999999999999999999999999999999 9999863311 1 111222221111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..... .+..++..||+.||++|||+.+|++++...
T Consensus 242 ~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 242 PICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TTBCH---HHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ccCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111 234566789999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=263.78 Aligned_cols=234 Identities=27% Similarity=0.424 Sum_probs=176.3
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++...+|.|+||.||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++.+++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 345677888999999999999985 4688999999976544333334678999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------CC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------------SN 440 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------------~~ 440 (572)
||||+++|+|.+++.... .+++.....++.+++.|+.|||. |++|..+....+. ..
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999999999987543 47888999999999999999984 4555444322110 11
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||.... .......+. ....+...+ ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~-- 233 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDFVT-EG-- 233 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCTTSC-HH--
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-------HHHHHHHHHhCCCCCCCcCC-HH--
Confidence 123468999999999999999999999999999999999999985321 111111111 112222222 11
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..+...||+.||++|||++|++++.|....
T Consensus 234 ----~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 234 ----ARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ----HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----HHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 2345668999999999999999999887543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=281.63 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=179.1
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+...+|.|+||.||+|+.. +|+.||||++...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456777889999999999999864 7999999999755433323346788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SSN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~~ 440 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+..+.+ ...
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999997543 4888999999999999999997 4566655433211 111
Q ss_pred ccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
.....||+.|+|||++.+..+ +.++||||+||++|||+||+.||+... .......+.+.....+.. ...
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--~s~- 241 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------VPTLFKKICDGIFYTPQY--LNP- 241 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------SHHHHHHHHTTCCCCCTT--CCH-
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCCcCCCcc--CCH-
Confidence 234569999999999988765 789999999999999999999986321 111122222222222211 001
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+..+...||+.||++|||++++++|.+.....
T Consensus 242 --~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 242 --SVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp --HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred --HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 123456689999999999999999998876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=287.75 Aligned_cols=232 Identities=22% Similarity=0.339 Sum_probs=174.3
Q ss_pred cCCccccccccccCeeEEEEEEcCC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..++.+...+|.|+||.||+|.... +..||||.++..... .++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3456677889999999999998764 889999999865432 36789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------CCC-
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------SSN- 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~~~- 440 (572)
||||++|+|.++++.... ..+++..+..++.+++.||+||| +|++|.++....+ ...
T Consensus 295 ~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999999986432 35889999999999999999997 4666655432110 000
Q ss_pred --ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 441 --RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 441 --~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.....+|+.|+|||++....++.++|||||||++|||+| |+.||..... . ...+.+......+.+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------S-QVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------G-GHHHHHHTTCCCCCCTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHcCCCCCCCCCCC
Confidence 111235678999999998899999999999999999999 9999853321 1 1112222221111111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. .+..++..||+.||++||||.+|++.|...
T Consensus 446 ~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 446 E---KVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1 123566789999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=274.55 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=175.7
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++...+|.|+||.||+|+. .+|+.||+|++...........+.+.+|++++++++|||||+++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35677788999999999999985 46899999999755433333356788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC----------------CCCC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP----------------DSSN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~----------------~~~~ 440 (572)
|||+++|+|..++.... .+++.....++.+++.|+.||| +|++|.++..+. ....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999999998543 4888889999999999999997 466666543321 1122
Q ss_pred ccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChH
Q 038466 441 RTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRK 515 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~ 515 (572)
.....||+.|+|||++.. ..++.++||||+||++|||+||+.||..... .........+.... .+...+.
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~p~~~s~- 245 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHTFETTVVTYPSAWSQ- 245 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHHHHHCCCCCCTTSCH-
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhhcccCCCCcCCH-
Confidence 334679999999999864 4589999999999999999999999853211 11111111111111 2222211
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPT-MQYVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPs-m~~V~~~l~~~ 551 (572)
.+..+...||+.||++||+ +++|.++.+..
T Consensus 246 ------~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 246 ------EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp ------HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred ------HHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 1234566899999999998 89998876654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.15 Aligned_cols=235 Identities=24% Similarity=0.414 Sum_probs=168.2
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHH----HHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELA----FIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
..+.+++.+.+|.|+||.||+|+. .+++.||||++......... ..++|.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 345677788999999999999986 57999999998754322111 1267899999999999999999999987665
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC--------CCCceeeCCCC-----------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--------SPSIASTCPDS----------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--------~~~i~~~~~~~----------- 438 (572)
++||||+++|+|.+.+.... ..+++..+..++.+++.|++|||... +|..+......
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred --eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999999887543 35899999999999999999998642 33322221111
Q ss_pred --------CCccccccccCccccccc--cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC
Q 038466 439 --------SNRTLLAGTYGYIAPELA--YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508 (572)
Q Consensus 439 --------~~~~~~~gt~~y~APE~~--~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l 508 (572)
.......||+.|+|||++ ....++.++||||+||++|||+||+.||+.... ..............
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----GKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-----CHHHHHHHHHHSCC
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-----cHHHHHHHHhccCC
Confidence 011224589999999998 445688999999999999999999999863211 01100111111122
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+........ .+..+...||+.||++|||+++|++.+.
T Consensus 248 ~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 248 RPTIPEDCPP---RLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCcccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1111111111 1235666899999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=281.01 Aligned_cols=229 Identities=21% Similarity=0.339 Sum_probs=171.2
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-eEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV 382 (572)
.+++.+...+|.|+||.||+|... |+.||||+++.... .+.|.+|+++|++++|||||+++|+|.+.+ ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345677789999999999999875 77999999986542 357899999999999999999999988765 79999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCcc
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNRT 442 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~~ 442 (572)
||||++|+|.++++.... ..+++..+..++.+++.||+||| +|++|.++....+. ....
T Consensus 266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc
Confidence 999999999999986432 24788899999999999999997 46666655432111 0111
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIRDI 520 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~ 520 (572)
...+|+.|+|||++....++.++|||||||++|||+| |+.||..... .. ....+... +++.+. ....
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~-~~~~i~~~~~~~~p~--~~~~-- 413 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYKMDAPD--GCPP-- 413 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT------TT-HHHHHHTTCCCCCCT--TCCH--
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCCCCC--cCCH--
Confidence 2356789999999999999999999999999999998 9999864321 11 11111111 121111 1111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..++..||+.||++|||+.++++.|...
T Consensus 414 -~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 414 -AVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 123466689999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=268.48 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=171.9
Q ss_pred cCCccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-- 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-- 376 (572)
.+.+++...+|.|+||.||+|++ .+|+.||||++...... ..++|.+|++++++++||||++++++|...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34567788999999999999983 36899999999865433 246799999999999999999999998653
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------ 438 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------ 438 (572)
...++||||+++|+|.+++.... ..+++..+..++.+++.|+.||| +|++|.++....+.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 55899999999999999997643 24889999999999999999997 45566544321100
Q ss_pred --------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc-----ccCCCCcch---hhhh
Q 038466 439 --------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-----LSSSSDPKI---MLID 502 (572)
Q Consensus 439 --------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~-----~~~~~~~~~---~~~~ 502 (572)
.......||..|+|||++.+..++.++||||||+++|||+||..|+..... ......... ...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 001123467779999999988999999999999999999999998753210 000000000 1111
Q ss_pred hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 503 VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 503 ~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+......+.+..... .+..++..||+.||++|||++++++.+...+
T Consensus 244 ~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTTCCCCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111111111111111 1235667899999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=278.95 Aligned_cols=239 Identities=20% Similarity=0.196 Sum_probs=166.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcch-----HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+.+.+...+|.|+||.||+|.. .+++.||||++..... .+......+.+|++++++++|||||++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45677788999999999999985 5689999999875431 11122346889999999999999999999975 55
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+......
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 6899999999999999887543 5889999999999999999997 46666655432111
Q ss_pred ------CCccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC
Q 038466 439 ------SNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~ 509 (572)
.......||++|+|||++.. ..++.++|||||||++|||+||+.||..... .......+......
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~------~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT------QVSLKDQITSGKYN 363 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS------SCCHHHHHHTTCCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc------hHHHHHHHhcCCCC
Confidence 01123568999999999853 6688999999999999999999999853211 00011111111111
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.. +.........+..+...||+.||++|||++|+++|.|....
T Consensus 364 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 364 FI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CC-chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 10 00000001123456679999999999999999999887543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=271.66 Aligned_cols=239 Identities=19% Similarity=0.286 Sum_probs=172.8
Q ss_pred ccCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+++.+...+|.|+||.||+|+. .++..||||.+...... ...+.+.+|+++++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 344566778899999999999985 24678999999754322 2346789999999999 99999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCc--------------------ccCCHHHHHHHHHHHHHHHHHHh------cCCCC
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDA--------------------VELDWAKRVNIVKAMAHALAYLH------HDCSP 429 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~--------------------~~l~~~~r~~i~~~ia~gl~yLH------~~~~~ 429 (572)
++..++||||+++|+|.+++...... ..+++..+..++.+++.||.||| +|++|
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 99999999999999999999864321 23789999999999999999997 45666
Q ss_pred CceeeCCCC----------------C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCcccc
Q 038466 430 SIASTCPDS----------------S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489 (572)
Q Consensus 430 ~i~~~~~~~----------------~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~ 489 (572)
..+....+. . ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 554332110 0 0112346788999999988899999999999999999998 9999853211
Q ss_pred ccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 490 LSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.......+......+.+..... .+..++..||+.||++|||+.+|++++...-.
T Consensus 281 -------~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 -------DANFYKLIQNGFKMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp -------SHHHHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------HHHHHHHHhcCCCCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111122222111111111111 12346668999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=273.85 Aligned_cols=232 Identities=19% Similarity=0.313 Sum_probs=175.9
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
..+++.+.+.+|.|+||.||+|+.. +|+.||||+++..........+.+..|.+++.++ +||||+++++++.+++..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4466788889999999999999864 6899999999764322222245677899999987 9999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
+||||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+..+.+
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999997533 4788899999999999999997 4666655433211
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRK 515 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~ 515 (572)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+.. +..+...+.
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~- 243 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDNPFYPRWLEK- 243 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCH-
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCCCCCcccCH-
Confidence 112234579999999999999999999999999999999999999985321 1111111211 222222211
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQ-YVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~-~V~~~l~~~ 551 (572)
.+..+...||+.||++||++. +|.+|.+..
T Consensus 244 ------~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~ 274 (345)
T 1xjd_A 244 ------EAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274 (345)
T ss_dssp ------HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred ------HHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence 123456689999999999997 888877654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=271.16 Aligned_cols=239 Identities=23% Similarity=0.258 Sum_probs=171.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchH--HHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
+.+.+...+|.|+||.||+|.. .+++.||+|++...... .....+.+.+|++++++++|||||++++++.+++..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3466778899999999999986 56899999998754321 12234689999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCC-------------------------------------cccCCHHHHHHHHHHHHHHHHHHh
Q 038466 382 IYEYMKRGSLFCNLHNNED-------------------------------------AVELDWAKRVNIVKAMAHALAYLH 424 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~-------------------------------------~~~l~~~~r~~i~~~ia~gl~yLH 424 (572)
||||+++|+|.+++..... ...+++.....++.+++.|++|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998852100 112345566789999999999997
Q ss_pred ------cCCCCCceeeCCCCC-----------------------CccccccccCccccccccC--CCcCcccchHHHHHH
Q 038466 425 ------HDCSPSIASTCPDSS-----------------------NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVV 473 (572)
Q Consensus 425 ------~~~~~~i~~~~~~~~-----------------------~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvv 473 (572)
+|++|..+....+.. ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 466666554321110 0123468999999999865 678999999999999
Q ss_pred HHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh--HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR--KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 474 l~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+|||+||+.||.... .......+.......+.+. .... .+..+...||+.||++|||+.+++++.|..
T Consensus 266 l~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 266 LHLLLMGAVPFPGVN-------DADTISQVLNKKLCFENPNYNVLSP---LARDLLSNLLNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp HHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCTTSGGGGGSCH---HHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHCCCCCCCCC-------hHHHHHHHHhcccccCCcccccCCH---HHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence 999999999985321 1111222222222211110 0111 123566689999999999999999998876
Q ss_pred cC
Q 038466 552 RK 553 (572)
Q Consensus 552 ~~ 553 (572)
..
T Consensus 336 ~~ 337 (345)
T 3hko_A 336 QF 337 (345)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=273.87 Aligned_cols=232 Identities=22% Similarity=0.336 Sum_probs=175.0
Q ss_pred ccCCccccccccccCeeEEEEEEc--------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFC 373 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~--------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 373 (572)
..+.+.+.+.+|.|+||.||+|+. .++..||||++....... ..+++.+|+++++++ +|||||+++++|
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH--HHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 345567778999999999999974 234689999998654332 346889999999999 999999999999
Q ss_pred EeCCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee
Q 038466 374 LHRKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST 434 (572)
Q Consensus 374 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~ 434 (572)
.+++..++||||+++|+|.+++..... ...+++..+..++.+++.||+||| +|++|..+..
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 999999999999999999999986431 235899999999999999999997 4666655433
Q ss_pred CCCC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCC
Q 038466 435 CPDS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS 494 (572)
Q Consensus 435 ~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~ 494 (572)
..+. .......||+.|+|||++.+..++.++|||||||++|||+| |+.|+....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 2110 11123456789999999999999999999999999999999 999985321
Q ss_pred Ccchhhhhhccc----CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 495 DPKIMLIDVLDQ----RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 495 ~~~~~~~~~~~~----~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
... ..+.+.. ..+...+ . .+..++..||+.||++|||+++|++++...
T Consensus 299 -~~~-~~~~~~~~~~~~~~~~~~-~------~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 -VEE-LFKLLKEGHRMDKPSNCT-N------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp -HHH-HHHHHHTTCCCCCCSSCC-H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH-HHHHHHcCCCCCCCccCC-H------HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111111 1111111 1 123566689999999999999999988554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.68 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=176.7
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+.+.+|.|+||.||+|+.. +++.||+|.+......+....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 34667788999999999999865 58999999987554333334578899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++.... .+++..+..++.+++.|+.|||. |++|..+....+ ...
T Consensus 95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999886532 48899999999999999999974 555554432211 111
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||+.... ......+.... .+...+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~---- 240 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEYSIPKHINP---- 240 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCTTSCH----
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhccCCCccccCH----
Confidence 2335689999999999998999999999999999999999999863211 11111111222 2222221
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.||++|||+++++++.+....
T Consensus 241 ---~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 241 ---VAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ---HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---HHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 12345668999999999999999999877544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=269.66 Aligned_cols=177 Identities=25% Similarity=0.274 Sum_probs=146.3
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-----CCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----HRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g~~~~~~ 377 (572)
.+.+.+...+|.|+||.||+|+. .+++.||||++...... .+.+..|++++++++ |||||++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH----HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh----hhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34567778999999999999986 57899999999754322 356778999999997 999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC---------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP--------------- 436 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~--------------- 436 (572)
..++||||+ +|+|.+++..... ..+++.....++.+++.||+||| +|++|.++....
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 999999999 9999999986432 24888899999999999999997 567776554431
Q ss_pred ----------C--------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 437 ----------D--------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 437 ----------~--------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 0 0011234689999999999999999999999999999999999999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=266.63 Aligned_cols=235 Identities=22% Similarity=0.334 Sum_probs=173.4
Q ss_pred ccCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 376 (572)
..+.+.+.+.+|.|+||.||+|.. .+++.||||+++..... ...+++.+|++++++++||||+++++++.++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345567778899999999999974 34689999999865432 2347889999999999999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCC---------------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCC
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHH------DCSP 429 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~ 429 (572)
+..++||||+++|+|.+++..... ...+++..+..++.++++|+.|||. |++|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 999999999999999999986432 1247889999999999999999974 5666
Q ss_pred CceeeCCCC----------------C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCcccc
Q 038466 430 SIASTCPDS----------------S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489 (572)
Q Consensus 430 ~i~~~~~~~----------------~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~ 489 (572)
..+....+. . ......||+.|+|||++.+..++.++||||+|+++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 544321110 0 0122346788999999988889999999999999999999 9999853211
Q ss_pred ccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 490 LSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.. ....+......+.+..... .+..+...||+.||++|||+.+|++++..
T Consensus 259 -------~~-~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 -------ER-LFNLLKTGHRMERPDNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp -------GG-HHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------HH-HHHHhhcCCcCCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 1111111111111111111 12356668999999999999999998854
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=282.17 Aligned_cols=230 Identities=23% Similarity=0.354 Sum_probs=169.9
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+.+...+|.|+||.||+|...++..||||+++..... .++|.+|+++|++++|||||+++|++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3456677889999999999999988888999999865432 2578999999999999999999999876 6689999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------S 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~ 439 (572)
||+++|+|.++++... ...+++..+..++.+++.||+||| +|++|.++....+. .
T Consensus 258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999997532 234889999999999999999997 45666544321100 0
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~ 517 (572)
......+|+.|+|||++....++.++|||||||++|||+| |+.||..... ......+.. .+++.+. ...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~~~~~--~~~ 407 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPP--ECP 407 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCT--TSC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCCCC--CCC
Confidence 0112346778999999998899999999999999999999 9999853211 111111111 1122111 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. .+..++..||+.||++|||+++|++.+...
T Consensus 408 ~---~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 408 E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred H---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 123566789999999999999999988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.15 Aligned_cols=234 Identities=25% Similarity=0.408 Sum_probs=177.4
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++...+|.|+||.||+|+.. +++.||||++...........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 345777889999999999999864 6889999998754433222346788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------CCCc
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD---------------SSNR 441 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~---------------~~~~ 441 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.|||+ |++|..+....+ ....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999999999987543 47888999999999999999984 455544432211 1112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--cCCCCCCChHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRD 519 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~ 519 (572)
....||+.|+|||++.+..++.++||||||+++|||++|+.||+.... ......+.. ...++..+. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~-~--- 238 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIVNVDLKFPPFLSD-G--- 238 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCTTSCH-H---
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHhccccCCCCcCCH-H---
Confidence 235689999999999999999999999999999999999999863211 111111222 222222221 1
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
+..+...|++.||++|||+++++++.+.....
T Consensus 239 ---~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 239 ---SKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 23456689999999999999999988775433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=265.90 Aligned_cols=235 Identities=23% Similarity=0.289 Sum_probs=173.5
Q ss_pred cCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 376 (572)
.+.+.+.+.+|.|+||.||+|+. .+++.||||+++...... ..+.|.+|+++++++ +||||+++++++.++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--HHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 45567778999999999999974 357899999998654322 246799999999999 999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCC---------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNED---------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC 435 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~---------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~ 435 (572)
+..++||||+++|+|.+++..... ...+++..+..++.+++.|+.|||. |++|..+...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 999999999999999999986432 1248999999999999999999974 5555544321
Q ss_pred CCC----------------CC---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCC
Q 038466 436 PDS----------------SN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD 495 (572)
Q Consensus 436 ~~~----------------~~---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~ 495 (572)
.+. .. .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------ 253 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc------
Confidence 110 00 112346788999999988899999999999999999999 9999853211
Q ss_pred cchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 496 PKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 496 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.......+.............. .+..++..||+.||++|||+.++++++..
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 254 -DSKFYKMIKEGFRMLSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -SHHHHHHHHHTCCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhHHHHHhccCCCCCCcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111211111111111111 12356668999999999999999999854
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=258.90 Aligned_cols=236 Identities=20% Similarity=0.306 Sum_probs=171.0
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+...+|.|+||.||+|+.. +|+.||||++...........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 345677789999999999999865 7999999999754433323346788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------SN 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~~ 440 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+....+. ..
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999999997543 4788899999999999999997 45666554332111 01
Q ss_pred ccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~ 517 (572)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||+... .......+.... .+...+ ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~- 237 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLFKKIRGGVFYIPEYLN-RS- 237 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSC-HH-
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcCcccCchhcC-HH-
Confidence 123458899999999887765 689999999999999999999985321 111111111111 222111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
+..+...||+.||++|||+++++++.+.....|.
T Consensus 238 -----l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 238 -----VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp -----HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred -----HHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 2345668999999999999999999887665443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=264.14 Aligned_cols=235 Identities=21% Similarity=0.306 Sum_probs=173.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 381 (572)
+++++.+.+|.|+||.||+|+.. +|+.||+|++....... ...+.|.+|++++++++||||+++++++.+ ++..++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45677788999999999999864 69999999997654322 234689999999999999999999998864 578999
Q ss_pred EEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhcC-----------CCCCceeeCCCCC----------
Q 038466 382 IYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHD-----------CSPSIASTCPDSS---------- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~-----------~~~~i~~~~~~~~---------- 439 (572)
||||+++|+|.+++.... ....+++..+..++.+++.|+.|||.. ++|..+..+.+..
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997532 223489999999999999999999853 3333332211110
Q ss_pred ----C---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCC
Q 038466 440 ----N---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLP 509 (572)
Q Consensus 440 ----~---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~ 509 (572)
. .....||+.|+|||++.+..++.++||||||+++|||+||+.||.... .......+... .++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKFRRIP 237 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCC
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-------HHHHHHHHhhcccccCC
Confidence 0 012357899999999998899999999999999999999999986331 11111111111 122
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
...+ . .+..+...||+.||++|||+++|+++++...+.
T Consensus 238 ~~~~-~------~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 YRYS-D------ELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TTSC-H------HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccC-H------HHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 2111 1 123456689999999999999999998766554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.80 Aligned_cols=235 Identities=23% Similarity=0.302 Sum_probs=173.3
Q ss_pred cCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 377 (572)
.+.+.+...+|.|+||.||+|+. .+++.||||++....... ..++|.+|+.++++++||||+++++++.+++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh--hHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45677788999999999999984 347799999997543322 2357899999999999999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC----cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------- 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~----~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------- 439 (572)
..++||||+++|+|.+++..... ...+++..+..++.+++.|+.|||. |++|..+.......
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999999986432 2358899999999999999999974 56666554431111
Q ss_pred --------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 440 --------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 440 --------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||.... .......+.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~ 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFVT 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-------HHHHHHHHh
Confidence 0112346889999999988899999999999999999998 999985321 111111111
Q ss_pred cc---CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 505 DQ---RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 505 ~~---~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. ..+...+ . .+..+...||+.||++||++.+|+++++.....
T Consensus 260 ~~~~~~~~~~~~-~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SGGRMDPPKNCP-G------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTCCCCCCTTCC-H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCC-H------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 1111111 1 123566689999999999999999998766443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.86 Aligned_cols=232 Identities=16% Similarity=0.267 Sum_probs=176.8
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
..+++++...+|.|+||.||+|+.. +|+.||||+++..........+.+..|.+++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3456788889999999999999865 5899999999765432223346788999999988 8999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
+||||+++|+|.+++.... .+++.....++.+++.||.||| +|++|..+..+.+
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999997543 4788899999999999999997 4666655433211
Q ss_pred CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChH
Q 038466 438 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRK 515 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~ 515 (572)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..... +...+.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~- 246 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKSMSK- 246 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCH-
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCH-
Confidence 112234579999999999999999999999999999999999999985321 1112222222222 222211
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
.+..+...||+.||++||+ +++|.+|.+..
T Consensus 247 ------~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 247 ------EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp ------HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred ------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 1234566899999999995 68998887653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=266.88 Aligned_cols=231 Identities=23% Similarity=0.325 Sum_probs=170.0
Q ss_pred cCCccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
.+.+++...+|.|+||.||+|+. .+|+.||+|+++..... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45677888999999999999985 47899999999865321 11224568899999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++||||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+..+.+.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999997533 4778888899999999999997 46677655432110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVD 513 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~ 513 (572)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... +++..+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-------RKKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCTTSC
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999985321 111122222222 222222
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
. . +..+...||+.||++|| +++++++|.+..
T Consensus 246 ~-~------~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 246 Q-E------ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp H-H------HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred H-H------HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 1 1 23455689999999999 889999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=282.13 Aligned_cols=231 Identities=20% Similarity=0.266 Sum_probs=167.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|+. .+|+.||||++...........+.+.+|++++++++||||++++++|.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4577788999999999999985 569999999997543322333467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~-----------------~~ 439 (572)
||+++|+|.+++.... .+++.....++.+++.||+|||+ |++|.++..+.+ ..
T Consensus 228 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 228 EYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 9999999999987543 47889999999999999999985 344544332111 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~ 517 (572)
......||++|+|||++.+..++.++|||||||++|||+||+.||.... .......+.... .+...+..
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~~~~-- 375 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRTLGPE-- 375 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCHH--
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCccCCHH--
Confidence 1234579999999999999999999999999999999999999985321 111111222222 22222211
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
+..+...||+.||++|| +++|+++|.+...
T Consensus 376 -----~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 376 -----AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp -----HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -----HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 23456689999999999 9999999887653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=265.05 Aligned_cols=241 Identities=19% Similarity=0.264 Sum_probs=170.0
Q ss_pred Ccccc-ccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEE
Q 038466 306 NIDVF-SIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 306 ~~~~~-~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+. ..+|.|+||.||+|+. .+|+.||||++....... .+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34443 5789999999999985 579999999997553322 35788999999984 799999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS----------------- 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~----------------- 439 (572)
|||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+....+..
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999997643 4788889999999999999997 456665543321110
Q ss_pred ----------CccccccccCccccccccC-----CCcCcccchHHHHHHHHHHHcCCCCCCccccccCC-----CC---c
Q 038466 440 ----------NRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-----SD---P 496 (572)
Q Consensus 440 ----------~~~~~~gt~~y~APE~~~~-----~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~-----~~---~ 496 (572)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||......... .. .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 0012348999999999864 56899999999999999999999998643211000 00 0
Q ss_pred chhhhhhcccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 497 KIMLIDVLDQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
......+.......+ .... .-...+..+..+||+.||++|||+.|++++.+.....
T Consensus 247 ~~~~~~i~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP--DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHCCCCCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHhccCcccC--chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 001111122222111 0000 0001234566799999999999999999998876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=260.84 Aligned_cols=233 Identities=21% Similarity=0.283 Sum_probs=167.2
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFL 381 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 381 (572)
+.+...+|.|+||.||+|.. .++..||+|++....... ...+.|.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 44556799999999999985 568899999987554322 235789999999999999999999999875 356899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC--------CCCceeeCCCC---------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--------SPSIASTCPDS--------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--------~~~i~~~~~~~--------------- 438 (572)
||||+++|+|.+++.... .+++.....++.+++.|+.|||... +|..+......
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999997532 4788899999999999999998642 33333221110
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.......||+.|+|||++. ..++.++||||+|+++|||+||+.||..... .............+...+....
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGGGCCC
T ss_pred ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCCccccCCCCC
Confidence 1112345899999999876 4589999999999999999999999853211 1111111111111111111110
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. .+..+...||+.||++|||+++++++.|....
T Consensus 257 ~---~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 P---EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp H---HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred H---HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 1 13456678999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=258.87 Aligned_cols=228 Identities=22% Similarity=0.319 Sum_probs=173.0
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+.+...+|.|+||.||+|...+++.||+|++....... +++.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 4566778899999999999998888999999998654332 568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------N 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------~ 440 (572)
|+++|+|.+++.... ..+++..+..++.+++.|+.|||. |++|..+..+.+.. .
T Consensus 84 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 999999999997643 247888999999999999999974 45555443211100 0
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc---CCCCCCChHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPVDRKV 516 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~~ 516 (572)
.....||+.|+|||++.+..++.++||||+|+++|||+| |+.||.... .......+... ..+...+ .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~~~~-~- 232 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKPRLAS-T- 232 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCCCCTTSC-H-
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-------HHHHHHHHhcCCcCCCCccCc-H-
Confidence 112346678999999988889999999999999999999 899985321 11111111111 1111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+..+...||+.||++|||++++++++....
T Consensus 233 -----~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 233 -----HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp -----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1235666899999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.15 Aligned_cols=232 Identities=21% Similarity=0.280 Sum_probs=172.5
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+...+|.|+||.||+|... ++..||+|++......+ .+.|.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4566778999999999999864 57899999987544332 3578899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC---CC----------------CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC---PD----------------SS 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~---~~----------------~~ 439 (572)
|+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+... .. ..
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999887543 4788999999999999999997 45666655431 10 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
......||+.|+|||++.+. ++.++||||+|+++|||+||+.||.... .......+.......+. ......
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~ 234 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-------DSEVMLKIREGTFTFPE-KDWLNV 234 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCH-HHHTTS
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCc-hhhhcC
Confidence 11234689999999988654 8999999999999999999999985321 11111222222222111 000000
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...+..+...|++.||++|||+.+++++.+..+
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 012345667899999999999999999887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=266.25 Aligned_cols=236 Identities=22% Similarity=0.259 Sum_probs=174.8
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH---HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+++...+|.|+||.||+|+.. +|+.||||.+........ ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34667788999999999999864 689999999875432110 01357889999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.+++.... .+++..+..++.+++.|+.||| +|++|..+....+.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999997532 4788899999999999999997 45666554332211
Q ss_pred ----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||.... .......+.......+ .
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~--~ 239 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITSVSYDFD--E 239 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCC--H
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcccccC--h
Confidence 11123458999999999999999999999999999999999999985321 1111111111111110 0
Q ss_pred HHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
... .....+..+...||+.||++|||+++++++.+...
T Consensus 240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 000 00012345667999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=285.28 Aligned_cols=232 Identities=22% Similarity=0.274 Sum_probs=173.9
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++..++|.|+||+||+|+.. +++.||||+++..........+.+.+|++++.+++|||||+++++|.+++..|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 456778889999999999999965 5899999999754332222234588999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------C-
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------S- 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~- 439 (572)
||||++|+|.+++.... ..+++.....++.+++.|++||| +|++|.++..+.+. .
T Consensus 153 ~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp ECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999998632 24888888999999999999997 56777655432110 0
Q ss_pred -CccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc----cCCC
Q 038466 440 -NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD----QRLP 509 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~ 509 (572)
.....+||++|+|||++. ...++.++|||||||++|||+||+.||.... .......++. ...+
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKERFQFP 303 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHHHHCCCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhhhhccccccCC
Confidence 112357999999999986 5679999999999999999999999985321 1111111111 1122
Q ss_pred CC---CChHHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhhc
Q 038466 510 PP---VDRKVIRDILLASTISFACLQSNPKS--RPTMQYVSQEFLIT 551 (572)
Q Consensus 510 ~~---~~~~~~~~~~~~~~i~~~Cl~~dP~~--RPsm~~V~~~l~~~ 551 (572)
.. .+ .. +.++...|+..+|++ ||+++|+++|.|..
T Consensus 304 ~~~~~~s-~~------~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 304 TQVTDVS-EN------AKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp SSCCCSC-HH------HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred cccccCC-HH------HHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 11 11 11 234455778777777 99999999998875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=264.56 Aligned_cols=240 Identities=19% Similarity=0.309 Sum_probs=170.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 379 (572)
+.+.+...+|.|+||.||+++. .+|+.||||++...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH---HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4567778999999999999986 67999999998654332 24678899999999999999999999873 3478
Q ss_pred EEEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCCc-----------
Q 038466 380 FLIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSNR----------- 441 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~~----------- 441 (572)
++||||+++|+|.+++... .....+++..+..++.+++.|+.||| +|++|..+....+..-.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999999988752 12345899999999999999999997 45666555432211000
Q ss_pred ---------------cccccccCccccccccCCC---cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhh
Q 038466 442 ---------------TLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV 503 (572)
Q Consensus 442 ---------------~~~~gt~~y~APE~~~~~~---~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 503 (572)
....||+.|+|||++.... ++.++||||||+++|||+||+.||+...... . .. ...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~--~~--~~~ 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--D--SV--ALA 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--S--CH--HHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--c--hh--hHH
Confidence 1123589999999987543 7899999999999999999999985321100 0 00 011
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
.......+....... .+..+...||+.||++|||+++|++++......+.
T Consensus 260 ~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 260 VQNQLSIPQSPRHSS---ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHCC--CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhccCCCCccccCCH---HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 111111111111111 12356668999999999999999999987655433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=268.80 Aligned_cols=235 Identities=22% Similarity=0.296 Sum_probs=172.8
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcc-----hHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 378 (572)
.+++...+|.|+||.||+|+.. +|+.||||++.... .......+.+.+|+++++++ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3566678999999999999875 79999999986432 22233456789999999999 79999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~--------------- 437 (572)
.++||||+++|+|.+++... ..+++.....++.+++.|+.|||+ |.+|.++....+
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999753 258899999999999999999974 566654433211
Q ss_pred -CCCccccccccCccccccccC------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC
Q 038466 438 -SSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~ 510 (572)
........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+.......
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-------QILMLRMIMEGQYQF 324 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCC
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCC
Confidence 111233568999999998753 358899999999999999999999985321 111111111121111
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+. +........+..+...||+.||++|||+.+++++.|..
T Consensus 325 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SS-PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CH-HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 10 00000001234566789999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=261.05 Aligned_cols=229 Identities=19% Similarity=0.302 Sum_probs=169.8
Q ss_pred ccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 309 VFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
...++|.|+||.||+|+. .+++.||||.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345899999999999985 56899999998765432 23678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC-CC-----------------CCccc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP-DS-----------------SNRTL 443 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~-~~-----------------~~~~~ 443 (572)
+|+|.+++........+++.....++.+++.|+.|||. |++|..+.... .. .....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 99999999876544557788888899999999999974 55555443321 00 01123
Q ss_pred cccccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh----hcccCCCCCCChHHH
Q 038466 444 LAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID----VLDQRLPPPVDRKVI 517 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~----~~~~~l~~~~~~~~~ 517 (572)
..||+.|+|||++... .++.++||||||+++|||+||+.||..... ....... ...+.++...+.
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~--- 253 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMFKVHPEIPESMSA--- 253 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHHCCCCCCCTTSCH---
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccccccccccccCCH---
Confidence 4689999999998764 388999999999999999999999853211 1110111 111222222221
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.||++|||+.+++++.+....
T Consensus 254 ----~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 254 ----EAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ----HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ----HHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 12345668999999999999999998876533
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=269.58 Aligned_cols=232 Identities=16% Similarity=0.153 Sum_probs=171.5
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 382 (572)
+++.+...+|.|+||.||+|+. .+|+.||||.+...... +.+.+|+++++++ +||||+++++++..++..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 4577788999999999999985 67999999998754322 3578899999999 999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+ +|+|.+++.... ..+++..+..++.+++.||+||| +|++|..+....+.
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 999999998642 35899999999999999999997 46666544321110
Q ss_pred ---C--------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 439 ---S--------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 439 ---~--------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKIGDTK 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHHHhhh
Confidence 0 01245689999999999999999999999999999999999999864311 01111111111111
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.+. .........+..++..||+.||++||++++|.+.+.
T Consensus 237 ~~~~~-~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 237 RATPI-EVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHSCH-HHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccCCH-HHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 11110 000000113456677899999999999999998774
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=269.37 Aligned_cols=234 Identities=22% Similarity=0.321 Sum_probs=169.9
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----e
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----C 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 378 (572)
.+.+++...+|.|+||.||+|+. .+|+.||||+++.....+....+.|.+|++++++++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35577788999999999999985 679999999998765444455678999999999999999999999987654 3
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------- 438 (572)
.++||||+++|+|.++++... .+++.....++.+++.|++|||. |++|..+....+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 499999999999999997543 48899999999999999999974 5565544321110
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..............++.
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPIPPS 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCCHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCCCcc
Confidence 01112458999999999999999999999999999999999999985321 11111111111111110
Q ss_pred --ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 513 --DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 513 --~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...... .+..+..+||+.||++||+..+++.+.+.
T Consensus 241 ~~~~~~~~---~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 241 ARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp HHSTTCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccCCCCH---HHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 000001 12356678999999999987777776544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=261.00 Aligned_cols=240 Identities=18% Similarity=0.216 Sum_probs=170.5
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++.+.+.+|.|+||.||+|.. .+|+.||||++......+....+++.+|++++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 34567778899999999999985 57999999999754333333457899999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----------------- 438 (572)
|||+++|+|.+++.... ....+++.....++.+++.|+.|||. |++|..+....+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999999886421 22357888999999999999999974 5555544332111
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||..... ........+.....++........
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccCCCCcccccCH
Confidence 011224589999999999999999999999999999999999999853210 000111111111111111011111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..+...||+.||++|||+.+|++.+...
T Consensus 266 ---~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 266 ---ELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 123566689999999999999999987554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=261.44 Aligned_cols=232 Identities=23% Similarity=0.291 Sum_probs=170.5
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+.+.+|.|+||.||+|+. .+|..+|+|++....... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3466778899999999999985 568999999987544221 1367889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 384 EYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
||+++|+|.+++.... ....+++.....++.+++.|+.||| +|++|..+......
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999999886431 1235889999999999999999997 45666555432110
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchh-hhhhcccCCCC---CCC
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM-LIDVLDQRLPP---PVD 513 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~l~~---~~~ 513 (572)
.......||+.|+|||++. ..++.++||||+|+++|||+||+.||..... .... ......+.... +.+
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCCC--CCCC
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCcccccccCcCC
Confidence 0112346899999999875 5689999999999999999999999853211 0000 00111111111 111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+ .+..+...||+.||++|||+.||+++.+..+
T Consensus 253 ~-------~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 P-------QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp H-------HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred H-------HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 1 1235666899999999999999999887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.50 Aligned_cols=230 Identities=19% Similarity=0.317 Sum_probs=169.7
Q ss_pred CCccccccccccCeeEEEEEEcCC-C-------cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-G-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 376 (572)
+.+.+...+|.|+||.||+|+... + ..||+|.+....... .+.|.+|++++++++||||+++++++.++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG---HHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 456677889999999999998542 3 579999997654332 36789999999999999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-----------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS----------- 439 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~----------- 439 (572)
+..++||||+++|+|.+++.... ..+++..+..++.+++.|+.||| +|++|..+....+..
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999998643 24788899999999999999997 456665443311110
Q ss_pred ----------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCC-CCccccccCCCCcchhhhhhcccC
Q 038466 440 ----------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 440 ----------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
......||+.|+|||++.+ ..++.++|||||||++|||+||..| +..... ............
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~ 236 (289)
T 4fvq_A 163 SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQFYEDRHQ 236 (289)
T ss_dssp CCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTCC
T ss_pred ccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHHhhccCC
Confidence 1122357899999999887 6799999999999999999996554 432110 000000111122
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+.+.+.. +..++..||+.||++|||++++++++...-
T Consensus 237 ~~~~~~~~-------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 237 LPAPKAAE-------LANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp CCCCSSCT-------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCCCCCHH-------HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22222221 234556899999999999999999996543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=266.37 Aligned_cols=232 Identities=21% Similarity=0.292 Sum_probs=176.8
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
..+.+...+|.|+||.||+++.. +++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34666788999999999999864 58999999987554333334578899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~-----------------~~~ 440 (572)
||+++|+|.+++.... .+++..+..++.+++.|+.|||. |++|..+....+ ...
T Consensus 121 e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999887532 48899999999999999999974 555554432211 111
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||+... .......+... .++...+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~--- 267 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYSIPKHINPV--- 267 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCTTSCHH---
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHhcCCCCCCccCCHH---
Confidence 233568999999999999899999999999999999999999985321 11111111111 222222211
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..+...||+.||++|||+++++++.+....
T Consensus 268 ----~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 ----AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ----HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ----HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 2345668999999999999999998877644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=255.90 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=172.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
++++...+|.|+||.||+|+.. +|+.||||++......+ ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4566778999999999999864 68999999987544322 23678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------------------S 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------------------~ 439 (572)
|+++|+|.+++... ..+++.....++.+++.|+.|||. |++|..+....+. .
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999998753 247888999999999999999974 5555544332110 0
Q ss_pred CccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
......||+.|+|||++.+..+ +.++||||||+++|||+||+.||+.... ...............+.......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 236 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPWKKIDS 236 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT------TSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHhhhcccccCchhhcCH
Confidence 1123458999999999987665 7899999999999999999999863221 00111111111111100001111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+..+...||+.||++|||++|++++.+..+.
T Consensus 237 ---~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 237 ---APLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---HHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 12356668999999999999999998776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=260.48 Aligned_cols=234 Identities=21% Similarity=0.255 Sum_probs=171.3
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH---HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.+.+...+|.|+||.||+|+.. +|+.||+|.++....... ...+.|.+|++++++++||||+++++++.+++..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3566778999999999999865 699999999875432110 113578899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------- 438 (572)
||||+++|+|.+++.... .+++..+..++.+++.|+.||| +|++|..+....+.
T Consensus 86 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999997532 4889999999999999999997 45666544332211
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
.......||+.|+|||++....++.++||||||+++|||+||+.||.... .......+.......+ ..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~--~~ 233 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-------KQETLTNISAVNYDFD--EE 233 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCC--HH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-------hHHHHHHhHhcccCCc--ch
Confidence 01122358899999999998999999999999999999999999985321 1111111111111110 00
Q ss_pred HH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 516 VI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 516 ~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. .....+..+...||+.||++|||+.+++++.+..
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 00 0001234566799999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=264.70 Aligned_cols=236 Identities=24% Similarity=0.327 Sum_probs=163.2
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc--CCCCcccEEEEEEeC----Ce
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRNIVKLYGFCLHR----KC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~----~~ 378 (572)
+.+.+.+.+|.|+||.||+|+.. |+.||||++..... ..+..|.+++... +||||+++++++... +.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 45677889999999999999875 89999999865432 2344555555554 999999999999887 78
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceeeCCCCCC-------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIASTCPDSSN------------- 440 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~i~~~~~~~~~------------- 440 (572)
.++||||+++|+|.++++.. .+++..+..++.+++.|+.|||..+ .+.++|.+.+..+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 99999999999999999753 4889999999999999999999642 2233433221110
Q ss_pred -----------------ccccccccCccccccccCCCcCcc------cchHHHHHHHHHHHcCC----------CCCCcc
Q 038466 441 -----------------RTLLAGTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGK----------HPRDLL 487 (572)
Q Consensus 441 -----------------~~~~~gt~~y~APE~~~~~~~s~k------sDVySfGvvl~ElltG~----------~P~~~~ 487 (572)
.....||+.|+|||++.+...+.+ +|||||||++|||+||. .|+...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 012368999999999987766655 99999999999999994 444321
Q ss_pred ccccCCCCcchhhhhhcccCCCCCCChH--HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 488 SSLSSSSDPKIMLIDVLDQRLPPPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
... .................+..+.. .......+..++..||+.||++|||+.+|++++.....
T Consensus 266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 266 VPS--DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SCS--SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC--CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 100 00000011111111222211110 01112234567789999999999999999999865543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=259.82 Aligned_cols=234 Identities=15% Similarity=0.208 Sum_probs=171.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 382 (572)
+.+++.+.+|.|+||.||+|+.. +++.||||++........ ...++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35667788999999999999865 799999999875433222 235788899999999 999999999999999999999
Q ss_pred EecccCCChhhhhhcCCC-cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~-~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------- 438 (572)
|||+++|+|.+++..... ...+++.....++.+++.|+.||| +|++|..+......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999999975321 135889999999999999999997 46666655432110
Q ss_pred ---------------CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhh
Q 038466 439 ---------------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 502 (572)
Q Consensus 439 ---------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~ 502 (572)
.......||+.|+|||++.+. .++.++|||||||++|||++|++|+..... ......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~~~~~ 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-------WHEIRQ 242 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-------HHHHHT
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-------HHHHHc
Confidence 011223589999999998766 567899999999999999999987532110 001111
Q ss_pred hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 503 VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 503 ~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.++...+. . +..+...||+.||++|||+.+++++.+....
T Consensus 243 ~~~~~~~~~~~~-~------~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLPRIPQVLSQ-E------FTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCCCCSSCCCH-H------HHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCCCCcccCH-H------HHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 111222222221 1 2345668999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.06 Aligned_cols=240 Identities=22% Similarity=0.283 Sum_probs=169.1
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
.+.+.+.+|.|+||+||+|+..+|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 456778899999999999998889999999997554322 1235678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCcc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNRT 442 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~~ 442 (572)
+++ +|.+++.... ..+++.....++.+++.|++||| +|++|..+....+. ....
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 985 8988887543 24788889999999999999997 45666554432211 1112
Q ss_pred ccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc----------C---CCCcchhhhhhcccCC
Q 038466 443 LLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------S---SSDPKIMLIDVLDQRL 508 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----------~---~~~~~~~~~~~~~~~l 508 (572)
...||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... . ...+........++..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 2458999999999875 458999999999999999999999986432100 0 0000000000011111
Q ss_pred CC--CCC-----hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 509 PP--PVD-----RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 509 ~~--~~~-----~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. +.+ ..... .+..+...||+.||++|||++|++++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDE---SGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCGGGTCCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCccHHHHhhhcCH---HHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00 000 00001 1235667899999999999999999887643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-30 Score=260.25 Aligned_cols=234 Identities=22% Similarity=0.304 Sum_probs=172.9
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+...+|.|+||.||+|+.. +|+.||+|.+....... .+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4667788999999999999864 79999999998654322 2568899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeC---CCC---------------CC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTC---PDS---------------SN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~---~~~---------------~~ 440 (572)
|+++|+|.+++.... .+++.....++.+++.|+.|||. |++|..+... ... ..
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999999999887533 47888899999999999999974 5566544331 000 01
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~ 518 (572)
.....||+.|+|||++.+..++.++||||+|+++|||+||+.||.... .......+.... .+.+.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-------ESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCccccccCCH
Confidence 122358999999999999999999999999999999999999985321 111111111111 11111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.+..+...|++.||++|||+++++++.+.....+
T Consensus 237 ---~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 237 ---SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp ---HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ---HHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 1235666899999999999999999988765543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=265.70 Aligned_cols=232 Identities=20% Similarity=0.331 Sum_probs=171.2
Q ss_pred cCCccccccccccCeeEEEEEEc--------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL 374 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~--------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 374 (572)
.+.+.+.+.+|.|+||.||+|+. .++..||||++...... ...+++.+|+++++++ +||||++++++|.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34566778899999999999975 34778999999865432 2346789999999999 9999999999999
Q ss_pred eCCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC
Q 038466 375 HRKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC 435 (572)
Q Consensus 375 ~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~ 435 (572)
+++..++||||+++|+|.+++..... ...+++..+..++.+++.|+.||| +|++|..+...
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 99999999999999999999986432 124889999999999999999997 45666554332
Q ss_pred CCCC-------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCC
Q 038466 436 PDSS-------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD 495 (572)
Q Consensus 436 ~~~~-------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~ 495 (572)
.+.. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------- 264 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 264 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-------
Confidence 1110 0112346788999999988889999999999999999999 999985321
Q ss_pred cchhhhhhcc---cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 496 PKIMLIDVLD---QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 496 ~~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.......+.. ...+...+ . .+..++..||+.||++|||+++|++++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~-~------~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDKPANCT-N------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHHTCCCCCCTTCC-H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCC-H------HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 11111111 1 123566689999999999999999988543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.31 Aligned_cols=236 Identities=15% Similarity=0.109 Sum_probs=172.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++...... +.+.+|+++++++ +|+|++++++++.++...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 45577888999999999999984 67999999998654322 3577899999999 89999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---------------- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---------------- 439 (572)
||||+ +|+|.+++.... ..+++..+..++.+++.|++|||. |++|..+....+..
T Consensus 84 v~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99999 999999998643 248899999999999999999974 56665443321110
Q ss_pred -------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc
Q 038466 440 -------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 440 -------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGEK 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc----ccHHHHHHHHhh
Confidence 012345899999999999999999999999999999999999998643210 011111111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+.+.......-...+..++..||+.||++||++++|++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 000000000000001234566789999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=278.40 Aligned_cols=233 Identities=20% Similarity=0.256 Sum_probs=174.1
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++...+|.|+||+||+|+.. +|+.||+|+++..........+.+.+|+++++.++|||||+++++|.+++..|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3456788889999999999999865 689999999975432222223458899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------C-
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------S- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------~- 439 (572)
||||+++|+|.+++++. .+++.....++.+++.|++||| +|++|..+..+.+. .
T Consensus 147 V~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999998753 3778888889999999999997 46666655432110 0
Q ss_pred --CccccccccCccccccccCCC----cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc----cCCC
Q 038466 440 --NRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD----QRLP 509 (572)
Q Consensus 440 --~~~~~~gt~~y~APE~~~~~~----~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~ 509 (572)
.....+||+.|+|||++.... ++.++|||||||++|||+||+.||.... .......+.. ...+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~p 295 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKNSLTFP 295 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHHHHCCCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-------hhhHHHHHHhccccccCC
Confidence 112457999999999987654 8899999999999999999999985321 1111122221 1122
Q ss_pred CC-CChHHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhhcc
Q 038466 510 PP-VDRKVIRDILLASTISFACLQSNPKS--RPTMQYVSQEFLITR 552 (572)
Q Consensus 510 ~~-~~~~~~~~~~~~~~i~~~Cl~~dP~~--RPsm~~V~~~l~~~~ 552 (572)
.. .-... +..+...|++.+|++ ||+++||.+|.|...
T Consensus 296 ~~~~~s~~------~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 296 DDNDISKE------AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp TTCCCCHH------HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred CcccccHH------HHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 11 01111 234556899999988 999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=260.79 Aligned_cols=234 Identities=23% Similarity=0.389 Sum_probs=165.6
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+.+...+|.|+||.||+|+..+ .||||+++...... ...+.|.+|++++++++||||+++++++ ..+..++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34557777899999999999998754 49999997654332 2357899999999999999999999976 45568999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
|||+++|+|.+++.... ..+++..+..++.+++.|+.||| +|++|..+....+
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999997543 35889999999999999999997 4566654432111
Q ss_pred CCCccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC--
Q 038466 438 SSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV-- 512 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-- 512 (572)
........||+.|+|||++. ...++.++||||||+++|||+||+.||..... .......+......+..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC------HHHHHHHHHHTSCCCCTTS
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch------HHHHHHHhcccccCcchhh
Confidence 01112346899999999986 56788999999999999999999999863211 11111111111111110
Q ss_pred -ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 513 -DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 513 -~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...... .+..++..||+.||++|||+.++++.+...
T Consensus 250 ~~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 250 VRSNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp SCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccccCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 001111 234566689999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=260.37 Aligned_cols=242 Identities=18% Similarity=0.232 Sum_probs=168.0
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||+||+|+. .+|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 466778899999999999986 468999999997544322 224678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+++ ++.+.+.... ..+++.....++.+++.|++||| +|++|..+....+ ....
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9986 5555554322 24888999999999999999997 4566655433211 1112
Q ss_pred cccccccCccccccccCCC-cCcccchHHHHHHHHHHHcCCCCCCccccc-----------cCCCCcch-hhhhhcccC-
Q 038466 442 TLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-----------SSSSDPKI-MLIDVLDQR- 507 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~ElltG~~P~~~~~~~-----------~~~~~~~~-~~~~~~~~~- 507 (572)
....||+.|+|||++.+.. ++.++||||+||++|||+||..|+...... ........ ......+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 2346899999999987765 899999999999999999998885311100 00000000 000000000
Q ss_pred ---CCC-----CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 508 ---LPP-----PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 508 ---l~~-----~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+. ........ .+.++...|++.||++|||++|+++|.|.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNA---TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccCCcchhhcccccCh---HHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 000 00000001 123566689999999999999999998876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=269.73 Aligned_cols=233 Identities=23% Similarity=0.312 Sum_probs=164.0
Q ss_pred Ccccc-ccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHH-hcCCCCcccEEEEEEe----CCe
Q 038466 306 NIDVF-SIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRNIVKLYGFCLH----RKC 378 (572)
Q Consensus 306 ~~~~~-~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~ 378 (572)
++.+. .++|.|+||+||+|.. .+|+.||||+++.. ..+.+|++++. ..+||||+++++++.. .+.
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34444 5789999999999986 46899999999643 24557888764 4589999999999875 567
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.|+||||+++|+|.+++.... ...+++.....++.+++.||.||| +|++|.++..+...
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 899999999999999998643 235899999999999999999997 46666655443210
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCC
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPP 511 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~ 511 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......... .. ....+... ..+.+
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG-MKTRIRMGQYEFPNP 289 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CS-HHHHHHHTCCCCCTT
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HH-HHHHHHcCcccCCCc
Confidence 0112346899999999999999999999999999999999999998643211100 00 11111111 11211
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
....... .+..+...||+.||++|||++++++|.|....
T Consensus 290 ~~~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 EWSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1011111 12456679999999999999999999887644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=257.45 Aligned_cols=229 Identities=21% Similarity=0.291 Sum_probs=167.7
Q ss_pred cCCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+.+++...+|.|+||.||+|... .+..||+|++...... ...+.|.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345677788999999999999863 2567999998764332 23468999999999999999999999984 5668
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
++||||+++|+|.+++.... ..+++..+..++.+++.|+.|||+ |++|..+....+.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999997543 258899999999999999999974 5666544321100
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc---CCCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPP 511 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~ 511 (572)
.......+|+.|+|||++....++.++||||||+++|||+| |+.||..... ......+... ..++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERLPMPPN 241 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCCCCCCTT
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-------HHHHHHHHcCCCCCCCCC
Confidence 01112346778999999988899999999999999999997 9999863321 1111111111 11221
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+ . .+..+...||+.||++|||+.++++++...
T Consensus 242 ~~-~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 242 CP-P------TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CC-H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-H------HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1 123466689999999999999999988643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=257.74 Aligned_cols=227 Identities=21% Similarity=0.304 Sum_probs=168.0
Q ss_pred Cccccc-cccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 306 NIDVFS-IWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 306 ~~~~~~-~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
++.+.. .+|.|+||.||+|... ++..||||+++..... ...+++.+|++++++++||||+++++++ ..+..++
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 344444 7999999999999753 5788999999865432 2356899999999999999999999999 5566899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C-
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~- 438 (572)
||||+++|+|.+++.... ..+++..+..++.+++.|+.|||. |++|..+....+ .
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999997532 358899999999999999999974 556654432110 0
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc---cCCCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPP 511 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~ 511 (572)
.......||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .. ....+.. +..++.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~-~~~~i~~~~~~~~~~~ 237 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PE-VMAFIEQGKRMECPPE 237 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HH-HHHHHHTTCCCCCCTT
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HH-HHHHHhcCCcCCCCCC
Confidence 00112346788999999988889999999999999999998 9999853211 11 1111111 112222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+ . .+..++..||+.||++||++.++++++...
T Consensus 238 ~~-~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 238 CP-P------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CC-H------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC-H------HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21 1 123466689999999999999999988654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=278.80 Aligned_cols=232 Identities=19% Similarity=0.255 Sum_probs=174.5
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++.+.+|.|+||+||+|+. .+|+.||||+++..........+.+.+|.+++.+++|||||++++++.+++..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 346678888999999999999986 4799999999976443333334568899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------S 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------~ 439 (572)
||||+++|+|.+++.+.+ ..+++.....++.+++.|++||| +|++|.++..+.+. .
T Consensus 139 VmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999999999997543 24788888899999999999997 56677655432110 0
Q ss_pred --CccccccccCcccccccc-------CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc----c
Q 038466 440 --NRTLLAGTYGYIAPELAY-------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD----Q 506 (572)
Q Consensus 440 --~~~~~~gt~~y~APE~~~-------~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~----~ 506 (572)
.....+||+.|+|||++. ...++.++|||||||++|||+||+.||.... .......+.. .
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-------TAETYGKIVHYKEHL 289 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHHHHC
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccCc
Confidence 112357999999999986 4578999999999999999999999985321 1111111211 1
Q ss_pred CCC---CCCChHHHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHhhc
Q 038466 507 RLP---PPVDRKVIRDILLASTISFACLQSNPKSR---PTMQYVSQEFLIT 551 (572)
Q Consensus 507 ~l~---~~~~~~~~~~~~~~~~i~~~Cl~~dP~~R---Psm~~V~~~l~~~ 551 (572)
..+ ...+ . .+..+..+|+. +|++| |+++||.+|.|..
T Consensus 290 ~~p~~~~~~s-~------~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 290 SLPLVDEGVP-E------EARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp CCC----CCC-H------HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred CCCccccCCC-H------HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 111 1111 1 12345568998 99998 6999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=261.11 Aligned_cols=240 Identities=20% Similarity=0.231 Sum_probs=161.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|... +|+.||||+++...... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 45677788999999999999864 68999999987543221 1256788999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC---CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 384 EYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
||++ |+|.+++.... ....+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9999 69998886531 2235888889999999999999997 46666654332110
Q ss_pred -CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc-------------CCCCcchhhh--
Q 038466 439 -SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------SSSDPKIMLI-- 501 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------------~~~~~~~~~~-- 501 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+.....
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 11123468999999999876 468999999999999999999999985322100 0000000000
Q ss_pred --------------hhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 502 --------------DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 502 --------------~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
+.+.+..+...+ ..+.++...||+.||++|||++|++++.|.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLD-------GNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCC-------HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhHHHhhcccccccCC-------HHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 000000011111 1234566789999999999999999998876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=260.55 Aligned_cols=245 Identities=21% Similarity=0.237 Sum_probs=170.5
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||.||+|+.. +|+.||||++....... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 34667788999999999999864 59999999987654332 33567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+....+. ..
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999988876532 4788899999999999999997 45666544332111 11
Q ss_pred ccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchh----hhhh-cc
Q 038466 441 RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM----LIDV-LD 505 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~----~~~~-~~ 505 (572)
.....||+.|+|||++.+ ..++.++||||+|+++|||+||+.||....... ....+... .... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 123468999999999875 668999999999999999999999985332100 00000000 0000 00
Q ss_pred cCCCCCCChHHH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 506 QRLPPPVDRKVI-----RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 506 ~~l~~~~~~~~~-----~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.+...... .....+..+...||+.||++|||++|++++.|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 111111100000 000123456779999999999999999999887644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.72 Aligned_cols=234 Identities=24% Similarity=0.290 Sum_probs=175.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+...+|.|+||.||+|+.. +|+.||||++...........+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4666788999999999999864 799999999864432111123678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------S 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------~ 439 (572)
|+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+...... .
T Consensus 107 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 107 VYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999887543 4788899999999999999997 46666655442111 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~ 517 (572)
......||+.|+|||++.+ .++.++||||+||++|||+||+.||.... .......+.......+.+ ....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-------EYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCCcccccCC
Confidence 1123468999999999865 68999999999999999999999985321 111112222222211111 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. .+..+...||+.||++|||+.++++|.|....
T Consensus 256 ~---~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 256 E---SAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred H---HHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 1 13356668999999999999999999887643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=280.07 Aligned_cols=238 Identities=22% Similarity=0.297 Sum_probs=178.7
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+....++|.|+||.||+|+.. +|+.||||++...........+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 345777788999999999999864 6999999999765433323346788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCC-cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 383 YEYMKRGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~-~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
|||+++|+|.+++..... ...+++.....++.+++.|+.||| +|++|.++..+.+ .
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999999999999876432 345889999999999999999997 4667665533211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~ 516 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..........+..... +...+. .
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p~~~s~-~ 419 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYPDKFSP-A 419 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCCTTSCH-H
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCCcccCH-H
Confidence 112234799999999999999999999999999999999999999863211 0011111122222222 222221 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHhhc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTM-----QYVSQEFLIT 551 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm-----~~V~~~l~~~ 551 (572)
+..+...||+.||++||++ ++|.+|.+..
T Consensus 420 ------~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 420 ------SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp ------HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred ------HHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 2345568999999999975 7888887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=260.99 Aligned_cols=232 Identities=20% Similarity=0.243 Sum_probs=172.0
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+...+|.|+||.||+|+.. +++.||||++......+....+.|.+|++++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 356777889999999999999864 6899999999866544445567899999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++.... .+++..+..++.+++.|+.|||. |++|..+....+.
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999997543 48899999999999999999974 5555544332110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC------CCCC
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL------PPPV 512 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~ 512 (572)
.......||+.|+|||++.+..++.++||||||+++|||+||+.||..... . .....+.... ++..
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~-~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------S-VMGAHINQAIPRPSTVRPGI 261 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------H-HHHHHHHSCCCCGGGTSTTC
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------H-HHHHHhccCCCCccccCCCC
Confidence 011234588999999999999999999999999999999999999863211 0 1111111111 1111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRP-TMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RP-sm~~V~~~l~~~~~ 553 (572)
+. . +..+...||+.||++|| +++++++.+...-.
T Consensus 262 ~~-~------l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 262 PV-A------FDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CT-H------HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CH-H------HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 11 1 23455689999999999 89999998865543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=279.40 Aligned_cols=239 Identities=23% Similarity=0.262 Sum_probs=173.7
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHH----------HHHHHHHHHHHHHHhcCCCCcccEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEEL----------AFIKSFRNEAQVLSQVLHRNIVKLYGF 372 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~ 372 (572)
.+.+.+...+|.|+||+||+|+.. +++.||||++........ ...+.+.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345777889999999999999864 689999999975432210 224678899999999999999999999
Q ss_pred EEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------
Q 038466 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------- 438 (572)
Q Consensus 373 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------- 438 (572)
|.+++..++|||||++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+......
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999887543 4889999999999999999997 45666554432211
Q ss_pred -----------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 439 -----------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 439 -----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
.......||+.|+|||++. ..++.++||||+||++|||++|+.||.... .......+....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~ 263 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-------DQDIIKKVEKGK 263 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCC
Confidence 1122346899999999986 469999999999999999999999985321 111112222222
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
...+.. ....-...+..+...|++.||++|||++|++++.|..+..
T Consensus 264 ~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 264 YYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 211100 0000001234566789999999999999999999886554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=258.94 Aligned_cols=236 Identities=21% Similarity=0.311 Sum_probs=170.5
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+.+++...+|.|+||.||+|+.. +|+.||+|++....... .++|.+|++++++++||||+++++++.+++..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 3455777888999999999999865 58999999987554322 4678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---------------- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---------------- 439 (572)
||||+++|+|.+++.... ..+++..+..++.+++.|+.|||. |++|..+....+..
T Consensus 94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999887532 248899999999999999999974 45555443322111
Q ss_pred -CccccccccCccccccc-----cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC-C
Q 038466 440 -NRTLLAGTYGYIAPELA-----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP-V 512 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~-----~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~ 512 (572)
......||+.|+|||++ ....++.++||||||+++|||+||+.|+..... ............+.. .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCCcccCC
Confidence 01123589999999987 466789999999999999999999999863321 111111111111110 0
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..... .+..+...||+.||++|||+.+++++.+....
T Consensus 245 ~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 245 PSKWSV---EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp GGGSCH---HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ccccCH---HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 111111 12356668999999999999999998876654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=269.12 Aligned_cols=231 Identities=20% Similarity=0.263 Sum_probs=171.4
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 382 (572)
+.+++...+|.|+||.||+|+.. +|+.||||++..... .+.+|++++.++ +|||||++++++.+++..|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 45677788999999999999864 689999999975532 234688888888 799999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.+++.... .+++.....++.+++.|++||| +|++|..+......
T Consensus 95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999997543 4788899999999999999997 46676655421110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC--CC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP--VD 513 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~ 513 (572)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..........+.......+ ..
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCcccCcccc
Confidence 11123468999999999988889999999999999999999999985321 0111111112222221111 10
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..... .+..+...||+.||++|||+.++++|.|...
T Consensus 248 ~~~s~---~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSD---TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCH---HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 11111 1235666899999999999999999988753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=260.37 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=174.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.....+|.|+||.||+|+. .+|+.||||.+....... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4466778899999999999985 568999999997554222 2467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++|+|.+++... .+++..+..++.+++.|+.|||. |++|..+....+. ..
T Consensus 100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999999999998642 48899999999999999999974 5555544322110 11
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhh---cccCCCCCCChHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV---LDQRLPPPVDRKVI 517 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~~~~~ 517 (572)
.....||+.|+|||++.+..++.++||||||+++|||+||+.|+..... ......+ ..+..+...+ ..
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~- 246 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNPPTLEGNYS-KP- 246 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCSSCC-HH-
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCCCCCCccccC-HH-
Confidence 2234689999999999999999999999999999999999999853211 1111111 1111222221 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+..+...||+.||++|||+.+++++.+..+.
T Consensus 247 -----l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 247 -----LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----HHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 2355668999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=265.60 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=169.7
Q ss_pred CCccccccccccCeeEEEEEEcC-C-----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-N-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~-----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
+.+.+...+|.|+||.||+|... + +..||+|.+......+ ..+.+.+|+++++++ +||||++++++|.+++
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34556678999999999999853 2 3489999997654322 246789999999999 8999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCC-----------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC---
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD--- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~-----------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~--- 437 (572)
..++||||+++|+|.+++..... ...+++.....++.+++.||.|||. |++|..+....+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 99999999999999999875321 2347889999999999999999974 555554322100
Q ss_pred -------------CC---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhh
Q 038466 438 -------------SS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 438 -------------~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~ 500 (572)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ....
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~ 276 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------NSKF 276 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------SHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-------hHHH
Confidence 00 0112346788999999988899999999999999999998 9999853211 1111
Q ss_pred hhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 501 IDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 501 ~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+......+.+..... .+..++..||+.||++|||+.+|++++...
T Consensus 277 ~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111111111110111 123566689999999999999999988543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=280.88 Aligned_cols=239 Identities=21% Similarity=0.249 Sum_probs=180.0
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+.+++...+|.|+||.||+|+. .+|+.||||++...........+.+.+|+++|++++|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 345677888999999999999986 4799999999975543322234578899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SS 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~ 439 (572)
||||+++|+|.+++.... ...+++.....++.+++.||.||| +|++|.++..+.+ ..
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999999997643 234889999999999999999997 4666665533211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~ 517 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..........+. ....+...+.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~---~~~~~~i~~~i~~~~~~~p~~~s~--- 414 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK---KIKREEVERLVKEVPEEYSERFSP--- 414 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS---CCCHHHHHHHHHHCCCCCCTTSCH---
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc---chhHHHHHHHhhcccccCCccCCH---
Confidence 12345799999999999999999999999999999999999999864211 001111111111 1122222221
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
.+..+...||+.||++|| +++||++|.|...
T Consensus 415 ----~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 ----QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp ----HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ----HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 123456689999999999 7899999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=266.17 Aligned_cols=178 Identities=24% Similarity=0.283 Sum_probs=146.2
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++.+.+|.|+||.||+|+.. +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 456777889999999999999864 6899999999765322 2346889999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCCCC---------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPDSS---------------N 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~~~---------------~ 440 (572)
|||+++|+|.+++.... .+++.....++.+++.|+.|||+ |++|..+..+.+.. .
T Consensus 110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999999997643 47888899999999999999984 34454443321110 1
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1234689999999999999999999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=266.49 Aligned_cols=227 Identities=21% Similarity=0.284 Sum_probs=172.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHH-----HHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEEL-----AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
+.+.+...+|.|+||.||+|+. .+|+.||||++......+. ...+.+.+|++++++++||||+++++++.+++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 3466778899999999999984 5799999999876432110 012457789999999999999999999999999
Q ss_pred EEEEEecccCC-ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 379 MFLIYEYMKRG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~G-sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
.++||||+.+| +|.+++.... .+++..+..++.+++.|+.||| +|++|..+....+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999877 9999987543 4889999999999999999997 4666665543211
Q ss_pred --CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC-C
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV-D 513 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~ 513 (572)
........||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... ........+. .
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~~~~~~~~ 247 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEAAIHPPYLV 247 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTTCCCCSSCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhhccCCCccc
Confidence 111223568999999999988776 8899999999999999999999863221 1111111111 1
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
... +..+...||+.||++|||+++++++.|....
T Consensus 248 ~~~------l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 248 SKE------LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CHH------HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CHH------HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 111 2345668999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=285.38 Aligned_cols=221 Identities=21% Similarity=0.308 Sum_probs=162.2
Q ss_pred cccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||.||+|... ++..||||+++...... ..++|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 6899999999999753 56789999998653221 24679999999999999999999999976 568999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------C-----------Ccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------S-----------NRT 442 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------~-----------~~~ 442 (572)
|+|.+++.... ..+++..+..++.+++.||+||| +|++|.++..+.+. . ...
T Consensus 420 g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 420 GPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp CBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred CcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999997543 35899999999999999999997 45666544321100 0 011
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRD 519 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~ 519 (572)
...+|+.|+|||++....++.++|||||||++|||+| |+.||..... .. ..+.+.. +++.+. ....
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~--~~~~i~~~~~~~~p~--~~~~- 566 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PE--VMAFIEQGKRMECPP--ECPP- 566 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HH--HHHHHHTTCCCCCCT--TCCH-
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HH--HHHHHHcCCCCCCCC--cCCH-
Confidence 1235688999999998999999999999999999998 9999864321 11 1111111 111111 1111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+..++..||+.||++||++.+|++.|..
T Consensus 567 --~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 567 --ELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp --HHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12356678999999999999999887743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=263.27 Aligned_cols=236 Identities=21% Similarity=0.321 Sum_probs=164.1
Q ss_pred ccCCccccccccccCeeEEEEEEcCC-C---cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPN-G---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~-g---~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
..+.+.+...+|.|+||.||+|+... + ..||||+++...... ...++|.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 44567788899999999999998654 3 279999997653222 224789999999999999999999999988765
Q ss_pred E------EEEEecccCCChhhhhhcCC---CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----
Q 038466 379 M------FLIYEYMKRGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----- 438 (572)
Q Consensus 379 ~------~lV~Ey~~~GsL~~~l~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----- 438 (572)
. ++||||+++|+|.+++.... ....+++..+..++.+++.|+.||| +|++|..+....+.
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 5 99999999999999986532 2225889999999999999999997 45666554332111
Q ss_pred --------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh
Q 038466 439 --------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV 503 (572)
Q Consensus 439 --------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 503 (572)
.......+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-------AEIYNYL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-------HHHHHHH
Confidence 00112345778999999998999999999999999999999 9999863221 1111111
Q ss_pred cccC---CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQR---LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~---l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... .++..+ . .+..+...||+.||++|||+.++++.+...-.
T Consensus 253 ~~~~~~~~~~~~~-~------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 253 IGGNRLKQPPECM-E------EVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HTTCCCCCCTTCC-H------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCccC-H------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 111111 1 13456678999999999999998888765533
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=269.05 Aligned_cols=230 Identities=21% Similarity=0.288 Sum_probs=165.1
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++.+.+|.|+||.||+|+.. +++.||||+++..........+.+.+|..+ ++.++|||||++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 346778889999999999999864 589999999976543333334566777776 578999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++|+|.+++.... .+++.....++.+++.||+||| +|++|.++..+.+ .
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999997533 4677788889999999999997 4666665433211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~ 516 (572)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ++..+. .
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~-~ 265 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKPNITN-S 265 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHHHHHHHSCCCCCSSSCH-H
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcccCCCCCCCH-H
Confidence 12234579999999999999999999999999999999999999985321 1112222222222 222221 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH----HHHHHHHhh
Q 038466 517 IRDILLASTISFACLQSNPKSRPTM----QYVSQEFLI 550 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm----~~V~~~l~~ 550 (572)
+..+...||+.||++||++ .++.+|.+.
T Consensus 266 ------~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 266 ------ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp ------HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred ------HHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 2345568999999999997 467666554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=257.50 Aligned_cols=233 Identities=22% Similarity=0.335 Sum_probs=174.1
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++.+...+|.|+||.||+|... ++..||+|.+...... .++|.+|++++++++||||+++++++.+++..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3455677789999999999999865 4889999999865432 3678899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------C-
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------S- 439 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------~- 439 (572)
||||+++|+|.+++..... ..+++..+..++.+++.|+.||| +|++|..+....+. .
T Consensus 87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999999976432 35889999999999999999997 45666554321110 0
Q ss_pred --CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHH
Q 038466 440 --NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516 (572)
Q Consensus 440 --~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 516 (572)
......||+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .. ..+.+......+.+...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~~ 237 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQ-VYELLEKDYRMERPEGC 237 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------GG-HHHHHHTTCCCCCCTTC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhccCCCCCCCCC
Confidence 0112346778999999988899999999999999999999 9999853211 11 11111111111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. .+..+...|++.||++|||+.++++.+...
T Consensus 238 ~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 238 PE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CH---HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11 123566689999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=261.58 Aligned_cols=233 Identities=20% Similarity=0.287 Sum_probs=171.2
Q ss_pred cCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 376 (572)
.+.+.+...+|.|+||.||+|+. .+++.||||+++...... ..+.+.+|++++.++ +||||++++++|...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH--HHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 45567778999999999999973 357899999998654332 246789999999999 799999999999875
Q ss_pred C-eEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC
Q 038466 377 K-CMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP 436 (572)
Q Consensus 377 ~-~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~ 436 (572)
+ ..++||||+++|+|.+++..... ...+++..+..++.+++.|+.|||+ |++|..+....
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 5 48999999999999999986532 1127888999999999999999974 55555443211
Q ss_pred C----------------CC---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCc
Q 038466 437 D----------------SS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 ~----------------~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~ 496 (572)
+ .. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~ 257 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------D 257 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------S
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch------h
Confidence 0 00 0122457889999999988899999999999999999998 9999853211 1
Q ss_pred chhhhhhcc---cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 497 KIMLIDVLD---QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 497 ~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+.. ...+...+. .+..+...||+.||++|||+.+|++++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 111211111 123456689999999999999999998643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=261.22 Aligned_cols=231 Identities=26% Similarity=0.341 Sum_probs=170.2
Q ss_pred CCccccccccccCeeEEEEEEcCC-----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~-----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
..+...+.+|.|+||.||+|.... +..||||.++...... ..++|.+|++++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 445666789999999999997532 3469999998654322 246799999999999999999999999999999
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC--------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS-------------- 439 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~-------------- 439 (572)
++||||+++|+|.+++.... ..+++..+..++.+++.|+.|||. |++|..+....+..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999997643 258899999999999999999974 55665443321110
Q ss_pred ------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCC
Q 038466 440 ------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPP 511 (572)
Q Consensus 440 ------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~ 511 (572)
......+|+.|+|||++....++.++|||||||++|||+| |+.||.... .......+.+. ..+.+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRLPTP 272 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCCCC
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHHCCCcCCCc
Confidence 0011235678999999998999999999999999999999 999985321 11111111111 11111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. .... .+..++..||+.||++||++.+|++++...
T Consensus 273 ~--~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 273 M--DCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp T--TCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred c--cCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111 123566789999999999999999988654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=276.68 Aligned_cols=235 Identities=21% Similarity=0.290 Sum_probs=174.5
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||+||+|+.. +|+.||||++....... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 34677889999999999999864 79999999986432211 11357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
||+++|+|.+.+.... .+++.....++.+++.|+.||| +|++|..+......
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999887543 4788899999999999999997 46666655432110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~ 516 (572)
.......||+.|+|||++.+ .++.++||||+||++|||+||+.||.... .......+.......+.+ ...
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCcccCCC
Confidence 11123468999999999875 59999999999999999999999985321 111111222222211111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. .+..+...||+.||++|||+.+++++.|..+..
T Consensus 250 s~---~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 250 SD---DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CH---HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CH---HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 11 134566789999999999999999998876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-30 Score=261.02 Aligned_cols=234 Identities=21% Similarity=0.217 Sum_probs=165.6
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcch-----HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+.+...+|.|+||.||+|+. .+|+.||||.+..... .+......|.+|++++++++||||+++++++..++ .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 466778899999999999985 4689999999875432 11122346889999999999999999999987665 8
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCC-------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSN------------- 440 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~------------- 440 (572)
++||||+++|+|.+++.... .+++.....++.+++.|+.||| +|++|..+........
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 99999999999999887532 5788889999999999999997 4566655543221110
Q ss_pred ------ccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 441 ------RTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 441 ------~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||..... .......+........
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT------QVSLKDQITSGKYNFI 240 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC------SSCHHHHHHHTCCCCC
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------HHHHHHHHHhCccccC
Confidence 01235899999999863 56789999999999999999999999853211 0000111111111110
Q ss_pred CChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 VDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.... .....+..+...||+.||++|||+.+++++.+..
T Consensus 241 --~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 241 --PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp --HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred --chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 0000 0011234566799999999999999999887764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=254.80 Aligned_cols=228 Identities=23% Similarity=0.396 Sum_probs=171.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-------- 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 375 (572)
..+++...+|.|+||.||+|+.. +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34667788999999999999865 79999999997653 246689999999999999999998864
Q ss_pred --------CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC-----
Q 038466 376 --------RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP----- 436 (572)
Q Consensus 376 --------~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~----- 436 (572)
....++||||+++|+|.+++.... ...+++..+..++.+++.|+.|||. |++|..+....
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 445899999999999999997542 2358899999999999999999974 55555442210
Q ss_pred -----------CCCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc
Q 038466 437 -----------DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD 505 (572)
Q Consensus 437 -----------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 505 (572)
.........||+.|+|||++.+..++.++||||||+++|||+||..|+.... .......+
T Consensus 163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~~ 233 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTDLRD 233 (284)
T ss_dssp ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHHHHHT
T ss_pred ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHHHhhc
Confidence 1111233468999999999999999999999999999999999999864211 01111222
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCc
Q 038466 506 QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPL 556 (572)
Q Consensus 506 ~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~ 556 (572)
..++...+.. +..+...||+.||++|||+.++++++...+..+.
T Consensus 234 ~~~~~~~~~~-------~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GIISDIFDKK-------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TCCCTTSCHH-------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccCCHH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 2233222221 2345568999999999999999999987766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=269.92 Aligned_cols=239 Identities=18% Similarity=0.240 Sum_probs=173.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--eEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l 381 (572)
+.+.+...+|.|+||.||+|+.. +|+.||||++....... ..+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 34667789999999999999865 59999999997544322 1356789999999999999999999998765 6899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee----CCC--------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST----CPD-------------- 437 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~----~~~-------------- 437 (572)
||||+++|+|.+++........+++..+..++.+++.|++||| +|++|..+.. +..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999999999986544445899999999999999999997 4677765532 110
Q ss_pred --CCCccccccccCccccccccC--------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc--
Q 038466 438 --SSNRTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD-- 505 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-- 505 (572)
........||+.|+|||++.. ..++.++|||||||++|||+||+.||....... .....+..+..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~~ 243 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIITGK 243 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---TCHHHHHHHHHSC
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---chHHHHHHHhcCC
Confidence 001123458999999998764 567899999999999999999999985322100 00011111111
Q ss_pred -------------------cCCCCC--CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 506 -------------------QRLPPP--VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 506 -------------------~~l~~~--~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+.. ..... . ..+..+...||+.||++||++.++++++...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~--~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGL-Q--VLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHH-H--HHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHH-H--hhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111111 11111 1 1234566799999999999999999987554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=277.52 Aligned_cols=232 Identities=24% Similarity=0.280 Sum_probs=168.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+...+|.|+||+||+|+.. ++..||||++........ ..+.+.+|++++++++|||||+++++|.+++..++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4667788999999999999864 689999999975432211 13578899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------C
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------S 439 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------~ 439 (572)
|+++|+|.+.+.... .+++.....++.+++.|+.||| +|++|..+...... .
T Consensus 117 ~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999998887542 4788889999999999999997 46666655432111 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~ 517 (572)
......||+.|+|||++. ..++.++||||+||++|||++|+.||.... .......+.......+.+ ....
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-------DQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCchhcccCC
Confidence 112346899999999876 569999999999999999999999985321 111111222221111110 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. .+..+...||+.||++|||+.++++|.|...
T Consensus 266 ~---~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 266 E---GAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp H---HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred H---HHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 1 1235666899999999999999999887653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=282.24 Aligned_cols=230 Identities=23% Similarity=0.353 Sum_probs=170.8
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
.+.+.+...+|.|+||.||+|.+.++..||||+++..... .++|.+|+++|++++|||||+++|+|.+ +..++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3445667789999999999999988888999999865432 2578999999999999999999999876 6689999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------C---------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------S--------- 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------~--------- 439 (572)
|||++|+|.++++... ...+++.+++.++.+++.||+||| +|++|.++....+. .
T Consensus 341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999997532 224889999999999999999997 45666544331110 0
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~ 517 (572)
......++..|+|||++....++.++|||||||++|||+| |+.||..... ......+.. .+++.+. ...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~~~~~--~~~ 490 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPP--ECP 490 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCT--TCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCCCC--CCC
Confidence 0112235678999999998899999999999999999999 9999853311 111111111 1122111 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. .+..++..||+.||++|||+++|++.|...
T Consensus 491 ~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 491 E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 123566789999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=260.93 Aligned_cols=235 Identities=20% Similarity=0.251 Sum_probs=169.3
Q ss_pred cccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CeEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 380 (572)
.+...+|.|+||.||++.+ .+|+.||||+++..... ...+.|.+|++++++++||||+++++++.+. ...+
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 6667899999999988854 26889999999865432 2346799999999999999999999999884 6789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~--------------- 439 (572)
+||||+++|+|.+++... .+++..+..++.+++.|+.||| +|++|..+....+..
T Consensus 112 lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999999754 3789999999999999999997 456665543321110
Q ss_pred -----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccc----cCCCCc---chhhhhhcccC
Q 038466 440 -----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----SSSSDP---KIMLIDVLDQR 507 (572)
Q Consensus 440 -----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~----~~~~~~---~~~~~~~~~~~ 507 (572)
......||..|+|||++.+..++.++||||+|+++|||+||+.|+...... ...... .....+.+...
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 011234677899999999889999999999999999999999998532100 000000 00111222222
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+.+..... .+..++..||+.||++|||++++++.+...
T Consensus 268 ~~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 268 ERLPRPDKCPA---EVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp CCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCccccH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22111111111 134566689999999999999999988543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=261.61 Aligned_cols=238 Identities=23% Similarity=0.276 Sum_probs=174.5
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 376 (572)
..+.+.+...+|.|+||.||+|... +++.||||.+....... ..++|.+|++++++++||||+++++++.++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH--HHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 3455677789999999999999754 37889999998654322 246789999999999999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCC-------CcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC----
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNE-------DAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS---- 439 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~-------~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~---- 439 (572)
+..++||||+++|+|.+++.... ....+++..+..++.+++.|+.|||. |++|..+....+..
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999999987532 11346889999999999999999974 55665543322110
Q ss_pred ---------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh
Q 038466 440 ---------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV 503 (572)
Q Consensus 440 ---------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 503 (572)
......||+.|+|||++.+..++.++||||||+++|||+| |+.|+.... .......+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-------HHHHHHHH
Confidence 0011245788999999988889999999999999999999 888985321 11111112
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
......... ..... .+..+...||+.||++|||+.++++++.....
T Consensus 254 ~~~~~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKP-DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCC-CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 222111110 11111 12345668999999999999999999876533
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=266.18 Aligned_cols=229 Identities=20% Similarity=0.312 Sum_probs=165.9
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcE----EEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~----vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
.+.+.+.+.+|.|+||.||+|+. .+|+. ||+|.+....... ..+.+.+|+.++++++||||++++++|. ++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 34577788999999999999985 34543 7888875433211 1246778999999999999999999986 456
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++||||+++|+|.+++.... ..+++..+..++.+++.|+.||| +|++|.++....+.
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 899999999999999997642 35788889999999999999997 46677655432110
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc--CC--
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--RL-- 508 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~--~l-- 508 (572)
.......||++|+|||++.+..++.++|||||||++|||+| |+.||..... .. ..+.+.. ..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~--~~~~~~~~~~~~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL------AE--VPDLLEKGERLAQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT------TH--HHHHHHTTCBCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH------HH--HHHHHHcCCCCCC
Confidence 01123457789999999998899999999999999999999 9999863211 01 1111111 11
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+...+.. +..++..||+.||++|||++++++++....
T Consensus 239 ~~~~~~~-------~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 PQICTID-------VYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CTTBCTT-------TTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCcCcHH-------HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 234556899999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=262.87 Aligned_cols=244 Identities=19% Similarity=0.228 Sum_probs=166.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||.||+|+. .+|+.||||+++...... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4567778999999999999984 579999999997654332 23467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
||++ |+|.+++.... .+++.....++.+++.|+.||| +|++|.++....+.
T Consensus 113 e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9998 59999987643 4788899999999999999997 45666655432110
Q ss_pred ---CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC-------------CCCcchhhh
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------------SSDPKIMLI 501 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------------~~~~~~~~~ 501 (572)
.......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...+.....
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 111223579999999998774 489999999999999999999999853221000 000000000
Q ss_pred hhcccCCCCCCC---hHHHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 502 DVLDQRLPPPVD---RKVIR--DILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 502 ~~~~~~l~~~~~---~~~~~--~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.......+.... ..... ....+..+...||+.||++|||++|+++|.|....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000000000000 00000 00123466779999999999999999999876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=269.37 Aligned_cols=240 Identities=10% Similarity=0.009 Sum_probs=155.9
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc--CCCCcccEE-------EEEEeC
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRNIVKLY-------GFCLHR 376 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~~~~ 376 (572)
+.....+|.|+||.||+|+. .+|+.||||++...........+.+.+|+++++.+ +|||||+++ +++..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 56677899999999999985 47999999999876544444456788885554444 699988755 444433
Q ss_pred -----------------CeEEEEEecccCCChhhhhhcCCCcccCCHHHH------HHHHHHHHHHHHHHh------cCC
Q 038466 377 -----------------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKR------VNIVKAMAHALAYLH------HDC 427 (572)
Q Consensus 377 -----------------~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r------~~i~~~ia~gl~yLH------~~~ 427 (572)
...++|||||+ |+|.+++..... .+.+..+ ..++.+++.||+||| +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33899999999 999999986422 2344455 778899999999997 466
Q ss_pred CCCceeeCCCCC--------------CccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCcccccc
Q 038466 428 SPSIASTCPDSS--------------NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 491 (572)
Q Consensus 428 ~~~i~~~~~~~~--------------~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~ 491 (572)
+|.++..+.+.. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 766554432210 1113457799999999987 679999999999999999999999986442111
Q ss_pred CCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 492 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 492 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...................+....... .+..+...||+.||++|||+.+++++.|...
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPD---FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCH---HHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCH---HHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 111000000011111111111001111 1234666899999999999999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=262.95 Aligned_cols=230 Identities=18% Similarity=0.233 Sum_probs=169.4
Q ss_pred ccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEecccC
Q 038466 311 SIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
+.+|.|+||.||+|+.. +|+.||||++....... ...+.+.+|++++.+++ ||||+++++++.+++..++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 57899999999999864 69999999987644322 11357889999999995 69999999999999999999999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------CCCccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------------SSNRTL 443 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------------~~~~~~ 443 (572)
|+|.+++.... ...+++..+..++.+++.|++||| +|++|..+..... ......
T Consensus 114 ~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 192 (327)
T 3lm5_A 114 GEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192 (327)
T ss_dssp EEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--------
T ss_pred CcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccccc
Confidence 99999986532 235889999999999999999997 4666665543320 001122
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~~~ 521 (572)
..||+.|+|||++....++.++||||+|+++|||+||+.||..... ......+. ....+.+.......
T Consensus 193 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~--- 262 (327)
T 3lm5_A 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-------QETYLNISQVNVDYSEETFSSVSQ--- 262 (327)
T ss_dssp -CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTTTTTSCH---
T ss_pred ccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHhcccccCchhhcccCH---
Confidence 4689999999999999999999999999999999999999853211 11111111 11111111111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+..+...||+.||++|||+++++++.+...
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 1235666899999999999999999988753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=254.78 Aligned_cols=231 Identities=20% Similarity=0.331 Sum_probs=169.6
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+++...+|.|+||.||+|...++..||||++...... .+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 34567778899999999999999888889999999765432 2578899999999999999999999864 458999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC-----------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS----------------- 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~----------------- 439 (572)
|||+++|+|.+++.... ...+++..+..++.+++.|++|||. |++|..+..+.+..
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999987532 2258899999999999999999974 55555443321100
Q ss_pred -CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 440 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.... .......+ ........+....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~-~~~~~~~~~~~~~ 236 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNL-ERGYRMVRPDNCP 236 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHH-HTTCCCCCCTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-------HHHHHHHH-hcccCCCCccccc
Confidence 0112345778999999988889999999999999999999 899985321 11111111 1111111111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. .+..+...||+.||++|||+.++++.+..
T Consensus 237 ~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 237 E---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1 12356668999999999999999987753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=261.84 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=172.8
Q ss_pred CCccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEE--eCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--HRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~ 377 (572)
+.+++...+|.|+||.||+|+. .+++.||||++....... .+.|.+|++++++++||||+++++++. +.+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH---HHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4567778999999999999983 468999999998664332 467899999999999999999999987 456
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
..++||||+++|+|.+++.... ..+++..+..++.+++.|++||| +|++|..+..+.+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred eEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 7899999999999999997532 24899999999999999999997 4566654432110
Q ss_pred --CC----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc-----cc--CCCCcchhhhhhc
Q 038466 438 --SS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-----LS--SSSDPKIMLIDVL 504 (572)
Q Consensus 438 --~~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~-----~~--~~~~~~~~~~~~~ 504 (572)
.. ......||+.|+|||++.+..++.++||||||+++|||+||+.|+..... .. ..........+.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 00 11123477889999999888899999999999999999999999753211 00 0000001111222
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+.+..... .+..++..||+.||++|||++++++++...
T Consensus 258 ~~~~~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 258 EEGQRLPAPPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hcccCCCCCCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22221111111111 123566689999999999999999988654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=262.06 Aligned_cols=235 Identities=21% Similarity=0.287 Sum_probs=167.2
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHh--cCCCCcccEEEEEEeCC----e
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCLHRK----C 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~ 378 (572)
+.+.+.+.+|.|+||.||+|+. +|+.||||++.... .+.+.+|++++.. ++||||+++++++...+ .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3466778899999999999987 48999999997543 2457788999887 79999999999998876 7
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------------CCCCCceeeCCCC------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------------DCSPSIASTCPDS------ 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------------~~~~~i~~~~~~~------ 438 (572)
.++||||+++|+|.+++... .+++..+..++.+++.|+.|||. |++|..+....+.
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 89999999999999999753 47899999999999999999993 3444433221110
Q ss_pred ----------C-----CccccccccCccccccccCC------CcCcccchHHHHHHHHHHHcC----------CCCCCcc
Q 038466 439 ----------S-----NRTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------KHPRDLL 487 (572)
Q Consensus 439 ----------~-----~~~~~~gt~~y~APE~~~~~------~~s~ksDVySfGvvl~ElltG----------~~P~~~~ 487 (572)
. ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 0 01223689999999998765 345789999999999999999 5665422
Q ss_pred ccccCCCCcchhhhhhcccCCCCCCChH--HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 488 SSLSSSSDPKIMLIDVLDQRLPPPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
... ..........+......+..+.. .......+..++..||+.||++|||+++|++++....
T Consensus 271 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 271 VPS--DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp SCS--SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcC--cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 110 00011111112222222222111 1112223456778999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=268.75 Aligned_cols=237 Identities=13% Similarity=0.131 Sum_probs=166.5
Q ss_pred CCccccccccccCeeEEEEEEcCC------CcEEEEEecCCcchHHHH---HH-----HHHHHHHHHHHhcCCCCcccEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPN------GKVFALKKLHTSETEELA---FI-----KSFRNEAQVLSQVLHRNIVKLY 370 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~------g~~vAvK~l~~~~~~~~~---~~-----~~f~~E~~~l~~l~H~niv~l~ 370 (572)
+.+.+...+|.|+||.||+|...+ ++.||||++......... .. ..+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 457777899999999999998654 478999998765422111 11 1344566778889999999999
Q ss_pred EEEEeC----CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC--CCC
Q 038466 371 GFCLHR----KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC--PDS 438 (572)
Q Consensus 371 g~~~~~----~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~--~~~ 438 (572)
+++... ...++||||+ +|+|.+++.... ..+++..+..++.+++.||+||| +|++|.++... ...
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999875 4589999999 999999997642 35899999999999999999997 56677655432 100
Q ss_pred C------------------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCC
Q 038466 439 S------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS 494 (572)
Q Consensus 439 ~------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~ 494 (572)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 0 0012349999999999999999999999999999999999999996321100000
Q ss_pred ---C--cchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 495 ---D--PKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 495 ---~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
. ........+++.++...... .+..++..||+.||++||++++|.+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPG------EIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHH------HHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 0 00011122222222111111 12356668999999999999999987744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.80 Aligned_cols=231 Identities=22% Similarity=0.264 Sum_probs=167.4
Q ss_pred cCCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+.+.+...+|.|+||.||+|+.. ++..||||.+......+ ..++|.+|++++++++||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH--HHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch--HHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 345677788999999999999743 24569999998654322 246899999999999999999999998654 56
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------- 438 (572)
++||||+++|+|.+++.... ..+++.....++.+++.|+.|||+ |++|..+....+.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 89999999999999997543 247888999999999999999974 5555544321100
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc-cCCCCCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVD 513 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~ 513 (572)
.......||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .. ....+.. ...+.+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~------~~-~~~~~~~~~~~~~~~- 237 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------KD-VIGVLEKGDRLPKPD- 237 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG------GG-HHHHHHHTCCCCCCT-
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh------HH-HHHHHhcCCCCCCCC-
Confidence 01122346788999999988889999999999999999998 9999853211 11 1111111 1111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.... .+..+...||+.||++|||+.++++++...
T Consensus 238 -~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 238 -LCPP---VLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCH---HHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1111 123566689999999999999999988643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=269.91 Aligned_cols=176 Identities=18% Similarity=0.214 Sum_probs=144.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc------CCCCcccEEEEEEeCC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV------LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~ 377 (572)
..+++...+|.|+||.||+|.. .+++.||||++..... ..+++.+|+++++.+ .|+||+++++++...+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3467778999999999999975 4689999999986532 235677888888887 5679999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------ 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------ 439 (572)
..++||||+. |+|.+++..... ..+++..+..++.+++.||+||| +|++|.++....+..
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999996 689988876432 34899999999999999999997 577776654432211
Q ss_pred ----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 440 ----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 440 ----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp ETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 12234689999999999999999999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=269.17 Aligned_cols=240 Identities=21% Similarity=0.192 Sum_probs=168.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 377 (572)
+.+++...+|.|+||+||+|+. .+|+.||||++....... ...+++.+|++++++++|||||++++++... +
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4567778899999999999985 569999999997643222 3346788999999999999999999999754 4
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
..|+|||||+++ +.+.+.. .+++.....++.|++.||+||| +|++|.++..+.+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 579999999875 5555542 3788888999999999999997 4666665543211
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcc------hhh
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK------IML 500 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~------~~~ 500 (572)
....+...||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+. ...
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 111234578999999999999999999999999999999999999986422100 000000 000
Q ss_pred hhhccc---------------CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 501 IDVLDQ---------------RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 501 ~~~~~~---------------~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...+.. ...+............+.++..+||+.||++|||++|+++|.|..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 000000 000000111111122356777899999999999999999998875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=256.46 Aligned_cols=232 Identities=21% Similarity=0.330 Sum_probs=170.1
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++...+|.|+||.||+|... +|+.||||.+..... .+++.+|++++++++||||+++++++.+++..++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 445777889999999999999864 599999999975432 24688999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------S 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~ 439 (572)
|||+++|+|.+++.... ..+++.....++.+++.|+.|||. |++|..+....+. .
T Consensus 103 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999999987422 257899999999999999999974 5555544332110 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~ 516 (572)
......||+.|+|||++.+..++.++||||||+++|||+||+.||..... ........ .+....+ ...
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--~~~ 251 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAIFMIPTNPPPTFRKP--ELW 251 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSSG--GGS
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCCCcccCCc--ccC
Confidence 12234689999999999998999999999999999999999999853221 00011110 1111111 010
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. .+..+...||+.||++|||+.+++++.+.....
T Consensus 252 ~~---~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 252 SD---NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CH---HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CH---HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 11 123566689999999999999999998876554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=257.36 Aligned_cols=237 Identities=19% Similarity=0.297 Sum_probs=171.5
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC--CCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 382 (572)
+.+.+...+|.|+||.||+|...+|+.||||++....... ...+.|.+|++++.+++| |||+++++++.+++..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4467778999999999999998889999999997543322 235789999999999984 9999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCC--------CC----------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCP--------DS---------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~--------~~---------- 438 (572)
|| +.+|+|.+++.... .+++..+..++.+++.|+.|||. |++|..+.... ..
T Consensus 107 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC-------
T ss_pred Ee-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCcccc
Confidence 99 67889999998643 57888999999999999999974 55555443210 00
Q ss_pred CCccccccccCccccccccC-----------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 439 SNRTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
.......||+.|+|||++.. ..++.++||||||+++|||+||+.||.... ..........++.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~ 256 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIIDPN 256 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHCTT
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------HHHHHHHHHHhcc
Confidence 00123458999999999865 468899999999999999999999985321 1111122223322
Q ss_pred CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCC
Q 038466 508 LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555 (572)
Q Consensus 508 l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~ 555 (572)
.....+..... .+..+...||+.||++|||+++++++.+......
T Consensus 257 ~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 257 HEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp SCCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cccCCcccchH---HHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 21111111011 1234566899999999999999999988765543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=256.51 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=164.7
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++...+|.|+||.||+|+. .+|+.||||++....... ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34577788999999999999985 579999999997653332 2234455666678899999999999999999999999
Q ss_pred EecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCCC----------------
Q 038466 383 YEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPDS---------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~~---------------- 438 (572)
|||++ |+|.+++... .....+++..+..++.+++.|++|||. |++|..+..+...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 99998 5887777542 122358999999999999999999985 3334333221110
Q ss_pred CCccccccccCccccccc----cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 439 SNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~----~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
.......||+.|+|||++ ....++.++||||+|+++|||+||+.||+... ..............+.....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHHHHHHHHHHSCCCCCCTT
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chHHHHHHHhccCCCCcccc
Confidence 111224689999999996 56678999999999999999999999986321 11111122222221111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.... .+..+...||+.||++|||+.|++++.+...
T Consensus 238 ~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSA---EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCH---HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCH---HHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1111 1235666899999999999999999887653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=284.77 Aligned_cols=233 Identities=16% Similarity=0.259 Sum_probs=178.8
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 381 (572)
.+++++..++|.|+||.||+|+.. +++.||||+++..........+.+..|.+++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 456777889999999999999864 6899999999754332223345778899999987 79999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++|+|.++++... .+++.....++.+++.||+||| +|++|.++..+.+ .
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999999998643 4888999999999999999997 5777776543211 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.......|.. ...
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--~s~ 567 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS--MSK 567 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHSSCCCCCTT--SCH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhCCCCCCcc--CCH
Confidence 12234679999999999999999999999999999999999999986321 122223333333322211 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCH-----HHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTM-----QYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm-----~~V~~~l~~~ 551 (572)
.+..+...||+.||++||++ +||.+|.+..
T Consensus 568 ---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 568 ---EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp ---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred ---HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 12355668999999999997 8998887654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=283.11 Aligned_cols=222 Identities=21% Similarity=0.277 Sum_probs=161.7
Q ss_pred cccccCeeEEEEEEc---CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecccC
Q 038466 312 IWNYDGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKR 388 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~---~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 388 (572)
.+|.|+||.||+|.+ .+++.||||+++...... ...++|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 689999999999954 346899999997643322 224679999999999999999999999964 458899999999
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------------CCcc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------------SNRT 442 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------------~~~~ 442 (572)
|+|.++++... .+++..+..++.+++.||+||| +|++|.++..+.+. ....
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999997543 4889999999999999999997 45666554321110 0112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 521 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 521 (572)
...||+.|+|||++....++.++|||||||++|||+| |+.||..... .. ....+......+.+.....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~-~~~~i~~~~~~~~p~~~~~--- 599 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SE-VTAMLEKGERMGCPAGCPR--- 599 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTTCCCCCCTTCCH---
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcCCCCCCCCCCCH---
Confidence 2346788999999999899999999999999999998 9999853321 11 1111111111111111111
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 522 LASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++..||+.||++||++++|++.|.
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1235666899999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=265.30 Aligned_cols=234 Identities=18% Similarity=0.123 Sum_probs=164.9
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHH---HH-----HHHHHHHHHHHHHhcCCCCcccEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEE---LA-----FIKSFRNEAQVLSQVLHRNIVKLYGF 372 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~---~~-----~~~~f~~E~~~l~~l~H~niv~l~g~ 372 (572)
+.+.+...+|.|+||.||+|+.. ++..+|||+........ .. ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45677789999999999999864 57889999987653211 11 11246788999999999999999999
Q ss_pred EEe----CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----
Q 038466 373 CLH----RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---- 438 (572)
Q Consensus 373 ~~~----~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---- 438 (572)
+.. ++..++||||+ +|+|.+++.... .+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 988 67899999999 999999987543 5899999999999999999997 46666544332111
Q ss_pred ----------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCc
Q 038466 439 ----------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 439 ----------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~ 496 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~ 267 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK-----DP 267 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT-----CH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-----cc
Confidence 001234689999999999999999999999999999999999999853110 00
Q ss_pred ch--hhhhhcccCCCCC--------CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 497 KI--MLIDVLDQRLPPP--------VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 497 ~~--~~~~~~~~~l~~~--------~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.. .........++.. .... .+..+...||+.||++|||+++|++.+.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCC------EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHH------HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00 0001111111110 0011 23456668999999999999999999965443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=253.67 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=174.0
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcc------hHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSE------TEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH 375 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~------~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 375 (572)
.+.+++...+|.|+||.||+|+.. +|+.||||++.... .......+.+.+|++++++++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 355777789999999999999864 68999999986542 122234567899999999996 9999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------ 437 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------ 437 (572)
++..++||||+++|+|.+++... ..+++.....++.+++.|+.|||. |++|..+....+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999753 247889999999999999999974 555554432211
Q ss_pred ----CCCccccccccCcccccccc------CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC
Q 038466 438 ----SSNRTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 507 (572)
Q Consensus 438 ----~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 507 (572)
........||+.|+|||++. ...++.++||||||+++|||++|+.|+.... .......+....
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~ 245 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRMIMSGN 245 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTC
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-------HHHHHHHHhcCC
Confidence 11122346899999999874 4568899999999999999999999985321 111111111111
Q ss_pred C--CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 508 L--PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 508 l--~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. +.+....... .+..+...||+.||++|||+.+++++.+...
T Consensus 246 ~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 246 YQFGSPEWDDYSD---TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp CCCCTTTGGGSCH---HHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCcccccccCH---HHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 1 1111111111 1235666899999999999999999877543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=258.27 Aligned_cols=238 Identities=19% Similarity=0.280 Sum_probs=167.0
Q ss_pred CccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC--Ce
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 378 (572)
.++..+.+|.|+||.||+|++ .+|+.||||++....... ..+.+.+|++++++++||||+++++++.+. +.
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 356677899999999999983 468999999997553221 246788999999999999999999999876 66
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------------- 437 (572)
.++||||+++|+|.+++.... ..+++..+..++.+++.|++||| +|++|..+....+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 899999999999999996543 24889999999999999999997 4566654432110
Q ss_pred -C----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc----ccCCCCcc---hhhhhhcc
Q 038466 438 -S----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS----LSSSSDPK---IMLIDVLD 505 (572)
Q Consensus 438 -~----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~----~~~~~~~~---~~~~~~~~ 505 (572)
. .......||..|+|||++.+..++.++||||+|+++|||+||+.|+..... ........ ......+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 0 011224577889999999988999999999999999999999998642210 00000000 01111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 506 QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 506 ~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.....+.+..... .+..++..||+.||++|||++++++.+..
T Consensus 258 ~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 258 EGKRLPCPPNCPD---EVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp TTCCCCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCCCCCCH---HHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111111111 12356668999999999999999998853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=257.73 Aligned_cols=236 Identities=19% Similarity=0.299 Sum_probs=161.7
Q ss_pred CCccccccccccCeeEEEEEEcC--CCc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP--NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~--~g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+++...+|.|+||.||+|+.. +++ .||||+++..........++|.+|++++++++||||+++++++.+++ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45677788999999999999852 333 68999997654333334578999999999999999999999998765 88
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~ 438 (572)
+||||+++|+|.+++.... ..+++.....++.+++.|+.|||. |++|..+....+ .
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 9999999999999997542 347889999999999999999974 556554432110 0
Q ss_pred C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 439 S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 439 ~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||.... .......+.......+..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCCCCC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HHHHHHHHHccCCCCCCC
Confidence 0 0112346778999999988889999999999999999999 999985321 111111111111111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..... .+..+...||+.||++|||+.++++.+.....
T Consensus 248 ~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 248 EDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCcCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11111 12356668999999999999999999876554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.29 Aligned_cols=247 Identities=21% Similarity=0.249 Sum_probs=167.0
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchH--HHHHHHHHHHHHHHHHhcC---CCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~--~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~ 377 (572)
.+.+++...+|.|+||+||+|+. .+|+.||||++...... .......+.+|++++++++ ||||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 45677888999999999999995 57999999998643211 0001134556777766665 999999999998765
Q ss_pred -----eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------
Q 038466 378 -----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD--------- 437 (572)
Q Consensus 378 -----~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~--------- 437 (572)
..++||||+. |+|.+++..... ..+++..+..++.+++.|++||| +|++|..+....+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5899999998 699999886432 34899999999999999999997 4666665543211
Q ss_pred -------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------------CCCcc
Q 038466 438 -------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------------SSDPK 497 (572)
Q Consensus 438 -------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------------~~~~~ 497 (572)
........||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...+.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 1122345789999999999999999999999999999999999999853221000 00000
Q ss_pred h-h-hhhhcccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 498 I-M-LIDVLDQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 498 ~-~-~~~~~~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. . ......+..+.+. .... .....+.++...|++.||++|||+.|+++|.|..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 0 0000000000000 0000 000123456678999999999999999999887654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=267.36 Aligned_cols=239 Identities=21% Similarity=0.300 Sum_probs=173.3
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHH--------------HHHHHHHHHHHHHhcCCCCcccE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELA--------------FIKSFRNEAQVLSQVLHRNIVKL 369 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~--------------~~~~f~~E~~~l~~l~H~niv~l 369 (572)
.+.+.+...+|.|+||.||+|+. +|+.||||++......... ..+.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45677888999999999999998 8999999998744321100 11578899999999999999999
Q ss_pred EEEEEeCCeEEEEEecccCCChhhh------hhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCC
Q 038466 370 YGFCLHRKCMFLIYEYMKRGSLFCN------LHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCP 436 (572)
Q Consensus 370 ~g~~~~~~~~~lV~Ey~~~GsL~~~------l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~ 436 (572)
++++.+++..++||||+++|+|.++ +... ....+++..+..++.+++.|+.|||. |.+|..+....
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 9999999999999999999999998 5432 13468999999999999999999996 23343332211
Q ss_pred CC---------------CCccccccccCccccccccCC-CcCc-ccchHHHHHHHHHHHcCCCCCCccccccCCCCcchh
Q 038466 437 DS---------------SNRTLLAGTYGYIAPELAYTM-VMTE-KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 499 (572)
Q Consensus 437 ~~---------------~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~ 499 (572)
+. .......||+.|+|||++.+. .++. ++||||||+++|||+||+.||...... ...
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------VEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------HHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHH
Confidence 10 111234689999999999877 6766 999999999999999999998633210 011
Q ss_pred hhhhcccCCCCCCC-----------------hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 500 LIDVLDQRLPPPVD-----------------RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 500 ~~~~~~~~l~~~~~-----------------~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.......+.. .... ..+..+...||+.||++|||+++++++.+....
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS---NEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCC---HHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcC---HHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 11111111111100 0000 123456678999999999999999999876554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=258.52 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=155.2
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+.+...+|.|+||.||+|.. .+++.||||++...... ...+++.+|++++++++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 45677788999999999999986 46899999999754322 2246788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcC-----CCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------------
Q 038466 383 YEYMKRGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~-----~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------- 438 (572)
|||+++|+|.+++... .....+++..+..++.+++.|+.|||. |++|..+....+.
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999999988641 122358899999999999999999984 4555544332111
Q ss_pred ---------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-----CCCcchhhhhh
Q 038466 439 ---------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-----SSDPKIMLIDV 503 (572)
Q Consensus 439 ---------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-----~~~~~~~~~~~ 503 (572)
.......||+.|+|||++.. ..++.++||||||+++|||+||+.||........ ...........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 00123468999999999865 5689999999999999999999999864321100 00000000000
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.++......+ . .+..+...||+.||++|||+.+++++.+....
T Consensus 252 ~~~~~~~~~~-~------~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 252 QDKEMLKKYG-K------SFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ---CCCCCCC-H------HHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccchhhhhhh-H------HHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0011111111 1 12356668999999999999999998776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=256.10 Aligned_cols=234 Identities=21% Similarity=0.316 Sum_probs=163.3
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe--
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC-- 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-- 378 (572)
+.+.+...+|.|+||.||+|... ++..||||+++...... ...+.|.+|++++++++||||+++++++.+.+.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 44566778999999999999753 35689999997554322 234679999999999999999999999987653
Q ss_pred ---EEEEEecccCCChhhhhhcC---CCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------
Q 038466 379 ---MFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-------- 438 (572)
Q Consensus 379 ---~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-------- 438 (572)
.++||||+++|+|.+++... .....+++..+..++.+++.|+.|||. |++|..+....+.
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 49999999999999998542 223458999999999999999999974 5555544332110
Q ss_pred -----------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc
Q 038466 439 -----------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 439 -----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 506 (572)
.......+++.|+|||++.+..++.++||||||+++|||+| |+.||..... ......+...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~ 265 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------HEMYDYLLHG 265 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------GGHHHHHHTT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHHcC
Confidence 01122346788999999999999999999999999999999 8888753211 1111111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 507 RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 507 ~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..+. .+..... .+..+...||+.||++|||+.++++++..
T Consensus 266 ~~~~-~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 266 HRLK-QPEDCLD---ELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp CCCC-CBTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-CCccccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 1111111 12356668999999999999999998854
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.74 Aligned_cols=228 Identities=21% Similarity=0.308 Sum_probs=164.4
Q ss_pred ccccccccccCeeEEEEEEcC--C--CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQLP--N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFL 381 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~--~--g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 381 (572)
+.+...+|.|+||.||+|+.. + +..||||.++..... ...++|.+|++++++++|||||+++++|.+ ++..++
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 345568999999999999853 2 346899998754322 234789999999999999999999999865 457899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------------- 438 (572)
||||+++|+|.++++... ..+++.....++.++++|++||| +|++|..+..+.+.
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999997643 24788889999999999999997 45666554332110
Q ss_pred ----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCC-
Q 038466 439 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPP- 511 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~- 511 (572)
.......||+.|+|||++.+..++.++|||||||++|||+| |.+||..... ... ...+... ....+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~------~~~-~~~~~~~~~~~~p~ 319 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDI-TVYLLQGRRLLQPE 319 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS------SCH-HHHHHTTCCCCCCT
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH------HHH-HHHHHcCCCCCCCC
Confidence 00122346778999999999999999999999999999999 6777653211 111 1111111 11111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..... +..++..||+.||++|||++++++++...
T Consensus 320 ~~~~~------l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 320 YCPDP------LYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp TCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHH------HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 23566689999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.84 Aligned_cols=245 Identities=19% Similarity=0.252 Sum_probs=172.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||.||+|+.. +|+.||||++....... ...+.+.+|++++++++||||++++++|.+++..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 45667789999999999999864 59999999986544322 23467889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~-----------------~~ 440 (572)
||+++++|.+++.... .+++.....++.+++.|+.|||. |++|..+....+. ..
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999999988766433 48899999999999999999974 5566554332110 01
Q ss_pred ccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcchh--------hhh
Q 038466 441 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM--------LID 502 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~~~--------~~~ 502 (572)
.....||+.|+|||++.+. .++.++||||+||++|||+||+.||....... ....+... ...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 1234689999999998775 78999999999999999999999985332100 00000000 000
Q ss_pred hcccCCCCCCChHH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 503 VLDQRLPPPVDRKV--IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 503 ~~~~~l~~~~~~~~--~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.......... ......+..++..||+.||++|||++|++++.+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00000000000000 0001123466779999999999999999999877544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=254.04 Aligned_cols=226 Identities=20% Similarity=0.287 Sum_probs=164.5
Q ss_pred CCccccc-cccccCeeEEEEEEc---CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFS-IWNYDGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~-~~~~~~fG~Vyk~~~---~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+.+.. .+|.|+||.||+|.. .+++.||||+++..... ....++|.+|++++++++||||+++++++ ..+..+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 3455566 899999999999953 34789999999765432 23356899999999999999999999999 667789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC----------------C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD----------------S 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~----------------~ 438 (572)
+||||+++|+|.+++.... .+++.....++.+++.|+.|||+ |++|..+....+ .
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999999998643 47888999999999999999974 555554422110 0
Q ss_pred C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc----cCCC
Q 038466 439 S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD----QRLP 509 (572)
Q Consensus 439 ~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~----~~l~ 509 (572)
. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .. ....+. +..+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SE-VTAMLEKGERMGCP 242 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTTCCCCCC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HH-HHHHHHcCCCCCCC
Confidence 0 0111235688999999988889999999999999999999 9999863211 11 111111 1112
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
...+ . .+..++..||+.||++||++.+|++.+..
T Consensus 243 ~~~~-~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 243 AGCP-R------EMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TTCC-H------HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCC-H------HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2111 1 12356668999999999999999988743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=252.28 Aligned_cols=234 Identities=18% Similarity=0.210 Sum_probs=168.5
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH-HHHHHHHHHHHHHHHhcCCCCcccEEEEEE--eCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--HRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 380 (572)
+.+.+...+|.|+||.||+|.. .+++.||+|+++...... ....+.+.+|++++++++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4567788999999999999986 468999999997643221 123467899999999999999999999985 445789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
+||||+++| +.+.+.... ...+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 85 lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 999999987 666666532 235889999999999999999997 45565544332110
Q ss_pred ---CCccccccccCccccccccCCC--cCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCC
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPP 511 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~--~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~ 511 (572)
.......||+.|+|||+..+.. ++.++||||||+++|||+||+.||+... .......+.... .+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKGSYAIPGD 235 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCCCSS
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcCCCCCCCc
Confidence 0112345899999999987643 4789999999999999999999986321 111111111111 2222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+ .. +..+...||+.||++|||+++++++.+.....
T Consensus 236 ~~-~~------l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 236 CG-PP------LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SC-HH------HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred cC-HH------HHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 21 11 23456689999999999999999998776543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-31 Score=275.49 Aligned_cols=229 Identities=14% Similarity=0.108 Sum_probs=163.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHH---HHHHhcCCCCcccEE-------EEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRNIVKLY-------GFC 373 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~ 373 (572)
+.+.+...+|.|+||.||+|+. .+|+.||||++...........+.|.+|+ +++++++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 3456678899999999999996 56999999999744322222346788999 566677899999998 666
Q ss_pred EeCC-----------------eEEEEEecccCCChhhhhhcCC----CcccCCHHHHHHHHHHHHHHHHHHh------cC
Q 038466 374 LHRK-----------------CMFLIYEYMKRGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLH------HD 426 (572)
Q Consensus 374 ~~~~-----------------~~~lV~Ey~~~GsL~~~l~~~~----~~~~l~~~~r~~i~~~ia~gl~yLH------~~ 426 (572)
.+++ ..++||||+ +|+|.+++.... ....++|..+..++.+++.||+||| +|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 6553 288999999 689999997532 1123557888899999999999997 46
Q ss_pred CCCCceeeCCCC--------------CCccccccccCccccccccCC-----------CcCcccchHHHHHHHHHHHcCC
Q 038466 427 CSPSIASTCPDS--------------SNRTLLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLMGK 481 (572)
Q Consensus 427 ~~~~i~~~~~~~--------------~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVySfGvvl~ElltG~ 481 (572)
++|.++..+.+. .......| +.|+|||++.+. .++.++|||||||++|||+||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 666655443221 11123457 999999999877 8999999999999999999999
Q ss_pred CCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 482 HPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 482 ~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.||....... ....+. ... +..+.. +..++..||+.||++|||+.+++++.+..
T Consensus 311 ~Pf~~~~~~~-------~~~~~~-~~~-~~~~~~-------~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 311 LPITKDAALG-------GSEWIF-RSC-KNIPQP-------VRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp CCC------C-------CSGGGG-SSC-CCCCHH-------HHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred CCCccccccc-------chhhhh-hhc-cCCCHH-------HHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 9985332110 001111 111 112111 23456689999999999999999987754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=257.72 Aligned_cols=234 Identities=23% Similarity=0.330 Sum_probs=168.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcE--EEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKV--FALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~--vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+++.+...+|.|+||.||+|+.. +|.. +|||.+...... ...+.+.+|+++++++ +||||+++++++.+++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 45667788999999999999864 5654 499998754322 2246789999999999 9999999999999999999
Q ss_pred EEEecccCCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---
Q 038466 381 LIYEYMKRGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--- 438 (572)
+||||+++|+|.+++.... ....+++..+..++.+++.|+.||| +|++|..+....+.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 9999999999999998643 1235889999999999999999997 45666554332110
Q ss_pred -------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc
Q 038466 439 -------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 439 -------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
.......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..... .. ..+.+
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~-~~~~~ 254 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEKL 254 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHG
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HH-HHHHh
Confidence 01122346788999999988889999999999999999998 9999853211 11 11111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 505 DQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 505 ~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
......+.+..... .+..+...||+.||++|||++++++++...
T Consensus 255 ~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 255 PQGYRLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp GGTCCCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111111 123566689999999999999999988543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=259.66 Aligned_cols=235 Identities=21% Similarity=0.323 Sum_probs=169.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcE----EEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~----vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
.+++++...+|.|+||.||+|+. .+++. ||+|.+....... ..+.|.+|++++++++||||++++++|..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 35677888999999999999985 34543 5888776433221 2367889999999999999999999998765
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++|+||+++|+|.+++..... .+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 7899999999999999986433 4788899999999999999997 45666544321100
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||+.... . .....+......+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------S-EISSILEKGERLPQ 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------G-GHHHHHHTTCCCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-------H-HHHHHHHcCCCCCC
Confidence 01112346778999999999999999999999999999999 9999863321 1 11122221111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
...... .+..++..||+.||++|||+.++++.+......
T Consensus 241 ~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 241 PPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111111 123566689999999999999999988665443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=251.09 Aligned_cols=230 Identities=20% Similarity=0.242 Sum_probs=165.2
Q ss_pred cccccccccCeeEEEEEEcC-C---CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE-EEE
Q 038466 308 DVFSIWNYDGYGSVYKAQLP-N---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM-FLI 382 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~-~---g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 382 (572)
+..+.+|.|+||.||+|... + +..+|+|.+...... ...+.|.+|++++++++||||+++++++.+.+.. ++|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34478999999999999742 2 347999999764432 2357899999999999999999999999876655 999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+.+|+|.+++.... ..+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999997633 35788899999999999999997 45566544322110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChH
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 515 (572)
.......||+.|+|||...+..++.++||||||+++|||+||..|+... ..... ....+......+.+..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH------IDPFD-LTHFLAQGRRLPQPEY 252 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCGGG-HHHHHHTTCCCCCCTT
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc------CCHHH-HHHHhhcCCCCCCCcc
Confidence 0112245788999999999999999999999999999999966554211 01111 1111111111111111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 516 VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 516 ~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
... .+..+...||+.||++|||++++++.+...
T Consensus 253 ~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 253 CPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 123566689999999999999999988654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=258.08 Aligned_cols=228 Identities=22% Similarity=0.267 Sum_probs=151.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEE--------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCL-------- 374 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~-------- 374 (572)
..+.+...+|.|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3466778999999999999985 57999999998655432 2467889999999996 999999999995
Q ss_pred eCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCCCCceeeCCCCCC--------------
Q 038466 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIASTCPDSSN-------------- 440 (572)
Q Consensus 375 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~i~~~~~~~~~-------------- 440 (572)
.....++||||+. |+|.+++........+++..+..++.+++.|+.|||... ++++|.+.+..+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3345899999996 799988875333345899999999999999999999542 123332211100
Q ss_pred ------------------------ccccccccCccccccc---cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCC
Q 038466 441 ------------------------RTLLAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 493 (572)
Q Consensus 441 ------------------------~~~~~gt~~y~APE~~---~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~ 493 (572)
.....||+.|+|||++ ....++.++|||||||++|||+||+.||+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 0023489999999998 56678999999999999999999999986322110
Q ss_pred CCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 494 SDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 494 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
............... .. +..++..||+.||++|||+.|+++++...
T Consensus 261 -----~~~~~~~~~~~~~~~-~~------~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 -----IVNGKYSIPPHDTQY-TV------FHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------CCCCTTCCSS-GG------GHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hhcCcccCCcccccc-hH------HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000001111111111 11 23455689999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=253.54 Aligned_cols=227 Identities=21% Similarity=0.322 Sum_probs=166.8
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-CeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 382 (572)
.+.+++...+|.|+||.||+|+.. |+.||||.++.... .++|.+|++++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 355777889999999999999874 88999999986542 35788999999999999999999997655 468999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC--------------CCcc
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------------SNRT 442 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------------~~~~ 442 (572)
|||+++|+|.+++.... ...+++.....++.+++.|++|||. |.+|..+....+. ....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999999997532 2237888899999999999999974 5555544332111 0112
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhc---ccCCCCCCChHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL---DQRLPPPVDRKVIR 518 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~ 518 (572)
...+|+.|+|||++.+..++.++||||||+++|||+| |+.||..... ......+. ....+...+ .
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~--- 241 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKGYKMDAPDGCP-P--- 241 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-------GGHHHHHTTTCCCCCCTTCC-H---
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCCCcccCC-H---
Confidence 2357889999999988899999999999999999998 9999853211 11111111 111111111 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..+...||+.||++|||+.++++.+...
T Consensus 242 ---~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 242 ---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 123456689999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=260.31 Aligned_cols=224 Identities=13% Similarity=0.131 Sum_probs=165.5
Q ss_pred cCCccccccccccCeeEEEEEE------cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC---CCCcccEEEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCL 374 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~------~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~ 374 (572)
.+.+.+...+|.|+||.||+|. ..+++.||||+++.... .+|..|++++.+++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456777889999999999994 45689999999986542 35677888888887 999999999999
Q ss_pred eCCeEEEEEecccCCChhhhhhcCC--CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC----------
Q 038466 375 HRKCMFLIYEYMKRGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP---------- 436 (572)
Q Consensus 375 ~~~~~~lV~Ey~~~GsL~~~l~~~~--~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~---------- 436 (572)
.++..++|||||++|+|.++++... ....++|..+..++.+++.||+||| +|++|.++....
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999999997521 2345899999999999999999997 466666554422
Q ss_pred -CC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCc
Q 038466 437 -DS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP 496 (572)
Q Consensus 437 -~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~ 496 (572)
.. .......||++|+|||++.+..++.++|||||||++|||+||+.|+..... .
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~ 291 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG------G 291 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET------T
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC------C
Confidence 00 011224589999999999999999999999999999999999999843211 0
Q ss_pred chhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHh
Q 038466 497 KIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRP-TMQYVSQEFL 549 (572)
Q Consensus 497 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RP-sm~~V~~~l~ 549 (572)
. ................. .+...|++.+|.+|| +++++.+.+.
T Consensus 292 ~----~~~~~~~~~~~~~~~~~------~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 292 E----CKPEGLFRRLPHLDMWN------EFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp E----EEECSCCTTCSSHHHHH------HHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred c----eeechhccccCcHHHHH------HHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 0 01111111111122222 344579999999995 5777766553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=258.54 Aligned_cols=240 Identities=20% Similarity=0.182 Sum_probs=167.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------ 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 377 (572)
+.+.+...+|.|+||.||+|.. .+|+.||||++....... ...+.+.+|++++++++||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh-HHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 5577788999999999999985 568999999997543222 23467889999999999999999999997654
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+++ +|.+.+.. .+++.....++.+++.|+.||| +|++|..+....+.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999985 68777753 3788888999999999999997 45666554332110
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc-------CCC--Ccch------hh
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSS--DPKI------ML 500 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------~~~--~~~~------~~ 500 (572)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||....... ... .+.. ..
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 01123468999999999999999999999999999999999999986432100 000 0000 00
Q ss_pred hh---------------hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 501 ID---------------VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 501 ~~---------------~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. .......+............+.++..+||+.||++|||++|+++|.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00 0000000111111111122345777899999999999999999998765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=256.43 Aligned_cols=233 Identities=22% Similarity=0.339 Sum_probs=168.9
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe-----
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----- 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----- 375 (572)
..+.+++...+|.|+||.||+|+. .+|+.||||++....... +.+.+|+++++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 345677788999999999999986 579999999987554322 5678999999999 89999999999987
Q ss_pred -CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC----------
Q 038466 376 -RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 376 -~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~---------- 438 (572)
.+..++||||+++|+|.+++.... ...+++.....++.+++.|+.|||. |++|..+....+.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 467999999999999999998643 2357888889999999999999974 5555544332110
Q ss_pred -------CCccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc-
Q 038466 439 -------SNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD- 505 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~- 505 (572)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~ 249 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPRN 249 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcC
Confidence 0112346899999999986 56789999999999999999999999853221 111111111
Q ss_pred --cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 506 --QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 506 --~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.......... +..+...||+.||++|||+++++++.+....
T Consensus 250 ~~~~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 PAPRLKSKKWSKK------FQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCCSCSCSCHH------HHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccccCCccccCHH------HHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 11111111111 2345568999999999999999999877654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=249.87 Aligned_cols=225 Identities=12% Similarity=0.067 Sum_probs=163.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||.||+|+.. +|+.||||++...........+.|.+|++.+++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 45777789999999999999865 58999999998665433344678999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCCCccccccccCcccccccc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAY 457 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~~~~~~~gt~~y~APE~~~ 457 (572)
||+++|+|.+++... ....+...++.+++.||+|||+ |++|.++....+ .....++++|++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~---g~~kl~~~~~~~~---- 178 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPATMPD---- 178 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT---SCEEECSCCCCTT----
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC---CCEEEEeccccCC----
Confidence 999999999998642 2344677899999999999984 445544443322 1234567888876
Q ss_pred CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC--ChHHHHHHHHHHHHHHHccccCC
Q 038466 458 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV--DRKVIRDILLASTISFACLQSNP 535 (572)
Q Consensus 458 ~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~~~i~~~Cl~~dP 535 (572)
++.++|||||||++|||+||+.||......... . ..........+++. ...... .+..+..+||+.||
T Consensus 179 ---~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dP 248 (286)
T 3uqc_A 179 ---ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---A-PAERDTAGQPIEPADIDRDIPF---QISAVAARSVQGDG 248 (286)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---E-ECCBCTTSCBCCHHHHCTTSCH---HHHHHHHHHHCTTS
T ss_pred ---CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---H-HHHHHhccCCCChhhcccCCCH---HHHHHHHHHcccCC
Confidence 789999999999999999999998643221100 0 00001111111100 000001 12356668999999
Q ss_pred CCCCCHHHHHHHHhhcc
Q 038466 536 KSRPTMQYVSQEFLITR 552 (572)
Q Consensus 536 ~~RPsm~~V~~~l~~~~ 552 (572)
++| |+.++++.+....
T Consensus 249 ~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 249 GIR-SASTLLNLMQQAT 264 (286)
T ss_dssp SCC-CHHHHHHHHHHHH
T ss_pred ccC-CHHHHHHHHHHHh
Confidence 999 9999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=264.40 Aligned_cols=177 Identities=21% Similarity=0.240 Sum_probs=140.6
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----C
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~ 377 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++...... ....+++.+|++++++++|||||++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35577788999999999999985 56899999999754322 22346889999999999999999999999876 5
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..|+||||++ |+|.+++... ..+++.....++.+++.||.||| +|++|.++..+.+.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7999999987 5999998753 24889999999999999999997 56777654332110
Q ss_pred --------------------------CCccccccccCccccccc-cCCCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 439 --------------------------SNRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 439 --------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
...+...||+.|+|||++ ....++.++||||+||++|||+||..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 012345789999999986 56679999999999999999999766653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=258.87 Aligned_cols=236 Identities=22% Similarity=0.349 Sum_probs=160.0
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHH--HHHhcCCCCcccEEEEEEe-----C
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ--VLSQVLHRNIVKLYGFCLH-----R 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~--~l~~l~H~niv~l~g~~~~-----~ 376 (572)
.+.+.+...+|.|+||.||+|+. +++.||||++..... +.+..|.+ .+..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 45677788999999999999976 688999999975432 23333444 4556899999999986653 2
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC------CCCceeeCCCCCC----------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC------SPSIASTCPDSSN---------- 440 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~------~~~i~~~~~~~~~---------- 440 (572)
...++||||+++|+|.+++.... .+|..+..++.+++.||.|||..+ .+.++|.+.+..+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 35789999999999999997543 478889999999999999999652 2244443322110
Q ss_pred ------------------------ccccccccCccccccccC-------CCcCcccchHHHHHHHHHHHcCCCCCCcccc
Q 038466 441 ------------------------RTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS 489 (572)
Q Consensus 441 ------------------------~~~~~gt~~y~APE~~~~-------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~ 489 (572)
.....||+.|+|||++.+ ..++.++|||||||++|||+||..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 112358999999999876 4677899999999999999999877532211
Q ss_pred ccCC---------CCcch--hhh----hhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 490 LSSS---------SDPKI--MLI----DVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 490 ~~~~---------~~~~~--~~~----~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.... ..+.. ... ....+.++...... ......+..++..||+.||++|||++||++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN-SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCC-SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccc-cchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1000 00000 000 01111222111110 01112245677799999999999999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=253.80 Aligned_cols=229 Identities=14% Similarity=0.176 Sum_probs=170.0
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEE-EeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC-LHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~l 381 (572)
.+.+.+.+.+|.|+||.||+|+. .+|+.||||++...... +++.+|++++++++|++++..++++ .+++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 45677888999999999999985 67999999998755432 3578899999999999988777766 56778899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC---CC---------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC---PD--------------- 437 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~---~~--------------- 437 (572)
||||+ +|+|.+++.... ..+++..+..++.+++.|++||| +|++|..+... ..
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 999999997433 25889999999999999999997 46666655431 00
Q ss_pred -C--------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC
Q 038466 438 -S--------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508 (572)
Q Consensus 438 -~--------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l 508 (572)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh----hhhhhhhhccccc
Confidence 0 00123468999999999999999999999999999999999999986432111 0011111111111
Q ss_pred C-------CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 509 P-------PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 509 ~-------~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. ...+. .+..++..||+.||++|||+++|++.+...
T Consensus 236 ~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 STPIEVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHHHHTTTSCH-------HHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CCchHHHHhhCCH-------HHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 1 11111 134566789999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=264.49 Aligned_cols=177 Identities=24% Similarity=0.330 Sum_probs=133.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC--eE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK--CM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 379 (572)
.+.+++...+|.|+||.||+|.. .+|+.||||++....... ...+++.+|+.++.++. |||||++++++...+ ..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35677788999999999999985 579999999986543222 22467789999999998 999999999998654 68
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------- 438 (572)
|+|||||+ |+|.++++.. .+++..+..++.+++.|+.||| +|++|.++..+.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999998 6898888753 4788888899999999999997 56676654332110
Q ss_pred -----------------------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 -----------------------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 -----------------------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
...+...||+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 00122469999999999876 6789999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=263.38 Aligned_cols=176 Identities=16% Similarity=0.202 Sum_probs=138.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC--------CCCcccEEEEEE-
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--------HRNIVKLYGFCL- 374 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~- 374 (572)
+.+.+...+|.|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4567778899999999999984 5689999999975532 2367889999999997 788999999987
Q ss_pred ---eCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCCC------
Q 038466 375 ---HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPDS------ 438 (572)
Q Consensus 375 ---~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~~------ 438 (572)
++...++||||+ +|++.+.+.... ...+++.....++.|++.||.|||.. ++|.++....+.
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 456799999999 566666665432 23588999999999999999999853 444433322110
Q ss_pred ---------------------------------------------------------CCccccccccCccccccccCCCc
Q 038466 439 ---------------------------------------------------------SNRTLLAGTYGYIAPELAYTMVM 461 (572)
Q Consensus 439 ---------------------------------------------------------~~~~~~~gt~~y~APE~~~~~~~ 461 (572)
.......||+.|+|||++.+..+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCC
Confidence 00112357999999999999999
Q ss_pred CcccchHHHHHHHHHHHcCCCCCCc
Q 038466 462 TEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 462 s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
+.++|||||||++|||+||+.||+.
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=250.49 Aligned_cols=229 Identities=21% Similarity=0.295 Sum_probs=164.6
Q ss_pred CccccccccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 380 (572)
.+++...+|.|+||.||+|+..+ +..+|+|.+...... ...++|.+|++++++++||||++++++|.+ ++..+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH--HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35666789999999999998542 346899998764432 234689999999999999999999999754 55789
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.++++... ..+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999997533 35788899999999999999997 45566544332110
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC-CCCCCccccccCCCCcchhhhhhccc-CCC-C
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP-P 510 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~-~ 510 (572)
.......||+.|+|||++.+..++.++||||+|+++|||+|| .+|+..... ... ....... ... +
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~ 254 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDI-TVYLLQGRRLLQP 254 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT------TTH-HHHHHTTCCCCCC
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH------HHH-HHHHhcCCCCCCC
Confidence 011223467889999999988999999999999999999994 555532211 111 1111111 111 1
Q ss_pred CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 511 ~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
...... +..+...||+.||++|||++++++.+...
T Consensus 255 ~~~~~~------l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 255 EYCPDP------LYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp TTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHH------HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 23566689999999999999999988654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=260.41 Aligned_cols=246 Identities=20% Similarity=0.220 Sum_probs=166.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHH--HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
+.+.+...+|.|+||.||+|+.. +|+.||||++......+ ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45677789999999999999864 68999999997543221 1123468899999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------C
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------S 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~ 438 (572)
||||+++ +|.+++.... ..+++.....++.++++|++||| +|++|..+..+.+ .
T Consensus 90 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 9999986 8888887543 24677788899999999999997 4566655433211 1
Q ss_pred CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc----------C---CCCcch-hhhhh
Q 038466 439 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------S---SSDPKI-MLIDV 503 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----------~---~~~~~~-~~~~~ 503 (572)
.......||+.|+|||++.+. .++.++|||||||++|||++|.+|+....... . ...+.. ...+.
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 112234689999999998654 58999999999999999999999975321100 0 000000 00000
Q ss_pred cccCCCCCCChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQRLPPPVDRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~l~~~~~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+.....+....... .....+.++...||+.||++|||++|++++.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 00000000000000 000123456678999999999999999999887654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=252.50 Aligned_cols=233 Identities=21% Similarity=0.292 Sum_probs=171.6
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||.||+|+.. +++.||||++....... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 34677788999999999999864 68999999986543221 12357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCC------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSS------------------ 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~------------------ 439 (572)
||+++|+|.+.+.... .+++.....++.+++.|+.|||. |++|..+.......
T Consensus 101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999998887533 47889999999999999999974 55665544322110
Q ss_pred -CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCC--hHH
Q 038466 440 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--RKV 516 (572)
Q Consensus 440 -~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~ 516 (572)
......||+.|+|||++.+ .++.++||||||+++|||+||+.||.... .......+.......+.+ ...
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCSGGGTTS
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCchhhhhc
Confidence 1112347889999998865 48999999999999999999999985321 111111111121111110 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. .+..+...||+.||++|||+.+++++.+..+
T Consensus 250 ~~---~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 250 SD---DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CH---HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CH---HHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 11 1235666899999999999999999887654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=258.77 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=170.6
Q ss_pred CCccccccccccCeeEEEEEEc-----CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-- 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-- 377 (572)
+.+.+...+|.|+||.||+|+. .+|+.||||++...... ..+.|.+|++++++++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH---HHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3466778899999999999983 46899999999865432 2467899999999999999999999987654
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
..++||||+++|+|.+++.... ..+++..+..++.+++.|+.||| +|++|..+....+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 6899999999999999998643 24889999999999999999997 4566654432110
Q ss_pred --CCC----ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc-----ccCCCCcch---hhhhh
Q 038466 438 --SSN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-----LSSSSDPKI---MLIDV 503 (572)
Q Consensus 438 --~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~-----~~~~~~~~~---~~~~~ 503 (572)
... .....+|..|+|||++.+..++.++||||||+++|||+||+.|+..... ......... ...+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 000 1123466779999999888899999999999999999999998752210 000000000 11122
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+......+.+..... .+..++..||+.||++|||+.+|++.+...+
T Consensus 276 ~~~~~~~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCCCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221111111111111 1335667899999999999999999886543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=262.47 Aligned_cols=242 Identities=17% Similarity=0.169 Sum_probs=165.1
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+.+...+|.|+||.||+|+.. +|+.||||++....... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 4667788999999999999864 78999999997544221 12346679999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~ 441 (572)
|++ |+|.+++..... .+++.....++.+++.|+.||| +|++|.++....+. ...
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 998 589888876432 4788889999999999999997 45666654432111 111
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc-------------CCCCcchhh-hhhccc
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------SSSDPKIML-IDVLDQ 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------------~~~~~~~~~-~~~~~~ 506 (572)
....||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... ....+.... ......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 22357999999999876 568999999999999999999999986422100 000000000 000000
Q ss_pred CCCCCCChHHHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 507 RLPPPVDRKVIR----DILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 507 ~l~~~~~~~~~~----~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..+......... ....+.++...|++.||++|||++|++++.|...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 000000000000 0012345667999999999999999999987753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=252.52 Aligned_cols=236 Identities=14% Similarity=0.177 Sum_probs=166.9
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEE-EeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC-LHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~l 381 (572)
.+.+.+...+|.|+||.||+|+. .+++.||||++...... +++.+|++++++++|+|++..++++ .+++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 35677788999999999999985 67999999987654322 3577899999999999988888776 56778899
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee---CCCC--------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST---CPDS-------------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~---~~~~-------------- 438 (572)
||||+ +|+|.+++..... .+++..+..++.+++.|+.||| +|++|..+.. ....
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999 9999999875332 4899999999999999999997 4666665543 1000
Q ss_pred ----------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC
Q 038466 439 ----------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508 (572)
Q Consensus 439 ----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l 508 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~ 235 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----RQKYERISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS----SSHHHHHHHHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh----hhhhhhhhcccc
Confidence 011234689999999999999999999999999999999999999864321111 001111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+.+...........+..+...||+.||++|||+++|++.+...
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 1110000000001234566689999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.86 Aligned_cols=177 Identities=18% Similarity=0.329 Sum_probs=145.2
Q ss_pred cCCccccccccccCeeEEEEEEc--CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCC------cccEEEEEEe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN------IVKLYGFCLH 375 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~--~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~ 375 (572)
.+.+++...+|.|+||.||+|.. .+|+.||||+++.... ..+.+.+|++++++++|+| ++++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 45677888999999999999985 4689999999975532 2367889999999998775 9999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------ 437 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------ 437 (572)
.+..++||||+ +|+|.+++..... ..+++.....++.+++.|++||| +|++|..+.....
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999999 8999999876432 35788899999999999999997 4666665543211
Q ss_pred ---------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 438 ---------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 438 ---------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 0111234689999999999999999999999999999999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.11 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=170.7
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcch--------HHHHHHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSET--------EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 374 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~--------~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 374 (572)
..+.+.+...+|.|+||.||+|...+|+.||||++..... .+....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4567888899999999999999988899999999864321 12233578999999999999999999999986
Q ss_pred eC-----CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-----
Q 038466 375 HR-----KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS----- 438 (572)
Q Consensus 375 ~~-----~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~----- 438 (572)
.. ...++||||++ |+|.+.+.... ..+++..+..++.+++.|+.|||+ |++|.++....+.
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 43 36899999998 68888887543 358899999999999999999974 5566544332111
Q ss_pred -----------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcch-
Q 038466 439 -----------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKI- 498 (572)
Q Consensus 439 -----------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~- 498 (572)
.......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ...+..
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 11223468899999999876 6789999999999999999999999863221000 000000
Q ss_pred --------hhhhhcccCCCC-CC-ChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 499 --------MLIDVLDQRLPP-PV-DRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 499 --------~~~~~~~~~l~~-~~-~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+........ +. ..... .....+..+...||+.||++|||+.|+++|.+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000011111100 00 00000 001123456779999999999999999999887644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=261.74 Aligned_cols=236 Identities=22% Similarity=0.320 Sum_probs=171.1
Q ss_pred cCCccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 377 (572)
.+++++...+|.|+||.||+|+. .+|+.||||+++..... .....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35677788999999999999986 46899999998753210 001124577899999999 6999999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+++|+|.+++.... .+++.....++.+++.||.||| +|++|.++..+.+.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999997543 4788899999999999999997 46666655432211
Q ss_pred -----CCccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCC
Q 038466 439 -----SNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLP 509 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~ 509 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ............. ..+
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPPYP 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCCCCC
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc---chHHHHHHHHhccCCCCC
Confidence 01122468999999999875 45789999999999999999999998532110 0111111111111 122
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
.... . .+..+...||+.||++|| ++++++++++...
T Consensus 287 ~~~~-~------~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 287 QEMS-A------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TTSC-H------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cccC-H------HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 2121 1 123566689999999999 9999999987653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=263.74 Aligned_cols=172 Identities=22% Similarity=0.266 Sum_probs=125.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----Ce
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 378 (572)
+.+++...+|.|+||+||+|+. .+|+.||||++...... ....+++.+|+++|++++|||||++++++... +.
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4577788999999999999985 47899999999754322 22346899999999999999999999999543 56
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.|+||||+. |+|.+++... ..+++.....++.+++.||.||| +|++|.++..+.+.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 899999985 7899888753 24888899999999999999997 56676654332110
Q ss_pred ------------------------------CCccccccccCccccccc-cCCCcCcccchHHHHHHHHHHHcCC
Q 038466 439 ------------------------------SNRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGK 481 (572)
Q Consensus 439 ------------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVySfGvvl~ElltG~ 481 (572)
...+..+||+.|+|||++ ....++.++|||||||++|||+||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 011234679999999986 5667999999999999999999943
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.98 Aligned_cols=242 Identities=21% Similarity=0.226 Sum_probs=164.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------ 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 377 (572)
+.+.....+|.|+||.||+|.. .+|+.||||++...... ....+++.+|++++++++||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4567778899999999999986 57999999999654322 233567899999999999999999999998653
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..|+||||+ +++|.+++... .+++.....++.+++.|+.||| +|++|.++....+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 88999988752 4788888999999999999997 46666655432111
Q ss_pred -CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhh--------
Q 038466 439 -SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML-------- 500 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~-------- 500 (572)
.......||+.|+|||++.+ ..++.++||||+||+++||+||+.||........ ...+....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 11233568999999999876 6799999999999999999999999863221000 00000000
Q ss_pred hhhcc--cCCCC-CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 IDVLD--QRLPP-PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~~~~~--~~l~~-~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...+. +..+. ............+..+..+|++.||++|||++++++|.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00000 00000 000000000012345667899999999999999999987764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.63 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=170.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-------- 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 375 (572)
+.+.+...+|.|+||.||+|+. .+|+.||||++....... .....+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4567778999999999999986 579999999986543221 112467789999999999999999999987
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------ 437 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------ 437 (572)
.+..++||||+++ +|.+.+.... ..+++.....++.+++.|++||| +|++|..+....+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999985 7777776543 24889999999999999999997 4666655433211
Q ss_pred ---------CCCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccc-------------cCCC
Q 038466 438 ---------SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSS 494 (572)
Q Consensus 438 ---------~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~-------------~~~~ 494 (572)
........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 011123467999999998876 45899999999999999999999998632210 0000
Q ss_pred Ccchhhhhhccc-CCCCCCChHHHHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 495 DPKIMLIDVLDQ-RLPPPVDRKVIRD------ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 495 ~~~~~~~~~~~~-~l~~~~~~~~~~~------~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+........+. ............. ...+.++..+||+.||++|||++|++++.|.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 000000000000 0000000000010 11245677799999999999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=251.58 Aligned_cols=242 Identities=18% Similarity=0.173 Sum_probs=163.4
Q ss_pred CCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEE---------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--------- 374 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--------- 374 (572)
+.+.+.+.+|.|+||.||+|... +|+.||||++...... ..+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH---HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 45677788999999999999865 5999999998765432 3467899999999999999999999874
Q ss_pred -----eCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----
Q 038466 375 -----HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----- 438 (572)
Q Consensus 375 -----~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----- 438 (572)
+.+..++||||++ |+|.+++... .+++.....++.+++.|++||| +|++|..+..+...
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 6999988642 4788888999999999999997 45566544332110
Q ss_pred ----------------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------C
Q 038466 439 ----------------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------S 493 (572)
Q Consensus 439 ----------------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~ 493 (572)
.......||..|+|||++.. ..++.++||||||+++|||+||+.||........ .
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 01122346888999998765 6789999999999999999999999864321000 0
Q ss_pred CCcchhhhhh-------cccCCCCCC-ChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 494 SDPKIMLIDV-------LDQRLPPPV-DRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 494 ~~~~~~~~~~-------~~~~l~~~~-~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
........+. .......+. ..... .-...+..+...||+.||++|||+++++++.+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 0000000000 000000000 00000 0001234566799999999999999999998876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.56 Aligned_cols=170 Identities=17% Similarity=0.233 Sum_probs=140.2
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEe--CCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH--RKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~ 379 (572)
.+.+++...+|.|+||.||+|+. .+++.||||+++.... +.+.+|++++++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 34567778999999999999985 6799999999975442 46889999999997 9999999999988 5678
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------- 437 (572)
++||||+++|+|.+++. .+++.....++.+++.|++||| +|++|..+....+
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999998875 2778888899999999999997 4666655433211
Q ss_pred -CCCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCC
Q 038466 438 -SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRD 485 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~ 485 (572)
........||..|+|||++.+ ..++.++||||+||++|||+||+.||.
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 111223468899999999876 678999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=265.04 Aligned_cols=229 Identities=22% Similarity=0.260 Sum_probs=157.4
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEecc
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
...+++|.|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +|||||++++++.+++..++||||+
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3356799999999987766789999999986543 13567899999986 8999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcc-c---CCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 387 KRGSLFCNLHNNEDAV-E---LDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~-~---l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
. |+|.+++....... . ..+.....++.+++.||+||| +|++|..+......
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 5 69999998643211 1 123345679999999999997 46666654331100
Q ss_pred ----------C------CccccccccCccccccccC-------CCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCC
Q 038466 439 ----------S------NRTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS 494 (572)
Q Consensus 439 ----------~------~~~~~~gt~~y~APE~~~~-------~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~ 494 (572)
. ......||++|+|||++.+ ..++.++|||||||++|||+| |+.||+....
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----- 245 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-----
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-----
Confidence 0 0112468999999999865 678999999999999999999 9999853210
Q ss_pred Ccchhhhhhcc-cCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 495 DPKIMLIDVLD-QRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 495 ~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
........... +........... ..+..++..||+.||++|||+.+|++|.+..
T Consensus 246 ~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 246 RESNIIRGIFSLDEMKCLHDRSLI---AEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp HHHHHHHTCCCCCCCTTCCCHHHH---HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hHHHHhcCCCCcccccccccccch---HHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 00000011111 111111111111 2345677799999999999999999987653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=251.14 Aligned_cols=229 Identities=21% Similarity=0.387 Sum_probs=161.1
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe---------
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--------- 375 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------- 375 (572)
++++...+|.|+||.||+|+. .+|+.||||++.... ...+.+.+|++++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 466778899999999999985 579999999996532 224678899999999999999999999865
Q ss_pred ----CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC-------
Q 038466 376 ----RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------- 438 (572)
Q Consensus 376 ----~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------- 438 (572)
.+..++||||+++|+|.+++.... ..+++.....++.+++.|++|||. |++|..+....+.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 356899999999999999998543 346788888999999999999974 5555544321110
Q ss_pred ------------------------CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccCC
Q 038466 439 ------------------------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 493 (572)
Q Consensus 439 ------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~ 493 (572)
.......||+.|+|||++.+. .++.++|||||||++|||+| |+.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---- 233 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---- 233 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh----
Confidence 011234588999999998754 78999999999999999999 4321100
Q ss_pred CCcchhhhhh--cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 494 SDPKIMLIDV--LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 494 ~~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.......+ .....++........ .+..+...||+.||++|||+++++++.|...
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 234 --RVNILKKLRSVSIEFPPDFDDNKMK---VEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp --HHHHHHHHHSTTCCCCTTCCTTTSH---HHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred --HHHHHHhccccccccCccccccchH---HHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 00001111 111222221111111 1235666899999999999999999887654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=258.60 Aligned_cols=233 Identities=18% Similarity=0.313 Sum_probs=169.8
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+.+++...+|.|+||.||+|...+ .+|+|+++...... ...+.|.+|++++++++||||+++++++.+++..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34567778899999999999998754 38999987543221 1124677899999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
|||+++|+|.+++.... ..+++..+..++.+++.|++||| +|++|..+..+..
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC--------
T ss_pred eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccc
Confidence 99999999999997643 35788899999999999999997 4566655433210
Q ss_pred --CCCccccccccCccccccccC---------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhh---
Q 038466 438 --SSNRTLLAGTYGYIAPELAYT---------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV--- 503 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~--- 503 (572)
........||+.|+|||++.. ..++.++||||||+++|||+||+.||+... .......+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-------HHHHHHHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHhccC
Confidence 011122358899999999864 457899999999999999999999986321 11111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..+.......... +..+...||+.||++|||+.+|++.+.....
T Consensus 259 ~~~~~~~~~~~~~------l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 259 MKPNLSQIGMGKE------ISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCCCCSSCCTT------HHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCCcCCCCHH------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111111 2345668999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=256.71 Aligned_cols=246 Identities=19% Similarity=0.161 Sum_probs=155.1
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe---
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC--- 378 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--- 378 (572)
..+.+.+...+|.|+||.||+|+. .+|+.||||++....... +++.+|++.++.++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345677888999999999999986 469999999986543221 356678888999999999999999976443
Q ss_pred ----EEEEEecccCCChhhhhhc-CCCcccCCHHHHHHHHHHHHHHHHHHh--c------CCCCCceeeCC-C-------
Q 038466 379 ----MFLIYEYMKRGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLH--H------DCSPSIASTCP-D------- 437 (572)
Q Consensus 379 ----~~lV~Ey~~~GsL~~~l~~-~~~~~~l~~~~r~~i~~~ia~gl~yLH--~------~~~~~i~~~~~-~------- 437 (572)
.++||||++++ |...+.. ......+++.....++.+++.|+.||| . |++|.++..+. +
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 88999999974 4433332 122335788888899999999999998 3 45555443321 0
Q ss_pred ---------CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC-------CCCcchhh
Q 038466 438 ---------SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIML 500 (572)
Q Consensus 438 ---------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~-------~~~~~~~~ 500 (572)
........||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...+....
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 1111234689999999998654 489999999999999999999999864221000 00000000
Q ss_pred hhhcccCCC-------CCCCh-HH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 501 IDVLDQRLP-------PPVDR-KV-----IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 501 ~~~~~~~l~-------~~~~~-~~-----~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
....++... ..... .. ......+..+...||+.||++|||+.|+++|.|....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000000000 00000 00 0011234567779999999999999999999877543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=255.71 Aligned_cols=240 Identities=21% Similarity=0.208 Sum_probs=169.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----Ce
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 378 (572)
..+.+.+.+|.|+||.||+|.. .+++.||||++...... ...+.+.+|++++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4567778999999999999985 46899999999754332 2346789999999999999999999999765 36
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++||||+. |+|.+++... .+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999998 5899888653 4788899999999999999997 46666554332110
Q ss_pred ------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhh---
Q 038466 439 ------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML--- 500 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~--- 500 (572)
.......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 00123468999999998654 4589999999999999999999999853321000 00000000
Q ss_pred -----hhhcccCCCC--CCChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 -----IDVLDQRLPP--PVDRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 -----~~~~~~~l~~--~~~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
..... ..+. ....... .....+..+...||+.||++|||+.|++++.+...
T Consensus 260 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 260 INLKARNYLL-SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp CCHHHHHHHH-TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhhHHHHHH-hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 00000 0000 0000000 00012345677999999999999999999988764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=260.45 Aligned_cols=170 Identities=22% Similarity=0.356 Sum_probs=126.5
Q ss_pred ccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey 385 (572)
.++|.|+||.||+|+.. +++.||||++...... +.+.+|++++++++|||||++++++.. +...++||||
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 36899999999999854 5789999999865432 357789999999999999999999965 6789999999
Q ss_pred ccCCChhhhhhcC------CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----C-----------
Q 038466 386 MKRGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----S----------- 438 (572)
Q Consensus 386 ~~~GsL~~~l~~~------~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----~----------- 438 (572)
++ |+|.+++... .....+++.....++.+++.||.||| +|++|..+..... .
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 97 4787777532 12234889999999999999999997 4666665544110 0
Q ss_pred ---------CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 ---------SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 ---------~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 01123468999999999877 4589999999999999999999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=252.90 Aligned_cols=237 Identities=20% Similarity=0.262 Sum_probs=148.3
Q ss_pred CCccccc-cccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCe
Q 038466 305 NNIDVFS-IWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKC 378 (572)
Q Consensus 305 ~~~~~~~-~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~ 378 (572)
+.+.+.. ++|.|+||.||+|+.. +|+.||||++...... ..+....++.++||||+++++++.. +..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3455543 6899999999999865 6999999999754321 1122344677899999999999876 445
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------- 439 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------- 439 (572)
.++||||+++|+|.+++..... ..+++..+..++.+++.|+.||| +|++|..+.......
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 8999999999999999986432 35889999999999999999997 456666554322110
Q ss_pred -----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 440 -----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 440 -----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
......||+.|+|||++....++.++||||||+++|||+||+.||........... ............+.+...
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp EC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTTST
T ss_pred eccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhhhccccccCchhhc
Confidence 11234579999999999888999999999999999999999999853321100000 000000011111111111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.... .+..+...||+.||++|||+++++++.|....
T Consensus 259 ~~~~---~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 259 EVSE---DAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TCCH---HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cCCH---HHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 1111 12356668999999999999999999887643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.73 Aligned_cols=237 Identities=22% Similarity=0.246 Sum_probs=150.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
.+++.....+|.|+||.||+|.. .+|+.||||++....... ..+++..|+. +++.++||||++++|++.+++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 45667778899999999999986 479999999997654322 1244555665 7888999999999999999999999
Q ss_pred EEecccCCChhhhhhcC--CCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC---------------
Q 038466 382 IYEYMKRGSLFCNLHNN--EDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD--------------- 437 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~--~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~--------------- 437 (572)
||||+++ +|.+++... .....+++.....++.+++.|+.|||+ |++|..+....+
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999985 777766531 112357888999999999999999975 444544322110
Q ss_pred -CCCccccccccCccccccc----cCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc---cCCC
Q 038466 438 -SSNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLP 509 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~ 509 (572)
........||+.|+|||++ .+..++.++||||||+++|||+||+.||+....... ....... +.++
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGDPPQLS 251 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCCCCCCC
Confidence 0111223689999999998 456789999999999999999999999864321100 0011111 1111
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
......... .+..++..||+.||++|||+.+|+++.+...
T Consensus 252 ~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 252 NSEEREFSP---SFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CcccccCCH---HHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 110000111 1235666899999999999999999877653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=255.82 Aligned_cols=242 Identities=22% Similarity=0.226 Sum_probs=169.6
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE---
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM--- 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 379 (572)
.+.+.....+|.|+||.||+|.. .+|+.||||++......+ ...+++.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34567778899999999999985 569999999997644322 3357889999999999999999999999877654
Q ss_pred ---EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------
Q 038466 380 ---FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------ 438 (572)
Q Consensus 380 ---~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------ 438 (572)
++||||+. |+|.+.+.. .+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 688777642 3788999999999999999997 45666554332111
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcch--------h
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI--------M 499 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~--------~ 499 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+.. .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 11223568999999999877 6799999999999999999999999864321000 000000 0
Q ss_pred hhhhcccCCCCCC-ChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 500 LIDVLDQRLPPPV-DRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 500 ~~~~~~~~l~~~~-~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...........+. ..... .....+..+...||+.||++|||+.|++++.+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 0000000000000 00000 00112345667999999999999999999988753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=250.47 Aligned_cols=243 Identities=18% Similarity=0.199 Sum_probs=169.6
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----C
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~ 377 (572)
.+++.+...+|.|+||.||+|+.. +|+.||||++...... ...+++.+|++++++++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 456777889999999999999864 6999999999754332 2346788999999999999999999998764 6
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS------------ 439 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~------------ 439 (572)
..++||||+. |+|.+++... .+++.....++.+++.|++||| +|++|..+....+..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999998 6898888752 4888999999999999999997 456665443211100
Q ss_pred ---------------CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc----------C-
Q 038466 440 ---------------NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------S- 492 (572)
Q Consensus 440 ---------------~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----------~- 492 (572)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 0112367999999998754 678999999999999999999999986432100 0
Q ss_pred --CC----Ccchhhhhhccc--CCCCCCChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 493 --SS----DPKIMLIDVLDQ--RLPPPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 493 --~~----~~~~~~~~~~~~--~l~~~~~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.. .......+.... ..+....... ......+..+...||+.||++|||+++++++.+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 000000000000 0000000000 0000123456679999999999999999999887643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=258.74 Aligned_cols=230 Identities=18% Similarity=0.197 Sum_probs=165.8
Q ss_pred CCccccccccccCeeEEEEEEcC---------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCccc-------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP---------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK------- 368 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~---------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~------- 368 (572)
+.+.+...+|.|+||.||+|+.. +++.||||.+... +.+.+|++++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 45677789999999999999865 3789999998754 35778999999999999988
Q ss_pred --------EEEEEEe-CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCcee
Q 038466 369 --------LYGFCLH-RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAS 433 (572)
Q Consensus 369 --------l~g~~~~-~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~ 433 (572)
+++++.. ++..++||||+ +|+|.+++.... ...+++..+..++.+++.||.||| +|++|..+.
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6888876 77899999999 999999998642 235899999999999999999997 456665443
Q ss_pred eCCCC--------------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcc
Q 038466 434 TCPDS--------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL 487 (572)
Q Consensus 434 ~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~ 487 (572)
.+.+. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 22110 0112236899999999999999999999999999999999999998643
Q ss_pred ccccCCCCcch-hhhhhcccCCCCCCC-----hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 488 SSLSSSSDPKI-MLIDVLDQRLPPPVD-----RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 488 ~~~~~~~~~~~-~~~~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.. ..... ..........+.... ..... .+..++..||+.||++|||+++|++.+...
T Consensus 272 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 272 LP----NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSE---TLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TT----CHHHHHHHHHHHHHSCCCEECTTSCEECCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred Cc----CHHHHHHHHHhccCChhhhhhhccccCCCcH---HHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 20 00000 000000111110000 00001 123566689999999999999999987544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.09 Aligned_cols=226 Identities=19% Similarity=0.211 Sum_probs=159.3
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.++....+|.|+||+||.....+|+.||||++..... +.+.+|+++++++ +|||||++++++.+++..|+|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3566678999999996655556789999999975432 2345799999999 79999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------- 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------- 438 (572)
||+ |+|.+++..... ...+.....++.+++.|+.||| +|++|.++......
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 997 699999986532 2233345679999999999997 56777765442100
Q ss_pred -----CCccccccccCcccccccc---CCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CC
Q 038466 439 -----SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RL 508 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~---~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l 508 (572)
.......||++|+|||++. ...++.++|||||||++|||+| |+.||.... ... ....... ..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------~~~-~~~~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------QRQ-ANILLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-------THH-HHHHTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-------HHH-HHHHhccCCc
Confidence 0112245899999999987 4567889999999999999999 899984221 000 0111111 11
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
......... ...+..++..||+.||++|||+++|++|.+.
T Consensus 248 ~~~~~~~~~--~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 248 DCLHPEKHE--DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp TTSCTTCHH--HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred cccCccccc--cHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 111111111 1123467779999999999999999988765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=273.66 Aligned_cols=227 Identities=22% Similarity=0.296 Sum_probs=166.7
Q ss_pred CCccccccccccCeeEEEEEEcC----CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+++...+|.|+||.||+|... .+..||||++...... ...+.|.+|+.++++++|||||+++|++. ++..+
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34566778999999999999863 2568999998764332 23468999999999999999999999985 45689
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
+||||+++|+|.++++... ..+++..+..++.+++.|+.||| +|++|.++..+.+.
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 9999999999999998543 24889999999999999999997 45666544321100
Q ss_pred --CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc---CCCCCC
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPPV 512 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~ 512 (572)
.......||+.|+|||++....++.++|||||||++|||++ |+.||.... .......+... ..++..
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~ 617 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPPNC 617 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHHTCCCCCCTTC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCCCCCCCccc
Confidence 00112346789999999988899999999999999999997 999985321 11111111111 122211
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+ . .+..++..||+.||++|||+.+|++++..
T Consensus 618 ~-~------~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 618 P-P------TLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp C-H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-H------HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1 12356668999999999999999998854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=255.74 Aligned_cols=238 Identities=16% Similarity=0.193 Sum_probs=169.9
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-----------CCCcccEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRNIVKLYG 371 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g 371 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++...... .+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34577788999999999999985 57999999999865432 356788999999887 899999999
Q ss_pred EEEeCC----eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeeCCC---
Q 038466 372 FCLHRK----CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------CSPSIASTCPD--- 437 (572)
Q Consensus 372 ~~~~~~----~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~-------~~~~i~~~~~~--- 437 (572)
++...+ ..++||||+ +|+|.+++..... ..+++.....++.+++.||+|||+. ++|..+.....
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 998654 789999999 8999999876432 2488889999999999999999853 44443322100
Q ss_pred -----------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhh
Q 038466 438 -----------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 500 (572)
Q Consensus 438 -----------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~ 500 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||+......... .....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~ 250 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDHI 250 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-HHHHH
T ss_pred cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-hHHHH
Confidence 001123468999999999999999999999999999999999999986332100000 00000
Q ss_pred hhh---c---------------------------------------ccCCCCCCChHHHHHHHHHHHHHHHccccCCCCC
Q 038466 501 IDV---L---------------------------------------DQRLPPPVDRKVIRDILLASTISFACLQSNPKSR 538 (572)
Q Consensus 501 ~~~---~---------------------------------------~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~R 538 (572)
..+ + ..... .+.. ....+..+...||+.||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK--FSKD---EAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC--CCHH---HHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc--CCcc---hHHHHHHHHHHHhccCcccc
Confidence 000 0 00000 0011 12234567789999999999
Q ss_pred CCHHHHHHHHhhccC
Q 038466 539 PTMQYVSQEFLITRK 553 (572)
Q Consensus 539 Psm~~V~~~l~~~~~ 553 (572)
||++|++++.+....
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=255.84 Aligned_cols=242 Identities=20% Similarity=0.201 Sum_probs=160.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 377 (572)
+.+.+...+|.|+||.||+|.. .+|+.||||++....... ...+++.+|++++++++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4567778999999999999984 579999999997543222 2346788999999999999999999999754 5
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+ +++|.+++.. ..+++.....++.++++|+.||| +|++|.++....+.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 6899888864 24889999999999999999997 45666655432211
Q ss_pred -CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcch--------hh
Q 038466 439 -SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI--------ML 500 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~--------~~ 500 (572)
.......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ...... ..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 11223468999999999876 6789999999999999999999999853321000 000000 00
Q ss_pred hhhcc--cCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 IDVLD--QRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~~~~~--~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...+. +..+........ .....+.++..+||+.||++|||+.++++|.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00000 000000000000 00012346677999999999999999999987764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=254.88 Aligned_cols=177 Identities=20% Similarity=0.273 Sum_probs=141.7
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CC-----CcccEEEEEEeC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR-----NIVKLYGFCLHR 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~ 376 (572)
.+.+.+...+|.|+||+||+|+. .+|+.||||+++.... ..+++..|+++++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34566778899999999999985 4689999999985432 2356778999998886 45 399999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------CCCCCceeeCCCC----------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------DCSPSIASTCPDS---------- 438 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------~~~~~i~~~~~~~---------- 438 (572)
+..++||||++ |+|.+++..... ..+++..+..++.+++.|+.|||. |++|.++....+.
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999996 599999886432 348899999999999999999983 4555544332110
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 207 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 207 SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 111234689999999999999999999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.56 Aligned_cols=239 Identities=22% Similarity=0.213 Sum_probs=167.5
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC---- 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 378 (572)
.+.+.....+|.|+||.||+|+. .+|+.||||++......+ ...+++.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 35677778899999999999985 569999999997643322 335678999999999999999999999987654
Q ss_pred --EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC------------
Q 038466 379 --MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS------------ 438 (572)
Q Consensus 379 --~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~------------ 438 (572)
.++||||+. |+|.+++.. .+++.....++.+++.|+.|||. |++|..+....+.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999998 688877642 37888999999999999999974 5555544332111
Q ss_pred --CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcch---------
Q 038466 439 --SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI--------- 498 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~--------- 498 (572)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+..
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 11123468999999999876 6789999999999999999999999864321000 000000
Q ss_pred --hhhhhcccCCCCCC---ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 499 --MLIDVLDQRLPPPV---DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 499 --~~~~~~~~~l~~~~---~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.....+........ ..... ..+..+...|++.||++|||+++++++.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRAS---PQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSC---HHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHhCcCCCCccHHHhcCCcC---HHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000000000000 00001 12345666899999999999999999987753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=255.91 Aligned_cols=240 Identities=20% Similarity=0.226 Sum_probs=163.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------ 376 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 376 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++..... ...+|++++++++|||||++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45677788999999999999985 6799999999875432 234699999999999999999998543
Q ss_pred --------------------------------CeEEEEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHH
Q 038466 377 --------------------------------KCMFLIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYL 423 (572)
Q Consensus 377 --------------------------------~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yL 423 (572)
...++||||++ |+|.+.+... .....+++.....++.++++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999999 5877777541 1223588999999999999999999
Q ss_pred h------cCCCCCceeeCCC-----------------CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHc
Q 038466 424 H------HDCSPSIASTCPD-----------------SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLM 479 (572)
Q Consensus 424 H------~~~~~~i~~~~~~-----------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~Ellt 479 (572)
| +|++|..+..+.. ........||+.|+|||++.+. .++.++||||+||++|||++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 7 4566655433211 1112234689999999998764 48999999999999999999
Q ss_pred CCCCCCccccccC--------CCCcchhhhhh----cccCCCCCCChHHHH-----HHHHHHHHHHHccccCCCCCCCHH
Q 038466 480 GKHPRDLLSSLSS--------SSDPKIMLIDV----LDQRLPPPVDRKVIR-----DILLASTISFACLQSNPKSRPTMQ 542 (572)
Q Consensus 480 G~~P~~~~~~~~~--------~~~~~~~~~~~----~~~~l~~~~~~~~~~-----~~~~~~~i~~~Cl~~dP~~RPsm~ 542 (572)
|+.||........ ........... .+...+......... ....+.++...||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999864321000 00000000000 000000000000000 001234566799999999999999
Q ss_pred HHHHHHhhc
Q 038466 543 YVSQEFLIT 551 (572)
Q Consensus 543 ~V~~~l~~~ 551 (572)
|+++|.+..
T Consensus 318 e~l~hp~f~ 326 (383)
T 3eb0_A 318 EAMAHPFFD 326 (383)
T ss_dssp HHHTSGGGH
T ss_pred HHhcCHHHH
Confidence 999987764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=251.11 Aligned_cols=245 Identities=17% Similarity=0.211 Sum_probs=172.2
Q ss_pred cCCccccccccccCeeEEEEEEcC-CC-cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCC------cccEEEEEEe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN------IVKLYGFCLH 375 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g-~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~ 375 (572)
.+.+++...+|.|+||.||+|... ++ +.||||+++.... ..+.+.+|++++++++|+| ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 356777889999999999999853 44 7999999976432 2357888999999998877 9999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC------------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------ 437 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------ 437 (572)
.+..++||||+ +|++.+++.... ...+++.....++.+++.||+|||. |++|..+.....
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999999 667777776543 2358899999999999999999974 566665543110
Q ss_pred ---------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc-----
Q 038466 438 ---------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----- 491 (572)
Q Consensus 438 ---------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----- 491 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123468999999999999999999999999999999999999986322100
Q ss_pred ---CCCCcchhhhhh------cccC--CCCCCC----------------hHHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 038466 492 ---SSSDPKIMLIDV------LDQR--LPPPVD----------------RKVIRDILLASTISFACLQSNPKSRPTMQYV 544 (572)
Q Consensus 492 ---~~~~~~~~~~~~------~~~~--l~~~~~----------------~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V 544 (572)
....+....... .... .+.... .........+..+...||+.||++|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 000000000000 0000 000000 0000011234567779999999999999999
Q ss_pred HHHHhhccCC
Q 038466 545 SQEFLITRKT 554 (572)
Q Consensus 545 ~~~l~~~~~~ 554 (572)
+++.+.....
T Consensus 332 l~hp~f~~~~ 341 (355)
T 2eu9_A 332 LLHPFFAGLT 341 (355)
T ss_dssp TTSGGGGGCC
T ss_pred hcChhhcCCC
Confidence 9998876544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=249.87 Aligned_cols=240 Identities=20% Similarity=0.265 Sum_probs=167.7
Q ss_pred cCCccccccccccCeeEEEEEEc--CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEE----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCL---- 374 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~--~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~---- 374 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++........ ....+.+|+++++++ +||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 35677888999999999999986 4689999999874432110 112455677777666 8999999999997
Q ss_pred -eCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCC---------
Q 038466 375 -HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDS--------- 438 (572)
Q Consensus 375 -~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~--------- 438 (572)
.....++||||++ |+|.+++..... ..+++..+..++.+++.|+.|||. |++|..+....+.
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567899999998 699999876432 248899999999999999999974 5555544332110
Q ss_pred -------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhh---
Q 038466 439 -------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML--- 500 (572)
Q Consensus 439 -------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~--- 500 (572)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 011234689999999999999999999999999999999999999863221000 00000000
Q ss_pred ----hhhccc-------CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 501 ----IDVLDQ-------RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 501 ----~~~~~~-------~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...... ...+..+ . .+..+...||+.||++|||+.+++++.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDID-E------LGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCC-H------HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhhcccCcchhhhccccCC-H------HHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 000000 0001111 1 12356668999999999999999999877544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=259.21 Aligned_cols=236 Identities=21% Similarity=0.260 Sum_probs=161.4
Q ss_pred CccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC----C--e
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR----K--C 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~ 378 (572)
.+.....+|.|+||.||+|+.. +|+.||||++..... .+.+|++++++++|||||+++++|... + .
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4667788999999999999864 699999999865431 234699999999999999999998642 2 3
Q ss_pred EEEEEecccCCChhhhhhcC-CCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
.++||||+++ ++.+.+... .....+++.....++.|+++||.||| +|++|.++..+.+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999996 555554421 12235889899999999999999997 4566655433211
Q ss_pred ---CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhhhcc
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDVLD 505 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~~~~ 505 (572)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......+.. ..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~-~~ 285 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MN 285 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH-HC
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh-hC
Confidence 1111234689999999998764 799999999999999999999999863321000 0000000000 00
Q ss_pred c-----CCCCCCChHHHHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 506 Q-----RLPPPVDRKVIRD------ILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 506 ~-----~l~~~~~~~~~~~------~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+ ..+... ...... ...+.++..+||+.||++|||+.|+++|.+..
T Consensus 286 ~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 286 PNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp SCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 0 111000 000000 01244677799999999999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=245.95 Aligned_cols=234 Identities=21% Similarity=0.258 Sum_probs=153.1
Q ss_pred cCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.++++....+|.|+||.||+|+.. +|+.||||++......+. ..+.+.++..+++.++||||+++++++.+++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 345666788999999999999864 799999999976543322 234455666778999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~----------------~~ 439 (572)
|||+ ++.+........ ..+++.....++.+++.|+.|||+ |++|..+....+ ..
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 444444443221 247888999999999999999984 334443332111 01
Q ss_pred CccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc---CCCCC
Q 038466 440 NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPP 511 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~ 511 (572)
......||+.|+|||++. ...++.++||||||+++|||+||+.||+... ............ ..+..
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSCCCCCCSS
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccCCCCCCcc
Confidence 112346899999999984 5568899999999999999999999986321 111111111111 11111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. .... .+..+...||+.||++|||+++++++.+..+
T Consensus 254 ~--~~~~---~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 254 M--GFSG---DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp S--CCCH---HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred C--CCCH---HHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0 0001 1234566899999999999999999877653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=247.97 Aligned_cols=230 Identities=16% Similarity=0.244 Sum_probs=164.6
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHH---HHHHHHHHHHHHHHhc----CCCCcccEEEEEEe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQV----LHRNIVKLYGFCLH 375 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~---~~~~~f~~E~~~l~~l----~H~niv~l~g~~~~ 375 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||+++....... .....+.+|++++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 45677788999999999999986 5689999999976543211 1224566899999999 89999999999999
Q ss_pred CCeEEEEEec-ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC-CC----------
Q 038466 376 RKCMFLIYEY-MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC-PD---------- 437 (572)
Q Consensus 376 ~~~~~lV~Ey-~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~-~~---------- 437 (572)
.+..++|||| +++|+|.+++.... .+++..+..++.+++.|+.||| +|++|..+... .+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 78999999997643 4889999999999999999997 46666554332 11
Q ss_pred -----CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 438 -----SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 438 -----~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
........||+.|+|||++.+..+ +.++||||||+++|||+||+.||+.... ... .....+..
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~-~~~~~~~~ 255 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILE-AELHFPAH 255 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHH-TCCCCCTT
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hhh-hccCCccc
Confidence 111223468999999999876665 4599999999999999999999853211 000 01112222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+.. +..++..||+.||++|||+++++++.+.....
T Consensus 256 ~~~~-------~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 256 VSPD-------CCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp SCHH-------HHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CCHH-------HHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 2211 23456689999999999999999998876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=257.44 Aligned_cols=239 Identities=19% Similarity=0.219 Sum_probs=161.5
Q ss_pred CccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe------E
Q 038466 306 NIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC------M 379 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 379 (572)
.+.+.+.+|.|+||+||+|+..++..+|+|++..... ...+|++++++++|||||+++++|...+. .
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4667789999999999999987766689998865432 12369999999999999999999965433 7
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCC-C---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCP-D--------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~-~--------------- 437 (572)
++||||++++.+....+.......+++.....++.++++||+||| +|++|.++..+. .
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 899999998654433322222235888888999999999999997 466666554321 0
Q ss_pred -CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhh----hh
Q 038466 438 -SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLI----DV 503 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~----~~ 503 (572)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||........ .......+. ..
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 1112234689999999998664 589999999999999999999999864321000 000000000 00
Q ss_pred cccCCCCCCChHHHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 504 LDQRLPPPVDRKVIR-----DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~-----~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.....+......... ....+.++..+||+.||++|||+.|+++|.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 011111000000000 001234667799999999999999999998765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=260.73 Aligned_cols=235 Identities=14% Similarity=0.165 Sum_probs=168.1
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCeEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~l 381 (572)
.+.+.+...+|.|+||.||+|+. .+|+.||||++...... +++..|+++++.++| +++..+..++.+.+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 35677888999999999999985 67999999987654432 357789999999987 555566667778889999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC---CC---------------
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC---PD--------------- 437 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~---~~--------------- 437 (572)
||||+ +|+|.+++.... ..+++..+..++.+++.||.||| +|++|.++... ..
T Consensus 81 vme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 999999997533 25899999999999999999997 56777655431 00
Q ss_pred -CC--------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC
Q 038466 438 -SS--------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 508 (572)
Q Consensus 438 -~~--------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l 508 (572)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SHHHHHHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch----hHHHHHHHHhhccc
Confidence 00 011456899999999999999999999999999999999999998643210 00111111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 509 PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 509 ~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
..............+..++..||+.||++||++++|++.|..
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 000000000000123456678999999999999999887643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=270.61 Aligned_cols=240 Identities=22% Similarity=0.235 Sum_probs=167.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe------CC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------RK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~ 377 (572)
+.+.+...+|.|+||.||+|.. .+|+.||||++...... ...++|.+|++++++++|||||++++++.. ++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4577788999999999999986 46899999999765322 234679999999999999999999999765 66
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+++|+|.+++........+++..+..++.+++.|++||| +|++|..+....+.
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999999999999987554445788888999999999999997 45666654332111
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccc---ccC----CCCcchhhhhh--
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS---LSS----SSDPKIMLIDV-- 503 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~---~~~----~~~~~~~~~~~-- 503 (572)
.......||++|+|||++.+..++.++|||||||++|||+||+.||..... +.. .........+.
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 111234689999999999999999999999999999999999999853210 000 00000000000
Q ss_pred ----cccCCCCC--CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 504 ----LDQRLPPP--VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 504 ----~~~~l~~~--~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.....+.+ ....... .+..+...||+.||++|||+.+++++.+
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~---~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAG---KLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHH---HHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred cccccccccCCchhhchhhhH---HHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 11111211 1111222 2345667999999999999988665443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=249.75 Aligned_cols=230 Identities=17% Similarity=0.217 Sum_probs=171.4
Q ss_pred ccCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH---HHHHHHHHHHHHHHHhcC--CCCcccEEEEEEeC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHR 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~---~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~ 376 (572)
..+.+.+...+|.|+||.||+|+. .+|+.||||++......+ ....+.+.+|++++++++ ||||+++++++.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 445678888999999999999984 578999999987543211 001235678999999996 59999999999999
Q ss_pred CeEEEEEecccC-CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------
Q 038466 377 KCMFLIYEYMKR-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------ 437 (572)
Q Consensus 377 ~~~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------ 437 (572)
+..++||||+.+ |+|.+++.... .+++.....++.+++.||+||| +|++|..+..+.+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999986 89999987532 4788899999999999999997 4666665543211
Q ss_pred ----CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 438 ----SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 438 ----~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
........||+.|+|||++....+ +.++||||||+++|||+||+.||+..... ... ....+...
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------~~~--~~~~~~~~ 266 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRG--QVFFRQRV 266 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------HHC--CCCCSSCC
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------hcc--cccccccC
Confidence 011123468999999999876665 68899999999999999999998532110 000 01111112
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+. . +..++..||+.||++|||+++|+++.+....
T Consensus 267 ~~-~------~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 267 SS-E------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CH-H------HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CH-H------HHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 11 1 2345668999999999999999999876654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=237.45 Aligned_cols=233 Identities=21% Similarity=0.288 Sum_probs=158.8
Q ss_pred Ccccc-ccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHH-HhcCCCCcccEEEEEEe----CCe
Q 038466 306 NIDVF-SIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRNIVKLYGFCLH----RKC 378 (572)
Q Consensus 306 ~~~~~-~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~ 378 (572)
.+.+. ..+|.|+||.||+|.. .+|+.||||++... ..+.+|++++ +..+||||+++++++.. +..
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34444 5789999999999985 57899999999643 2456788887 66699999999999987 667
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCCCCCccccccccCccc
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPDSSNRTLLAGTYGYIA 452 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~~~~~~~~~gt~~y~A 452 (572)
.++||||+++|+|.+++..... ..+++.....++.+++.|+.|||. |++|..+.......+.....+.+|.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~-- 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT--
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc--
Confidence 8999999999999999986432 358899999999999999999974 4555555443322122233333442
Q ss_pred cccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccc
Q 038466 453 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQ 532 (572)
Q Consensus 453 PE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~ 532 (572)
.+...+..++.++||||+||++|||+||+.||.......... . ............+. .........+..+...||+
T Consensus 167 a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 242 (299)
T 3m2w_A 167 AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-MKTRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLK 242 (299)
T ss_dssp CEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C-SCCSSCTTCCSSCH-HHHTTSCHHHHHHHHHHTC
T ss_pred ccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H-HHHHHhhccccCCc-hhcccCCHHHHHHHHHHcc
Confidence 233456778999999999999999999999985432110000 0 00000011111110 0000000123456668999
Q ss_pred cCCCCCCCHHHHHHHHhhccC
Q 038466 533 SNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 533 ~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.||++|||+.|++++.+....
T Consensus 243 ~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 243 TEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSTTTSCCHHHHHTSHHHHTG
T ss_pred cChhhCCCHHHHhcChhhccc
Confidence 999999999999999877544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=265.63 Aligned_cols=219 Identities=24% Similarity=0.310 Sum_probs=160.5
Q ss_pred cCCccccccccccCeeEEEEEEcC--CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe---
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC--- 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~--~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--- 378 (572)
.+.+.+...+|.|+||.||+|... +|+.||||++...... ...+.|.+|++++++++|||||+++++|.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 356778889999999999999864 6899999998754332 234678999999999999999999999987665
Q ss_pred --EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------
Q 038466 379 --MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------ 438 (572)
Q Consensus 379 --~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------ 438 (572)
.|+||||+++|+|.+++.. .++|.++..++.+++.||.||| +|++|.++....+.
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEET
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhc
Confidence 7999999999999887653 4899999999999999999997 46666655432210
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||++|+|||++.+. ++.++|||||||++|||++|..|+..... ..++... ....
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~~~~~~~--~~~~ 292 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV----------------DGLPEDD--PVLK 292 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC----------------SSCCTTC--HHHH
T ss_pred ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc----------------ccccccc--cccc
Confidence 111335699999999998655 48999999999999999999988642110 0011100 1111
Q ss_pred HHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 038466 519 DILLASTISFACLQSNPKSRPT-MQYVSQEF 548 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPs-m~~V~~~l 548 (572)
....+..+..+||+.||++||+ ++++.+.+
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 1122345677999999999997 45554444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=234.89 Aligned_cols=226 Identities=15% Similarity=0.100 Sum_probs=151.0
Q ss_pred ccccccccccCeeEEEEEE-cCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCc----------ccE-----
Q 038466 307 IDVFSIWNYDGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNI----------VKL----- 369 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~ni----------v~l----- 369 (572)
+.....+|.|+||.||+|+ ..+|+.||||++...........+.|.+|+.+++.++| +|. +.+
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 4556789999999999999 56799999999985443333335689999999999987 321 111
Q ss_pred ------EEEEEe-----CCeEEEEEecccCCChhhhhhc----CCCcccCCHHHHHHHHHHHHHHHHHHh------cCCC
Q 038466 370 ------YGFCLH-----RKCMFLIYEYMKRGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH------HDCS 428 (572)
Q Consensus 370 ------~g~~~~-----~~~~~lV~Ey~~~GsL~~~l~~----~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~ 428 (572)
..++.. ....+++|+++ +|+|.+++.. ......++|..++.++.|++.||+||| +|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 111111 12356677755 5899888841 122335788899999999999999997 5677
Q ss_pred CCceeeCCCCC--------------CccccccccCccccccc----------cCCCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 429 PSIASTCPDSS--------------NRTLLAGTYGYIAPELA----------YTMVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 429 ~~i~~~~~~~~--------------~~~~~~gt~~y~APE~~----------~~~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
|.++..+.+.. ......| +.|+|||++ ....++.++|||||||++|||+||+.||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 76665432211 1123457 999999998 6667899999999999999999999998
Q ss_pred CccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 485 DLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
....... .....+... ...+ . .+..++..||+.||++||++.+++++.+.
T Consensus 318 ~~~~~~~-------~~~~~~~~~--~~~~-~------~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 318 TDDAALG-------GSEWIFRSC--KNIP-Q------PVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp CTTGGGS-------CSGGGGSSC--CCCC-H------HHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCcchhh-------hHHHHHhhc--ccCC-H------HHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 6432110 011111111 1111 1 12355668999999999999888776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=212.57 Aligned_cols=229 Identities=11% Similarity=0.051 Sum_probs=157.4
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchH-----HHHHHHHHHHHHHHHHhcC---------CCCcccEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVL---------HRNIVKLY 370 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~-----~~~~~~~f~~E~~~l~~l~---------H~niv~l~ 370 (572)
+.+.+...+|.|+||+||+|+. +|+.||||++...... .....+.+.+|++++++++ |||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4566778899999999999987 6899999999754311 1112356888999999886 88888888
Q ss_pred EEEE------------------------------eCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHH
Q 038466 371 GFCL------------------------------HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 420 (572)
Q Consensus 371 g~~~------------------------------~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl 420 (572)
+.+. +++..++||||+++|++.+.+.+ ..+++.....++.|++.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 8653 26789999999999987777643 2478889999999999999
Q ss_pred HHHh-------cCCCCCceeeCCCCC--------------------------------CccccccccCccccccccCCCc
Q 038466 421 AYLH-------HDCSPSIASTCPDSS--------------------------------NRTLLAGTYGYIAPELAYTMVM 461 (572)
Q Consensus 421 ~yLH-------~~~~~~i~~~~~~~~--------------------------------~~~~~~gt~~y~APE~~~~~~~ 461 (572)
+||| +|++|.++....+.. ......||+.|+|||++.+..
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-
Confidence 9998 367776554332210 011246899999999998766
Q ss_pred CcccchHHHHHH-HHHHHcCCCCCCccccccCCCCcchhhhhhccc-CCC-CCCChHHHHHHHHHHHHHHHccccCCCCC
Q 038466 462 TEKCDVYSFGVV-TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP-PPVDRKVIRDILLASTISFACLQSNPKSR 538 (572)
Q Consensus 462 s~ksDVySfGvv-l~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~-~~~~~~~~~~~~~~~~i~~~Cl~~dP~~R 538 (572)
+.++||||+|++ .+++++|..|+....+. .......... ... .+...........+.++..+||+.|
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWL------HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH------HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhh------hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 899999998777 77788999997431100 0000011101 001 1111111111223456777999976
Q ss_pred CCHHHHH-HHHhh
Q 038466 539 PTMQYVS-QEFLI 550 (572)
Q Consensus 539 Psm~~V~-~~l~~ 550 (572)
|++|++ +|.|.
T Consensus 324 -sa~e~l~~Hp~f 335 (336)
T 2vuw_A 324 -SATDLLCQHSLF 335 (336)
T ss_dssp -SHHHHHHHCGGG
T ss_pred -CHHHHHhcCCCc
Confidence 999999 88764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.88 E-value=6.9e-23 Score=208.90 Aligned_cols=180 Identities=30% Similarity=0.518 Sum_probs=152.5
Q ss_pred hhhhHHHHhhhcCCC---CCCCCCCCCCCCC--ccceeeCCC---CCEEEEEeCCCccCcccccCccccCCCCCCcEEEc
Q 038466 62 LSPIQLEKKALINTG---WWNSSFWTTDHCK--WEGITCNSA---GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTI 133 (572)
Q Consensus 62 ~~~l~~~~~~~~~~~---~~~~~~~~~~~c~--w~Gv~c~~~---~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 133 (572)
..+++.+|.++..+. .|+. +.+||. |.||+|+.. ++|+.|++++........+ ...+..+++|++|++
T Consensus 8 ~~aL~~~k~~~~~~~~l~~W~~---~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~-~~~l~~l~~L~~L~L 83 (313)
T 1ogq_A 8 KQALLQIKKDLGNPTTLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI-PSSLANLPYLNFLYI 83 (313)
T ss_dssp HHHHHHHHHHTTCCGGGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEEC-CGGGGGCTTCSEEEE
T ss_pred HHHHHHHHHhcCCcccccCCCC---CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCccc-ChhHhCCCCCCeeeC
Confidence 356778888874332 3433 368998 999999864 7899999985432210011 125788999999999
Q ss_pred cC-CcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCC
Q 038466 134 QF-FALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG 212 (572)
Q Consensus 134 ~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g 212 (572)
++ |.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|.++|
T Consensus 84 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 163 (313)
T 1ogq_A 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163 (313)
T ss_dssp EEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred CCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccC
Confidence 95 99999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhhhcc-ccCccccCCCcccCCccccCCCC
Q 038466 213 KIPPEIAGMK-NLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 213 ~~p~~~~~l~-~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
.+|..++.+. +|+.|++++|+++|.+|..+...
T Consensus 164 ~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l 197 (313)
T 1ogq_A 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197 (313)
T ss_dssp ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred cCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC
Confidence 9999999998 99999999999999999877543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-21 Score=213.69 Aligned_cols=176 Identities=20% Similarity=0.368 Sum_probs=142.2
Q ss_pred hhhHHHHhhhcCCCCC----------CCCCCCCCCCCc---cceeeCCCCCEEEEEeCCCc--cCcccccCccccCCCCC
Q 038466 63 SPIQLEKKALINTGWW----------NSSFWTTDHCKW---EGITCNSAGSIFELYLSGYY--AGFNWRLSQLNFSCFPN 127 (572)
Q Consensus 63 ~~l~~~~~~~~~~~~~----------~~~~~~~~~c~w---~Gv~c~~~~~v~~l~l~~~~--~~~~~~l~~~~~~~l~~ 127 (572)
.++.+.+.++.++.|- +|. .+.++|.| .||+|+..|+|++|++++.. |.+ . ..++++++
T Consensus 33 ~aL~~~~~~~~~~~w~~~~~~~~~~~~W~-~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~l----p-~~l~~L~~ 106 (636)
T 4eco_A 33 LALKEIWDALNGKNWSQQGFGTQPGANWN-FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRV----P-DAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHTTGGGCCCCC------CCCC-CSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEE----C-GGGGGCTT
T ss_pred HHHHHHHHHcCCCCcccCCcCCccCCCCC-CCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcC----C-hHHhcCcc
Confidence 4666777766443321 122 14789999 99999888999999998532 222 2 25788999
Q ss_pred CcEEEccCCc----------------------------------------------------------------------
Q 038466 128 LVKLTIQFFA---------------------------------------------------------------------- 137 (572)
Q Consensus 128 L~~L~l~~n~---------------------------------------------------------------------- 137 (572)
|+.|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999998883
Q ss_pred --------ccccCchhccCCccCCEEEccCCcCCCC-----------------CCcCCc--CCCCcceeecccccccCCC
Q 038466 138 --------LTGSIPPEISALSKLQLLDLSSNGLTGT-----------------IPPEIG--NLKNLIELNVGSNSLIGPI 190 (572)
Q Consensus 138 --------l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-----------------ip~~~~--~l~~L~~L~Ls~N~l~g~i 190 (572)
++| +|..++++++|++|+|++|.++|. +|+.++ ++++|++|+|++|++.|.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 445 788899999999999999999986 899988 9999999999999999999
Q ss_pred CccccCCCccCeeEeccCc-CCC-CCchhhhhc------cccCccccCCCcccCCccc--cCCCCC
Q 038466 191 PSALGSLTNLSNLDLSSNK-LSG-KIPPEIAGM------KNLTWLDLSNNNIKGSIPV--RLSPNK 246 (572)
Q Consensus 191 p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~L~ls~N~l~g~ip~--~~s~n~ 246 (572)
|..++++++|+.|++++|+ ++| .+|..++.+ ++|+.|++++|+++ .+|. .++...
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~ 330 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK 330 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC
Confidence 9999999999999999998 888 889988887 89999999999998 8887 665444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.6e-21 Score=218.14 Aligned_cols=178 Identities=19% Similarity=0.317 Sum_probs=149.0
Q ss_pred hhhhHHHHhhhcCCCCCCCCC--CCCCC--CCc------------cceeeCCCCCEEEEEeCCCc--cCcccccCccccC
Q 038466 62 LSPIQLEKKALINTGWWNSSF--WTTDH--CKW------------EGITCNSAGSIFELYLSGYY--AGFNWRLSQLNFS 123 (572)
Q Consensus 62 ~~~l~~~~~~~~~~~~~~~~~--~~~~~--c~w------------~Gv~c~~~~~v~~l~l~~~~--~~~~~~l~~~~~~ 123 (572)
..+|..+++++.++ .|+.+. +..+| |+| .||+|+..++|++|+|++.. |.+ + ..++
T Consensus 271 ~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i----p-~~l~ 344 (876)
T 4ecn_A 271 YKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV----P-DAIG 344 (876)
T ss_dssp HHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE----C-GGGG
T ss_pred HHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC----c-hHHh
Confidence 45788899987554 565542 12355 999 99999988999999998532 322 1 3588
Q ss_pred CCCCCcEEEc-cCCccccc-------------------------------------------------------------
Q 038466 124 CFPNLVKLTI-QFFALTGS------------------------------------------------------------- 141 (572)
Q Consensus 124 ~l~~L~~L~l-~~n~l~g~------------------------------------------------------------- 141 (572)
++++|+.|+| ++|.+.|.
T Consensus 345 ~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~ 424 (876)
T 4ecn_A 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424 (876)
T ss_dssp GCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCC
T ss_pred ccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccc
Confidence 8999999999 77766555
Q ss_pred ---------------CchhccCCccCCEEEccCCcCCC-----------------CCCcCCc--CCCCcceeeccccccc
Q 038466 142 ---------------IPPEISALSKLQLLDLSSNGLTG-----------------TIPPEIG--NLKNLIELNVGSNSLI 187 (572)
Q Consensus 142 ---------------ip~~~~~l~~L~~L~Ls~N~l~g-----------------~ip~~~~--~l~~L~~L~Ls~N~l~ 187 (572)
+|..+++|++|++|+|++|.++| .+|+.++ ++++|++|+|++|++.
T Consensus 425 l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~ 504 (876)
T 4ecn_A 425 LKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504 (876)
T ss_dssp CCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTC
T ss_pred hhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCC
Confidence 88899999999999999999998 4999988 9999999999999999
Q ss_pred CCCCccccCCCccCeeEeccCc-CCC-CCchhhhhcc-------ccCccccCCCcccCCccc--cCCCCC
Q 038466 188 GPIPSALGSLTNLSNLDLSSNK-LSG-KIPPEIAGMK-------NLTWLDLSNNNIKGSIPV--RLSPNK 246 (572)
Q Consensus 188 g~ip~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l~-------~L~~L~ls~N~l~g~ip~--~~s~n~ 246 (572)
|.+|..++++++|+.|+|++|+ ++| .+|..++.+. +|+.|++++|+++ .+|. .++...
T Consensus 505 ~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~ 573 (876)
T 4ecn_A 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV 573 (876)
T ss_dssp CSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT
T ss_pred ccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCC
Confidence 9999999999999999999998 998 8999888887 9999999999999 8988 665444
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=215.05 Aligned_cols=179 Identities=27% Similarity=0.400 Sum_probs=127.7
Q ss_pred ChhhhHHHHhhhcCCC---CCCCCCCCCCCCCccceeeCCCCCEEEEEeCCC--ccC---cccc---cC-----------
Q 038466 61 ALSPIQLEKKALINTG---WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGY--YAG---FNWR---LS----------- 118 (572)
Q Consensus 61 ~~~~l~~~~~~~~~~~---~~~~~~~~~~~c~w~Gv~c~~~~~v~~l~l~~~--~~~---~~~~---l~----------- 118 (572)
+..+++.+|+++.++. .|+. +.+||+|.||+|+ .++|+.|++++. .+. +... +.
T Consensus 13 ~~~all~~k~~~~~~~~l~~W~~---~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~ 88 (768)
T 3rgz_A 13 EIHQLISFKDVLPDKNLLPDWSS---NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSH 88 (768)
T ss_dssp HHHHHHHHHTTCSCTTSSTTCCT---TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSC
T ss_pred HHHHHHHHHhhCCCcccccCCCC---CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCC
Confidence 3457889999876432 3432 4789999999998 699999999853 232 1110 10
Q ss_pred --c--cccCCCCCCcEEEccCCcccccCch--hccCCccCCEEEccCCcCCCCCCcCC-cCCCCcceeecccccccCCCC
Q 038466 119 --Q--LNFSCFPNLVKLTIQFFALTGSIPP--EISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIP 191 (572)
Q Consensus 119 --~--~~~~~l~~L~~L~l~~n~l~g~ip~--~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~Ls~N~l~g~ip 191 (572)
. ..+..+++|++|+|++|.+.|.+|. .++++++|++|||++|.+++.+|..+ ..+++|++|+|++|++++..|
T Consensus 89 ~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 168 (768)
T 3rgz_A 89 INGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168 (768)
T ss_dssp EEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETH
T ss_pred cCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCC
Confidence 0 2477889999999999999999998 89999999999999999999888776 778888888888888877776
Q ss_pred cc---ccCC----------------------CccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 192 SA---LGSL----------------------TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 192 ~~---~~~l----------------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
.. ++++ ++|++|++++|.+++.+|. ++++++|++|++++|.++|.+|..+..
T Consensus 169 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~ 245 (768)
T 3rgz_A 169 VGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST 245 (768)
T ss_dssp HHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTT
T ss_pred hhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhc
Confidence 55 4444 4555555555555555554 555566666666666666655555543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9.2e-19 Score=199.83 Aligned_cols=110 Identities=48% Similarity=0.792 Sum_probs=88.1
Q ss_pred CccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccc
Q 038466 149 LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLD 228 (572)
Q Consensus 149 l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ 228 (572)
+++|++|||++|+++|.+|..++++++|++|+|++|+++|.+|..++++++|+.|||++|+++|.+|..++.+++|++||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 46677888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cCCCcccCCcccc----------CCCCCCCCCCCccCCCCCCC
Q 038466 229 LSNNNIKGSIPVR----------LSPNKGLCGGNFLDLPSCDT 261 (572)
Q Consensus 229 ls~N~l~g~ip~~----------~s~n~~l~~~~~~~l~~c~~ 261 (572)
+++|+++|.||.. +.+|.+||+.. ++.|..
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~ 750 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDP 750 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCS
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCC---CcCCCC
Confidence 8888888888853 24566777653 336754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=177.92 Aligned_cols=173 Identities=20% Similarity=0.297 Sum_probs=109.1
Q ss_pred hhhhHHHHhhhcCC--C---CCCC-CCCCCCCCCccceeeCC---------CCCEEEEEeCCCccCcccccCccccCCCC
Q 038466 62 LSPIQLEKKALINT--G---WWNS-SFWTTDHCKWEGITCNS---------AGSIFELYLSGYYAGFNWRLSQLNFSCFP 126 (572)
Q Consensus 62 ~~~l~~~~~~~~~~--~---~~~~-~~~~~~~c~w~Gv~c~~---------~~~v~~l~l~~~~~~~~~~l~~~~~~~l~ 126 (572)
..++..++.++..+ + .|.. .....++|.|.|+.|+. ..+|+.|++++.... .+.. .+..++
T Consensus 29 ~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~---~lp~-~l~~l~ 104 (328)
T 4fcg_A 29 HDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP---QFPD-QAFRLS 104 (328)
T ss_dssp HHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS---SCCS-CGGGGT
T ss_pred HHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch---hcCh-hhhhCC
Confidence 34677888766332 1 2420 11247889999999952 367899998753221 1111 245566
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccC---------C
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS---------L 197 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~---------l 197 (572)
+|++|+|++|.+. .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|++.+.+|..++. +
T Consensus 105 ~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 6777777777766 66666667777777777777766 56666666667777777766666666665543 6
Q ss_pred CccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 198 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++|+.|++++|.++ .+|..++.+++|+.|++++|.+++ +|..+
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l 225 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGG
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhh
Confidence 66666666666666 566666666666666666666664 44333
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=192.14 Aligned_cols=163 Identities=17% Similarity=0.034 Sum_probs=106.1
Q ss_pred cccCeeEEEEEE-cCCCcEEEEEecCCcc-------hHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEEEEEe
Q 038466 314 NYDGYGSVYKAQ-LPNGKVFALKKLHTSE-------TEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 314 ~~~~fG~Vyk~~-~~~g~~vAvK~l~~~~-------~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+++|.+++++ ...|+.+|||.+.... .......++|.+|+++|+++ .|+||+++++++.+++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 445566666654 4468899999996431 12223456899999999999 79999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~ 441 (572)
|++||+|.+.|...+ .++.. +|+.||+.||+|+| ||+||.++....+. ...
T Consensus 323 yv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 323 KLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp CCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred cCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999998643 34432 48899999999996 68888876543221 112
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCC
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 483 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P 483 (572)
...+||++|||||++.+ .+..++|+||.|++++++.+|..|
T Consensus 397 ~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 34569999999999865 467889999999999887766544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-17 Score=159.82 Aligned_cols=143 Identities=24% Similarity=0.259 Sum_probs=117.8
Q ss_pred CCCCCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCC
Q 038466 85 TDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG 164 (572)
Q Consensus 85 ~~~c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 164 (572)
...|+|++|.|...+ +..++..-.++|+.|+|++|.+.+..|..+.++++|++|+|++|.+++
T Consensus 16 ~~~Cs~~~v~c~~~~-----------------l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 78 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKR-----------------HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78 (229)
T ss_dssp TCEEETTEEECTTSC-----------------CSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCEEeCCEeEccCCC-----------------cCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC
Confidence 577999999997532 112222334789999999999999889889999999999999999986
Q ss_pred CCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 165 TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 165 ~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++..+..+..
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 157 (229)
T 3e6j_A 79 LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence 65566789999999999999999877778899999999999999998 78989999999999999999998655544543
Q ss_pred C
Q 038466 245 N 245 (572)
Q Consensus 245 n 245 (572)
.
T Consensus 158 l 158 (229)
T 3e6j_A 158 L 158 (229)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-17 Score=156.87 Aligned_cols=150 Identities=23% Similarity=0.255 Sum_probs=100.2
Q ss_pred CCCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEE
Q 038466 87 HCKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLD 156 (572)
Q Consensus 87 ~c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~ 156 (572)
.|.|++|.|...+ .++.|++++.... .+....|..+++|+.|++++|.+.+..+..+.++++|++|+
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK---SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC---CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC---cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 4889999997532 3455555532111 11222356677777777777777765555567777777777
Q ss_pred ccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 157 LSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 157 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
|++|.+++..+..++++++|++|+|++|++++..+..+.++++|+.|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 77777775555556777777777777777776666667777777777777777776555556777777777777776665
Q ss_pred Ccc
Q 038466 237 SIP 239 (572)
Q Consensus 237 ~ip 239 (572)
..|
T Consensus 163 ~~~ 165 (208)
T 2o6s_A 163 TCP 165 (208)
T ss_dssp CTT
T ss_pred CCC
Confidence 554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-17 Score=161.18 Aligned_cols=124 Identities=23% Similarity=0.278 Sum_probs=90.5
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+++|+.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..++.+++|++|+|++|++++..+..++++++|
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 133 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc
Confidence 36667777777777777777777677777777777777777776666667777777777777777776666667777777
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
+.|+|++|.+++..|..++.+++|++|++++|++++..|..+..
T Consensus 134 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 177 (251)
T 3m19_A 134 KELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177 (251)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhC
Confidence 77777777777655556777777777777777777655545543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=157.90 Aligned_cols=118 Identities=19% Similarity=0.208 Sum_probs=68.9
Q ss_pred CCcEEEccCCcccccCch-hccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 127 NLVKLTIQFFALTGSIPP-EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
.++.|+|++|.+++..|. .+.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 345666666666555432 3555666666666666666555555666666666666666665555555666666666666
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
++|++++..|..|..+++|+.|+|++|++++..|..+..
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 151 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTT
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcC
Confidence 666666555555666666666666666666555555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.9e-17 Score=155.78 Aligned_cols=120 Identities=23% Similarity=0.271 Sum_probs=90.6
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++|+.|+|++|.+.+..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 56777888888877776667777788888888888887777777777888888888888777655556677788888888
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
++|.+++..|..|..+++|+.|+|++|++++..|..+...
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 151 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence 8888877777777777788888888888777666555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=153.64 Aligned_cols=114 Identities=24% Similarity=0.285 Sum_probs=107.5
Q ss_pred CCCcEEEccCCcccccCch-hccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 126 PNLVKLTIQFFALTGSIPP-EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.+|+.|+|++|.+.+..+. .++++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 4899999999999988775 489999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|++|++++.+|..+..+++|++|++++|.+++..+
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999999999999999999999999999998776
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.6e-17 Score=149.04 Aligned_cols=135 Identities=23% Similarity=0.254 Sum_probs=116.5
Q ss_pred CCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCC
Q 038466 88 CKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP 167 (572)
Q Consensus 88 c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 167 (572)
|.|+++.|...+ + ..+.....++|+.|++++|.+.+..+..+.++++|++|+|++|.+++..+
T Consensus 7 C~~~~l~~~~~~-l----------------~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 7 CSGTEIRCNSKG-L----------------TSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp EETTEEECCSSC-C----------------SSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred eCCCEEEecCCC-C----------------ccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 789999997532 1 12223334789999999999998777778999999999999999997777
Q ss_pred cCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 168 PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 168 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
..++++++|++|+|++|++++..+..+.++++|+.|++++|.+++..+..+..+++|++|++++|.+++..|
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 778999999999999999998888889999999999999999997666667889999999999999998776
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-16 Score=158.22 Aligned_cols=152 Identities=24% Similarity=0.219 Sum_probs=71.8
Q ss_pred CCCCCccceeeCCCCCEEEEEeCCCccC-cc----c-------------ccCccccCCCCCCcEEEccCCcccccCchhc
Q 038466 85 TDHCKWEGITCNSAGSIFELYLSGYYAG-FN----W-------------RLSQLNFSCFPNLVKLTIQFFALTGSIPPEI 146 (572)
Q Consensus 85 ~~~c~w~Gv~c~~~~~v~~l~l~~~~~~-~~----~-------------~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~ 146 (572)
.+.|.|.|+.|.-.+..+.+++++..-. +. . .+....|..+++|++|++++|.++...+..+
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~ 81 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF 81 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh
Confidence 4679999999864444455665532110 00 0 0011123444445555555554443333333
Q ss_pred cCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCc
Q 038466 147 SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTW 226 (572)
Q Consensus 147 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~ 226 (572)
.++++|++|+|++|.+++..+..+.++++|++|+|++|++++..|..|+++++|+.|++++|.+++..+..++.+++|+.
T Consensus 82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 161 (270)
T 2o6q_A 82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE 161 (270)
T ss_dssp SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccce
Confidence 44455555555555544433334444445555555555544444444444555555555555544433333444445555
Q ss_pred cccCCCcccC
Q 038466 227 LDLSNNNIKG 236 (572)
Q Consensus 227 L~ls~N~l~g 236 (572)
|++++|.+++
T Consensus 162 L~L~~n~l~~ 171 (270)
T 2o6q_A 162 LRLYNNQLKR 171 (270)
T ss_dssp EECCSSCCSC
T ss_pred eEecCCcCcE
Confidence 5555554444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-18 Score=184.48 Aligned_cols=120 Identities=26% Similarity=0.245 Sum_probs=94.3
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCc-CCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIG-NLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
...+++|+.|+|++|.+++..|..++++++|++|+|++|.+++.+|..+. .+++|++|+|++|.+++. | .+..+++|
T Consensus 116 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L 193 (487)
T 3oja_A 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKL 193 (487)
T ss_dssp ECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTC
T ss_pred ccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCC
Confidence 34567888888888888888888888888888888888888887777775 688888888888888765 2 24458888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
+.|+|++|.+++ +|+.+..+++|+.|++++|.+++ +|..+...
T Consensus 194 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l 236 (487)
T 3oja_A 194 KTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236 (487)
T ss_dssp CEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred CEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence 888888888886 44558888888888888888886 67665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.6e-17 Score=178.70 Aligned_cols=162 Identities=12% Similarity=0.016 Sum_probs=121.4
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcc-----hHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~-----~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+|.|+||.||+|.. .++.+|+|+..... ..+....++|.+|++++++++||||+++..++...+..++||||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4789999999999954 46778888764322 12222356799999999999999999777777788888999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------C----CC--------
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------S----SN-------- 440 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------~----~~-------- 440 (572)
+++|+|.+++.. +..++.|+++|+.||| +|++|.++..+.. . ..
T Consensus 421 ~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 421 INGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp CCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHHHHH
T ss_pred CCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECCeEEEEECccCEECCCccccccch
Confidence 999999999875 3468899999999997 5777776543220 0 00
Q ss_pred ---ccccccccCccccccccC--CCcCcccchHHHHHHHHHHHcCCCCC
Q 038466 441 ---RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPR 484 (572)
Q Consensus 441 ---~~~~~gt~~y~APE~~~~--~~~s~ksDVySfGvvl~ElltG~~P~ 484 (572)
.....||+.|||||++.. ..|+..+|+||..+-.+|.+.++.+|
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 023568999999999876 66888999999999999998888775
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.3e-16 Score=159.56 Aligned_cols=119 Identities=26% Similarity=0.410 Sum_probs=69.7
Q ss_pred cCCCCCCcEEEccCCcccccCchhccC---------CccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISA---------LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS 192 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~---------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~ 192 (572)
+..+++|+.|++++|.+.+.+|..+.. +++|++|+|++|.++ .+|..++.+++|++|+|++|++++ +|.
T Consensus 146 l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~ 223 (328)
T 4fcg_A 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP 223 (328)
T ss_dssp GGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCG
T ss_pred HhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cch
Confidence 555566666666666666666555443 556666666666655 555555556666666666665553 444
Q ss_pred cccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 193 ALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 193 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.++++++|+.|++++|.+.+.+|..++.+++|+.|++++|++.+.+|..+
T Consensus 224 ~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~ 273 (328)
T 4fcg_A 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273 (328)
T ss_dssp GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred hhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence 55556666666666665555555555555666666666655555555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=142.08 Aligned_cols=112 Identities=23% Similarity=0.300 Sum_probs=103.7
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|+|++|.++ .+|..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 30 ~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 30 PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 368999999999998 6788999999999999999999988888899999999999999999999899999999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
|++|.+++..+..|..+++|+.|++++|.+...
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 109 LHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999999976666799999999999999998753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-16 Score=159.44 Aligned_cols=125 Identities=35% Similarity=0.641 Sum_probs=115.2
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCC-c
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLT-N 199 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~ 199 (572)
.+..+++|++|+|++|.+.+.+|..+.++++|++|+|++|.+++.+|..++.+++|++|+|++|+++|.+|..+++++ +
T Consensus 96 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~ 175 (313)
T 1ogq_A 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred hHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhc
Confidence 478899999999999999999999999999999999999999999999999999999999999999999999999998 9
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
|+.|++++|.+++.+|..++.+. |+.|++++|.+++.+|..++...
T Consensus 176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~ 221 (313)
T 1ogq_A 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK 221 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTS
T ss_pred CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCC
Confidence 99999999999999999999887 99999999999998888776544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.9e-15 Score=144.36 Aligned_cols=146 Identities=21% Similarity=0.239 Sum_probs=125.8
Q ss_pred CCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEc
Q 038466 88 CKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL 157 (572)
Q Consensus 88 c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 157 (572)
|.|..|.|...+ .++.|++++.... .+....|..+++|+.|+|++|.+.+..|..|.++++|++|+|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~---~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 87 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK---VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCC---EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCC---CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence 789999997532 4667776643211 123335888999999999999999999999999999999999
Q ss_pred cCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 158 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
++|.+++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|.+++..+..+..+++|+.|++++|.+..
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 9999996655668999999999999999999999999999999999999999998888889999999999999999864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=145.04 Aligned_cols=149 Identities=20% Similarity=0.202 Sum_probs=127.6
Q ss_pred CCccceeeCCCC----------CEEEEEeCCCccCccccc-CccccCCCCCCcEEEccCCcccccCchhccCCccCCEEE
Q 038466 88 CKWEGITCNSAG----------SIFELYLSGYYAGFNWRL-SQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLD 156 (572)
Q Consensus 88 c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l-~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~ 156 (572)
|.|+.+.|...+ .++.|++++.... .+ ..-.|..+++|+.|+|++|.+++..|..|.++++|++|+
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~---~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT---VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC---EECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCC---ccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 789988886421 3455666542211 11 112378899999999999999999888999999999999
Q ss_pred ccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 157 LSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 157 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|++++|.+++
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 99999998888889999999999999999999999999999999999999999999889999999999999999999987
Q ss_pred Ccc
Q 038466 237 SIP 239 (572)
Q Consensus 237 ~ip 239 (572)
..+
T Consensus 168 ~c~ 170 (220)
T 2v70_A 168 NCY 170 (220)
T ss_dssp SGG
T ss_pred CCc
Confidence 654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=167.19 Aligned_cols=155 Identities=23% Similarity=0.276 Sum_probs=124.5
Q ss_pred CCCccceeeCCC------------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCE
Q 038466 87 HCKWEGITCNSA------------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQL 154 (572)
Q Consensus 87 ~c~w~Gv~c~~~------------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~ 154 (572)
.|.|.|+ |+.. ..++.|++++.... .+....|..+++|++|+|++|.+.+..|..|+++++|++
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 78 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKIT---YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCC---EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccC---ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCE
Confidence 4999998 8632 24666666643211 122235788899999999999999988888999999999
Q ss_pred EEccCCcCCCCCCcCCcCCCCcceeecccccccC-CCCccccCCCccCeeEeccCcCCCCCc-hhhhhccccCccccCCC
Q 038466 155 LDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIP-PEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 155 L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~ls~N 232 (572)
|||++|.+++..|..++++++|++|+|++|.+++ .+|..++++++|+.|++++|.+.+.+| ..++++++|++|++++|
T Consensus 79 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n 158 (549)
T 2z81_A 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158 (549)
T ss_dssp EECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred EECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence 9999999998777778999999999999999887 467889999999999999998666665 57888999999999999
Q ss_pred cccCCccccCCCC
Q 038466 233 NIKGSIPVRLSPN 245 (572)
Q Consensus 233 ~l~g~ip~~~s~n 245 (572)
.+++.+|..+...
T Consensus 159 ~l~~~~~~~l~~l 171 (549)
T 2z81_A 159 SLRNYQSQSLKSI 171 (549)
T ss_dssp TCCEECTTTTTTC
T ss_pred cccccChhhhhcc
Confidence 9999888777543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-15 Score=146.87 Aligned_cols=136 Identities=25% Similarity=0.199 Sum_probs=116.8
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+....|..+++|+.|+|++|.+++..+..+.++++|++|+|++|.+++..+..++.+++|++
T Consensus 59 ~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 135 (251)
T 3m19_A 59 TKLTWLNLDYNQLQ---TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKE 135 (251)
T ss_dssp TTCCEEECTTSCCC---CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCEEECCCCcCC---ccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccE
Confidence 34566666542111 122224788999999999999999888888999999999999999999777777899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+++|+.|++++|.+++.
T Consensus 136 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 136 LRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred EECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999988787899999999999999999988888899999999999999999886
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.6e-15 Score=165.39 Aligned_cols=140 Identities=26% Similarity=0.287 Sum_probs=121.5
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.++.|++++... ..+....|.++++|++|+|++|.+++..|..|.+|++|++|+|++|++++..|..|++|++|++|
T Consensus 53 ~~~~LdLs~N~i---~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L 129 (635)
T 4g8a_A 53 STKNLDLSFNPL---RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 129 (635)
T ss_dssp TCCEEECTTSCC---CEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEE
T ss_pred CCCEEEeeCCCC---CCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEE
Confidence 567888775321 12344468999999999999999999888889999999999999999998777789999999999
Q ss_pred ecccccccCCCCccccCCCccCeeEeccCcCCC-CCchhhhhccccCccccCCCcccCCccccC
Q 038466 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 180 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
+|++|++++..+..|+++++|+.|++++|.+++ .+|..++.+++|++|++++|++++..|..+
T Consensus 130 ~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 130 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 999999998878889999999999999999976 578889999999999999999998877665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.7e-15 Score=145.99 Aligned_cols=143 Identities=24% Similarity=0.189 Sum_probs=118.7
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+ ..+..+++|++|++++|.+++..|..+.++++|++|+|++|.+++..|..++++++|++
T Consensus 63 ~~L~~L~l~~n~l~---~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 137 (272)
T 3rfs_A 63 PNVRYLALGGNKLH---DI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137 (272)
T ss_dssp TTCCEEECTTSCCC---CC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCcEEECCCCCCC---Cc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence 45677777643211 11 14778899999999999999888888899999999999999999877777899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
|+|++|++++..|..++++++|+.|++++|.+++..|..++.+++|+.|++++|++++..|..+....
T Consensus 138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 205 (272)
T 3rfs_A 138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 205 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCc
Confidence 99999999988788889999999999999999987777788999999999999999987776555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.4e-15 Score=163.20 Aligned_cols=141 Identities=24% Similarity=0.244 Sum_probs=123.4
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
.+++.|++++.... .+....|..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|+++++|++
T Consensus 32 ~~l~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 108 (606)
T 3vq2_A 32 SSTKNIDLSFNPLK---ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN 108 (606)
T ss_dssp TTCCEEECTTSCCC---EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCE
T ss_pred CCcCEEECCCCCcC---EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCE
Confidence 35777877753221 123335889999999999999999999999999999999999999999988999999999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCC-CCchhhhhccccCccccCCCcccCCccccC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
|+|++|.+.+..|..++++++|++|++++|.+++ .+|..++++++|++|++++|++++..|..+
T Consensus 109 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp EECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred EEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 9999999998888899999999999999999986 689999999999999999999998777655
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.5e-15 Score=159.26 Aligned_cols=155 Identities=25% Similarity=0.266 Sum_probs=126.8
Q ss_pred CCCCccc--eeeCCC---------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCc-hhccCCccCC
Q 038466 86 DHCKWEG--ITCNSA---------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIP-PEISALSKLQ 153 (572)
Q Consensus 86 ~~c~w~G--v~c~~~---------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip-~~~~~l~~L~ 153 (572)
..|.|.+ |.|... .+++.|++++.... .+....|..+++|++|++++|.+.+.+| ..|.++++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~ 82 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIA---ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCC---EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCC
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccC---cCChhHhccCccccEEECcCCcccceECcccccccccCC
Confidence 3477766 888653 24677777643211 1223358889999999999999987774 5689999999
Q ss_pred EEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCcc--ccCCCccCeeEeccCcCCCCCchh-hhhccccCccccC
Q 038466 154 LLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSA--LGSLTNLSNLDLSSNKLSGKIPPE-IAGMKNLTWLDLS 230 (572)
Q Consensus 154 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~--~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~ls 230 (572)
+|+|++|.+++..|..++++++|++|+|++|++++.+|.. ++++++|+.|++++|.+++..|.. ++++++|++|+++
T Consensus 83 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~ 162 (455)
T 3v47_A 83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162 (455)
T ss_dssp EEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECT
T ss_pred EEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCC
Confidence 9999999999888999999999999999999999876665 999999999999999999887876 8899999999999
Q ss_pred CCcccCCccccCC
Q 038466 231 NNNIKGSIPVRLS 243 (572)
Q Consensus 231 ~N~l~g~ip~~~s 243 (572)
+|.+++..|..+.
T Consensus 163 ~n~l~~~~~~~l~ 175 (455)
T 3v47_A 163 FNKVKSICEEDLL 175 (455)
T ss_dssp TCCBSCCCTTTSG
T ss_pred CCcccccChhhhh
Confidence 9999998887664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=9.9e-15 Score=145.31 Aligned_cols=140 Identities=26% Similarity=0.288 Sum_probs=107.0
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.++.|++++.... .+....|..+++|+.|++++|.+.+..+..+.++++|++|+|++|.+++..|..+.++++|++|
T Consensus 29 ~l~~L~ls~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (276)
T 2z62_A 29 STKNLDLSFNPLR---HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (276)
T ss_dssp TCCEEECTTCCCC---EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CccEEECCCCccc---ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEE
Confidence 3566666542211 1222246778888888888888887777778888888888888888887777788888888888
Q ss_pred ecccccccCCCCccccCCCccCeeEeccCcCCC-CCchhhhhccccCccccCCCcccCCccccC
Q 038466 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 180 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++++|++.+..+..++++++|+.|++++|.+++ .+|..++.+++|+.|++++|++++..|..+
T Consensus 106 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 888888887777778888888888888888876 368888888888888888888877655444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-14 Score=144.79 Aligned_cols=138 Identities=24% Similarity=0.258 Sum_probs=119.6
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..+..|++++.... .+....+..+++|+.|++++|.+.+..|..+.++++|++|+|++|.+++..|..++.+++|++
T Consensus 85 ~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 85 TNLTYLILTGNQLQ---SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TTCCEEECTTSCCC---CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCEEECCCCccC---ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 45777777643211 122234788999999999999999888888999999999999999999877777899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|++++|++++..|..++++++|+.|++++|.+++..|..++.+++|+.|++++|.+.|..|
T Consensus 162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999998888889999999999999999999888889999999999999999988776
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-14 Score=140.49 Aligned_cols=137 Identities=26% Similarity=0.247 Sum_probs=117.8
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+....|..+++|+.|+|++|.+.+..+..+.++++|++|+|++|.+++..+..+..+++|++
T Consensus 40 ~~L~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 116 (229)
T 3e6j_A 40 TNAQILYLHDNQIT---KLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKE 116 (229)
T ss_dssp TTCSEEECCSSCCC---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCEEEcCCCccC---ccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCe
Confidence 46778887753221 122335788999999999999998776677899999999999999999877777899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|+|++|+++ .+|..+.++++|+.|+|++|++++..+..+..+++|+.|++++|.+.+..+
T Consensus 117 L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 117 LFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp EECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred EeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999998 789999999999999999999998777789999999999999999987654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.9e-14 Score=136.97 Aligned_cols=126 Identities=21% Similarity=0.157 Sum_probs=110.2
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.....++|+.|++++|.+.+..+..+.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..++++++|
T Consensus 23 p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 102 (208)
T 2o6s_A 23 PTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQL 102 (208)
T ss_dssp CSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCC
Confidence 34446789999999999998777778999999999999999997766678999999999999999998777788999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+.|++++|.+++..+..+..+++|+.|++++|++++..+..+....
T Consensus 103 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 148 (208)
T 2o6s_A 103 KELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148 (208)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred CEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCC
Confidence 9999999999987777789999999999999999976554454433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=172.13 Aligned_cols=117 Identities=27% Similarity=0.334 Sum_probs=107.6
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|+
T Consensus 220 ~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 296 (727)
T 4b8c_D 220 KYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK 296 (727)
T ss_dssp --CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCS
T ss_pred hccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCC
Confidence 677889999999999998 78888899999999999999999 89999999999999999999998 7899999999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.|+|++|.++ .+|..|+.+++|+.|+|++|.|+|.+|..+
T Consensus 297 ~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 297 YFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp EEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred EEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 9999999997 789999999999999999999999888665
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.3e-15 Score=151.06 Aligned_cols=154 Identities=27% Similarity=0.316 Sum_probs=113.5
Q ss_pred CCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCccc--ccCchhccCCccCCEE
Q 038466 88 CKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALT--GSIPPEISALSKLQLL 155 (572)
Q Consensus 88 c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~--g~ip~~~~~l~~L~~L 155 (572)
|.|++|.|...+ .++.|++++.... .+....|..+++|+.|+|++|.+. +.+|..+..+++|++|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~---~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ---SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC---CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC---ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 899999997532 4667777643211 122223678888899999888887 4446677778888888
Q ss_pred EccCCcCCCCCCcCCcCCCCcceeecccccccCCCC-ccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcc
Q 038466 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 156 ~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 234 (572)
+|++|.++ .+|..+..+++|++|++++|++++..+ ..+.++++|+.|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 88888887 466677788888888888888876555 5678888888888888888877777788888888888888888
Q ss_pred cC-CccccCCCC
Q 038466 235 KG-SIPVRLSPN 245 (572)
Q Consensus 235 ~g-~ip~~~s~n 245 (572)
++ .+|..+...
T Consensus 163 ~~~~~~~~~~~l 174 (306)
T 2z66_A 163 QENFLPDIFTEL 174 (306)
T ss_dssp GGGEECSCCTTC
T ss_pred ccccchhHHhhC
Confidence 76 466555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=8.8e-15 Score=146.38 Aligned_cols=142 Identities=24% Similarity=0.251 Sum_probs=101.1
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCc-CCCCCCcCCcCCCCcce
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG-LTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l~~L~~ 178 (572)
.++.|++++.... .+....|..+++|+.|++++|.+.+..|..+.++++|++|+|++|. +++..|..+..+++|++
T Consensus 33 ~l~~L~l~~n~i~---~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~ 109 (285)
T 1ozn_A 33 ASQRIFLHGNRIS---HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (285)
T ss_dssp TCSEEECTTSCCC---EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CceEEEeeCCcCC---ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence 4566666542211 1122236777788888888888887777778888888888888886 66555777778888888
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
|++++|.+++..|..+.++++|+.|++++|.+++..+..++.+++|+.|++++|++++..+..+..
T Consensus 110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 175 (285)
T 1ozn_A 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175 (285)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcC
Confidence 888888887777777888888888888888887666666777888888888888877544444433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.9e-15 Score=153.07 Aligned_cols=158 Identities=23% Similarity=0.248 Sum_probs=108.7
Q ss_pred CCCCCccceeeCCC------------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccC
Q 038466 85 TDHCKWEGITCNSA------------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKL 152 (572)
Q Consensus 85 ~~~c~w~Gv~c~~~------------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L 152 (572)
..+|.|.|+ |+-. ..++.|++++.... .+....+..+++|+.|++++|.+++..|..+.++++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT---YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCC---EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCc---ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCC
Confidence 456999998 6532 13555665532211 1222246777888888888888887777778888888
Q ss_pred CEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCC-ccccCCCccCeeEeccCc-CCCCCchhhhhccccCccccC
Q 038466 153 QLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIP-SALGSLTNLSNLDLSSNK-LSGKIPPEIAGMKNLTWLDLS 230 (572)
Q Consensus 153 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l~~L~~L~ls 230 (572)
++|+|++|.+++..+..++++++|++|+|++|++.+..+ ..++++++|+.|++++|. +++..|..++++++|+.|+++
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 888888888875444447778888888888888775333 367788888888888874 555556677778888888888
Q ss_pred CCcccCCccccCCCCC
Q 038466 231 NNNIKGSIPVRLSPNK 246 (572)
Q Consensus 231 ~N~l~g~ip~~~s~n~ 246 (572)
+|.+++..|..+....
T Consensus 183 ~n~l~~~~~~~l~~l~ 198 (353)
T 2z80_A 183 ASDLQSYEPKSLKSIQ 198 (353)
T ss_dssp ETTCCEECTTTTTTCS
T ss_pred CCCcCccCHHHHhccc
Confidence 8888777776664443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.4e-14 Score=142.20 Aligned_cols=126 Identities=25% Similarity=0.223 Sum_probs=112.5
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+++|++|++++|.+.+..+..+.++++|++|+|++|.+++..|..++.+++|++|+|++|.+.+..+..++.+++|
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 159 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL 159 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccc
Confidence 36789999999999999998877888999999999999999998888889999999999999999998777779999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+.|++++|.+++..+..|..+++|+.|++++|++++..+..+....
T Consensus 160 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 205 (270)
T 2o6q_A 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205 (270)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred ceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhcccc
Confidence 9999999999987777899999999999999999875554454433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.9e-15 Score=132.75 Aligned_cols=114 Identities=22% Similarity=0.295 Sum_probs=98.1
Q ss_pred CCCCCcEEEccCCccc-ccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCe
Q 038466 124 CFPNLVKLTIQFFALT-GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSN 202 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 202 (572)
..++|+.|++++|.+. +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..++++++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467889999999998 88888889999999999999999865 67888999999999999998888888888999999
Q ss_pred eEeccCcCCCC-CchhhhhccccCccccCCCcccCCcc
Q 038466 203 LDLSSNKLSGK-IPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 203 L~ls~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|++++|.+++. .|..++.+++|++|++++|.+++..+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999999863 44788889999999999999887654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.6e-14 Score=144.47 Aligned_cols=145 Identities=23% Similarity=0.266 Sum_probs=107.4
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCc-ccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcc
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFA-LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI 177 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 177 (572)
..++.|++++.... .+....|..+++|+.|++++|. +....|..+.++++|++|+|++|.+++..|..+.++++|+
T Consensus 56 ~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 132 (285)
T 1ozn_A 56 RNLTILWLHSNVLA---RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132 (285)
T ss_dssp TTCCEEECCSSCCC---EECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred CCCCEEECCCCccc---eeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCC
Confidence 35666776542111 1222246778888888888886 6666677788888888888888888877777788888888
Q ss_pred eeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 178 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+|++++|++++..+..++++++|+.|++++|.+++..+..+..+++|+.|++++|.+++..|..+....
T Consensus 133 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 201 (285)
T 1ozn_A 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (285)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred EEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc
Confidence 888888888876667788888888888888888865556678888888888888888877777665443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=150.17 Aligned_cols=113 Identities=27% Similarity=0.247 Sum_probs=73.3
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 56667777777777766666666667777777777777665555566666777777777777666666666667777777
Q ss_pred EeccCcCCCCCchhh---hhccccCccccCCCcccC
Q 038466 204 DLSSNKLSGKIPPEI---AGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~---~~l~~L~~L~ls~N~l~g 236 (572)
+|++|.+++..+..+ ..+++|+.|+|++|+|++
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 777777664323333 456667777777776664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-14 Score=159.28 Aligned_cols=120 Identities=18% Similarity=0.136 Sum_probs=108.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|+
T Consensus 71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 150 (597)
T 3oja_B 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150 (597)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCC
Confidence 66788999999999999998888999999999999999999998888899999999999999999876666679999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
.|+|++|.+++..|..++.+++|+.|++++|.+++.-+..
T Consensus 151 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 190 (597)
T 3oja_B 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL 190 (597)
T ss_dssp EEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGG
T ss_pred EEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhh
Confidence 9999999999988889999999999999999998754333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-14 Score=164.56 Aligned_cols=148 Identities=23% Similarity=0.268 Sum_probs=68.2
Q ss_pred CCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccC-chhccCCccCCEEEccCCcCCCCC
Q 038466 88 CKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSI-PPEISALSKLQLLDLSSNGLTGTI 166 (572)
Q Consensus 88 c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~i 166 (572)
|+|+.|-+ -..+++.|++++.... .+....|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~---~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~ 89 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIR---TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLH 89 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCC---EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEEC
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCC---ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccC
Confidence 55666655 4456666766542211 111123444444444444444444333 334444444444444444444444
Q ss_pred CcCCcCCCCcceeecccccccCCCCcc--ccCCCccCeeEeccCcCCCCCc-hhhhhccccCccccCCCcccCCcc
Q 038466 167 PPEIGNLKNLIELNVGSNSLIGPIPSA--LGSLTNLSNLDLSSNKLSGKIP-PEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 167 p~~~~~l~~L~~L~Ls~N~l~g~ip~~--~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|..|+++++|++|+|++|.+++.+|.. ++++++|+.|+|++|.+++..| ..|+++++|+.|++++|.+++..|
T Consensus 90 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~ 165 (844)
T 3j0a_A 90 PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165 (844)
T ss_dssp TTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCS
T ss_pred HhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCH
Confidence 444444444444444444444443333 4444444444444444444322 234444444444444444444433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.52 E-value=5e-15 Score=165.28 Aligned_cols=120 Identities=17% Similarity=0.285 Sum_probs=113.6
Q ss_pred cCCCCCCcEEEccCCccccc-----------------Cchhcc--CCccCCEEEccCCcCCCCCCcCCcCCCCcceeecc
Q 038466 122 FSCFPNLVKLTIQFFALTGS-----------------IPPEIS--ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVG 182 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~-----------------ip~~~~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 182 (572)
++++++|++|+|++|.++|. +|..++ ++++|++|+|++|.++|.+|..++++++|++|+|+
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 78899999999999999996 999999 99999999999999999999999999999999999
Q ss_pred ccc-ccC-CCCccccCC------CccCeeEeccCcCCCCCch--hhhhccccCccccCCCcccCCccccCC
Q 038466 183 SNS-LIG-PIPSALGSL------TNLSNLDLSSNKLSGKIPP--EIAGMKNLTWLDLSNNNIKGSIPVRLS 243 (572)
Q Consensus 183 ~N~-l~g-~ip~~~~~l------~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~ip~~~s 243 (572)
+|+ ++| .+|..++++ ++|+.|++++|.++ .+|. .++++++|+.|++++|+++|.+| .++
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 998 998 899999887 99999999999999 8998 99999999999999999999999 653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=131.07 Aligned_cols=113 Identities=24% Similarity=0.311 Sum_probs=81.5
Q ss_pred CCCCcEEEccCCccc-ccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 125 FPNLVKLTIQFFALT-GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.++|+.|++++|.+. +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 466777777777776 67777777777777777777777754 567777777777777777777677777777777777
Q ss_pred EeccCcCCCCC-chhhhhccccCccccCCCcccCCcc
Q 038466 204 DLSSNKLSGKI-PPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 204 ~ls~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++++|.+++.. +..+..+++|++|++++|.+++..+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 77777777531 2567777777777777777765443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-14 Score=143.89 Aligned_cols=123 Identities=26% Similarity=0.298 Sum_probs=82.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCC-CCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG-TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
+..+++|+.|++++|.+.+..|..+.++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+.++++|
T Consensus 122 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 201 (306)
T 2z66_A 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201 (306)
T ss_dssp TTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCC
Confidence 5556666667776666666666666666677777777776665 456666666677777777776666666666666777
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
+.|++++|.+++..+..+..+++|+.|++++|++++..|..+..
T Consensus 202 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp CEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred CEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 77777777766655556666667777777777776666655543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.5e-14 Score=151.48 Aligned_cols=121 Identities=21% Similarity=0.194 Sum_probs=100.5
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|++++|.+.+.+|..++++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..++++++|+.|+
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 36788888888888888888888888888888888888888888888888888888888888887788888888888888
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
|++|.+++..|..+..+++|++|++++|++++..+..+...
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 394 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence 88888888778888888888888888888887544444433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-14 Score=152.05 Aligned_cols=152 Identities=24% Similarity=0.274 Sum_probs=113.4
Q ss_pred CccceeeCCC----------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEcc
Q 038466 89 KWEGITCNSA----------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158 (572)
Q Consensus 89 ~w~Gv~c~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls 158 (572)
.|..|.|... ..++.|++++.... .+....|..+++|+.|+|++|.+.+..|..|.++++|++|+|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 88 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK---TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCC---EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccc---eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence 3667888642 23555666532211 1222357788888888888888888888888888888888888
Q ss_pred CCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCc
Q 038466 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238 (572)
Q Consensus 159 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~i 238 (572)
+|.+++..+..|+++++|++|+|++|++.+..|..|.++++|+.|++++|.+++..|..|.++++|+.|++++|.+++..
T Consensus 89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 88888655566788888888888888888888888888888888888888888777778888888888888888887655
Q ss_pred cccCC
Q 038466 239 PVRLS 243 (572)
Q Consensus 239 p~~~s 243 (572)
+..+.
T Consensus 169 ~~~l~ 173 (477)
T 2id5_A 169 TEALS 173 (477)
T ss_dssp HHHHT
T ss_pred hhHhc
Confidence 44443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=6.3e-14 Score=129.29 Aligned_cols=88 Identities=24% Similarity=0.213 Sum_probs=61.0
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 56677777777777766666777777777777777777555555667777777777777776655556777777777777
Q ss_pred ccCcCCCC
Q 038466 206 SSNKLSGK 213 (572)
Q Consensus 206 s~N~l~g~ 213 (572)
++|.++..
T Consensus 110 ~~N~~~c~ 117 (170)
T 3g39_A 110 LNNPWDCA 117 (170)
T ss_dssp CSSCBCTT
T ss_pred CCCCCCCC
Confidence 77776654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-14 Score=133.31 Aligned_cols=116 Identities=24% Similarity=0.320 Sum_probs=100.9
Q ss_pred cEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCc-CCcCCCCcceeecccccccCCCCccccCCCccCeeEecc
Q 038466 129 VKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPP-EIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207 (572)
Q Consensus 129 ~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~ 207 (572)
+.|++++|.+ +.+|..+.. +|++|+|++|.+++..+. .++.+++|++|+|++|++++..|..|+++++|+.|+|++
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4566666766 356766554 899999999999977665 489999999999999999999999999999999999999
Q ss_pred CcCCCCCchhhhhccccCccccCCCcccCCccccCCCCCC
Q 038466 208 NKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKG 247 (572)
Q Consensus 208 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~~ 247 (572)
|++++..|..|.++++|++|++++|++++.+|..+.....
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 127 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTT
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCC
Confidence 9999988888999999999999999999999988765543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.50 E-value=9.6e-14 Score=139.51 Aligned_cols=118 Identities=30% Similarity=0.347 Sum_probs=63.0
Q ss_pred CCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCe
Q 038466 123 SCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSN 202 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 202 (572)
..+++|+.|+|++|.+. .+|..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 34455555555555554 34445555555555555555555444445555555555555555555544444555555555
Q ss_pred eEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 203 L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
|+|++|++++..+..+..+++|+.|++++|+++ .+|..+
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~ 191 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhh
Confidence 555555555433334455555555555555554 344443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=6.1e-14 Score=155.49 Aligned_cols=118 Identities=22% Similarity=0.223 Sum_probs=108.5
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++++.|+|++|.|++..|..|.++++|++|||++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47999999999999988889999999999999999999887888999999999999999999888888999999999999
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccC-CccccCC
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG-SIPVRLS 243 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~ip~~~s 243 (572)
++|++++..+..|+++++|++|++++|.+++ .+|..++
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~ 170 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 170 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhc
Confidence 9999998777789999999999999999976 4666553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-13 Score=143.82 Aligned_cols=116 Identities=25% Similarity=0.149 Sum_probs=107.1
Q ss_pred CCCCcEEEccCCcccccCchhcc-CCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 125 FPNLVKLTIQFFALTGSIPPEIS-ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.+.++.|+|++|.+++..+..+. ++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|
T Consensus 38 ~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 117 (361)
T 2xot_A 38 PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117 (361)
T ss_dssp CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEE
Confidence 35689999999999998888887 99999999999999998888889999999999999999998888889999999999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
+|++|.+++..|..|..+++|+.|+|++|++++ +|..
T Consensus 118 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~ 154 (361)
T 2xot_A 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGG
T ss_pred ECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHH
Confidence 999999998889999999999999999999987 4443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=8.4e-14 Score=135.55 Aligned_cols=137 Identities=22% Similarity=0.218 Sum_probs=107.3
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCc-ccccCchhccCCccCCEEEccC-CcCCCCCCcCCcCCCCcc
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFA-LTGSIPPEISALSKLQLLDLSS-NGLTGTIPPEIGNLKNLI 177 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~-l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~ 177 (572)
.++.|++++.... .+....|..+++|+.|++++|. +.+..+..+.++++|++|+|++ |.+++..+..|.++++|+
T Consensus 32 ~l~~L~l~~n~l~---~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 32 STQTLKLIETHLR---TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TCCEEEEESCCCS---EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred cccEEEEeCCcce---EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 4566666532211 1223357788999999999996 7776667888999999999998 899877677888999999
Q ss_pred eeecccccccCCCCccccCCCccC---eeEeccC-cCCCCCchhhhhccccC-ccccCCCcccCCccccC
Q 038466 178 ELNVGSNSLIGPIPSALGSLTNLS---NLDLSSN-KLSGKIPPEIAGMKNLT-WLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 178 ~L~Ls~N~l~g~ip~~~~~l~~L~---~L~ls~N-~l~g~~p~~~~~l~~L~-~L~ls~N~l~g~ip~~~ 242 (572)
+|++++|++++ +|. ++++++|+ .|++++| .+++..+..|..+++|+ .|++++|+++ .+|...
T Consensus 109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~ 175 (239)
T 2xwt_C 109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA 175 (239)
T ss_dssp EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTT
T ss_pred EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhh
Confidence 99999999887 776 88888888 9999999 88876666788899999 9999999987 666543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-13 Score=127.55 Aligned_cols=86 Identities=24% Similarity=0.256 Sum_probs=41.6
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++|+.|+|++|.+.+..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 44455555555555444444555555555555555555433333444555555555555554433333444555555555
Q ss_pred ccCcCC
Q 038466 206 SSNKLS 211 (572)
Q Consensus 206 s~N~l~ 211 (572)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=7e-14 Score=153.48 Aligned_cols=108 Identities=25% Similarity=0.337 Sum_probs=101.1
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
.|+.|+|++|.+++ +|. ++++++|+.|+|++|.++ .+|..+++|++|+.|+|++|++++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999998 676 999999999999999999 889999999999999999999997 77 89999999999999
Q ss_pred cCcCCCCC-chhhhhccccCccccCCCcccCCcc
Q 038466 207 SNKLSGKI-PPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 207 ~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+|++++.+ |..++.+++|+.|+|++|.+++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999887 9999999999999999999998766
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=138.53 Aligned_cols=138 Identities=28% Similarity=0.232 Sum_probs=110.2
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.++.|++++.... .+....|..+++|+.|+|++|.+++..+. +.+++|++|+|++|.++ .+|..+.++++|++|
T Consensus 32 ~l~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 105 (290)
T 1p9a_G 32 DTTILHLSENLLY---TFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL 105 (290)
T ss_dssp TCCEEECTTSCCS---EEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEE
T ss_pred CCCEEEcCCCcCC---ccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEE
Confidence 4566666643211 12223478889999999999999875432 78899999999999998 788888999999999
Q ss_pred ecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCC
Q 038466 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243 (572)
Q Consensus 180 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s 243 (572)
+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++++..+..+.
T Consensus 106 ~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 169 (290)
T 1p9a_G 106 DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN 169 (290)
T ss_dssp ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTT
T ss_pred ECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhc
Confidence 9999999988888899999999999999999987777788899999999999999854443333
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=9.9e-14 Score=155.83 Aligned_cols=139 Identities=29% Similarity=0.292 Sum_probs=98.4
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
.+++.|++++.... .+....|..+++|++|+|++|.+.+..|..++++++|++|+|++|.+++..+..|+++++|++
T Consensus 25 ~~l~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 101 (680)
T 1ziw_A 25 TNITVLNLTHNQLR---RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTE 101 (680)
T ss_dssp TTCSEEECCSSCCC---CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSE
T ss_pred CCCcEEECCCCCCC---CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCE
Confidence 35677777643211 122234667777888888888777777777777778888888877777544446777777777
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccc
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPV 240 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 240 (572)
|+|++|++.+..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..|.
T Consensus 102 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp EECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred EECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 77777777766667777777777777777777777777777777777777777777766554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=137.79 Aligned_cols=141 Identities=28% Similarity=0.291 Sum_probs=118.3
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+....|..+++|+.|+|++|.+.+..|..+.++++|++|++++|.+++..+..++.+++|++
T Consensus 52 ~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 128 (276)
T 2z62_A 52 PELQVLDLSRCEIQ---TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128 (276)
T ss_dssp TTCSEEECTTCCCC---EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCE
T ss_pred cCCcEEECCCCcCC---ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCE
Confidence 45777777643211 122234788999999999999999998899999999999999999999877778999999999
Q ss_pred eecccccccC-CCCccccCCCccCeeEeccCcCCCCCchhhhhccccC----ccccCCCcccCCccccC
Q 038466 179 LNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLT----WLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 179 L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~----~L~ls~N~l~g~ip~~~ 242 (572)
|++++|++.+ .+|..++++++|+.|++++|.+++..+..+..+.+|+ .|++++|.+++..|..+
T Consensus 129 L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~ 197 (276)
T 2z62_A 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197 (276)
T ss_dssp EECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS
T ss_pred EECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc
Confidence 9999999987 4799999999999999999999988888888888887 78999999986555443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.4e-14 Score=131.88 Aligned_cols=112 Identities=22% Similarity=0.294 Sum_probs=74.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+. .++.+..+++|++|++++|.+++..|..++.+++|++|+|++|++++..|..++++++|+
T Consensus 62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 139 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139 (197)
T ss_dssp GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence 555666777777776443 234566677777777777777666666667777777777777777666666677777777
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|++++|.+.+.+| .+..+++|+.|++++|.+++
T Consensus 140 ~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 140 SIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp EEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred EEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 77777776333455 46666777777777776665
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=143.70 Aligned_cols=116 Identities=18% Similarity=0.167 Sum_probs=95.7
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+..|..+.++++|++|+|++|.+++..|..++++++|++|+|++|+++...+..++++++|+
T Consensus 65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 144 (390)
T 3o6n_A 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144 (390)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCc
Confidence 56678888888888888887777888888888888888888877777788888888888888888754444568888888
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
.|++++|.+++..|..++.+++|+.|++++|.+++.
T Consensus 145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp EEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred EEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 888888888877777788888888888888888764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=151.19 Aligned_cols=122 Identities=24% Similarity=0.240 Sum_probs=114.1
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 37899999999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccC-CccccCCCCC
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG-SIPVRLSPNK 246 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~ip~~~s~n~ 246 (572)
+++|.+++..|..++++++|++|++++|.+++ .+|..++...
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~ 153 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcC
Confidence 99999998877889999999999999999986 7898775443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.4e-14 Score=162.64 Aligned_cols=123 Identities=19% Similarity=0.251 Sum_probs=111.0
Q ss_pred ccCCCCCCcEEEccCCcccc-----------------cCchhcc--CCccCCEEEccCCcCCCCCCcCCcCCCCcceeec
Q 038466 121 NFSCFPNLVKLTIQFFALTG-----------------SIPPEIS--ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g-----------------~ip~~~~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 181 (572)
.++++++|+.|+|++|.++| .+|..++ ++++|++|+|++|.+.|.+|..+++|++|++|+|
T Consensus 443 ~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~L 522 (876)
T 4ecn_A 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522 (876)
T ss_dssp GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEEC
T ss_pred HHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEEC
Confidence 37889999999999999999 4899988 9999999999999999999999999999999999
Q ss_pred cccc-ccC-CCCccccCCC-------ccCeeEeccCcCCCCCch--hhhhccccCccccCCCcccCCccccCCCCC
Q 038466 182 GSNS-LIG-PIPSALGSLT-------NLSNLDLSSNKLSGKIPP--EIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 182 s~N~-l~g-~ip~~~~~l~-------~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
++|+ ++| .+|..+++++ +|+.|+|++|.++ .+|. .++++++|+.|++++|+++ .+| .++...
T Consensus 523 s~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~ 595 (876)
T 4ecn_A 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV 595 (876)
T ss_dssp TTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS
T ss_pred cCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCC
Confidence 9998 888 8998888776 9999999999999 8998 8999999999999999998 888 664443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.5e-13 Score=145.17 Aligned_cols=144 Identities=24% Similarity=0.238 Sum_probs=100.1
Q ss_pred ccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccC
Q 038466 90 WEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159 (572)
Q Consensus 90 w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~ 159 (572)
|..|.|...+ .++.|++++.... .+....|..+++|+.|+|++|.+.+..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~---~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQ---MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCC---EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCc---eECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 5678886422 3556666542211 12223467788888888888888887777788888888888888
Q ss_pred CcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCch-hhhhccccCccccCCCcccC
Q 038466 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 160 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g 236 (572)
|.+++..+..++++++|++|+|++|++.+..+..|.++++|+.|++++|...+.+|. .|.++++|+.|++++|++++
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 888866666677888888888888888766666777777777777777444444444 46777777777777777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5.7e-14 Score=126.24 Aligned_cols=129 Identities=26% Similarity=0.261 Sum_probs=106.5
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++..... ..+.. .+..+++|+.|++++|.+.+. ..++++++|++|+|++|.+++.+|..++.+++|++
T Consensus 17 ~~l~~L~l~~n~l~~-~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 17 SDVKELVLDNSRSNE-GKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp GGCSEEECTTCBCBT-TBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred ccCeEEEccCCcCCh-hHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 346667766432110 01121 467889999999999999987 78999999999999999999888988888999999
Q ss_pred eecccccccCC-CCccccCCCccCeeEeccCcCCCCCc---hhhhhccccCccccCC
Q 038466 179 LNVGSNSLIGP-IPSALGSLTNLSNLDLSSNKLSGKIP---PEIAGMKNLTWLDLSN 231 (572)
Q Consensus 179 L~Ls~N~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~L~~L~ls~ 231 (572)
|++++|.+++. .|..++++++|+.|++++|.+++..+ ..++.+++|+.||+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999873 45889999999999999999997666 5789999999999873
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=129.55 Aligned_cols=130 Identities=25% Similarity=0.296 Sum_probs=108.2
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..+..|++++..... + ..+..+++|+.|++++|.+++..|..++.+++|++|+|++|.+++..|..++.+++|++
T Consensus 66 ~~L~~L~l~~n~~~~---~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~ 140 (197)
T 4ezg_A 66 HNIKDLTINNIHATN---Y--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140 (197)
T ss_dssp TTCSEEEEESCCCSC---C--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCE
T ss_pred CCCCEEEccCCCCCc---c--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCE
Confidence 356777776432211 1 15788999999999999999988999999999999999999999888889999999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
|++++|.+.+.+| .+.++++|+.|++++|.+++ ++ .+..+++|+.|++++|++.+
T Consensus 141 L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 141 IDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred EEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 9999998566777 69999999999999999986 44 78899999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=151.48 Aligned_cols=141 Identities=22% Similarity=0.105 Sum_probs=110.0
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.++.|++++.... .+....|..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..|..++++++|++|
T Consensus 34 ~l~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 110 (606)
T 3t6q_A 34 STECLEFSFNVLP---TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110 (606)
T ss_dssp TCCEEECTTCCCS---EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEE
T ss_pred cCcEEEccCCccC---cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEe
Confidence 4667776643211 1223357888889999999999888888888999999999999999988888888889999999
Q ss_pred ecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCC
Q 038466 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243 (572)
Q Consensus 180 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s 243 (572)
+|++|.+++..|..++++++|++|++++|.+++..++.+..+++|+.|++++|.+++..|..++
T Consensus 111 ~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 174 (606)
T 3t6q_A 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174 (606)
T ss_dssp ECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHH
T ss_pred eccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhh
Confidence 9999988887677888888999999999988874333344488888888888888876665543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=5.7e-13 Score=136.25 Aligned_cols=142 Identities=25% Similarity=0.418 Sum_probs=79.9
Q ss_pred CCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEc
Q 038466 88 CKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL 157 (572)
Q Consensus 88 c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 157 (572)
|.|+.+.|...+ .++.|++++.... .+....|..+++|+.|++++|.+++..|..+.++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS---ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC---EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCC---ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 789999986422 2344444321110 111123555666666666666666665666666666666666
Q ss_pred cCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCC--CCCchhhhhccccCccccCCCccc
Q 038466 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS--GKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 158 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~--g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
++|.++ .+|..+. ++|++|++++|++.+..+..++++++|+.|++++|.++ +..|..+..+ +|+.|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 666665 4454443 56666666666665544455666666666666666664 2445555555 5666666666655
Q ss_pred C
Q 038466 236 G 236 (572)
Q Consensus 236 g 236 (572)
+
T Consensus 186 ~ 186 (332)
T 2ft3_A 186 G 186 (332)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2e-13 Score=149.70 Aligned_cols=140 Identities=26% Similarity=0.288 Sum_probs=109.5
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.++.|++++.... .+....|..+++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|+++++|++|
T Consensus 29 ~l~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 29 STKNLDLSFNPLR---HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (570)
T ss_dssp SCCEEECCSCCCC---EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred cccEEEccCCccC---ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccc
Confidence 4667777643211 1223357788888888888888888777788888888888888888887777888888888888
Q ss_pred ecccccccCCCCccccCCCccCeeEeccCcCCC-CCchhhhhccccCccccCCCcccCCccccC
Q 038466 180 NVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 180 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++++|++++..+..++++++|++|++++|.+++ .+|..++++++|++|++++|.+++..|..+
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~ 169 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGG
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHc
Confidence 888888887666678888888888888888886 578888888888888888888887666544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=7.2e-13 Score=135.32 Aligned_cols=143 Identities=25% Similarity=0.371 Sum_probs=82.7
Q ss_pred CCCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEE
Q 038466 87 HCKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLD 156 (572)
Q Consensus 87 ~c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~ 156 (572)
.|.|+.+.|...+ .++.|++++... ..+....|..+++|++|+|++|.+.+..|..+.++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i---~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKI---TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCC---CCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcC---CEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 4789999986421 233444432111 011122355566666666666666666666666666666666
Q ss_pred ccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCC--CCchhhhhccccCccccCCCcc
Q 038466 157 LSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG--KIPPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 157 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~ls~N~l 234 (572)
|++|.++ .+|..+. ++|++|++++|.+.+..+..+.++++|+.|++++|.++. ..|..+..+++|+.|++++|.+
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 6666665 4454443 566666666666665555556666666666666666642 4555566666666666666666
Q ss_pred c
Q 038466 235 K 235 (572)
Q Consensus 235 ~ 235 (572)
+
T Consensus 184 ~ 184 (330)
T 1xku_A 184 T 184 (330)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=126.80 Aligned_cols=134 Identities=25% Similarity=0.248 Sum_probs=110.6
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++..... ..+.. .+..+++|+.|++++|.+.+. ..+..+++|++|+|++|.+++.+|..+..+++|++
T Consensus 24 ~~L~~L~l~~n~l~~-~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 24 AAVRELVLDNCKSND-GKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp TSCSEEECCSCBCBT-TBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred ccCCEEECCCCCCCh-hhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 346777776432110 01222 267889999999999999987 78999999999999999999888888888999999
Q ss_pred eecccccccCCC-CccccCCCccCeeEeccCcCCCCCc---hhhhhccccCccccCCCcccC
Q 038466 179 LNVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIP---PEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 179 L~Ls~N~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~L~~L~ls~N~l~g 236 (572)
|+|++|++++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 999999998742 3789999999999999999997655 488999999999999998753
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.43 E-value=6.3e-14 Score=158.43 Aligned_cols=119 Identities=28% Similarity=0.344 Sum_probs=107.8
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|+|++|.|+ .+|..|++|++|++|||++|.|+ .+|..|++|++|++|+|++|.++ .+|..|+++++|+
T Consensus 243 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~ 319 (727)
T 4b8c_D 243 IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQ 319 (727)
T ss_dssp GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCC
T ss_pred hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCcc
Confidence 557899999999999999 89999999999999999999999 88999999999999999999986 7899999999999
Q ss_pred eeEeccCcCCCCCchhhhhccc-cCccccCCCcccCCccccCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKN-LTWLDLSNNNIKGSIPVRLS 243 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~-L~~L~ls~N~l~g~ip~~~s 243 (572)
.|+|++|.+++.+|..+..+.. +..++|++|.++|.+|..+.
T Consensus 320 ~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~ 362 (727)
T 4b8c_D 320 FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR 362 (727)
T ss_dssp CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc
Confidence 9999999999999998876543 34589999999999998774
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.1e-13 Score=155.68 Aligned_cols=142 Identities=24% Similarity=0.324 Sum_probs=120.3
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcC--CcCCCCc
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPE--IGNLKNL 176 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~--~~~l~~L 176 (572)
...+.|++++... ...+..-.|.++++|++|+|++|.+.+..|..|.++++|++|+|++|.+++.+|.. ++++++|
T Consensus 48 ~~L~~LdLs~n~~--~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L 125 (844)
T 3j0a_A 48 EQLQLLELGSQYT--PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125 (844)
T ss_dssp CSCSEEEECTTCC--CCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSC
T ss_pred ccCeEEeCCCCCC--ccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCC
Confidence 4566777764311 11223345889999999999999999999999999999999999999999887776 8999999
Q ss_pred ceeecccccccCCCC-ccccCCCccCeeEeccCcCCCCCchhhhhc--cccCccccCCCcccCCccccC
Q 038466 177 IELNVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIAGM--KNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 177 ~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l--~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++|+|++|.+++..| ..|+++++|+.|+|++|.+++..|..++.+ ++|+.|++++|.+.+.+|..+
T Consensus 126 ~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~ 194 (844)
T 3j0a_A 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194 (844)
T ss_dssp CEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCC
T ss_pred CEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccch
Confidence 999999999988765 679999999999999999999999999887 789999999999888877654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=6.8e-13 Score=122.29 Aligned_cols=108 Identities=25% Similarity=0.288 Sum_probs=96.1
Q ss_pred cEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccC
Q 038466 129 VKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208 (572)
Q Consensus 129 ~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N 208 (572)
+.|++++|.++. +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 467777777765 666553 89999999999999988999999999999999999999888888899999999999999
Q ss_pred cCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 209 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++++..|..|..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9998777789999999999999999987754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=149.16 Aligned_cols=125 Identities=23% Similarity=0.261 Sum_probs=111.0
Q ss_pred cCCCCCCcEEEccCCcccccCc-hhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeeccccccc-CCCCccccCCCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIP-PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLI-GPIPSALGSLTN 199 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~ 199 (572)
+..+++|+.|++++|.+.+..| ..+.++++|++|++++|.+++..|..+.++++|++|+|++|.+. +.+|..++.+++
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 6778899999999999998776 46889999999999999999888989999999999999999987 678999999999
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
|+.|++++|++++..|..+..+++|+.|++++|++++..|..+....
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 518 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhccc
Confidence 99999999999988899999999999999999999988776665544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.8e-13 Score=124.97 Aligned_cols=113 Identities=25% Similarity=0.312 Sum_probs=97.1
Q ss_pred EEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCc
Q 038466 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209 (572)
Q Consensus 130 ~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~ 209 (572)
.+++++|.+. .+|..+. ++|+.|+|++|.++ .+|..+.++++|++|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 5666666665 4565543 58999999999998 788999999999999999999999888999999999999999999
Q ss_pred CCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 210 LSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 210 l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+++..|..|..+++|+.|+|++|++++..+..+....
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 126 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLS 126 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCc
Confidence 9988888999999999999999999965554554443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.9e-13 Score=145.46 Aligned_cols=144 Identities=24% Similarity=0.207 Sum_probs=115.6
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+....|.++++|+.|+|++|.+.+..+..|.++++|++|+|++|.+++..|..+.++++|++
T Consensus 56 ~~L~~L~L~~n~i~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 56 PHLEELELNENIVS---AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCCEEECTTSCCC---EECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEEECCCCccC---EeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCE
Confidence 45677777643211 122235788889999999999988776667888999999999999999888888899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
|+|++|.+.+..|..|+++++|+.|++++|.+++..+..+.++++|+.|++++|.+.+..+..+...
T Consensus 133 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp EEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred EECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 9999999988888889999999999999999987766778889999999999999887666555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.7e-13 Score=146.31 Aligned_cols=110 Identities=19% Similarity=0.080 Sum_probs=80.5
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCcccc-CCCccCee
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALG-SLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L 203 (572)
.++|+.|++++|.+++..+. .+++|+.|+|++|.+++..|..++++++|++|+|++|.+++.+|..+. ++++|+.|
T Consensus 98 ~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 98 GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 36777888888887776553 356778888888888877777777788888888888888777777765 67788888
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+|++|.+++. |. ...+++|+.|+|++|.+++..|
T Consensus 175 ~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG
T ss_pred ecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCH
Confidence 8888887754 32 3347778888888888876433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.1e-13 Score=148.68 Aligned_cols=121 Identities=26% Similarity=0.256 Sum_probs=56.9
Q ss_pred cCCCCCCcEEEccCCcccccCchh-ccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccC---CCCccccCC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPE-ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG---PIPSALGSL 197 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g---~ip~~~~~l 197 (572)
+..+++|+.|++++|.+.+..|+. +.++++|+.|++++|.+++..|..++.+++|++|++++|++.+ ..+..+..+
T Consensus 396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 334444444444444444443332 4444444444444444444444444444455555555544443 122334444
Q ss_pred CccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 198 TNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 198 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++|+.|++++|.+++..|..++.+++|+.|++++|++++.+|..+
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 520 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGG
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHh
Confidence 555555555555544444444455555555555555554444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=134.45 Aligned_cols=147 Identities=12% Similarity=0.029 Sum_probs=102.4
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHH---------------HHHHHHHHHHHHHHhcCCCCcccEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEEL---------------AFIKSFRNEAQVLSQVLHRNIVKLYGF 372 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~---------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 372 (572)
.+...+|.|+||.||+|+..+|+.||||.++....... ....+|.+|++++++++ | ++++++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 34478999999999999987799999999975332110 13467899999999999 5 666665
Q ss_pred EEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC----Ccc
Q 038466 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS----NRT 442 (572)
Q Consensus 373 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~----~~~ 442 (572)
+.. +..++||||+++|+|.+ +... ....++.+++.|+.||| +|.+|.++... +.. +..
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred Eec-cceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 543 45699999999999988 4321 12358999999999997 46666665544 211 112
Q ss_pred ccccccCccccccccC----------CCcCcccchHH
Q 038466 443 LLAGTYGYIAPELAYT----------MVMTEKCDVYS 469 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~----------~~~s~ksDVyS 469 (572)
...++..|+|||++.+ .+++..+|+|.
T Consensus 238 ~a~~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 238 QSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCeECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 2235667999998753 34566667764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-13 Score=140.03 Aligned_cols=116 Identities=20% Similarity=0.230 Sum_probs=56.0
Q ss_pred CCCCCCcEEEccCCcccccCchhccCC-----ccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCC--CCccc-
Q 038466 123 SCFPNLVKLTIQFFALTGSIPPEISAL-----SKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP--IPSAL- 194 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--ip~~~- 194 (572)
..+++|+.|+|++|.+++. |..++.+ ++|++|+|++|.+++..|..++.+++|++|+|++|++.|. +|..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 4445555555555555554 4444444 4555555555555544445555555555555555554443 22222
Q ss_pred -cCCCccCeeEeccCcCCC--CCc-hhhhhccccCccccCCCcccCCcc
Q 038466 195 -GSLTNLSNLDLSSNKLSG--KIP-PEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 195 -~~l~~L~~L~ls~N~l~g--~~p-~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+++++|+.|++++|.+++ .++ ..+..+++|+.|++++|++++.+|
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 455555555555555542 111 112344555555555555555443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=146.84 Aligned_cols=122 Identities=21% Similarity=0.216 Sum_probs=111.7
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|+|++|.+++..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 47899999999999999999999999999999999999998889999999999999999999998888899999999999
Q ss_pred eccCcCCC-CCchhhhhccccCccccCCCcccCCccc-cCCCCC
Q 038466 205 LSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGSIPV-RLSPNK 246 (572)
Q Consensus 205 ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~s~n~ 246 (572)
+++|.+++ .+|..++++++|++|++++|.+.+.+|. .++...
T Consensus 105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 99999987 4678899999999999999998788874 454433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.2e-13 Score=135.27 Aligned_cols=121 Identities=14% Similarity=0.135 Sum_probs=66.7
Q ss_pred CCCCCCcEEEccCCcccccCc----hhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCC--C--Cccc
Q 038466 123 SCFPNLVKLTIQFFALTGSIP----PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP--I--PSAL 194 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~ip----~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--i--p~~~ 194 (572)
..+++|+.|+|++|.+.+..| ..+..+++|++|+|++|.+++..|..++.+++|++|+|++|++.+. + +..+
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 193 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP 193 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence 455566666666666665444 2334556666666666666655555566666666666666655432 1 1223
Q ss_pred cCCCccCeeEeccCcCCCCCch----hhhhccccCccccCCCcccCCccccCCC
Q 038466 195 GSLTNLSNLDLSSNKLSGKIPP----EIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 195 ~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
+++++|++|++++|+++. +|. .++.+++|++|++++|++++.+|..+..
T Consensus 194 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 194 HKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp TSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred hcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 455666666666666642 222 1345566666666666666655555433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.2e-13 Score=138.02 Aligned_cols=120 Identities=22% Similarity=0.206 Sum_probs=101.6
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCC--C--CcCCcCCCCcceeecccccccCCCCc----
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGT--I--PPEIGNLKNLIELNVGSNSLIGPIPS---- 192 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--i--p~~~~~l~~L~~L~Ls~N~l~g~ip~---- 192 (572)
.+..+++|+.|+|++|.+.+..|..++++++|++|||++|++.+. + +..++.+++|++|+|++|+++. +|.
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~ 218 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAA 218 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHH
Confidence 456789999999999999999889999999999999999998763 2 2334789999999999999863 333
Q ss_pred cccCCCccCeeEeccCcCCCCCchhhhhc---cccCccccCCCcccCCccccC
Q 038466 193 ALGSLTNLSNLDLSSNKLSGKIPPEIAGM---KNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 193 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.++++++|++|+|++|.+++.+|..++.+ ++|++|++++|+++ .+|..+
T Consensus 219 l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 219 LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC
T ss_pred HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh
Confidence 35788999999999999999888888776 69999999999998 778766
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.6e-12 Score=141.12 Aligned_cols=116 Identities=29% Similarity=0.395 Sum_probs=76.0
Q ss_pred cCCCCCCcEEEccCCcccc--cCchhccCCccCCEEEccCCcCCCCCCcC-CcCCCCcceeecccccccCCCCccccCCC
Q 038466 122 FSCFPNLVKLTIQFFALTG--SIPPEISALSKLQLLDLSSNGLTGTIPPE-IGNLKNLIELNVGSNSLIGPIPSALGSLT 198 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 198 (572)
+..+++|+.|++++|.+.+ .+|..+.++++|++|+|++|.+++.+|.. +..+++|++|++++|++++.+|..+. +
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 5566666677776666665 45566666667777777777766655543 56666677777777766666665543 5
Q ss_pred ccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 199 NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 199 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
+|+.|++++|+++ .+|..+..+++|+.|++++|+++ .+|..
T Consensus 422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 462 (520)
T 2z7x_B 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462 (520)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTT
T ss_pred cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHH
Confidence 6777777777776 56666667777777777777776 45544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=147.19 Aligned_cols=120 Identities=25% Similarity=0.214 Sum_probs=111.4
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++++.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 68999999999999988888999999999999999999999999999999999999999999766668999999999999
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
++|.+++..|..|+++++|++|++++|.+++..|..+...
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 144 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhccc
Confidence 9999998777899999999999999999999888776443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.2e-13 Score=138.18 Aligned_cols=111 Identities=23% Similarity=0.328 Sum_probs=80.4
Q ss_pred CCCCCcEEEccCCcccccCchhc--cCCccCCEEEccCCcCCCCCCcCCcCC-----CCcceeecccccccCCCCccccC
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEI--SALSKLQLLDLSSNGLTGTIPPEIGNL-----KNLIELNVGSNSLIGPIPSALGS 196 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~--~~l~~L~~L~Ls~N~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~ip~~~~~ 196 (572)
.+++|++|+|++|.+++.+|..+ .++++|++|+|++|.+++. |..++.+ ++|++|+|++|++.+..|..+++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 46777777777777777777765 7777777777777777766 6666665 77777777777777777677777
Q ss_pred CCccCeeEeccCcCCCC--Cchhh--hhccccCccccCCCccc
Q 038466 197 LTNLSNLDLSSNKLSGK--IPPEI--AGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 197 l~~L~~L~ls~N~l~g~--~p~~~--~~l~~L~~L~ls~N~l~ 235 (572)
+++|+.|++++|++.+. +|..+ +.+++|+.|++++|+++
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 77777777777777654 33444 66777777777777776
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=139.72 Aligned_cols=139 Identities=24% Similarity=0.235 Sum_probs=78.8
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCc-CCcCCCCcc
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPP-EIGNLKNLI 177 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~ 177 (572)
.++..|++++.... .+....|..+++|+.|+|++|.+.+..+..+.++++|++|+|++|+..+.+|. .|.++++|+
T Consensus 112 ~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~ 188 (440)
T 3zyj_A 112 ANLNTLELFDNRLT---TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188 (440)
T ss_dssp SSCCEEECCSSCCS---SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCC
T ss_pred ccCCEEECCCCcCC---eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccC
Confidence 45667777642111 12222356667777777777777666555666666666666666433333333 455666666
Q ss_pred eeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 178 ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 178 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
+|+|++|+++ .+| .+..+++|+.|+|++|.+++..|..|.++++|+.|++++|++++..|..+
T Consensus 189 ~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 251 (440)
T 3zyj_A 189 YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251 (440)
T ss_dssp EEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSS
T ss_pred eecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhh
Confidence 6666666555 333 25555666666666666665555555566666666666666555555444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=138.91 Aligned_cols=146 Identities=23% Similarity=0.251 Sum_probs=112.6
Q ss_pred ccceeeCCC----------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccC
Q 038466 90 WEGITCNSA----------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSS 159 (572)
Q Consensus 90 w~Gv~c~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~ 159 (572)
|..|.|... ..++.|++++.... .+....|..+++|+.|+|++|.+.+..|..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~---~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQ---IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCC---EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCC---eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 567888642 23455665532211 12233578889999999999999988888899999999999999
Q ss_pred CcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCch-hhhhccccCccccCCCcccCCc
Q 038466 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIAGMKNLTWLDLSNNNIKGSI 238 (572)
Q Consensus 160 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~i 238 (572)
|++++..+..|..+++|++|+|++|.+.+..+..|.++++|+.|++++|...+.+|. .|.++++|+.|++++|+++ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 999876666788999999999999998877777889999999999998655555554 6888999999999999887 45
Q ss_pred c
Q 038466 239 P 239 (572)
Q Consensus 239 p 239 (572)
|
T Consensus 201 ~ 201 (440)
T 3zyj_A 201 P 201 (440)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=142.80 Aligned_cols=136 Identities=23% Similarity=0.210 Sum_probs=99.4
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+....|..+++|++|+|++|.+++..|..|.++++|++|||++|.++ .+|.. .+++|++
T Consensus 52 ~~L~~L~Ls~N~i~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~ 125 (562)
T 3a79_B 52 PRTKALSLSQNSIS---ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRH 125 (562)
T ss_dssp TTCCEEECCSSCCC---CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSE
T ss_pred CCcCEEECCCCCcc---ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCE
Confidence 45677777643211 122235777888888888888888887888888888888888888887 56665 7888888
Q ss_pred eecccccccC-CCCccccCCCccCeeEeccCcCCCCCchhhhhcccc--CccccCCCcc--cCCccccCC
Q 038466 179 LNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL--TWLDLSNNNI--KGSIPVRLS 243 (572)
Q Consensus 179 L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L--~~L~ls~N~l--~g~ip~~~s 243 (572)
|+|++|++++ .+|..|+++++|+.|++++|.+++. .+..+++| +.|++++|.+ ++..|..+.
T Consensus 126 L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~ 192 (562)
T 3a79_B 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192 (562)
T ss_dssp EECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEE
T ss_pred EECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCccccc
Confidence 8888888876 4567888888888888888888753 34455555 8888888888 777776653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.9e-13 Score=144.30 Aligned_cols=132 Identities=25% Similarity=0.302 Sum_probs=74.1
Q ss_pred CCCC-----Cccce-eeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEcc
Q 038466 85 TDHC-----KWEGI-TCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLS 158 (572)
Q Consensus 85 ~~~c-----~w~Gv-~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls 158 (572)
.++| .|.|+ .|.. ++++.|++++.... .++-.-+++|+.|+|++|.++ .+| ..+++|++|+|+
T Consensus 40 ~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~------~lp~~l~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls 108 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLI-NQFSELQLNRLNLS------SLPDNLPPQITVLEITQNALI-SLP---ELPASLEYLDAC 108 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCS------CCCSCCCTTCSEEECCSSCCS-CCC---CCCTTCCEEECC
T ss_pred CCccccccchhhhcccccc-CCccEEEeCCCCCC------ccCHhHcCCCCEEECcCCCCc-ccc---cccCCCCEEEcc
Confidence 5678 79999 7863 57888888753211 111111255666666666665 345 345566666666
Q ss_pred CCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCc
Q 038466 159 SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSI 238 (572)
Q Consensus 159 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~i 238 (572)
+|.+++ +|. +.+ +|++|+|++|++++ +|. .+++|+.|+|++|.+++ +|. .+++|+.|++++|++++ +
T Consensus 109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp SSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-c
Confidence 666664 554 443 56666666666555 444 45555555555555554 443 34555555555555554 4
Q ss_pred cc
Q 038466 239 PV 240 (572)
Q Consensus 239 p~ 240 (572)
|.
T Consensus 176 p~ 177 (571)
T 3cvr_A 176 PE 177 (571)
T ss_dssp CC
T ss_pred ch
Confidence 44
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-12 Score=138.90 Aligned_cols=118 Identities=19% Similarity=0.112 Sum_probs=108.5
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
-.++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|+++++|+.|
T Consensus 73 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 152 (452)
T 3zyi_A 73 IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL 152 (452)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEE
T ss_pred CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEE
Confidence 34689999999999999999999999999999999999999888999999999999999999998888889999999999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCcccc
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 241 (572)
+|++|.+++..+..|.++++|+.|++++|+..+.+|..
T Consensus 153 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~ 190 (452)
T 3zyi_A 153 WLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190 (452)
T ss_dssp ECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT
T ss_pred ECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh
Confidence 99999999777778999999999999997776777653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=133.97 Aligned_cols=145 Identities=19% Similarity=0.193 Sum_probs=115.1
Q ss_pred cceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCC
Q 038466 91 EGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI 170 (572)
Q Consensus 91 ~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 170 (572)
....|...+ + .+.++. .+..++-.-.++|+.|++++|.+++..+..+.++++|++|+|++|.+++..|..+
T Consensus 26 ~~~~C~~~~-~--c~~~~~------~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 96 (353)
T 2z80_A 26 ASLSCDRNG-I--CKGSSG------SLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96 (353)
T ss_dssp -CCEECTTS-E--EECCST------TCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cCCCCCCCe-E--eeCCCC------CcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhc
Confidence 357787644 3 333321 1223333344689999999999999877789999999999999999998888899
Q ss_pred cCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCch--hhhhccccCccccCCCc-ccCCccccCCCC
Q 038466 171 GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP--EIAGMKNLTWLDLSNNN-IKGSIPVRLSPN 245 (572)
Q Consensus 171 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~ls~N~-l~g~ip~~~s~n 245 (572)
+++++|++|+|++|++++..+..++++++|++|++++|.+++ +|. .+..+++|+.|++++|+ +.+..|..+...
T Consensus 97 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 97 SSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp TTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred CCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 999999999999999997666669999999999999999995 554 78999999999999995 554445555443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=144.25 Aligned_cols=123 Identities=18% Similarity=0.161 Sum_probs=111.8
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.+++++.|++++|.+....+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|+.|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 36788999999999988777778999999999999999999888899999999999999999999989999999999999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+|++|.+++..+..|+++++|++|++++|.+++..|..++...
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 171 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCC
Confidence 9999999976566679999999999999999998887775544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=120.48 Aligned_cols=109 Identities=21% Similarity=0.267 Sum_probs=64.2
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCc-cCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALS-KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
+..+++|+.|++++|.+.. +|. +..+. +|++|+|++|.+++. +.++.+++|++|+|++|.+++..|..++.+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4445566666666666663 333 33333 666666666666643 456666666666666666665433444666666
Q ss_pred CeeEeccCcCCCCCch--hhhhccccCccccCCCccc
Q 038466 201 SNLDLSSNKLSGKIPP--EIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~ 235 (572)
+.|++++|.++ .+|. .+..+++|+.|++++|.++
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 66666666664 3454 5566666666666666665
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=142.46 Aligned_cols=137 Identities=23% Similarity=0.219 Sum_probs=111.4
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
.+++.|++++.... .+....|..+++|++|+|++|.+++..|..|+++++|++|||++|.++ .+|.. .+++|++
T Consensus 21 ~~L~~L~Ls~n~i~---~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~ 94 (520)
T 2z7x_B 21 QKTTILNISQNYIS---ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKH 94 (520)
T ss_dssp TTCSEEECCSSCCC---CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSE
T ss_pred ccccEEECCCCccc---ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccE
Confidence 56777887753211 112224788899999999999999988889999999999999999998 57766 7899999
Q ss_pred eecccccccC-CCCccccCCCccCeeEeccCcCCCCCchhhhhcccc--CccccCCCcc--cCCccccCCC
Q 038466 179 LNVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL--TWLDLSNNNI--KGSIPVRLSP 244 (572)
Q Consensus 179 L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L--~~L~ls~N~l--~g~ip~~~s~ 244 (572)
|+|++|++++ .+|..++++++|+.|++++|.+++ ..+..+++| +.|++++|.+ .+.+|..+..
T Consensus 95 L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp EECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred EeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccc
Confidence 9999999987 688899999999999999999886 456777788 9999999999 7888877654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.4e-13 Score=133.86 Aligned_cols=122 Identities=25% Similarity=0.254 Sum_probs=101.2
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCC-cCCCCcceeecccccccCCCCccccCCCc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTN 199 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 199 (572)
....+++|+.|++++|.+++..|..++.+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++. | ....+++
T Consensus 115 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~ 192 (317)
T 3o53_A 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAK 192 (317)
T ss_dssp EECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTT
T ss_pred CccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-ccccccc
Confidence 34557889999999999999888888999999999999999998777776 4789999999999998765 3 3345899
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
|+.|++++|.+++ +|..+..+++|+.|++++|+++ .+|..+....
T Consensus 193 L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 193 LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp CCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred CCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 9999999999985 5666889999999999999998 4777665443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=120.87 Aligned_cols=128 Identities=21% Similarity=0.205 Sum_probs=103.8
Q ss_pred CEEEEEeCCCccCcccccCccccCCC-CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCF-PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l-~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
.++.|++++.... .+. .+..+ ++|+.|++++|.+++. +.+.++++|++|+|++|.+++..|..++.+++|++
T Consensus 20 ~L~~L~l~~n~l~---~i~--~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 20 RDRELDLRGYKIP---VIE--NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp SCEEEECTTSCCC---SCC--CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CceEEEeeCCCCc---hhH--HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 4677777653221 111 23344 4999999999999986 67999999999999999999654444589999999
Q ss_pred eecccccccCCCCc--cccCCCccCeeEeccCcCCCCCchh----hhhccccCccccCCCcccC
Q 038466 179 LNVGSNSLIGPIPS--ALGSLTNLSNLDLSSNKLSGKIPPE----IAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 179 L~Ls~N~l~g~ip~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~l~~L~~L~ls~N~l~g 236 (572)
|+|++|++. .+|. .++++++|+.|++++|.++ .+|.. +..+++|+.||++.|....
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999994 5776 8999999999999999998 56764 8999999999999998753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.5e-12 Score=115.75 Aligned_cols=115 Identities=23% Similarity=0.212 Sum_probs=97.5
Q ss_pred CcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEecc
Q 038466 128 LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207 (572)
Q Consensus 128 L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~ 207 (572)
.+.+++++|.+.. +|..+ .++|+.|+|++|.+++..+..++.+++|++|+|++|++++..+..++++++|+.|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4678889998875 45544 37999999999999977777789999999999999999987777889999999999999
Q ss_pred CcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 208 NKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 208 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
|.+++..+..+..+++|+.|++++|++++..+..+...
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 123 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRL 123 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCC
Confidence 99998777778999999999999999986444334433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.33 E-value=6.4e-12 Score=116.24 Aligned_cols=108 Identities=30% Similarity=0.317 Sum_probs=95.5
Q ss_pred cEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccC
Q 038466 129 VKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208 (572)
Q Consensus 129 ~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N 208 (572)
+.+++++|.+. .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46788888884 5777664 89999999999999988999999999999999999999877777899999999999999
Q ss_pred cCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 209 KLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 209 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++++..+..|..+++|++|+|++|.+....+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9997666669999999999999999986543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-12 Score=141.01 Aligned_cols=110 Identities=27% Similarity=0.306 Sum_probs=102.7
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 379999999999999998899999999999999999999988999999999999999999998 67776 899999999
Q ss_pred eccCcCCC-CCchhhhhccccCccccCCCcccCC
Q 038466 205 LSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 205 ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
+++|++++ .+|..++++++|++|++++|.+++.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~ 161 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC
Confidence 99999997 5678999999999999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=125.70 Aligned_cols=118 Identities=17% Similarity=0.153 Sum_probs=104.2
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCc-CCCCCCcCCcCCCCcceeeccc-ccccCCCCccccCCCccCee
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG-LTGTIPPEIGNLKNLIELNVGS-NSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L 203 (572)
++|+.|++++|.+++..+..+.++++|++|+|++|. +++..+..|.++++|++|++++ |++++..|..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999999888899999999999999997 8866666899999999999999 99998777899999999999
Q ss_pred EeccCcCCCCCchhhhhccccC---ccccCCC-cccCCccccCCCC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLT---WLDLSNN-NIKGSIPVRLSPN 245 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~---~L~ls~N-~l~g~ip~~~s~n 245 (572)
++++|.+++ +|. ++.+++|+ .|++++| .+++..+..+...
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l 154 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccch
Confidence 999999997 777 88889998 9999999 8876555445443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=132.74 Aligned_cols=110 Identities=25% Similarity=0.268 Sum_probs=88.9
Q ss_pred CCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccC-CcccccCchhccCCccCCEEEccCCcCCCCC
Q 038466 88 CKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQF-FALTGSIPPEISALSKLQLLDLSSNGLTGTI 166 (572)
Q Consensus 88 c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i 166 (572)
|.|.+|.|...+.++ .+.. +..+++|+.|+|++ |.|.+..|..|++|++|+.|+|++|+|++..
T Consensus 8 C~~~~v~~~~~n~l~-------------~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 8 HGSSGLRCTRDGALD-------------SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (347)
T ss_dssp SSSSCEECCSSCCCT-------------TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred ccCCEEEcCCCCCCC-------------ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC
Confidence 899999997532211 1233 67788899999986 9999888888999999999999999999888
Q ss_pred CcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCC
Q 038466 167 PPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK 213 (572)
Q Consensus 167 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ 213 (572)
|..|++|++|++|+|++|+|++..|..+..++ |+.|+|.+|.+...
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 88889999999999999999876666666665 99999999988753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.1e-12 Score=133.70 Aligned_cols=123 Identities=18% Similarity=0.161 Sum_probs=109.1
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCee
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
.+++++.|++++|.+....+..+.++++|++|+|++|.+++..|..++.+++|++|+|++|.+.+..|..++++++|+.|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46789999999999987666668999999999999999998888899999999999999999999889999999999999
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
++++|.++...+..++++++|++|++++|.+++..|..+....
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 165 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCT
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCC
Confidence 9999999954444568999999999999999987777665444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.5e-12 Score=128.74 Aligned_cols=120 Identities=25% Similarity=0.370 Sum_probs=75.1
Q ss_pred cCCCCCCcEEEccCCccc--ccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCc
Q 038466 122 FSCFPNLVKLTIQFFALT--GSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTN 199 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~--g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 199 (572)
+..+++|+.|++++|.+. +..|..+.++++|++|++++|.++ .+|..+. ++|++|++++|++++..|..+.++++
T Consensus 141 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~ 217 (330)
T 1xku_A 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 217 (330)
T ss_dssp HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTT
T ss_pred hcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCC
Confidence 445555666666666553 244555556666666666666655 2444332 56666666666666666667777777
Q ss_pred cCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 200 LSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 200 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
|+.|++++|.+++..|..+..+++|+.|++++|+++ .+|..+..+
T Consensus 218 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred CCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 777777777777666666777777777777777776 566555433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.1e-12 Score=127.64 Aligned_cols=116 Identities=21% Similarity=0.345 Sum_probs=104.4
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
.++|+.|++++|.+.+..|..+.++++|++|+|++|.+++..|..++++++|++|+|++|+++ .+|..+. ++|++|+
T Consensus 53 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~ 129 (332)
T 2ft3_A 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELR 129 (332)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEE
T ss_pred CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEE
Confidence 478999999999999988889999999999999999999988999999999999999999998 6776665 8999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCccc--CCccccCC
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK--GSIPVRLS 243 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~--g~ip~~~s 243 (572)
+++|.+++..+..+..+++|+.|++++|.++ |..|..+.
T Consensus 130 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 170 (332)
T 2ft3_A 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170 (332)
T ss_dssp CCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC
T ss_pred CCCCccCccCHhHhCCCccCCEEECCCCccccCCCCccccc
Confidence 9999999877777999999999999999996 45565554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=6.3e-12 Score=129.21 Aligned_cols=105 Identities=25% Similarity=0.207 Sum_probs=94.0
Q ss_pred EEEccCC-cccccCchhccCCccCCEEEccC-CcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEecc
Q 038466 130 KLTIQFF-ALTGSIPPEISALSKLQLLDLSS-NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207 (572)
Q Consensus 130 ~L~l~~n-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~ 207 (572)
.++++++ .|++ +|. +..+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++..|..|+++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4678887 7876 788 99999999999996 999988888999999999999999999999999999999999999999
Q ss_pred CcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 208 NKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 208 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
|+|++..|..+..+. |+.|+|++|.+...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999976666666665 99999999999754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=4.3e-12 Score=139.29 Aligned_cols=121 Identities=23% Similarity=0.246 Sum_probs=102.2
Q ss_pred EEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceee
Q 038466 101 IFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN 180 (572)
Q Consensus 101 v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 180 (572)
+..|++++.... .++ .+..+++|+.|+|++|.++ .+|..++++++|+.|+|++|.+++ +| .+++|++|++|+
T Consensus 443 L~~L~Ls~n~l~---~lp--~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~ 514 (567)
T 1dce_A 443 VRVLHLAHKDLT---VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELL 514 (567)
T ss_dssp CSEEECTTSCCS---SCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred ceEEEecCCCCC---CCc--CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEE
Confidence 555666643211 122 3788999999999999999 889999999999999999999997 77 899999999999
Q ss_pred cccccccCCC-CccccCCCccCeeEeccCcCCCCCchh---hhhccccCcccc
Q 038466 181 VGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIPPE---IAGMKNLTWLDL 229 (572)
Q Consensus 181 Ls~N~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~~p~~---~~~l~~L~~L~l 229 (572)
|++|++++.+ |..++++++|+.|+|++|.+++.+|.. +..+++|+.|++
T Consensus 515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999987 999999999999999999999765532 345788988864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=124.43 Aligned_cols=107 Identities=30% Similarity=0.430 Sum_probs=66.2
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+ ++.+.++++|++|+|++|.+++. +.+..+++|++|++++|++++. ..++++++|+
T Consensus 86 l~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 159 (291)
T 1h6t_A 86 LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD 159 (291)
T ss_dssp GTTCTTCCEEECCSSCCCC--GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred cccCCCCCEEECCCCcCCC--ChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCC
Confidence 5566666666666666655 22366666666666666666642 3456666666666666666553 4566666666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|++++|.+++..| +..+++|+.|++++|.+++
T Consensus 160 ~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred EEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 66666666665333 6666666666666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=123.80 Aligned_cols=111 Identities=27% Similarity=0.401 Sum_probs=95.4
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.+..| +.++++|++|+|++|.+++ +| .++.+++|++|+|++|++.+. ..+.++++|
T Consensus 63 ~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L 136 (291)
T 1h6t_A 63 GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQL 136 (291)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTC
T ss_pred hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCC
Confidence 36778999999999999988654 8999999999999999986 34 488999999999999998863 468899999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+.|++++|.+++. +.++.+++|+.|++++|++++..|
T Consensus 137 ~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 137 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 9999999999864 678899999999999999988655
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-12 Score=129.35 Aligned_cols=112 Identities=18% Similarity=0.066 Sum_probs=82.3
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccc-cCCCccCee
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSAL-GSLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L 203 (572)
.++|+.|++++|.+++..+. .+++|+.|+|++|.+++..|..++.+++|++|+|++|.+++..|..+ ..+++|+.|
T Consensus 98 ~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 98 GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp CTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 36777777777777765443 35678888888888887777778888888888888888887777666 467888888
Q ss_pred EeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
++++|.+++. |. ...+++|+.|++++|++++. |..+
T Consensus 175 ~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~ 210 (317)
T 3o53_A 175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEF 210 (317)
T ss_dssp ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGG
T ss_pred ECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhh
Confidence 8888888754 33 23477888888888888753 4334
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=123.16 Aligned_cols=108 Identities=28% Similarity=0.454 Sum_probs=66.6
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|+|++|.+.+. +.+.++++|++|+|++|.+++ +|. ++.+++|++|++++|.+++..+ ++++++|+
T Consensus 81 ~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~ 154 (308)
T 1h6u_A 81 LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154 (308)
T ss_dssp GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCcc
Confidence 55666666666666666653 246666666666666666664 332 6666666666666666654332 66666666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
.|++++|.+++ ++. +..+++|+.|++++|.+++.
T Consensus 155 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 155 YLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp EEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred EEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC
Confidence 66666666664 333 56666666666666666553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.25 E-value=6.4e-14 Score=132.41 Aligned_cols=115 Identities=22% Similarity=0.258 Sum_probs=99.4
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.+ +| .+.++++|++|+|++|.++ .+|..+..+++|++|+|++|++++ +| .++++++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 46778899999999999988 67 8899999999999999998 678878888999999999999987 55 68899999
Q ss_pred CeeEeccCcCCCCCc-hhhhhccccCccccCCCcccCCccc
Q 038466 201 SNLDLSSNKLSGKIP-PEIAGMKNLTWLDLSNNNIKGSIPV 240 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~ip~ 240 (572)
+.|++++|.+++..+ ..+..+++|++|++++|.+++.+|.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999999985322 4788899999999999999887764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=3e-11 Score=119.38 Aligned_cols=108 Identities=28% Similarity=0.365 Sum_probs=80.7
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|+|++|.+.+..| +.++++|++|+|++|++++ +|.. .. ++|++|+|++|++++. | .++++++|
T Consensus 58 ~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L 130 (263)
T 1xeu_A 58 GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNL 130 (263)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTC
T ss_pred HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccc
Confidence 36667888888888888877544 7888888888888888875 4433 23 7888888888887763 3 57788888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
+.|++++|++++ +| .++.+++|+.|++++|++++.
T Consensus 131 ~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 131 EILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred cEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence 888888888875 34 577788888888888888765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-11 Score=134.67 Aligned_cols=126 Identities=29% Similarity=0.424 Sum_probs=101.3
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..+..|++++.... .+. .+..+++|+.|+|++|.+.+. +.+.+|++|+.|+|++|.+++ + +.+..|++|+.
T Consensus 65 ~~L~~L~Ls~N~l~---~~~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~ 135 (605)
T 1m9s_A 65 PNVTKLFLNGNKLT---DIK--PLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLES 135 (605)
T ss_dssp TTCCEEECTTSCCC---CCG--GGGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSE
T ss_pred CCCCEEEeeCCCCC---CCh--hhccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCE
Confidence 45777777643211 111 277889999999999998873 378899999999999999986 3 45888999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
|+|++|.+++. ..++.+++|+.|+|++|.+++..| +..+++|+.|+|++|++++.
T Consensus 136 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 136 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp EECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred EECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 99999998875 678899999999999999987655 88899999999999999873
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=124.36 Aligned_cols=111 Identities=30% Similarity=0.462 Sum_probs=96.8
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.+. |. +..+++|++|+|++|.+++..+ ++.+++|++|+|++|++++. |. +.++++|
T Consensus 102 ~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L 175 (308)
T 1h6u_A 102 AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKL 175 (308)
T ss_dssp GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTC
T ss_pred hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCC
Confidence 478899999999999999884 43 8999999999999999996543 88999999999999999864 43 8999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+.|++++|.+++. |. +..+++|+.|++++|++++..|
T Consensus 176 ~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~ 212 (308)
T 1h6u_A 176 TTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP 212 (308)
T ss_dssp CEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred CEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc
Confidence 9999999999864 43 8899999999999999987654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=134.13 Aligned_cols=106 Identities=23% Similarity=0.289 Sum_probs=67.5
Q ss_pred CCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc---
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL--- 200 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L--- 200 (572)
.+++|+.|+|++|.+++ +|. .+++|++|+|++|.+++ +|. ++ ++|++|+|++|+++ .+|. +.. +|
T Consensus 138 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~ 205 (571)
T 3cvr_A 138 LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHS 205 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------
T ss_pred cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcc
Confidence 34556666666666665 444 45666666666666665 555 44 66777777777666 4555 443 55
Q ss_pred ----CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 201 ----SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 201 ----~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
+.|+|++|.++ .+|..+..+++|+.|+|++|.++|.+|..+
T Consensus 206 ~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp --CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred cccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 77777777776 467767677777777777777777776654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.3e-11 Score=124.81 Aligned_cols=112 Identities=33% Similarity=0.428 Sum_probs=100.6
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++. +.+..+++|++|++++|++++. +.+..+++|+
T Consensus 217 ~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~ 290 (347)
T 4fmz_A 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLN 290 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCC
Confidence 7788999999999999987644 89999999999999999863 4688999999999999999874 4689999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
.|++++|.+++..|..++.+++|+.|++++|.+++..|
T Consensus 291 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 99999999999889999999999999999999998777
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.22 E-value=3.1e-11 Score=133.28 Aligned_cols=107 Identities=28% Similarity=0.413 Sum_probs=63.2
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|+|++|.+.+. +.+.+|++|+.|+|++|.+++. +.++.|++|+.|+|++|.+.+..| +..+++|+
T Consensus 105 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~ 178 (605)
T 1m9s_A 105 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 178 (605)
T ss_dssp STTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCC
Confidence 55556666666666666552 3455666666666666666643 445566666666666666655444 56666666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|+|++|.+++ +| .+..+++|+.|+|++|.+++
T Consensus 179 ~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 179 NLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp EEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEEC
T ss_pred EEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcC
Confidence 66666666654 22 45566666666666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=124.33 Aligned_cols=117 Identities=24% Similarity=0.356 Sum_probs=101.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++. |. +..+++|++|++++|.+++. ..+..+++|+
T Consensus 195 ~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~ 268 (347)
T 4fmz_A 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLK 268 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCC
T ss_pred ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcC
Confidence 6778999999999999987655 88999999999999999964 43 88999999999999999864 4689999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
.|++++|.+++. +.+..+++|+.|++++|.+++..|..+....
T Consensus 269 ~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 311 (347)
T 4fmz_A 269 MLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311 (347)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCT
T ss_pred EEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccc
Confidence 999999999864 4588999999999999999988877664433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-10 Score=124.91 Aligned_cols=132 Identities=20% Similarity=0.220 Sum_probs=64.2
Q ss_pred CCccceeeCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCC
Q 038466 88 CKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP 167 (572)
Q Consensus 88 c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 167 (572)
|...|+.-........|++++.. +..++++.+++|+.|++++|.+++. | ++++++|++|++++|...+.+
T Consensus 95 N~l~~~~~~~l~~L~~L~L~~N~------l~~l~~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~- 164 (457)
T 3bz5_A 95 NKLTNLDVTPLTKLTYLNCDTNK------LTKLDVSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL- 164 (457)
T ss_dssp SCCSCCCCTTCTTCCEEECCSSC------CSCCCCTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-
T ss_pred CCCceeecCCCCcCCEEECCCCc------CCeecCCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-
Confidence 44444432223445666665321 1222355666666666666666652 2 455555555555555444444
Q ss_pred cCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 168 PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 168 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.++.+++|++|++++|++++ +| ++.+++|+.|++++|.+++. .++.+++|+.|++++|++++
T Consensus 165 -~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 165 -DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp -CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred -ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence 24445555555555555544 23 44444555555555554432 14444444455555554444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.8e-11 Score=125.96 Aligned_cols=127 Identities=25% Similarity=0.278 Sum_probs=91.9
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
.++..|++++.. +..++++.+++|+.|++++|...+.+ .++.+++|+.|++++|.+++ +| ++.+++|+.
T Consensus 127 ~~L~~L~l~~N~------l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~ 195 (457)
T 3bz5_A 127 PLLTYLNCARNT------LTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNR 195 (457)
T ss_dssp TTCCEEECTTSC------CSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCE
T ss_pred CcCCEEECCCCc------cceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCE
Confidence 456666665321 23345777888888888888766666 36778888888888888886 44 777888888
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
|++++|++++. .++++++|+.|++++|++++ +| ++.+++|+.|++++|+++|..+..+
T Consensus 196 L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 196 LNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp EECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred EECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 88888888764 37778888888888888886 56 6777888888888888877544443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4.7e-13 Score=126.42 Aligned_cols=110 Identities=29% Similarity=0.395 Sum_probs=98.8
Q ss_pred cCCCCCCcEEEccCCcccccCch------hccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCcccc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPP------EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALG 195 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~------~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 195 (572)
+.....++.++++.+.+.|.+|. .+.++++|++|+|++|.+++ +| .++.+++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34456778888888999998887 89999999999999999997 77 8999999999999999998 6898899
Q ss_pred CCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 196 SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 196 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.+++|+.|++++|.+++ +| .++.+++|+.|++++|++++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 99999999999999997 55 68999999999999999985
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.3e-11 Score=117.64 Aligned_cols=125 Identities=27% Similarity=0.355 Sum_probs=103.9
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+. .+..+++|+.|+|++|.+.+ +|. +.. ++|+.|+|++|.+++ +| .++.+++|++
T Consensus 63 ~~L~~L~L~~N~i~---~~~--~l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~ 132 (263)
T 1xeu_A 63 TNLKELHLSHNQIS---DLS--PLKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEI 132 (263)
T ss_dssp TTCCEEECCSSCCC---CCG--GGTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCE
T ss_pred CCCCEEECCCCccC---CCh--hhccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccE
Confidence 46778887753211 112 27889999999999999998 443 333 999999999999996 34 6899999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
|+|++|++++. | .++.+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.
T Consensus 133 L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 133 LSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp EECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred EECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 99999999874 4 699999999999999999976 6788999999999999999876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.9e-11 Score=127.79 Aligned_cols=107 Identities=28% Similarity=0.449 Sum_probs=59.5
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+..| +..+++|+.|++++|.+++..| +..+++|++|+|++|++.+..| ++.+++|+
T Consensus 239 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 312 (466)
T 1o6v_A 239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT 312 (466)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCS
T ss_pred hhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCC
Confidence 4455666666666666665433 5556666666666666654322 5555566666666665554332 55555555
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|++++|.+++..| +..+++|+.|++++|.+++
T Consensus 313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred EEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 55555555554433 4455555555555555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.6e-11 Score=128.81 Aligned_cols=110 Identities=32% Similarity=0.477 Sum_probs=97.7
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|+.|++++|.+.+..| +..+++|+.|+|++|.+++..| ++.+++|+.|+|++|++++..| ++.+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 334 (466)
T 1o6v_A 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334 (466)
T ss_dssp GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCC
T ss_pred hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCC
Confidence 7788999999999999998644 8899999999999999997544 7889999999999999998766 78999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
.|++++|.+++. +.+..+++|+.|++++|++++.+|
T Consensus 335 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 335 RLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred EeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 999999999874 568899999999999999999887
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2e-12 Score=132.14 Aligned_cols=142 Identities=17% Similarity=0.178 Sum_probs=81.8
Q ss_pred CCCccceeeCCCCCEEEEEeCCCccCcccccCccccCCC--CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCC
Q 038466 87 HCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCF--PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG 164 (572)
Q Consensus 87 ~c~w~Gv~c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l--~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 164 (572)
+.+|.++.|+. ...+.+++++.... ...+..+ ++++.|++++|.+.+.+|. +.++++|++|+|++|.+++
T Consensus 36 c~~W~~~~~~~-~~~~~l~l~~~~~~------~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 36 CKRWYRLASDE-SLWQTLDLTGKNLH------PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp CHHHHHHHTCS-TTSSEEECTTCBCC------HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHhcCc-hhheeeccccccCC------HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 34688887753 34556666542111 1112223 4566666666666665444 4456666666666666654
Q ss_pred C-CCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccC-cCCC-CCchhhhhccccCccccCCC-cccC
Q 038466 165 T-IPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN-KLSG-KIPPEIAGMKNLTWLDLSNN-NIKG 236 (572)
Q Consensus 165 ~-ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N-~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g 236 (572)
. +|..+..+++|++|+|++|.+++..|..++.+++|+.|++++| .+++ .+|..+..+++|+.|++++| .+++
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 4 5555666666666666666666556666666666666666666 4554 24555566666666666666 5554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.13 E-value=4.2e-12 Score=129.67 Aligned_cols=121 Identities=22% Similarity=0.309 Sum_probs=69.0
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCC-cCCCC-CCcCCcCCCCcceeecccc-cccCC-CCccccCC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSN-GLTGT-IPPEIGNLKNLIELNVGSN-SLIGP-IPSALGSL 197 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l 197 (572)
+..+++|+.|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++| .+++. +|..+.++
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l 193 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV 193 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhc
Confidence 445556666666666666555555666666666666666 45542 4444555666666666666 55543 45555566
Q ss_pred C-ccCeeEeccC--cCC-CCCchhhhhccccCccccCCCc-ccCCccccC
Q 038466 198 T-NLSNLDLSSN--KLS-GKIPPEIAGMKNLTWLDLSNNN-IKGSIPVRL 242 (572)
Q Consensus 198 ~-~L~~L~ls~N--~l~-g~~p~~~~~l~~L~~L~ls~N~-l~g~ip~~~ 242 (572)
+ +|+.|++++| .++ +.+|..+..+++|+.|++++|. +++..+..+
T Consensus 194 ~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 194 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred ccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 6 6666666666 343 3445555566666666666666 454444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.11 E-value=8.9e-11 Score=120.95 Aligned_cols=106 Identities=22% Similarity=0.211 Sum_probs=63.4
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCc-CCcCCCCcce-eecccccccCCCCccccCCCccCee
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPP-EIGNLKNLIE-LNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~-L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
++++.|+|++|.++...+..|.+|++|++|+|++|.+.+.+|. .|.++++|++ +.+++|++++..|..|.++++|+.|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 4566666666666654444566666666666666666555543 3556666553 4555566666556666666666666
Q ss_pred EeccCcCCCCCchhhhhccccCccccCC
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDLSN 231 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~ls~ 231 (572)
++++|.+++..+..+....++..+++++
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred cccccccccCCchhhcccchhhhhhhcc
Confidence 6666666654444444445555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.09 E-value=6.2e-10 Score=118.88 Aligned_cols=101 Identities=27% Similarity=0.375 Sum_probs=66.4
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEe
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 205 (572)
++|++|++++|.+.+ +| .++++++|++|++++|.+++ +|..+ .+|++|++++|++++ +| .++++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 467777777777776 56 47777777777777777774 55433 467777777777765 55 4677777777777
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++|.+++ +|... .+|+.|++++|.++ .+|
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence 7777664 44322 36666666666665 555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8e-12 Score=130.44 Aligned_cols=117 Identities=22% Similarity=0.297 Sum_probs=99.7
Q ss_pred CCCcEEEccCCccc-ccCc---hhccCCccCCEEEccCCcCC--C---CCCcCCcCCCCcceeeccccccc----CCCCc
Q 038466 126 PNLVKLTIQFFALT-GSIP---PEISALSKLQLLDLSSNGLT--G---TIPPEIGNLKNLIELNVGSNSLI----GPIPS 192 (572)
Q Consensus 126 ~~L~~L~l~~n~l~-g~ip---~~~~~l~~L~~L~Ls~N~l~--g---~ip~~~~~l~~L~~L~Ls~N~l~----g~ip~ 192 (572)
++|+.|+|++|.++ +.+| ..+.++++|+.|+|++|.++ | .+|..+..+++|++|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 89999999999998 5556 46778999999999999998 3 35557888999999999999986 77888
Q ss_pred cccCCCccCeeEeccCcCCCC----Cchhhhh--ccccCccccCCCcccC----CccccC
Q 038466 193 ALGSLTNLSNLDLSSNKLSGK----IPPEIAG--MKNLTWLDLSNNNIKG----SIPVRL 242 (572)
Q Consensus 193 ~~~~l~~L~~L~ls~N~l~g~----~p~~~~~--l~~L~~L~ls~N~l~g----~ip~~~ 242 (572)
.+..+++|+.|+|++|.+++. +|..+.. +++|+.|++++|.+++ .+|..+
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 999999999999999999875 5666643 8999999999999988 577665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.2e-10 Score=126.83 Aligned_cols=107 Identities=27% Similarity=0.330 Sum_probs=74.0
Q ss_pred CCCcEEEccCCcccccCchhccC-----------------CccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccC
Q 038466 126 PNLVKLTIQFFALTGSIPPEISA-----------------LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIG 188 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~-----------------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 188 (572)
++|+.|++++|.+++ +|..+.+ +++|+.|+|++|.+++ +| ..+++|+.|+|++|+++
T Consensus 181 ~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~- 254 (622)
T 3g06_A 181 SGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT- 254 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-
T ss_pred CCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-
Confidence 566667777766665 2222111 2566777777777764 55 34567777888887776
Q ss_pred CCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccC
Q 038466 189 PIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 189 ~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.+|. .+++|+.|+|++|.++ .+|..+.++++|+.|++++|.++|.+|..+
T Consensus 255 ~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 255 SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 4555 5677888888888888 678888888888888888888888777654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.2e-10 Score=122.38 Aligned_cols=106 Identities=34% Similarity=0.500 Sum_probs=71.1
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCC--CCCcCCc-------------CC-CCcceeecccccccCC
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTG--TIPPEIG-------------NL-KNLIELNVGSNSLIGP 189 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~-------------~l-~~L~~L~Ls~N~l~g~ 189 (572)
++|+.|++++|.+.+ +|.. +++|+.|++++|.+++ .+|..+. .+ ++|++|++++|++++
T Consensus 257 ~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~- 331 (454)
T 1jl5_A 257 PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE- 331 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-
T ss_pred cccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-
Confidence 345555555555554 3432 3667777777777765 3443322 22 478888888888876
Q ss_pred CCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC--CccccCC
Q 038466 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG--SIPVRLS 243 (572)
Q Consensus 190 ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g--~ip~~~s 243 (572)
+|.. +++|+.|++++|.++ .+|. .+++|+.|++++|+++| .+|.++.
T Consensus 332 lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 332 LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence 6654 578888888888888 4666 46788888888888888 7887763
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.2e-10 Score=124.54 Aligned_cols=129 Identities=25% Similarity=0.280 Sum_probs=79.5
Q ss_pred CCCCCcccee--------eCCCCCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEE
Q 038466 85 TDHCKWEGIT--------CNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLD 156 (572)
Q Consensus 85 ~~~c~w~Gv~--------c~~~~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~ 156 (572)
.++|.|.|.. |.. ..++.|++++.... .++-.-.++|+.|+|++|.++. +|. .+++|++|+
T Consensus 19 ~~~~~~~~r~~~~~~~~~c~~-~~l~~L~ls~n~L~------~lp~~l~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~ 87 (622)
T 3g06_A 19 APAEESRGRAAVVQKMRACLN-NGNAVLNVGESGLT------TLPDCLPAHITTLVIPDNNLTS-LPA---LPPELRTLE 87 (622)
T ss_dssp CCGGGHHHHHHHHHHHHHHHH-HCCCEEECCSSCCS------CCCSCCCTTCSEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred CCcchhccccccCcccccccC-CCCcEEEecCCCcC------ccChhhCCCCcEEEecCCCCCC-CCC---cCCCCCEEE
Confidence 5778997643 221 34667777643211 1111112677788888777773 454 467777777
Q ss_pred ccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 157 LSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 157 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
|++|.++ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++
T Consensus 88 Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 88 VSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp ECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence 7777777 3554 56777777777777765 343 45667777777777664 4543 3566667777776664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.99 E-value=9.1e-11 Score=121.43 Aligned_cols=119 Identities=23% Similarity=0.281 Sum_probs=68.3
Q ss_pred cCCCC-CCcEEEccCCcccccCchhccCC-----ccCCEEEccCCcCCCCCCcCCc----CC-CCcceeecccccccCCC
Q 038466 122 FSCFP-NLVKLTIQFFALTGSIPPEISAL-----SKLQLLDLSSNGLTGTIPPEIG----NL-KNLIELNVGSNSLIGPI 190 (572)
Q Consensus 122 ~~~l~-~L~~L~l~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~ip~~~~----~l-~~L~~L~Ls~N~l~g~i 190 (572)
+..++ +|+.|+|++|.+.+..+..+..+ ++|++|+|++|.+++..+..+. .+ ++|++|+|++|++++..
T Consensus 46 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 46 FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS 125 (362)
T ss_dssp HHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred HHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence 44455 66666666666666655555543 6666666666666655554332 22 56666666666666555
Q ss_pred CccccC-----CCccCeeEeccCcCCCCCchh----hhhcc-ccCccccCCCcccCCccc
Q 038466 191 PSALGS-----LTNLSNLDLSSNKLSGKIPPE----IAGMK-NLTWLDLSNNNIKGSIPV 240 (572)
Q Consensus 191 p~~~~~-----l~~L~~L~ls~N~l~g~~p~~----~~~l~-~L~~L~ls~N~l~g~ip~ 240 (572)
+..+.. .++|+.|+|++|.+++..+.. +..++ +|+.|++++|++++..+.
T Consensus 126 ~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~ 185 (362)
T 3goz_A 126 SSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCA 185 (362)
T ss_dssp HHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred HHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHH
Confidence 544332 246666666666666433322 33333 666666666666655543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.97 E-value=8.4e-11 Score=122.68 Aligned_cols=114 Identities=18% Similarity=0.217 Sum_probs=65.6
Q ss_pred cCCCCCCcEEEccCC---cccccCchhc-------cCCccCCEEEccCCcCCC----CCCcCCcCCCCcceeeccccccc
Q 038466 122 FSCFPNLVKLTIQFF---ALTGSIPPEI-------SALSKLQLLDLSSNGLTG----TIPPEIGNLKNLIELNVGSNSLI 187 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n---~l~g~ip~~~-------~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~Ls~N~l~ 187 (572)
+..+++|+.|+|++| .+.+.+|..+ .++++|++|+|++|.+++ .+|..+..+++|++|+|++|.++
T Consensus 56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 445666666666663 4445555544 466666666666666665 35555566666666666666664
Q ss_pred CCCCcccc----CC---------CccCeeEeccCcCC-CCCc---hhhhhccccCccccCCCccc
Q 038466 188 GPIPSALG----SL---------TNLSNLDLSSNKLS-GKIP---PEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 188 g~ip~~~~----~l---------~~L~~L~ls~N~l~-g~~p---~~~~~l~~L~~L~ls~N~l~ 235 (572)
+..+..+. .+ ++|+.|++++|.++ +.+| ..+..+++|+.|++++|.++
T Consensus 136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 33333222 22 66666666666665 3344 34555666666666666665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.8e-10 Score=119.28 Aligned_cols=117 Identities=22% Similarity=0.210 Sum_probs=96.1
Q ss_pred CCCCCCcEEEccCCcccccCc----hhccCCc-cCCEEEccCCcCCCCCCcCCcCC-----CCcceeecccccccCCCCc
Q 038466 123 SCFPNLVKLTIQFFALTGSIP----PEISALS-KLQLLDLSSNGLTGTIPPEIGNL-----KNLIELNVGSNSLIGPIPS 192 (572)
Q Consensus 123 ~~l~~L~~L~l~~n~l~g~ip----~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~ip~ 192 (572)
...++|+.|+|++|.+++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++|++|+|++|.+++..+.
T Consensus 19 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~ 98 (362)
T 3goz_A 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSD 98 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH
T ss_pred hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHH
Confidence 344569999999999998877 6788888 89999999999998877777665 8999999999999888777
Q ss_pred cccCC-----CccCeeEeccCcCCCCCchhhhhc-----cccCccccCCCcccCCcc
Q 038466 193 ALGSL-----TNLSNLDLSSNKLSGKIPPEIAGM-----KNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 193 ~~~~l-----~~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~ls~N~l~g~ip 239 (572)
.+... ++|+.|++++|.+++..+..+... ++|++|++++|.+++..+
T Consensus 99 ~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 99 ELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 55544 899999999999988777666542 589999999999986443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.90 E-value=5e-11 Score=117.39 Aligned_cols=80 Identities=26% Similarity=0.303 Sum_probs=58.6
Q ss_pred cCCccCCEEEccCCcCCC--CCCcCCcCCCCcceeecccccccCCCCccccCCC--ccCeeEeccCcCCCCCch------
Q 038466 147 SALSKLQLLDLSSNGLTG--TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLT--NLSNLDLSSNKLSGKIPP------ 216 (572)
Q Consensus 147 ~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~--~L~~L~ls~N~l~g~~p~------ 216 (572)
.++++|+.|+|++|++++ .+|..++.+++|+.|+|++|++.+. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 567788888888888887 4556667788888888888888764 3344444 788888888888876663
Q ss_pred -hhhhccccCccc
Q 038466 217 -EIAGMKNLTWLD 228 (572)
Q Consensus 217 -~~~~l~~L~~L~ 228 (572)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356677777776
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.85 E-value=4e-09 Score=108.49 Aligned_cols=149 Identities=21% Similarity=0.148 Sum_probs=111.1
Q ss_pred CCccceeeCCC----------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCch-hccCCccCCE-E
Q 038466 88 CKWEGITCNSA----------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPP-EISALSKLQL-L 155 (572)
Q Consensus 88 c~w~Gv~c~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~-~~~~l~~L~~-L 155 (572)
|.|+.|.|... ..++.|++++... ..+..-.|.++++|+.|+|++|.+.+.+|. .|.++++|.. +
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i---~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKL---RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCC---SEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcC---CCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 78899999642 2456777664321 123333588999999999999999887775 5788988775 7
Q ss_pred EccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEecc-CcCCCCCchhhhhcc-ccCccccCCCc
Q 038466 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS-NKLSGKIPPEIAGMK-NLTWLDLSNNN 233 (572)
Q Consensus 156 ~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~-~L~~L~ls~N~ 233 (572)
+++.|++++..|..|.++++|++|++++|++.+..+..+....++..|++.+ |.+....+..|..+. .++.|++++|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 7788999988888899999999999999999887777777777788888865 455543344555554 57788888888
Q ss_pred ccCCccc
Q 038466 234 IKGSIPV 240 (572)
Q Consensus 234 l~g~ip~ 240 (572)
++. ||.
T Consensus 166 i~~-i~~ 171 (350)
T 4ay9_X 166 IQE-IHN 171 (350)
T ss_dssp CCE-ECT
T ss_pred ccC-CCh
Confidence 874 443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=5.4e-09 Score=102.79 Aligned_cols=120 Identities=14% Similarity=0.110 Sum_probs=81.3
Q ss_pred cccccccccCeeEEEEEEc-CCCcE--EEEEecCCcchH---------------------HHHHHHHHHHHHHHHHhcCC
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKV--FALKKLHTSETE---------------------ELAFIKSFRNEAQVLSQVLH 363 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~--vAvK~l~~~~~~---------------------~~~~~~~f~~E~~~l~~l~H 363 (572)
++...+|.|+||.||+|.. .+|+. ||||+++..... .......+.+|++.+.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999997 78988 999987543211 01112468899999999999
Q ss_pred CCc--ccEEEEEEeCCeEEEEEecccC-C----ChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh-cCCCCCceeeC
Q 038466 364 RNI--VKLYGFCLHRKCMFLIYEYMKR-G----SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDCSPSIASTC 435 (572)
Q Consensus 364 ~ni--v~l~g~~~~~~~~~lV~Ey~~~-G----sL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH-~~~~~~i~~~~ 435 (572)
+++ ..++++ +..++||||+.+ | +|.+.... .++.....++.+++.|+.||| +. +++|.+
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 864 344442 346899999953 5 55544322 112345678999999999999 42 455655
Q ss_pred CCCCC
Q 038466 436 PDSSN 440 (572)
Q Consensus 436 ~~~~~ 440 (572)
.+..|
T Consensus 197 lkp~N 201 (258)
T 1zth_A 197 LSEYN 201 (258)
T ss_dssp CSTTS
T ss_pred CCHHH
Confidence 55544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.77 E-value=2.4e-10 Score=121.78 Aligned_cols=125 Identities=23% Similarity=0.155 Sum_probs=99.6
Q ss_pred cCCCCCCcEEEccCCccccc----CchhccCCccCCEEEccCCcCCCCCCcCCc-----CCCCcceeecccccccCC---
Q 038466 122 FSCFPNLVKLTIQFFALTGS----IPPEISALSKLQLLDLSSNGLTGTIPPEIG-----NLKNLIELNVGSNSLIGP--- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-----~l~~L~~L~Ls~N~l~g~--- 189 (572)
+..+++|+.|++++|.+++. ++..+.++++|++|+|++|.+++..+..+. ..++|++|+|++|.+++.
T Consensus 252 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 331 (461)
T 1z7x_W 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS 331 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH
Confidence 34688999999999999875 677788899999999999998765444433 236899999999998876
Q ss_pred -CCccccCCCccCeeEeccCcCCCCCchhhhh-----ccccCccccCCCcccC----CccccCCCCC
Q 038466 190 -IPSALGSLTNLSNLDLSSNKLSGKIPPEIAG-----MKNLTWLDLSNNNIKG----SIPVRLSPNK 246 (572)
Q Consensus 190 -ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~g----~ip~~~s~n~ 246 (572)
+|..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+++ .+|..+..+.
T Consensus 332 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~ 398 (461)
T 1z7x_W 332 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398 (461)
T ss_dssp HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred HHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCC
Confidence 5677788899999999999988765665553 5699999999999986 7776664444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.77 E-value=1.8e-10 Score=122.82 Aligned_cols=121 Identities=21% Similarity=0.171 Sum_probs=97.7
Q ss_pred cCCCCCCcEEEccCCcccccC-----chhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeecccccccCCCCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSI-----PPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGPIPS 192 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~i-----p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~ip~ 192 (572)
+..+++|+.|++++|.+.+.- +..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+.+..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 557899999999999987642 22234689999999999999864 677788899999999999998765555
Q ss_pred cccCC-----CccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccCCccccC
Q 038466 193 ALGSL-----TNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKGSIPVRL 242 (572)
Q Consensus 193 ~~~~l-----~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 242 (572)
.+... ++|+.|++++|.+++. +|..+..+++|+.|++++|.+++..+..+
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l 361 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHH
Confidence 55443 7999999999999875 56777888999999999999987654433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=9e-09 Score=106.82 Aligned_cols=137 Identities=18% Similarity=0.187 Sum_probs=94.9
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhc-----cCCccCCEEEccCCcCCC----CCCcC
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEI-----SALSKLQLLDLSSNGLTG----TIPPE 169 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~-----~~l~~L~~L~Ls~N~l~g----~ip~~ 169 (572)
..++.|++++...... .+. .-...+++|+.|+|++|.++..-...+ ...++|+.|+|++|.++. .++..
T Consensus 101 ~~L~~L~Ls~n~l~~~-~~~-~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 178 (372)
T 3un9_A 101 HALDEVNLASCQLDPA-GLR-TLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEG 178 (372)
T ss_dssp SCEEEEECTTCCCCHH-HHH-HTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHH-HHH-HHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHH
Confidence 4688888875321100 000 012234578999999998876544443 356789999999999864 24444
Q ss_pred CcCCCCcceeecccccccCC----CCccccCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccCC
Q 038466 170 IGNLKNLIELNVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 170 ~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
+..+++|++|+|++|.+... ++..+...++|+.|+|++|.++.. ++..+...++|+.|||++|.++..
T Consensus 179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 56788899999999988642 356677788999999999998753 344455668899999999988653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.50 E-value=4.7e-07 Score=93.56 Aligned_cols=108 Identities=9% Similarity=-0.029 Sum_probs=69.5
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchH------------------HHHH-HHHHHHHHHHHHhcCCCCcc
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETE------------------ELAF-IKSFRNEAQVLSQVLHRNIV 367 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~------------------~~~~-~~~f~~E~~~l~~l~H~niv 367 (572)
+.+...+|.|+||.||+|..++|+.||||+++..... .... .....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4566789999999999999999999999987532110 0000 01123566777777655543
Q ss_pred cEEEEEEeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc
Q 038466 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425 (572)
Q Consensus 368 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~ 425 (572)
-..-+.... .+|||||+++++|.+..... . ...++.+++.++.|||+
T Consensus 177 vp~p~~~~~--~~LVME~i~G~~L~~l~~~~------~---~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 177 VPEPIAQSR--HTIVMSLVDALPMRQVSSVP------D---PASLYADLIALILRLAK 223 (397)
T ss_dssp CCCEEEEET--TEEEEECCSCEEGGGCCCCS------C---HHHHHHHHHHHHHHHHH
T ss_pred CCeeeeccC--ceEEEEecCCccHhhhcccH------H---HHHHHHHHHHHHHHHHH
Confidence 222222222 36999999999886554211 1 23467889999999974
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=3.7e-08 Score=91.69 Aligned_cols=114 Identities=17% Similarity=0.173 Sum_probs=88.5
Q ss_pred cCCCCCCcEEEccCC-cccc----cCchhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeecccccccCC---
Q 038466 122 FSCFPNLVKLTIQFF-ALTG----SIPPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLIGP--- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n-~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~--- 189 (572)
+...+.|+.|+|++| .+.. .+...+...++|++|+|++|.++.. +...+...++|++|+|++|.+...
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 567889999999999 8864 2445677789999999999999743 233445567899999999998653
Q ss_pred -CCccccCCCccCeeEe--ccCcCCCC----CchhhhhccccCccccCCCccc
Q 038466 190 -IPSALGSLTNLSNLDL--SSNKLSGK----IPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 190 -ip~~~~~l~~L~~L~l--s~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+...+...++|+.|+| ++|.++.. +...+...++|+.|++++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566777889999999 88998753 3344555688999999999874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-08 Score=109.47 Aligned_cols=114 Identities=17% Similarity=0.079 Sum_probs=81.7
Q ss_pred CCCCCcEEEccCCcccccCchhccC-CccCCEEEcc----CCcCCCC-----CCcCCcCCCCcceeecccc--cccCCCC
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEISA-LSKLQLLDLS----SNGLTGT-----IPPEIGNLKNLIELNVGSN--SLIGPIP 191 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~~-l~~L~~L~Ls----~N~l~g~-----ip~~~~~l~~L~~L~Ls~N--~l~g~ip 191 (572)
.+++|+.|+++.|.+++..+..++. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|+.| .+++..+
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~ 455 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHH
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHH
Confidence 3788999999888888877777765 8889999996 6777753 3333566788888888643 3555544
Q ss_pred ccccC-CCccCeeEeccCcCCC-CCchhhhhccccCccccCCCcccCC
Q 038466 192 SALGS-LTNLSNLDLSSNKLSG-KIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 192 ~~~~~-l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
..++. +++|+.|++++|.+++ .++..+..+++|+.|++++|.+++.
T Consensus 456 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 44443 7788888888888775 3455556778888888888887654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.8e-08 Score=104.65 Aligned_cols=112 Identities=15% Similarity=0.192 Sum_probs=82.1
Q ss_pred CCCCcEEEccCCcccccCchhc-cCCccCCEEEccCCcCCCCCCcCC-----cCCCCcceeecccccccC----CCCccc
Q 038466 125 FPNLVKLTIQFFALTGSIPPEI-SALSKLQLLDLSSNGLTGTIPPEI-----GNLKNLIELNVGSNSLIG----PIPSAL 194 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~-~~l~~L~~L~Ls~N~l~g~ip~~~-----~~l~~L~~L~Ls~N~l~g----~ip~~~ 194 (572)
.++|+.|+|++|.++..-...+ ..+++|+.|+|++|.++......+ ...++|++|+|++|.++. .++..+
T Consensus 100 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 100 RHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 4688999999998875433333 345688999999998875433333 245789999999998854 344556
Q ss_pred cCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccC
Q 038466 195 GSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 195 ~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
..+++|++|+|++|.++.. ++..+...++|+.|+|++|.++.
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 7788899999999988742 35556677889999999998864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.39 E-value=7.5e-07 Score=90.50 Aligned_cols=94 Identities=17% Similarity=0.170 Sum_probs=68.7
Q ss_pred CccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC-eeEeccCcCCCCCchhhhhccccCcc
Q 038466 149 LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS-NLDLSSNKLSGKIPPEIAGMKNLTWL 227 (572)
Q Consensus 149 l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~L 227 (572)
+++|+.|+|++|+++...+..|.++++|+.|+|++| +...-+..|.++++|+ .+++.+ .++..-+..|.++++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 677888888888887555556888888888888877 6555556788888888 888877 5664455678888888888
Q ss_pred ccCCCcccCCccccCCC
Q 038466 228 DLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 228 ~ls~N~l~g~ip~~~s~ 244 (572)
+++.|+++.--+..+.+
T Consensus 303 ~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 303 LATGDKITTLGDELFGN 319 (329)
T ss_dssp EECSSCCCEECTTTTCT
T ss_pred EeCCCccCccchhhhcC
Confidence 88888776544444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.39 E-value=6.6e-08 Score=106.24 Aligned_cols=82 Identities=10% Similarity=0.044 Sum_probs=33.6
Q ss_pred CCccCCEEEccCCcCCCC----CCcCCcCCCCcceeeccccccc----CCCCccccCCCccCeeEeccCcCCCCCchhhh
Q 038466 148 ALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSNSLI----GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219 (572)
Q Consensus 148 ~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~----g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 219 (572)
++++|++|+|++|.+++. ++....++++|++|+|++|.++ +.++..+.++++|+.|++++|.+.+ +|..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 344444444444444333 1112233444444444444443 1222233344444444444444442 334444
Q ss_pred hccccCccccC
Q 038466 220 GMKNLTWLDLS 230 (572)
Q Consensus 220 ~l~~L~~L~ls 230 (572)
.+++|+.|+++
T Consensus 241 ~~~~L~~L~l~ 251 (592)
T 3ogk_B 241 AAANLEEFCGG 251 (592)
T ss_dssp HCTTCCEEEEC
T ss_pred hhhHHHhhccc
Confidence 44444444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.38 E-value=1.7e-07 Score=92.14 Aligned_cols=79 Identities=27% Similarity=0.373 Sum_probs=67.6
Q ss_pred CCCCCcEEEccCCcccc--cCchhccCCccCCEEEccCCcCCCCCCcCCcCCC--CcceeecccccccCCCCc-------
Q 038466 124 CFPNLVKLTIQFFALTG--SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLK--NLIELNVGSNSLIGPIPS------- 192 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~--~L~~L~Ls~N~l~g~ip~------- 192 (572)
++++|+.|+|++|.+++ .+|..+..+++|+.|+|++|.+++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 47899999999999998 6678888999999999999999975 3455555 999999999999988873
Q ss_pred cccCCCccCeeE
Q 038466 193 ALGSLTNLSNLD 204 (572)
Q Consensus 193 ~~~~l~~L~~L~ 204 (572)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 367889999886
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.29 E-value=8.6e-07 Score=90.05 Aligned_cols=103 Identities=18% Similarity=0.065 Sum_probs=91.0
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcc-eeecccccccCCCCccccCCCccCee
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLI-ELNVGSNSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~ip~~~~~l~~L~~L 203 (572)
+++|+.|+|++|.+....+..|.++++|+.|+|++| ++..-+..|.++++|+ .+++++ +++..-+..|.+|++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 789999999999999777778999999999999998 7766667799999999 999988 6776667899999999999
Q ss_pred EeccCcCCCCCchhhhhccccCcccc
Q 038466 204 DLSSNKLSGKIPPEIAGMKNLTWLDL 229 (572)
Q Consensus 204 ~ls~N~l~g~~p~~~~~l~~L~~L~l 229 (572)
++++|.++..-+..|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 99999999766778999999998763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.06 E-value=3.1e-07 Score=100.77 Aligned_cols=135 Identities=16% Similarity=0.135 Sum_probs=96.9
Q ss_pred CCCCCcEEEccCCcccccCchhcc-CCccCCEEEcc--C----CcCCCC-----CCcCCcCCCCcceeecccccccCCCC
Q 038466 124 CFPNLVKLTIQFFALTGSIPPEIS-ALSKLQLLDLS--S----NGLTGT-----IPPEIGNLKNLIELNVGSNSLIGPIP 191 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g~ip~~~~-~l~~L~~L~Ls--~----N~l~g~-----ip~~~~~l~~L~~L~Ls~N~l~g~ip 191 (572)
.+++|+.|.+..|.+++..+..+. ++++|+.|+|+ + |.+++. ++..+.++++|+.|+|++ ++++..+
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 378999999999999887776665 58999999999 4 556522 122256788999999977 6666656
Q ss_pred ccccC-CCccCeeEeccCcCCCCCchhh-hhccccCccccCCCcccCCccccCCCCCCCCCCCccCCCCCCC
Q 038466 192 SALGS-LTNLSNLDLSSNKLSGKIPPEI-AGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPSCDT 261 (572)
Q Consensus 192 ~~~~~-l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~ls~N~l~g~ip~~~s~n~~l~~~~~~~l~~c~~ 261 (572)
..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++..+..+.. .+.....+++..|..
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~--~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS--KLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGG--GGGGSSEEEEESSCC
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHH--hCCCCCEEeeeCCCC
Confidence 66665 8999999999999876655555 67899999999999986544432211 122334445556653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.6e-06 Score=95.16 Aligned_cols=104 Identities=16% Similarity=0.214 Sum_probs=42.2
Q ss_pred CCCCcEEEccCC-ccccc-CchhccCCccCCEEEccCCcCCCCCCcCC----cCCCCcceeecccccccCCCC-----cc
Q 038466 125 FPNLVKLTIQFF-ALTGS-IPPEISALSKLQLLDLSSNGLTGTIPPEI----GNLKNLIELNVGSNSLIGPIP-----SA 193 (572)
Q Consensus 125 l~~L~~L~l~~n-~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~----~~l~~L~~L~Ls~N~l~g~ip-----~~ 193 (572)
+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|++|++++|. +.++ ..
T Consensus 129 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~--~~~~~~~l~~l 206 (594)
T 2p1m_B 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA--SEVSFSALERL 206 (594)
T ss_dssp CTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC--SCCCHHHHHHH
T ss_pred CCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC--CcCCHHHHHHH
Confidence 444555555444 22221 22223344455555555554443322222 133445555555443 1111 11
Q ss_pred ccCCCccCeeEeccCcCCCCCchhhhhccccCccccC
Q 038466 194 LGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLS 230 (572)
Q Consensus 194 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls 230 (572)
+.++++|+.|++++|...+.+|..+..+++|+.|+++
T Consensus 207 ~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG 243 (594)
T ss_dssp HHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECS
T ss_pred HHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccc
Confidence 2233455555555442211244444445555555433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.8e-06 Score=89.02 Aligned_cols=113 Identities=19% Similarity=0.179 Sum_probs=70.3
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCc--CCCCcceeeccc--ccccCC-----CCc
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIG--NLKNLIELNVGS--NSLIGP-----IPS 192 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~--~l~~L~~L~Ls~--N~l~g~-----ip~ 192 (572)
+..+|+|+.|+|++|.- -.+|+ +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...|. +..
T Consensus 168 l~~~P~L~~L~L~g~~~-l~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~ 244 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNN-LSIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244 (362)
T ss_dssp HHTCTTCCEEEEECCBT-CBCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred HhcCCCCcEEEEeCCCC-ceecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence 45678888888877631 12333 33 77888888888776543333333 578888888753 222221 111
Q ss_pred cc--cCCCccCeeEeccCcCCCCCchhhh---hccccCccccCCCcccCC
Q 038466 193 AL--GSLTNLSNLDLSSNKLSGKIPPEIA---GMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 193 ~~--~~l~~L~~L~ls~N~l~g~~p~~~~---~l~~L~~L~ls~N~l~g~ 237 (572)
.+ ..+++|+.|+|.+|.+....+..+. .+++|+.|+|+.|.+.+.
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 22 2467888888888877654444443 467888888888887663
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=8.9e-05 Score=72.18 Aligned_cols=107 Identities=12% Similarity=0.033 Sum_probs=80.2
Q ss_pred ccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
+.+....+.++.+.||+.... |+.+++|......... ...+.+|+++++.+. |.++.++++++.+.+..|+||||
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 444555666778899999865 6789999987532111 135778999999885 67788999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 425 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~ 425 (572)
++|.++.+.+... .....++.++++.++.||+
T Consensus 92 i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 92 ADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp CSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHH
T ss_pred cCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhC
Confidence 9999987653211 1234678899999999997
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=9.3e-06 Score=83.60 Aligned_cols=111 Identities=22% Similarity=0.264 Sum_probs=61.2
Q ss_pred CCCCcEEEccCCcccccCchhcc--CCccCCEEEccC--CcCCCC-----CCcCC--cCCCCcceeecccccccCCCCcc
Q 038466 125 FPNLVKLTIQFFALTGSIPPEIS--ALSKLQLLDLSS--NGLTGT-----IPPEI--GNLKNLIELNVGSNSLIGPIPSA 193 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~--~l~~L~~L~Ls~--N~l~g~-----ip~~~--~~l~~L~~L~Ls~N~l~g~ip~~ 193 (572)
+++|+.|+|..+.+.......+. .+++|+.|+|+. |...|. +...+ +.+++|++|+|.+|.+....+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 56777777776665543333333 567777777643 221111 11112 24567777777777665433333
Q ss_pred cc---CCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCccc
Q 038466 194 LG---SLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 194 ~~---~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+. .+++|+.|+|+.|.+++. ++..+..+++|+.|++++|.++
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 32 456777777777776642 3333445667777777766654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.56 E-value=1e-05 Score=75.00 Aligned_cols=90 Identities=19% Similarity=0.211 Sum_probs=71.5
Q ss_pred cCCCCCCcEEEccCCcccc----cCchhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeec--ccccccCC--
Q 038466 122 FSCFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNV--GSNSLIGP-- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~L--s~N~l~g~-- 189 (572)
+...++|+.|+|++|.+.. .+...+...++|++|+|++|.++.. +...+...++|++|+| ++|.+...
T Consensus 61 L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~ 140 (185)
T 1io0_A 61 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 140 (185)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHH
Confidence 5567899999999999874 2345566778999999999999853 4556677789999999 88988654
Q ss_pred --CCccccCCCccCeeEeccCcCC
Q 038466 190 --IPSALGSLTNLSNLDLSSNKLS 211 (572)
Q Consensus 190 --ip~~~~~l~~L~~L~ls~N~l~ 211 (572)
+...+...++|+.|+|++|.+.
T Consensus 141 ~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 141 MEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCcCEEeccCCCCC
Confidence 3445666799999999999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00038 Score=67.20 Aligned_cols=95 Identities=17% Similarity=0.175 Sum_probs=71.9
Q ss_pred ccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCc--ccEEEEEEeCCeEEEEEecccCCChh
Q 038466 315 YDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI--VKLYGFCLHRKCMFLIYEYMKRGSLF 392 (572)
Q Consensus 315 ~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~Ey~~~GsL~ 392 (572)
.|..+.||+....+|+.+++|...... ...+.+|+++++.+.+.++ .+++++...++..++||||++|.++.
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 444689999988888889999976542 1356789999999876554 45899888888899999999998884
Q ss_pred hhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 393 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 393 ~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
... .+ ...++.++++.++.||+-
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTS
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCC
Confidence 211 11 235788899999999963
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00028 Score=73.63 Aligned_cols=108 Identities=16% Similarity=0.149 Sum_probs=57.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeeccccccc-----CCCCcccc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLI-----GPIPSALG 195 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~-----g~ip~~~~ 195 (572)
.|.++++|+.+++..| +...-...|.+ ++|+.++| .|.++..-+..|.++++|+.+++.+|.+. ..-+..|.
T Consensus 221 aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~ 297 (401)
T 4fdw_A 221 AFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLE 297 (401)
T ss_dssp TTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTT
T ss_pred HhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhh
Confidence 4777777888877654 33222333444 56666666 33344333445566666666666655443 12334556
Q ss_pred CCCccCeeEeccCcCCCCCchhhhhccccCccccCCC
Q 038466 196 SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 196 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N 232 (572)
+|++|+.++|.+ .++..-...|.++.+|+.+++..|
T Consensus 298 ~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 298 GCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp TCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence 666666666652 344333344555566666665433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00028 Score=73.63 Aligned_cols=111 Identities=9% Similarity=0.078 Sum_probs=87.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCC-----CCCCcCCcCCCCcceeecccccccCCCCcccc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLT-----GTIPPEIGNLKNLIELNVGSNSLIGPIPSALG 195 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~-----g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 195 (572)
.|.+ .+|+.+++. +++...-+..|.++++|+.+++.+|.+. ..-+..|.++++|+.++|. |++...-...|.
T Consensus 244 aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~ 320 (401)
T 4fdw_A 244 AFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLG 320 (401)
T ss_dssp TTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTT
T ss_pred cccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhc
Confidence 3555 689999994 5566555678999999999999998875 3445678899999999998 457665667899
Q ss_pred CCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 196 SLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 196 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
+|++|+.++|..| ++..-+..|.++ +|+.+++++|.+.-
T Consensus 321 ~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 321 GNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp TCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred CCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 9999999999665 654446678888 99999999997654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.36 E-value=3.9e-05 Score=70.07 Aligned_cols=83 Identities=16% Similarity=0.120 Sum_probs=50.4
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCc-CCCCCCcCCcCC----CCcceeeccccc-ccCCCCccccCCCcc
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNG-LTGTIPPEIGNL----KNLIELNVGSNS-LIGPIPSALGSLTNL 200 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l----~~L~~L~Ls~N~-l~g~ip~~~~~l~~L 200 (572)
+|+.||++++.++..--..+.++++|+.|+|++|. ++..--..+..+ ++|++|+|++|. ++..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57788888777664433456777778888887774 553222234443 357777777764 432222345667777
Q ss_pred CeeEeccCc
Q 038466 201 SNLDLSSNK 209 (572)
Q Consensus 201 ~~L~ls~N~ 209 (572)
+.|+++++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.24 E-value=5.7e-05 Score=68.98 Aligned_cols=83 Identities=16% Similarity=0.183 Sum_probs=48.2
Q ss_pred cCCEEEccCCcCCCCCCcCCcCCCCcceeeccccc-ccCCCCccccCC----CccCeeEeccCc-CCCCCchhhhhcccc
Q 038466 151 KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS-LIGPIPSALGSL----TNLSNLDLSSNK-LSGKIPPEIAGMKNL 224 (572)
Q Consensus 151 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~l~~L 224 (572)
+|+.|||+++.++..--..+.++++|+.|+|++|. ++..-=..++.+ ++|+.|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57777777777664434445667777777777764 332211234433 357777777764 553323345566777
Q ss_pred CccccCCCc
Q 038466 225 TWLDLSNNN 233 (572)
Q Consensus 225 ~~L~ls~N~ 233 (572)
++|+++++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.001 Score=67.88 Aligned_cols=109 Identities=17% Similarity=0.273 Sum_probs=77.6
Q ss_pred cccccccCeeEEEEEEcCCCcEEEEEecC--CcchHHHHHHHHHHHHHHHHHhcC--CCCcccEEEEEEeC---CeEEEE
Q 038466 310 FSIWNYDGYGSVYKAQLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHR---KCMFLI 382 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~--~~~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV 382 (572)
...++.|.++.||+....+ ..+++|+.. ...... ....+.+|.++++.+. +..+.++++++.+. +..|+|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3456778899999998765 467888776 332111 1246778999999987 45678999998776 458999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
|||++|..+.+... ..++..++..++.++++.|+.||.-
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999988753211 2366778888999999999999974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0036 Score=54.08 Aligned_cols=35 Identities=29% Similarity=0.333 Sum_probs=15.8
Q ss_pred cCCEEEccCCcCCCCCCcCCcCCCCcceeeccccc
Q 038466 151 KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNS 185 (572)
Q Consensus 151 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~ 185 (572)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 34455555555543333334444444444444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0054 Score=52.97 Aligned_cols=57 Identities=28% Similarity=0.413 Sum_probs=44.0
Q ss_pred CEEEccCCcCC-CCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCC
Q 038466 153 QLLDLSSNGLT-GTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS 211 (572)
Q Consensus 153 ~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~ 211 (572)
..+|.+++.++ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47788888886 35665442 36888999999988776777888888988988888775
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0071 Score=62.49 Aligned_cols=111 Identities=11% Similarity=0.139 Sum_probs=82.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+.+|+.+.+..+.. ..-...+.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.+|++|
T Consensus 260 aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 488889999999875533 2334567889999999996 4555444556889999999999765 554445789999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
+.+.+..+ ++..-...|.++.+|+.+++.+|...
T Consensus 337 ~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 337 ERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 99999765 55333567888999999999887643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0009 Score=62.16 Aligned_cols=112 Identities=13% Similarity=0.127 Sum_probs=65.2
Q ss_pred cCCCCCCcEEEccCC-cccc----cCchhccCCccCCEEEccCCcCCCCCCcC----CcCCCCcceeecccccccCC---
Q 038466 122 FSCFPNLVKLTIQFF-ALTG----SIPPEISALSKLQLLDLSSNGLTGTIPPE----IGNLKNLIELNVGSNSLIGP--- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n-~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~----~~~l~~L~~L~Ls~N~l~g~--- 189 (572)
+.+-+.|+.|+|++| .+.. .+-..+..-+.|+.|+|++|.+...--.. +..=+.|++|+|+.|.+...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344567888888875 6542 23445666678888888888886332222 22335788888888877532
Q ss_pred -CCccccCCCccCeeEeccCcC---CCC----CchhhhhccccCccccCCCc
Q 038466 190 -IPSALGSLTNLSNLDLSSNKL---SGK----IPPEIAGMKNLTWLDLSNNN 233 (572)
Q Consensus 190 -ip~~~~~l~~L~~L~ls~N~l---~g~----~p~~~~~l~~L~~L~ls~N~ 233 (572)
+-..+..-+.|+.|+|++|.. ... +-..+..-+.|+.|+++.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 222344445678888875532 211 22233344566666666544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.014 Score=59.80 Aligned_cols=106 Identities=19% Similarity=0.116 Sum_probs=52.1
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+.+|+.+.+..+ +...-...+.++..|+.+.+..+ ++..-...+.++.+|+.+.+..+ +...-...|.++++|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 445555666655433 22222334555566666666544 33233334555555555555433 3222234455556666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLS 230 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls 230 (572)
.+.+.++.++..-...|.++.+|+.+++.
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cccccccccceehhhhhcCCCCCCEEEcC
Confidence 66665555543333445555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.021 Score=58.86 Aligned_cols=81 Identities=11% Similarity=0.200 Sum_probs=32.5
Q ss_pred ccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccC
Q 038466 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLT 225 (572)
Q Consensus 146 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 225 (572)
|.++.+|+.+.+..+..+ .-...|.++++|+.+.+. +.+...-...|.++.+|+.+++..+ ++..-...|.++.+|+
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence 444444554444433221 222334444445544443 2222222234444455555544432 2211123344444444
Q ss_pred cccc
Q 038466 226 WLDL 229 (572)
Q Consensus 226 ~L~l 229 (572)
.+.+
T Consensus 338 ~i~i 341 (394)
T 4gt6_A 338 RIAI 341 (394)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 4444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.013 Score=60.48 Aligned_cols=106 Identities=15% Similarity=0.108 Sum_probs=73.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+..++.+.+..+.+. ...+..+.+|+.+.+..+ ++..-...|.++.+|+.++|..+ ++..-..+|.+|++|
T Consensus 271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 4677778888777665432 235677888888888765 55444556788888888888644 544445678888888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N 232 (572)
+.+++..| ++..-...|.++.+|+.+++..|
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 88888766 55333456778888888887654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.24 E-value=0.027 Score=58.13 Aligned_cols=106 Identities=17% Similarity=0.057 Sum_probs=76.7
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+..|+.+.+..+... .-...+.++..|+.+.+..+.+. ...+.++.+|+.+.+..+ +...-...|.++++|
T Consensus 248 ~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L 322 (394)
T 4fs7_A 248 VFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL 322 (394)
T ss_dssp TTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCC
Confidence 4777888898888766432 33456788888888888776532 235778889999998755 544445678899999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N 232 (572)
+.+++..+ ++..-...|.++.+|+.+++..|
T Consensus 323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 323 VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 99998754 55333557888889999988765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=94.72 E-value=0.13 Score=51.17 Aligned_cols=93 Identities=18% Similarity=0.151 Sum_probs=68.9
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCeEEEEEeccc
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
..++.|....+|+.... +..+++|.-.... ...|..|.+.|+.+. ...+.++++++..++..++||||++
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 44677788999999874 5567788765332 245778988888874 3567889999888889999999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCC
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 427 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~ 427 (572)
+..+.. ..+.++++.|+-||+-.
T Consensus 115 G~~~~~-----------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 115 KSKNKQ-----------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCCCCT-----------------THHHHHHHHHHHHHHCC
T ss_pred CCCCCc-----------------hhHHHHHHHHHHHHcCC
Confidence 876421 13456788889999753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=94.63 E-value=0.16 Score=50.27 Aligned_cols=101 Identities=11% Similarity=-0.042 Sum_probs=72.0
Q ss_pred cccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC---CcccEEEEEE-eCCeEEEEEeccc
Q 038466 312 IWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---NIVKLYGFCL-HRKCMFLIYEYMK 387 (572)
Q Consensus 312 ~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~ 387 (572)
.++.|....||+. |..+++|.-... .....+.+|.++|+.+.+. .+-+.++++. ..+..++||||++
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred ecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 4556667789987 455778874321 1235788999999999763 2456677764 3456789999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
|.++.+.... .++..++..++.++++.++-||.-
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~ 130 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAF 130 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcC
Confidence 9888653221 245667888999999999999963
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=94.34 E-value=0.19 Score=48.44 Aligned_cols=95 Identities=20% Similarity=0.143 Sum_probs=68.3
Q ss_pred eEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCeEEEEEecccCCChhhhhh
Q 038466 319 GSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLH 396 (572)
Q Consensus 319 G~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~ 396 (572)
+.||+.... ++..+.+|+-.... ...+.+|.+.|+.+.. --+-++++++.+++..|+|||++++.++.+...
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 369988764 46678888765332 2357789988887742 235578999999999999999999988876543
Q ss_pred cCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 397 NNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 397 ~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
.. ...+..++.++++.++-||+-
T Consensus 113 ~~-------~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 113 EY-------PDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp HC-------GGGHHHHHHHHHHHHHHHHTS
T ss_pred CC-------HHHHHHHHHHHHHHHHHhcCC
Confidence 21 113445778889999999963
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.15 E-value=0.12 Score=52.66 Aligned_cols=108 Identities=14% Similarity=0.102 Sum_probs=72.6
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.|..+..|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|.++++|+.+.+.++.+...-...|.++.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 3666777888887654 44333456777888888888654 443334457778888888888777765555678888888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~ 231 (572)
+.+.|..+ ++..-...|.++.+|+.+.+..
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 88888654 4422344677777787776653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.1 Score=51.51 Aligned_cols=102 Identities=19% Similarity=0.096 Sum_probs=70.5
Q ss_pred ccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCC--cccEEEEEEeCC---eEEEEEe
Q 038466 311 SIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRN--IVKLYGFCLHRK---CMFLIYE 384 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E 384 (572)
..++.|....||+.. ..+++|..... .....+.+|+++++.+. +.. +-+++++...++ ..|+|||
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 346778888899864 34788886533 12356889999999884 333 334555443333 3589999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
|++|.++.+... ..++..++..++.++++.++.||+-
T Consensus 97 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~ 133 (304)
T 3sg8_A 97 KIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSI 133 (304)
T ss_dssp CCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred ccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcC
Confidence 999988865332 1356677889999999999999963
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.80 E-value=0.015 Score=53.88 Aligned_cols=88 Identities=10% Similarity=0.134 Sum_probs=61.9
Q ss_pred hccCCccCCEEEccCC-cCCCC----CCcCCcCCCCcceeecccccccC----CCCccccCCCccCeeEeccCcCCCC--
Q 038466 145 EISALSKLQLLDLSSN-GLTGT----IPPEIGNLKNLIELNVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGK-- 213 (572)
Q Consensus 145 ~~~~l~~L~~L~Ls~N-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~-- 213 (572)
-+.+-+.|+.|+|++| .+... +-+.+..-+.|+.|+|++|++.. .+...+..-+.|+.|+|++|.++..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3456689999999986 76531 23334555789999999999863 3334455668899999999999742
Q ss_pred --CchhhhhccccCccccCCC
Q 038466 214 --IPPEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 214 --~p~~~~~l~~L~~L~ls~N 232 (572)
+-+.+..-..|+.|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 2223344457999999865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=92.51 E-value=0.28 Score=49.40 Aligned_cols=114 Identities=11% Similarity=-0.033 Sum_probs=73.8
Q ss_pred ccc-cccCeeEEEEEEcC-------CCcEEEEEecCCcch--HHHHHHHHHHHHHHHHHhcCC---CCcccEEEEEEeC-
Q 038466 311 SIW-NYDGYGSVYKAQLP-------NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLH---RNIVKLYGFCLHR- 376 (572)
Q Consensus 311 ~~~-~~~~fG~Vyk~~~~-------~g~~vAvK~l~~~~~--~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~- 376 (572)
..+ +.|..+.+|+.... ++..+++|.-..... ... ...+.+|+++++.+.. -.+-++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 345 66778899988754 266788887654320 000 0245678888887753 2466788887665
Q ss_pred --CeEEEEEecccCCChhhhhhcC---CCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 377 --KCMFLIYEYMKRGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 377 --~~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
+..|+||||++|..+.+.+... .....++-.++..++.++++.++-||+-
T Consensus 104 ~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~ 158 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSI 158 (357)
T ss_dssp TTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTC
T ss_pred ccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 3568999999998876543110 0001245566778889999999999963
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.31 E-value=0.39 Score=49.21 Aligned_cols=104 Identities=12% Similarity=0.076 Sum_probs=59.6
Q ss_pred ccccccCeeEEEEEEcC-CCcEEEEEecCCcch--HHH--HHHHHHHHHHHHHHhcCC--CCcc-cEEEEEEeCCeEEEE
Q 038466 311 SIWNYDGYGSVYKAQLP-NGKVFALKKLHTSET--EEL--AFIKSFRNEAQVLSQVLH--RNIV-KLYGFCLHRKCMFLI 382 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~--~~~~~f~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~lV 382 (572)
..+|.|.++.||++... +++.++||....... .+. ....++..|.++++.+.+ +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 45678889999999764 467899998653221 000 012346678888887743 3444 55554 44556899
Q ss_pred EecccCCCh-hhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh
Q 038466 383 YEYMKRGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 424 (572)
Q Consensus 383 ~Ey~~~GsL-~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH 424 (572)
|||+++... ...+..... .. ..+..+++.++-+|
T Consensus 114 mE~l~g~~~~~~~l~~~~~--~~------~~~~~l~~~La~lH 148 (397)
T 2olc_A 114 MEDLSHLKIARKGLIEGEN--YP------HLSQHIGEFLGKTL 148 (397)
T ss_dssp ECCCTTSEEHHHHHHTTCC--CT------THHHHHHHHHHHHH
T ss_pred EEeCCCcchHHHHHhcCCc--CH------HHHHHHHHHHHHHh
Confidence 999986433 222222111 11 13456677777777
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=90.18 E-value=0.58 Score=45.57 Aligned_cols=95 Identities=18% Similarity=0.174 Sum_probs=62.2
Q ss_pred cccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCC---CcccEEEEEEeCCeEEEEEecc
Q 038466 310 FSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---NIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
...+|.|..+.||+.++.||+.|.+|+-....... ...|..|++.|+.+.-. -+.+++++. . -++||||+
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~l 92 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEWV 92 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEECC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEee
Confidence 34567788999999999999999999865433211 12467899888887432 244555542 2 37899999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 428 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~ 428 (572)
+++... .. .+.++.+.++-+|....
T Consensus 93 ~~~~~~-------------~~----~~~~lg~~La~lH~~~~ 117 (288)
T 3f7w_A 93 DERPPT-------------PE----AAERFGHQLAAMHLAGA 117 (288)
T ss_dssp CCCCCC-------------HH----HHHHHHHHHHHHHHTCC
T ss_pred cccCCC-------------hH----HHHHHHHHHHhhhhccc
Confidence 876431 11 12345677788886543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.07 E-value=0.073 Score=56.27 Aligned_cols=58 Identities=14% Similarity=0.122 Sum_probs=15.6
Q ss_pred CeeEEEEEEcCC-CcEEEE------EecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe
Q 038466 317 GYGSVYKAQLPN-GKVFAL------KKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375 (572)
Q Consensus 317 ~fG~Vyk~~~~~-g~~vAv------K~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 375 (572)
|||.||+|.+.. ...||| |..+...... +..+.|.+|..+++..+|||+++.++|...
T Consensus 151 GfG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 151 GYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp SBCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred CchhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEEe
Confidence 399999998764 467888 7665433222 234578899999999999999999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=83.46 E-value=3.2 Score=38.73 Aligned_cols=92 Identities=16% Similarity=0.081 Sum_probs=47.3
Q ss_pred CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHH-hcCCC-CCc-----eeeCCCCCC----ccccccccCcccccccc
Q 038466 389 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL-HHDCS-PSI-----ASTCPDSSN----RTLLAGTYGYIAPELAY 457 (572)
Q Consensus 389 GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yL-H~~~~-~~i-----~~~~~~~~~----~~~~~gt~~y~APE~~~ 457 (572)
-||.+.|...+. ++...+...++.|.+++|.=+ ++... +.+ ++...++.. .........+.|||...
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~~~~~~~~~pe~~~ 110 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGY 110 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC------------CCSS
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccccccccccCCCChhhcc
Confidence 367888876543 577777777888888776654 21111 111 111111100 00001223466888763
Q ss_pred CCCcCcccchHHHHHHHHHHHc-CCCC
Q 038466 458 TMVMTEKCDVYSFGVVTLEVLM-GKHP 483 (572)
Q Consensus 458 ~~~~s~ksDVySfGvvl~Ellt-G~~P 483 (572)
...+.+.=|||+|+++|.-+- |-++
T Consensus 111 -~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 111 -SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 345788899999999999884 4444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 572 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-43
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 41/268 (15%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G+VYK + A+K L+ + +++F+NE VL + H NI+ G+
Sbjct: 20 SFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 75
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPS 430
+ ++ ++ + SL+ +LH E + + K ++I + A + YLH D +
Sbjct: 76 PQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 431 -------------------IASTCPDSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVY 468
+ S S L+G+ ++APE+ + + DVY
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 469 SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISF 528
+FG+V E++ G+ P S+ ++ ++ V L P + + +
Sbjct: 194 AFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247
Query: 529 ACLQSNPKSRPTMQYVSQEF-LITRKTP 555
CL+ RP + L+ R P
Sbjct: 248 ECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-43
Identities = 47/257 (18%), Positives = 93/257 (36%), Gaps = 42/257 (16%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ A+K L +F EA ++ Q+ H+ +V+LY
Sbjct: 25 QFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----------- 425
+++I EYM+ GSL L ++L K +++ +A +A++
Sbjct: 81 P-IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 426 -------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
D + + + R + APE T K DV+SFG+
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIRDILLASTISFACL 531
+ E++ ++P+++ R+ P + + + ++ C
Sbjct: 199 LLTEIVTHGRIPY-----PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR------LCW 247
Query: 532 QSNPKSRPTMQYVSQEF 548
+ P+ RPT Y+
Sbjct: 248 KERPEDRPTFDYLRSVL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 6e-42
Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 45/285 (15%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G+VY A+ + N +V A+KK+ S + + E + L ++ H N ++ G L
Sbjct: 27 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSP 429
+L+ EY + + + L + + LAYLH D
Sbjct: 87 EHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 430 S-----------IA--STCPDSSNRTLLAGTYGYIAPELAYTMVM---TEKCDVYSFGVV 473
+ + + GT ++APE+ M K DV+S G+
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 474 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISFAC 530
+E+ K P + + L + P R+ + +C
Sbjct: 204 CIELAERKPPLF-------NMNAMSALYHIAQNESPALQSGHWSEYFRNFVD------SC 250
Query: 531 LQSNPKSRPTMQYVSQ-EFLITRKTPLVKHAAIQDI--SISELRN 572
LQ P+ RPT + + + F++ + P V IQ ++ EL N
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 310 FSIWNYD--------GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 360
+++ +++ +G+VY A+ + + ALK L ++ E+ R E ++ S
Sbjct: 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 361 VLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 420
+ H NI++LYG+ ++LI EY G+++ L + D + + +A+AL
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANAL 119
Query: 421 AYLH-----------------HDCSPSIA----STCPDSSNRTLLAGTYGYIAPELAYTM 459
+Y H IA S SS RT L GT Y+ PE+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519
+ EK D++S GV+ E L+GK P + +++ I ++ P V RD
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFTFPDFVTEGA-RD 233
Query: 520 ILLASTISFACLQSNPKSRPTMQ 542
++ L+ NP RP ++
Sbjct: 234 LIS------RLLKHNPSQRPMLR 250
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 64/283 (22%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G V+K P+G V A K +H E QVL + IV YG
Sbjct: 18 NGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCS 428
+ + E+M GSL L + + A+ L YL D
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 429 PS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
PS ++ DS + GT Y++PE + + D++S G+
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 473 VTLEVLMGKHP-------------------------------RDLLSSLSSSSDPKIMLI 501
+E+ +G++P LSS S P + +
Sbjct: 192 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251
Query: 502 DVLDQRL--PPPVDRKVIRDILLASTISFACLQSNPKSRPTMQ 542
++LD + PPP + + ++ CL NP R ++
Sbjct: 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERADLK 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-40
Identities = 47/262 (17%), Positives = 86/262 (32%), Gaps = 48/262 (18%)
Query: 317 GYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+G+V K K A+K L + A EA V+ Q+ + IV++ G C
Sbjct: 19 NFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGIC 77
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC------ 427
+ L+ E + G L L N + + +V ++ + YL
Sbjct: 78 -EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 428 --------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
S ++ + +T + APE + K DV
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 468 YSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLAST 525
+SFGV+ E G+ P ++ + +R+ P + + D++
Sbjct: 194 WSFGVLMWEAFSYGQKP------YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN--- 244
Query: 526 ISFACLQSNPKSRPTMQYVSQE 547
C + ++RP V
Sbjct: 245 ---LCWTYDVENRPGFAAVELR 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-40
Identities = 49/258 (18%), Positives = 89/258 (34%), Gaps = 42/258 (16%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V + A+K + E F EA+V+ + H +V+LYG C +
Sbjct: 16 QFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----------- 425
+ +F+I EYM G L L + + + K + A+ YL
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 129
Query: 426 -------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
D S + ++ + PE+ + K D+++FGV
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 473 VTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACL 531
+ E+ +GK P + ++ + + Q L + TI ++C
Sbjct: 190 LMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHLASEKVY---TIMYSCW 238
Query: 532 QSNPKSRPTMQYVSQEFL 549
RPT + + L
Sbjct: 239 HEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 6e-40
Identities = 47/254 (18%), Positives = 89/254 (35%), Gaps = 40/254 (15%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V G A+K + T + +F EA V++Q+ H N+V+L G +
Sbjct: 19 EFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGVIVEE 72
Query: 377 K-CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
K ++++ EYM +GSL L + +V L + + A+ YL D +
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131
Query: 430 S--------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475
T SS + + APE + K DV+SFG++
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 191
Query: 476 EVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIRDILLASTISFACLQSN 534
E+ ++ ++ P + +++ C +
Sbjct: 192 EIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK------NCWHLD 240
Query: 535 PKSRPTMQYVSQEF 548
RP+ + ++
Sbjct: 241 AAMRPSFLQLREQL 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 47/257 (18%), Positives = 90/257 (35%), Gaps = 42/257 (16%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ N A+K + E + F EA+V+ ++ H +V+LYG CL +
Sbjct: 17 QFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----------- 425
+ L++E+M+ G L + + + + +AYL
Sbjct: 73 APICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130
Query: 426 -------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
D + ++ T + +PE+ + K DV+SFGV
Sbjct: 131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIRDILLASTISFACL 531
+ EV + S+ +++ RL P + I+ C
Sbjct: 191 LMWEVFSEGKI-----PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN------HCW 239
Query: 532 QSNPKSRPTMQYVSQEF 548
+ P+ RP + ++
Sbjct: 240 KERPEDRPAFSRLLRQL 256
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-39
Identities = 55/277 (19%), Positives = 107/277 (38%), Gaps = 52/277 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G+VY A + G+ A+++++ + + + NE V+ + + NIV L
Sbjct: 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
++++ EY+ GSL + D + + + AL +LH D
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 430 S-----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
A P+ S R+ + GT ++APE+ K D++S G+
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISFA 529
+ +E++ G+ P + + + + + + K+ RD L
Sbjct: 205 MAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN------R 252
Query: 530 CLQSNPKSRPTMQYVSQ-EFLITRK-----TPLVKHA 560
CL + + R + + + Q +FL K TPL+ A
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-39
Identities = 46/262 (17%), Positives = 87/262 (33%), Gaps = 48/262 (18%)
Query: 317 GYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+GSV + A+K L + + EAQ++ Q+ + IV+L G C
Sbjct: 21 NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVC 78
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DC 427
+ + L+ E G L L + E+ + ++ ++ + YL D
Sbjct: 79 -QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 428 SPS--------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
+ + + + R+ + APE + + DV
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 468 YSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLAST 525
+S+GV E L G+ P P++M +R+ P + + ++
Sbjct: 196 WSYGVTMWEALSYGQKPYK------KMKGPEVMAFIEQGKRMECPPECPPELYALMS--- 246
Query: 526 ISFACLQSNPKSRPTMQYVSQE 547
C + RP V Q
Sbjct: 247 ---DCWIYKWEDRPDFLTVEQR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-38
Identities = 53/255 (20%), Positives = 95/255 (37%), Gaps = 43/255 (16%)
Query: 317 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL- 374
+ +VYK A +L + + + + F+ EA++L + H NIV+ Y
Sbjct: 21 SFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWES 79
Query: 375 ---HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 431
+KC+ L+ E M G+L L + + + + + L +LH P I
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPII 136
Query: 432 ------------------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 467
+T +S + GT ++APE+ Y E DV
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM-YEEKYDESVDV 195
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
Y+FG+ LE+ ++P S + + V P D+ I + I
Sbjct: 196 YAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAIPE---VKEII 246
Query: 528 FACLQSNPKSRPTMQ 542
C++ N R +++
Sbjct: 247 EGCIRQNKDERYSIK 261
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-38
Identities = 52/282 (18%), Positives = 89/282 (31%), Gaps = 64/282 (22%)
Query: 317 GYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKL 369
+G V +A A+K L S ++ +E +VLS + H NIV L
Sbjct: 35 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNL 92
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNN---------------EDAVELDWAKRVNIVK 414
G C +I EY G L L +D + LD ++
Sbjct: 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 415 AMAHALAYLHH------DCSPS----------------IASTCPDSSNRTL---LAGTYG 449
+A +A+L D + +A + SN +
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212
Query: 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509
++APE + V T + DV+S+G+ E+ ++ +
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKFYKMIKEGFR 266
Query: 510 PPVDRKV---IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ DI+ C ++P RPT + + Q
Sbjct: 267 MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLI 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 50/260 (19%), Positives = 92/260 (35%), Gaps = 48/260 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG K + +GK+ K+L E A + +E +L ++ H NIV+ Y +
Sbjct: 16 SYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIID 74
Query: 376 R--KCMFLIYEYMKRGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHALAYLHH------- 425
R ++++ EY + G L + + LD + ++ + AL H
Sbjct: 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134
Query: 426 ----DCSPS----------------IASTC-PDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
D P+ +A D+S GT Y++PE M EK
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 194
Query: 465 CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR--KVIRDILL 522
D++S G + E+ P + K + + + + R + +I+
Sbjct: 195 SDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIPYRYSDELNEIIT 247
Query: 523 ASTISFACLQSNPKSRPTMQ 542
L RP+++
Sbjct: 248 ------RMLNLKDYHRPSVE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 49/259 (18%), Positives = 93/259 (35%), Gaps = 46/259 (17%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V+ A+K L ++F EAQV+ ++ H +V+LY
Sbjct: 29 CFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVV-SE 83
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----------- 425
+ ++++ EYM +GSL + E L + V++ +A +AY+
Sbjct: 84 EPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142
Query: 426 -------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
D + + + R + APE A T K DV+SFG+
Sbjct: 143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 202
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISFA 529
+ E+ ++D +++ P + + D++
Sbjct: 203 LLTELTTKGRVPY-------PGMVNREVLDQVERGYRMPCPPECPESLHDLMC------Q 249
Query: 530 CLQSNPKSRPTMQYVSQEF 548
C + P+ RPT +Y+
Sbjct: 250 CWRKEPEERPTFEYLQAFL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 54/256 (21%), Positives = 87/256 (33%), Gaps = 47/256 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG V A + A+K + + ++ + E + + H N+VK YG
Sbjct: 17 AYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
+L EY G LF + + + + + YLH D P
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 131
Query: 430 S----------------IASTCPDSSNRTLL---AGTYGYIAPELAYTM-VMTEKCDVYS 469
+A+ ++ LL GT Y+APEL E DV+S
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191
Query: 470 FGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTI 526
G+V +L G+ P D SD D +++ +K+ +L
Sbjct: 192 CGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---- 241
Query: 527 SFACLQSNPKSRPTMQ 542
L NP +R T+
Sbjct: 242 --KILVENPSARITIP 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 7e-37
Identities = 42/254 (16%), Positives = 88/254 (34%), Gaps = 44/254 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V++ G+VF K ++T + + +NE +++Q+ H ++ L+
Sbjct: 41 AFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFED 97
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH----------- 424
+ M LI E++ G LF + + ++ A+ +N ++ L ++H
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 425 -------------HDCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
+A+ + T + APE+ + D+++ G
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 215
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISF 528
V+ +L G P + + D V +D +
Sbjct: 216 VLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK------ 264
Query: 529 ACLQSNPKSRPTMQ 542
LQ P+ R T+
Sbjct: 265 NLLQKEPRKRLTVH 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 48/281 (17%), Positives = 95/281 (33%), Gaps = 51/281 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCL 374
+G V+ A+ + FA+K L ++ E +VLS H + ++
Sbjct: 14 SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCS 428
++ +F + EY+ G L ++ + + D ++ + L +L + D
Sbjct: 74 TKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 130
Query: 429 PSI-----------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
+ GT YIAPE+ D +SFG
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG 190
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACL 531
V+ E+L+G+ P + ++ +D P K +D+L+
Sbjct: 191 VLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLV------KLF 238
Query: 532 QSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISISELRN 572
P+ R ++ + +H ++I+ EL
Sbjct: 239 VREPEKRLGVR---GDIR--------QHPLFREINWEELER 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 45/283 (15%), Positives = 87/283 (30%), Gaps = 49/283 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+ +V A+ L + +A+K L + + E V+S++ H VKLY
Sbjct: 20 SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
+ ++ Y K G L + D + AL YLH D P
Sbjct: 80 DEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136
Query: 430 S----------------IASTCPDSSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSF 470
A S + GT Y++PEL + D+++
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLASTISFA 529
G + +++ G P + + ++ ++ P RD++
Sbjct: 197 GCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFPEKFFPKARDLVE------K 243
Query: 530 CLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISISELRN 572
L + R + + + H + ++ L
Sbjct: 244 LLVLDATKRLGCEEMEGYGPL------KAHPFFESVTWENLHQ 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (339), Expect = 2e-36
Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 51/269 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G V+ A+ L + A+K L + +F FR EAQ + + H IV +Y
Sbjct: 19 GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78
Query: 376 R----KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------ 425
+++ EY+ +L +H + + + ++ AL + H
Sbjct: 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIHR 135
Query: 426 DCSPS--------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P+ IA + + + GT Y++PE A + +
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI----RDIL 521
DVYS G V EVL G+ P + S + V + +PP + + ++
Sbjct: 196 DVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 249
Query: 522 LASTISFACLQSNPKSRP-TMQYVSQEFL 549
L L NP++R T + + +
Sbjct: 250 L------KALAKNPENRYQTAAEMRADLV 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-36
Identities = 50/265 (18%), Positives = 86/265 (32%), Gaps = 46/265 (17%)
Query: 317 GYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G V + + A+K L + + F E + + HRN+++LYG
Sbjct: 20 SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 79
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC----- 427
L M ++ E GSL L ++ L R +A + YL
Sbjct: 80 VLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHRD 136
Query: 428 ---------------------SPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCD 466
++ + + + APE T + D
Sbjct: 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 196
Query: 467 VYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLAS 524
+ FGV E+ G+ P + + ID +RLP P D + I ++++
Sbjct: 197 TWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV-- 249
Query: 525 TISFACLQSNPKSRPTMQYVSQEFL 549
C P+ RPT + L
Sbjct: 250 ----QCWAHKPEDRPTFVALRDFLL 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 5e-36
Identities = 55/273 (20%), Positives = 94/273 (34%), Gaps = 45/273 (16%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG VY+ A+K L E ++ F EA V+ ++ H N+V+L G C
Sbjct: 29 QYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---------- 425
++I E+M G+L L E+ + + ++ A+ YL
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 143
Query: 426 --------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
D S T + + APE + K DV++FG
Sbjct: 144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACL 531
V+ E+ LS + ++L++ + + AC
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVY---ELMRACW 253
Query: 532 QSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQD 564
Q NP RP+ + Q F + + ++I D
Sbjct: 254 QWNPSDRPSFAEIHQAF-----ETMFQESSISD 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (341), Expect = 6e-36
Identities = 50/254 (19%), Positives = 92/254 (36%), Gaps = 44/254 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V++ G FA K + T + ++ R E Q +S + H +V L+
Sbjct: 38 AFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFED 94
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
M +IYE+M G LF + + + + + V ++ + L ++H D P
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 152
Query: 430 SIASTCPDSSNRTLLA------------------GTYGYIAPELAYTMVMTEKCDVYSFG 471
SN L GT + APE+A + D++S G
Sbjct: 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 212
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISF 528
V++ +L G P + D + + D + + +D +
Sbjct: 213 VLSYILLSGLSPFG-----GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR------ 261
Query: 529 ACLQSNPKSRPTMQ 542
L ++P +R T+
Sbjct: 262 KLLLADPNTRMTIH 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 53/259 (20%), Positives = 92/259 (35%), Gaps = 51/259 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G VYKAQ + A K + T EE ++ + E +L+ H NIVKL +
Sbjct: 24 AFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYY 80
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
++++ E+ G++ + E L ++ + K AL YLH D
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 138
Query: 430 S----------------IASTCPDS-SNRTLLAGTYGYIAPELAYTMVM-----TEKCDV 467
+++ + R GT ++APE+ K DV
Sbjct: 139 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 198
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI----RDILLA 523
+S G+ +E+ + P +P +L+ + P +D L
Sbjct: 199 WSLGITLIEMAEIEPPHH-------ELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK- 250
Query: 524 STISFACLQSNPKSRPTMQ 542
CL+ N +R T
Sbjct: 251 -----KCLEKNVDARWTTS 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 53/272 (19%)
Query: 317 GYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGF 372
+G V KA++ A+K++ +++ + F E +VL ++ H NI+ L G
Sbjct: 22 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNIINLLGA 79
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHN-------------NEDAVELDWAKRVNIVKAMAHA 419
C HR ++L EY G+L L N A L + ++ +A
Sbjct: 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 139
Query: 420 LAYL------HHDCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAY 457
+ YL H D + ++ +T+ ++A E
Sbjct: 140 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199
Query: 458 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-KV 516
V T DV+S+GV+ E++ + ++ RL P++
Sbjct: 200 YSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQGYRLEKPLNCDDE 254
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ D++ C + P RP+ +
Sbjct: 255 VYDLMR------QCWREKPYERPSFAQILVSL 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 3e-35
Identities = 48/255 (18%), Positives = 84/255 (32%), Gaps = 45/255 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+ V A+ K+ A+K + E S NE VL ++ H NIV L
Sbjct: 21 AFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP 429
++LI + + G LF + ++ + A+ YL H D P
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 135
Query: 430 S-------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSF 470
++ S + GT GY+APE+ ++ D +S
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTIS 527
GV+ +L G P + I + P + +D +
Sbjct: 196 GVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR----- 245
Query: 528 FACLQSNPKSRPTMQ 542
++ +P+ R T +
Sbjct: 246 -HLMEKDPEKRFTCE 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 53/277 (19%), Positives = 101/277 (36%), Gaps = 45/277 (16%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V++ + K + K + T++ + E +L+ HRNI+ L+
Sbjct: 17 EFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFES 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSP 429
+ + +I+E++ +F ++ + A EL+ + V+ V + AL +LH D P
Sbjct: 73 MEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 430 S------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
A N LL Y APE+ V++ D++S G
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 472 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISF 528
+ +L G +P + ++ I I + +++ D +
Sbjct: 191 TLVYVLLSGINPFL-----AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD------ 239
Query: 529 ACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDI 565
L KSR T Q + +K V I+ +
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 2e-34
Identities = 56/266 (21%), Positives = 99/266 (37%), Gaps = 50/266 (18%)
Query: 317 GYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G V L A+K L + TE+ + F +EA ++ Q H N++ L G
Sbjct: 38 EFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGV 95
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHD 426
+ +I E+M+ GSL L N+ + + V +++ +A + YL H D
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNYVHRD 153
Query: 427 CSPS----------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
+ ++ P ++ + APE T
Sbjct: 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213
Query: 465 CDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILL 522
DV+S+G+V EV+ G+ P ++ ++ D RLPPP+D + ++L
Sbjct: 214 SDVWSYGIVMWEVMSYGERP------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML 267
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEF 548
C Q + RP +
Sbjct: 268 ------DCWQKDRNHRPKFGQIVNTL 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-34
Identities = 52/263 (19%), Positives = 83/263 (31%), Gaps = 45/263 (17%)
Query: 317 GYGSVYKAQLPNG-----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G VYK L A+K L TE+ F EA ++ Q H NI++L G
Sbjct: 19 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEG 76
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HH 425
K M +I EYM+ G+ + E E + V +++ +A + YL H
Sbjct: 77 VISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 134
Query: 426 DCSPS--------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D + + + + + APE T
Sbjct: 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525
DV+SFG+V EV+ ++ ++ P I
Sbjct: 195 DVWSFGIVMWEVMTYGERPY-------WELSNHEVMKAINDGFRLPTPMDCPSAIY---Q 244
Query: 526 ISFACLQSNPKSRPTMQYVSQEF 548
+ C Q RP +
Sbjct: 245 LMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 48/276 (17%), Positives = 87/276 (31%), Gaps = 48/276 (17%)
Query: 317 GYGSVYKAQLPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G VY L + A+K L+ + F E ++ H N++ L G
Sbjct: 39 HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGI 96
Query: 373 CLHRK-CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------ 425
CL + ++ YMK G L + + +A + +L
Sbjct: 97 CLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154
Query: 426 -----------DCSPSIA----------STCPDSSNRTLLAGTYGYIAPELAYTMVMTEK 464
+ +A N+T ++A E T T K
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 465 CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIRDILLA 523
DV+SFGV+ E++ P + I + + +RL P + +++L
Sbjct: 215 SDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML- 268
Query: 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559
C + RP+ + T + +H
Sbjct: 269 -----KCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 9e-34
Identities = 57/308 (18%), Positives = 105/308 (34%), Gaps = 70/308 (22%)
Query: 297 PKLE--ERATNNIDVFSIWNYDGYGSVYKAQLPN------GKVFALKKLHTSETEELAFI 348
PKL E NNI+ +G V++A+ P + A+K L + +
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQ 60
Query: 349 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNN---------- 398
F+ EA ++++ + NIVKL G C K M L++EYM G L L +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 399 -----------EDAVELDWAKRVNIVKAMAHALAYLHH------DCSPS----------- 430
L A+++ I + +A +AYL D +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180
Query: 431 -----IASTCPDSSNRTLL---AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 482
++ + A ++ PE + T + DV+++GVV E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 483 PRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR--KVIRDILLASTISFACLQSNPKSRPT 540
+ ++ V D + + + +++ C P RP+
Sbjct: 241 QPY------YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPS 288
Query: 541 MQYVSQEF 548
+ +
Sbjct: 289 FCSIHRIL 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-33
Identities = 49/287 (17%), Positives = 90/287 (31%), Gaps = 64/287 (22%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
+G V++ + G+ A+K + E E + H NI+
Sbjct: 15 RFGEVWRGKW-RGEEVAVKIFSSREERSWFR----EAEIYQTVMLRHENILGFIAADNKD 69
Query: 377 ----KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC----- 427
++L+ +Y + GSLF L+ + + + + A LA+LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 428 SPSIASTCPDSSN------------------------------RTLLAGTYGYIAPELAY 457
P+IA S N GT Y+APE+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 458 TMVM------TEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDPKIMLIDV 503
+ ++ D+Y+ G+V E+ + S + M V
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 504 LDQRLPPPVDRKVIRDILLASTISFA--CLQSNPKSRPTMQYVSQEF 548
+Q+L P + + L C +N +R T + +
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 46/285 (16%), Positives = 86/285 (30%), Gaps = 69/285 (24%)
Query: 317 GYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKL 369
+G V A A+K L ++ +E ++++Q+ H NIV L
Sbjct: 49 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNL 106
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNN--------------------EDAVELDWAKR 409
G C ++LI+EY G L L + ED L +
Sbjct: 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 166
Query: 410 VNIVKAMAHALAYLHH------DCSPS----------------IASTCPDSSNRTL---L 444
+ +A + +L D + +A SN +
Sbjct: 167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 226
Query: 445 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 504
++APE + + T K DV+S+G++ E+ ++
Sbjct: 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PYPGIPVDANFYKLI 280
Query: 505 DQRLPPPVDRKV---IRDILLASTISFACLQSNPKSRPTMQYVSQ 546
I I+ +C + + RP+ ++
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 50/262 (19%), Positives = 82/262 (31%), Gaps = 47/262 (17%)
Query: 317 GYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+G V++ + A+K ++ + F EA + Q H +IVKL G
Sbjct: 19 QFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIVKLIGV 76
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------- 425
+++I E G L LD A + ++ ALAYL
Sbjct: 77 I-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRD 133
Query: 426 -----------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVY 468
D S + ++APE T DV+
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 193
Query: 469 SFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLASTI 526
FGV E+LM G P + ++ +RLP P + + ++
Sbjct: 194 MFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLPMPPNCPPTLYSLMT---- 243
Query: 527 SFACLQSNPKSRPTMQYVSQEF 548
C +P RP + +
Sbjct: 244 --KCWAYDPSRRPRFTELKAQL 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 52/272 (19%), Positives = 88/272 (32%), Gaps = 54/272 (19%)
Query: 317 GYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 370
+G VY+ A+K ++ + + F NEA V+ + ++V+L
Sbjct: 32 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLL 89
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALAYL 423
G + +I E M RG L L NN +K + + +A +AYL
Sbjct: 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149
Query: 424 ------HHDCSPS-------------------IASTCPDSSNRTLLAGTYGYIAPELAYT 458
H D + +++PE
Sbjct: 150 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209
Query: 459 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR--KV 516
V T DV+SFGVV E+ + +L V++ L D +
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLRFVMEGGLLDKPDNCPDM 263
Query: 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ +++ C Q NPK RP+ +
Sbjct: 264 LFELMR------MCWQYNPKMRPSFLEIISSI 289
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-33
Identities = 47/259 (18%), Positives = 89/259 (34%), Gaps = 47/259 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
+ V K + G +A K + T + + E +L ++ H N++ L+
Sbjct: 22 QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HD 426
++ + LI E + G LF L E L + +K + + + YLH D
Sbjct: 82 YENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQIAHFD 138
Query: 427 CSPS--------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCD 466
P +A + + GT ++APE+ + + D
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 198
Query: 467 VYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLA 523
++S GV+T +L G P + + + ++ +D +
Sbjct: 199 MWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR- 252
Query: 524 STISFACLQSNPKSRPTMQ 542
L +PK R T+Q
Sbjct: 253 -----RLLVKDPKKRMTIQ 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (308), Expect = 1e-31
Identities = 55/290 (18%), Positives = 104/290 (35%), Gaps = 47/290 (16%)
Query: 310 FSIWNYD--------GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 360
+S+ ++ +G V+ + NG+ +A+K L L ++ +E +LS
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 361 VLHRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 420
V H I++++G + +F+I +Y++ G LF L ++ V L
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 421 A---YLHHDCSPS--------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTE 463
++ D P L GT YIAPE+ T +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 464 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIRDILL 522
D +SFG++ E+L G P S+ +L+ L PP + ++D+L
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 523 ASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKHAAIQDISISELRN 572
+ + R E + H +++ +L +
Sbjct: 234 ------RLITRDLSQRLGNLQNGTEDVK-------NHPWFKEVVWEKLLS 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 55/270 (20%), Positives = 99/270 (36%), Gaps = 47/270 (17%)
Query: 317 GYGSVYKAQ-LPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 371
+G+VYK +P G+ A+K+L + + + K +EA V++ V + ++ +L G
Sbjct: 21 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLG 78
Query: 372 FCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HH 425
CL + LI + M G L + ++D + +N +A + YL H
Sbjct: 79 ICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHR 135
Query: 426 DCSPS----------------IASTCPDSSNRTLL---AGTYGYIAPELAYTMVMTEKCD 466
D + +A ++A E + T + D
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195
Query: 467 VYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLAST 525
V+S+GV E++ G P D P + +L++ P D+
Sbjct: 196 VWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERLPQPPICTIDVY---M 244
Query: 526 ISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
I C + SRP + + EF + P
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-31
Identities = 48/280 (17%), Positives = 94/280 (33%), Gaps = 61/280 (21%)
Query: 317 GYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIV 367
+G V A+ A+K L + TE+ + +E +++ + H+NI+
Sbjct: 25 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNII 82
Query: 368 KLYGFCLHRKCMFLIYEYMKRGSLFCNLHNN-------------EDAVELDWAKRVNIVK 414
L G C +++I EY +G+L L +L V+
Sbjct: 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142
Query: 415 AMAHALAYL------HHDCSPSIASTCPDSSNR-------------------TLLAGTYG 449
+A + YL H D + D+ + T
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 450 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509
++APE + + T + DV+SFGV+ E+ ++ + R+
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFKLLKEGHRMD 257
Query: 510 PPVD-RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548
P + + ++ C + P RPT + + ++
Sbjct: 258 KPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-31
Identities = 43/255 (16%), Positives = 77/255 (30%), Gaps = 49/255 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQV--LHRNIVKLY 370
G+GSVY + + A+K + S+ EL E +L +V +++L
Sbjct: 16 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 371 GFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------H 424
+ LI E + + A L + + A+ + H
Sbjct: 76 DWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLH 133
Query: 425 HDCSPSI----------------ASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDV 467
D + + T GT Y PE + Y V
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 193
Query: 468 YSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTIS 527
+S G++ +++ G P + + I QR+ + ++
Sbjct: 194 WSLGILLYDMVCGDIPFE-------HDEEIIRGQVFFRQRVSSEC-----QHLIR----- 236
Query: 528 FACLQSNPKSRPTMQ 542
CL P RPT +
Sbjct: 237 -WCLALRPSDRPTFE 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (298), Expect = 1e-30
Identities = 47/265 (17%), Positives = 89/265 (33%), Gaps = 53/265 (20%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELA------FIKSFRNEAQVLSQVL-HRNIVK 368
V + P K +A+K + + + ++ E +L +V H NI++
Sbjct: 15 VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 74
Query: 369 LYGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--- 425
L FL+++ MK+G LF L L + I++A+ + LH
Sbjct: 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNI 131
Query: 426 ---DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVM----- 461
D P + + GT Y+APE+ +
Sbjct: 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 191
Query: 462 -TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---I 517
++ D++S GV+ +L G P + +I + + P +
Sbjct: 192 YGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246
Query: 518 RDILLASTISFACLQSNPKSRPTMQ 542
+D++ L P+ R T +
Sbjct: 247 KDLVS------RFLVVQPQKRYTAE 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (300), Expect = 3e-30
Identities = 47/286 (16%), Positives = 84/286 (29%), Gaps = 53/286 (18%)
Query: 317 GYGSVYKAQLP-NGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 372
G+G VY + GK++A+K L + + R ++S IV +
Sbjct: 16 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75
Query: 373 CLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------D 426
+ I + M G L +L + E D + L ++H+ D
Sbjct: 76 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEHMHNRFVVYRD 132
Query: 427 CSPS---------------IASTCPDSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSF 470
P+ + GT+GY+APE L + D +S
Sbjct: 133 LKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 192
Query: 471 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTIS 527
G + ++L G P ID + + + +R +L
Sbjct: 193 GCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE----- 241
Query: 528 FACLQSNPKSRPTMQYVS-QEFLITRKTPLVKHAAIQDISISELRN 572
LQ + R QE + + + +
Sbjct: 242 -GLLQRDVNRRLGCLGRGAQEVK--------ESPFFRSLDWQMVFL 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 53/260 (20%), Positives = 91/260 (35%), Gaps = 50/260 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFC- 373
G V + + FALK L R E ++ + +IV++
Sbjct: 24 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 75
Query: 374 ---LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH----- 425
RKC+ ++ E + G LF + + D + I+K++ A+ YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 426 -DCSPS-------------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P A ++ T T Y+APE+ + C
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 466 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILL 522
D++S GV+ +L G P L+ S K I + P P +V ++ ++
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYEFPNPEWSEVSEEVKMLIR 253
Query: 523 ASTISFACLQSNPKSRPTMQ 542
L++ P R T+
Sbjct: 254 ------NLLKTEPTQRMTIT 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (285), Expect = 5e-29
Identities = 52/267 (19%), Positives = 94/267 (35%), Gaps = 45/267 (16%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376
YG VYKAQ G+ FALKK+ + +E + E +L ++ H NIVKLY +
Sbjct: 14 TYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTK 72
Query: 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP- 429
K + L++E++ + L+ + + + + +AY H D P
Sbjct: 73 KRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 430 -----------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
+ A P + + L + + D++S G
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 473 VTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVLDQRLP--PPVDRKVI 517
+ E++ G +L + +S + P + + D P+ +
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 518 RDILLASTISF--ACLQSNPKSRPTMQ 542
L S I L+ +P R T +
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 7e-29
Identities = 35/271 (12%), Positives = 68/271 (25%), Gaps = 55/271 (20%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G +Y + G+ A+K E+++ + + +C
Sbjct: 19 SFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 376 -RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCS 428
++ E + + + + + M + Y+H D
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 130
Query: 429 P---------------------------SIASTCPDSSNRTLLAGTYGYIAPELAYTMVM 461
P + L GT Y + +
Sbjct: 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190
Query: 462 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI---- 517
+ + D+ S G V + +G P L +++ K I P V K
Sbjct: 191 SRRDDLESLGYVLMYFNLGSLPWQGLK--AATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 518 RDILLASTISFACLQSNPKSRPTMQYVSQEF 548
L C +P Y+ Q F
Sbjct: 249 ATYLN------FCRSLRFDDKPDYSYLRQLF 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-28
Identities = 48/269 (17%), Positives = 87/269 (32%), Gaps = 46/269 (17%)
Query: 317 GYGSVYKAQLPN-GKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRNIVKLYGFC 373
+ +VYKA+ N ++ A+KK+ E ++ E ++L ++ H NI+ L
Sbjct: 10 QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 69
Query: 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDC 427
H+ + L++++M+ N+ L + + L YLH D
Sbjct: 70 GHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 428 SPS-----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYS 469
P+ S + T T Y APEL + M D+++
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 470 FGVVTLEVLMGKHP--------------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515
G + E+L+ L + L D + + P +
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 516 VIRDILLASTISF--ACLQSNPKSRPTMQ 542
I + NP +R T
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 47/274 (17%), Positives = 90/274 (32%), Gaps = 55/274 (20%)
Query: 317 GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G VY+A+L +G++ A+KK+ + + E Q++ ++ H NIV+L F
Sbjct: 32 SFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYS 84
Query: 376 ------RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---- 425
+ L+ +Y+ H + L + + +LAY+H
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 426 --DCSPSIASTCPD------------------SSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P PD N + + Y + T
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204
Query: 466 DVYSFGVVTLEVLMGKHP----------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515
DV+S G V E+L+G+ +++ L + + +I ++ P +
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 264
Query: 516 VIRDILLASTISFA-------CLQSNPKSRPTMQ 542
+ L+ P +R T
Sbjct: 265 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-26
Identities = 48/277 (17%), Positives = 88/277 (31%), Gaps = 57/277 (20%)
Query: 317 GYGSVYKA------QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKL 369
+G V +A + + A+K L T ++ +E ++L + H N+V L
Sbjct: 25 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNL 82
Query: 370 YGFCLH-RKCMFLIYEYMKRGSLFCNLHNNEDAVE-------------LDWAKRVNIVKA 415
G C + +I E+ K G+L L + + L +
Sbjct: 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142
Query: 416 MAHALAYLHH------DCSPS-------------------IASTCPDSSNRTLLAGTYGY 450
+A + +L D + PD + +
Sbjct: 143 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202
Query: 451 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 510
+APE + V T + DV+SFGV+ E+ + + L + R P
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPD 260
Query: 511 PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQE 547
++ + +L C P RPT + +
Sbjct: 261 YTTPEMYQTMLD-------CWHGEPSQRPTFSELVEH 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 45/272 (16%), Positives = 83/272 (30%), Gaps = 48/272 (17%)
Query: 317 GYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFR--NEAQVLSQVLHRNIVKLYGF 372
YG V+KA+ G+ ALK++ EE + + R + L H N+V+L+
Sbjct: 19 AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 78
Query: 373 CL-----HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-- 425
C + L++E++ + E + +++ + L +LH
Sbjct: 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLHSHR 136
Query: 426 ----DCSPS----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKC 465
D P +A T + T Y APE+
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 196
Query: 466 DVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512
D++S G + E+ K D++ P+ + +
Sbjct: 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 256
Query: 513 DRKVIRDILLASTISF--ACLQSNPKSRPTMQ 542
+ + CL NP R +
Sbjct: 257 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-26
Identities = 50/273 (18%), Positives = 84/273 (30%), Gaps = 49/273 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG V A N A+KK+ E + + + E ++L + H NI+ +
Sbjct: 20 AYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLRFRHENIIGINDIIRA 77
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
+ Y+ + +L+ L + + L Y+H D P
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP 137
Query: 430 S--------------------IASTCPDSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVY 468
S + T T Y APE+ T+ D++
Sbjct: 138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197
Query: 469 SFGVVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRK 515
S G + E+L + +L S S I+ + + L P K
Sbjct: 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257
Query: 516 VIRDILLASTISFA------CLQSNPKSRPTMQ 542
V + L + S A L NP R ++
Sbjct: 258 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (264), Expect = 5e-26
Identities = 34/269 (12%), Positives = 67/269 (24%), Gaps = 49/269 (18%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCL 374
+G +++ L N + A+K R+E + + I +Y F
Sbjct: 17 SFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 375 HRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCS 428
L+ + + + K M + +H D
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128
Query: 429 PS-----------------------------IASTCPDSSNRTLLAGTYGYIAPELAYTM 459
P + + L+GT Y++
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519
+ + D+ + G V + L G P L ++++ K I Q P +
Sbjct: 189 EQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 520 ILLASTISFACLQSNPKSRPTMQYVSQEF 548
+ P Y+ F
Sbjct: 247 EF--YKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 7e-26
Identities = 49/268 (18%), Positives = 85/268 (31%), Gaps = 45/268 (16%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG VYKA+ G+V ALKK+ +TE + E +L ++ H NIVKL
Sbjct: 14 TYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL------HHDCSP 429
++L++E++ + + + + + + LA+ H D P
Sbjct: 73 ENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 430 SIASTCPD-----------------SSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFG 471
+ T T Y APE L + D++S G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 472 VVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVLDQRLP--PPVDRKV 516
+ E++ + L + P + + P D
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250
Query: 517 IRDILLASTISF--ACLQSNPKSRPTMQ 542
+ L S L +P R + +
Sbjct: 251 VVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-25
Identities = 48/273 (17%), Positives = 88/273 (32%), Gaps = 53/273 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG+V A G A+KKL+ EL F K E ++L + H N++ L
Sbjct: 30 AYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMRHENVIGLLDVFTP 88
Query: 376 RKCM------FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---- 425
+ + +L+ +M G+ L +E +L + +V M L Y+H
Sbjct: 89 DETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGII 143
Query: 426 --DCSPS---------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVY 468
D P + DS + + + M T+ D++
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 203
Query: 469 SFGVVTLEVLMGKHP--------------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514
S G + E++ GK + + + + P +++
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263
Query: 515 KVIRDILLASTISFA-----CLQSNPKSRPTMQ 542
K IL ++ L + + R T
Sbjct: 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 46/282 (16%), Positives = 85/282 (30%), Gaps = 50/282 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V + G+ +A+K L + E++VL H + L
Sbjct: 17 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY------LHHDCSP 429
+ + EY G LF +L + + AL Y ++ D
Sbjct: 77 HDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 430 SI-----------------ASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 472
D + GT Y+APE+ D + GV
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 473 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLASTISFACL 531
V E++ G+ P + D + + +L + + P + +L L
Sbjct: 194 VMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPEAKSLLA------GLL 240
Query: 532 QSNPKSRPTMQYVS-QEFLITRKTPLVKHAAIQDISISELRN 572
+ +PK R +E + +H I+ ++
Sbjct: 241 KKDPKQRLGGGPSDAKEVM--------EHRFFLSINWQDVVQ 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (263), Expect = 2e-25
Identities = 45/244 (18%), Positives = 79/244 (32%), Gaps = 36/244 (14%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V + +G +A+K L + +L I+ NE ++L V +VKL
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSP 429
++++ EY+ G +F +L + YLH D P
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 430 S--------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 475
L GT +APE+ + + D ++ GV+
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 476 EVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNP 535
E+ G P + +I V + P ++D+L LQ +
Sbjct: 230 EMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR------NLLQVDL 277
Query: 536 KSRP 539
R
Sbjct: 278 TKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 63/330 (19%), Positives = 108/330 (32%), Gaps = 70/330 (21%)
Query: 287 LLLAKRKYKKPKLEERATNNIDVFSIWNYD--------GYGSVYKAQL----PNGKVFAL 334
LL K + + L T + + I N++ YG V+ + GK++A+
Sbjct: 2 LLTVKHELRTANL----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 335 KKLHTSE-TEELAFIKSFRNEAQVLSQVLHR-NIVKLYGFCLHRKCMFLIYEYMKRGSLF 392
K L + ++ + R E QVL + +V L+ + LI +Y+ G LF
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 393 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------------------------DCS 428
+L E + V + AL +LH D
Sbjct: 118 THLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 174
Query: 429 PSIASTCPDSSNRTLLAGTYGYIAPELAYTMVM--TEKCDVYSFGVVTLEVLMGKHPRDL 486
S ++ GT Y+AP++ + D +S GV+ E+L G P
Sbjct: 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT- 233
Query: 487 LSSLSSSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLASTISFACLQSNPKSRPTMQY 543
I + PP +++ +D++ L +PK R
Sbjct: 234 ----VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ------RLLMKDPKKRLGCGP 283
Query: 544 VS-QEFLITRKTPLVKHAAIQDISISELRN 572
E +H Q I+ +L
Sbjct: 284 RDADEIK--------EHLFFQKINWDDLAA 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-24
Identities = 40/269 (14%), Positives = 88/269 (32%), Gaps = 47/269 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YG+V+KA+ ++ ALK++ + +E S E +L ++ H+NIV+L+
Sbjct: 14 TYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---------- 425
K + L++E+ + N D + + L + H
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS---FLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 426 --------------DCSPSIASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG 471
+ + A P + + L + + D++S G
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 472 VVTLEVLMGKHP-----------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520
+ E+ P + + L + ++ + + L P P+ +
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 521 LLASTISFA-------CLQSNPKSRPTMQ 542
+ ++ L+ NP R + +
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAE 278
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (243), Expect = 7e-23
Identities = 46/279 (16%), Positives = 76/279 (27%), Gaps = 54/279 (19%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
G V A + A+KKL + K E ++ V H+NI+ L
Sbjct: 29 AQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 376 RKCM------FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 429
+K + +L+ E M + ++ H+ +H D P
Sbjct: 88 QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147
Query: 430 S----------------IASTCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
S +A T S T T Y APE+ M E D++S G +
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 474 TLEVLMGKHP-----------------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 516
E++ K P + + K+
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 517 IRDILLASTISFA-------------CLQSNPKSRPTMQ 542
D L + L +P R ++
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 1e-22
Identities = 42/283 (14%), Positives = 90/283 (31%), Gaps = 61/283 (21%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+G V+KA+ G+ ALKK+ +E F + E ++L + H N+V L C
Sbjct: 22 TFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRT 80
Query: 376 RK--------CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL---- 423
+ ++L++++ + + V+ ++ +++ + + L Y+
Sbjct: 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK 137
Query: 424 --HHDCSPS---------------------IASTCPDSSNRTLLAGTYGYIAPE-LAYTM 459
H D + + + T T Y PE L
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197
Query: 460 VMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVLDQ 506
D++ G + E+ L S++ P + ++ ++
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257
Query: 507 RLPPPVDRKVIRDILLASTISFA-------CLQSNPKSRPTMQ 542
++ ++D L A L +P R
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 9e-22
Identities = 51/307 (16%), Positives = 93/307 (30%), Gaps = 52/307 (16%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
YGSV A G A+KKL + + K E ++L + H N++ L
Sbjct: 30 AYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88
Query: 376 RKCM-----FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMA--HALAYLHHDCS 428
+ + + ++ L + + + I++ + H+ +H D
Sbjct: 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148
Query: 429 PSIA---------------STCPDSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 473
PS + D +A + + M + D++S G +
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 474 TLEVLMGKHP------RDLLSSL-------------SSSSDPKIMLIDVLDQRLPPPVDR 514
E+L G+ D L + SS+ I L Q
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 515 KVIRDILLASTISFACLQSNPKSRPTMQ------YVSQEFLITRK---TPLVKHAAIQDI 565
I LA + L + R T Y +Q + P + +D+
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
Query: 566 SISELRN 572
I E ++
Sbjct: 329 LIDEWKS 335
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.4 bits (231), Expect = 2e-21
Identities = 45/309 (14%), Positives = 89/309 (28%), Gaps = 69/309 (22%)
Query: 291 KRKYKKPKLEERATNNIDVFSIWNYDG---YGSVYKAQ-LPNGKVFALKKLHTSETEELA 346
R+Y + N D + + G Y V++A + N + +K L + ++
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-- 75
Query: 347 FIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR--KCMFLIYEYMKRGSLFCNLHNNEDAVE 403
+ E ++L + NI+ L + L++E++
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------ 125
Query: 404 LDWAKRVNIVKAMAHALAYLH------HDCSPS-----------------IASTCPDSSN 440
L + + AL Y H D P +A
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 441 RTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHP---------------- 483
+ + + PEL M D++S G + ++ K P
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 484 -------RDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIRDILLASTISF--ACLQS 533
D + + DP+ I R + ++ + F L+
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 534 NPKSRPTMQ 542
+ +SR T +
Sbjct: 306 DHQSRLTAR 314
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 2e-16
Identities = 41/283 (14%), Positives = 90/283 (31%), Gaps = 50/283 (17%)
Query: 317 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 375
+ +V+ A+ + N A+K + + + ++ +E ++L +V + K +
Sbjct: 25 HFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 376 R---------------KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 420
+ +++E + L + L + K+ I K + L
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLLGL 138
Query: 421 AYL-------HHDCSPS--------------------IASTCPDSSNRTLLAGTYGYIAP 453
Y+ H D P + + C + T T Y +P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 454 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP-KIMLIDVLDQRLPPPV 512
E+ D++S + E++ G + S + D I I L LP +
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTP 555
R ++ S K P +++++ ++
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.2 bits (186), Expect = 2e-15
Identities = 30/139 (21%), Positives = 52/139 (37%), Gaps = 26/139 (18%)
Query: 114 NWRLSQLNFSCFPNLVKLTIQFFALTGSIP--------------------PEISALSKLQ 153
N + S L +L + ++ P IS L L
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 154 LLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK 213
L L N ++ P + +L L L +N + S+L +LTN++ L N++S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDL 366
Query: 214 IPPEIAGMKNLTWLDLSNN 232
P +A + +T L L++
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 3e-15
Identities = 44/191 (23%), Positives = 67/191 (35%), Gaps = 30/191 (15%)
Query: 74 NTGWWNSSFWTTDHCKWEGITCNSAGSIFELY----LSGYYAGFNWRLSQLNFSCFPNLV 129
N S + + T N I L L N + NL
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT 244
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP--------------------PE 169
L + ++ P +S L+KL L L +N ++ P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 170 IGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDL 229
I NLKNL L + N++ P + SLT L L ++NK+S +A + N+ WL
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 230 SNNNIKGSIPV 240
+N I P+
Sbjct: 359 GHNQISDLTPL 369
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 1e-09
Identities = 44/215 (20%), Positives = 71/215 (33%), Gaps = 31/215 (14%)
Query: 73 INTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLT 132
I+ S + + + L N + NL L
Sbjct: 144 ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLI 203
Query: 133 IQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS 192
++ P I + L L L+ N L + +L NL +L++ +N + P
Sbjct: 204 ATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 193 ALGSLTNLSNLDLSSNKLSGKIP--------------------PEIAGMKNLTWLDLSNN 232
L LT L+ L L +N++S P I+ +KNLT+L L N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 233 NIKGSIPVRLSPNKGLCGGNFLDLPSCDTTKPATL 267
NI PV L L + + ++L
Sbjct: 318 NISDISPVS-----SLTKLQRLFFANNKVSDVSSL 347
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 4e-08
Identities = 18/123 (14%), Positives = 39/123 (31%), Gaps = 4/123 (3%)
Query: 62 LSPIQLEKKALINTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLN 121
L+ ++L + N T+ E + + L+ FN
Sbjct: 265 LTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
S L +L ++ ++ L+ + L N ++ P + NL + +L +
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
Query: 182 GSN 184
Sbjct: 381 NDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 12/69 (17%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
L ++ +G ++ + L ++ L + I + + NLT ++ SN
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 232 NNIKGSIPV 240
N + P+
Sbjct: 76 NQLTDITPL 84
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 6e-07
Identities = 17/87 (19%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 147 SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206
+AL++ L +T T+ +L + L + + L NL+ ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 207 SNKLSGKIPPEIAGMKNLTWLDLSNNN 233
+N+L+ P + + L + ++NN
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 16/82 (19%), Positives = 34/82 (41%), Gaps = 6/82 (7%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
+K + +T ++ + L ++ L G+ + L NL ++N +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 185 SLIGPIPSALGSLTNLSNLDLS 206
L P L +LT L ++ ++
Sbjct: 77 QLTDITP--LKNLTKLVDILMN 96
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 2e-12
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 17/86 (19%)
Query: 174 KNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNN 233
KNL L++ +N + G +P L L L +L++S N L G+I P+ ++ +NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNK 302
Query: 234 IKGSIPVRLSPNKGLCGGNFLDLPSC 259
LCG LP+C
Sbjct: 303 -------------CLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 3e-12
Identities = 24/62 (38%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 156 DLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSGKI 214
DL +N + GT+P + LK L LNV N+L G IP G+L ++NK L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
Query: 215 PP 216
P
Sbjct: 309 LP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 21/118 (17%), Positives = 42/118 (35%), Gaps = 3/118 (2%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+ + + + + A + NL L ++
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLI--GPIPS 192
+ G++P ++ L L L++S N L G I P+ GNL+ +N + P+P+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 7e-07
Identities = 52/184 (28%), Positives = 72/184 (39%), Gaps = 25/184 (13%)
Query: 69 KKALINTGWWNSSFWTTDHC--KWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFP 126
KK L N +S TTD C W G+ C++ +R++ L+ S
Sbjct: 15 KKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-------------TYRVNNLDLSGL- 60
Query: 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSN-GLTGTIPPEIGNLKNLIELNVGSNS 185
IP ++ L L L + L G IPP I L L L + +
Sbjct: 61 --------NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
Query: 186 LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
+ G IP L + L LD S N LSG +PP I+ + NL + N I G+IP
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 246 KGLC 249
L
Sbjct: 173 SKLF 176
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.3 bits (155), Expect = 8e-12
Identities = 27/113 (23%), Positives = 45/113 (39%), Gaps = 2/113 (1%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
+P ++ LLDL +N +T + NLKNL L + +N + P A L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNF 253
L LS N+L ++ L + ++ S+ L+ + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 6e-10
Identities = 34/243 (13%), Positives = 64/243 (26%), Gaps = 31/243 (12%)
Query: 24 ISMDPASSIFRLAALVWVAIFTCDNVAVRSGTIVTASALSPIQLEKKAL--INTGWWNSS 81
I+ L L + + + G L + L K L + +
Sbjct: 43 ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL 102
Query: 82 FWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGS 141
H S + + + S + F + KL+ A T
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
Query: 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELN--------------------- 180
L L L N +T + L NL +L
Sbjct: 163 TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 181 --VGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG------KIPPEIAGMKNLTWLDLSNN 232
+N+ + +P L + + L +N +S P + + + L +N
Sbjct: 223 ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
Query: 233 NIK 235
++
Sbjct: 283 PVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 8e-09
Identities = 34/182 (18%), Positives = 57/182 (31%), Gaps = 41/182 (22%)
Query: 87 HCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEI 146
C + C+ G L ++ P+ L +Q +T +
Sbjct: 9 QCHLRVVQCSDLG-----------------LEKVPKDLPPDTALLDLQNNKITEIKDGDF 51
Query: 147 SALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206
L L L L +N ++ P L L L + N L +L L +
Sbjct: 52 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE 111
Query: 207 SNKL-----------------------SGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
K+ SG GMK L+++ +++ NI +IP L
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP 170
Query: 244 PN 245
P+
Sbjct: 171 PS 172
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 23/172 (13%), Positives = 50/172 (29%), Gaps = 30/172 (17%)
Query: 76 GWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQF 135
N + G+ + Y + ++ + P+L +L +
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 180
Query: 136 FALTGSIPPEISALSKLQLLDLSSNGLTGTI-----------------------PPEIGN 172
+T + L+ L L LS N ++ P + +
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 240
Query: 173 LKNLIELNVGSNSLIG------PIPSALGSLTNLSNLDLSSNKLS-GKIPPE 217
K + + + +N++ P + S + L SN + +I P
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-11
Identities = 13/118 (11%), Positives = 34/118 (28%), Gaps = 13/118 (11%)
Query: 317 GYGSVYKAQLPNGKVFALKKLHTSETEELAFI-------KSFRNEAQVLSQVLHRNIVKL 369
+V+ +K T F A ++ R + KL
Sbjct: 12 KESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 71
Query: 370 YGFCLHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 427
G + + +Y + ++ L + ++ + ++ + +A +H
Sbjct: 72 QGLAVPK-----VYAWE-GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (144), Expect = 3e-10
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 152 LQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSL----IGPIPSALGSLTNLSNLDLS 206
+Q LD+ L+ E+ L+ + + L I SAL L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 207 SNKLSGKIPPEIAGM-----KNLTWLDLSNNN 233
SN+L + + L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 7e-07
Identities = 11/75 (14%), Positives = 23/75 (30%), Gaps = 5/75 (6%)
Query: 175 NLIELNVGSNSLI-GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM----KNLTWLDL 229
++ L++ L L L + L L+ +I+ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 230 SNNNIKGSIPVRLSP 244
+N + +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 172 NLKNLIELNVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAG-----MK 222
L L + + + + L + +L LDLS+N L ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 223 NLTWLDLSNNNIKGSIPVRL 242
L L L + + RL
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 12/50 (24%), Positives = 22/50 (44%), Gaps = 4/50 (8%)
Query: 198 TNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
+ L L L+ +S + + +L LDLSNN + + ++L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 21/164 (12%), Positives = 42/164 (25%), Gaps = 31/164 (18%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
S + N ++ + L Q L L +
Sbjct: 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379
Query: 137 ALTG----SIPPEISALSKLQLLDLSSNGLTGTIPPEIGN-LKNLIELNVGSNSLIGPIP 191
++ S+ + A L+ LDLS+N L ++ ++
Sbjct: 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---------------- 423
Query: 192 SALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
L L L S ++ L L+ +++
Sbjct: 424 ----PGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 9e-10
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
++ + L + LDLS N L +PP + L+ L L N + +L L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN--ALENVDGVANLPRL 67
Query: 201 SNLDLSSNKL-SGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLS 243
L L +N+L + L L+L N++ ++
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 6e-04
Identities = 10/37 (27%), Positives = 19/37 (51%), Gaps = 2/37 (5%)
Query: 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239
L L+ L+ + + + +T LDLS+N ++ P
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP 37
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 2e-09
Identities = 28/155 (18%), Positives = 48/155 (30%), Gaps = 9/155 (5%)
Query: 70 KALINTGWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLV 129
L N+ T N + + +S+ FS L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 130 KLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP 189
A + I L+ L++S+N L +P L+ LI S + +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA----SFNHLAE 318
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL 224
+P NL L + N L + P +++L
Sbjct: 319 VPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 5/61 (8%)
Query: 150 SKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209
+ L+L++ GL+ ++P +L+ L NSL +P SL +L + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 210 L 210
L
Sbjct: 93 L 93
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 2e-08
Identities = 36/174 (20%), Positives = 55/174 (31%), Gaps = 2/174 (1%)
Query: 86 DHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPE 145
D C + + + L L F NL L + ++
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
L L L L N + P +L L+ L + +N+L AL L L L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPSC 259
+ N L S++ + S+P RL+ + L DL C
Sbjct: 233 NDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDLQGC 284
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 7e-08
Identities = 33/165 (20%), Positives = 53/165 (32%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+D+ + + + + L+ L F L L +Q
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS 196
AL L L L L N ++ L +L L + N + P A
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVR 241
L L L L +N LS +A ++ L +L L++N R
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (117), Expect = 4e-07
Identities = 24/160 (15%), Positives = 54/160 (33%), Gaps = 4/160 (2%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+ + + ++ + L + + + F +L +L +
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS 196
+ P L +L L L +N L+ + L+ L L + N + +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246
Query: 197 LTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236
L SS+++ +P +AG L+ N+++G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 38/192 (19%), Positives = 58/192 (30%), Gaps = 37/192 (19%)
Query: 79 NSSFWTTDHCKWEGITCNSAG---SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQF 135
+ T C +G+ G + ++L R+S + + F LTI +
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLH------GNRISHVPAASFRACRNLTILW 62
Query: 136 FA----------------------------LTGSIPPEISALSKLQLLDLSSNGLTGTIP 167
L P L +L L L GL P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 168 PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWL 227
L L L + N+L L NL++L L N++S G+ +L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 228 DLSNNNIKGSIP 239
L N + P
Sbjct: 183 LLHQNRVAHVHP 194
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 39/180 (21%), Positives = 54/180 (30%), Gaps = 1/180 (0%)
Query: 82 FWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGS 141
W + G L + F L L + L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201
P L+ LQ L L N L +L NL L + N + A L +L
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLP-SCD 260
L L N+++ P + L L L NN+ L+P + L D P CD
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 9e-04
Identities = 25/134 (18%), Positives = 38/134 (28%), Gaps = 27/134 (20%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI---------- 190
++P I A Q + L N ++ +NL L + SN L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 191 ---------------PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235
P+ L L L L L P G+ L +L L +N ++
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 236 GSIPVRLSPNKGLC 249
L
Sbjct: 143 ALPDDTFRDLGNLT 156
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 8e-08
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 4/67 (5%)
Query: 165 TIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNL 224
+ + NL L L N + P L SL NL + L +N++S P +A NL
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 225 TWLDLSN 231
+ L+N
Sbjct: 220 FIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 4e-06
Identities = 13/63 (20%), Positives = 27/63 (42%), Gaps = 4/63 (6%)
Query: 172 NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
L N I++ G +++ + A L ++ L ++ + + NL L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 232 NNI 234
N I
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 17/52 (32%), Positives = 26/52 (50%), Gaps = 2/52 (3%)
Query: 194 LGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245
L +L+ L+ L NK+S P +A + NL + L NN I P+ + N
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 4/109 (3%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
++ L+ + + NL KLT
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 137 ALTG-SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
S +++L L + L +N ++ P + N NL + + +N
Sbjct: 181 DDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 4/62 (6%)
Query: 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSN 184
N +K+ +T ++ + L + L G+T + L NLI L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 185 SL 186
+
Sbjct: 74 QI 75
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 169 EIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLD 228
E+ + + +E+N +L +P L + + L LS N L + LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 229 LSNNN 233
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 8e-06
Identities = 21/73 (28%), Positives = 28/73 (38%), Gaps = 1/73 (1%)
Query: 160 NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 219
N L P + L +L++ +N+L L L NL L L N L IP
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 220 GMKNLTWLDLSNN 232
G L + L N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNV 181
S + +++ LT ++PP++ +L LS N L + L +LN+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 182 GSNS 185
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 20/111 (18%), Positives = 32/111 (28%), Gaps = 1/111 (0%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+ + + + + EL L + P L KL++
Sbjct: 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLI 187
LT ++ L L L L N L TIP L + N +
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 7e-04
Identities = 12/54 (22%), Positives = 22/54 (40%), Gaps = 3/54 (5%)
Query: 195 GSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL 248
+ + ++ L+ +PP++ K+ T L LS N + L P L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL 57
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 25/134 (18%), Positives = 39/134 (29%), Gaps = 1/134 (0%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
++ L + L L +L ++
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGS 196
L P ++ KL+ L L++N LT + L+NL L + NSL IP
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 197 LTNLSNLDLSSNKL 210
L L N
Sbjct: 194 SHLLPFAFLHGNPW 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 1e-06
Identities = 13/78 (16%), Positives = 29/78 (37%), Gaps = 10/78 (12%)
Query: 165 TIPPEIG------NLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 218
T+P I I+ N+ S+ + L ++ + +++ + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 219 AGMKNLTWLDLSNNNIKG 236
+ N+T L L+ N +
Sbjct: 65 QYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 2/41 (4%)
Query: 191 PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231
L LT L NL LS N +S +AG+KNL L+L +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 4e-05
Identities = 13/78 (16%), Positives = 32/78 (41%), Gaps = 10/78 (12%)
Query: 141 SIPPEIS------ALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSAL 194
++P I A ++ +L +T + L ++ ++ ++ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 195 GSLTNLSNLDLSSNKLSG 212
L N++ L L+ NKL+
Sbjct: 65 QYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 19/107 (17%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
E + + L N +++ + +
Sbjct: 106 SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGS 183
I P ++ L+KLQ L LS N ++ + LKNL L + S
Sbjct: 166 NQISDIVP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 12/41 (29%), Positives = 16/41 (39%), Gaps = 2/41 (4%)
Query: 167 PPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSS 207
+ L L L + N + AL L NL L+L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 2e-06
Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 5/125 (4%)
Query: 141 SIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200
+ +S L GL P++ + LN S+ + + ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPEL 67
Query: 201 SNLDLSSNKLSGK--IPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGLCGGNFLDLPS 258
+L+LS+N+L + + NL L+LS N +K + L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 259 CDTTK 263
DT +
Sbjct: 128 SDTFR 132
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 9/88 (10%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 151 KLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSL----IGPIPSALGSLTNLSNLDLS 206
L+L +++ ++ + ++ E+ + N++ + + S +L + S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
++ L L +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 9/48 (18%), Positives = 17/48 (35%), Gaps = 5/48 (10%)
Query: 193 ALGSLTNLSNLDLSSNKLSGKIPPEIA-----GMKNLTWLDLSNNNIK 235
+ L L L N++ + M +L +L+L+ N
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 12/134 (8%), Positives = 35/134 (26%), Gaps = 28/134 (20%)
Query: 76 GWWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQF 135
+ + + + G+ + G + + L L +Q+
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSAR----------GAAAVVDAFSKLENIGLQTLRLQY 282
Query: 136 FALTGSIPPEISA-----LSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI 190
+ + + L L+L+ N + + ++ +
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTR---------- 331
Query: 191 PSALGSLTNLSNLD 204
G L L +++
Sbjct: 332 --GRGELDELDDME 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.004
Identities = 10/79 (12%), Positives = 27/79 (34%), Gaps = 12/79 (15%)
Query: 157 LSSNGLTGTIPPEIGN------LKNLIELNVGSNSLIGPIPSALGS-----LTNLSNLDL 205
L+ L+ + + L L + N + L + + +L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 206 SSNKLSGKIPPEIAGMKNL 224
+ N+ + + ++ +
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 12/52 (23%), Positives = 18/52 (34%), Gaps = 2/52 (3%)
Query: 183 SNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNI 234
+ LI + LDL K+ I A + +D S+N I
Sbjct: 4 TAELIEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 5e-05
Identities = 22/118 (18%), Positives = 38/118 (32%), Gaps = 5/118 (4%)
Query: 144 PEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS-ALGSLTNLSN 202
P+ L + +G + +NL EL + + + + L L L N
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNKGL---CGGNFLDLP 257
L + + L P L+ L+LS N ++ + GN L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 1/69 (1%)
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEI-GNLKNLIELNVGSNSLIGPIPSALG 195
+ E + ++Q +DLS++ + + I L L++ L PI + L
Sbjct: 33 SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 92
Query: 196 SLTNLSNLD 204
+NL L+
Sbjct: 93 KNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 8e-05
Identities = 15/88 (17%), Positives = 31/88 (35%), Gaps = 2/88 (2%)
Query: 143 PPEISALSKLQLLDLS-SNGLTGTIPPEIGNLKNLIELNVGSNSL-IGPIPSALGSLTNL 200
P L ++ E + + +++ ++ + + + L + L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLD 228
NL L +LS I +A NL L+
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 23/148 (15%), Positives = 49/148 (33%), Gaps = 4/148 (2%)
Query: 86 DHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPE 145
D+ + G + L + F ++ +L + +
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97
Query: 146 ISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDL 205
L +L+ L+L N ++ +P +L +L LN+ SN A L L
Sbjct: 98 FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSL 156
Query: 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNN 233
+ P + ++++ DL ++
Sbjct: 157 NGGAARCGAPSK---VRDVQIKDLPHSE 181
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 20/83 (24%)
Query: 145 EISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204
+ + L G IPP I + + L +L +L
Sbjct: 13 IFEERKSVVATEAEKVELHGMIPP------------------IEKMDATLSTLKACKHLA 54
Query: 205 LSSNKLSGKIPPEIAGMKNLTWL 227
LS+N + KI ++GM+NL L
Sbjct: 55 LSTNNIE-KISS-LSGMENLRIL 75
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 6/43 (13%), Positives = 12/43 (27%)
Query: 190 IPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNN 232
+ LD+S ++ + +K L N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 9e-04
Identities = 8/54 (14%), Positives = 18/54 (33%), Gaps = 4/54 (7%)
Query: 164 GTIPPEI-GNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP 216
+P ++ + L++ + L +L L + K K+P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 13/114 (11%), Positives = 26/114 (22%), Gaps = 3/114 (2%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+ H + L+L+ F+
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH---NCAFNGTQLDELNLSDNN 187
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI 190
L S +LD+S + + NLK L + + + +
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 241
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.003
Identities = 15/37 (40%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 191 PSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWL 227
L +LT L LD+SSNK+S +A + NL L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.003
Identities = 19/103 (18%), Positives = 34/103 (33%), Gaps = 4/103 (3%)
Query: 77 WWNSSFWTTDHCKWEGITCNSAGSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFF 136
+ T + + L+ N S +L +L
Sbjct: 101 PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSN 160
Query: 137 ALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179
+T P ++ L+ L+ LD+SSN ++ + L NL L
Sbjct: 161 QVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 572 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.98 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.42 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.39 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.38 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.36 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.32 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.29 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.28 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.26 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.21 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.05 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.05 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.0 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.89 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.6 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.59 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.18 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.12 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.11 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.98 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.97 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.94 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.71 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.42 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.39 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 92.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.45 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=328.29 Aligned_cols=229 Identities=22% Similarity=0.327 Sum_probs=171.4
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++++.+.+|.|+||+||+|++.+++.||||+++.....+ ++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 4567778899999999999999889999999998655433 578999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------CCC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------SSN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~~~ 440 (572)
||++|+|.+++.... ..++|..+..++.|+|+||+||| +|.+|.++..+.+ ...
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999987643 35889999999999999999997 5666665432110 011
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC-CCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~ 518 (572)
.....||+.|||||++.+..++.++|||||||++|||+|| ++|++... .......+... +...|. ....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~~~p~--~~~~ 229 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKPR--LAST 229 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCCCCCCT--TSCH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCCCCCcc--ccCH
Confidence 1224689999999999999999999999999999999995 55543211 11111111111 111111 1111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+..++..||+.||++||||+||+++|...
T Consensus 230 ---~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 234567799999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=329.43 Aligned_cols=235 Identities=23% Similarity=0.394 Sum_probs=171.0
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+++.+.+.+|.|+||+||+|++.+ .||||+++...... ...++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34567777899999999999998754 59999997543322 235789999999999999999999999855 568999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
||||++|+|.++++.... .++|..++.++.|+|+||+||| +|++|.++..+.+
T Consensus 82 ~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999975432 5899999999999999999997 4666665432110
Q ss_pred CCCccccccccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC-CCCC--
Q 038466 438 SSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR-LPPP-- 511 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-l~~~-- 511 (572)
........||+.|||||++.. ..|+.++|||||||++|||+||+.||+.... .......+... .++.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHHTSCCCCGG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCcch
Confidence 011233579999999999864 3589999999999999999999999864321 11111111111 1110
Q ss_pred -CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 512 -VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 512 -~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
......+ .+..++..||+.||++||||+||+++|....+
T Consensus 233 ~~~~~~~~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPK---AMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GSCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0011111 12356679999999999999999999865443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=323.42 Aligned_cols=231 Identities=28% Similarity=0.432 Sum_probs=181.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||++......+....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4577788999999999999986 468999999997654443344568899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------CCCcc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------SSNRT 442 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~~~~~ 442 (572)
|||++|+|.+++.... .+++.....++.|++.|++||| +|++|.++..+.+ .....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 9999999999997543 4889999999999999999997 5777766543211 12234
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDI 520 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~ 520 (572)
...||+.|||||++.+..++.++|||||||++|||+||+.||+... .......+.... .+...++ .
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~-~---- 230 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDFVTE-G---- 230 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCCTTSCH-H----
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCccCCH-H----
Confidence 4579999999999999999999999999999999999999986321 111122222222 2222221 1
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
+.++...||+.||++|||++||++|.|...
T Consensus 231 --~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 231 --ARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --HHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --HHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 234566899999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=320.19 Aligned_cols=227 Identities=22% Similarity=0.376 Sum_probs=175.4
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+++++.+.+|.|+||+||+|+.++++.||||+++.....+ ++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 4677888999999999999999889999999998765443 578999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC------------------CCC
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD------------------SSN 440 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~------------------~~~ 440 (572)
|+++|+|.+++.... ..++|..+..++.|+|+||+|||+ |.+|..+..+.+ ...
T Consensus 80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999877543 357899999999999999999984 455544332111 111
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc-CCCCCCChHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIR 518 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~ 518 (572)
.....||+.|+|||++....++.|+|||||||++|||+| |+.||+.... ......+... +++.|. ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~~p~--~~~~ 228 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLYRPH--LASE 228 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCCCCCT--TCCH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCCCCCcc--cccH
Confidence 223458999999999999999999999999999999998 8999864321 1111112111 222221 1111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+..++..||+.||++||||++|++++.
T Consensus 229 ---~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 229 ---KVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ---HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2345667999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-40 Score=324.64 Aligned_cols=231 Identities=20% Similarity=0.309 Sum_probs=171.5
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+++++.+.+|.|+||+||+|++++++.||||+++...... ++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 445677788899999999999999888999999998654332 578999999999999999999998855 557999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------ 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------ 438 (572)
|||+++|+|.++++... ...++|..++.|+.|||+||.||| +|++|.++..+.+.
T Consensus 86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999998876532 235899999999999999999996 56776655432110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||+.|||||++.+..++.++|||||||++|||+||..|+.... .... ....+.....++.+.....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~~~-~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPE-VIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHH-HHHHHHTTCCCCCCTTCCH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC------CHHH-HHHHHHhcCCCCCcccChH
Confidence 01123468899999999998999999999999999999999766543111 1111 1111111111111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+ +..++..||+.||++||||++|++.|.
T Consensus 238 ~---l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 238 E---LYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp H---HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H---HHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1 345677999999999999999998663
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=320.96 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=174.4
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.....+ ..++|.+|+++|++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 4577888999999999999986 579999999997654322 2367899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
|||++|+|.+++.... .+++.....++.|++.|++||| +|++|.++..+.+.
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999997533 5888999999999999999997 57777665432111
Q ss_pred CCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||+.... ...............+......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~s 233 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPWKKID 233 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST------TSHHHHHHHTTCTTSTTGGGSC
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCCCCccccCC
Confidence 11233579999999999987775 6789999999999999999999863211 1111111111111111111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. .+.++..+||+.||++|||++|+++|.|..+
T Consensus 234 ~---~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 234 S---APLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp H---HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1 1234566899999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-39 Score=327.28 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=180.1
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEec
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY 385 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 385 (572)
|+....+|.|+||+||+|+. .+|+.||||+++.....+....++|.+|+++|++++|||||+++|++.+++..|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 66677899999999999985 57999999999866544445567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------CCCcccccc
Q 038466 386 MKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------SSNRTLLAG 446 (572)
Q Consensus 386 ~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------~~~~~~~~g 446 (572)
|++|++..++.... .+++.+...++.|++.||.||| +|++|.++..+.+ ........|
T Consensus 97 ~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~G 173 (309)
T d1u5ra_ 97 CLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 173 (309)
T ss_dssp CSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred cCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCcccc
Confidence 99999977665432 5899999999999999999997 5677765533211 111234579
Q ss_pred ccCccccccccC---CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHHHHH
Q 038466 447 TYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLA 523 (572)
Q Consensus 447 t~~y~APE~~~~---~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 523 (572)
|+.|||||++.+ ..|+.++|||||||++|||+||+.||.... .......+.....+........+ .+
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~s~---~~ 243 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSGHWSE---YF 243 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCSCTTSCH---HH
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCCCCCCCH---HH
Confidence 999999999853 468999999999999999999999985321 11112222222222111111111 12
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 524 STISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 524 ~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
..+...||+.||++|||++|+++|.|..+..+..
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~ 277 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence 3566689999999999999999998887665443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=322.47 Aligned_cols=230 Identities=22% Similarity=0.306 Sum_probs=170.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCeEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFL 381 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 381 (572)
+++++...+|.|+||+||+|+. .+|+.||||+++.....+ ...+.|.+|++++++++|||||++++++.+ ++..|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4578888999999999999985 579999999998665433 235789999999999999999999999975 456899
Q ss_pred EEecccCCChhhhhhcCC-CcccCCHHHHHHHHHHHHHHHHHHh-----------cCCCCCceeeCCCC-----------
Q 038466 382 IYEYMKRGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLH-----------HDCSPSIASTCPDS----------- 438 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH-----------~~~~~~i~~~~~~~----------- 438 (572)
|||||++|+|.+++.+.. ....+++.....++.|++.||+||| +|++|.++..+.+.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999987532 2335899999999999999999996 44555544332111
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC---C
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL---P 509 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l---~ 509 (572)
.......||+.|||||++.+..++.++|||||||++|||+||+.||.... .......+..... +
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKFRRIP 235 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence 11223579999999999999999999999999999999999999985321 1111122222222 2
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
...++ .+..+..+||+.||++|||++|+++|.|
T Consensus 236 ~~~s~-------~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 236 YRYSD-------ELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp TTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccCH-------HHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 21221 1235566899999999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=319.83 Aligned_cols=236 Identities=21% Similarity=0.305 Sum_probs=180.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.++....+|.|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4578888999999999999985 579999999987554332 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~ 440 (572)
|||++|+|.+++.+. .++..+...++.|++.||.||| +|++|.++....+ ...
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999887653 4788888999999999999996 5777776543211 112
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC-CCCChHHHHH
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIRD 519 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~ 519 (572)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+.....+ .+.+.....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~- 244 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGTPELQNPEKLSA- 244 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCSCCCSSGGGSCH-
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCcccCCH-
Confidence 234569999999999999999999999999999999999999985321 11111111111111 111111111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcc
Q 038466 520 ILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLV 557 (572)
Q Consensus 520 ~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~ 557 (572)
.+..+..+||+.||++|||++|+++|.|.....|..
T Consensus 245 --~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~ 280 (293)
T d1yhwa1 245 --IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280 (293)
T ss_dssp --HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred --HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 123556689999999999999999998886554443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-39 Score=320.28 Aligned_cols=224 Identities=21% Similarity=0.309 Sum_probs=167.3
Q ss_pred ccccc-cccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 307 IDVFS-IWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 307 ~~~~~-~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+.+.. .+|.|+||+||+|.+. ++..||||+++..... ...++|.+|+++|++++|||||+++|+|.+ +..|+|
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 33444 3899999999999753 4568999999765432 235789999999999999999999999865 458999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------C---
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------S--- 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~--- 438 (572)
||||++|+|.+++.... ..++|..+..++.|+|.||+||| +|.+|.++..+.+ .
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999886543 35899999999999999999997 4666665432100 0
Q ss_pred --CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc---cCCCCCC
Q 038466 439 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPV 512 (572)
Q Consensus 439 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 512 (572)
.......||+.|||||++....++.++|||||||++|||+| |+.||..... .+ ....+.. +..|+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~~-~~~~i~~~~~~~~p~~~ 237 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PE-VMAFIEQGKRMECPPEC 237 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HH-HHHHHHTTCCCCCCTTC
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCCCCCcC
Confidence 11123458899999999999999999999999999999998 9999863321 11 1111111 1222222
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
+ .+ +.+++..||+.||++||||.+|.+.|.
T Consensus 238 ~----~~---l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 238 P----PE---LYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp C----HH---HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred C----HH---HHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 11 235677999999999999999987764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-39 Score=322.08 Aligned_cols=229 Identities=23% Similarity=0.369 Sum_probs=171.0
Q ss_pred CCccccccccccCeeEEEEEEcC-CC---cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g---~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+++...+|.|+||+||+|+.. +| ..||||++....... ..++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH--HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 34566778999999999999864 23 369999987654332 3468999999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC---------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS--------------- 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~--------------- 439 (572)
+|||||++|+|.+++.... ..++|.++..++.|+|+||+||| +|++|.++..+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999999887543 25899999999999999999997 566666554321100
Q ss_pred -------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcc--cCCC
Q 038466 440 -------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLP 509 (572)
Q Consensus 440 -------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~--~~l~ 509 (572)
......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ... ....+. .+++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-------~~~-~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-------NQD-VINAIEQDYRLP 253 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HHHHHHTTCCCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-------HHH-HHHHHHcCCCCC
Confidence 0011347889999999999999999999999999999998 899985321 111 111222 2222
Q ss_pred CCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 510 PPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 510 ~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+. ....+ +.+++..||+.||++||||+||++.|..
T Consensus 254 ~~~--~~~~~---l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 254 PPM--DCPSA---LHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CCT--TCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCc--cchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 221 11111 2456779999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-39 Score=321.97 Aligned_cols=234 Identities=22% Similarity=0.305 Sum_probs=176.4
Q ss_pred ccCCccccccccccCeeEEEEEEcC-CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL 381 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 381 (572)
..+++++...+|.|+||+||+|+.. +|+.||||+++..... .++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3445667788999999999999865 5899999999865433 3578999999999999999999999999999999
Q ss_pred EEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------CCC
Q 038466 382 IYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------SSN 440 (572)
Q Consensus 382 V~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~~~ 440 (572)
|||||++|+|.+++.... ...++|..+..++.|+|+||+||| +|++|.++..+.+ ...
T Consensus 91 v~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999997643 246899999999999999999997 5666665533110 000
Q ss_pred ---ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHH
Q 038466 441 ---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 517 (572)
Q Consensus 441 ---~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 517 (572)
.....||+.|||||++.+..++.++|||||||++|||+||..|+... ... ....+.+.....++.+....
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~------~~~-~~~~~~i~~~~~~~~~~~~~ 242 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDL-SQVYELLEKDYRMERPEGCP 242 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT------CCH-HHHHHHHHTTCCCCCCTTCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc------chH-HHHHHHHhcCCCCCCCccch
Confidence 11234788999999999999999999999999999999977765311 111 11222332222222211111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.+ +.+++..||+.||++||||+||++.|...
T Consensus 243 ~~---l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 243 EK---VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 21 34567799999999999999999987543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=319.56 Aligned_cols=222 Identities=21% Similarity=0.277 Sum_probs=162.3
Q ss_pred ccccccCeeEEEEEEcC---CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEeccc
Q 038466 311 SIWNYDGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMK 387 (572)
Q Consensus 311 ~~~~~~~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 387 (572)
+.+|.|+||+||+|.+. .++.||||+++..... ....++|.+|+++|++++|||||+++|+|.+ +..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 35899999999999753 3578999999754332 2335789999999999999999999999965 45789999999
Q ss_pred CCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------CC----Cc
Q 038466 388 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------SS----NR 441 (572)
Q Consensus 388 ~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~~----~~ 441 (572)
+|+|.++++... .++|..++.++.|||+||+||| +|++|.++..+.+ .. ..
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999998643 4899999999999999999996 5677765432110 00 01
Q ss_pred cccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHHH
Q 038466 442 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 520 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 520 (572)
....||+.|||||++....++.++|||||||++|||+| |+.||.... .. .....+.....++.+.....
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-------~~-~~~~~i~~~~~~~~p~~~~~-- 237 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GS-EVTAMLEKGERMGCPAGCPR-- 237 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HH-HHHHHHHTTCCCCCCTTCCH--
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCcccCH--
Confidence 22468999999999999999999999999999999998 899986332 11 11122221111111111111
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 521 LLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+.+++..||+.||++||||++|.+.|
T Consensus 238 -~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 238 -EMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp -HHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -HHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 123566799999999999999997765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=318.89 Aligned_cols=233 Identities=24% Similarity=0.305 Sum_probs=176.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||+||+|+. .+|+.||||+++.....+ .++|.+|+++|++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4567788999999999999985 579999999997654332 367889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC-----------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS-----------------N 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~-----------------~ 440 (572)
|||++|+|.+++.+.. ..+++.+...++.|++.|+.||| +|++|.++..+.+.. .
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999887533 24888899999999999999996 577777665432211 0
Q ss_pred ccccccccCcccccccc-----CCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCC-CCCh
Q 038466 441 RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDR 514 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~ 514 (572)
.....||+.|||||++. ...|+.++|||||||++|||+||+.||.... +......+.....+. +.+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~ 239 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-------PMRVLLKIAKSEPPTLAQPS 239 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------GGGHHHHHHHSCCCCCSSGG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCccc
Confidence 12356999999999974 4568999999999999999999999985321 111122222221111 1111
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.... .+.++..+||+.||++|||++|+++|.|...
T Consensus 240 ~~s~---~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 240 RWSS---NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp GSCH---HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred cCCH---HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 1111 1235666899999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=314.56 Aligned_cols=229 Identities=21% Similarity=0.291 Sum_probs=167.7
Q ss_pred cccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCeEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLI 382 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 382 (572)
++...+|.|+||+||+|+. .+++.||+|++......+ ...+.|.+|+++|++++|||||+++|++.+ +...|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3345799999999999986 468999999987654332 234689999999999999999999999875 3468999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------CCCCCceeeCCC----------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------DCSPSIASTCPD----------------S 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------~~~~~i~~~~~~----------------~ 438 (572)
||||++|+|.+++.+.. .+++.....++.|+++|++|||+ |++|.++....+ .
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999997543 48888899999999999999984 344444332111 1
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||+.|||||++.+ .++.++|||||||++|||+||+.||.... ........+.....++..+.....
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCCCCcccCccCCH
Confidence 11233579999999998865 59999999999999999999999985321 111111111111111111111111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+.++..+||+.||++|||++|+++|.|.
T Consensus 241 ---~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 241 ---EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp ---HHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ---HHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence 13456679999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=316.43 Aligned_cols=234 Identities=22% Similarity=0.275 Sum_probs=173.2
Q ss_pred cCCccccccccccCeeEEEEEEcCC-C----cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCe
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN-G----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC 378 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~-g----~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 378 (572)
...++..+++|.|+||+||+|.+.+ + ..||||+++...... ..++|.+|++++++++|||||+++|+|.+.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 3456677889999999999998653 2 479999997654332 24679999999999999999999999999999
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++|||||.+|++.+.+.... ..++|.+++.++.|+|+|++||| +|++|.++..+.+.
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999998877543 35899999999999999999996 56777655432110
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
.......||+.|||||++.+..++.++|||||||++|||+||..|+... .... ...+.+.....++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~------~~~~-~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------LSNH-EVMKAINDGFRLPT 234 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------CCHH-HHHHHHHTTCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc------CCHH-HHHHHHhccCCCCC
Confidence 0112245789999999999999999999999999999999976664311 1111 12222222222222
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+..... .+.+++.+||+.||++||||+||++.|...
T Consensus 235 ~~~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 235 PMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred chhhHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 211111 234577799999999999999999988543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-38 Score=320.81 Aligned_cols=235 Identities=22% Similarity=0.262 Sum_probs=171.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++...+|.|+||+||+|+. .+|+.||||++........ .+.|.+|+++|++++|||||++++++.+++..|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4477888999999999999986 4699999999976543322 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------------S 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------------~ 438 (572)
|||++|+|.+++.... .+++.....++.|++.|++||| +|++|..+..... .
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999997543 4889999999999999999997 5677765543110 0
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~ 516 (572)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.... .+.+.....
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHTTCCCCCTTTTTTS
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHhccCCCCCCccccCC
Confidence 11123569999999999999999999999999999999999999985321 111111222221 111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.. .+..+...||+.||++|||++|+++|.|.....
T Consensus 237 s~---~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 237 SD---SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp CH---HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CH---HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 11 123566689999999999999999998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=320.60 Aligned_cols=228 Identities=18% Similarity=0.226 Sum_probs=176.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.....+....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4588889999999999999986 579999999997654333333567999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------- 438 (572)
|||++|+|.+++...+ .+++.....++.|++.|++||| +|++|.++..+.+.
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999887543 4888888999999999999996 57777765432110
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKV 516 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~ 516 (572)
.......||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+.... .+...++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~-- 235 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EYLIFQKIIKLEYDFPEKFFP-- 235 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCCCCTTCCH--
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-------HHHHHHHHHcCCCCCCccCCH--
Confidence 01123569999999999999999999999999999999999999986321 111122222222 2222221
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.++..+||+.||++|||++|+.++.+
T Consensus 236 -----~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 236 -----KARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -----HHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -----HHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 1235666999999999999999766544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=323.39 Aligned_cols=235 Identities=19% Similarity=0.295 Sum_probs=172.6
Q ss_pred ccCCccccccccccCeeEEEEEEcCC------CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~------g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+++++.+.+|.|+||+||+|+... ...||||++...... ...+.|.+|+++|.++ +|||||+++|+|.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 34567778899999999999998532 236999998754332 2246789999999998 89999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC--------------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCC
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED--------------------AVELDWAKRVNIVKAMAHALAYLH------HDCSP 429 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~--------------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~ 429 (572)
.+..++|||||++|+|.++|+.... ...++|..++.++.|+++||+||| +|++|
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 9999999999999999999986432 134899999999999999999996 57777
Q ss_pred CceeeCCCC----------------C---CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCcccc
Q 038466 430 SIASTCPDS----------------S---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 489 (572)
Q Consensus 430 ~i~~~~~~~----------------~---~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~ 489 (572)
.++..+.+. . ......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~- 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP- 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC-
Confidence 655432110 0 0123457999999999999999999999999999999998 899985321
Q ss_pred ccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 490 LSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
....+..++.....++.+..... .+..++..||+.||++||||+||+++|.
T Consensus 272 ------~~~~~~~~~~~~~~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 ------VDANFYKLIQNGFKMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------CSHHHHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHHHHHHhcCCCCCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11112222222222111111111 1345667999999999999999999984
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=314.43 Aligned_cols=227 Identities=22% Similarity=0.329 Sum_probs=168.0
Q ss_pred cCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-CeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 382 (572)
.+++++.+.+|.|+||.||+|++. |+.||||+++.... .++|.+|++++++++|||||+++|+|.++ +..++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 345677788999999999999984 77899999976542 35789999999999999999999999764 568999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeeCCC--------------CCCcc
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH------DCSPSIASTCPD--------------SSNRT 442 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~------~~~~~i~~~~~~--------------~~~~~ 442 (572)
|||+++|+|.++++... ...++|..+++++.|||.|+.|||+ |.+|..+..+.+ .....
T Consensus 80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 99999999999997532 2358999999999999999999984 455544432211 11123
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhh---cccCCCCCCChHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV---LDQRLPPPVDRKVIR 518 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~~~~~~ 518 (572)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.|++... .......+ ..+..++..+ .
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-------~~~~~~~i~~~~~~~~~~~~~----~ 227 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGCP----P 227 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-------GGGHHHHHTTTCCCCCCTTCC----H
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCCccCC----H
Confidence 3467899999999999999999999999999999998 677765321 11111111 1222222221 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
+ +.++...||+.||++||||.+|+++|...
T Consensus 228 ~---~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 228 A---VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 23566799999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=314.78 Aligned_cols=232 Identities=21% Similarity=0.314 Sum_probs=170.5
Q ss_pred ccCCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
..+++.+...+|.|+||+||+|+.++++.||||+++...... ++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 345677778899999999999999888889999998655432 578999999999999999999999854 568999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------S 438 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~ 438 (572)
||||++|+|..+++... ...++|.+++.++.+||+|++||| +|.+|..+..+.+ .
T Consensus 90 ~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999998887532 235899999999999999999997 4566654432110 0
Q ss_pred CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHH
Q 038466 439 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 518 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 518 (572)
.......||+.|+|||++....++.++|||||||++|||+||..|+.... ... .....+......+.+....+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~------~~~-~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNR-EVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHH-HHHHHHHTTCCCCCCTTSCH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC------CHH-HHHHHHHhcCCCCCCcccCH
Confidence 11223468999999999999999999999999999999999766653211 111 11222222222222111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 519 DILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 519 ~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
+ +.+++.+||+.||++||||++|++.+..
T Consensus 242 ~---l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 242 S---LHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp H---HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H---HHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 2 3456779999999999999999987643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=319.70 Aligned_cols=178 Identities=24% Similarity=0.295 Sum_probs=148.3
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++.+.+|.|+||+||+|+. .+|+.||||+++...... ..+++.+|+++|++++|||||+++++|.+++..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45677888999999999999985 579999999997543222 246789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh-------cCCCCCceeeCCCCC---------------C
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-------HDCSPSIASTCPDSS---------------N 440 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH-------~~~~~~i~~~~~~~~---------------~ 440 (572)
||||++|+|.+++++.. .+++.....++.|++.|+.||| +|++|.++....+.. .
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999997543 4889999999999999999997 356666554322110 1
Q ss_pred ccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCc
Q 038466 441 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDL 486 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~ 486 (572)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2235799999999999999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=314.42 Aligned_cols=236 Identities=22% Similarity=0.248 Sum_probs=177.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH---HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+.+++...+|.|+||+||+|+. .+|+.||||+++...... ....+.|.+|+++|++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4577888999999999999986 579999999986432211 112467899999999999999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
+|||||++|+|.+++.... .+++.....++.|++.|++||| +|++|.++..+..
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999997643 4889999999999999999997 5677765543211
Q ss_pred ---CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.......+ .
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~--~ 237 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYEFE--D 237 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCCCC--H
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCCCC--c
Confidence 111223568999999999999999999999999999999999999986321 1111112222111111 0
Q ss_pred HHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIR-DILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~-~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.... ....+.++...||+.||++|||++|+++|.|...
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000 0012345667999999999999999999987754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-37 Score=316.75 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=180.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||++......+ .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577888999999999999985 579999999998665433 367889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~~ 439 (572)
|||++|+|.+++..... .+++.....++.|++.||.||| +|++|.++....+ ..
T Consensus 103 E~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999865432 4889999999999999999996 5777776543211 01
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCC--CCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~ 517 (572)
......||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+..... +........
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCcccccCCC
Confidence 1223578999999999999999999999999999999999999985321 1111122222211 111111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
+ .+.++..+||+.||++|||++|+++|.|....
T Consensus 254 ~---~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 254 E---DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp H---HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1 12356668999999999999999999877643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-38 Score=310.14 Aligned_cols=233 Identities=20% Similarity=0.304 Sum_probs=161.9
Q ss_pred CCccccccccccCeeEEEEEEcC--CC--cEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP--NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~--~g--~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
+++++.+.+|.|+||.||+|+.. ++ ..||||+++.....+....++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45777888999999999999753 33 4789999986554444456789999999999999999999999965 4678
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------C
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------S 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------~ 438 (572)
+|||||++|++.+++.... ..++|..++.++.|+|+||.||| +|++|..+..+.+ .
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 9999999999998887543 35899999999999999999997 4566654432110 0
Q ss_pred C----CccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 439 S----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 439 ~----~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .......+......++..
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERLPRP 237 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCCCCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHHHHHHHHhCCCCCCCc
Confidence 0 0112357889999999999999999999999999999998 899985321 111112222222222111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.....+ +.+++..||+.||++||||.+|.+.|..
T Consensus 238 ~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 238 EDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111111 2356779999999999999999887754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-37 Score=309.89 Aligned_cols=236 Identities=23% Similarity=0.317 Sum_probs=177.0
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 376 (572)
+.+++++.+.+|.|+||+||+|+.. +++.||||+++.....+ ..++|.+|+++|++++||||++++|+|.++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH--HHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 4567888999999999999999753 46799999998654332 357899999999999999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCC---------------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCC
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLH------HDCSP 429 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~ 429 (572)
+..++||||+++|+|.++++.... ...++|..++.|+.|+|+||+||| +|.+|
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 999999999999999999975321 234889999999999999999997 46666
Q ss_pred CceeeCCC-------------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCC-CCCCcccc
Q 038466 430 SIASTCPD-------------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSS 489 (572)
Q Consensus 430 ~i~~~~~~-------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~-~P~~~~~~ 489 (572)
.++..+.+ ........||+.|+|||++.+..++.++|||||||++|||+||. +|+....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~- 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-
Confidence 55433211 01112345789999999999999999999999999999999996 5664221
Q ss_pred ccCCCCcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 490 LSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
.......+.+...++ .+..... .+..++..||+.||++||||.||+++|...
T Consensus 248 ------~~e~~~~v~~~~~~~-~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 ------HEEVIYYVRDGNILA-CPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp ------HHHHHHHHHTTCCCC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------HHHHHHHHHcCCCCC-CCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111222222322221 1111112 234577799999999999999999988643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-37 Score=308.15 Aligned_cols=233 Identities=22% Similarity=0.319 Sum_probs=170.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----eE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 379 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+....++|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4577888999999999999985 679999999998665544455678999999999999999999999987654 48
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC---------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------- 438 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------- 438 (572)
|+||||+++|+|.+++...+ .+++.+...++.|+++|++||| +|++|.++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999998887543 4889999999999999999997 57777765331110
Q ss_pred -----CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC--
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP-- 511 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~-- 511 (572)
.......||+.|||||++.+..++.++||||+||++|||+||+.||.... +.......+.....++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPIPPSA 236 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCCGGG
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHHHHhcCCCCCch
Confidence 11223569999999999999999999999999999999999999986321 1111111221111111
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRP-TMQYVSQEFLI 550 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RP-sm~~V~~~l~~ 550 (572)
....... .+..+..+|++.||++|| |++++.+.+..
T Consensus 237 ~~~~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 237 RHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TSSSCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hccCCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0001111 123456689999999999 79999887753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=302.19 Aligned_cols=228 Identities=21% Similarity=0.293 Sum_probs=169.2
Q ss_pred cCCccccccccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.+++++...+|.|+||+||+|+... +..||||+++..... ...+.|.+|++++++++|||||+++|+|. ++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 3457778899999999999998532 457999998754433 23468999999999999999999999985 4678
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------- 437 (572)
++||||+++|+|.+++.... ..+++..+..++.|+++||.||| +|++|.++..+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999998877543 35899999999999999999997 4666665432110
Q ss_pred --CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhccc---CCCCC
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---RLPPP 511 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~---~l~~~ 511 (572)
........||+.|+|||++....++.++|||||||++|||+| |++|+..... ......+... ..++.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-------~~~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERLPMPPN 233 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCCCCCCTT
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCCCC
Confidence 011223468999999999999999999999999999999998 8999864321 1111111211 12222
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.+ . .+..++..||+.||++|||++||+++|..
T Consensus 234 ~~----~---~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 234 CP----P---TLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp CC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 21 1 13456679999999999999999998854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=309.21 Aligned_cols=231 Identities=21% Similarity=0.304 Sum_probs=165.9
Q ss_pred CCccccccccccCeeEEEEEEcC-CCc----EEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM 379 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~----~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 379 (572)
.++++.+.+|.|+||+||+|+.. +|+ .||||+++.....+ ..++|.+|++++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C--THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 35778889999999999999853 454 58999987543222 246899999999999999999999999875 46
Q ss_pred EEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----------------
Q 038466 380 FLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------- 437 (572)
Q Consensus 380 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------- 437 (572)
++++||+.+|+|.+++.... ..++|..+..++.|||.||+||| +|.+|.++..+.+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 78999999999998887643 35899999999999999999997 4666655432100
Q ss_pred ---CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCCCcchhhhhhcccCCCCCCC
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 513 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 513 (572)
........||+.|||||++.++.++.++|||||||++|||+| |+.||+.... . .+...+.....++.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-------~-~~~~~i~~~~~~~~p 235 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------S-EISSILEKGERLPQP 235 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-------G-GHHHHHHHTCCCCCC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-------H-HHHHHHHcCCCCCCC
Confidence 011123458999999999999999999999999999999998 7888863321 1 111222211111111
Q ss_pred hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 514 RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 514 ~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..... .+..++.+||+.||++||||+||++++...
T Consensus 236 ~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 236 PICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCH---HHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11111 134567799999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-36 Score=311.76 Aligned_cols=234 Identities=19% Similarity=0.245 Sum_probs=179.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+ .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467778999999999999985 579999999998665433 357889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC------------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------SS 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------~~ 439 (572)
|||++|+|.+.+.... ..+++.+...++.|++.||.||| +|++|.++..... ..
T Consensus 106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999998876533 35888899999999999999996 6777776654211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 517 (572)
......||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+... ..+.+......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCcccccCCC
Confidence 1223568999999999999999999999999999999999999985321 11111122211 11211111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
. .+.++...||+.||++|||++|+++|.|....
T Consensus 257 ~---~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 257 P---EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp H---HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1 12356679999999999999999999877543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-36 Score=306.58 Aligned_cols=230 Identities=22% Similarity=0.335 Sum_probs=178.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.....+....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4577888999999999999986 569999999997654333334578999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCccc
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNRTL 443 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~~~ 443 (572)
|||++|+|..++.... .+++.....++.|++.|++||| +|++|.++..+.+. .....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 9999999998887643 3677777789999999999997 46777665432211 12234
Q ss_pred cccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHHHHHHH
Q 038466 444 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDIL 521 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~ 521 (572)
..||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.... .++..+..
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~~------ 227 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNAELRFPPFFNED------ 227 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHCCCCCCTTSCHH------
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHHHHcCCCCCCCCCCHH------
Confidence 679999999999999999999999999999999999999985321 111122222222 22222222
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHHHhhc
Q 038466 522 LASTISFACLQSNPKSRP-----TMQYVSQEFLIT 551 (572)
Q Consensus 522 ~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~ 551 (572)
+..+..+|++.||++|| |++++++|.|..
T Consensus 228 -~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 228 -VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp -HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred -HHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 23455689999999996 899999987754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=306.55 Aligned_cols=234 Identities=20% Similarity=0.256 Sum_probs=178.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+.+.+...+|.|+||+||+|.. .+|+.||||+++...... +.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3466778899999999999986 579999999998765432 46789999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC------------------C
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------------S 439 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------------~ 439 (572)
|||++|+|.+++.... ..+++.+...++.|++.|++||| +|++|.++....+. .
T Consensus 81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999997543 24788899999999999999997 57777655432111 1
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCChHHHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 519 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 519 (572)
......||+.|+|||...+..++.++||||+||++|||+||+.||.... .......+.......+. .....
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~--~~~~~ 229 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFDE--EAFKE 229 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCH--HHHTT
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCh--hhccC
Confidence 1123468999999999999999999999999999999999999985321 11112222222222111 10000
Q ss_pred -HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 520 -ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 520 -~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...+.++...|++.||++|||++|+++|.|..+.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0123456679999999999999999999877544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=305.78 Aligned_cols=228 Identities=20% Similarity=0.273 Sum_probs=167.4
Q ss_pred cccccccCeeEEEEEEcCC----CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCeEEEEEe
Q 038466 310 FSIWNYDGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIYE 384 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 384 (572)
..++|.|+||+||+|++.+ ...||||+++..... ...++|.+|+++|++++|||||+++|+|.+ ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3578999999999998643 236899999754322 235789999999999999999999999876 468999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------------
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------------- 438 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------------- 438 (572)
||++|+|.++++... ..++|..++.++.|+|+||.|+| +|++|..+..+...
T Consensus 110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999988643 35778889999999999999996 46666655332110
Q ss_pred -CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcc-cCCCCCCChHH
Q 038466 439 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDRKV 516 (572)
Q Consensus 439 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~ 516 (572)
.......||+.|+|||++....++.++||||||+++|||+||+.|+..... ... ....+.. .+...|. ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~-~~~~i~~g~~~~~p~--~~ 259 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFD-ITVYLLQGRRLLQPE--YC 259 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCCCCT--TC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHH-HHHHHHcCCCCCCcc--cC
Confidence 011224589999999999999999999999999999999998888642211 001 1111111 1111111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 517 IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. .+.+++..||+.||++||||+||+++|....
T Consensus 260 ~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 260 PD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1345677999999999999999999986654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=307.06 Aligned_cols=236 Identities=21% Similarity=0.269 Sum_probs=175.5
Q ss_pred ccCCccccccccccCeeEEEEEEc------CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~------~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+++++.+.+|.|+||.||+|++ .+++.||||+++...... ...+|.+|+.+++++ +|||||+++|+|.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH--HHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 445677778999999999999974 356799999998654332 246799999999999 69999999999999
Q ss_pred CCeEEEEEecccCCChhhhhhcCCC---------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNED---------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST 434 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~---------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~ 434 (572)
++..++|||||++|+|.++++.... ...+++..+..++.|||+|++||| +|.+|..+..
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 9999999999999999999976431 235889999999999999999997 4666655432
Q ss_pred CCC----------------C---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcC-CCCCCccccccCCC
Q 038466 435 CPD----------------S---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSS 494 (572)
Q Consensus 435 ~~~----------------~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG-~~P~~~~~~~~~~~ 494 (572)
+.+ . .......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~------ 252 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------ 252 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC------
Confidence 110 0 011235689999999999999999999999999999999995 55443211
Q ss_pred CcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 495 DPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 495 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.......++....++..+.....+ +.+++.+||+.||++||||++|++.|..
T Consensus 253 -~~~~~~~~i~~~~~~~~~~~~~~~---l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 253 -VDSKFYKMIKEGFRMLSPEHAPAE---MYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp -SSHHHHHHHHHTCCCCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHHhcCCCCCCcccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111222333333322221111121 3456679999999999999999998853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=305.71 Aligned_cols=231 Identities=21% Similarity=0.279 Sum_probs=178.8
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+++++.+++|.|+||+||+|+. .+|+.||||+++..........+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35678889999999999999985 57999999999765433333356788999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~ 439 (572)
||||++|+|.+++...+ .++......++.|++.|++||| +|++|.++..+.+ ..
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999988643 3667777788999999999997 5777766543211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc--CCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 517 (572)
.....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+... ..|...+..
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~~s~~-- 231 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRTLSPE-- 231 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCHH--
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-------HHHHHHHHhcCCCCCCccCCHH--
Confidence 2234679999999999999999999999999999999999999985321 11111222222 222222221
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 518 RDILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+..+...||+.||++||+ ++|+++|.|..
T Consensus 232 -----~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 232 -----AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp -----HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred -----HHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 234566899999999995 89999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=302.33 Aligned_cols=235 Identities=19% Similarity=0.229 Sum_probs=163.8
Q ss_pred cccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----eEEEEE
Q 038466 308 DVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMFLIY 383 (572)
Q Consensus 308 ~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 383 (572)
-+.+.+|.|+||.||+|++ +|+.||||+++.....+ ..+..|+..+.+++|||||+++|+|.+.+ ..++||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3445789999999999986 58899999997553221 12334566667899999999999998754 589999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc--------------CCCCCceeeCCCC-----------
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH--------------DCSPSIASTCPDS----------- 438 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~--------------~~~~~i~~~~~~~----------- 438 (572)
|||++|+|.+++++. .++|.++++++.++|.|++|+|. |++|.++..+.+.
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999863 48999999999999999999974 4455443221110
Q ss_pred ----------CCccccccccCccccccccCC------CcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CC
Q 038466 439 ----------SNRTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SS 494 (572)
Q Consensus 439 ----------~~~~~~~gt~~y~APE~~~~~------~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~ 494 (572)
.......||++|||||++... .++.|+|||||||++|||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 011234689999999998654 367899999999999999999988643221100 00
Q ss_pred CcchhhhhhcccCCCCCCChH--HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 495 DPKIMLIDVLDQRLPPPVDRK--VIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 495 ~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..........++...++.+.. .......+..++..||+.||++||||.||+++|...
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 001111122333333222111 112223345688899999999999999999988654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=304.94 Aligned_cols=232 Identities=22% Similarity=0.338 Sum_probs=168.1
Q ss_pred CCccccccccccCeeEEEEEEcC-CCc--EEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~-~g~--~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 380 (572)
+++++.+.+|.|+||+||+|++. +|. .||||+++.....+ ..++|.+|+++|+++ +|||||+++|+|.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH--HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 45667788999999999999865 444 57888876443322 246899999999998 7999999999999999999
Q ss_pred EEEecccCCChhhhhhcCC-------------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC----
Q 038466 381 LIYEYMKRGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---- 437 (572)
+||||+++|+|.++++... ....++|..+..++.|+|+|+.|+| +|.+|..+..+..
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 9999999999999997642 2346899999999999999999997 4566654432110
Q ss_pred ------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCC-CCCccccccCCCCcchhhhhhc
Q 038466 438 ------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH-PRDLLSSLSSSSDPKIMLIDVL 504 (572)
Q Consensus 438 ------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~-P~~~~~~~~~~~~~~~~~~~~~ 504 (572)
........||..|+|||.+....++.++|||||||++|||+||.. |+.... .......+.
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~~i~ 240 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLP 240 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHGG
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHHHHH
Confidence 011123468999999999999999999999999999999999765 554221 111111122
Q ss_pred cc-CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 505 DQ-RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 505 ~~-~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.. +.+.+. .... .+..++.+||+.||++||||+||+++|..
T Consensus 241 ~~~~~~~~~--~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 241 QGYRLEKPL--NCDD---EVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp GTCCCCCCT--TBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCCCCc--cCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 222111 1111 12356678999999999999999998744
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-36 Score=297.23 Aligned_cols=235 Identities=22% Similarity=0.277 Sum_probs=177.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcch------HHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSET------EELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR 376 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~------~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 376 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++.... ......+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4577788999999999999985 5799999999865431 12234467899999999997 99999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------- 437 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------- 437 (572)
+..|+|||||++|+|.++++... .+++.+...++.|+++|++||| +|.+|.++..+.+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999997543 5899999999999999999997 5677765543211
Q ss_pred ---CCCccccccccCccccccccC------CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC-
Q 038466 438 ---SSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR- 507 (572)
Q Consensus 438 ---~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~- 507 (572)
........||+.|+|||++.+ ..++.++||||+||++|||+||+.||.... .......+....
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-------~~~~~~~i~~~~~ 232 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRMIMSGNY 232 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-------HHHHHHHHHhCCC
Confidence 112234568999999998753 357889999999999999999999986321 111112222222
Q ss_pred -CCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 508 -LPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 508 -l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.+.+......+ .+.++..+||+.||++|||++||++|.|..+
T Consensus 233 ~~~~~~~~~~s~---~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 233 QFGSPEWDDYSD---TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCCTTTGGGSCH---HHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCcccccCCH---HHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 22211111112 2345667999999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=305.49 Aligned_cols=229 Identities=20% Similarity=0.331 Sum_probs=173.0
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHH-hcCCCCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 382 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++..........+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4577788999999999999986 479999999997544322223456677777765 68999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CC
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SS 439 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~ 439 (572)
||||++|+|.++++... .++..+...++.+++.|++||| +|++|..+..+.. ..
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999998643 4677788899999999999997 5667665533211 11
Q ss_pred CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhc--ccCCCCCCChHHH
Q 038466 440 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVI 517 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~ 517 (572)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.... .......+. .+..+...++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~p~~~s~~-- 229 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDNPFYPRWLEKE-- 229 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTSCHH--
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCccCCHH--
Confidence 2234579999999999999999999999999999999999999985321 111111121 22222222211
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhh
Q 038466 518 RDILLASTISFACLQSNPKSRPTMQ-YVSQEFLI 550 (572)
Q Consensus 518 ~~~~~~~~i~~~Cl~~dP~~RPsm~-~V~~~l~~ 550 (572)
+..+..+||+.||++|||+. ++.+|.|.
T Consensus 230 -----~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 230 -----AKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp -----HHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -----HHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 23556689999999999995 88887655
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-36 Score=300.69 Aligned_cols=235 Identities=21% Similarity=0.319 Sum_probs=171.1
Q ss_pred ccCCccccccccccCeeEEEEEEcC--------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEE
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFC 373 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~--------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 373 (572)
..+.+++.+.+|.|+||.||+|+.. ++..||||+++...... ...+|.+|...+.++ +|||||+++|+|
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3456677789999999999999742 23589999998655432 246788999999998 899999999999
Q ss_pred EeCCeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceee
Q 038466 374 LHRKCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIAST 434 (572)
Q Consensus 374 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~ 434 (572)
.+++..++|||||++|+|.++++.... ...+++..++.++.|+|.|++||| +|++|.++..
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 999999999999999999999976432 235899999999999999999996 5677766533
Q ss_pred CCCC-------------------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHc-CCCCCCccccccCCC
Q 038466 435 CPDS-------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS 494 (572)
Q Consensus 435 ~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~Ellt-G~~P~~~~~~~~~~~ 494 (572)
..+. .......||+.|+|||++.++.|+.|+|||||||++|||+| |+.||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------
Confidence 2110 01123568999999999999999999999999999999998 688875321
Q ss_pred CcchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 038466 495 DPKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLI 550 (572)
Q Consensus 495 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~ 550 (572)
.. .....+.....++.+.....+ +.+++.+||+.||++|||+.||++.|..
T Consensus 243 -~~-~~~~~i~~~~~~~~p~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 243 -VE-ELFKLLKEGHRMDKPSNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp -HH-HHHHHHHTTCCCCCCSSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HH-HHHHHHHcCCCCCCCccchHH---HHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 112222222222111111121 3457779999999999999999998843
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=302.02 Aligned_cols=236 Identities=21% Similarity=0.267 Sum_probs=171.2
Q ss_pred CCccccc-cccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe----CC
Q 038466 305 NNIDVFS-IWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----RK 377 (572)
Q Consensus 305 ~~~~~~~-~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~ 377 (572)
+++++.. ++|.|+||+||+|+. .+|+.||||+++.. +.+.+|++++.++ +|||||++++++.+ +.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 4566664 699999999999985 67999999999653 2456799887655 89999999999875 45
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
..|+|||||++|+|.+++.... ...+++.+...++.|++.|++||| +|++|.++.....
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6899999999999999998643 235889999999999999999996 5777765543211
Q ss_pred -----CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCC
Q 038466 438 -----SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 512 (572)
Q Consensus 438 -----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 512 (572)
........||+.|||||++.+..|+.++||||+||++|||+||+.||........ .......+.......+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCCCCCC
Confidence 1112345699999999999999999999999999999999999999864321100 00000111111111111
Q ss_pred ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 513 DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 513 ~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
... ..-...+.++...|++.||++|||+.|+++|.|..+.
T Consensus 239 ~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 239 PEW-SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp THH-HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccc-ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 110 0001123456679999999999999999999876544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=298.31 Aligned_cols=235 Identities=19% Similarity=0.250 Sum_probs=168.4
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH 375 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 375 (572)
..+++++.+.+|.|+||.||+|+.. +++.||||+++...... ..+.|.+|.+.+.++ +|+|||.+++++.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3456778889999999999999742 35789999997544332 246788888888877 68999999999876
Q ss_pred C-CeEEEEEecccCCChhhhhhcCCC-------------cccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeC
Q 038466 376 R-KCMFLIYEYMKRGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTC 435 (572)
Q Consensus 376 ~-~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~ 435 (572)
+ +..++|||||++|+|.++++.... ...++|.++..++.|+++||+||| +|++|.++..+
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 5 468999999999999999975421 234889999999999999999996 67777765331
Q ss_pred C-------------------CCCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCC-CCCCccccccCCCC
Q 038466 436 P-------------------DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSSSD 495 (572)
Q Consensus 436 ~-------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~-~P~~~~~~~~~~~~ 495 (572)
. .........||+.|||||++.+..++.++|||||||++|||+||. +||....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~------- 241 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------- 241 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-------
Confidence 1 011123357999999999999999999999999999999999975 5664221
Q ss_pred cchhhhhhcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 496 PKIMLIDVLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 496 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
........+.....++.+..... .+.+++.+||+.||++||||+||+++|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111122211111111111111 1345667999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=299.36 Aligned_cols=238 Identities=23% Similarity=0.269 Sum_probs=176.5
Q ss_pred ccCCccccccccccCeeEEEEEEcC------CCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q 038466 303 ATNNIDVFSIWNYDGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 376 (572)
Q Consensus 303 ~~~~~~~~~~~~~~~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 376 (572)
..+++.+.+.+|.|+||+||+|.+. +++.||||+++...... ....|.+|++++++++|||||+++|+|..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3456677788999999999999763 36789999998654332 246799999999999999999999999999
Q ss_pred CeEEEEEecccCCChhhhhhcCC-------CcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCC----
Q 038466 377 KCMFLIYEYMKRGSLFCNLHNNE-------DAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSS---- 439 (572)
Q Consensus 377 ~~~~lV~Ey~~~GsL~~~l~~~~-------~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~---- 439 (572)
+..++|||||++|+|.++++... ....++|..+..++.++|+||.||| +|++|.++..+.+..
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999999887531 2235789999999999999999997 456665543321100
Q ss_pred ---------------CccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCC-CCCCccccccCCCCcchhhhhh
Q 038466 440 ---------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSSSDPKIMLIDV 503 (572)
Q Consensus 440 ---------------~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~-~P~~~~~~~~~~~~~~~~~~~~ 503 (572)
......||+.|+|||.+.+..++.++|||||||++|||+||. .|+.... .......+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence 011235789999999999999999999999999999999985 6664221 11122223
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 504 LDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 504 ~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
.+...++.. ..... .+.+++.+||+.||++||||++|+++|....+
T Consensus 249 ~~~~~~~~p-~~~~~---~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDKP-DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCCc-ccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 333222111 11111 23456778999999999999999999865544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-35 Score=303.81 Aligned_cols=233 Identities=21% Similarity=0.240 Sum_probs=171.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHH---HHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 380 (572)
++|++.+.+|.|+||+||+|+. .+|+.||||++......... ...+..+|+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5678888999999999999985 57999999998754322211 1223344577888889999999999999999999
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC---------------CC
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD---------------SS 439 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~---------------~~ 439 (572)
+|||||++|+|.+++.... .+++.....++.+++.|++||| +|++|.++..+.+ ..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999997643 4678888899999999999997 5777776543211 11
Q ss_pred CccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccC--CCCCCChHH
Q 038466 440 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDRKV 516 (572)
Q Consensus 440 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~ 516 (572)
......||+.|||||++.. ..|+.++||||+||++|||+||+.||..... .............. .+...++.
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~- 235 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELPDSFSPE- 235 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHHHHSSSCCCCCCSSSCHH-
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccCCCCCCCCCCHH-
Confidence 2234579999999999865 5689999999999999999999999863211 01111111111111 12222211
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhhc
Q 038466 517 IRDILLASTISFACLQSNPKSRPT-----MQYVSQEFLIT 551 (572)
Q Consensus 517 ~~~~~~~~~i~~~Cl~~dP~~RPs-----m~~V~~~l~~~ 551 (572)
+..+...||+.||++||| ++|+++|.|..
T Consensus 236 ------~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 236 ------LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp ------HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred ------HHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 234566899999999999 69999887754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-35 Score=302.51 Aligned_cols=231 Identities=18% Similarity=0.247 Sum_probs=180.4
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEE
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 382 (572)
.+.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+....+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 35678888999999999999986 57999999999755433333456789999999999999999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------CCcc
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS--------------SNRT 442 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~--------------~~~~ 442 (572)
|||+.+|+|..++.... .++......++.|++.||.||| +|++|.++..+.+. ....
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999999999987643 4788888899999999999996 67787766443211 1223
Q ss_pred ccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC--CCCChHHHHHH
Q 038466 443 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--PPVDRKVIRDI 520 (572)
Q Consensus 443 ~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~~ 520 (572)
...||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+...... ...++.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~s~~----- 264 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPSHFSSD----- 264 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTTCCHH-----
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-------HHHHHHHHhcCCCCCCccCCHH-----
Confidence 4579999999999999999999999999999999999999985321 11122222222222 222211
Q ss_pred HHHHHHHHHccccCCCCC-----CCHHHHHHHHhhc
Q 038466 521 LLASTISFACLQSNPKSR-----PTMQYVSQEFLIT 551 (572)
Q Consensus 521 ~~~~~i~~~Cl~~dP~~R-----Psm~~V~~~l~~~ 551 (572)
+..+...||+.||++| ||++++++|.|..
T Consensus 265 --~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 265 --LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp --HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred --HHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence 2345568999999999 4899999987754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=296.15 Aligned_cols=241 Identities=20% Similarity=0.215 Sum_probs=165.2
Q ss_pred cccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH--HHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEecc
Q 038466 310 FSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM 386 (572)
Q Consensus 310 ~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 386 (572)
.+++|.|+||+||+|+. .+|+.||||+++...... ....+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 45789999999999996 469999999997554322 122357889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCccc
Q 038466 387 KRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNRTL 443 (572)
Q Consensus 387 ~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~~~ 443 (572)
.+|++....... ..+++.....++.|++.||+||| +|++|.++..+.. ......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 998877665432 24666778889999999999996 5777765543211 111223
Q ss_pred cccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc-------------CCCCcch-hhhhhcc-cC
Q 038466 444 LAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------SSSDPKI-MLIDVLD-QR 507 (572)
Q Consensus 444 ~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------------~~~~~~~-~~~~~~~-~~ 507 (572)
..||+.|+|||++... .++.++|||||||++|||+||+.||....... ....+.. ....... ..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 5699999999998654 57999999999999999999999985321100 0000000 0000000 00
Q ss_pred CCCCCChHHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 508 LPPPVDRKVI--RDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 508 l~~~~~~~~~--~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
.+. .+.... .....+.++..+|++.||++|||++|+++|.|.....
T Consensus 240 ~~~-~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPG-IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCC-CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCC-CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 010 000000 0001234566799999999999999999998876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-34 Score=288.84 Aligned_cols=252 Identities=19% Similarity=0.208 Sum_probs=173.2
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY 383 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 383 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++..... ....+++.+|+++|++++|||||++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 4577788999999999999985 67999999999754322 223467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CC
Q 038466 384 EYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SN 440 (572)
Q Consensus 384 Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~ 440 (572)
||+.++.+. .+... ....+++.....++.|++.||+||| +|++|.++..+.+. ..
T Consensus 81 e~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999866544 33322 2235899999999999999999997 56777766442211 11
Q ss_pred ccccccccCccccccccCCC-cCcccchHHHHHHHHHHHcCCCCCCccccc-------------cCCCCcchhhhhhccc
Q 038466 441 RTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSSDPKIMLIDVLDQ 506 (572)
Q Consensus 441 ~~~~~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~ElltG~~P~~~~~~~-------------~~~~~~~~~~~~~~~~ 506 (572)
.....||+.|+|||...... ++.++||||+||++|||+||+.||+..... .....+..........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 22346999999999876655 588999999999999999999998632210 0000000000000000
Q ss_pred CCCCCCChHHHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCCCcccc
Q 038466 507 RLPPPVDRKVIR----DILLASTISFACLQSNPKSRPTMQYVSQEFLITRKTPLVKH 559 (572)
Q Consensus 507 ~l~~~~~~~~~~----~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~~~~~~ 559 (572)
..+......... ....+.++..+|++.||++|||++|+++|.|...-+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~ 295 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCCC
Confidence 010000000000 00123456668999999999999999999887665555554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.8e-34 Score=283.93 Aligned_cols=243 Identities=21% Similarity=0.234 Sum_probs=170.8
Q ss_pred CCccccccccccCeeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
+.+++.+.+|.|+||+||+|+.++|+.||||+++.....+ ...++|.+|+++|++++|||||++++++.+++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 3567788999999999999999899999999997654322 224678999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------------CCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-----------------SNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-----------------~~~ 441 (572)
|+.++.+....... ..++......++.|++.||+||| +|++|.++..+.+. ...
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 99988777665543 35888889999999999999997 56777665432211 112
Q ss_pred cccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc-------------CCCCcchhhhhhccc-
Q 038466 442 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------SSSDPKIMLIDVLDQ- 506 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~-------------~~~~~~~~~~~~~~~- 506 (572)
....||+.|+|||.+.. ..++.++||||+||++|||+||+.||....... ....+........+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 23458899999999865 457999999999999999999999986432100 000000000000000
Q ss_pred ---CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 507 ---RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 507 ---~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+.+.......-...+.++..+|++.||++|||++|+++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 000000000000001234566689999999999999999987754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=286.74 Aligned_cols=227 Identities=18% Similarity=0.225 Sum_probs=169.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHH---HHHHHHHHHHHHHHHhcC--CCCcccEEEEEEeCCe
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHRKC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~---~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 378 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+ ....+++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3567778999999999999985 579999999986432111 011234678999999997 8999999999999999
Q ss_pred EEEEEecccC-CChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC--------------
Q 038466 379 MFLIYEYMKR-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-------------- 437 (572)
Q Consensus 379 ~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-------------- 437 (572)
.++||||+.+ +++.+++.... .+++.....++.|++.|++||| +|++|.++..+.+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999986 67777776532 4888889999999999999997 5777765543211
Q ss_pred --CCCccccccccCccccccccCCCc-CcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCCCCh
Q 038466 438 --SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDR 514 (572)
Q Consensus 438 --~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 514 (572)
....+...||+.|||||++.+..+ +.++||||+||++|||+||+.||+.... .. ......+...+.
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i~---~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II---RGQVFFRQRVSS 229 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH---HCCCCCSSCCCH
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------Hh---hcccCCCCCCCH
Confidence 111234579999999999887665 5779999999999999999999853211 00 001112222221
Q ss_pred HHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 515 KVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 515 ~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
. +.++..+||+.||++|||++|+++|.|...
T Consensus 230 ~-------~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 230 E-------CQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp H-------HHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred H-------HHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1 234566899999999999999999988654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-34 Score=286.51 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=164.6
Q ss_pred CCccccccccccCeeEEEEEEc-CC-CcEEEEEecCCcchHHHHHHHHHHHHHHHHHhc---CCCCcccEEEEEEe----
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH---- 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~-g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~---- 375 (572)
+.+++.+.+|.|+||+||+|+. .+ ++.||||+++.....+. ...++.+|+++|+.+ +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4678888999999999999985 44 67899999864332211 112455677776655 79999999999864
Q ss_pred -CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------
Q 038466 376 -RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------- 438 (572)
Q Consensus 376 -~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------- 438 (572)
....+++|||+++|++....... ...+++.....++.|++.||+||| +|++|.++......
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 24689999999998776544432 235788888899999999999996 57777665432110
Q ss_pred ------CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc----------CCC---Ccc-h
Q 038466 439 ------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSS---DPK-I 498 (572)
Q Consensus 439 ------~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----------~~~---~~~-~ 498 (572)
.......||+.|||||++.+..|+.++||||+||++|||+||+.||....... ... .+. .
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 11234579999999999999999999999999999999999999986332100 000 000 0
Q ss_pred h-hhhhcccCCCCCC---ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 499 M-LIDVLDQRLPPPV---DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 499 ~-~~~~~~~~l~~~~---~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
. ...........+. .....+ .+.++..+||+.||++|||++|+++|.|..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cchhhhhccccccchhhccccCCH---HHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 0 0000000000000 000001 123566689999999999999999998764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.2e-32 Score=280.84 Aligned_cols=242 Identities=22% Similarity=0.229 Sum_probs=165.0
Q ss_pred cCCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----- 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 377 (572)
.+.+++...+|.|+||+||+|+. .+|+.||||+++.....+ ...+++.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 45677788999999999999985 579999999998644332 33578899999999999999999999998654
Q ss_pred -eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------
Q 038466 378 -CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------- 437 (572)
Q Consensus 378 -~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------- 437 (572)
..++||||+ +++|....+.. .+++.....++.|++.||.||| +|++|..+..+.+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 479999999 55777666532 4889999999999999999997 5777766544221
Q ss_pred -CCCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcch---------
Q 038466 438 -SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI--------- 498 (572)
Q Consensus 438 -~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~--------- 498 (572)
....+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...+..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 112334679999999999876 4578999999999999999999999853221000 000000
Q ss_pred --hhhhhcccCCCCCCChHHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 499 --MLIDVLDQRLPPPVDRKVI-RDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 499 --~~~~~~~~~l~~~~~~~~~-~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
...... +........... ..-..+.++...|++.||++|||++|+++|.|...
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 251 AKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 000000 000000000000 00012345667899999999999999999987754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=276.55 Aligned_cols=245 Identities=17% Similarity=0.208 Sum_probs=166.3
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-------- 375 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 375 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||++......+ ...+++.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4577788999999999999985 579999999986543322 224578899999999999999999999865
Q ss_pred CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-----------
Q 038466 376 RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS----------- 438 (572)
Q Consensus 376 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~----------- 438 (572)
++..++||||+.+|.+....... ..+.......++.|+++|+.||| +|++|..+....+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34589999999988776554432 24677777889999999999996 56777655332110
Q ss_pred ----------CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCc--
Q 038466 439 ----------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP-- 496 (572)
Q Consensus 439 ----------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~-- 496 (572)
.......||+.|+|||++.+. .++.++||||+||++|||+||+.||+...... ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 011224689999999998765 68999999999999999999999986322100 00000
Q ss_pred -----chhhhhhcccCCCCCCC-hHHHHH---HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 497 -----KIMLIDVLDQRLPPPVD-RKVIRD---ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 497 -----~~~~~~~~~~~l~~~~~-~~~~~~---~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
..............+.. ...... ...+.++..+||+.||++|||++|+++|.|....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00000000000000000 111110 1123456779999999999999999999987654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=276.59 Aligned_cols=241 Identities=20% Similarity=0.169 Sum_probs=166.8
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEe------CC
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------RK 377 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~ 377 (572)
+.+++...+|.|+||+||+|+. .+|+.||||++....... ...+++.+|++++++++|||||++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4577888999999999999985 579999999997554322 234678999999999999999999999964 36
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..|+|||||.+|.+. .++. .+++.....++.|++.|+.||| +|++|.++....+.
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 789999999766554 4432 3788888899999999999996 57777665432211
Q ss_pred ---CCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcc------hhh
Q 038466 439 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK------IML 500 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~------~~~ 500 (572)
.......||+.|+|||++.+..++.++||||+||+++||++|+.||....... ....++ ...
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 11233468999999999999999999999999999999999999984221000 000000 000
Q ss_pred hh---------------hcccCCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 501 ID---------------VLDQRLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 501 ~~---------------~~~~~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.. .......+............+.++..+|++.||++|||++|+++|.|...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00 01111111111111112223456777999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.4e-32 Score=278.33 Aligned_cols=236 Identities=22% Similarity=0.266 Sum_probs=162.8
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC------Ce
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KC 378 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 378 (572)
.+...+++|.|+||+||+|+. .+|+.||||++..... .+.+|+++|++++|||||+++++|... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 356677899999999999996 5699999999976532 234799999999999999999998653 24
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.++|||||++|.+....+.......+++.+...++.|++.||+||| +|++|.++..+.+.
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 7899999997754444332223346899999999999999999997 56777655432211
Q ss_pred ---CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCccccccC--------CCCcchhhhh----
Q 038466 439 ---SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLID---- 502 (572)
Q Consensus 439 ---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~--------~~~~~~~~~~---- 502 (572)
.......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||........ ..........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 11223468999999998764 5789999999999999999999999853211000 0000000000
Q ss_pred hcccCCCC----CC----ChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 503 VLDQRLPP----PV----DRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 503 ~~~~~l~~----~~----~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
..+...+. +. ...... .+.++..+|++.||++|||+.|+++|.|..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccccCchhhhcccCCCH---HHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00000000 00 000001 134556689999999999999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=274.92 Aligned_cols=241 Identities=19% Similarity=0.169 Sum_probs=166.3
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----eEE
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMF 380 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 380 (572)
.+++.+.+|.|+||+||+|+. .+|+.||||+++..... ...+++.+|+++|++++|||||++++++..+. ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467788999999999999984 68999999999754432 23468899999999999999999999997653 235
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS---------------- 438 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~---------------- 438 (572)
+++||+.+|+|.+++... .+++.....++.|++.|++||| +|++|.++..+.+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 556777899999999753 4888999999999999999996 57777765432211
Q ss_pred ----CCccccccccCccccccccC-CCcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCcc-------
Q 038466 439 ----SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK------- 497 (572)
Q Consensus 439 ----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~~------- 497 (572)
.......||+.|+|||++.. ..++.++||||+||++|||+||+.||+...... ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 01123458999999999854 567899999999999999999999986322100 000000
Q ss_pred --hhhhhh-cccCCCCCCChHHHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHhhccC
Q 038466 498 --IMLIDV-LDQRLPPPVDRKVIRD-ILLASTISFACLQSNPKSRPTMQYVSQEFLITRK 553 (572)
Q Consensus 498 --~~~~~~-~~~~l~~~~~~~~~~~-~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~ 553 (572)
...... .......+. ...... ...+..+...|++.||++|||++|+++|.|....
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCH-HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000 000000000 000000 0123456779999999999999999999876533
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-31 Score=266.32 Aligned_cols=242 Identities=19% Similarity=0.196 Sum_probs=172.1
Q ss_pred CccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeCCeEEEEEe
Q 038466 306 NIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 384 (572)
Q Consensus 306 ~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 384 (572)
.+++.+.+|.|+||+||+|+. .+|+.||||+++.....+ ...+++.+|+++|++++|||||+++++|.+++..++|+|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 567788999999999999985 579999999986544322 235788999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------CCCc
Q 038466 385 YMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD-----------------SSNR 441 (572)
Q Consensus 385 y~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~-----------------~~~~ 441 (572)
|+.++++..+++..+ .+++.....++.|++.||+||| +|++|..+..... ....
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988776543 4678888899999999999997 5677765533211 1111
Q ss_pred cccccccCccccccccCCC-cCcccchHHHHHHHHHHHcCCCCCCcccccc----------C----CCCcch-hhhhhcc
Q 038466 442 TLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------S----SSDPKI-MLIDVLD 505 (572)
Q Consensus 442 ~~~~gt~~y~APE~~~~~~-~s~ksDVySfGvvl~ElltG~~P~~~~~~~~----------~----~~~~~~-~~~~~~~ 505 (572)
....+++.|+|||++.... ++.++||||+||++|||+||+.|+....... . ...+.. ...+...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 2345678899999987665 6899999999999999999999963211000 0 000000 0000000
Q ss_pred -----cCCCC-CCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhccCC
Q 038466 506 -----QRLPP-PVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLITRKT 554 (572)
Q Consensus 506 -----~~l~~-~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~~~ 554 (572)
..... ........ .+.++..+|++.||++|||++||++|.|...-.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~---~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNA---TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccchhhhccccCCH---HHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 00000 00000001 133456689999999999999999998876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.3e-31 Score=269.40 Aligned_cols=229 Identities=14% Similarity=0.176 Sum_probs=159.9
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEE-EEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG-FCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~~~lV 382 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||.+...... +++..|++++++++|+|+|..++ +..+++..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 3577888999999999999985 57999999998765432 35778999999998887666555 45677889999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
|||+. |++.+.+.... ..+++.....++.|+++|++||| +|++|.++.....
T Consensus 82 me~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99995 56655555432 25889999999999999999996 6788876532100
Q ss_pred --------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCC
Q 038466 438 --------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 509 (572)
Q Consensus 438 --------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~ 509 (572)
........||+.|||||+..+..++.++|||||||++|||+||+.||.......... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~ 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----KYERISEKKMS 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH----HHHHhhcccCC
Confidence 001123569999999999999999999999999999999999999986432111000 00011111110
Q ss_pred CCCC---hHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 510 PPVD---RKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 510 ~~~~---~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+.. ..... .+..++..||+.||++||+++++.+.+
T Consensus 235 ~~~~~~~~~~p~---~~~~li~~cl~~~p~~RP~~~~i~~~l 273 (299)
T d1ckia_ 235 TPIEVLCKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLF 273 (299)
T ss_dssp SCHHHHTTTSCH---HHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred CChhHhccCCCH---HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 1000 00001 123566689999999999998775543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-31 Score=271.60 Aligned_cols=243 Identities=19% Similarity=0.175 Sum_probs=170.7
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----Ce
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KC 378 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 378 (572)
+.+++.+.+|.|+||+||+|+. .+|+.||||+++...... ...+++.+|+++|++++|||||++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4577888999999999999984 679999999998654332 2346788999999999999999999998643 34
Q ss_pred EEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC--------------
Q 038466 379 MFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS-------------- 438 (572)
Q Consensus 379 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~-------------- 438 (572)
.+++|||+.+|+|.++++.. .+++.....++.|++.||.||| +|++|.++..+.+.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 57788889999999998643 4888888999999999999997 46777665443221
Q ss_pred CCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------CCCCc-------chhhh
Q 038466 439 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP-------KIMLI 501 (572)
Q Consensus 439 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------~~~~~-------~~~~~ 501 (572)
.......||+.|+|||+..+. .++.++||||+||++|||+||+.||....... ..... .....
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 112234688999999986665 56899999999999999999999985321100 00000 00000
Q ss_pred hhcc--cCCCCCCChHH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhcc
Q 038466 502 DVLD--QRLPPPVDRKV-IRDILLASTISFACLQSNPKSRPTMQYVSQEFLITR 552 (572)
Q Consensus 502 ~~~~--~~l~~~~~~~~-~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~~ 552 (572)
.... ...+....... ......+.++..+|++.||++|||++|+++|.|...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0000 00010000000 000012345667999999999999999999988764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=3.6e-30 Score=262.26 Aligned_cols=233 Identities=16% Similarity=0.171 Sum_probs=166.6
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeC--CeEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR--KCMF 380 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~ 380 (572)
+++++.+.+|.|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 4577788999999999999985 579999999997654 246788999999995 99999999999754 4689
Q ss_pred EEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-----------------
Q 038466 381 LIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD----------------- 437 (572)
Q Consensus 381 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~----------------- 437 (572)
+|||||++|+|....+ .++......++.|++.||.||| +|++|.++..+.+
T Consensus 109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999976543 3778888899999999999995 6788776543211
Q ss_pred CCCccccccccCccccccccCC-CcCcccchHHHHHHHHHHHcCCCCCCcccccc---------------------CCCC
Q 038466 438 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------------------SSSD 495 (572)
Q Consensus 438 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~---------------------~~~~ 495 (572)
........||+.|+|||.+.+. .++.++||||+||+++||++|+.|+....... ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 1122345689999999997765 57999999999999999999999985321100 0000
Q ss_pred cchhhhhhccc-------CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhc
Q 038466 496 PKIMLIDVLDQ-------RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEFLIT 551 (572)
Q Consensus 496 ~~~~~~~~~~~-------~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~~~ 551 (572)
........... ............ ..+.++..+|++.||++|||++|+++|.|..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVS--PEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCC--HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cCcccchhcccccccchhhcccccccccCC--HHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00000000000 000000001110 1234566789999999999999999988754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=269.18 Aligned_cols=238 Identities=22% Similarity=0.317 Sum_probs=168.7
Q ss_pred cCCccccccccccCeeEEEEEEc----CCCcEEEEEecCCcchH-HHHHHHHHHHHHHHHHhcCC-CCcccEEEEEEeCC
Q 038466 304 TNNIDVFSIWNYDGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRK 377 (572)
Q Consensus 304 ~~~~~~~~~~~~~~fG~Vyk~~~----~~g~~vAvK~l~~~~~~-~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~ 377 (572)
.+++++.+.+|.|+||+||+|+. .+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 35677888999999999999974 25899999998754211 11113568899999999987 89999999999999
Q ss_pred eEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCC-------------
Q 038466 378 CMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDS------------- 438 (572)
Q Consensus 378 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~------------- 438 (572)
..++||||+.+|+|.+++..... +.......++.|++.|+.|+| +|.+|.++..+.+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999876542 445566778899999999997 46777655432211
Q ss_pred -----CCccccccccCccccccccCC--CcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhcccCCCCC
Q 038466 439 -----SNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 511 (572)
Q Consensus 439 -----~~~~~~~gt~~y~APE~~~~~--~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 511 (572)
.......||+.|+|||.+... .++.++||||+||+||||+||+.||...... ...............+.+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~---~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPPYP 256 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCCCCC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcccCCCCCc
Confidence 111234689999999998654 4788999999999999999999998643210 000111111112222211
Q ss_pred CChHHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhhcc
Q 038466 512 VDRKVIRDILLASTISFACLQSNPKSRP-----TMQYVSQEFLITR 552 (572)
Q Consensus 512 ~~~~~~~~~~~~~~i~~~Cl~~dP~~RP-----sm~~V~~~l~~~~ 552 (572)
. .... .+..+..+||+.||++|| |++|+++|.|...
T Consensus 257 ~--~~s~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 257 Q--EMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp T--TSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred c--cCCH---HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 1 1111 123455689999999999 4899999877643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=9.1e-31 Score=262.38 Aligned_cols=225 Identities=16% Similarity=0.125 Sum_probs=166.1
Q ss_pred CCccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCeEEEE
Q 038466 305 NNIDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFLI 382 (572)
Q Consensus 305 ~~~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 382 (572)
+.+.+.+.+|.|+||+||+|+. .+|+.||||++...... ..+.+|++.++.++| +|++.+++++.++...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 4567788999999999999985 57999999998654322 346678899999976 8999999999999999999
Q ss_pred EecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCC-------------------
Q 038466 383 YEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPD------------------- 437 (572)
Q Consensus 383 ~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~------------------- 437 (572)
|||+ +|+|.++++.... .+++.....++.+++.|++||| +|++|.++.....
T Consensus 80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 6899988875433 5788899999999999999996 5777775543110
Q ss_pred ----------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCCCcchhhhhhccc-
Q 038466 438 ----------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ- 506 (572)
Q Consensus 438 ----------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~- 506 (572)
........||+.|||||++.+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~~~~~i~~~~ 232 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGEKK 232 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch----hHHHHHHHHHhcc
Confidence 00112356999999999999999999999999999999999999998633210 000011111110
Q ss_pred ------CCCCCCChHHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 038466 507 ------RLPPPVDRKVIRDILLASTISFACLQSNPKSRPTMQYVSQEF 548 (572)
Q Consensus 507 ------~l~~~~~~~~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l 548 (572)
.+.+..+ + .+..+...|++.+|++||+.+.+.+.+
T Consensus 233 ~~~~~~~l~~~~p----~---~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 233 QSTPLRELCAGFP----E---EFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp HHSCHHHHTTTSC----H---HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CCCChHHhcCCCC----H---HHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 0111111 1 123455689999999999988776654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=2.7e-27 Score=243.88 Aligned_cols=241 Identities=16% Similarity=0.166 Sum_probs=162.4
Q ss_pred ccccccccccCeeEEEEEEc-CCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-----------CCCcccEEEEEE
Q 038466 307 IDVFSIWNYDGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRNIVKLYGFCL 374 (572)
Q Consensus 307 ~~~~~~~~~~~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~ 374 (572)
+.+...+|.|+||+||+|+. .+|+.||||+++..... .+.+.+|++++++++ |+|||++++++.
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 77888999999999999985 67999999999865432 256778898888875 578999999876
Q ss_pred e--CCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHhc-------CCCCCceeeCCC--------
Q 038466 375 H--RKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------DCSPSIASTCPD-------- 437 (572)
Q Consensus 375 ~--~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~-------~~~~~i~~~~~~-------- 437 (572)
. ....+++|+++..+..............++......++.++++|++|||+ |++|.++.....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 45677888887766544333333334457777888899999999999974 456654432100
Q ss_pred ------------CCCccccccccCccccccccCCCcCcccchHHHHHHHHHHHcCCCCCCccccccCCC-----------
Q 038466 438 ------------SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS----------- 494 (572)
Q Consensus 438 ------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVySfGvvl~ElltG~~P~~~~~~~~~~~----------- 494 (572)
........||+.|+|||+.....++.++||||+||+++||++|+.||..........
T Consensus 171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 011123568999999999999999999999999999999999999986322100000
Q ss_pred ---Ccchhh------hhhcc-----cCCCCCC--C-hH--------HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 038466 495 ---DPKIML------IDVLD-----QRLPPPV--D-RK--------VIRDILLASTISFACLQSNPKSRPTMQYVSQEFL 549 (572)
Q Consensus 495 ---~~~~~~------~~~~~-----~~l~~~~--~-~~--------~~~~~~~~~~i~~~Cl~~dP~~RPsm~~V~~~l~ 549 (572)
.+.... ....+ ....... . .. .......+.++..+|++.||++|||++|+++|.|
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000000 00000 0000000 0 00 0111223567788999999999999999999987
Q ss_pred hc
Q 038466 550 IT 551 (572)
Q Consensus 550 ~~ 551 (572)
..
T Consensus 331 f~ 332 (362)
T d1q8ya_ 331 LK 332 (362)
T ss_dssp GT
T ss_pred cC
Confidence 65
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.87 E-value=6.2e-23 Score=206.55 Aligned_cols=179 Identities=31% Similarity=0.544 Sum_probs=152.1
Q ss_pred hhhhHHHHhhhcCCC---CCCCCCCCCCCCC--ccceeeCCCC---CEEEEEeCCCccCcccccCccccCCCCCCcEEEc
Q 038466 62 LSPIQLEKKALINTG---WWNSSFWTTDHCK--WEGITCNSAG---SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTI 133 (572)
Q Consensus 62 ~~~l~~~~~~~~~~~---~~~~~~~~~~~c~--w~Gv~c~~~~---~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 133 (572)
..+++.+|+++.++. .|.. ++|||. |.||+|+..+ +|++|++++........+. ..++++++|++|+|
T Consensus 8 ~~aLl~~k~~~~~~~~l~sW~~---~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp-~~l~~L~~L~~L~L 83 (313)
T d1ogqa_ 8 KQALLQIKKDLGNPTTLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFLYI 83 (313)
T ss_dssp HHHHHHHHHHTTCCGGGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCSEEEE
T ss_pred HHHHHHHHHHCCCCCcCCCCCC---CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC-hHHhcCcccccccc
Confidence 467899999876543 3432 379994 9999998653 7999999864322111121 25889999999999
Q ss_pred cC-CcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCC
Q 038466 134 QF-FALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG 212 (572)
Q Consensus 134 ~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g 212 (572)
++ |.+.|.+|++|++|++|++|+|++|++++..|..+..+.+|+.++++.|++.+.+|..+++++.|+.+++++|.++|
T Consensus 84 s~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~ 163 (313)
T d1ogqa_ 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163 (313)
T ss_dssp EEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred ccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccc
Confidence 86 89999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhhhcccc-CccccCCCcccCCccccCCC
Q 038466 213 KIPPEIAGMKNL-TWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 213 ~~p~~~~~l~~L-~~L~ls~N~l~g~ip~~~s~ 244 (572)
.+|..++.+.++ +.++++.|+++|..|..+..
T Consensus 164 ~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 999999988876 88999999999999877643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=8e-16 Score=142.77 Aligned_cols=114 Identities=24% Similarity=0.280 Sum_probs=101.2
Q ss_pred CCCcEEEccCCcccccC-chhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 126 PNLVKLTIQFFALTGSI-PPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
+++++|+|++|.+++.+ +..|.++++|+.|+|++|.+++..+..+..+++|++|+|++|++.+..|..|.++++|+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 57899999999998765 45578899999999999999988888999999999999999999988888899999999999
Q ss_pred eccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 205 LSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 205 ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
|++|++++..|..|..+++|++|+|++|.+....+
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999998778888999999999999998876543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.56 E-value=8.8e-16 Score=153.49 Aligned_cols=120 Identities=33% Similarity=0.546 Sum_probs=113.5
Q ss_pred CCCcEEEccCCcccc--cCchhccCCccCCEEEccC-CcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCe
Q 038466 126 PNLVKLTIQFFALTG--SIPPEISALSKLQLLDLSS-NGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSN 202 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g--~ip~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 202 (572)
.+++.|+|++|.+.| .+|+++++|++|++|||++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 368899999999998 5899999999999999997 8999999999999999999999999999999999999999999
Q ss_pred eEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 203 LDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 203 L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
+++++|.+.+.+|..++++++|+.+++++|.++|.+|..+...
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l 172 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCC
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccc
Confidence 9999999999999999999999999999999999999877544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.6e-13 Score=117.48 Aligned_cols=103 Identities=26% Similarity=0.359 Sum_probs=87.1
Q ss_pred cEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccC
Q 038466 129 VKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSN 208 (572)
Q Consensus 129 ~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N 208 (572)
+.|+|++|.++. +| .+.++++|++||+++|.++ .+|+.++.+++|++|++++|.++. +| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 578999999984 44 4889999999999999998 678889999999999999999875 45 4899999999999999
Q ss_pred cCCCCC-chhhhhccccCccccCCCcccC
Q 038466 209 KLSGKI-PPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 209 ~l~g~~-p~~~~~l~~L~~L~ls~N~l~g 236 (572)
+++... +..++.+++|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998532 2568889999999999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.42 E-value=2.6e-13 Score=125.39 Aligned_cols=153 Identities=24% Similarity=0.282 Sum_probs=124.5
Q ss_pred CCccceeeCCC----------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEc
Q 038466 88 CKWEGITCNSA----------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL 157 (572)
Q Consensus 88 c~w~Gv~c~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 157 (572)
|+|+.|.|... ..++.|++++.... ..+....|..+++|+.|+|++|.+.+..+..+..+++|++|+|
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~--~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELG--RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCC--SBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCc--ccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 67888999743 24677777653221 1123345788999999999999999999999999999999999
Q ss_pred cCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 158 SSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 158 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeC
Confidence 999999888888999999999999999999988999999999999999999998654322 2224567778888888888
Q ss_pred ccccCC
Q 038466 238 IPVRLS 243 (572)
Q Consensus 238 ip~~~s 243 (572)
.|..+.
T Consensus 165 ~p~~l~ 170 (192)
T d1w8aa_ 165 APSKVR 170 (192)
T ss_dssp SSTTTT
T ss_pred CChhhc
Confidence 887653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=5.4e-13 Score=131.04 Aligned_cols=128 Identities=24% Similarity=0.250 Sum_probs=110.3
Q ss_pred ccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCC
Q 038466 119 QLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLT 198 (572)
Q Consensus 119 ~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 198 (572)
...|.++++|+.|++++|.+.+..+..+..+.+|+.+++++|.+++..+..|..+++|+.|++++|++.+..|..|.+++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~ 177 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcccc
Confidence 33578888999999999998887777888889999999999999876677788889999999999999888888889999
Q ss_pred ccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCCC
Q 038466 199 NLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPNK 246 (572)
Q Consensus 199 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n~ 246 (572)
+|+.+++++|++++..|..|..+++|++||+++|.+++..|..+....
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred ccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 999999999999988889999999999999999999887776665444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=5.3e-13 Score=131.09 Aligned_cols=117 Identities=25% Similarity=0.230 Sum_probs=76.3
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.+++++|.+++..+..|..+++|+.|+|++|++++..|..+.++++|+.+++++|++++..|..|.++++|
T Consensus 124 ~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L 203 (284)
T d1ozna_ 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred ccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhc
Confidence 34555666666666666665555556666666666666666666556666666666666666666666666666666666
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
+.|++++|.+.+..|..|+.+++|++|++++|.+.+.
T Consensus 204 ~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 6666666666666666666666666666666666543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.6e-12 Score=126.38 Aligned_cols=122 Identities=28% Similarity=0.296 Sum_probs=78.6
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
++.+++|+.|+|++|.+.+. |..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.+.+..+..+..+++|+
T Consensus 73 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~ 151 (266)
T d1p9ag_ 73 DGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (266)
T ss_dssp CSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch
Confidence 34455566666666655543 44455566666666666666555555556666666666666666665566666777777
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+
T Consensus 152 ~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~ 194 (266)
T d1p9ag_ 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194 (266)
T ss_dssp EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred hcccccccccccCccccccccccceeecccCCCc-ccChhHCCC
Confidence 7777777777666666777777777777777777 677665443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.3e-12 Score=117.32 Aligned_cols=112 Identities=20% Similarity=0.242 Sum_probs=95.2
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+.+..+++.|+|++|.++.. |..+..+++|++|||++|.++. ++ .+..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 366777899999999999864 6666889999999999999984 44 58899999999999999987666667889999
Q ss_pred CeeEeccCcCCCCCc--hhhhhccccCccccCCCcccC
Q 038466 201 SNLDLSSNKLSGKIP--PEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g 236 (572)
+.|++++|+++. ++ ..+..+++|++|++++|.++.
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCcccc
Confidence 999999999984 34 467889999999999998864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=5e-12 Score=122.81 Aligned_cols=114 Identities=28% Similarity=0.273 Sum_probs=106.7
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|++++..|..|..+++|
T Consensus 95 ~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L 174 (266)
T d1p9ag_ 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174 (266)
T ss_dssp CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTC
T ss_pred ccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccc
Confidence 46788999999999999999888889999999999999999997777778899999999999999999888999999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
++|+|++|+++ .+|+.+..+++|+.|+|++|.+.
T Consensus 175 ~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 99999999999 79999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.28 E-value=4.3e-12 Score=116.94 Aligned_cols=151 Identities=13% Similarity=0.028 Sum_probs=96.9
Q ss_pred ccccccccCeeEEEEEEcCCCcEEEEEecCCcchH---------------HHHHHHHHHHHHHHHHhcCCCCcccEEEEE
Q 038466 309 VFSIWNYDGYGSVYKAQLPNGKVFALKKLHTSETE---------------ELAFIKSFRNEAQVLSQVLHRNIVKLYGFC 373 (572)
Q Consensus 309 ~~~~~~~~~fG~Vyk~~~~~g~~vAvK~l~~~~~~---------------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 373 (572)
+...+|.|+||+||+|+..+|+.||||+++..... .........+|.+.+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 34678999999999999889999999987532110 111234566789999999999999988763
Q ss_pred EeCCeEEEEEecccCCChhhhhhcCCCcccCCHHHHHHHHHHHHHHHHHHh------cCCCCCceeeCCCCCCccccccc
Q 038466 374 LHRKCMFLIYEYMKRGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH------HDCSPSIASTCPDSSNRTLLAGT 447 (572)
Q Consensus 374 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~r~~i~~~ia~gl~yLH------~~~~~~i~~~~~~~~~~~~~~gt 447 (572)
. .+++|||++++.+.+. .......++.+++++++||| +|++|.++...... -..+..|+
T Consensus 84 --~--~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 84 --G--NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp --T--TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred --C--CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 2 3699999998765331 11223468899999999997 46666655443211 01111222
Q ss_pred cC----cccccccc----------CCCcCcccchHHHHHHH
Q 038466 448 YG----YIAPELAY----------TMVMTEKCDVYSFGVVT 474 (572)
Q Consensus 448 ~~----y~APE~~~----------~~~~s~ksDVySfGvvl 474 (572)
.. ..+.+++. ...|+.++|+||..--+
T Consensus 149 a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 11 12222221 24678999999975433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.26 E-value=2.1e-11 Score=120.53 Aligned_cols=154 Identities=25% Similarity=0.297 Sum_probs=94.3
Q ss_pred CCccceeeCCC----------CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEc
Q 038466 88 CKWEGITCNSA----------GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDL 157 (572)
Q Consensus 88 c~w~Gv~c~~~----------~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~L 157 (572)
|.|++|.|+.. ..++.|++++... ..+....|.++++|+.|++++|.+....|..|.++++|++|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i---~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKI---TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCC---CCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcC---CCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 78999999752 2356677664311 1233335778888888888888888877778888888888888
Q ss_pred cCCcCCCC-----------------------------------------------CCcCCcCCCCcc-------------
Q 038466 158 SSNGLTGT-----------------------------------------------IPPEIGNLKNLI------------- 177 (572)
Q Consensus 158 s~N~l~g~-----------------------------------------------ip~~~~~l~~L~------------- 177 (572)
++|+++.. .+..+..+++|+
T Consensus 87 ~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~ 166 (305)
T d1xkua_ 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166 (305)
T ss_dssp CSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred cCCccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccC
Confidence 88866421 011122233344
Q ss_pred --------eeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCCC
Q 038466 178 --------ELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSPN 245 (572)
Q Consensus 178 --------~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~n 245 (572)
.|++++|...+..|..+.+++.++.|++++|.+++..|..+.++++|+.|+|++|.|+ .+|.++..+
T Consensus 167 ~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l 241 (305)
T d1xkua_ 167 QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241 (305)
T ss_dssp SSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred cccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence 4444444444445555556666666666666666555556666666666666666665 455555433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.21 E-value=1.8e-11 Score=104.42 Aligned_cols=104 Identities=25% Similarity=0.326 Sum_probs=86.1
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCC-CccccCCCc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPI-PSALGSLTN 199 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~ 199 (572)
.+..+++|++|++++|.++ .+|+.++.+++|+.|++++|.+++ +| .++.+++|++|++++|++.... ...++.+++
T Consensus 15 ~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~ 91 (124)
T d1dcea3 15 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91 (124)
T ss_dssp CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCC
Confidence 3678899999999999998 478889999999999999999995 55 5899999999999999997543 367899999
Q ss_pred cCeeEeccCcCCCC--Cch-hhhhccccCcc
Q 038466 200 LSNLDLSSNKLSGK--IPP-EIAGMKNLTWL 227 (572)
Q Consensus 200 L~~L~ls~N~l~g~--~p~-~~~~l~~L~~L 227 (572)
|+.|++++|.++.. .+. -...+++|+.+
T Consensus 92 L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 92 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 99999999999742 223 34456777654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=5.6e-11 Score=117.39 Aligned_cols=112 Identities=29% Similarity=0.362 Sum_probs=90.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.+++++|.+.. +|.. .+++|+.|++++|..++..+..+.+++.+++|++++|.+.+..|..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 36667888888888888764 4443 35788888888888888888888888888888888888888778888888888
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
++|+|++|.++ .+|..+..+++|++|+|++|+++.
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 88888888887 578888888888888888888874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=4.9e-11 Score=106.00 Aligned_cols=89 Identities=25% Similarity=0.203 Sum_probs=69.4
Q ss_pred cCCCCCCcEEEccCCc-ccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 122 FSCFPNLVKLTIQFFA-LTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
+..+++|+.|++++|. ++..-+..|.++++|+.|+|++|+++...|..|.++++|++|+|++|+++...+..+. ..+|
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~-~~~l 105 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ-GLSL 105 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC-SCCC
T ss_pred ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhc-cccc
Confidence 5567788888887664 7766667788888999999999998877777788888999999999988754444444 4478
Q ss_pred CeeEeccCcCC
Q 038466 201 SNLDLSSNKLS 211 (572)
Q Consensus 201 ~~L~ls~N~l~ 211 (572)
+.|+|++|.+.
T Consensus 106 ~~L~L~~Np~~ 116 (156)
T d2ifga3 106 QELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCC
T ss_pred cccccCCCccc
Confidence 88888888875
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=5.5e-11 Score=105.68 Aligned_cols=103 Identities=21% Similarity=0.139 Sum_probs=84.0
Q ss_pred EEccCCcccccCchhccCCccCCEEEccCC-cCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCc
Q 038466 131 LTIQFFALTGSIPPEISALSKLQLLDLSSN-GLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNK 209 (572)
Q Consensus 131 L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~ 209 (572)
++.+++.+. .+|..+..+++|+.|++++| .++..-+..|.++++|+.|+|++|+++...|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 334444443 34677888999999999876 4886666779999999999999999998888999999999999999999
Q ss_pred CCCCCchhhhhccccCccccCCCccc
Q 038466 210 LSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 210 l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
++. +|.......+|+.|+|++|.+.
T Consensus 92 l~~-l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LES-LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred Ccc-cChhhhccccccccccCCCccc
Confidence 994 5555445558999999999885
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.05 E-value=4.5e-10 Score=103.74 Aligned_cols=107 Identities=31% Similarity=0.468 Sum_probs=52.5
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+..+++|++|++++|.+++..| ++++++|++|++++|.+.. +| .++++++|+.|++++|..... ..+.++++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred cccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhH
Confidence 3445555555555555554322 5555555555555555542 22 244555555555555544332 2244455555
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
.|++++|++.. +| .+..+++|+.|++++|++++
T Consensus 132 ~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 132 RLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp EEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC
T ss_pred Hhhhhhhhhcc-cc-cccccccccccccccccccC
Confidence 55555555442 22 34445555555555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=6.9e-11 Score=105.72 Aligned_cols=124 Identities=20% Similarity=0.151 Sum_probs=96.0
Q ss_pred CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCccee
Q 038466 100 SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIEL 179 (572)
Q Consensus 100 ~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 179 (572)
.+.+|++++.... .+.. .+..+++|+.|+|++|.+... + .+..+++|++|++++|.++...+..+..+++|+.|
T Consensus 19 ~lr~L~L~~n~I~---~i~~-~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 19 RDRELDLRGYKIP---VIEN-LGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp SCEEEECTTSCCC---SCCC-GGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCcEEECCCCCCC---ccCc-cccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 4567777754322 1221 246688999999999999854 3 58999999999999999996555556789999999
Q ss_pred ecccccccCCCC-ccccCCCccCeeEeccCcCCCCCch----hhhhccccCccccC
Q 038466 180 NVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPP----EIAGMKNLTWLDLS 230 (572)
Q Consensus 180 ~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~ls 230 (572)
++++|++...-. ..+..+++|+.|++++|.++. .|. .+..+++|++||-+
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~~ 147 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQ 147 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTE
T ss_pred eeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCCC
Confidence 999999875321 468899999999999999974 443 57889999998843
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=3.1e-10 Score=105.84 Aligned_cols=106 Identities=32% Similarity=0.468 Sum_probs=61.2
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
++.+++|+.|++++|.+++ +| .+.++++|+.|++++|.++. + +.+..+++|+.++++.|.+++ +..++.+++|+
T Consensus 86 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~ 159 (210)
T d1h6ta2 86 LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 159 (210)
T ss_dssp GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCS
T ss_pred cccCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccc
Confidence 4555666666666666554 22 35556666666666665542 2 235555666666666666543 23455666666
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCCCccc
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 235 (572)
.+++++|++++ +++ ++++++|+.|++++|+++
T Consensus 160 ~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 160 TLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp EEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred ccccccccccc-ccc-ccCCCCCCEEECCCCCCC
Confidence 66666666664 332 566666666666666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.00 E-value=3e-12 Score=118.84 Aligned_cols=113 Identities=23% Similarity=0.288 Sum_probs=95.3
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.++.+++|+.|+|++|.+.. ++ .+.+|++|+.|+|++|.++ .+|..+..+++|++|++++|+++. + +.+.++++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence 37788999999999999985 44 5889999999999999998 567666667789999999999875 3 358899999
Q ss_pred CeeEeccCcCCCCCc--hhhhhccccCccccCCCcccCCcc
Q 038466 201 SNLDLSSNKLSGKIP--PEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+.|++++|+++. ++ ..+..+++|+.|++++|.+....+
T Consensus 118 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 118 RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 999999999985 34 468899999999999999876443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.94 E-value=1.4e-09 Score=100.42 Aligned_cols=125 Identities=26% Similarity=0.397 Sum_probs=101.7
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcce
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIE 178 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 178 (572)
..++.|++++.... .+ ..+..+++|+.|++++|.+... | .+.++++|+.|++++|.+... +.+..+++|+.
T Consensus 62 ~nL~~L~Ls~N~l~---~~--~~l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~ 132 (199)
T d2omxa2 62 NNLTQINFSNNQLT---DI--TPLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNR 132 (199)
T ss_dssp TTCCEEECCSSCCC---CC--GGGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred CCcCcCcccccccc---Cc--ccccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHH
Confidence 45777887753211 11 1478999999999999988753 3 489999999999999998853 34788999999
Q ss_pred eecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 179 LNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 179 L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
|++++|++.. +| .+..+++|+.|++++|++++ ++ .++++++|+.|++++|+++.
T Consensus 133 L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 133 LELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp EECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhhhhcc-cc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC
Confidence 9999999864 44 68999999999999999986 44 48899999999999999976
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.91 E-value=1.1e-09 Score=110.97 Aligned_cols=111 Identities=29% Similarity=0.423 Sum_probs=95.1
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.+.. .+.++..++.++++.|.+++ +..+..+++++.|++++|++++.. .+..+++|
T Consensus 258 ~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L 331 (384)
T d2omza2 258 PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKL 331 (384)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTC
T ss_pred cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCC
Confidence 3777899999999999998754 37889999999999999986 345788899999999999998753 38899999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
+.|++++|++++ +| .++++++|++|++++|++++.+|
T Consensus 332 ~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 332 QRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 999999999985 44 68999999999999999998665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.90 E-value=1.9e-09 Score=109.08 Aligned_cols=114 Identities=25% Similarity=0.403 Sum_probs=95.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+++..| ++.+++|+.|++++|.+++.. .+.+++.++.++++.|.+.+ +..+..++++
T Consensus 236 ~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l 309 (384)
T d2omza2 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNL 309 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTC
T ss_pred hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhccc
Confidence 36778999999999999998543 888999999999999998643 37788999999999999986 3458899999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCCCcccCCccccCCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIPVRLSP 244 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~s~ 244 (572)
+.|++++|++++. + .+..+++|+.|++++|++++ +| .++.
T Consensus 310 ~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~ 349 (384)
T d2omza2 310 TYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLAN 349 (384)
T ss_dssp SEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred CeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence 9999999999974 3 38899999999999999986 44 3443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=3.2e-09 Score=100.61 Aligned_cols=145 Identities=21% Similarity=0.187 Sum_probs=72.4
Q ss_pred CCccceeeCCCC----------CEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCch-hccCCccCCEEE
Q 038466 88 CKWEGITCNSAG----------SIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPP-EISALSKLQLLD 156 (572)
Q Consensus 88 c~w~Gv~c~~~~----------~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~-~~~~l~~L~~L~ 156 (572)
|.+..|.|...+ .++.|++++... ..+....|.++++|++|++++|.+...+|. .|.++++++.|+
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i---~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKL---RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCC---CEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcC---CccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 567778885321 344455443211 112222356666667777766666554433 456666666666
Q ss_pred cc-CCcCCCCCCcCCcCCCCcceeecccccccCCCCc-cccCCCccCeeEeccCcCCCCCchhhhhcc-ccCccccCCCc
Q 038466 157 LS-SNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIAGMK-NLTWLDLSNNN 233 (572)
Q Consensus 157 Ls-~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-~L~~L~ls~N~ 233 (572)
+. .|++....+..+.++++|++|++++|++....+. .+..+..+..+..+++.+....+..+..++ .++.|++++|+
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence 54 3556555555666667777777766666432221 122223333333333333322222333332 45556666666
Q ss_pred cc
Q 038466 234 IK 235 (572)
Q Consensus 234 l~ 235 (572)
++
T Consensus 165 l~ 166 (242)
T d1xwdc1 165 IQ 166 (242)
T ss_dssp CC
T ss_pred cc
Confidence 55
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.87 E-value=3e-09 Score=100.09 Aligned_cols=127 Identities=26% Similarity=0.411 Sum_probs=82.2
Q ss_pred CCEEEEEeCCCccCcccccCccccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCC-----------
Q 038466 99 GSIFELYLSGYYAGFNWRLSQLNFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP----------- 167 (572)
Q Consensus 99 ~~v~~l~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip----------- 167 (572)
.++..|++++.... .-..+..+++|+.|++++|.++. ++ .+.++++|+.|++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~-----~~~~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~ 135 (227)
T d1h6ua2 63 NNLIGLELKDNQIT-----DLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135 (227)
T ss_dssp TTCCEEECCSSCCC-----CCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEE
T ss_pred CCCcEeecCCceee-----ccccccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhh
Confidence 45667777642211 01137778888888888887763 33 47788888888888887654311
Q ss_pred ---------cCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhccccCccccCCCcccC
Q 038466 168 ---------PEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 168 ---------~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
..+.++++|+.|++++|.+.... .++++++|+.|++++|++++ +|. ++++++|++|++++|++++
T Consensus 136 ~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp CCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB
T ss_pred chhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC
Confidence 12344566777777777665432 36777777777777777764 433 6677777777777777765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.82 E-value=3.8e-09 Score=98.21 Aligned_cols=103 Identities=29% Similarity=0.410 Sum_probs=88.9
Q ss_pred ccCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCcc
Q 038466 121 NFSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNL 200 (572)
Q Consensus 121 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 200 (572)
.+..+++|+.|++++|.+.. .+.+.++++|+.+++++|.+++ +..+..+++|+++++++|++++ ++ .++++++|
T Consensus 107 ~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L 180 (210)
T d1h6ta2 107 SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKL 180 (210)
T ss_dssp GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTC
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCC
Confidence 37889999999999999864 3468899999999999999985 3457789999999999999986 44 38999999
Q ss_pred CeeEeccCcCCCCCchhhhhccccCccccCC
Q 038466 201 SNLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231 (572)
Q Consensus 201 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~ 231 (572)
+.|++++|.++ .+| .+.++++|++|+|++
T Consensus 181 ~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 181 QNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 99999999998 466 589999999999874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=9.4e-09 Score=96.51 Aligned_cols=102 Identities=27% Similarity=0.455 Sum_probs=81.3
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccC
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLS 201 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 201 (572)
+...+.+..+.++.+.+... ..+.++++|+.|++++|.+++.. .++++++|++|+|++|++++ +| .++++++|+
T Consensus 125 ~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~ 198 (227)
T d1h6ua2 125 LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLI 198 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCC
T ss_pred hccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCC
Confidence 44455666666666666543 34678889999999999998543 48899999999999999986 44 389999999
Q ss_pred eeEeccCcCCCCCchhhhhccccCccccCC
Q 038466 202 NLDLSSNKLSGKIPPEIAGMKNLTWLDLSN 231 (572)
Q Consensus 202 ~L~ls~N~l~g~~p~~~~~l~~L~~L~ls~ 231 (572)
+|+|++|++++ +|+ ++++++|+.|++++
T Consensus 199 ~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 199 EVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp EEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred EEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 99999999985 553 88999999999873
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.60 E-value=1.3e-09 Score=100.46 Aligned_cols=90 Identities=28% Similarity=0.382 Sum_probs=78.6
Q ss_pred CchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchhhhhc
Q 038466 142 IPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAGM 221 (572)
Q Consensus 142 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l 221 (572)
+|.++..|++|++|+|++|+++ .++ .+.+|++|++|+|++|.++ .+|..+..+++|+.|++++|.++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 4678999999999999999998 455 5889999999999999986 577777777899999999999985 4 458899
Q ss_pred cccCccccCCCcccC
Q 038466 222 KNLTWLDLSNNNIKG 236 (572)
Q Consensus 222 ~~L~~L~ls~N~l~g 236 (572)
++|+.|++++|+++.
T Consensus 115 ~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 115 VNLRVLYMSNNKITN 129 (198)
T ss_dssp HHSSEEEESEEECCC
T ss_pred ccccccccccchhcc
Confidence 999999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=3e-08 Score=93.71 Aligned_cols=111 Identities=23% Similarity=0.250 Sum_probs=84.2
Q ss_pred CCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCC-cCCcCCCCcceeeccc-ccccCCCCccccCCCccCee
Q 038466 126 PNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIP-PEIGNLKNLIELNVGS-NSLIGPIPSALGSLTNLSNL 203 (572)
Q Consensus 126 ~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L 203 (572)
+++++|+|++|.++...+..|.++++|++|+|++|.+...+| ..|.+++++++|.+.. |++....+..|.++++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 578999999999987666678899999999999999887654 4578889999988764 67777778888999999999
Q ss_pred EeccCcCCCCCch-hhhhccccCccccCCCcccC
Q 038466 204 DLSSNKLSGKIPP-EIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 204 ~ls~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g 236 (572)
++++|.+....+. .+..+..+..+..+++.+..
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~ 142 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 142 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred ccchhhhccccccccccccccccccccccccccc
Confidence 9999988743222 23345555555556666543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.43 E-value=3e-07 Score=90.96 Aligned_cols=97 Identities=28% Similarity=0.375 Sum_probs=65.6
Q ss_pred CCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEec
Q 038466 127 NLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLS 206 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 206 (572)
+++.|+|++|.++. +|+. +++|++|+|++|+++ .+|..+ .+|+.|++++|+++. ++.. .++|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 56778888887763 5643 457778888888887 667553 467777777777652 3321 1357788888
Q ss_pred cCcCCCCCchhhhhccccCccccCCCcccCC
Q 038466 207 SNKLSGKIPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 207 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
+|.++ .+|. ++.+++|+.|++++|.+.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc
Confidence 88877 4554 56777888888887777643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=3e-07 Score=89.18 Aligned_cols=124 Identities=24% Similarity=0.256 Sum_probs=76.5
Q ss_pred cCCCCCCcEEEccCCcccccCchhccCCccCCEEEccCC-cCCCC-CCcCCcCCCCcceeeccccc--------------
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSN-GLTGT-IPPEIGNLKNLIELNVGSNS-------------- 185 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l~~L~~L~Ls~N~-------------- 185 (572)
+..+++|++|+|+++.+++..+..++.+++|++|+|++| .++.. +..-..++++|++|+++++.
T Consensus 67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~ 146 (284)
T d2astb2 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV 146 (284)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred HHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccc
Confidence 455666777777766666666666666666777776664 34311 11112344555555555431
Q ss_pred ---------------ccC-CCCccccCCCccCeeEeccC-cCCCCCchhhhhccccCccccCC-CcccCCccccCCCC
Q 038466 186 ---------------LIG-PIPSALGSLTNLSNLDLSSN-KLSGKIPPEIAGMKNLTWLDLSN-NNIKGSIPVRLSPN 245 (572)
Q Consensus 186 ---------------l~g-~ip~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~ip~~~s~n 245 (572)
++. .+.....++++|++|++++| .+++..+..+.++++|++|++++ +.+++.....++..
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~ 224 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGC
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcC
Confidence 111 11222356789999999986 57777788889999999999998 46766555555433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=7.2e-08 Score=85.50 Aligned_cols=87 Identities=24% Similarity=0.182 Sum_probs=60.2
Q ss_pred CchhccCCccCCEEEccCCcCCCC--CCcCCcCCCCcceeecccccccCCCCccccCCCccCeeEeccCcCCCCCchh--
Q 038466 142 IPPEISALSKLQLLDLSSNGLTGT--IPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-- 217 (572)
Q Consensus 142 ip~~~~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-- 217 (572)
++....++++|++|+|++|+++.. ++..+..+++|+.|+|++|.++..-+-......+|+.|++++|.++......
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 344445678888888888888753 2344567888888888888887543323444557888888888887655432
Q ss_pred -----hhhccccCccc
Q 038466 218 -----IAGMKNLTWLD 228 (572)
Q Consensus 218 -----~~~l~~L~~L~ 228 (572)
+..+++|+.||
T Consensus 137 y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 137 YISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHTTSTTCCEET
T ss_pred HHHHHHHHCCCCCEEC
Confidence 45678888776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.11 E-value=8e-06 Score=80.21 Aligned_cols=78 Identities=27% Similarity=0.329 Sum_probs=62.4
Q ss_pred CCCCcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCCCCccccCCCccCeeE
Q 038466 125 FPNLVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGPIPSALGSLTNLSNLD 204 (572)
Q Consensus 125 l~~L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 204 (572)
+++|++|+|++|.++ .+|.. +.+|+.|++++|+++ .++. + .+.|++|++++|.+. .+|. ++++++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 578999999999998 66765 457889999999988 4442 2 146999999999987 5664 68899999999
Q ss_pred eccCcCCC
Q 038466 205 LSSNKLSG 212 (572)
Q Consensus 205 ls~N~l~g 212 (572)
+++|.++.
T Consensus 127 l~~~~~~~ 134 (353)
T d1jl5a_ 127 VDNNSLKK 134 (353)
T ss_dssp CCSSCCSC
T ss_pred cccccccc
Confidence 99998874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=6.1e-08 Score=99.55 Aligned_cols=110 Identities=25% Similarity=0.318 Sum_probs=65.1
Q ss_pred CCcEEEccCCcccccC-chhccCCccCCEEEccCCcCCC----CCCcCCcCCCCcceeecccccccCC----CCcccc-C
Q 038466 127 NLVKLTIQFFALTGSI-PPEISALSKLQLLDLSSNGLTG----TIPPEIGNLKNLIELNVGSNSLIGP----IPSALG-S 196 (572)
Q Consensus 127 ~L~~L~l~~n~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~-~ 196 (572)
+|+.|++++|.+++.- ..-+..+++|+.|+|++|.++. .++..+..+++|++|||++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4667777777776531 2334556677777777777652 2333455667777777777766421 111121 1
Q ss_pred CCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccC
Q 038466 197 LTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 197 l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
..+|+.|+|++|.++.. ++..+..+++|++|++++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 24677777777776543 34455566777777777777653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=2.5e-07 Score=81.85 Aligned_cols=107 Identities=22% Similarity=0.213 Sum_probs=72.9
Q ss_pred CcEEEccCCcccccCchhccCCccCCEEEccCCcCCCCCCcCCcCCCCcceeecccccccCC--CCccccCCCccCeeEe
Q 038466 128 LVKLTIQFFALTGSIPPEISALSKLQLLDLSSNGLTGTIPPEIGNLKNLIELNVGSNSLIGP--IPSALGSLTNLSNLDL 205 (572)
Q Consensus 128 L~~L~l~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~l 205 (572)
.+.|+++++... +.+..+..+..|++.+|..+ .++.....+++|++|+|++|+++.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 345555544322 23444455555565555443 3444445789999999999999864 3466788999999999
Q ss_pred ccCcCCCCCchhhhhccccCccccCCCcccCCcc
Q 038466 206 SSNKLSGKIPPEIAGMKNLTWLDLSNNNIKGSIP 239 (572)
Q Consensus 206 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 239 (572)
++|.++..-+-.+....+|+.|++++|.++....
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 9999985333234445679999999999987554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.97 E-value=3.3e-06 Score=81.53 Aligned_cols=110 Identities=18% Similarity=0.233 Sum_probs=71.6
Q ss_pred CCCCCCcEEEccCC-cccc-cCchhccC-CccCCEEEccCC--cCCCC-CCcCCcCCCCcceeecccc-cccCCCCcccc
Q 038466 123 SCFPNLVKLTIQFF-ALTG-SIPPEISA-LSKLQLLDLSSN--GLTGT-IPPEIGNLKNLIELNVGSN-SLIGPIPSALG 195 (572)
Q Consensus 123 ~~l~~L~~L~l~~n-~l~g-~ip~~~~~-l~~L~~L~Ls~N--~l~g~-ip~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~ 195 (572)
..+++|+.|+++++ .++. .++..+.. .++|+.|+++++ .++.. +.....++++|++|++++| .+++..+..++
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~ 197 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 197 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred HHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhc
Confidence 45788888888875 3332 12222333 457888888764 33321 2222345778888888775 46666667778
Q ss_pred CCCccCeeEeccC-cCCCCCchhhhhccccCccccCCC
Q 038466 196 SLTNLSNLDLSSN-KLSGKIPPEIAGMKNLTWLDLSNN 232 (572)
Q Consensus 196 ~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~ls~N 232 (572)
++++|++|+++++ .++......++++++|+.|+++++
T Consensus 198 ~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 198 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 8888888888874 566555666777788888888766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.94 E-value=4.6e-07 Score=90.18 Aligned_cols=113 Identities=20% Similarity=0.208 Sum_probs=65.0
Q ss_pred CCCCCcEEEccCCcccc----cCchhccCCccCCEEEccCCcCCCC-----CCcCCcCCCCcceeecccccccCC----C
Q 038466 124 CFPNLVKLTIQFFALTG----SIPPEISALSKLQLLDLSSNGLTGT-----IPPEIGNLKNLIELNVGSNSLIGP----I 190 (572)
Q Consensus 124 ~l~~L~~L~l~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~-----ip~~~~~l~~L~~L~Ls~N~l~g~----i 190 (572)
..+.|+.|++++|.+.. .+...+..++.|+.|+|++|.++.. +...+..+++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 45566777777766642 2233345566777777777776531 223345566777777777765422 3
Q ss_pred CccccCCCccCeeEeccCcCCCCCchhh----hh--ccccCccccCCCcccC
Q 038466 191 PSALGSLTNLSNLDLSSNKLSGKIPPEI----AG--MKNLTWLDLSNNNIKG 236 (572)
Q Consensus 191 p~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~--l~~L~~L~ls~N~l~g 236 (572)
...+..+++|+.|+|++|.+++.-...+ .. ...|+.|++++|+++.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 3445666777777777777654322222 21 2356777777776643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.78 E-value=1.9e-06 Score=85.53 Aligned_cols=115 Identities=17% Similarity=0.160 Sum_probs=72.6
Q ss_pred cCCCCCCcEEEccCCccc--c--cC---------chhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeecccc
Q 038466 122 FSCFPNLVKLTIQFFALT--G--SI---------PPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNVGSN 184 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~--g--~i---------p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N 184 (572)
+...++|+.|++++|.+. | .+ .......+.|+.|++++|.++.. +...+...++|++|+|++|
T Consensus 117 l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n 196 (344)
T d2ca6a1 117 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 196 (344)
T ss_dssp HHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSS
T ss_pred hcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccc
Confidence 445677888888877652 0 01 11124566788888888877532 2223445677888888888
Q ss_pred cccCC-----CCccccCCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccC
Q 038466 185 SLIGP-----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKG 236 (572)
Q Consensus 185 ~l~g~-----ip~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 236 (572)
++... +...+..+++|+.|+|++|.++.. +...+...++|+.|++++|.+++
T Consensus 197 ~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 197 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp CCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 76532 234466677888888888876532 33445667778888888887764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.71 E-value=2.4e-06 Score=87.16 Aligned_cols=116 Identities=22% Similarity=0.215 Sum_probs=77.4
Q ss_pred cCCCCCCcEEEccCCcccccCchhc-----cCCccCCEEEccCCcCCCCCCcC----CcCCCCcceeecccccccCC---
Q 038466 122 FSCFPNLVKLTIQFFALTGSIPPEI-----SALSKLQLLDLSSNGLTGTIPPE----IGNLKNLIELNVGSNSLIGP--- 189 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~ip~~~-----~~l~~L~~L~Ls~N~l~g~ip~~----~~~l~~L~~L~Ls~N~l~g~--- 189 (572)
+...+.++.+++++|.+...-...+ .....|+.+++++|.++...... +...++|++|+|++|+++..
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc
Confidence 4456778888888888764322221 23457888888888887543222 23456788888888887542
Q ss_pred -CCcccc-CCCccCeeEeccCcCCCC----CchhhhhccccCccccCCCcccCC
Q 038466 190 -IPSALG-SLTNLSNLDLSSNKLSGK----IPPEIAGMKNLTWLDLSNNNIKGS 237 (572)
Q Consensus 190 -ip~~~~-~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~ 237 (572)
++..+. ..+.|+.|+|++|.++.. +++.+...++|++||+++|+++..
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 333343 356788888888888742 445566678888888888888653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=2.9e-05 Score=68.45 Aligned_cols=110 Identities=14% Similarity=0.102 Sum_probs=68.7
Q ss_pred CCCCCcEEEccCC-ccccc----CchhccCCccCCEEEccCCcCCCCC----CcCCcCCCCcceeecccccccCC----C
Q 038466 124 CFPNLVKLTIQFF-ALTGS----IPPEISALSKLQLLDLSSNGLTGTI----PPEIGNLKNLIELNVGSNSLIGP----I 190 (572)
Q Consensus 124 ~l~~L~~L~l~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~i----p~~~~~l~~L~~L~Ls~N~l~g~----i 190 (572)
+.+.|+.|+|+++ .++.. +-..+...+.|+.|+|++|.++... ...+...+.|++|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4577888888864 45421 2334667788888888888886322 22234457788888888877542 2
Q ss_pred CccccCCCccCeeEeccCcCCCC-------CchhhhhccccCccccCCCc
Q 038466 191 PSALGSLTNLSNLDLSSNKLSGK-------IPPEIAGMKNLTWLDLSNNN 233 (572)
Q Consensus 191 p~~~~~l~~L~~L~ls~N~l~g~-------~p~~~~~l~~L~~L~ls~N~ 233 (572)
-..+...++|++|++++|..... +...+..-++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 23455667788888888765531 22333445667777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.42 E-value=0.00024 Score=62.11 Aligned_cols=112 Identities=17% Similarity=0.191 Sum_probs=72.4
Q ss_pred CCCCCCcEEEccC-Ccccc----cCchhccCCccCCEEEccCCcCCCCC----CcCCcCCCCcceeecccccccCC----
Q 038466 123 SCFPNLVKLTIQF-FALTG----SIPPEISALSKLQLLDLSSNGLTGTI----PPEIGNLKNLIELNVGSNSLIGP---- 189 (572)
Q Consensus 123 ~~l~~L~~L~l~~-n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~i----p~~~~~l~~L~~L~Ls~N~l~g~---- 189 (572)
.+.+.|+.|+|++ +.++. .+-..+...++|+.|+|++|.++... -..+...++++.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4567888888886 44542 12344567788999999999886432 22344567888888888877532
Q ss_pred CCccccCCCccCeeEe--ccCcCCC----CCchhhhhccccCccccCCCcc
Q 038466 190 IPSALGSLTNLSNLDL--SSNKLSG----KIPPEIAGMKNLTWLDLSNNNI 234 (572)
Q Consensus 190 ip~~~~~l~~L~~L~l--s~N~l~g----~~p~~~~~l~~L~~L~ls~N~l 234 (572)
+-..+...++|+.++| +.|.+.. .+...+...++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2245566778886555 4566643 2344455677888888876654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.39 E-value=0.00039 Score=60.86 Aligned_cols=89 Identities=10% Similarity=0.147 Sum_probs=63.3
Q ss_pred cCCccCCEEEccCC-cCCCC----CCcCCcCCCCcceeecccccccC----CCCccccCCCccCeeEeccCcCCCCC---
Q 038466 147 SALSKLQLLDLSSN-GLTGT----IPPEIGNLKNLIELNVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGKI--- 214 (572)
Q Consensus 147 ~~l~~L~~L~Ls~N-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~~--- 214 (572)
.+.++|+.|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|+.|+|++|.++..-
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45689999999974 46532 22335667889999999998863 23345566789999999999987432
Q ss_pred -chhhhhccccCccccCCCccc
Q 038466 215 -PPEIAGMKNLTWLDLSNNNIK 235 (572)
Q Consensus 215 -p~~~~~l~~L~~L~ls~N~l~ 235 (572)
-..+..-++|+.|++++|...
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 123444567999999988654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.21 E-value=0.0073 Score=52.09 Aligned_cols=89 Identities=19% Similarity=0.210 Sum_probs=65.0
Q ss_pred cCCCCCCcEEEccCCccccc----CchhccCCccCCEEEccCCcCCCC----CCcCCcCCCCcceeec--ccccccC---
Q 038466 122 FSCFPNLVKLTIQFFALTGS----IPPEISALSKLQLLDLSSNGLTGT----IPPEIGNLKNLIELNV--GSNSLIG--- 188 (572)
Q Consensus 122 ~~~l~~L~~L~l~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~L--s~N~l~g--- 188 (572)
+...++|+.|++++|.++.. +-..+...+.|+.|++++|.++.. +-..+...++|+.++| ++|.+..
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 56778999999999988753 233456778999999999998743 2244566788887555 5666643
Q ss_pred -CCCccccCCCccCeeEeccCcC
Q 038466 189 -PIPSALGSLTNLSNLDLSSNKL 210 (572)
Q Consensus 189 -~ip~~~~~l~~L~~L~ls~N~l 210 (572)
.+...+...++|+.|+++.+..
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCcCEEeCcCCCC
Confidence 3445567789999999987754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=92.98 E-value=0.3 Score=44.29 Aligned_cols=97 Identities=14% Similarity=0.071 Sum_probs=65.0
Q ss_pred eeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCeEEEEEecccCCChhhhhh
Q 038466 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMKRGSLFCNLH 396 (572)
Q Consensus 318 fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l~ 396 (572)
.+.||+....++ .+.+|+........ ...+.+|...+..+. +--+-++++++.+++..++|||++++.++.+...
T Consensus 27 ~~~v~rv~~~~~-~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 27 PAKVYKLVGENE-NLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SSEEEEEECSSC-EEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCcEEEEEeCCC-eEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 468999876544 56677765433221 124567777777664 3335677888888899999999999988865443
Q ss_pred cCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 397 NNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 397 ~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
.. .. +..++.++++.++-||+.
T Consensus 103 ~~-----~~---~~~~~~~l~~~l~~lH~~ 124 (263)
T d1j7la_ 103 DE-----QS---PEKIIELYAECIRLFHSI 124 (263)
T ss_dssp TC-----SC---HHHHHHHHHHHHHHHHTS
T ss_pred cc-----cc---HHHHHHHHHHHHHHHhcc
Confidence 21 11 334677888999999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.45 E-value=0.14 Score=46.43 Aligned_cols=92 Identities=17% Similarity=0.185 Sum_probs=63.6
Q ss_pred eeEEEEEEcCCCcEEEEEecCCcchHHHHHHHHHHHHHHHHHhcCCCC--cccEEEEEEeCCeEEEEEecccCCChhhhh
Q 038466 318 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLYGFCLHRKCMFLIYEYMKRGSLFCNL 395 (572)
Q Consensus 318 fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~l 395 (572)
-+.||+...++|..+.+|.-...... .+..|++.++.+.... +-++++++.+++..++||||+++-++.+.
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~- 96 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS- 96 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS-
T ss_pred CCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc-
Confidence 36799999888888888986654322 3456777777664433 45678888888899999999998765331
Q ss_pred hcCCCcccCCHHHHHHHHHHHHHHHHHHhcC
Q 038466 396 HNNEDAVELDWAKRVNIVKAMAHALAYLHHD 426 (572)
Q Consensus 396 ~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~ 426 (572)
... ....+.++++.++-||+-
T Consensus 97 -------~~~---~~~~~~~l~~~la~LH~~ 117 (255)
T d1nd4a_ 97 -------HLA---PAEKVSIMADAMRRLHTL 117 (255)
T ss_dssp -------CCC---HHHHHHHHHHHHHHHTTS
T ss_pred -------ccc---HHHHHHHHHHHHHHHccC
Confidence 111 233456777888899963
|